data_1b6f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1b6f _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.522 HG12 ' ND1' ' A' ' 121' ' ' HIS . 5.1 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.748 0.785 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -108.89 158.45 17.66 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.736 -0.602 . . . . 0.0 109.717 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.68 140.09 51.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.024 -1.048 . . . . 0.0 110.894 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.575 ' CZ ' HG12 ' A' ' 133' ' ' VAL . 9.8 m-85 -146.52 61.99 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 12.9 pt-20 -87.59 157.48 19.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 111.129 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -156.64 174.93 14.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 0.0 109.944 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.71 150.38 19.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 110.231 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 m -145.29 168.15 21.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.295 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.91 164.29 12.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.218 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -157.68 144.46 18.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.426 -0.796 . . . . 0.0 109.855 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 15.1 t -79.8 -7.63 10.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.839 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.534 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 30.2 mm -78.85 146.87 69.44 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.93 145.94 81.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.659 1.347 . . . . 0.0 111.331 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.532 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -66.86 -28.41 68.32 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.54 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.95 2.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.943 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -58.53 -37.04 74.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.728 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 5.6 tt -68.44 -39.44 81.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.007 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CE1' HG12 ' A' ' 23' ' ' ILE . 80.8 t80 -60.84 -65.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 109.983 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -43.04 -49.26 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.24 96.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.873 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.95 -9.17 52.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.232 -0.917 . . . . 0.0 110.811 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.538 HG13 ' CG ' ' A' ' 81' ' ' TYR . 1.2 mp -118.16 -69.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.988 -1.07 . . . . 0.0 110.191 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 mt -60.69 -43.42 97.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.57 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.36 13.42 16.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.88 -59.66 10.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.447 ' O ' HG22 ' A' ' 41' ' ' VAL . 85.3 m-20 -52.21 -29.07 20.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -1.161 . . . . 0.0 110.304 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -86.29 -28.93 23.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.424 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.68 -21.73 25.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.312 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.536 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -54.02 -57.55 17.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.533 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -73.34 -0.07 8.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.95 1.5 . . . . 0.0 110.832 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.44 -59.12 1.76 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.436 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -90.7 12.91 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.356 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.448 ' HB2' ' HB1' ' A' ' 37' ' ' ALA . . . -159.77 75.87 3.0 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.297 -0.877 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.36 -7.97 21.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.008 1.53 . . . . 0.0 110.716 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -100.79 0.05 38.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 110.262 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.459 ' HA ' HD22 ' A' ' 139' ' ' LEU . . . -107.28 -69.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.167 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mt -119.14 135.13 60.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.868 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 -49.94 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.316 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.477 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -157.09 171.33 20.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 110.304 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 27' ' ' ASP . 40.6 t -129.81 140.52 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' CB ' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -133.28 84.27 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.406 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -50.4 117.74 2.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 0.0 110.283 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.532 HG22 HD11 ' A' ' 44' ' ' ILE . 12.5 mt -88.58 -37.83 10.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.271 1.034 . . . . 0.0 108.666 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 . . . . . 0 C--N 1.294 -1.813 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.335 -179.807 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.9 Cg_endo -73.09 129.43 14.13 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.028 1.541 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.62 -3.92 81.79 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.56 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.1 m -63.68 154.66 32.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -1.215 . . . . 0.0 109.255 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.494 HD12 ' NE ' ' A' ' 70' ' ' ARG . 8.7 mm -124.81 127.69 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -139.7 136.91 34.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.299 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HB3' ' CB ' ' A' ' 42' ' ' GLU . 22.1 tttt -80.5 98.41 7.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 110.297 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 56' ' ' ILE . 43.6 mm -86.7 134.81 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -103.76 145.94 29.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.199 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -118.33 131.55 24.17 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.213 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 44.9 Cg_endo . . . . . 0 C--N 1.306 -1.668 0 O-C-N 123.953 1.501 . . . . 0.0 110.574 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 57' ' ' SER . 20.3 p90 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.26 0.552 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -178.45 171.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.278 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -90.14 -61.76 1.61 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.513 -0.742 . . . . 0.0 109.598 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 68' ' ' LYS . 7.6 t70 59.2 124.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.494 ' NE ' HD12 ' A' ' 53' ' ' ILE . 1.8 ttt180 -110.78 147.85 33.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.56 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 3.5 t -67.02 152.03 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.481 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 7.7 t70 -99.95 -71.4 0.7 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.311 0.577 . . . . 0.0 110.459 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -145.85 104.19 3.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.439 -0.788 . . . . 0.0 109.985 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.57 HG23 ' CE1' ' A' ' 81' ' ' TYR . 18.6 t -92.78 149.88 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.265 -0.897 . . . . 0.0 110.324 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -148.42 101.62 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 109.927 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.462 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 m-70 -76.23 1.18 16.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.584 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -116.5 -44.61 2.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.058 -1.026 . . . . 0.0 110.041 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.13 15.06 9.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.435 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.504 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 20.0 m-30 51.49 54.43 11.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.911 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -126.62 126.55 43.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CE1' HG23 ' A' ' 74' ' ' VAL . 28.1 t80 -143.34 97.94 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.499 ' ND2' ' OE2' ' A' ' 101' ' ' GLU . 9.4 m-20 -114.37 146.48 40.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 23.6 p90 -142.22 139.96 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.864 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 50.5 m -106.04 164.91 11.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.095 -1.003 . . . . 0.0 110.928 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.533 HG13 ' CD1' ' A' ' 91' ' ' ILE . 24.4 t -103.06 130.2 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -126.96 -68.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.287 -178.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 1.4 tt0 -91.93 78.83 5.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.621 -1.3 . . . . 0.0 110.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -94.8 153.03 20.75 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.522 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.46 -57.99 4.83 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -72.44 -41.56 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.545 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.533 ' CD1' HG13 ' A' ' 85' ' ' VAL . 48.8 mt -61.62 134.3 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.23 -39.34 0.75 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -120.8 -84.14 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -1.091 . . . . 0.0 110.008 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 t -150.83 14.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 123' ' ' LYS . 18.5 mt -88.81 156.92 18.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -0.969 . . . . 0.0 110.077 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-10 54.56 34.28 20.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.12 -0.987 . . . . 0.0 109.48 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -77.02 170.3 16.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 -179.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.64 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 4.6 mp -143.11 125.15 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.478 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 11.2 t -117.35 109.86 17.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.57 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 3.1 t-20 -98.92 169.94 9.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 117' ' ' SER . 18.6 mt-10 -152.38 130.11 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.777 -0.577 . . . . 0.0 109.565 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.5 mt -121.14 132.41 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 110.459 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HD2' ' HD2' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -139.61 122.54 16.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.467 ' CG2' ' HB3' ' A' ' 15' ' ' ALA . 3.3 mp -108.92 144.23 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.363 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.423 HG21 ' C ' ' A' ' 104' ' ' ILE . 55.0 t -145.67 117.94 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.532 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -71.47 146.23 48.73 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.347 0.594 . . . . 0.0 110.554 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.024 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 106' ' ' ALA . 7.6 t -141.78 -175.89 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.998 . . . . 0.0 110.525 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.418 ' N ' ' OG ' ' A' ' 112' ' ' SER . 19.9 mt -134.99 128.19 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 109.599 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 pp -108.81 139.39 43.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -123.79 113.92 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.77 115.13 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.797 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.524 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -103.4 135.92 44.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -126.71 144.25 50.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.144 -0.973 . . . . 0.0 110.815 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -126.55 150.9 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 109.884 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -131.57 105.65 7.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.522 ' ND1' HG12 ' A' ' 2' ' ' VAL . 24.1 m-70 -86.0 125.29 33.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 110.605 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.455 HG22 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.3 167.86 12.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.435 ' HB2' HD21 ' A' ' 95' ' ' LEU . 19.1 tptt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.33 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.364 0.602 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 128' ' ' VAL . 2.1 t -121.8 99.5 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.434 -0.791 . . . . 0.0 109.89 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -64.46 125.81 25.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -42.57 -34.79 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.8 mp0 -39.83 -70.36 0.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.306 -0.871 . . . . 0.0 110.872 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -27.83 38.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.568 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.575 HG12 ' CZ ' ' A' ' 5' ' ' TYR . 21.4 t -74.91 -49.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -30.86 70.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.515 -0.741 . . . . 0.0 109.792 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.81 -30.42 61.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.623 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.0 t -73.39 -37.69 65.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.412 -0.805 . . . . 0.0 109.682 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -68.89 -38.31 79.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.6 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -68.0 -40.26 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 37' ' ' ALA . 1.1 tp -72.83 -40.42 65.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.827 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.43 97.77 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.5 mm-40 -65.95 -34.72 78.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -1.133 . . . . 0.0 109.917 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 75.2 m -67.98 -29.96 69.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.927 . . . . 0.0 109.723 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 71.9 mt -70.25 -46.54 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.497 ' HG ' ' N ' ' A' ' 145' ' ' ARG . 1.0 OUTLIER -67.3 -30.84 70.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.745 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.497 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 4.5 ttt180 -79.5 -32.93 42.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 0.0 109.938 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.67 98.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.85 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.27 -47.49 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 110.007 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -56.98 -43.3 81.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.5 t -60.72 -49.82 75.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.647 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.3 t80 -52.35 -70.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.838 . . . . 0.0 110.473 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.466 ' HB3' ' CD1' ' A' ' 13' ' ' ILE . 1.2 mt -40.6 -35.43 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 110.684 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -25.09 50.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.007 . . . . 0.0 110.498 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 110.461 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.565 HG23 ' CE1' ' A' ' 121' ' ' HIS . 2.7 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.494 0.664 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -100.91 137.5 39.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.384 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.24 146.8 44.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 110.91 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -152.29 56.63 0.82 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.472 0.654 . . . . 0.0 109.298 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.528 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 4.9 pt-20 -80.19 153.2 28.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 110.368 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -149.7 -175.6 5.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.882 . . . . 0.0 110.099 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -159.45 162.52 35.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.7 -176.24 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.07 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.453 HG21 HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -133.67 159.61 40.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.483 ' HB3' ' CG ' ' A' ' 148' ' ' GLU . 3.7 m -160.03 145.51 15.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 109.991 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.457 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 11.9 t -79.93 -7.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.41 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.544 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 41.7 mm -77.1 148.2 77.94 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.46 150.47 84.22 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 123.589 1.31 . . . . 0.0 111.063 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.438 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.15 -49.95 8.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.92 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.435 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 8.0 tpt180 -67.15 -34.33 77.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.712 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 5.8 tt -76.92 -35.41 57.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.47 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 75.2 t80 -61.12 -57.76 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.867 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 27.3 mttp -58.2 -41.21 83.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.828 . . . . 0.0 109.96 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 17' ' ' ARG . . . -70.68 -32.91 70.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 7.9 t80 -87.98 -15.82 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.883 . . . . 0.0 110.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 1.1 mp -120.15 -58.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.092 -1.005 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' CE1' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -63.05 -37.25 86.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.344 -0.848 . . . . 0.0 110.687 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -110.11 -0.81 17.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -46.0 -48.51 14.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -56.46 -17.21 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.307 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -113.1 -19.77 11.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.297 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.99 -33.76 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.736 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.549 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -63.25 -58.21 17.0 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.701 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -76.7 46.11 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.825 1.434 . . . . 0.0 111.347 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.32 -54.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.921 -1.112 . . . . 0.0 110.397 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 146' ' ' ALA . 9.9 p -84.85 -26.0 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.48 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.62 75.61 79.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.385 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.59 -3.98 14.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.389 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -91.21 -12.72 34.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.24 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.51 -72.65 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.908 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -105.78 154.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.439 -0.788 . . . . 0.0 109.5 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 8.1 t -100.85 -56.44 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 110.415 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 36.5 m -153.55 175.34 13.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 110.489 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 25.8 t -138.53 143.5 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.889 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -145.82 99.82 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.152 -0.967 . . . . 0.0 110.658 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.493 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 90.5 m-20 -58.36 117.33 4.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 42' ' ' GLU . 22.8 mm -85.87 -38.07 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.366 1.079 . . . . 0.0 108.301 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 52' ' ' THR . 61.5 tt0 . . . . . 0 C--N 1.295 -1.772 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.084 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.31 124.05 7.55 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.018 1.536 . . . . 0.0 110.437 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.74 -3.0 70.57 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.552 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.2 m -61.43 152.13 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -1.164 . . . . 0.0 109.787 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 10.4 mt -112.75 136.48 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 110.327 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 2.7 ptmt -153.13 139.18 18.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.229 -0.92 . . . . 0.0 110.305 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HG3' ' CD1' ' A' ' 66' ' ' TYR . 15.6 ttpp -91.67 109.28 20.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.457 HD11 ' OD1' ' A' ' 69' ' ' ASP . 96.7 mt -98.6 120.89 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.928 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 39' ' ' SER . 54.3 m -77.3 133.78 38.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.857 . . . . 0.0 110.46 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.29 140.05 22.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.025 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.72 -179.841 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' CD1' ' HG3' ' A' ' 55' ' ' LYS . 5.0 p90 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.869 0.843 . . . . 0.0 112.065 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.568 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -148.54 175.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -123.48 50.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.795 -1.191 . . . . 0.0 111.124 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.457 ' OD1' HD11 ' A' ' 56' ' ' ILE . 11.8 p-10 -61.78 131.03 48.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.943 . . . . 0.0 109.99 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -96.61 -179.22 4.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.552 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 3.0 t -90.27 151.39 3.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 120.916 -1.115 . . . . 0.0 109.891 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -100.44 -73.23 0.65 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.524 0.678 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -137.44 132.59 33.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.126 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.463 HG22 HG13 ' A' ' 71' ' ' VAL . 2.6 t -119.14 146.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 0.0 110.117 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.529 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -150.09 110.9 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.907 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.479 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -76.64 -12.84 60.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -109.94 -39.78 4.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.028 -1.045 . . . . 0.0 109.836 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -88.2 15.93 6.89 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.302 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 19.6 m-85 42.23 57.21 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.2 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.73 115.68 21.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.982 . . . . 0.0 110.679 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.439 ' HB2' HG12 ' A' ' 23' ' ' ILE . 13.1 t80 -135.82 102.17 4.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.505 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 32.7 m-20 -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.099 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.631 ' CE2' ' CB ' ' A' ' 100' ' ' ASN . 2.8 p90 -137.93 145.16 41.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.6 m -105.38 155.43 19.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.277 -0.889 . . . . 0.0 111.451 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.511 HG13 ' CD1' ' A' ' 91' ' ' ILE . 38.2 t -100.07 122.13 51.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -120.98 -66.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 111.531 -178.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HB2' ' CB ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -80.5 52.66 1.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.674 -1.266 . . . . 0.0 109.917 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -63.65 125.64 33.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -38.58 -58.46 1.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -72.88 -26.6 15.39 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.866 1.456 . . . . 0.0 110.555 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.511 ' CD1' HG13 ' A' ' 85' ' ' VAL . 17.9 mt -69.75 161.69 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.75 -51.95 0.08 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.444 ' C ' ' HG ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -87.6 50.66 2.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.091 -1.241 . . . . 0.0 110.593 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 49.23 24.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.528 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.478 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -118.56 175.43 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.948 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' O ' HD12 ' A' ' 91' ' ' ILE . 4.0 mt-10 54.89 32.6 18.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -80.02 159.39 26.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.409 -0.807 . . . . 0.0 110.069 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 97' ' ' LYS . 17.1 mt -143.03 137.09 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.687 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.48 94.45 4.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.76 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.631 ' CB ' ' CE2' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -84.31 141.31 31.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 2.5 mt-10 -128.28 146.37 50.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 110.168 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.4 mt -137.15 125.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 0.0 110.236 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.516 ' HE3' ' CG2' ' A' ' 105' ' ' VAL . 11.9 tttt -124.89 157.43 35.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 10.5 mt -148.09 119.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 110.495 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.516 ' CG2' ' HE3' ' A' ' 103' ' ' LYS . 83.6 t -118.52 129.63 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.414 -0.804 . . . . 0.0 109.987 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.529 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -80.59 154.18 27.59 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.414 0.626 . . . . 0.0 110.767 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.868 -179.923 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 3.8 t -147.45 -174.86 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -1.031 . . . . 0.0 110.593 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 105' ' ' VAL . 68.4 mt -138.63 136.58 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.8 . . . . 0.0 109.383 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.505 ' N ' HD13 ' A' ' 114' ' ' LEU . 6.5 mp -105.19 136.29 44.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.08 104.23 8.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.438 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 5.4 mp -99.56 139.55 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.83 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -126.54 105.82 9.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.42 -0.8 . . . . 0.0 110.081 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -98.43 142.49 29.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.219 -0.925 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.0 OUTLIER -135.97 127.57 28.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CD2' HG23 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -111.8 123.41 50.18 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.151 -0.968 . . . . 0.0 110.014 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.565 ' CE1' HG23 ' A' ' 2' ' ' VAL . 43.9 m-70 -104.51 116.39 32.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.853 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.439 HG22 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -112.14 169.36 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 109.777 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 110.243 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.421 ' CA ' HG23 ' A' ' 122' ' ' THR . 1.4 pm0 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.115 0.483 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.524 ' CG1' HG23 ' A' ' 133' ' ' VAL . 4.6 t -113.93 96.3 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -64.3 127.24 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.966 . . . . 0.0 109.385 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.73 -46.3 63.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.983 . . . . 0.0 110.458 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.456 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 6.9 tp10 -41.27 -47.68 3.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.012 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -70.3 -31.55 68.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 108.818 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 130' ' ' ALA . 14.5 t -74.05 -47.97 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 109.31 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -66.48 -30.78 71.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.197 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 131' ' ' GLU . . . -72.14 -27.92 62.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -72.78 -40.6 65.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 110.365 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -77.24 -22.07 52.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 0.0 110.254 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.64 -57.46 11.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.335 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 142' ' ' THR . 38.6 mt -70.88 -42.05 70.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.219 -0.926 . . . . 0.0 110.429 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 139' ' ' LEU . . . -41.53 -44.63 4.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.499 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.3 tt0 -57.75 -36.28 71.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -1.2 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 139' ' ' LEU . 92.8 m -67.97 -22.0 65.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 64.4 mt -76.39 -49.99 15.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.921 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.499 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.38 -23.81 65.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.25 -38.17 22.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.964 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.449 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . . . -60.77 -39.97 90.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -0.915 . . . . 0.0 109.514 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.47 ' O ' HD13 ' A' ' 151' ' ' LEU . 40.2 t -71.36 -52.77 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.483 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.412 -0.805 . . . . 0.0 109.571 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -50.95 69.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.54 -70.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.295 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.479 ' CB ' HD13 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.066 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -61.83 -43.81 98.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.456 HG23 ' CE1' ' A' ' 121' ' ' HIS . 2.4 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.447 0.642 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.13 154.29 17.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.673 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -127.26 149.34 50.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.911 -1.118 . . . . 0.0 111.038 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 40.9 m-85 -158.29 61.31 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.668 -0.645 . . . . 0.0 109.438 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 19.5 pt-20 -85.62 148.63 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 110.948 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.48 173.87 13.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 0.0 109.63 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.2 pm0 -147.61 169.98 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 0.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 152.12 29.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.746 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.53 161.57 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 110.552 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.465 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 9.4 t -159.85 138.16 10.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.639 -0.663 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 t -80.04 -14.25 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.866 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 44.3 mm -72.01 148.02 91.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.4 Cg_endo -66.85 150.07 83.22 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.432 1.228 . . . . 0.0 111.112 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 19' ' ' PHE . . . -76.05 -29.42 58.02 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.405 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.81 -54.55 13.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.898 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.429 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 5.5 ttm180 -66.7 -35.69 80.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.437 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 11.3 tp -75.25 -32.9 61.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 0.0 109.984 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 55.3 t80 -64.2 -68.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -52.75 -38.62 61.18 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.514 -0.741 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 -37.37 69.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 47.7 t80 -82.64 -20.79 35.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 19' ' ' PHE . 1.1 mp -110.84 -69.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.834 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -49.24 -41.42 37.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 110.1 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.6 0.65 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.187 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.93 -52.69 29.61 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -47.86 -29.36 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -101.42 -29.64 11.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 0.0 110.269 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -80.56 -21.09 42.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.7 m-85 -66.1 -60.77 6.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.388 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -72.4 -0.11 8.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.989 1.521 . . . . 0.0 110.784 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -101.78 -48.74 4.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.035 -1.04 . . . . 0.0 110.562 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 29' ' ' LEU . 17.0 m -91.44 7.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 110.6 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 75.39 3.34 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.143 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.33 -9.65 24.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.082 1.569 . . . . 0.0 110.69 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -92.81 -8.08 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 110.232 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -102.5 -72.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.016 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.48 131.33 57.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.443 -0.786 . . . . 0.0 109.758 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.07 -34.9 37.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 110.208 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 p -178.09 157.77 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.44 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 60.5 t -117.49 152.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 109.982 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.9 tm-20 -139.05 89.68 2.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 15.9 t-20 -56.52 115.84 2.76 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.914 0.864 . . . . 0.0 110.532 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' ILE . 6.0 mt -87.55 -39.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.902 0.858 . . . . 0.0 109.081 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' O ' HG22 ' A' ' 52' ' ' THR . 14.1 mt-10 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.833 0.825 . . . . 0.0 111.689 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.3 Cg_endo -72.65 128.7 13.7 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.009 1.531 . . . . 0.0 110.529 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.21 -7.17 62.04 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.513 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 2.3 m -69.76 144.42 52.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -1.164 . . . . 0.0 109.886 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' ILE . 7.5 mt -114.55 141.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.936 -1.103 . . . . 0.0 109.264 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -153.38 134.43 14.01 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 110.069 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -86.49 116.78 24.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 111.041 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 56.0 mt -104.69 123.73 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.402 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 35.2 m -93.07 141.4 28.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 110.594 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -110.16 154.41 42.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.922 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.512 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 44.5 Cg_endo . . . . . 0 C--N 1.304 -1.813 0 O-C-N 124.0 1.526 . . . . 0.0 110.381 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 6.4 p90 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.972 0.892 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 1.9 m -166.84 167.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HD2' ' CB ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -99.3 -64.75 1.01 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.613 -1.304 . . . . 0.0 110.017 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 68' ' ' LYS . 9.2 m-20 59.08 129.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.888 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -112.56 149.56 32.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 108.908 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.513 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 11.6 t -65.12 153.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.864 -1.147 . . . . 0.0 110.268 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.5 t70 -104.69 -75.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.407 0.622 . . . . 0.0 110.038 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -137.13 128.45 28.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.568 HG21 ' CD2' ' A' ' 81' ' ' TYR . 4.1 t -119.19 142.89 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -144.37 114.8 7.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -81.08 -10.58 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -108.93 -39.11 5.41 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.071 -1.018 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.64 9.27 27.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.518 -0.739 . . . . 0.0 109.997 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 48.32 51.41 15.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.185 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.92 117.54 24.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.269 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.568 ' CD2' HG21 ' A' ' 74' ' ' VAL . 45.9 t80 -137.83 106.16 5.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.773 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 35.2 m-20 -119.61 152.35 37.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.229 -0.919 . . . . 0.0 110.331 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 11.5 p90 -142.79 136.46 28.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' ARG . 50.4 m -95.6 168.13 10.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.117 -0.989 . . . . 0.0 111.132 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.531 HG13 ' CD1' ' A' ' 91' ' ' ILE . 53.8 t -107.98 123.94 63.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -74.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.815 -1.178 . . . . 0.0 111.451 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.538 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 2.8 mm-40 -91.87 71.65 5.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.195 . . . . 0.0 110.131 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.439 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . -151.24 161.54 29.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 52.55 -157.95 3.76 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.85 -0.86 10.96 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.032 1.543 . . . . 0.0 111.197 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' CD1' HG13 ' A' ' 85' ' ' VAL . 50.0 mt -51.13 156.35 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.48 -58.0 0.2 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.2 p-10 -146.23 -49.09 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -1.162 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 t -145.08 12.45 1.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.81 144.94 28.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.408 ' HA ' HG22 ' A' ' 122' ' ' THR . 2.7 tt0 55.99 33.4 21.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 109.859 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.492 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -70.48 150.43 46.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.639 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mt -132.62 134.43 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.364 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -118.78 107.64 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.043 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.496 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 18.4 m-80 -92.73 127.93 38.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.305 -0.872 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.475 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 4.1 mt-10 -121.22 143.9 48.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 116' ' ' ILE . 58.0 mt -137.63 129.59 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.469 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 ttpt -124.82 142.46 51.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.653 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.543 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 84.1 mt -130.65 103.98 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.471 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 106' ' ' ALA . 73.4 t -108.7 146.2 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.06 159.69 18.14 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.728 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 110.274 -179.884 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -135.75 -176.52 4.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -1.089 . . . . 0.0 110.513 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 33.6 mt -136.5 117.55 18.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -88.63 124.31 33.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 110.626 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 7.0 ttmt -116.14 100.02 7.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.78 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 102' ' ' ILE . 28.7 mt -96.48 139.57 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.395 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.475 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -122.16 109.3 14.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.2 t-20 -98.17 131.34 44.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.993 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 138.09 49.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.639 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.51 141.41 43.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.492 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 49.2 m-70 -123.37 95.99 4.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.408 HG22 ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -118.06 172.15 7.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 tttp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 110.14 -179.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.109 0.48 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.559 HG22 ' CG ' ' A' ' 120' ' ' TYR . 4.4 t -116.68 99.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.165 -0.959 . . . . 0.0 110.449 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.483 ' CD ' ' HB2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -68.06 146.74 53.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.993 . . . . 0.0 109.498 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 134' ' ' LYS . . . -66.59 -9.66 37.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.971 -1.081 . . . . 0.0 110.808 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.483 ' HB2' ' CD ' ' A' ' 129' ' ' LYS . 12.9 mt-10 -68.0 -54.58 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.994 -1.066 . . . . 0.0 109.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.14 -23.7 63.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.89 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.48 ' CG2' ' CG1' ' A' ' 128' ' ' VAL . 17.5 t -80.85 -46.59 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 130' ' ' ALA . 27.8 tttt -64.27 -26.02 68.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.955 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.41 74.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.885 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -75.91 -40.41 54.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -47.5 -69.43 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.7 -22.74 63.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.169 -0.957 . . . . 0.0 109.902 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.17 -32.86 51.11 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 34.8 mt-10 -72.46 -61.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -1.095 . . . . 0.0 110.082 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 141' ' ' GLU . 3.0 m -45.62 -33.37 2.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.904 -1.123 . . . . 0.0 109.708 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.54 -59.38 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.856 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.8 pp -65.9 -24.64 66.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -81.96 -29.23 32.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.47 -38.44 77.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.675 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.47 -44.91 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -56.29 -46.08 79.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.573 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.4 OUTLIER -64.24 -49.76 70.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.733 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -47.71 -71.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 110.038 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.22 -37.21 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.379 -0.825 . . . . 0.0 110.298 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 149' ' ' SER . 5.3 mt -59.33 -23.66 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 110.507 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 3' ' ' PHE . 2.9 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.403 0.62 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.471 ' N ' HG11 ' A' ' 2' ' ' VAL . 23.1 m-85 -95.28 155.01 16.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.626 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.64 140.97 51.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.718 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CE2' HG12 ' A' ' 133' ' ' VAL . 20.2 m-85 -149.32 61.53 1.03 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.398 -0.813 . . . . 0.0 109.723 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.0 148.44 26.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.862 . . . . 0.0 110.915 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 116' ' ' ILE . 3.1 p -151.8 175.24 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.793 . . . . 0.0 109.565 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 11.8 pt-20 -155.26 146.42 22.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.93 -1.106 . . . . 0.0 110.621 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 m -129.26 143.18 50.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 110.019 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -82.06 159.69 23.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.416 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 m -156.77 136.91 12.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 m -79.98 -16.37 12.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.09 -1.006 . . . . 0.0 108.66 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 26.0 mm -67.03 149.44 98.51 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.69 150.55 83.59 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.509 1.268 . . . . 0.0 110.875 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.51 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -76.81 -27.02 55.05 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.57 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.07 -52.57 9.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 0.0 109.396 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 9.8 tt -75.5 -42.45 52.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.523 -0.735 . . . . 0.0 109.829 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 79' ' ' PHE . 51.0 t80 -56.65 -62.23 1.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 0.0 110.17 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -53.41 -45.61 69.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.81 . . . . 0.0 110.277 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.49 65.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.459 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 5.8 t80 -88.13 -22.98 23.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.435 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.455 HD11 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -112.18 -58.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -60.23 -30.35 69.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.876 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -122.24 11.65 10.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.935 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.23 -54.52 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 36.2 p-10 -55.44 -25.55 36.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -1.179 . . . . 0.0 110.393 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.415 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 37.2 m-20 -92.99 -41.21 10.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -72.99 -31.31 64.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 110.524 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.0 m-85 -50.17 -61.96 3.14 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -72.4 -7.46 20.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.84 1.442 . . . . 0.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -93.42 -67.2 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.397 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 m -88.98 -0.29 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.339 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 35' ' ' PRO . . . -146.8 56.33 2.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 110.344 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 34' ' ' ALA . 45.4 Cg_endo -71.88 -23.19 22.48 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.335 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.84 -16.92 61.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.45 ' O ' ' HD3' ' A' ' 59' ' ' PRO . . . -96.66 -58.74 1.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.195 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.446 HD11 ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -110.47 137.78 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.969 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.15 -52.59 6.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 110.353 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.71 -179.23 7.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.192 -0.942 . . . . 0.0 110.453 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 p -159.94 112.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.3 145.68 44.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.896 . . . . 0.0 110.044 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.542 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 1.4 m120 -93.88 121.95 35.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.684 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 44' ' ' ILE . 25.4 mm -83.8 -37.59 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.345 1.069 . . . . 0.0 108.363 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--N 1.295 -1.792 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.289 -179.866 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.8 Cg_endo -71.25 114.96 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.971 1.511 . . . . 0.0 110.315 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.14 -2.89 51.2 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.544 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.4 m -62.91 154.45 30.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.111 . . . . 0.0 109.815 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 44' ' ' ILE . 6.0 mt -125.35 136.1 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -154.48 139.32 17.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.915 . . . . 0.0 110.35 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -84.07 119.88 25.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.3 mt -103.24 118.04 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -85.75 140.49 30.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.49 158.53 37.06 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 42.7 Cg_endo . . . . . 0 C--N 1.304 -1.788 0 O-C-N 124.007 1.53 . . . . 0.0 110.908 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 9.0 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -157.52 172.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.098 -1.001 . . . . 0.0 110.662 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.565 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 2.5 mtpp -93.46 -65.02 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.662 -0.649 . . . . 0.0 109.811 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' HB2' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER 60.6 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ptm180 -106.37 167.22 9.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 4.6 t -82.18 152.32 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.88 -1.137 . . . . 0.0 110.348 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 48.5 t0 -101.2 -72.34 0.68 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.235 0.541 . . . . 0.0 109.878 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -146.82 124.58 11.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.361 -0.837 . . . . 0.0 110.124 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.61 149.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.479 ' CB ' ' HB3' ' A' ' 80' ' ' LYS . 5.3 t0 -151.94 115.06 4.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 109.908 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -85.86 3.14 43.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.647 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -110.34 -48.38 3.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.305 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -91.77 17.84 8.47 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.701 -0.624 . . . . 0.0 110.03 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 20.2 m-85 43.74 58.97 3.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.93 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 75' ' ' ASP . 28.1 tttt -122.18 119.44 31.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -135.51 109.16 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.526 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 51.4 m-20 -125.86 150.29 47.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 110.427 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 51.3 p90 -142.64 139.64 31.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.447 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' ARG . 3.1 m -96.16 155.87 16.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.973 -1.079 . . . . 0.0 110.808 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 54.7 t -99.91 124.43 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.61 -76.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 110.956 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.68 78.88 9.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.649 -1.282 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.424 ' C ' ' HD2' ' A' ' 90' ' ' PRO . . . -100.63 145.97 17.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.552 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.57 -50.01 8.44 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.5 Cg_endo -73.62 -48.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.636 1.335 . . . . 0.0 111.02 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 91' ' ' ILE . 33.7 mt -54.52 141.7 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.078 -1.014 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -108.73 -65.06 0.57 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 4.7 m-20 -114.3 -82.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -1.113 . . . . 0.0 110.0 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.9 p -134.27 12.2 3.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.975 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.2 mt -90.87 156.38 18.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.016 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.515 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 12.1 tt0 61.96 31.76 17.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.522 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.7 mtpt -65.25 161.56 19.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.552 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.556 HG12 ' CD1' ' A' ' 120' ' ' TYR . 87.6 mt -143.9 132.52 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 110.614 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 1.2 m -116.24 111.34 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 109.547 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 2.0 m-80 -103.06 142.17 34.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.526 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 4.2 mp0 -136.19 150.23 48.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.973 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.6 mt -140.63 125.55 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.509 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 2.4 ttpt -125.15 111.91 15.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 109.65 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.552 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 12.1 mt -102.96 112.59 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.43 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.78 142.32 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.827 . . . . 0.0 110.188 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.51 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -87.94 159.96 18.12 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.595 -0.691 . . . . 0.0 110.665 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.406 ' CG2' HG13 ' A' ' 113' ' ' ILE . 14.9 p . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -135.98 -174.17 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.407 -1.055 . . . . 0.0 110.511 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' CG2' ' A' ' 107' ' ' THR . 23.5 mt -137.59 109.39 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.0 108.982 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -84.42 129.19 34.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG2' ' CB ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -122.44 98.47 5.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 109.692 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.429 HG21 ' O ' ' A' ' 7' ' ' THR . 2.6 tt -94.82 120.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.509 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.451 ' HB3' ' OE1' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -102.04 116.26 32.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.051 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.454 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -103.08 158.62 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 1.8 ttmt -148.51 142.0 25.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.447 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.556 ' CD1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -123.52 133.48 54.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -0.931 . . . . 0.0 110.106 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.619 ' CD2' ' N ' ' A' ' 121' ' ' HIS . 4.4 m-70 -119.37 97.67 5.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.52 163.21 14.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.951 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.397 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.476 0.655 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.6 p -98.46 89.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.514 -0.742 . . . . 0.0 110.223 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -50.16 155.31 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.118 -0.989 . . . . 0.0 110.145 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -64.76 -33.15 75.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.278 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -41.03 -59.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -27.31 65.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 109.274 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 5' ' ' TYR . 18.8 t -77.2 -49.47 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.425 -0.797 . . . . 0.0 109.372 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.43 65.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.857 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.02 -21.44 59.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t -76.44 -43.72 38.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.467 -0.77 . . . . 0.0 110.056 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.75 -30.29 68.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.942 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.97 -40.45 46.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.882 . . . . 0.0 110.125 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -50.03 -40.99 36.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 23.2 tt0 -60.88 -43.98 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -1.122 . . . . 0.0 109.699 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 38.7 m -62.43 -30.36 71.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.533 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 74.1 mt -64.85 -45.55 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' A' ' 145' ' ' ARG . 1.0 OUTLIER -66.64 -26.2 66.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.517 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -78.79 -39.66 35.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.82 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.59 88.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.579 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.92 -39.66 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.01 -50.86 69.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -17.25 63.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.448 -0.782 . . . . 0.0 110.749 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.53 ' CD2' ' HG ' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -79.81 -42.24 24.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.966 -1.084 . . . . 0.0 109.503 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.53 ' HG ' ' CD2' ' A' ' 150' ' ' TYR . 5.7 mt -67.48 -48.16 67.95 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.821 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -53.34 56.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.912 179.809 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.578 HG23 ' CE1' ' A' ' 121' ' ' HIS . 5.1 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.431 0.634 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -104.35 128.66 52.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 109.883 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.17 142.07 32.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.846 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CE2' HG13 ' A' ' 133' ' ' VAL . 27.8 m-85 -149.93 54.96 0.94 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.46 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 0.1 OUTLIER -83.16 158.0 22.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.529 -0.732 . . . . 0.0 110.878 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -154.44 153.84 32.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.677 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -138.5 146.71 42.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.539 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.54 -178.97 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -121.64 163.29 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.949 . . . . 0.0 110.664 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.404 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 2.7 t -159.29 136.86 10.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.78 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 16.6 t -80.03 -13.87 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.125 -0.984 . . . . 0.0 109.008 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.1 mp -71.89 153.97 92.83 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.4 Cg_endo -67.93 149.15 77.49 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.619 1.326 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . . . -75.08 -29.06 60.55 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.513 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -68.16 -55.07 13.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 16.3 mtt-85 -63.93 -36.63 84.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.462 HD21 HG22 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -71.79 -35.81 70.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.09 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 36.4 t80 -60.54 -58.73 7.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.921 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 16' ' ' ALA . 13.7 mtpt -50.69 -52.62 38.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.67 67.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.293 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -89.13 -12.06 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.556 HD12 ' CD2' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -124.45 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.742 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.419 HD22 ' CE1' ' A' ' 76' ' ' HIS . 0.3 OUTLIER -50.34 -56.2 12.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 2.5 m-20 -111.95 35.43 3.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 109.829 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.13 -58.91 2.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -53.03 -26.72 16.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 110.052 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -87.56 -34.8 18.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 13.9 mt -80.44 -38.75 29.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.316 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.514 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.0 m-30 -43.79 -57.72 5.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.619 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.8 Cg_endo -70.71 -18.89 32.21 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.884 1.465 . . . . 0.0 110.629 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.1 mtpp -86.15 -54.46 4.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 146' ' ' ALA . 5.5 p -83.76 -25.33 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.48 77.29 15.5 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.01 -4.73 15.89 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.082 1.569 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.93 -26.5 60.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.124 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.433 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -95.6 -70.34 0.72 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.861 . . . . 0.0 109.967 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.02 128.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.819 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -88.49 -44.69 10.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.29 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -159.5 139.96 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.476 ' CG1' HG12 ' A' ' 56' ' ' ILE . 3.8 t -119.04 130.87 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -135.61 101.82 4.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.686 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.5 m120 -50.64 118.86 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.22 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.503 ' CD1' ' HG2' ' A' ' 68' ' ' LYS . 12.8 mt -86.42 -37.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.336 1.065 . . . . 0.0 108.403 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' HG21 ' A' ' 52' ' ' THR . 24.6 tt0 . . . . . 0 C--N 1.296 -1.734 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.072 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.6 122.28 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.005 1.529 . . . . 0.0 110.293 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.73 59.9 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.4 m -54.85 158.72 2.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -1.167 . . . . 0.0 109.305 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 45.8 mt -125.79 142.57 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.048 -1.033 . . . . 0.0 110.559 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -145.32 150.39 36.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 14.7 ttpp -102.2 93.47 5.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.638 -0.664 . . . . 0.0 110.079 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.476 HG12 ' CG1' ' A' ' 41' ' ' VAL . 66.1 mt -87.92 122.47 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 110.055 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.513 ' CB ' ' OG ' ' A' ' 39' ' ' SER . 17.6 m -86.7 138.14 31.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.14 135.31 19.47 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 45.3 Cg_endo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.936 1.493 . . . . 0.0 110.416 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.8 p90 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.26 0.552 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -144.33 167.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.403 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HG2' ' CD1' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -123.05 41.8 3.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.945 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 18.6 p-10 -41.84 136.21 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.9 ttm180 -97.46 151.84 19.58 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 4.1 t -75.75 149.06 6.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.67 -1.269 . . . . 0.0 110.459 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 46.2 t0 -101.87 -72.14 0.69 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.416 0.627 . . . . 0.0 110.306 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 122.47 11.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -0.855 . . . . 0.0 109.96 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 81' ' ' TYR . 5.1 t -108.7 154.22 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 110.265 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.488 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 2.1 t0 -156.48 121.85 4.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.887 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.505 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -87.54 -15.29 37.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.788 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -102.37 -45.13 5.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.126 -0.984 . . . . 0.0 109.356 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.13 7.48 15.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.546 -0.722 . . . . 0.0 110.091 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.4 m-30 46.25 58.46 4.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HG3' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.61 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CE2' HG23 ' A' ' 74' ' ' VAL . 38.9 t80 -127.95 100.08 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 109.804 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.507 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 6.7 m120 -109.58 139.77 44.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.466 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 39.7 p90 -136.14 136.29 39.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 70' ' ' ARG . 10.6 m -100.13 162.51 12.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 111.223 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 24.3 t -104.54 123.66 58.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.4 -72.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.303 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.75 88.27 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.268 . . . . 0.0 110.211 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -107.1 148.2 16.37 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.54 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.53 -51.91 5.44 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.9 Cg_endo -76.3 -46.96 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.934 1.492 . . . . 0.0 110.732 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.457 ' CD1' HG13 ' A' ' 85' ' ' VAL . 52.8 mt -56.51 164.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.107 -0.995 . . . . 0.0 110.459 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 91' ' ' ILE . . . -150.91 -69.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -86.4 -87.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -148.62 15.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -89.66 160.62 16.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 110.38 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.6 OUTLIER 58.16 35.63 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.28 147.73 39.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.646 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 4.9 mp -127.77 137.01 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.763 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.7 114.69 19.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.87 . . . . 0.0 109.661 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.571 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 1.1 m120 -110.04 141.14 43.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.448 ' CG ' ' CG ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -130.26 135.68 48.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.44 101.67 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.056 -1.027 . . . . 0.0 110.344 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -107.63 121.46 44.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.926 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.493 ' CG2' ' HB3' ' A' ' 15' ' ' ALA . 54.9 mt -110.48 139.35 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.6 t -138.77 135.78 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.372 -0.83 . . . . 0.0 109.816 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.16 145.92 25.66 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.486 0.66 . . . . 0.0 111.096 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 111' ' ' GLY . 1.4 p . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.271 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -140.4 163.46 32.74 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.549 -0.971 . . . . 0.0 110.676 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.85 127.33 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.53 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.492 ' CG ' ' O ' ' A' ' 114' ' ' LEU . 2.1 pp -105.79 112.87 26.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.001 -1.062 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -99.31 104.58 16.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.322 -0.861 . . . . 0.0 109.951 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 9.7 mt -89.56 125.38 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.485 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -112.63 112.51 24.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.126 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -106.39 155.63 19.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.8 mptt -147.21 131.02 17.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.511 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.646 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.21 128.28 55.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.742 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.578 ' CE1' HG23 ' A' ' 2' ' ' VAL . 23.0 m-70 -113.75 130.01 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.63 175.65 5.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 110.086 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.446 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 110.183 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.49 HG22 ' CZ ' ' A' ' 120' ' ' TYR . 2.4 p -106.52 86.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 O-C-N 121.658 -0.651 . . . . 0.0 109.839 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 128' ' ' VAL . 1.3 mttp -39.56 144.66 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.508 -0.745 . . . . 0.0 110.603 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -57.31 -27.34 62.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 110.059 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ALA . 60.8 tt0 -41.57 -64.16 0.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -24.36 38.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.571 HG13 ' CE2' ' A' ' 5' ' ' TYR . 5.3 t -78.88 -50.95 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.365 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -24.55 67.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.465 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.58 -38.26 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.649 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 t -66.9 -31.94 72.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.316 -0.865 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -36.73 73.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.804 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.49 -48.08 79.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.844 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.88 -36.55 56.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.59 -50.25 61.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.1 tt0 -56.08 -33.21 64.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -1.194 . . . . 0.0 110.289 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.415 ' O ' HG21 ' A' ' 142' ' ' THR . 20.3 m -70.88 -24.76 62.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.514 HD12 ' CE2' ' A' ' 30' ' ' PHE . 21.3 mt -75.7 -47.31 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.993 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 144' ' ' LEU . 3.5 pp -70.66 -24.06 62.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.767 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -81.05 -32.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.519 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -70.37 -35.42 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 18' ' ' LEU . 47.0 t -73.5 -46.03 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.465 -0.772 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 49.6 tt0 -54.79 -50.87 67.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.33 -47.35 84.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -48.73 -70.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.436 HD11 HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -49.31 -23.64 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.452 -0.78 . . . . 0.0 110.242 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -81.11 -20.47 41.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.466 HG21 ' ND1' ' A' ' 121' ' ' HIS . 4.8 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.382 0.61 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.5 m-85 -112.0 163.82 13.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.679 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.09 137.52 32.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.106 . . . . 0.0 110.714 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 118' ' ' ASN . 46.6 m-85 -144.89 57.89 1.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.777 . . . . 0.0 109.556 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.462 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 1.2 tm-20 -80.03 154.52 28.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 110.783 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.68 -179.06 7.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.494 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -158.04 151.74 23.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.0 110.47 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 t -140.4 169.57 17.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.928 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.4 162.99 13.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 110.256 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -158.86 137.88 11.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.444 -0.785 . . . . 0.0 109.916 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.98 -3.02 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 36.1 mm -81.58 147.47 59.51 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.049 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.88 150.56 83.11 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.473 1.249 . . . . 0.0 111.091 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB3' HG23 ' A' ' 104' ' ' ILE . . . -75.18 -33.15 61.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.935 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.03 -47.81 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.469 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 5.1 ttt180 -68.64 -38.92 80.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 109.764 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 2.4 tp -72.69 -30.45 64.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.517 ' CD1' HD12 ' A' ' 23' ' ' ILE . 67.6 t80 -68.13 -63.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.368 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HA ' HD11 ' A' ' 24' ' ' LEU . 1.4 mptp? -53.24 -40.98 64.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -0.777 . . . . 0.0 110.512 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.76 -32.15 63.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.541 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.7 t80 -90.61 -8.72 49.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 19' ' ' PHE . 1.2 mp -118.83 -65.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -61.33 -46.73 89.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -97.05 -15.35 21.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 110.06 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -45.94 -42.51 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 4.6 m-20 -52.77 -27.98 20.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -113.31 -20.29 11.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' O ' HG21 ' A' ' 33' ' ' VAL . 2.6 tp -86.66 -27.79 23.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 110.106 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.526 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.0 m-85 -54.84 -53.76 57.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.406 -0.809 . . . . 0.0 110.657 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -74.31 -4.59 15.66 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.833 1.438 . . . . 0.0 111.101 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.5 -40.71 8.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.59 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 29' ' ' LEU . 13.5 m -86.03 -26.66 6.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 110.8 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.24 88.44 5.81 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.092 -1.005 . . . . 0.0 110.594 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 59' ' ' PRO . 49.3 Cg_endo -76.34 0.68 9.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.006 1.53 . . . . 0.0 110.489 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -29.75 23.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.282 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -92.4 -66.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.82 126.86 64.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.444 -0.785 . . . . 0.0 109.936 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 2.9 t -83.35 -53.35 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.285 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -149.6 146.99 27.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 5.8 t -121.45 127.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.63 108.95 8.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.093 -1.005 . . . . 0.0 110.838 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 2.7 m120 -62.4 118.39 7.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 44' ' ' ILE . 12.1 mt -87.36 -37.71 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.236 1.017 . . . . 0.0 108.585 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 C--N 1.296 -1.755 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.405 -179.678 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.7 Cg_endo -72.47 110.22 2.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.112 1.585 . . . . 0.0 110.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.82 47.41 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 2.4 m -60.72 152.65 26.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.181 -1.188 . . . . 0.0 109.728 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -119.43 133.95 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.452 ' HD3' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -141.08 150.84 43.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.533 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.41 101.44 13.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 109.751 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.452 HD13 ' HD3' ' A' ' 54' ' ' LYS . 4.4 mm -94.48 134.01 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.963 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.498 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -102.97 131.81 49.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.92 . . . . 0.0 110.337 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.14 117.73 62.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.911 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 48.7 Cg_endo . . . . . 0 C--N 1.307 -1.654 0 O-C-N 123.912 1.48 . . . . 0.0 110.638 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.498 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 33.6 p90 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.218 0.532 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.559 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 1.4 p -167.16 171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 110.657 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.559 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.7 tttt -106.89 46.42 0.93 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.715 -0.615 . . . . 0.0 109.912 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' CG2' ' A' ' 67' ' ' VAL . 48.5 m-20 -45.62 130.98 9.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.693 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttp180 -102.56 162.92 12.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 12.3 t -86.56 151.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.596 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 32.1 t70 -100.33 -68.01 0.83 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.194 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.3 mt-10 -143.77 137.86 28.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.414 -0.804 . . . . 0.0 110.205 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.5 t -123.97 144.22 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.158 -0.964 . . . . 0.0 110.101 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -147.43 114.06 6.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.476 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 12.3 m170 -82.56 -2.07 52.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.338 -0.851 . . . . 0.0 110.708 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -118.08 -42.45 2.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.037 -1.039 . . . . 0.0 109.891 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.452 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -90.26 18.85 5.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.516 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.2 m-85 42.17 64.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.111 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.48 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -131.11 117.14 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.442 ' OH ' ' NZ ' ' A' ' 54' ' ' LYS . 9.5 t80 -137.34 99.63 4.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.527 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 56.8 m-20 -113.81 147.01 39.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.495 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 36.2 p90 -140.99 142.48 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 70' ' ' ARG . 26.3 m -107.07 165.14 11.58 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.176 -0.953 . . . . 0.0 110.974 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 91' ' ' ILE . 71.4 t -108.06 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -123.06 -77.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.898 -1.126 . . . . 0.0 110.834 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -85.61 77.28 9.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.835 -1.166 . . . . 0.0 109.891 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.473 ' HA2' ' CB ' ' A' ' 67' ' ' VAL . . . -104.23 159.74 16.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.53 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.75 -54.84 5.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -71.06 -48.76 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.768 1.404 . . . . 0.0 111.013 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 86' ' ' ILE . 4.8 mt -64.89 164.59 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 91' ' ' ILE . . . -153.15 -40.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.3 -85.97 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -1.152 . . . . 0.0 110.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -139.26 6.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.47 ' O ' ' HB3' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -92.91 158.44 15.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 58.39 31.3 20.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 110.162 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -75.31 146.35 41.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.787 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.577 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.1 mp -132.29 127.82 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -0.951 . . . . 0.0 110.685 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.49 116.24 30.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 109.679 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.52 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 12.6 m-80 -104.35 156.34 18.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.937 . . . . 0.0 110.749 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 94.2 mt-10 -144.91 138.38 26.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.792 . . . . 0.0 109.815 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -128.76 128.67 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.521 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -129.17 132.29 47.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.937 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.516 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 1.3 mp -121.66 129.17 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.85 123.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 111.195 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -58.12 162.9 3.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.864 -0.523 . . . . 0.0 110.503 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.488 HG21 ' HA ' ' A' ' 112' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 111.371 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 11.3 t -157.19 -179.98 8.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.255 . . . . 0.0 111.218 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 107' ' ' THR . 4.9 mt -125.21 124.79 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 mp -99.09 114.67 27.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 110.952 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -103.83 106.48 17.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.334 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 101' ' ' GLU . 26.3 mt -101.99 127.27 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.679 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -105.43 143.44 33.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.801 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.52 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 2.0 m120 -131.07 153.15 49.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.413 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -146.26 132.65 19.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 110.375 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.577 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.07 131.5 55.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.81 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 97' ' ' LYS . 66.5 m-70 -118.28 109.15 15.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 110.371 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.48 173.07 6.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 110.361 -179.859 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.466 0.65 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.488 HG23 ' CG ' ' A' ' 120' ' ' TYR . 1.8 t -122.82 105.38 15.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.499 -0.751 . . . . 0.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -78.22 126.76 31.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.371 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.57 -37.28 26.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.405 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -42.49 -48.85 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.024 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -70.51 -27.73 64.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 108.934 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 130' ' ' ALA . 16.9 t -76.5 -47.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.569 -0.707 . . . . 0.0 109.12 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -27.94 66.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.658 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.92 66.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.1 t -66.87 -31.32 71.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -45.34 54.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 110.046 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.84 -57.36 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.884 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 139' ' ' LEU . 4.0 mm? -75.37 -35.08 61.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.034 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.86 -49.5 22.69 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 40.7 tt0 -55.88 -44.51 78.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -1.14 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.457 ' O ' ' HB1' ' A' ' 146' ' ' ALA . 17.1 m -55.57 -34.15 64.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.0 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 17.4 mt -67.86 -49.36 62.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 0.9 OUTLIER -69.87 -27.11 64.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.086 -1.009 . . . . 0.0 109.83 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.402 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 3.4 ttm180 -81.47 -28.81 33.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.92 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 142' ' ' THR . . . -72.11 -43.53 64.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 109.918 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.22 -38.26 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.794 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.5 tt0 -65.06 -46.09 82.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -63.5 -40.73 97.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.586 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -73.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.977 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.433 ' CD1' HD13 ' A' ' 18' ' ' LEU . 1.6 mt -50.11 -38.98 41.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.412 -0.805 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 3.9 mt -50.98 -26.77 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.808 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.938 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.583 HG13 ' CG ' ' A' ' 121' ' ' HIS . 8.6 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.687 0.755 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.533 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 3.4 m-85 -107.81 164.33 12.34 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.628 -0.67 . . . . 0.0 109.714 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.99 138.49 42.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.053 -1.029 . . . . 0.0 110.848 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.428 ' CZ ' HG12 ' A' ' 133' ' ' VAL . 50.0 m-85 -146.57 53.89 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.3 pt-20 -81.66 144.43 31.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.766 . . . . 0.0 111.149 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -171.03 3.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.443 -0.786 . . . . 0.0 109.674 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -159.9 164.46 33.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 110.711 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.83 -169.92 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 110.048 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -129.52 160.94 31.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 110.35 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.98 135.3 8.14 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.622 -0.674 . . . . 0.0 109.834 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.96 -17.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 108.642 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 21.9 mm -68.24 150.35 97.76 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.2 Cg_endo -65.92 151.71 83.37 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.508 1.267 . . . . 0.0 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.61 -25.06 59.0 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.412 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -78.13 -47.6 17.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.45 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -69.61 -34.12 73.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.707 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 10.6 tp -74.38 -28.7 61.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 110.007 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' ILE . 50.6 t80 -70.44 -60.18 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -54.72 -45.79 74.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.43 70.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.63 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 8.2 t80 -91.54 -20.76 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.97 . . . . 0.0 110.461 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 81' ' ' TYR . 1.3 mp -114.08 -62.8 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.67 -35.19 20.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.871 . . . . 0.0 110.209 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.58 26.45 4.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -61.0 -44.97 97.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' HA ' HG12 ' A' ' 41' ' ' VAL . 26.9 m-20 -64.88 -8.13 14.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -1.203 . . . . 0.0 110.412 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 4.6 t30 -107.68 -38.79 5.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -80.64 -38.74 28.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -42.12 -59.27 2.77 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.449 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.2 Cg_endo -72.73 -10.65 25.27 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.637 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 6.6 tttm -90.78 -63.74 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -81.51 -17.4 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 110.741 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.85 64.37 62.24 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 110.383 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.7 -13.26 20.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.001 1.527 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -79.05 -23.61 44.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.434 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -89.07 -61.01 1.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.427 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -106.42 155.45 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 109.841 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.49 -61.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 110.177 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.65 135.17 16.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.519 ' CG2' HG12 ' A' ' 56' ' ' ILE . 1.7 p -124.04 128.77 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.125 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 2.9 mt-10 -130.77 159.61 36.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 110.344 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 54' ' ' LYS . 25.8 m120 -95.06 119.27 33.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.156 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' ILE . 19.2 mm -87.14 -36.84 10.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.315 1.055 . . . . 0.0 108.479 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 53' ' ' ILE . 45.0 tt0 . . . . . 0 C--N 1.295 -1.8 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.444 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.426 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.7 Cg_endo -74.02 106.8 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.959 1.505 . . . . 0.0 110.27 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.98 5.48 33.08 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.1 m -69.74 157.16 37.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 109.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 6.3 mt -124.48 131.18 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -137.95 149.83 46.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.196 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.6 tttp -98.34 109.62 22.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.565 -0.709 . . . . 0.0 110.758 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.519 HG12 ' CG2' ' A' ' 41' ' ' VAL . 72.9 mt -104.1 141.98 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.214 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -121.08 154.1 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 111.155 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.46 135.44 21.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 46.8 Cg_endo . . . . . 0 C--N 1.304 -1.787 0 O-C-N 123.847 1.446 . . . . 0.0 111.033 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 2.2 p90 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 66' ' ' TYR . 18.3 m -151.51 156.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.566 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.6 mttt -111.43 46.67 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 109.724 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.461 ' OD2' HD11 ' A' ' 56' ' ' ILE . 4.2 p30 -39.35 140.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.947 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -99.44 154.1 18.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.4 t -76.81 147.43 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.678 -1.264 . . . . 0.0 109.72 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.519 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 64.6 t0 -97.28 -69.45 0.76 Allowed 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.719 -0.613 . . . . 0.0 110.461 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 mm-40 -154.8 106.69 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 110.463 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.26 149.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.129 -0.982 . . . . 0.0 109.706 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -139.2 112.54 8.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 110.48 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -87.75 1.52 53.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.584 -0.697 . . . . 0.0 110.123 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -113.14 -57.63 2.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.09 13.76 5.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.524 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 14.3 m-85 48.59 61.72 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.495 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -130.12 110.33 11.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.977 . . . . 0.0 110.699 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.482 ' CD2' HG13 ' A' ' 23' ' ' ILE . 4.0 t80 -120.13 96.98 5.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.496 -0.753 . . . . 0.0 109.602 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.519 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 7.1 m120 -102.75 138.89 39.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.6 p90 -136.63 137.92 40.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.2 m -104.02 152.81 21.59 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.106 -0.996 . . . . 0.0 111.365 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 91' ' ' ILE . 19.4 t -100.71 124.2 54.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.8 OUTLIER -124.92 -75.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.74 -178.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -65.1 70.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.758 -1.214 . . . . 0.0 109.793 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ILE . . . -96.6 131.86 10.8 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.531 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.92 -56.87 3.05 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.0 Cg_endo -71.52 -27.74 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.782 1.412 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.519 ' CD1' HG13 ' A' ' 85' ' ' VAL . 59.1 mt -72.81 158.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.56 -58.04 0.37 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -56.63 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 0.0 109.838 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 t -146.34 18.28 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.939 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.3 149.78 22.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 52.42 33.98 14.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.373 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.511 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 9.9 tttt -67.38 164.68 18.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.451 -0.78 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.65 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -136.27 125.54 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.258 -0.901 . . . . 0.0 110.157 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.02 115.55 27.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.868 . . . . 0.0 109.488 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.586 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 1.6 m-80 -112.31 140.5 46.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.973 . . . . 0.0 110.709 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB2' ' OG ' ' A' ' 117' ' ' SER . 0.5 OUTLIER -127.35 132.3 50.24 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.444 -0.785 . . . . 0.0 109.59 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mt -120.45 105.39 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 110.625 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 32.6 tttm -104.44 117.41 34.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.524 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 3.8 mt -105.58 111.18 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.296 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.47 146.0 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.662 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.21 142.32 27.85 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.434 0.635 . . . . 0.0 111.066 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.436 -0.79 . . . . 0.0 109.496 179.682 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -143.53 157.86 44.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.303 -1.116 . . . . 0.0 111.418 -179.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 1.1 tt -107.2 129.61 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.03 136.61 33.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 110.588 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.35 105.71 9.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 109.654 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 4.4 mp -105.62 105.74 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -90.42 133.21 35.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.551 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.446 ' ND2' ' ND2' ' A' ' 100' ' ' ASN . 2.5 t-20 -127.45 140.66 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.758 -1.214 . . . . 0.0 110.59 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.87 149.6 52.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 109.872 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.65 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -126.46 107.25 10.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.101 -1.0 . . . . 0.0 109.439 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.583 ' CG ' HG13 ' A' ' 2' ' ' VAL . 17.5 m-70 -88.52 93.02 9.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.986 . . . . 0.0 110.531 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -117.33 167.58 11.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.994 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.1 tptt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.905 . . . . 0.0 110.193 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.379 0.609 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.475 ' O ' ' CG1' ' A' ' 128' ' ' VAL . 2.0 t -129.86 96.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.401 -0.812 . . . . 0.0 109.678 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -62.79 126.02 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.027 . . . . 0.0 109.612 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.22 -41.36 18.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 110.55 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.8 mt-10 -40.25 -58.62 1.46 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 110.244 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.97 -30.67 69.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.179 -0.95 . . . . 0.0 108.954 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 130' ' ' ALA . 22.7 t -72.7 -53.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 109.035 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -55.49 -28.62 55.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.191 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.14 -25.85 62.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 133' ' ' VAL . 26.9 t -68.6 -30.92 69.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -79.09 -49.56 12.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.92 -48.71 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.928 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.29 -39.75 53.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' A' ' 143' ' ' LEU . . . -54.07 -50.67 54.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.505 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 2.8 tt0 -57.78 -48.46 79.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -1.174 . . . . 0.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.6 -29.53 59.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.426 HD11 ' HA2' ' A' ' 140' ' ' GLY . 78.0 mt -72.78 -53.38 11.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.505 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -68.42 -22.17 64.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -81.88 -35.11 29.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.752 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.13 -40.96 91.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.12 -46.44 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.682 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.452 ' OE1' HD13 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -56.35 -45.8 80.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -25.3 64.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.843 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.553 ' CD1' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.53 -41.07 63.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' ' CD1' ' A' ' 150' ' ' TYR . 4.5 mt -66.86 -34.64 78.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.452 HD13 ' OE1' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -63.86 -34.12 77.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.865 . . . . 0.0 110.197 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.505 HG13 ' ND1' ' A' ' 121' ' ' HIS . 4.7 m . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.754 0.787 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 7.4 m-85 -121.96 145.15 48.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 109.911 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.458 ' OD1' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -124.27 133.47 53.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 110.713 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.501 ' CD2' HG12 ' A' ' 133' ' ' VAL . 62.2 m-85 -139.42 57.13 1.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.526 -0.734 . . . . 0.0 109.447 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 3.1 tm-20 -80.2 153.81 28.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.585 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.04 176.1 13.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 109.719 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -158.54 152.18 23.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.002 -1.061 . . . . 0.0 110.572 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 10' ' ' THR . 1.8 t -134.72 -170.77 2.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -122.36 165.57 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 138.24 10.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.423 -0.798 . . . . 0.0 109.754 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.7 t -80.11 -14.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.685 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 31.0 mm -70.24 149.42 95.97 Favored Pre-proline 0 N--CA 1.487 1.421 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -68.2 148.25 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.317 1.167 . . . . 0.0 110.82 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.37 -33.82 65.25 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.977 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.15 35.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.487 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -66.74 -37.28 84.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.962 . . . . 0.0 109.847 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 18' ' ' LEU . 7.8 tt -73.94 -32.16 63.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 76' ' ' HIS . 30.7 t80 -63.21 -55.93 20.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -58.05 -45.03 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.45 -31.08 71.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' HB2' HD22 ' A' ' 18' ' ' LEU . 20.3 t80 -89.72 -23.96 21.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.577 HD11 ' CD2' ' A' ' 81' ' ' TYR . 7.3 mm -106.18 -65.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -51.92 -42.77 63.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.985 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 18.9 m-20 -115.39 23.54 12.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 110.193 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -62.83 -54.18 35.43 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 21.5 m-20 -59.72 -13.15 8.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -1.141 . . . . 0.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -104.15 -36.26 7.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -83.44 -23.48 32.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.566 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -56.43 -60.25 9.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.6 Cg_endo -73.91 -3.56 13.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.944 1.497 . . . . 0.0 110.286 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 20.7 tttm -103.29 -32.93 9.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 110.433 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 146' ' ' ALA . 1.6 p -101.68 -33.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.116 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.43 ' CB ' HD22 ' A' ' 143' ' ' LEU . . . -121.4 78.76 36.34 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.41 -0.806 . . . . 0.0 110.1 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 -18.98 31.17 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.99 1.521 . . . . 0.0 110.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.55 -4.29 57.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 110.276 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -107.5 -67.82 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.15 152.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.529 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -113.84 -27.88 7.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.021 -1.05 . . . . 0.0 110.83 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.82 162.14 34.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.076 -1.015 . . . . 0.0 110.832 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 27' ' ' ASP . 3.7 m -142.62 133.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.45 -0.781 . . . . 0.0 109.719 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -135.7 110.45 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.524 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.534 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -69.2 118.31 11.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 110.257 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.436 ' H ' ' HA ' ' A' ' 54' ' ' LYS . 11.6 mt -80.0 -39.98 20.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.4 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.2 Cg_endo -71.64 96.18 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.913 1.481 . . . . 0.0 110.271 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.22 -0.74 6.08 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.562 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 88.4 m -67.69 160.58 27.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -1.159 . . . . 0.0 109.186 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 11.5 mt -130.38 142.55 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.833 -1.167 . . . . 0.0 111.017 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 19.1 pttt -159.87 136.88 9.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.569 -0.707 . . . . 0.0 110.196 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -87.91 113.54 23.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.411 HD13 ' CG ' ' A' ' 69' ' ' ASP . 47.9 mt -92.16 153.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.645 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -118.0 148.53 42.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 110.784 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -126.76 118.51 22.57 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 109.625 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 39' ' ' SER . 48.6 Cg_endo . . . . . 0 C--N 1.306 -1.669 0 O-C-N 123.89 1.468 . . . . 0.0 111.034 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 20.4 p90 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -173.0 172.93 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.496 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.0 ttmt -112.41 122.65 48.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 110.069 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -118.93 129.39 55.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.789 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -100.28 145.41 28.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.227 -0.921 . . . . 0.0 108.86 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.562 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 4.0 t -76.5 147.22 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.881 -1.137 . . . . 0.0 110.668 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.459 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 6.8 t70 -99.1 -71.71 0.68 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.448 0.642 . . . . 0.0 109.966 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 3.1 tp10 -141.64 133.1 26.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.45 -0.782 . . . . 0.0 110.168 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG23 ' CE2' ' A' ' 81' ' ' TYR . 2.6 t -118.37 157.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -159.77 124.26 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 110.064 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 18.7 m170 -98.63 1.17 46.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -112.82 -46.81 3.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.34 10.91 27.82 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 109.966 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-85 51.09 64.0 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 110.445 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -129.7 123.16 30.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.577 ' CD2' HD11 ' A' ' 23' ' ' ILE . 28.0 t80 -144.11 103.77 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.475 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 77.5 m-20 -113.97 140.58 48.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.216 -0.927 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 22.9 p90 -137.25 137.22 38.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.488 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 53.8 m -103.76 166.54 10.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.022 -1.049 . . . . 0.0 110.915 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 91' ' ' ILE . 53.0 t -108.19 124.62 64.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -115.79 -67.89 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.899 -1.126 . . . . 0.0 112.0 -178.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HB2' ' CB ' ' A' ' 68' ' ' LYS . 0.5 OUTLIER -88.24 82.1 7.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 67' ' ' VAL . . . -100.54 141.13 15.25 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.513 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.71 -58.59 2.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.6 Cg_endo -71.78 -45.18 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.933 1.491 . . . . 0.0 110.393 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.534 ' CD1' HG13 ' A' ' 85' ' ' VAL . 50.4 mt -58.07 149.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.7 -114.73 2.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -70.03 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -1.166 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 3.2 t -143.93 15.06 1.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.069 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.05 152.55 22.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 109.99 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.535 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 56.33 34.82 24.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.58 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -68.36 157.36 35.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.386 -0.821 . . . . 0.0 110.112 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.581 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.7 mp -137.12 131.16 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.94 . . . . 0.0 110.402 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.84 114.8 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.785 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.577 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 5.7 m120 -106.62 138.02 43.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.152 -0.968 . . . . 0.0 110.411 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.498 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 26.2 mt-10 -127.53 132.27 49.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 110.191 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.32 121.82 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.33 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 3.9 mttt -128.36 126.39 40.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 109.91 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 12.5 mt -115.36 130.25 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.165 -0.96 . . . . 0.0 110.655 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.12 143.94 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 109.603 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.11 138.77 31.15 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 110.8 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.96 -179.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -136.72 164.02 29.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.092 . . . . 0.0 110.702 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.48 127.55 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 109.353 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.52 143.45 29.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 0.0 110.955 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 8' ' ' GLU . 1.8 ttmt -135.13 105.01 6.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.465 -0.772 . . . . 0.0 109.795 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.8 mt -106.4 112.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.336 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.498 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -90.39 154.42 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -143.86 135.56 26.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HG3' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -125.56 153.48 43.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.581 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -135.04 101.88 5.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.079 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.535 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 21.3 m-70 -85.98 120.54 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.047 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.449 HG22 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -113.09 173.58 6.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 0.0 110.012 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.396 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.33 0.586 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 120' ' ' TYR . 2.3 t -121.5 93.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -58.69 129.57 42.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 109.562 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.43 -46.45 26.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.942 . . . . 0.0 110.541 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 130' ' ' ALA . 26.7 tt0 -40.18 -50.72 2.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.198 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -35.3 80.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.016 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 130' ' ' ALA . 15.9 t -72.55 -50.87 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.414 -0.804 . . . . 0.0 108.982 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -63.0 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.746 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.3 -44.23 72.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.628 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t -57.78 -33.01 68.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.19 12.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.888 . . . . 0.0 110.106 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -48.38 -52.9 19.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 110.285 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.9 mt -69.62 -44.52 70.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 143' ' ' LEU . . . -49.33 -46.52 35.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.526 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 30.8 tt0 -61.29 -30.23 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -30.75 68.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.475 ' CD1' ' HA2' ' A' ' 140' ' ' GLY . 3.0 mt -73.03 -47.46 44.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.1 pp -69.44 -22.51 63.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 109.904 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 149' ' ' SER . 2.9 ttp180 -83.78 -34.54 24.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -63.35 -44.43 94.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.379 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.91 -49.66 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.557 -0.714 . . . . 0.0 109.94 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 8.9 tt0 -56.53 -46.43 80.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.641 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 1.1 t -64.93 -43.92 91.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.456 -0.777 . . . . 0.0 109.872 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -50.99 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.099 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.455 ' HB3' HD13 ' A' ' 13' ' ' ILE . 3.8 mt -44.97 -34.39 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -34.2 62.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.829 . . . . 0.0 110.131 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 150' ' ' TYR . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.206 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.473 HG23 ' CG ' ' A' ' 121' ' ' HIS . 2.6 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.412 0.625 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -94.31 149.63 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -0.759 . . . . 0.0 109.427 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.497 ' ND2' ' HG3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -121.54 144.49 48.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.125 -0.984 . . . . 0.0 110.634 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 118' ' ' ASN . 34.1 m-85 -153.77 69.92 0.81 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.436 -0.79 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 10.7 pt-20 -100.59 135.81 41.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.758 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' HD2' ' A' ' 137' ' ' LYS . 0.2 OUTLIER -134.92 177.93 7.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.017 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -158.12 161.12 37.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 110.356 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -147.6 -175.88 5.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 110.097 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 p -122.19 160.98 24.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 110.308 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -157.93 136.84 11.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.768 . . . . 0.0 109.803 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.02 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.103 -0.998 . . . . 0.0 109.154 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 45.3 mm -77.75 149.22 77.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.5 Cg_endo -64.02 148.48 91.52 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.264 1.139 . . . . 0.0 111.187 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -73.46 -24.36 60.21 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.114 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.03 -50.96 11.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.277 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 3.0 tpm_? -64.57 -40.3 95.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.098 -1.001 . . . . 0.0 109.603 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 8.5 tt -71.23 -37.47 72.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.598 -0.689 . . . . 0.0 110.187 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.488 ' CE2' ' HA ' ' A' ' 76' ' ' HIS . 76.4 t80 -61.59 -69.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.314 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.15 -51.77 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.878 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.1 74.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.0 t80 -84.86 -10.08 57.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -124.78 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.902 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -51.96 -42.25 62.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.264 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -104.3 -1.51 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -47.95 -52.69 16.07 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' OD2' ' HB ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -48.05 -23.15 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -1.21 . . . . 0.0 110.06 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -112.55 -23.84 10.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -84.81 -27.94 26.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.141 -0.974 . . . . 0.0 110.045 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -64.51 -60.08 9.25 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -74.01 53.14 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.823 1.433 . . . . 0.0 110.254 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.84 -58.1 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG13 ' CE1' ' A' ' 150' ' ' TYR . 27.0 m -85.92 -16.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.373 -0.829 . . . . 0.0 110.45 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.56 71.18 5.46 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.48 -12.5 27.18 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.993 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.411 ' C ' ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -64.55 -21.15 66.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.467 -0.771 . . . . 0.0 110.115 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.9 -60.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.868 . . . . 0.0 110.02 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.471 HD11 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -113.56 145.01 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.747 . . . . 0.0 109.745 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.55 -57.69 2.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.7 t -155.3 157.51 37.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.554 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.465 ' HB ' ' OD2' ' A' ' 27' ' ' ASP . 59.0 t -114.4 138.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -129.35 87.24 2.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.895 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 6.2 m-20 -54.73 114.34 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.717 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.509 HG23 HD11 ' A' ' 44' ' ' ILE . 4.9 mt -82.54 -38.51 15.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.197 0.999 . . . . 0.0 108.676 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' HG21 ' A' ' 52' ' ' THR . 23.1 tt0 . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 121.655 0.741 . . . . 0.0 110.176 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.4 Cg_endo -72.95 101.54 1.33 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.048 1.552 . . . . 0.0 110.909 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 111.32 -1.25 28.08 Favored Glycine 0 N--CA 1.48 1.579 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -58.4 154.14 14.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -1.201 . . . . 0.0 109.585 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.418 HD13 ' HB3' ' A' ' 45' ' ' GLU . 18.2 mt -116.64 143.38 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -157.49 144.43 18.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 110.539 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -92.34 102.22 14.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.432 HD12 HG12 ' A' ' 41' ' ' VAL . 5.5 mm -82.76 130.09 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.86 . . . . 0.0 109.48 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.87 153.73 22.6 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.288 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 32.8 p90 -110.92 155.64 42.09 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 110.12 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.457 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 45.6 Cg_endo . . . . . 0 C--N 1.304 -1.782 0 O-C-N 124.032 1.543 . . . . 0.0 110.626 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 29.6 p90 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.066 0.46 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 66' ' ' TYR . 10.4 m -152.23 179.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 0.0 110.413 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 12.5 mttt -128.83 41.84 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.689 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 84' ' ' SER . 45.2 p-10 -39.17 138.94 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 110.816 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HB2' HD12 ' A' ' 86' ' ' ILE . 8.8 ttm180 -100.08 155.24 17.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.401 -0.812 . . . . 0.0 108.887 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.2 t -79.94 144.04 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.8 -1.188 . . . . 0.0 110.195 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.467 ' HB2' ' CB ' ' A' ' 82' ' ' ASN . 46.8 m-20 -96.32 -69.2 0.76 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.292 0.568 . . . . 0.0 110.159 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -146.76 132.29 18.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 1.1 m-20 -151.61 107.01 3.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.488 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -81.81 -10.38 59.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 110.398 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -108.82 -45.83 3.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.15 6.39 25.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.562 -0.711 . . . . 0.0 109.987 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-30 48.56 58.75 4.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.255 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.6 ttmt -134.09 110.38 9.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.469 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' A' ' 81' ' ' TYR . 13.2 t80 -126.82 122.1 33.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.881 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 73.1 m-20 -128.3 141.36 51.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 46.9 p90 -138.44 133.14 32.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.316 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 64.7 m -100.95 168.27 9.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.003 -1.061 . . . . 0.0 111.156 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.545 HG13 ' CD1' ' A' ' 91' ' ' ILE . 71.7 t -104.48 127.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -126.83 -75.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.97 -1.081 . . . . 0.0 111.196 -178.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.525 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -79.06 83.36 5.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.892 -1.13 . . . . 0.0 110.109 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -109.09 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.546 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.45 -54.0 3.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -73.33 -49.58 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.871 1.458 . . . . 0.0 110.826 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.545 ' CD1' HG13 ' A' ' 85' ' ' VAL . 42.3 mt -58.8 138.0 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.024 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.27 -60.98 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -97.6 -90.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.194 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 t -139.92 9.11 2.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -86.77 162.14 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.239 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 95' ' ' LEU . 6.5 mm-40 57.67 36.33 26.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.939 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -81.33 155.6 25.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.558 HG12 ' CD2' ' A' ' 120' ' ' TYR . 2.7 mp -138.64 129.05 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 110.516 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.07 120.47 41.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 1.9 m-20 -110.02 149.36 30.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.515 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 34.5 mt-10 -141.63 163.92 31.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.371 -0.831 . . . . 0.0 110.048 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.441 ' CG1' ' C ' ' A' ' 101' ' ' GLU . 19.4 mt -153.57 106.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.806 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -108.11 118.41 36.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.415 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 3.9 mp -110.35 133.52 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.055 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -137.43 134.06 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 0.0 110.487 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -82.15 148.31 28.57 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.703 -0.623 . . . . 0.0 110.718 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 111' ' ' GLY . 1.3 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.415 -0.803 . . . . 0.0 109.437 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -135.17 -178.74 5.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.477 -1.014 . . . . 0.0 110.557 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.439 HG13 ' C ' ' A' ' 112' ' ' SER . 25.1 mt -134.41 124.6 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.67 135.83 39.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.008 . . . . 0.0 110.65 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -128.64 98.99 5.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.778 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.1 mt -87.57 145.67 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.497 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.441 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -129.65 108.38 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -0.874 . . . . 0.0 110.005 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -109.81 128.4 55.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.415 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.497 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -128.64 137.11 51.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.053 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.558 ' CD2' HG12 ' A' ' 98' ' ' ILE . 5.9 t80 -109.67 143.01 40.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.473 ' CG ' HG23 ' A' ' 2' ' ' VAL . 13.5 m-70 -120.81 131.54 54.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.407 ' CG2' ' HA ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -114.11 174.75 5.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.235 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HA ' ' CG2' ' A' ' 122' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 121.651 0.739 . . . . 0.0 109.784 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 120' ' ' TYR . 2.4 p -112.98 108.55 25.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.369 0.604 . . . . 0.0 110.759 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 133.25 55.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.463 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -63.17 -9.44 11.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.734 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -55.21 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.171 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -54.84 -36.04 64.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.358 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 t -67.45 -47.79 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.541 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 1.4 mmtt -59.4 -34.48 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.428 -0.795 . . . . 0.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.89 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -74.74 -35.69 62.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.466 -0.771 . . . . 0.0 109.874 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HD2' HG22 ' A' ' 7' ' ' THR . 26.1 ttpp -72.46 -37.11 68.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.837 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -58.5 -42.68 88.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 140' ' ' GLY . 2.0 tp -75.17 -43.85 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 139' ' ' LEU . . . -45.27 -50.19 9.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.488 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.4 mt-10 -59.87 -31.35 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -1.159 . . . . 0.0 110.215 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.6 m -70.69 -27.48 64.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.012 -1.055 . . . . 0.0 109.649 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.8 mt -72.53 -49.38 33.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 110.061 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 2.3 pp -65.6 -25.4 67.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.015 . . . . 0.0 109.472 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.2 OUTLIER -78.92 -33.8 45.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.427 -0.796 . . . . 0.0 109.676 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.97 84.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.381 -0.825 . . . . 0.0 109.638 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.6 t -71.19 -46.97 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -54.18 -46.5 72.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.63 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 t -61.01 -50.35 73.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.656 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.457 ' CE1' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -48.07 -72.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 109.936 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 150' ' ' TYR . 5.4 mt -43.09 -43.72 4.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.002 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -61.38 -43.31 99.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.202 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 110.381 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.391 0.615 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.8 m-85 -94.36 138.59 32.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.51 -0.744 . . . . 0.0 109.916 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.07 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.054 . . . . 0.0 110.42 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -141.16 59.26 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.542 -0.723 . . . . 0.0 109.218 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.0 pt-20 -88.47 142.89 27.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.484 -0.76 . . . . 0.0 110.797 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.39 178.55 8.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.527 -0.733 . . . . 0.0 109.818 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.4 ' HB2' ' HG3' ' A' ' 115' ' ' LYS . 2.3 pp20? -150.61 143.15 24.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m -130.2 -174.76 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -119.95 159.43 24.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 110.614 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.467 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -154.26 135.58 14.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 17.7 m -79.91 -12.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.914 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 5.1 mm -71.31 150.44 94.24 Favored Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.31 150.77 86.89 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 123.293 1.154 . . . . 0.0 111.08 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -73.16 -29.85 63.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.88 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.26 -54.23 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 110.076 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.442 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -67.42 -30.97 70.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 109.771 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' A' ' 14' ' ' PRO . 29.1 tp -73.8 -29.19 62.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.959 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.563 ' CG ' HD11 ' A' ' 23' ' ' ILE . 71.8 t80 -71.71 -57.17 4.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 110.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 31.9 mtpt -54.34 -41.24 68.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.78 . . . . 0.0 110.298 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 17' ' ' ARG . . . -68.58 -33.79 74.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -91.6 -7.34 50.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.719 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.563 HD11 ' CG ' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -121.16 -56.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 8.4 mt -72.99 -25.25 60.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -130.03 14.53 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -58.69 -42.47 96.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -65.05 -27.19 68.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -1.14 . . . . 0.0 110.317 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.423 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.3 m-20 -92.14 -38.95 11.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.491 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.8 mp -76.13 -25.97 55.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -55.64 -59.69 10.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.914 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.5 Cg_endo -71.37 0.43 6.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.994 1.523 . . . . 0.0 111.256 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -105.58 -50.94 3.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.988 -1.07 . . . . 0.0 110.577 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 150' ' ' TYR . 35.9 m -87.33 -11.15 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.04 71.24 3.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.013 . . . . 0.0 110.396 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.73 -6.73 19.75 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.033 1.544 . . . . 0.0 110.504 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.503 ' O ' ' CG ' ' A' ' 59' ' ' PRO . 16.1 mt-30 -73.33 -30.01 63.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -89.52 -51.28 5.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.517 HD12 ' CD2' ' A' ' 30' ' ' PHE . 1.5 mp -112.32 141.39 28.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 110.031 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.423 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -109.74 -19.19 13.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.19 165.07 11.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.143 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.0 m -147.15 154.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.217 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 1.6 mt-10 -153.2 152.98 31.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.532 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.7 112.5 25.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.0 110.055 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.518 HG22 HD11 ' A' ' 44' ' ' ILE . 6.3 mt -80.2 -39.9 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.233 1.016 . . . . 0.0 108.346 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.827 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.81 87.54 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.071 1.564 . . . . 0.0 110.602 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.89 -6.63 3.78 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.576 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 95.5 m -67.91 164.07 20.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -1.211 . . . . 0.0 109.32 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 53' ' ' ILE . 8.3 mt -137.13 149.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.729 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.515 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -155.21 141.6 18.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.393 -0.817 . . . . 0.0 110.561 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.5 tptm -90.39 113.03 24.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.663 -0.648 . . . . 0.0 110.508 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 56' ' ' ILE . 28.4 mt -101.49 139.88 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -102.53 159.93 15.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.64 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -136.82 136.99 22.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 0.0 109.857 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 36' ' ' GLN . 46.5 Cg_endo . . . . . 0 C--N 1.304 -1.807 0 O-C-N 123.888 1.467 . . . . 0.0 110.466 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.479 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 55.7 p90 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.609 0.719 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -179.68 172.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.858 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -115.64 132.33 56.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.902 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 8.9 p-10 -133.29 131.04 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' CG ' ' HB2' ' A' ' 84' ' ' SER . 8.2 ptt180 -98.23 151.24 20.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.071 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.576 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 4.6 t -80.02 147.05 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.782 -1.199 . . . . 0.0 110.251 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.532 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 11.3 t0 -97.56 -62.35 1.26 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.099 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.3 tt0 -155.22 120.91 5.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.236 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.405 HG22 ' CG1' ' A' ' 71' ' ' VAL . 2.9 t -116.02 142.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.321 -0.862 . . . . 0.0 110.085 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.537 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -139.98 118.24 12.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.91 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -82.6 1.45 38.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.831 . . . . 0.0 110.796 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -119.86 -38.31 2.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.05 20.36 10.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 22.9 m-30 44.66 58.56 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -127.01 129.6 48.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.052 -1.03 . . . . 0.0 110.16 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.48 ' HB2' HG12 ' A' ' 23' ' ' ILE . 77.5 t80 -148.51 94.37 2.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.947 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.532 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 71.6 m-20 -109.98 137.78 47.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.195 -0.94 . . . . 0.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.7 p90 -137.89 143.48 40.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.9 . . . . 0.0 110.004 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.415 ' HB2' ' CG ' ' A' ' 70' ' ' ARG . 74.2 m -106.17 170.61 7.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.075 -1.015 . . . . 0.0 111.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.523 HG13 ' CD1' ' A' ' 91' ' ' ILE . 53.9 t -112.16 125.38 69.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -116.61 -72.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.856 -1.152 . . . . 0.0 111.735 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -87.78 85.64 7.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.269 . . . . 0.0 110.436 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.474 ' HA2' HG22 ' A' ' 67' ' ' VAL . . . -106.42 141.31 15.46 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.545 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.02 -53.39 2.57 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.7 Cg_endo -71.66 -40.34 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.744 1.391 . . . . 0.0 110.512 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.523 ' CD1' HG13 ' A' ' 85' ' ' VAL . 70.3 mt -70.57 140.19 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 0.0 110.025 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.59 -85.06 1.13 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -83.42 -80.04 0.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -1.172 . . . . 0.0 110.434 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -145.34 13.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.464 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.442 HD22 ' CB ' ' A' ' 123' ' ' LYS . 4.1 mp -87.7 153.73 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.051 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.4 tt0 61.34 36.05 17.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.481 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.4 OUTLIER -69.67 162.54 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.463 HG12 ' CD1' ' A' ' 120' ' ' TYR . 8.3 mt -145.89 136.02 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 110.565 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -120.97 117.27 26.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.656 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 7.0 m120 -101.37 141.27 34.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.76 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 0.9 OUTLIER -131.19 132.36 44.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.713 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 81' ' ' TYR . 43.0 mt -126.5 124.34 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.002 -1.061 . . . . 0.0 110.704 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -129.12 127.23 41.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.672 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.491 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 93.3 mt -116.72 125.46 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.718 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.5 t -127.3 136.47 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.425 -0.797 . . . . 0.0 109.716 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.499 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -88.1 143.55 27.01 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.552 0.691 . . . . 0.0 111.035 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 111' ' ' GLY . 2.3 p . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.469 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -133.27 155.99 48.39 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.724 -0.868 . . . . 0.0 110.774 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 6.0 tt -109.66 120.12 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.05 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -101.45 122.49 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.931 -1.105 . . . . 0.0 111.18 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 8' ' ' GLU . 4.8 mttt -102.23 111.09 23.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 7' ' ' THR . 55.4 mt -97.19 140.29 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.638 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -125.87 118.04 24.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.074 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.85 125.41 48.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.173 -0.954 . . . . 0.0 110.23 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 3.6 mtpp -116.35 138.2 51.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 110.466 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.497 ' CG ' HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -112.83 124.72 53.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.262 -0.899 . . . . 0.0 109.707 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 36.0 m-70 -106.22 113.12 26.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.985 . . . . 0.0 110.355 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.434 HG21 ' HG3' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -122.59 167.05 13.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.1 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.442 ' CB ' HD22 ' A' ' 95' ' ' LEU . 5.0 mmtp . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.6 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.497 HG23 ' CG ' ' A' ' 120' ' ' TYR . 3.8 t -118.92 88.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 110.117 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -59.73 127.81 33.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -44.82 -45.46 10.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.113 -0.992 . . . . 0.0 110.204 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.0 mm-40 -38.64 -59.1 0.97 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -29.1 69.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 130' ' ' ALA . 8.9 t -78.6 -49.64 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -63.21 -25.71 68.46 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.419 -0.801 . . . . 0.0 109.531 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.99 -39.56 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.542 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 t -65.46 -33.79 76.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 109.688 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -79.15 -46.09 18.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.769 . . . . 0.0 109.818 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' OG1' ' A' ' 142' ' ' THR . 1.7 mt-10 -43.25 -67.47 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 37' ' ' ALA . 2.5 mp -67.04 -30.2 70.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.91 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -55.82 -63.81 4.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.514 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -52.23 -32.13 35.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -69.78 -27.24 64.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.675 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 69.3 mt -72.15 -50.31 28.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.749 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.514 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.3 pp -68.14 -28.52 67.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.402 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.13 -34.53 43.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.794 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.22 77.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.882 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.65 -48.07 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.931 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 11' ' ' SER . 0.5 OUTLIER -50.59 -41.05 54.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.432 179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -66.34 -47.55 73.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.593 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.53 ' CE1' HG11 ' A' ' 33' ' ' VAL . 1.8 t80 -45.69 -67.6 0.27 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.469 -0.77 . . . . 0.0 110.563 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.443 HD11 ' CG2' ' A' ' 13' ' ' ILE . 10.3 mt -57.49 -39.03 75.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.362 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -49.2 -40.38 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.5 HG23 ' ND1' ' A' ' 121' ' ' HIS . 2.7 t . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.482 0.658 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 4.0 m-85 -93.33 167.63 11.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -138.25 144.23 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.994 . . . . 0.0 110.811 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 64.6 m-85 -156.12 57.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.74 . . . . 0.0 109.604 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 14.9 mt-10 -88.94 145.88 25.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.372 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -150.65 173.06 14.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 4.6 pt-20 -151.15 155.79 39.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 110.551 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -139.36 176.84 8.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.405 HG23 HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -112.75 163.65 14.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 110.581 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -159.93 136.46 9.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.648 -0.657 . . . . 0.0 109.454 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.19 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.806 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 42.0 mm -71.81 149.15 92.71 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -64.9 148.66 89.97 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.463 1.244 . . . . 0.0 111.282 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -66.48 -47.11 74.08 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.82 74.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -63.38 -37.97 89.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -72.25 -35.84 68.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.432 -0.792 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' ILE . 40.1 t80 -64.55 -63.84 1.03 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -48.57 -48.46 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.102 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -38.6 91.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 4.1 t80 -86.3 -11.11 53.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.215 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.568 HD11 ' CG ' ' A' ' 81' ' ' TYR . 12.0 mm -114.72 -74.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.178 -0.951 . . . . 0.0 110.491 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.3 mt -54.87 -51.76 64.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 110.471 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.99 8.73 36.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.17 -47.92 88.69 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 79.5 m-20 -58.51 -28.42 65.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -1.14 . . . . 0.0 110.252 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.412 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 m-20 -86.56 -46.79 9.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -35.79 80.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.222 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -48.97 -60.07 5.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.953 . . . . 0.0 110.046 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -73.5 53.77 2.74 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.048 1.552 . . . . 0.0 110.274 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -63.91 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 110.392 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 HG21 ' N ' ' A' ' 34' ' ' ALA . 33.2 m -82.96 -24.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 110.435 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.504 ' CB ' HD22 ' A' ' 143' ' ' LEU . . . -134.66 70.0 71.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.6 -14.58 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.995 1.524 . . . . 0.0 110.512 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -71.67 -24.19 61.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.37 -60.02 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.274 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -113.13 143.92 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -0.815 . . . . 0.0 109.888 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -47.56 8.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.266 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.4 133.89 2.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.273 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.518 ' CG1' ' HD3' ' A' ' 54' ' ' LYS . 94.6 t -100.46 142.01 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 53.9 mt-10 -140.88 99.28 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -61.52 117.78 6.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.517 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.4 mm -85.99 -37.59 11.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 108.425 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 1.4 tm-20 . . . . . 0 C--N 1.294 -1.806 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.437 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.97 99.19 0.65 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.807 1.425 . . . . 0.0 110.094 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 71' ' ' VAL . . . 109.48 9.39 25.34 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.546 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.1 m -65.39 166.75 9.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.407 -1.055 . . . . 0.0 109.364 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 14.6 mt -129.55 138.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 110.392 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' HD3' ' CG1' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.743 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 20.9 tttt -92.14 98.36 11.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.313 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.467 HD13 ' OD2' ' A' ' 69' ' ' ASP . 52.0 mt -87.88 120.55 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.633 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.93 143.3 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -0.963 . . . . 0.0 110.291 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.04 136.2 20.46 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.208 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--N 1.304 -1.763 0 O-C-N 123.997 1.525 . . . . 0.0 110.463 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.9 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.268 0.556 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER 178.98 172.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.3 ttmt -119.18 52.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.523 -0.736 . . . . 0.0 110.47 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.467 ' OD2' HD13 ' A' ' 56' ' ' ILE . 10.2 p-10 -46.09 137.81 5.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.106 -0.996 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttm180 -100.75 157.85 16.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.228 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.546 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.6 t -84.7 146.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.877 -1.14 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.3 t70 -94.51 -68.91 0.78 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.275 0.56 . . . . 0.0 110.491 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -144.61 143.72 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 0.0 110.377 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -123.66 155.64 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.239 -0.913 . . . . 0.0 109.947 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -154.75 130.13 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 110.085 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -5.54 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 0.0 110.894 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -112.55 -40.6 4.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 109.884 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.468 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.88 16.21 16.6 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.337 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.7 m-85 46.74 69.01 0.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.78 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.49 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 6.2 tttt -131.19 127.14 37.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.568 ' CG ' HD11 ' A' ' 23' ' ' ILE . 34.1 t80 -150.67 88.66 1.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.459 -0.775 . . . . 0.0 109.39 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.508 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 86.3 m-20 -100.95 145.66 28.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.129 -0.982 . . . . 0.0 110.617 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 7.7 p90 -141.81 137.97 31.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.499 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ARG . 58.8 m -108.32 168.24 9.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.048 -1.032 . . . . 0.0 111.232 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 91' ' ' ILE . 45.1 t -105.86 131.18 56.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER -129.5 -77.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.942 -1.099 . . . . 0.0 110.583 -179.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -69.58 65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.838 -1.164 . . . . 0.0 109.997 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -87.86 136.68 13.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.535 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -41.66 -54.87 4.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.0 Cg_endo -72.01 -42.1 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.823 1.433 . . . . 0.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.518 ' CD1' HG13 ' A' ' 85' ' ' VAL . 69.8 mt -56.31 145.82 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.23 -76.0 0.26 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.33 -75.94 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -1.136 . . . . 0.0 110.083 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.1 p -144.61 9.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.06 161.91 14.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.13 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.9 OUTLIER 61.59 28.42 17.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.147 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 98' ' ' ILE . 10.5 ttmt -80.94 159.64 24.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.105 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.569 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.6 mp -141.13 133.0 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 110.641 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 m -114.79 115.64 27.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.58 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 19.3 m120 -104.77 142.76 34.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.631 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.508 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -130.6 128.63 41.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.807 . . . . 0.0 109.634 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.5 mm -120.34 113.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.659 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -125.37 139.79 53.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 109.648 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.431 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 7.2 mt -127.53 142.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.027 -1.046 . . . . 0.0 110.823 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.7 t -137.52 130.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 109.548 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.04 155.98 19.53 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.635 -0.665 . . . . 0.0 111.307 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 109.868 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.485 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -141.25 162.97 34.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -1.087 . . . . 0.0 110.639 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 113' ' ' ILE . 49.0 mt -120.08 120.92 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 109.377 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.28 131.99 44.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 8' ' ' GLU . 19.8 mttt -112.4 110.97 21.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 7' ' ' THR . 29.0 mm -94.95 119.92 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -106.81 120.65 42.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.131 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -115.0 147.13 40.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -137.35 133.26 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.073 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.569 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -109.93 138.35 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.444 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.5 ' ND1' HG23 ' A' ' 2' ' ' VAL . 75.1 m-70 -123.69 102.37 7.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.92 165.35 12.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.943 . . . . 0.0 110.099 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.123 0.487 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 128' ' ' VAL . 2.3 t -128.94 92.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.921 . . . . 0.0 110.023 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HE2' ' CB ' ' A' ' 131' ' ' GLU . 20.1 ptmt -69.4 131.19 44.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.312 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.455 ' O ' ' C ' ' A' ' 131' ' ' GLU . . . -40.47 -38.59 0.86 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 110.826 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.476 ' CB ' ' HE2' ' A' ' 129' ' ' LYS . 9.8 tp10 -39.16 -65.96 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.07 -29.93 61.26 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.558 HG12 ' CE1' ' A' ' 5' ' ' TYR . 12.9 t -74.01 -49.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 0.0 109.423 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.37 -32.72 73.57 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.23 -17.79 64.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.651 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -81.27 -33.38 32.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 109.845 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -28.51 60.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.893 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -60.61 -62.14 2.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.033 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.52 -30.68 66.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.25 -38.8 93.76 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.7 mt-10 -61.59 -38.5 87.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.151 -1.205 . . . . 0.0 110.254 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.5 m -66.83 -27.75 67.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.109 -0.994 . . . . 0.0 109.875 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.504 HD22 ' CB ' ' A' ' 34' ' ' ALA . 66.1 mt -73.33 -46.41 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.315 -0.866 . . . . 0.0 110.005 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -68.27 -30.01 68.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.005 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.431 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.65 -33.87 40.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.28 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.431 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -64.3 -46.97 81.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.29 -41.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.975 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.4 tm-20 -60.3 -48.37 82.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.64 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -44.19 93.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.462 -0.774 . . . . 0.0 110.002 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -50.55 -71.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 110.368 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.0 mt -49.4 -32.77 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 110.668 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -64.82 -34.49 78.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.084 -1.01 . . . . 0.0 110.404 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.704 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.417 HG21 ' ND1' ' A' ' 121' ' ' HIS . 2.6 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.374 0.607 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -118.68 127.4 53.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 10.1 p-10 -131.93 124.97 30.52 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.857 -1.152 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.552 ' CZ ' HG13 ' A' ' 133' ' ' VAL . 93.9 m-85 -103.38 74.29 1.26 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -80.06 149.12 30.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.863 . . . . 0.0 110.528 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.512 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -160.07 -173.55 4.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.588 -0.695 . . . . 0.0 109.818 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -159.36 153.33 23.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 0.0 110.478 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 170.07 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.909 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.63 159.84 21.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.265 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.6 m -158.86 141.66 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.645 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.528 HG21 ' CD1' ' A' ' 13' ' ' ILE . 12.5 m -79.85 -10.97 12.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.607 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.61 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.2 mp -67.92 149.91 98.0 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.81 151.71 83.55 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.397 1.209 . . . . 0.0 110.796 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -74.42 -23.09 58.89 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.698 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.42 -56.57 3.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.941 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -59.84 -32.69 70.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.945 . . . . 0.0 109.798 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.442 ' CD1' HG13 ' A' ' 147' ' ' VAL . 19.3 tp -71.47 -41.73 69.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.252 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.556 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 41.4 t80 -60.89 -66.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -47.2 -42.85 20.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 110.29 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.59 69.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.449 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -89.88 -12.17 39.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.58 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.1 mp -124.11 -62.27 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.76 -34.78 54.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.878 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' GLY . 1.1 m-20 -125.0 -6.29 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.019 -1.05 . . . . 0.0 110.793 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -44.89 -45.67 9.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 15.3 p-10 -51.56 -33.41 32.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.309 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 21.8 t-20 -100.41 -33.35 10.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.46 ' HG ' HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -69.01 -41.89 77.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.561 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -45.04 -58.93 4.83 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.301 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.6 Cg_endo -72.04 -2.73 12.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.998 1.525 . . . . 0.0 110.621 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 4.8 mmtp -104.51 -60.61 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.46 HG12 ' HG ' ' A' ' 29' ' ' LEU . 26.7 m -84.69 -18.15 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.454 -0.779 . . . . 0.0 110.528 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.01 68.52 70.58 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.591 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.47 -1.4 11.28 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.036 1.545 . . . . 0.0 110.119 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.475 ' HB3' HD13 ' A' ' 139' ' ' LEU . 0.6 OUTLIER -87.62 -20.94 25.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 110.333 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.67 -58.21 1.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.459 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -104.1 129.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 110.093 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -83.85 -48.38 10.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.357 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -163.72 155.95 17.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.458 HG21 HD11 ' A' ' 56' ' ' ILE . 61.5 t -118.69 146.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.87 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -144.15 90.38 2.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.347 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 74.4 m-20 -56.38 119.35 5.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.454 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.518 ' CD1' ' HD3' ' A' ' 68' ' ' LYS . 15.2 mt -87.83 -37.81 11.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.232 1.015 . . . . 0.0 108.525 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.48 ' O ' HG21 ' A' ' 52' ' ' THR . 32.1 tt0 . . . . . 0 C--N 1.294 -1.821 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.379 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -74.0 122.44 7.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.079 1.568 . . . . 0.0 110.376 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.6 0.66 62.5 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -71.01 156.54 39.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.464 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 44' ' ' ILE . 5.3 mt -119.83 135.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.934 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 6.7 ptmt -149.33 143.44 25.8 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 110.278 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -89.22 106.48 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.46 HD12 ' HG3' ' A' ' 54' ' ' LYS . 41.9 mm -89.55 122.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.882 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.47 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 52.1 m -84.15 142.0 30.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 110.38 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.19 146.05 33.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 124.077 1.567 . . . . 0.0 110.563 -179.737 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 4.3 p90 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.386 0.612 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.475 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 19.6 m -156.79 140.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.473 -0.767 . . . . 0.0 109.768 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -83.83 127.48 33.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.023 . . . . 0.0 110.401 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 83' ' ' TYR . 12.1 t70 -126.24 124.44 40.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.824 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.9 ttp85 -98.73 144.08 28.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.0 109.031 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.549 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.3 t -75.26 146.3 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.819 -1.175 . . . . 0.0 110.126 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.442 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 22.6 t70 -98.68 -72.43 0.65 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.43 0.634 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -135.94 144.06 45.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 2.5 t -130.65 128.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 13.4 m-20 -135.97 104.03 5.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.458 ' CD2' ' N ' ' A' ' 76' ' ' HIS . 13.6 m-70 -79.37 -9.92 59.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.273 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -111.27 -37.81 5.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -89.66 3.22 53.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 110.045 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.556 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.6 m-30 55.7 59.67 3.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 75' ' ' ASP . 12.1 tttp -139.36 114.87 9.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 110.074 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.58 ' CG ' HG12 ' A' ' 23' ' ' ILE . 59.8 t80 -136.26 116.47 13.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.1 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.442 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 53.5 m-20 -127.47 151.08 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 27.2 p90 -145.28 136.63 25.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.877 . . . . 0.0 109.506 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.2 m -100.51 164.5 11.88 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.121 -0.987 . . . . 0.0 111.14 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.525 HG13 ' CD1' ' A' ' 91' ' ' ILE . 55.4 t -108.82 126.15 65.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -115.52 -74.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.767 -1.208 . . . . 0.0 111.869 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.89 59.34 3.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.655 -1.278 . . . . 0.0 110.274 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 148.95 16.95 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 52.5 -157.18 4.05 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.35 6.71 4.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.067 1.561 . . . . 0.0 111.021 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.525 ' CD1' HG13 ' A' ' 85' ' ' VAL . 50.0 mt -51.47 148.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.63 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' THR . . . -152.88 141.96 8.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.87 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -1.173 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 16.7 p -147.61 14.72 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.408 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 1.6 pp -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.793 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-10 53.31 34.84 18.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.115 -0.991 . . . . 0.0 109.247 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -71.68 157.72 37.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.543 -0.723 . . . . 0.0 110.262 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.572 HG12 ' CD1' ' A' ' 120' ' ' TYR . 61.9 mt -142.18 125.35 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 110.628 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.63 108.55 13.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.539 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -97.03 142.96 28.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.707 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 102' ' ' ILE . 25.5 mt-10 -130.23 164.18 25.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -0.796 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 101' ' ' GLU . 23.1 mm -151.63 110.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -113.59 134.17 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.151 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.447 ' C ' ' CG2' ' A' ' 105' ' ' VAL . 52.9 mt -117.86 152.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.399 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.447 ' CG2' ' C ' ' A' ' 104' ' ' ILE . 27.0 t -153.22 119.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 109.856 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.523 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -75.86 151.06 37.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.477 0.656 . . . . 0.0 111.037 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 111' ' ' GLY . 3.1 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -135.57 168.71 18.74 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.705 -0.879 . . . . 0.0 110.505 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 113' ' ' ILE . 50.0 mt -127.92 124.36 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.194 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 1.6 pp -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 111.024 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -110.31 114.8 28.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.6 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 35.5 mt -90.89 131.95 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.366 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -118.31 105.58 11.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 110.258 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 4.6 t-20 -92.94 155.38 17.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.022 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -152.76 132.99 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.572 ' CD1' HG12 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -132.75 103.18 5.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 89.2 m-70 -82.2 142.38 32.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.984 -1.072 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 p -106.28 -170.29 1.7 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 0.0 109.887 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 1.2 ttmt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 110.273 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.39 0.614 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.569 HG23 ' CG ' ' A' ' 120' ' ' TYR . 2.6 t -112.67 101.51 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 110.076 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.456 ' O ' HG22 ' A' ' 133' ' ' VAL . 1.6 mmtp -68.57 129.08 38.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.24 -49.12 61.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 111.071 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -38.4 -48.36 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -68.73 -34.09 75.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.079 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.552 HG13 ' CZ ' ' A' ' 5' ' ' TYR . 6.0 t -75.15 -47.46 35.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -61.1 -31.16 70.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.424 -0.797 . . . . 0.0 109.561 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.88 -49.48 51.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 t -65.83 -33.01 74.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 0.0 109.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -71.7 -34.86 69.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.052 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -49.95 -55.61 13.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' A' ' 36' ' ' GLN . 4.3 mm? -67.05 -36.0 81.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.015 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.1 -40.13 13.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -70.29 -63.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -1.072 . . . . 0.0 109.878 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.2 m -51.32 -22.33 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 13.2 mt -69.94 -54.25 14.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.985 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.474 ' HG ' ' N ' ' A' ' 145' ' ' ARG . 1.6 pp -57.63 -25.43 60.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.085 -1.01 . . . . 0.0 109.257 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.474 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -82.3 -33.58 28.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.98 85.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.449 -0.782 . . . . 0.0 109.743 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.472 HG11 HD13 ' A' ' 151' ' ' LEU . 70.2 t -76.21 -52.52 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.428 -0.795 . . . . 0.0 109.869 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 26.7 tt0 -51.73 -36.6 47.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.879 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 2.4 t -67.36 -54.45 20.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 110.026 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.423 ' CD1' HG13 ' A' ' 33' ' ' VAL . 1.3 t80 -48.74 -69.95 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 0.0 110.433 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.472 HD13 HG11 ' A' ' 147' ' ' VAL . 10.9 mt -41.56 -46.35 3.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.524 -0.735 . . . . 0.0 110.75 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.9 mt -70.34 -27.6 64.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.915 . . . . 0.0 110.549 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 110.198 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.402 0.62 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.51 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 18.1 m-85 -100.7 161.79 13.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.421 -0.799 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -138.19 140.98 40.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 110.369 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 23.4 m-85 -152.18 59.18 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.855 . . . . 0.0 109.775 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.414 ' CG ' ' HA ' ' A' ' 117' ' ' SER . 4.5 tm-20 -80.98 153.22 27.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.525 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.4 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 1.4 p -149.93 163.27 38.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.684 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.38 164.45 34.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.669 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.14 -179.9 7.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -112.75 160.52 17.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 110.407 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.72 136.71 10.52 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.528 -0.732 . . . . 0.0 109.812 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 19.6 m -79.91 -16.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.139 -0.975 . . . . 0.0 108.57 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.544 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 24.9 mm -65.79 148.59 98.15 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.1 150.06 85.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.613 1.323 . . . . 0.0 110.917 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -74.27 -30.64 62.21 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.903 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.32 -49.32 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.083 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.532 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 1.2 tpt180 -66.57 -32.02 73.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.952 . . . . 0.0 109.709 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.5 tt -74.81 -37.63 62.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.564 ' CE1' HG13 ' A' ' 23' ' ' ILE . 6.1 t80 -64.05 -57.06 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.04 -52.85 59.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 110.292 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.84 69.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.698 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 36.2 t80 -91.96 -16.14 27.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.203 -0.936 . . . . 0.0 110.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.564 HG13 ' CE1' ' A' ' 19' ' ' PHE . 12.5 mm -109.21 -69.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.104 -0.997 . . . . 0.0 110.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 mt -59.03 -34.48 71.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.455 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.5 -14.17 16.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.88 -30.55 9.29 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.91 -36.83 77.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -1.131 . . . . 0.0 110.396 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 8.0 p-10 -109.13 -22.89 11.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -72.5 -42.54 64.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -47.44 -59.91 4.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.353 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -72.46 -1.26 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.04 1.548 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.3 mttt -99.41 -65.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.6 m -82.91 5.31 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 110.516 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.509 ' CB ' HD22 ' A' ' 143' ' ' LEU . . . -157.04 64.33 3.3 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.293 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.16 1.82 6.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.075 1.566 . . . . 0.0 110.738 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -89.44 -19.31 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.56 -69.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.512 HD11 ' N ' ' A' ' 38' ' ' ILE . 2.0 mp -94.42 149.55 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.326 -0.858 . . . . 0.0 109.504 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.424 ' HB3' ' CA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.93 -33.47 9.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 110.75 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.76 171.16 11.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.958 -1.088 . . . . 0.0 110.822 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.424 HG23 HD11 ' A' ' 56' ' ' ILE . 73.3 t -138.9 139.0 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.933 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -145.08 112.25 6.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 110.64 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -69.7 114.9 8.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 110.113 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mm -80.63 -38.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.275 1.036 . . . . 0.0 108.484 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.532 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 6.4 tp10 . . . . . 0 C--N 1.294 -1.815 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.043 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' HG13 ' A' ' 71' ' ' VAL . 49.8 Cg_endo -75.88 131.73 13.59 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.056 1.556 . . . . 0.0 110.354 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA2' ' HD3' ' A' ' 70' ' ' ARG . . . 90.74 -1.26 78.17 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.537 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.6 m -72.69 167.6 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.532 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 10.0 mt -127.04 131.17 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.804 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.51 ' CD ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -144.0 141.46 30.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 110.561 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -99.38 107.63 19.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 110.459 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.51 HD12 ' CD ' ' A' ' 54' ' ' LYS . 28.4 mm -88.22 128.04 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -92.59 156.04 17.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 67' ' ' VAL . 30.0 m-85 -132.93 141.46 41.1 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.119 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 124.037 1.546 . . . . 0.0 110.431 -179.839 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 5.0 p90 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 2.5 m -162.95 133.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 110.048 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 16.5 ttpt -91.67 141.25 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -0.957 . . . . 0.0 110.046 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.82 134.04 36.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 109.839 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 84' ' ' SER . 3.8 ttm180 -95.4 134.3 38.38 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.537 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.7 t -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.014 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 12.6 t0 -99.41 -72.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.445 0.64 . . . . 0.0 110.407 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 tt0 -137.39 138.25 39.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.526 -0.734 . . . . 0.0 110.175 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.581 ' CG2' ' CD2' ' A' ' 81' ' ' TYR . 2.1 t -124.69 143.34 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.725 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 m-20 -150.91 93.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -72.85 -1.66 17.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -110.34 -33.23 6.69 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.331 -0.856 . . . . 0.0 108.821 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.48 16.22 27.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.676 -0.64 . . . . 0.0 109.997 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.52 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.2 m-30 44.91 48.71 9.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 5.8 ttpt -126.42 113.6 17.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.109 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.581 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 42.1 t80 -138.31 117.62 12.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 110.191 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 29.2 t-20 -124.7 165.45 17.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.171 -0.956 . . . . 0.0 109.889 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 7.7 p90 -159.37 134.55 8.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 14.4 m -93.29 161.98 14.18 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.173 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.9 t -103.51 123.71 57.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -117.07 -72.92 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 111.61 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -82.91 89.63 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.596 -1.315 . . . . 0.0 110.49 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -109.08 152.04 17.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.462 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.14 -61.37 2.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.5 Cg_endo -71.69 -47.33 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.964 1.507 . . . . 0.0 110.64 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.469 HD13 HG13 ' A' ' 85' ' ' VAL . 29.0 mt -53.98 150.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.089 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.83 -72.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.71 -75.88 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.168 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.55 21.36 0.92 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.141 -0.975 . . . . 0.0 110.495 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.441 HD22 ' HB3' ' A' ' 123' ' ' LYS . 2.5 mp -96.69 158.94 15.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.947 . . . . 0.0 110.337 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.433 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 57.09 35.39 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.996 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -67.72 151.69 46.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.629 ' CD1' ' CE1' ' A' ' 120' ' ' TYR . 19.7 mt -139.54 129.26 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 t -119.29 111.55 18.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.397 -0.814 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 1.8 m-20 -103.52 144.4 31.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.69 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.523 ' HB3' ' CB ' ' A' ' 117' ' ' SER . 13.2 tm-20 -122.84 163.28 20.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.403 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.439 HG13 ' C ' ' A' ' 101' ' ' GLU . 92.5 mt -145.52 102.42 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.898 . . . . 0.0 110.043 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.41 128.31 55.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.503 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 15.8 mt -118.96 124.68 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 110.379 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.8 t -129.12 133.24 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.293 -0.88 . . . . 0.0 110.109 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.94 147.78 24.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.665 -0.647 . . . . 0.0 111.288 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 111' ' ' GLY . 1.7 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 0.0 109.022 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.469 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -140.79 167.49 22.05 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.577 -0.955 . . . . 0.0 110.552 -179.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.4 120.71 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.204 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.75 142.02 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.992 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -130.8 96.49 4.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.605 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.9 115.51 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.567 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.523 ' CB ' ' HB3' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -91.36 152.13 20.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.67 124.86 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.097 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.88 144.5 49.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.11 -0.994 . . . . 0.0 110.471 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.629 ' CE1' ' CD1' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -122.02 135.35 54.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.989 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.525 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 22.5 m-70 -117.42 120.05 36.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 110.467 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.45 167.3 10.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB3' HD22 ' A' ' 95' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.492 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HA ' HG23 ' A' ' 122' ' ' THR . 10.0 pt-20 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.719 0.771 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.3 p -113.35 95.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.675 -0.641 . . . . 0.0 110.631 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 128' ' ' VAL . 15.4 mttt -42.87 139.04 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 133' ' ' VAL . . . -64.8 -9.66 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 110.062 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -67.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.954 . . . . 0.0 109.887 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -53.7 -30.65 44.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.217 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.457 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 5.8 t -71.62 -52.07 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.496 -0.753 . . . . 0.0 109.486 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -61.84 -29.21 70.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.85 . . . . 0.0 109.792 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.88 60.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.788 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.3 t -71.66 -31.21 66.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.835 . . . . 0.0 110.097 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -74.89 -36.91 62.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -62.77 -46.62 87.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 110.072 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -38.85 58.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.2 -34.91 89.86 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.92 -50.68 65.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -1.142 . . . . 0.0 110.211 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -58.78 -24.57 61.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.509 HD22 ' CB ' ' A' ' 34' ' ' ALA . 36.0 mt -74.65 -42.79 57.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -67.58 -27.82 67.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.437 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -81.76 -32.03 31.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 109.831 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.66 93.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.783 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.2 -43.68 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.815 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 27.2 tt0 -59.43 -43.98 92.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.834 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -62.01 -42.41 99.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 109.57 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -57.14 -73.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 110.098 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 150' ' ' TYR . 1.4 mt -42.5 -33.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.142 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -58.98 -32.08 69.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.336 -0.853 . . . . 0.0 110.172 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.478 HG11 ' N ' ' A' ' 3' ' ' PHE . 2.8 t . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.354 0.597 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.496 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 20.8 m-85 -107.47 169.09 8.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 109.865 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -149.21 143.18 25.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CD2' ' CG1' ' A' ' 133' ' ' VAL . 55.5 m-85 -154.86 60.57 0.66 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 109.581 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -80.16 150.93 30.0 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.587 0.708 . . . . 0.0 110.501 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.438 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -147.75 174.5 11.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.486 -0.759 . . . . 0.0 109.712 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -158.7 163.54 36.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.434 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 12.0 m -159.91 154.99 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 110.213 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.49 163.37 13.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -158.47 138.92 12.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.489 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 76.2 t -80.0 -14.01 13.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.136 -0.978 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.543 HG22 HD11 ' A' ' 13' ' ' ILE . 22.0 mm -67.52 150.3 97.92 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.3 Cg_endo -67.09 149.95 82.33 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.503 1.265 . . . . 0.0 110.701 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.92 -25.2 58.74 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.892 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 -54.79 6.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 14.5 mtp180 -65.8 -31.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.722 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.409 HD21 HG22 ' A' ' 104' ' ' ILE . 30.0 tp -71.29 -32.39 68.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.811 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CD2' HD11 ' A' ' 23' ' ' ILE . 6.3 t80 -70.45 -64.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -46.67 -42.55 16.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 110.481 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -70.68 -36.04 73.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.517 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 17.4 t80 -91.96 -11.3 36.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.816 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.57 HD11 ' CD2' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -118.75 -62.19 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 109.982 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.493 ' N ' HG21 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -72.87 -23.43 60.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.833 . . . . 0.0 110.109 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.7 t70 -128.85 3.13 5.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -59.85 -37.81 93.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -59.61 -25.45 64.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -1.101 . . . . 0.0 110.262 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -98.67 -22.62 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.45 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -93.04 -22.89 18.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.548 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -58.13 -58.08 21.36 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 109.932 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 49.4 Cg_endo -75.36 2.9 6.29 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.065 1.56 . . . . 0.0 110.679 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 1.2 mtpt -105.27 -60.09 1.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.016 -1.052 . . . . 0.0 110.76 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.4 m -82.73 -18.88 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB2' ' CD2' ' A' ' 143' ' ' LEU . . . -138.41 72.08 44.78 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.79 -16.8 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.03 1.542 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -74.78 -16.22 60.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.85 -63.74 1.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 110.053 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.62 144.14 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.486 -0.758 . . . . 0.0 110.305 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.03 -40.26 6.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.02 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.482 ' HB2' ' CB ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -166.93 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.472 HG13 HD11 ' A' ' 56' ' ' ILE . 3.7 m -134.55 153.48 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.91 104.37 1.92 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 111.297 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.66 117.74 7.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.645 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 53' ' ' ILE . 14.2 mm -84.26 -38.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.231 1.015 . . . . 0.0 108.779 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' O ' HG21 ' A' ' 52' ' ' THR . 47.1 tt0 . . . . . 0 C--N 1.295 -1.764 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.245 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -76.08 119.23 5.26 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.054 1.555 . . . . 0.0 110.438 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.99 2.26 59.45 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.56 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.1 m -67.87 156.78 36.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.171 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 44' ' ' ILE . 10.9 mt -121.86 131.15 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.222 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.45 140.63 30.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 11.7 ttmt -93.78 119.01 32.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.472 HD11 HG13 ' A' ' 41' ' ' VAL . 7.9 mm -102.34 128.03 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.089 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' A' ' 40' ' ' SER . 0.7 OUTLIER -90.01 153.75 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.333 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -119.56 134.95 23.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.153 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.304 -1.782 0 O-C-N 123.991 1.521 . . . . 0.0 110.146 179.662 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.444 ' O ' ' CB ' ' A' ' 67' ' ' VAL . 12.8 p90 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.296 0.57 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.555 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER 173.16 171.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 110.377 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.47 137.83 52.26 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.594 -0.691 . . . . 0.0 109.746 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD1' HG21 ' A' ' 85' ' ' VAL . 94.1 m-20 -125.22 125.78 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 110.656 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -94.07 133.59 37.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.56 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.4 t -72.58 144.38 13.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.825 -1.172 . . . . 0.0 110.743 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 82' ' ' ASN . 86.4 m-20 -92.87 -68.92 0.77 Allowed 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.339 0.59 . . . . 0.0 110.193 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.8 tp10 -143.35 134.67 26.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.177 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 HG23 ' CD2' ' A' ' 81' ' ' TYR . 3.8 t -117.29 147.79 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.897 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.35 105.0 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -80.47 -4.42 53.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -108.12 -33.2 7.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.182 -0.949 . . . . 0.0 109.305 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.66 4.52 43.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.665 -0.647 . . . . 0.0 110.109 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.503 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 22.9 m-85 53.56 46.71 25.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.07 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.39 109.97 15.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.149 -0.97 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.427 ' CD2' HG23 ' A' ' 74' ' ' VAL . 44.5 t80 -127.62 107.47 9.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.897 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.503 ' CB ' ' HB2' ' A' ' 72' ' ' ASP . 7.8 m120 -114.23 140.57 48.47 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.091 -1.005 . . . . 0.0 109.999 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 100' ' ' ASN . 48.8 p90 -143.16 138.62 29.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.7 m -103.97 172.17 6.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 111.376 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.52 HG13 ' CD1' ' A' ' 91' ' ' ILE . 42.4 t -111.21 126.57 68.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -120.94 -76.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.818 -1.176 . . . . 0.0 111.518 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.6 102.42 7.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.818 -1.176 . . . . 0.0 110.652 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -129.42 145.43 16.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.529 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.59 -57.28 3.93 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.6 Cg_endo -71.21 -30.58 15.72 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.394 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.52 ' CD1' HG13 ' A' ' 85' ' ' VAL . 73.9 mt -78.64 147.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.81 -36.32 0.73 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.07 -74.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.1 t -137.3 4.52 2.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.928 . . . . 0.0 110.416 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 5.6 mp -84.37 150.88 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.935 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.402 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.9 34.25 21.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.59 162.53 29.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 110.253 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.585 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.0 mp -136.5 131.42 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 119' ' ' LYS . 1.8 m -118.75 119.73 35.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.364 -0.835 . . . . 0.0 109.603 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 13.9 m-80 -112.17 160.6 17.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 110.721 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.474 ' CG ' ' CG ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -150.84 132.1 14.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.11 125.67 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.027 -1.046 . . . . 0.0 110.564 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 69.5 tttt -129.7 119.22 23.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.858 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.501 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 70.5 mt -118.42 112.49 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.763 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.0 t -112.01 141.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.414 -0.804 . . . . 0.0 109.879 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.0 147.08 25.18 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.499 -0.75 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 111' ' ' GLY . 2.7 p . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 0.0 109.089 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -136.87 163.04 31.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.755 -0.85 . . . . 0.0 110.644 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.466 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 1.7 tt -112.16 126.81 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.166 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 2.0 pp -106.14 135.72 47.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.869 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -124.52 106.55 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 0.0 109.712 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.22 112.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.47 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -97.8 114.02 25.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.27 135.37 48.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 99' ' ' SER . 4.7 mttt -126.22 155.74 41.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.371 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.585 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -132.04 130.21 41.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 71.8 m-70 -113.11 140.2 48.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.159 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.491 HG23 ' CA ' ' A' ' 127' ' ' GLU . 0.3 OUTLIER -129.78 170.71 13.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.974 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.491 ' CA ' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.1 p -87.12 108.78 18.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 121.475 -0.765 . . . . 0.0 110.291 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.47 ' O ' HG22 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -50.61 156.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -79.57 -7.46 58.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -50.4 -73.27 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -22.92 6.12 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.569 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 11.5 t -76.09 -48.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.845 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -26.76 65.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.392 -0.817 . . . . 0.0 109.58 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -38.74 63.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.859 . . . . 0.0 109.366 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -60.52 -35.97 77.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.688 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -68.49 -48.14 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.869 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -52.43 -58.72 5.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.925 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -72.37 -33.06 66.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.08 -42.52 31.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.6 tp10 -63.11 -47.69 81.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -1.187 . . . . 0.0 109.975 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.1 m -59.89 -26.86 66.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.085 -1.009 . . . . 0.0 109.747 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 17.3 mt -67.68 -49.98 59.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.981 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.3 pp -66.97 -23.21 65.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.01 -1.056 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.441 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 2.0 tmm_? -80.9 -35.85 31.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.067 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 150' ' ' TYR . . . -65.32 -44.23 88.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.733 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.83 -45.26 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.514 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.47 ' HA ' HG13 ' A' ' 13' ' ' ILE . 1.1 tt0 -60.35 -56.24 23.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.51 47.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.552 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -83.24 -25.52 31.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.552 ' CD2' ' CE2' ' A' ' 150' ' ' TYR . 43.1 mt -88.8 -25.12 22.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -22.64 33.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.423 -179.824 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.441 HG11 ' N ' ' A' ' 3' ' ' PHE . 2.9 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.368 0.604 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.462 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 3.2 m-85 -101.4 152.89 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.753 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.76 142.65 51.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.042 -1.036 . . . . 0.0 110.843 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -154.12 53.7 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.645 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.492 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 1.9 pt-20 -81.61 160.0 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 110.557 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 116' ' ' ILE . 3.5 p -159.8 172.26 17.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.857 . . . . 0.0 109.874 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 12.7 pt-20 -146.34 141.88 27.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.017 . . . . 0.0 110.381 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.7 m -131.69 166.95 20.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -102.23 164.01 11.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.336 -0.853 . . . . 0.0 110.425 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -159.84 134.8 7.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 m -80.03 -14.06 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.556 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 36.2 mm -73.56 148.7 88.07 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.551 -0.718 . . . . 0.0 109.146 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.91 150.59 85.56 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.55 1.29 . . . . 0.0 110.965 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -70.09 -35.09 73.93 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.942 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.55 -56.44 6.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER -62.31 -36.29 81.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 14' ' ' PRO . 4.4 tt -74.13 -33.94 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.407 -0.808 . . . . 0.0 110.241 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 32.5 t80 -60.81 -61.06 2.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.957 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttt -57.08 -36.87 71.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 110.058 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.51 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.91 -11.29 36.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.457 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.0 OUTLIER -121.69 -64.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -58.13 -48.38 80.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -105.01 7.55 34.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.155 -0.966 . . . . 0.0 110.463 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.85 -48.65 65.53 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' HB2' HG23 ' A' ' 41' ' ' VAL . 5.3 p-10 -57.67 -26.54 61.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.236 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -99.34 -30.93 11.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.649 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -81.54 -35.62 30.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.301 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.542 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.4 m-30 -44.8 -59.15 4.41 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 110.348 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -71.79 -10.45 26.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.877 1.462 . . . . 0.0 110.774 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.64 -57.26 2.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.984 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -94.18 -2.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 110.988 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.42 71.27 9.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.92 -1.112 . . . . 0.0 110.76 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.26 -20.11 16.67 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.005 1.529 . . . . 0.0 110.026 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -80.55 -29.06 37.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 110.092 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.02 -55.92 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 110.133 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.2 151.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.453 -0.78 . . . . 0.0 110.318 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -98.7 -46.49 5.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.865 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.406 ' O ' HG11 ' A' ' 41' ' ' VAL . 22.1 t -162.37 174.07 13.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 110.099 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 24.7 m -147.71 146.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -144.26 151.06 38.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.447 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -100.09 116.73 32.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 44' ' ' ILE . 19.6 mm -86.12 -37.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.19 0.995 . . . . 0.0 108.679 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' O ' HG21 ' A' ' 52' ' ' THR . 27.5 tt0 . . . . . 0 C--N 1.295 -1.798 0 CA-C-O 121.701 0.763 . . . . 0.0 110.734 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.03 117.8 5.03 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.019 1.536 . . . . 0.0 110.744 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.14 2.02 56.95 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.53 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.3 m -69.79 149.42 47.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.039 -1.271 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.444 HG12 ' HG3' ' A' ' 70' ' ' ARG . 4.7 mt -115.31 128.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.548 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -137.03 148.87 47.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.92 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 42' ' ' GLU . 8.6 tttt -94.13 95.07 8.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.822 -0.549 . . . . 0.0 109.988 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 66' ' ' TYR . 13.7 mt -84.04 137.0 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.439 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -109.03 133.3 53.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.622 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.97 144.35 29.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 109.842 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--N 1.306 -1.676 0 O-C-N 123.972 1.511 . . . . 0.0 110.475 -179.717 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 18.3 p90 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.274 0.559 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 18.2 m -154.47 154.38 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 25.8 ttmt -105.39 48.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -48.19 132.07 16.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 84' ' ' SER . 38.0 ttt180 -96.43 151.09 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 108.637 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.5 t -76.55 147.81 7.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.619 -1.301 . . . . 0.0 110.375 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 29.5 t0 -101.55 -74.07 0.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.373 0.606 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.32 146.6 36.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.209 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.9 t -137.37 127.95 38.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -124.64 113.65 18.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 109.747 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.413 ' CE1' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -75.68 -13.45 60.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 111.105 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -106.68 -35.49 6.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.017 -1.052 . . . . 0.0 109.672 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.462 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.31 14.88 19.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.549 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 41.68 48.26 3.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.382 -0.824 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -116.65 113.7 23.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.217 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.457 ' CG ' HG12 ' A' ' 23' ' ' ILE . 41.1 t80 -133.04 120.29 21.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.383 -0.823 . . . . 0.0 110.071 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 42.6 t-20 -130.69 162.42 29.49 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 110.194 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.604 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 23.7 p90 -153.94 140.86 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.2 m -98.08 154.01 18.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.475 HG13 HD13 ' A' ' 91' ' ' ILE . 39.1 t -99.39 123.05 51.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -125.09 -77.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 111.041 -178.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.528 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 3.9 tm-20 -71.97 65.62 0.55 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -86.36 140.72 17.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.528 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.18 -53.83 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.9 Cg_endo -74.59 -45.26 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.784 1.412 . . . . 0.0 110.704 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.475 HD13 HG13 ' A' ' 85' ' ' VAL . 49.2 mt -59.51 172.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.012 . . . . 0.0 110.189 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.401 ' N ' ' CG2' ' A' ' 91' ' ' ILE . . . -152.42 -65.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.475 ' O ' HG21 ' A' ' 94' ' ' THR . 2.4 m-20 -99.56 -85.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 110.107 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 93' ' ' ASP . 64.6 p -140.12 19.2 2.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 110.35 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -94.28 153.83 17.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.557 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 36.2 mt-10 57.14 36.02 27.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.396 -0.815 . . . . 0.0 109.932 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.452 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.6 mttt -69.2 153.26 43.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.915 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.57 HG12 ' CE1' ' A' ' 120' ' ' TYR . 12.6 mt -138.93 132.0 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.722 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.6 m -121.91 110.36 15.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.623 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.604 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 5.0 m120 -104.03 125.89 50.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -110.18 167.13 10.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 102' ' ' ILE . 12.2 mt -155.39 118.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.479 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 5.9 tttt -119.46 114.19 21.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.509 ' CG1' ' HG ' ' A' ' 114' ' ' LEU . 2.7 mp -103.28 125.43 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 112' ' ' SER . 42.6 t -131.21 145.71 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.246 -0.909 . . . . 0.0 110.542 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.96 153.43 21.3 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.777 -0.577 . . . . 0.0 110.218 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.064 -1.022 . . . . 0.0 111.331 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -157.14 170.63 22.07 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.407 HG23 HD11 ' A' ' 113' ' ' ILE . 48.4 mt -122.76 120.58 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.509 ' HG ' ' CG1' ' A' ' 104' ' ' ILE . 1.4 mp -86.95 122.05 30.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.667 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -104.27 97.48 7.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.8 mt -85.67 144.59 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.861 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.492 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -128.05 120.58 27.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.55 123.93 51.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.015 -1.053 . . . . 0.0 110.612 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -120.76 128.43 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.746 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.57 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -109.31 143.5 38.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -0.985 . . . . 0.0 110.243 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 66.9 m-70 -128.11 129.64 46.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.058 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -113.85 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.384 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.435 ' HA ' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.7 p -100.05 98.15 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.372 -0.83 . . . . 0.0 110.527 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 128' ' ' VAL . 3.8 mttm -54.94 -172.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.49 16.73 16.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.85 -72.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.875 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -30.49 38.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 109.201 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.553 ' CG2' ' CE2' ' A' ' 120' ' ' TYR . 11.3 t -70.88 -48.83 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.463 -0.773 . . . . 0.0 109.531 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -65.46 -36.31 83.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 0.0 110.173 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.52 72.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.661 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 t -66.4 -38.36 87.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.752 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -64.22 -43.8 93.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.993 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -51.18 -53.79 31.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.32 -24.35 62.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -57.63 -44.03 94.1 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.481 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 15.8 mt-10 -64.43 -57.51 9.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -1.161 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.8 m -46.27 -29.94 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 20.2 mt -70.61 -59.33 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.847 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 2.3 pp -66.72 -17.89 65.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.172 -0.955 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 149' ' ' SER . 0.0 OUTLIER -84.12 -33.64 24.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.798 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.05 73.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.907 . . . . 0.0 109.438 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.7 t -67.95 -43.97 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.679 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.5 OUTLIER -61.2 -36.74 80.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.249 -0.907 . . . . 0.0 109.374 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.9 OUTLIER -68.08 -52.87 30.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 0.0 109.755 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -47.46 -69.92 0.11 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 110.312 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.44 HD11 HG23 ' A' ' 13' ' ' ILE . 2.3 mt -46.21 -36.53 6.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.394 -0.817 . . . . 0.0 110.403 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -71.3 -56.41 6.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.084 -1.01 . . . . 0.0 110.297 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.933 . . . . 0.0 110.241 -179.876 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.53 HG13 ' ND1' ' A' ' 121' ' ' HIS . 4.2 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.729 0.776 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -107.31 153.04 23.32 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.261 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 143.8 48.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.971 -1.08 . . . . 0.0 111.183 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CD2' HG12 ' A' ' 133' ' ' VAL . 10.8 m-85 -153.59 58.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 0.0 109.151 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 9.9 pt-20 -84.94 145.07 27.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 110.807 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -146.78 167.53 23.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -147.42 166.87 25.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.99 . . . . 0.0 110.369 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.12 -168.4 2.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 p -130.35 160.81 32.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.461 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . 41.5 m -159.95 139.26 11.03 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 14.8 p -79.83 -6.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.203 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 9.9 mm -74.27 148.96 86.64 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.0 150.25 88.33 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.561 1.296 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -67.04 -36.99 83.29 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.457 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.66 -54.16 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.565 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.525 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 12.0 ttt180 -57.83 -39.5 77.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 1.4 tt -67.32 -39.1 85.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CZ ' ' O ' ' A' ' 75' ' ' ASP . 61.9 t80 -61.23 -71.0 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 0.0 110.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -47.4 -45.67 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.144 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 0.0 110.496 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 16.2 t80 -90.86 -7.09 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -121.42 -64.9 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.978 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.472 ' N ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -61.82 -48.27 81.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 110.299 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.431 ' OD2' HD12 ' A' ' 29' ' ' LEU . 29.9 t0 -110.82 16.7 21.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 110.313 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.72 -61.18 6.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -45.89 -23.88 0.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -1.125 . . . . 0.0 110.711 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -89.74 -32.51 16.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 0.0 110.518 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.431 HD12 ' OD2' ' A' ' 25' ' ' ASP . 3.8 mp -84.4 -18.08 37.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -62.49 -61.81 6.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.675 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -72.72 53.76 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.841 1.443 . . . . 0.0 110.981 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -151.64 -63.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.119 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.534 HG12 ' CE1' ' A' ' 150' ' ' TYR . 17.0 m -86.18 -19.93 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.44 66.12 35.52 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 110.264 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.66 -10.77 21.97 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.003 1.528 . . . . 0.0 110.397 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -22.91 64.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.285 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.459 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -95.19 -55.91 2.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.49 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.4 mp -107.72 137.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 110.112 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.19 -29.33 14.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.987 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -178.61 145.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.012 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 2.3 p -126.99 119.21 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.167 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -115.01 119.68 37.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.3 m-20 -65.54 117.59 8.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.493 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 55' ' ' LYS . 20.8 mm -79.91 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.36 1.076 . . . . 0.0 108.422 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.2 mm-40 . . . . . 0 C--N 1.295 -1.761 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.064 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 71' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 43.8 Cg_endo -70.72 83.68 0.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.05 1.553 . . . . 0.0 110.286 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.86 -8.69 2.25 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 32.7 m -67.69 165.54 17.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.965 -1.315 . . . . 0.0 109.257 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 19.5 mt -138.03 143.37 33.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.961 -1.087 . . . . 0.0 111.056 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -154.9 136.9 14.63 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.569 ' HE2' ' CD1' ' A' ' 66' ' ' TYR . 1.1 ttpm? -95.56 112.48 24.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 111.404 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.49 ' CG2' HG12 ' A' ' 38' ' ' ILE . 15.1 mt -98.17 122.33 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 109.266 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.48 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -84.08 150.89 25.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.691 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -111.19 137.06 20.87 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.198 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.459 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 48.6 Cg_endo . . . . . 0 C--N 1.304 -1.765 0 O-C-N 123.994 1.523 . . . . 0.0 110.529 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.569 ' CD1' ' HE2' ' A' ' 55' ' ' LYS . 21.5 p90 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.227 0.537 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 66' ' ' TYR . 4.2 m -143.09 175.74 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.177 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.9 ttpt -122.46 37.93 4.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 4.6 p-10 -42.24 138.57 1.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.618 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.0 ptt180 -102.81 167.26 9.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 108.947 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 16.3 t -77.85 152.34 5.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.94 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 34.2 t70 -104.71 -66.34 0.97 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -144.7 130.09 18.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.251 -0.906 . . . . 0.0 110.742 -179.736 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 5.4 t -116.12 150.83 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.578 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -158.33 111.23 2.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.221 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -21.25 51.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -104.77 -40.32 6.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.19 -0.944 . . . . 0.0 109.756 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.41 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -84.48 7.22 20.56 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.762 . . . . 0.0 110.274 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.526 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 8.0 m-85 46.25 59.26 3.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.29 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -131.27 107.94 9.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.965 -1.084 . . . . 0.0 110.741 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.534 ' CD2' HD11 ' A' ' 102' ' ' ILE . 13.9 t80 -125.99 104.1 8.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.521 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 37.3 m-20 -121.02 149.1 43.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.2 p90 -139.04 138.38 37.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' ARG . 5.7 m -101.89 159.94 14.92 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.906 -1.121 . . . . 0.0 111.008 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 69' ' ' ASP . 55.5 t -106.98 121.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.16 -75.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.067 -1.021 . . . . 0.0 110.873 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' CA ' ' OE1' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -74.04 95.24 2.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.72 -1.238 . . . . 0.0 110.101 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -122.79 138.31 11.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.536 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.4 -54.36 3.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.4 Cg_endo -72.47 -48.43 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.831 1.437 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 91' ' ' ILE . 64.4 mt -54.5 160.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.178 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.469 ' N ' HG21 ' A' ' 91' ' ' ILE . . . -155.59 -70.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' O ' ' OG1' ' A' ' 94' ' ' THR . 0.5 OUTLIER -103.31 74.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 110.198 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 46.6 p 43.7 24.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 96' ' ' GLU . 3.6 pp -96.96 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 0.0 110.126 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER 56.45 34.66 24.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -67.95 151.48 47.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.301 -0.874 . . . . 0.0 110.018 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.654 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -126.79 120.67 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.612 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.45 ' O ' ' OE1' ' A' ' 101' ' ' GLU . 1.0 OUTLIER -108.83 104.23 13.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.541 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -96.25 145.43 25.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.782 -179.249 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.521 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 1.2 mp0 -136.11 139.73 43.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.437 -0.79 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.534 HD11 ' CD2' ' A' ' 81' ' ' TYR . 3.0 mp -130.21 100.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 110.476 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 59.3 tttt -104.76 124.47 49.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.01 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 50.0 mt -110.45 138.63 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.895 . . . . 0.0 110.377 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 t -139.2 138.87 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.05 -1.031 . . . . 0.0 109.912 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.08 144.08 26.7 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.497 0.665 . . . . 0.0 110.479 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 111' ' ' GLY . 1.9 p . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.81 . . . . 0.0 108.924 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -134.51 163.56 29.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.785 -0.832 . . . . 0.0 110.538 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.1 mt -109.49 133.25 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 109.349 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -97.88 133.93 41.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.976 -1.078 . . . . 0.0 110.803 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -129.55 98.66 4.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.413 -0.804 . . . . 0.0 109.642 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.494 ' CD1' HD21 ' A' ' 114' ' ' LEU . 1.5 mp -101.02 136.86 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.933 . . . . 0.0 110.421 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -113.33 125.44 54.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.374 -0.829 . . . . 0.0 110.232 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.78 134.0 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 0.7 OUTLIER -125.82 143.59 51.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.956 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.654 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -125.56 104.02 8.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.97 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.53 ' ND1' HG13 ' A' ' 2' ' ' VAL . 33.2 m-70 -83.42 101.44 11.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.88 . . . . 0.0 110.409 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.5 166.98 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.804 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.325 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.551 0.691 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 128' ' ' VAL . 3.0 p -104.79 86.62 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -48.48 150.29 1.39 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -60.46 -27.34 67.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.959 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 130' ' ' ALA . 28.5 mt-10 -41.71 -64.59 0.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 110.046 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -55.12 -29.7 58.23 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.577 HG12 ' CD2' ' A' ' 5' ' ' TYR . 9.3 t -72.88 -50.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.415 -0.803 . . . . 0.0 109.442 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.2 -21.4 60.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.198 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 -32.29 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.122 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -35.58 37.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -49.36 -60.57 2.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 110.004 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -76.94 -31.7 56.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 110.116 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.52 -55.03 14.38 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -50.06 -40.3 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.154 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.06 -24.91 67.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.987 . . . . 0.0 109.695 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 54.7 mt -73.81 -51.49 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.94 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.4 pp -64.54 -22.01 66.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 tpt85 -81.66 -43.08 19.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.444 -0.785 . . . . 0.0 109.682 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -57.75 -36.72 72.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.3 t -73.22 -53.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 109.603 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 11' ' ' SER . 50.7 tt0 -53.48 -53.15 55.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -36.3 73.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.128 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.534 ' CE1' HG12 ' A' ' 33' ' ' VAL . 1.2 t80 -48.93 -71.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.573 -0.704 . . . . 0.0 109.823 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.488 ' CB ' ' CD1' ' A' ' 13' ' ' ILE . 1.9 mp -56.45 -26.53 54.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.725 . . . . 0.0 110.071 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -77.74 -14.38 59.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.32 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -179.875 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 120' ' ' TYR . 4.5 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.427 0.632 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -111.24 151.31 28.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.33 135.61 49.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 110.363 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD2' HG12 ' A' ' 133' ' ' VAL . 28.2 m-85 -148.39 70.68 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.445 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -95.19 154.21 17.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 6' ' ' GLU . 2.1 p -158.15 -169.77 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.507 -0.746 . . . . 0.0 109.844 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.9 pt-20 -159.96 150.93 19.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.748 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.424 ' CG2' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -132.17 153.39 50.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.402 -0.811 . . . . 0.0 109.77 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.403 ' CG2' ' CD1' ' A' ' 113' ' ' ILE . 1.8 p -92.93 160.2 15.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.741 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.48 ' OG ' ' CD1' ' A' ' 114' ' ' LEU . 17.3 m -158.07 137.78 12.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 109.673 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' O ' HG11 ' A' ' 12' ' ' VAL . 56.7 t -80.05 -11.0 12.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.611 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.0 OUTLIER -75.85 150.73 84.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.083 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.3 Cg_endo -66.71 150.74 83.52 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.716 1.377 . . . . 0.0 111.145 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.73 -19.57 60.76 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.497 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.8 -54.87 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.471 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 14.4 ttp180 -64.15 -38.35 90.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.759 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 18' ' ' LEU . 6.4 tt -71.29 -33.48 69.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.569 ' CD2' HD11 ' A' ' 23' ' ' ILE . 33.8 t80 -62.26 -65.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.115 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -51.64 -47.82 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 110.266 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 17' ' ' ARG . . . -64.26 -32.29 73.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 25.9 t80 -91.73 -13.01 32.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.569 HD11 ' CD2' ' A' ' 19' ' ' PHE . 1.1 mp -114.98 -71.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.192 -0.942 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.43 ' N ' HG23 ' A' ' 23' ' ' ILE . 8.1 mt -62.22 -34.2 76.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.845 . . . . 0.0 110.766 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.4 m-20 -118.0 23.8 11.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.156 -0.965 . . . . 0.0 110.444 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.56 -38.22 33.19 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 41' ' ' VAL . 1.9 p30 -56.49 -30.57 63.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -1.152 . . . . 0.0 110.408 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 25' ' ' ASP . 4.9 p-10 -96.02 -18.81 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 tp -82.21 -39.75 22.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 110.341 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.588 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -53.05 -62.04 3.99 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.224 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.8 Cg_endo -73.27 54.89 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.813 1.428 . . . . 0.0 110.476 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.7 -67.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 110.564 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.479 HG13 ' CD1' ' A' ' 150' ' ' TYR . 30.6 m -80.14 -15.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.512 -0.742 . . . . 0.0 110.449 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.447 ' HB2' HD22 ' A' ' 143' ' ' LEU . . . -156.25 76.87 4.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.346 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.0 -2.19 11.64 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.044 1.549 . . . . 0.0 110.214 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -72.72 -28.31 62.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -86.42 -61.66 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.961 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.532 HD11 ' CG ' ' A' ' 30' ' ' PHE . 1.2 mp -105.8 128.91 59.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.402 -0.811 . . . . 0.0 109.699 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.451 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -91.33 -25.3 19.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.18 -0.95 . . . . 0.0 110.485 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.39 141.02 0.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.693 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 27' ' ' ASP . 2.1 p -127.47 139.88 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mm-40 -142.23 158.74 43.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.973 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -103.87 115.73 31.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.465 -0.772 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.431 HD13 ' HG3' ' A' ' 68' ' ' LYS . 10.0 mt -81.23 -39.01 17.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.8 tp10 . . . . . 0 C--N 1.296 -1.739 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.708 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.32 89.34 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.6 -3.03 3.17 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.189 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.564 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 33.5 m -78.48 161.34 27.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.319 . . . . 0.0 109.697 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 14.0 mt -130.9 144.91 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.911 -1.118 . . . . 0.0 110.619 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -152.47 144.45 23.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.778 . . . . 0.0 109.784 179.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -93.52 117.45 30.1 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.434 -0.791 . . . . 0.0 110.757 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.5 mm -102.73 141.76 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -112.19 142.72 44.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.048 -1.032 . . . . 0.0 110.437 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -118.2 123.2 29.61 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 O-C-N 123.855 1.45 . . . . 0.0 110.383 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 40.6 p90 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.855 0.836 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.556 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -173.91 172.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.556 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -107.95 128.68 54.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.161 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.464 ' OD1' HG21 ' A' ' 85' ' ' VAL . 17.0 m-20 -127.19 130.67 50.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 2.4 ttp180 -101.15 145.26 29.02 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 0.0 108.935 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.564 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 9.7 t -67.9 149.79 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.965 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t70 -101.33 -68.95 0.79 Allowed 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.403 0.621 . . . . 0.0 110.386 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.1 tt0 -145.8 121.94 10.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 110.339 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.7 t -108.91 151.6 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 1.2 m-20 -152.08 113.77 4.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -88.89 2.13 54.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 110.144 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -117.43 -40.84 3.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.692 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.1 11.77 28.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.219 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.508 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 50.35 57.79 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 3.8 mtpt -129.61 126.27 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.498 ' OH ' ' NZ ' ' A' ' 54' ' ' LYS . 16.4 t80 -143.63 106.62 4.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 62.7 t-20 -117.0 165.99 12.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.631 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.3 p90 -161.17 137.76 8.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.818 . . . . 0.0 109.467 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 69.8 m -106.85 168.53 9.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.581 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 91' ' ' ILE . 39.8 t -106.58 127.87 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -114.8 -70.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 111.879 -178.462 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.544 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -90.48 98.09 11.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.492 -1.38 . . . . 0.0 110.147 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -111.33 141.53 16.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.03 -58.7 3.63 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.0 Cg_endo -74.06 -31.46 7.88 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.986 1.519 . . . . 0.0 110.461 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.519 ' CD1' HG13 ' A' ' 85' ' ' VAL . 54.0 mt -67.66 145.61 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.306 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.433 ' N ' HG21 ' A' ' 91' ' ' ILE . . . -107.11 -92.21 2.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.58 -72.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.9 p -132.06 15.11 4.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.47 146.67 23.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 110.315 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.429 ' HA ' HG21 ' A' ' 122' ' ' THR . 16.6 tt0 62.33 33.05 16.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.972 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -79.08 149.66 32.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.56 HD12 ' CE1' ' A' ' 120' ' ' TYR . 11.0 mt -127.69 153.93 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.816 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 63.3 m -145.64 105.39 3.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.489 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 7.7 m120 -101.19 124.4 46.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.147 -0.971 . . . . 0.0 110.889 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.525 ' HG3' ' ND2' ' A' ' 82' ' ' ASN . 1.9 tt0 -106.71 152.41 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.545 -0.722 . . . . 0.0 109.776 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.442 HG13 ' C ' ' A' ' 101' ' ' GLU . 13.5 mt -137.6 144.44 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.206 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.405 ' C ' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -143.98 132.42 22.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.473 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 7.3 mm -119.94 119.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 109.908 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 112' ' ' SER . 14.4 t -133.49 126.15 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 110.918 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -72.96 158.17 35.99 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.149 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.026 -1.046 . . . . 0.0 111.22 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 13.7 t -159.99 -178.86 7.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 111.274 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.403 ' CD1' ' CG2' ' A' ' 10' ' ' THR . 39.1 mm -130.0 117.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.48 ' CD1' ' OG ' ' A' ' 11' ' ' SER . 3.4 mp -87.2 121.12 29.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.966 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -104.34 106.83 17.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.662 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 1.2 tt -105.63 132.17 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 40.7 t -121.1 115.18 22.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -99.25 134.71 41.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 134.3 50.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.56 ' CE1' HD12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -116.75 131.93 56.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.87 . . . . 0.0 109.998 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 86.9 m-70 -116.25 101.51 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.038 . . . . 0.0 110.29 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.463 HG22 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -118.28 167.15 11.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.201 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 110.367 -179.875 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.262 0.553 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 122' ' ' THR . 2.1 t -132.09 103.43 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 110.092 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -75.95 139.91 41.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.496 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -61.76 -10.17 8.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.989 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.42 -52.88 41.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.875 -1.141 . . . . 0.0 109.878 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -28.91 68.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 108.881 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.567 HG12 ' CD2' ' A' ' 5' ' ' TYR . 22.1 t -76.98 -49.97 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.5 -0.75 . . . . 0.0 109.12 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 15.6 tptt -66.58 -27.33 67.64 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.722 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.96 -33.47 63.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.762 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.6 t -67.07 -34.69 78.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.106 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -29.57 66.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.24 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.23 -66.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -17.91 62.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.43 -41.12 86.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.8 tt0 -67.62 -42.2 82.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 110.109 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -61.47 -29.01 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.495 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 34' ' ' ALA . 18.1 mt -68.85 -54.5 15.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.409 -0.807 . . . . 0.0 109.908 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.495 ' HG ' ' N ' ' A' ' 145' ' ' ARG . 1.1 pp -61.48 -29.43 69.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.495 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -72.86 -34.05 66.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.429 -0.794 . . . . 0.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -65.56 -43.21 90.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.426 HG11 HD13 ' A' ' 151' ' ' LEU . 21.6 t -64.98 -40.86 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.609 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 2.8 tt0 -54.66 -48.9 71.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.842 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t -59.53 -50.36 74.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.479 ' CD1' HG13 ' A' ' 33' ' ' VAL . 1.6 t80 -47.18 -70.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.66 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.426 HD13 HG11 ' A' ' 147' ' ' VAL . 8.5 mt -47.59 -45.17 27.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -50.92 -46.25 60.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 110.277 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.545 HG13 ' ND1' ' A' ' 121' ' ' HIS . 13.1 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.618 0.723 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 31.9 m-85 -117.62 141.58 48.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.996 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.6 141.14 46.72 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.022 . . . . 0.0 110.258 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.47 ' CE1' HG13 ' A' ' 133' ' ' VAL . 42.8 m-85 -147.16 55.63 1.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.725 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.67 148.85 30.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.787 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.61 -0.681 . . . . 0.0 109.78 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.81 158.03 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 -171.4 3.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.586 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.81 162.16 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -159.2 143.36 15.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 0.0 109.936 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.493 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 7.2 p -79.94 -12.85 13.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.618 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.585 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.2 mp -69.95 149.28 96.42 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.28 149.59 85.09 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.437 1.23 . . . . 0.0 111.157 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 112' ' ' SER . . . -74.63 -25.91 59.54 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.53 -53.53 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.918 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.501 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -66.1 -34.2 77.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.8 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.51 ' HB2' ' CG2' ' A' ' 13' ' ' ILE . 7.0 tt -74.95 -30.99 61.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.615 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CE1' HG13 ' A' ' 23' ' ' ILE . 59.3 t80 -67.92 -71.82 0.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -50.45 -42.68 54.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.853 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 17' ' ' ARG . . . -66.21 -36.16 82.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.493 -0.754 . . . . 0.0 110.294 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 25.8 t80 -91.98 -10.93 37.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.578 HG13 ' CE1' ' A' ' 19' ' ' PHE . 7.7 mm -100.35 -74.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.211 -0.931 . . . . 0.0 110.157 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.478 ' CD1' ' HG2' ' A' ' 20' ' ' LYS . 19.8 mt -68.0 -40.99 82.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.44 -0.788 . . . . 0.0 109.796 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -85.39 -18.79 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 110.026 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.52 -40.43 62.19 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 9.5 m-20 -55.74 -26.04 43.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -1.157 . . . . 0.0 110.11 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 67.6 m-20 -109.19 -23.32 11.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mp -85.33 -28.48 25.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.219 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.564 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.6 m-30 -54.2 -59.79 9.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.6 Cg_endo -73.41 0.19 8.38 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.99 1.521 . . . . 0.0 110.556 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -96.25 -69.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.685 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.2 m -81.81 7.27 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.396 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.16 2.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.325 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.33 -2.03 11.49 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.979 1.515 . . . . 0.0 110.653 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -90.62 -3.49 57.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.274 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' O ' ' HD3' ' A' ' 59' ' ' PRO . . . -110.88 -71.56 0.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.13 138.59 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.453 -0.78 . . . . 0.0 110.162 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.2 t -81.57 -48.82 11.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -163.65 176.75 9.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.296 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 27' ' ' ASP . 2.6 m -135.45 147.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 1.1 tt0 -136.44 161.29 36.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.84 110.16 20.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.481 ' HB ' ' HB ' ' A' ' 53' ' ' ILE . 15.5 mm -82.04 -39.45 16.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 122.231 1.015 . . . . 0.0 108.414 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.0 tm-20 . . . . . 0 C--N 1.296 -1.752 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.166 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.487 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.28 94.84 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.876 1.461 . . . . 0.0 110.221 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.38 -6.92 4.64 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.581 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 38.1 m -80.25 162.74 24.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -1.112 . . . . 0.0 109.53 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.481 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 31.5 mt -137.41 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.099 -1.001 . . . . 0.0 110.37 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -148.79 142.7 25.76 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.267 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HB2' HD13 ' A' ' 44' ' ' ILE . 25.0 tttp -91.77 117.24 29.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.532 -0.73 . . . . 0.0 110.197 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.5 HD13 ' CD ' ' A' ' 54' ' ' LYS . 39.7 mm -97.15 119.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.244 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.472 ' HB2' ' N ' ' A' ' 40' ' ' SER . 3.7 m -82.54 130.68 35.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.869 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.538 ' CD1' HG23 ' A' ' 67' ' ' VAL . 2.3 m-85 -108.24 163.63 16.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 110.617 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 45.2 Cg_endo . . . . . 0 C--N 1.304 -1.769 0 O-C-N 124.238 1.652 . . . . 0.0 110.726 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.463 ' O ' HG11 ' A' ' 67' ' ' VAL . 8.3 p90 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.765 0.793 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' A' ' 58' ' ' PHE . 29.2 m -152.21 150.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.534 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 11.6 mtmt -110.48 139.91 45.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.95 -1.094 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 20.2 p-10 -134.73 133.58 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 110.276 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 84' ' ' SER . 7.4 ttt180 -100.07 139.65 35.43 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.581 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 14.1 t -61.31 153.92 5.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.541 -1.349 . . . . 0.0 111.039 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 18.4 t0 -106.32 -73.6 0.68 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.874 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.31 112.63 7.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.385 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.502 HG23 ' CZ ' ' A' ' 81' ' ' TYR . 2.6 t -102.89 141.5 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' LYS . 16.8 t0 -142.63 120.55 12.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.64 1.33 57.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 110.383 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -115.39 -35.63 4.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.089 -1.007 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -102.14 20.81 15.97 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.488 -0.758 . . . . 0.0 110.503 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.8 m-30 43.21 56.72 4.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 75' ' ' ASP . 25.7 tttt -125.99 123.16 37.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.53 ' CD2' HG22 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -142.48 105.09 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.087 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.48 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 47.3 m-20 -121.0 144.01 48.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 110.185 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 31.1 p90 -135.49 137.37 42.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.848 . . . . 0.0 109.379 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.5 m -94.66 161.66 14.1 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 110.977 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.539 HG13 ' CD1' ' A' ' 91' ' ' ILE . 25.2 t -102.69 128.22 55.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -119.33 -74.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.06 -1.025 . . . . 0.0 111.349 -178.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.534 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -92.11 64.84 4.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.638 -1.289 . . . . 0.0 109.881 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . -131.77 159.67 23.3 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 44.98 -157.08 0.24 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.83 1.57 6.9 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.024 1.539 . . . . 0.0 110.782 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.539 ' CD1' HG13 ' A' ' 85' ' ' VAL . 75.9 mt -51.63 155.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.052 . . . . 0.0 110.321 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.1 -107.08 0.24 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.476 ' HB2' HD22 ' A' ' 95' ' ' LEU . 18.4 m-20 -47.7 -86.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.933 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.419 ' CG2' ' C ' ' A' ' 93' ' ' ASP . 30.6 p -148.23 12.34 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -92.82 157.85 16.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 110.239 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.4 mm-40 59.51 33.04 22.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.902 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.497 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.2 ttpm? -76.55 159.36 30.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.622 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mp -142.02 127.59 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.875 . . . . 0.0 110.228 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t -116.42 112.9 22.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.603 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -99.24 136.62 38.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 110.495 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.518 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 90.2 mt-10 -125.97 144.28 50.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.794 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.4 mt -136.08 113.6 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.352 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.45 124.66 48.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 3.2 mt -118.2 127.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.0 t -132.56 141.59 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -87.93 144.45 26.55 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.393 0.616 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 111' ' ' GLY . 4.4 p . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.493 2.496 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -133.6 163.59 29.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.813 -0.816 . . . . 0.0 110.671 -179.3 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.3 mt -108.32 131.6 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.42 -0.8 . . . . 0.0 109.022 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.01 135.29 47.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.937 -1.102 . . . . 0.0 110.504 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.45 111.12 11.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' THR . 3.2 mt -102.84 125.61 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 110.587 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.518 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -109.55 119.39 39.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.807 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -118.26 141.66 48.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.319 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -124.9 151.73 44.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 109.993 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.622 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -130.26 99.8 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 109.759 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.545 ' ND1' HG13 ' A' ' 2' ' ' VAL . 14.7 m-70 -86.01 105.83 16.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.804 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.468 HG22 ' CG2' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -113.02 172.94 6.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.1 tttt . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.866 . . . . 0.0 110.386 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.5 ' O ' ' CG1' ' A' ' 128' ' ' VAL . 2.4 t -122.36 89.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -60.18 132.03 52.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.615 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.9 -16.84 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.018 . . . . 0.0 110.632 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.22 -59.01 5.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.898 -1.126 . . . . 0.0 109.495 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -63.59 -30.2 71.34 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 109.061 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.47 HG13 ' CE1' ' A' ' 5' ' ' TYR . 16.1 t -71.74 -47.25 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -65.07 -30.67 71.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.773 . . . . 0.0 110.048 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.44 -19.94 61.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.0 t -72.43 -43.47 63.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 110.092 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 138' ' ' GLU . 21.9 ptmt -79.91 -37.71 34.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 137' ' ' LYS . 6.5 tt0 -51.8 -57.58 8.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 -25.94 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -60.44 -46.49 94.25 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.462 ' HA ' HD22 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -62.26 -44.11 97.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.26 -1.141 . . . . 0.0 110.453 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.465 ' O ' ' HB1' ' A' ' 146' ' ' ALA . 56.6 m -62.67 -22.82 66.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.003 -1.06 . . . . 0.0 109.775 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 19.6 mt -74.32 -52.66 11.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 110.041 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.64 -27.32 66.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.602 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.454 ' HG2' HD13 ' A' ' 144' ' ' LEU . 27.0 mmt180 -77.17 -29.26 54.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.878 . . . . 0.0 109.492 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 142' ' ' THR . . . -67.41 -49.64 62.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.3 -41.55 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.694 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -63.38 -50.67 69.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.678 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.33 -16.78 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.676 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.45 ' CD2' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -83.53 -38.45 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.6 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.45 ' HG ' ' CD2' ' A' ' 150' ' ' TYR . 8.7 mt -68.72 -55.29 11.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 110.285 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.63 -27.31 1.83 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.936 . . . . 0.0 109.994 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 110.018 179.797 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.459 HG23 ' ND1' ' A' ' 121' ' ' HIS . 2.4 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.523 0.677 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.483 ' CD2' ' HB ' ' A' ' 128' ' ' VAL . 1.2 m-85 -91.4 164.27 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -143.95 143.56 31.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.504 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 68.2 m-85 -155.49 65.83 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.587 -0.695 . . . . 0.0 109.291 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 1.8 pp20? -85.15 153.1 22.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 110.888 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.43 176.45 9.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.972 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 2.0 pt-20 -158.44 149.38 20.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.127 -0.983 . . . . 0.0 110.483 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 -170.04 2.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -125.95 168.37 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.442 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -158.81 138.26 11.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.553 -0.717 . . . . 0.0 109.595 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 13' ' ' ILE . 4.0 p -79.89 -14.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.559 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.596 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.0 OUTLIER -72.39 152.16 92.03 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.73 150.3 86.27 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 123.505 1.266 . . . . 0.0 111.132 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -74.25 -22.07 59.49 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.642 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.24 -57.31 3.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.436 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 3.4 ttt-85 -60.38 -29.49 68.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.482 HD13 ' CG1' ' A' ' 147' ' ' VAL . 4.3 tp -74.28 -42.19 59.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 42.4 t80 -59.52 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 110.166 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.0 ttpt -53.49 -45.29 69.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 17' ' ' ARG . . . -70.83 -28.6 64.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.868 . . . . 0.0 110.588 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 42.1 t80 -92.03 -17.55 24.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.915 . . . . 0.0 110.486 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.558 HG12 ' CD2' ' A' ' 81' ' ' TYR . 1.6 mt -117.64 -63.55 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -48.14 -47.89 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 110.265 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.1 m-20 -107.15 -12.03 15.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 30' ' ' PHE . . . -41.8 -30.49 0.64 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.63 -59.49 4.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -1.179 . . . . 0.0 110.048 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -87.89 -17.26 31.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.1 tp -75.72 -45.39 36.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 110.131 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 26' ' ' GLY . 1.6 m-85 -43.46 -57.72 5.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 110.457 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.2 Cg_endo -70.05 -8.91 24.77 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.914 1.481 . . . . 0.0 110.608 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 29' ' ' LEU . 6.0 ttmm -95.57 -46.2 6.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.91 -8.11 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.381 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.09 81.05 3.35 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.82 -6.32 18.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.975 1.513 . . . . 0.0 110.298 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.18 -18.43 27.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.269 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -97.39 -71.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -99.69 152.58 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.546 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.414 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -114.39 -33.15 5.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.537 -179.675 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.07 146.79 6.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.089 -1.007 . . . . 0.0 110.596 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.47 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 47.5 t -133.5 139.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 84.6 tt0 -152.48 158.74 43.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.441 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.49 117.88 35.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 110.377 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.422 ' HA ' HD11 ' A' ' 44' ' ' ILE . 21.6 mm -83.16 -38.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.301 1.048 . . . . 0.0 108.335 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.531 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 25.3 tp10 . . . . . 0 C--N 1.296 -1.741 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.099 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.48 100.86 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.858 1.452 . . . . 0.0 110.243 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.417 ' O ' HD12 ' A' ' 53' ' ' ILE . . . 111.39 1.32 27.91 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.1 m -61.12 155.81 19.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -1.117 . . . . 0.0 109.5 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 11.7 mm -112.94 133.14 59.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.943 . . . . 0.0 109.775 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.507 ' CG ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -145.34 144.5 30.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.102 -0.999 . . . . 0.0 110.285 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -92.83 112.67 24.7 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.619 -0.676 . . . . 0.0 110.608 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.507 HD12 ' CG ' ' A' ' 54' ' ' LYS . 38.8 mm -103.85 138.77 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 109.347 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.45 141.67 47.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 110.757 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -116.67 135.03 22.85 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.94 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo . . . . . 0 C--N 1.304 -1.787 0 O-C-N 123.93 1.49 . . . . 0.0 110.784 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.487 ' O ' ' CB ' ' A' ' 67' ' ' VAL . 6.7 p90 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.195 0.521 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER 168.81 171.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.367 -0.833 . . . . 0.0 110.586 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.572 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -106.03 54.36 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.642 -0.662 . . . . 0.0 109.938 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.463 ' OD2' HG21 ' A' ' 85' ' ' VAL . 5.2 m-20 -41.83 129.41 3.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.338 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -98.14 150.65 21.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 108.896 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.551 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.3 t -81.03 144.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.71 -1.243 . . . . 0.0 110.219 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 36.3 t0 -98.42 -71.0 0.7 Allowed 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.367 0.603 . . . . 0.0 110.004 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -143.84 113.01 6.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 0.0 110.047 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 4.9 t -104.17 136.21 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.267 -0.896 . . . . 0.0 109.932 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 74' ' ' VAL . 83.4 m-20 -141.07 113.03 7.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -82.51 -3.02 55.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -110.42 -36.68 5.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.201 -0.937 . . . . 0.0 109.653 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.39 15.24 20.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.549 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 m-30 45.86 51.97 10.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 110.34 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -129.21 124.54 34.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.973 -1.079 . . . . 0.0 110.751 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.558 ' CD2' HG12 ' A' ' 23' ' ' ILE . 2.2 t80 -139.44 101.6 4.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.421 -0.799 . . . . 0.0 109.861 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.506 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 74.0 m-20 -113.87 136.04 53.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.0 p90 -134.71 133.04 39.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.582 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' ARG . 68.3 m -99.41 170.58 8.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 111.433 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.463 HG21 ' OD2' ' A' ' 69' ' ' ASP . 48.9 t -106.71 131.27 56.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.39 -79.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.899 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 68' ' ' LYS . 1.1 tt0 -91.87 106.52 18.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.941 -1.099 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 164.13 175.74 35.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 47.27 -159.81 0.41 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.92 -7.76 21.7 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.135 1.597 . . . . 0.0 110.691 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 91' ' ' ILE . 47.7 mt -51.55 154.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.35 -58.1 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -121.33 -69.2 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.252 . . . . 0.0 110.645 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 t -147.31 9.14 0.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 0.0 110.748 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.7 155.74 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 0.0 110.091 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 57.84 36.33 26.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -78.82 159.35 27.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 110.408 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.479 HG13 ' CD1' ' A' ' 120' ' ' TYR . 2.3 mt -139.82 137.69 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.528 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 m -123.46 112.72 17.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.33 -0.856 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 13.7 m120 -99.39 130.03 45.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.506 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 2.6 mt-10 -123.76 139.74 53.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.852 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 102' ' ' ILE . 16.9 mt -135.59 114.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.369 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -114.53 124.22 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.862 . . . . 0.0 109.878 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.49 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 4.3 mp -111.92 134.79 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.416 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -140.58 137.94 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 0.0 110.417 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.0 146.62 25.41 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.78 -0.575 . . . . 0.0 110.968 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 111' ' ' GLY . 1.5 p . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.352 -0.843 . . . . 0.0 108.957 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -137.34 166.38 23.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.477 -1.013 . . . . 0.0 111.13 -179.087 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.5 mt -118.86 126.0 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 109.103 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.12 146.08 25.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 0.0 110.863 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 13.4 mttt -141.58 109.97 5.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.525 -0.734 . . . . 0.0 109.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 101' ' ' GLU . 19.0 mt -105.92 135.45 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.6 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.519 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -116.7 115.78 26.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.129 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -103.88 126.1 50.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.392 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -115.5 130.14 56.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.316 -0.865 . . . . 0.0 109.959 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.479 ' CD1' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -116.72 117.21 29.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.453 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.459 ' ND1' HG23 ' A' ' 2' ' ' VAL . 25.3 m-70 -94.26 130.64 40.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.457 ' CG2' HG22 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -114.96 169.24 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 110.088 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.19 0.519 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.483 ' HB ' ' CD2' ' A' ' 3' ' ' PHE . 2.3 t -121.14 116.11 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -80.16 132.4 35.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.731 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.96 -48.41 52.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 110.913 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.9 mt-10 -36.98 -55.97 0.9 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 110.907 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.48 77.05 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 130' ' ' ALA . 7.2 t -74.68 -48.3 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 109.315 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -67.42 -30.22 69.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.531 -0.73 . . . . 0.0 109.824 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.54 60.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -35.1 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -79.74 -23.93 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.23 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -53.86 -52.81 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 4.6 mt -75.15 -28.75 60.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.468 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -55.49 -46.57 80.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 33.5 tt0 -56.34 -52.53 64.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -1.205 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.3 m -57.61 -28.86 64.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.201 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.511 HD23 ' CB ' ' A' ' 37' ' ' ALA . 84.7 mt -69.48 -46.08 67.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 110.358 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.1 pp -68.77 -26.13 65.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.779 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.461 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -81.93 -41.0 21.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -56.1 -50.37 71.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.37 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.482 ' CG1' HD13 ' A' ' 18' ' ' LEU . 3.6 t -62.4 -48.84 86.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.475 -0.765 . . . . 0.0 108.954 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 36.5 tt0 -53.03 -46.83 68.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.8 t -67.43 -51.27 53.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 1.8 t80 -44.9 -69.38 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.809 . . . . 0.0 110.392 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.9 mt -49.17 -37.1 21.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.503 -0.748 . . . . 0.0 110.629 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.2 mt -77.1 -18.84 57.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.048 -1.033 . . . . 0.0 110.373 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.935 . . . . 0.0 110.071 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.573 HG22 ' CG ' ' A' ' 121' ' ' HIS . 9.3 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.586 0.708 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.513 ' N ' HG21 ' A' ' 2' ' ' VAL . 25.5 m-85 -101.89 -178.93 3.86 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.67 138.39 34.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.861 -1.149 . . . . 0.0 111.018 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -144.44 54.83 1.27 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 9.0 pt-20 -80.1 152.55 29.24 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.543 0.687 . . . . 0.0 110.962 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.74 172.72 13.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -157.84 153.54 26.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.402 ' OG1' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -144.03 -169.14 3.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 110.12 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -132.14 167.64 19.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.349 -0.845 . . . . 0.0 110.391 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.899 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 17.3 t -79.92 -17.25 12.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 17.8 mm -70.42 149.31 95.71 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.6 Cg_endo -65.72 146.75 84.68 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.143 1.075 . . . . 0.0 111.053 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 112' ' ' SER . . . -71.86 -30.13 65.11 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.45 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.54 -56.85 10.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.937 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -35.15 79.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -69.78 -38.31 76.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.485 -0.76 . . . . 0.0 109.418 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CZ ' ' O ' ' A' ' 75' ' ' ASP . 41.9 t80 -62.2 -59.1 5.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.895 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -49.76 -48.42 50.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 110.314 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.84 76.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.6 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.2 t80 -88.43 -14.01 39.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.614 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.512 HD12 ' CD2' ' A' ' 19' ' ' PHE . 1.3 mp -114.62 -48.9 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.95 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -72.12 -48.56 42.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 110.036 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' HB3' ' CD1' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -115.99 20.81 14.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.993 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.02 -58.18 14.97 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' HB3' HG13 ' A' ' 41' ' ' VAL . 21.8 m-20 -56.71 -19.08 14.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -1.174 . . . . 0.0 110.213 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.82 -37.03 10.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.9 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 3.9 mp -79.97 -20.84 44.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 0.0 110.163 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.518 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.1 m-85 -58.37 -57.03 29.33 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.552 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.7 Cg_endo -73.0 -13.62 26.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.054 1.555 . . . . 0.0 110.945 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.17 -43.38 11.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.989 . . . . 0.0 110.58 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 29' ' ' LEU . 26.8 m -89.68 -24.76 5.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 110.315 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HB2' HD22 ' A' ' 143' ' ' LEU . . . -150.36 78.84 7.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.48 -31.31 7.26 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.093 1.575 . . . . 0.0 110.63 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.37 -18.65 11.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.062 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.422 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . . . -96.83 -48.0 5.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.221 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -123.29 146.49 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 109.923 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.423 ' C ' ' OG ' ' A' ' 40' ' ' SER . 1.6 t -92.56 -53.05 4.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -162.32 172.51 15.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 0.0 110.634 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 27' ' ' ASP . 12.6 t -145.83 138.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.311 -0.868 . . . . 0.0 109.886 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mt-10 -137.62 163.89 30.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.723 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.7 116.56 32.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 44' ' ' ILE . 23.9 mm -83.63 -37.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.345 1.069 . . . . 0.0 108.372 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 6.1 tp10 . . . . . 0 C--N 1.293 -1.857 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 45.4 Cg_endo -71.72 118.35 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.939 1.494 . . . . 0.0 110.249 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.75 54.68 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.56 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.4 m -68.41 154.46 41.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -1.183 . . . . 0.0 109.348 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.526 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 9.3 mt -116.96 133.39 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.011 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 1.4 ptpt -143.28 147.54 34.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.661 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB2' HD13 ' A' ' 44' ' ' ILE . 12.7 tttp -105.35 118.27 36.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.688 -0.633 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.0 mt -107.26 147.83 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.082 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -107.25 139.49 41.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.127 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -112.58 125.63 29.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.307 -1.63 0 O-C-N 123.852 1.448 . . . . 0.0 110.557 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.5 p90 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.551 0.691 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -170.57 172.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 0.0 109.801 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.571 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.25 151.51 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.161 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 84' ' ' SER . 6.8 p-10 -148.41 135.39 20.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 110.357 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 84' ' ' SER . 14.6 ttp-105 -99.02 141.22 32.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.394 -0.816 . . . . 0.0 108.849 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.56 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 3.4 t -72.56 147.14 10.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.847 -1.158 . . . . 0.0 110.199 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 84' ' ' SER . 4.7 m-20 -93.04 -70.09 0.72 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.404 0.621 . . . . 0.0 109.98 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.5 tt0 -149.91 131.28 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.74 146.68 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.528 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 35.2 m-20 -145.63 119.98 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -88.9 0.19 56.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -116.67 -35.96 4.05 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.75 8.74 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.46 -0.775 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.512 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.5 m-30 53.62 69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 5.4 tttt -136.79 133.1 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.377 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.403 ' HB2' HG12 ' A' ' 23' ' ' ILE . 9.7 t80 -149.86 94.58 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.883 . . . . 0.0 110.071 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.524 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 33.2 m-20 -116.78 145.2 43.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.568 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 36.3 p90 -146.76 137.38 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 70' ' ' ARG . 62.2 m -98.78 170.83 8.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 111.232 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.538 HG13 ' CD1' ' A' ' 91' ' ' ILE . 41.5 t -108.35 127.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -116.96 -70.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 111.272 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -85.05 95.6 9.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.594 -1.316 . . . . 0.0 110.052 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -116.93 139.82 15.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.515 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.11 -57.12 2.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.2 Cg_endo -71.91 -38.34 4.17 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.922 1.485 . . . . 0.0 110.308 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.538 ' CD1' HG13 ' A' ' 85' ' ' VAL . 46.5 mt -68.16 170.53 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.503 ' N ' ' CG2' ' A' ' 91' ' ' ILE . . . -162.66 -77.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.92 -90.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -1.196 . . . . 0.0 110.297 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.1 t -146.94 18.39 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.2 164.76 12.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 110.105 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.92 34.43 22.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 121' ' ' HIS . 1.1 ttmt -76.42 150.95 36.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.233 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.651 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 56.2 mt -128.39 132.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 t -119.17 102.41 8.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.579 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.568 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 3.4 m120 -87.08 135.51 33.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.524 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 52.1 mt-10 -131.45 134.6 46.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 110.095 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.7 mt -128.33 126.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.031 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 15' ' ' ALA . 4.5 mp -134.45 141.09 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.752 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.5 t -141.9 144.16 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 109.546 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.06 162.7 16.64 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.395 -0.815 . . . . 0.0 111.09 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.477 HG21 ' O ' ' A' ' 111' ' ' GLY . 1.5 p . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.501 -0.749 . . . . 0.0 109.245 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.477 ' O ' HG21 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.48 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -142.44 159.98 41.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.708 -0.878 . . . . 0.0 110.627 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.45 ' O ' HG21 ' A' ' 113' ' ' ILE . 19.7 tt -109.19 142.0 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.945 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 116' ' ' ILE . 1.0 OUTLIER -121.72 150.49 41.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 110.181 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.15 124.29 18.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 2.4 mt -111.19 117.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -102.05 111.8 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.33 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.05 123.49 47.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.121 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.56 151.54 35.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.354 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.651 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -131.6 99.72 4.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.834 . . . . 0.0 110.193 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.573 ' CG ' HG22 ' A' ' 2' ' ' VAL . 85.5 m-70 -79.8 113.69 18.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.37 172.47 6.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.979 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.604 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 122' ' ' THR . 4.1 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.355 0.598 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.563 HG12 ' CD2' ' A' ' 120' ' ' TYR . 2.8 t -116.08 101.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -54.75 125.19 19.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.027 -1.045 . . . . 0.0 109.501 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -53.16 -48.06 68.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 110.396 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.1 mt-10 -35.63 -55.22 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.58 -0.7 . . . . 0.0 110.661 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -42.35 92.85 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 108.998 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 130' ' ' ALA . 14.1 t -68.03 -48.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.248 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -59.86 -31.46 69.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.529 -0.732 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.89 -47.72 61.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -24.08 67.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.173 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.44 -36.09 45.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.88 . . . . 0.0 110.184 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -44.67 83.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.12 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 37' ' ' ALA . 3.1 mp -73.47 -31.54 63.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 110.019 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -65.72 -41.1 96.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.4 mm-40 -56.67 -37.05 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -1.203 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.8 m -70.15 -18.86 63.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 98.0 mt -77.13 -44.82 28.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 0.0 109.896 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.6 pp -66.93 -29.94 69.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.459 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 17.2 ttp180 -77.64 -36.4 51.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.765 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.12 67.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.785 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.0 t -60.23 -47.26 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.444 -0.785 . . . . 0.0 109.781 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 35.8 tt0 -51.64 -48.91 63.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 -43.67 85.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.948 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -52.03 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.159 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.487 ' CD1' HG23 ' A' ' 13' ' ' ILE . 35.5 mt -42.62 -51.82 5.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -48.72 -25.21 1.69 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.074 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.418 0.628 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.553 ' CD1' HG13 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -106.54 161.93 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.949 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.79 139.21 50.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.942 . . . . 0.0 110.156 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.564 ' CE2' HG12 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -146.84 56.21 1.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.025 179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 7' ' ' THR . 0.3 OUTLIER -82.83 153.7 25.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.38 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 6' ' ' GLU . 1.4 p -156.14 169.06 25.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.814 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 15.2 pt-20 -158.8 138.37 11.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 110.619 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 t -133.15 -172.6 2.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.316 -0.865 . . . . 0.0 109.928 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -117.97 159.52 23.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.7 t -152.67 136.75 16.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.689 -0.632 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.96 -12.17 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.017 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 41.2 mm -69.86 148.4 96.39 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.0 Cg_endo -65.58 151.23 85.37 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.503 1.265 . . . . 0.0 111.007 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.68 -29.16 61.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.035 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.6 -48.46 16.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.287 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.481 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -68.14 -37.54 81.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.994 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' CD1' HG13 ' A' ' 147' ' ' VAL . 25.7 tp -74.79 -26.24 59.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.185 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.539 ' CE1' HG13 ' A' ' 23' ' ' ILE . 75.2 t80 -69.69 -59.69 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 110.046 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -57.18 -39.95 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.387 -0.821 . . . . 0.0 110.128 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -72.54 -31.99 65.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.846 . . . . 0.0 110.546 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -91.9 -18.25 24.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.539 HG13 ' CE1' ' A' ' 19' ' ' PHE . 9.3 mm -104.06 -67.33 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.49 -27.54 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -109.38 -5.06 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.356 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.42 -56.54 24.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.98 -23.84 1.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 110.556 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -100.37 -39.79 7.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 110.305 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 1.9 tp -71.18 -38.01 72.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.0 m-30 -48.21 -61.02 3.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 110.55 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.0 Cg_endo -71.65 -2.09 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.972 1.512 . . . . 0.0 110.715 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -104.28 -36.11 7.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 110.469 -179.756 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.503 ' CG2' ' HB2' ' A' ' 146' ' ' ALA . 7.2 p -96.67 -26.08 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.959 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.24 78.61 8.58 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.78 2.75 6.16 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.117 1.588 . . . . 0.0 110.964 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.05 -38.36 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 110.481 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.55 -49.4 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.229 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.43 146.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.987 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.508 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -100.95 -32.3 10.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.212 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.5 168.11 2.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.601 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 t -138.51 141.27 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.598 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -144.62 110.94 5.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.067 -1.021 . . . . 0.0 110.757 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.6 116.89 5.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.214 -0.929 . . . . 0.0 110.419 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' ILE . 12.3 mt -84.97 -39.64 14.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 122.172 0.987 . . . . 0.0 108.556 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 52' ' ' THR . 22.3 tt0 . . . . . 0 C--N 1.296 -1.731 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.3 Cg_endo -72.83 118.04 5.39 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.026 1.54 . . . . 0.0 110.381 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 -1.65 40.88 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.565 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 7.0 m -67.35 154.64 40.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.252 . . . . 0.0 109.226 179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' ILE . 9.9 mt -121.97 135.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 110.512 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.559 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -142.38 138.71 31.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.99 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -92.43 101.08 13.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.574 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.433 HD13 ' CG ' ' A' ' 69' ' ' ASP . 22.3 mt -88.97 129.09 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.533 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.1 m -93.24 141.22 28.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.473 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.18 131.27 22.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.863 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 39' ' ' SER . 47.3 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 O-C-N 123.874 1.46 . . . . 0.0 110.663 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.533 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 32.8 p90 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.269 0.557 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.574 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -170.35 172.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.191 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.574 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -121.25 62.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.477 -0.765 . . . . 0.0 110.468 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.433 ' CG ' HD13 ' A' ' 56' ' ' ILE . 7.4 p-10 -52.97 133.08 38.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.906 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -97.81 142.86 29.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.937 . . . . 0.0 108.716 179.491 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.565 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 3.5 t -69.73 149.56 10.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.645 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.3 t70 -101.29 -74.42 0.62 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.434 0.635 . . . . 0.0 110.044 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.2 tt0 -135.39 136.13 41.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.109 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.78 147.32 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -152.57 101.32 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -75.14 -9.42 58.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.736 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -102.78 -34.09 9.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 108.638 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.75 11.26 39.15 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.342 0.591 . . . . 0.0 109.752 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 23.4 m-30 44.36 43.85 6.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 110.191 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 5.7 tttm -118.09 114.21 22.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.267 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 8.3 t80 -131.48 109.36 10.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 6.9 m120 -112.4 145.97 39.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 110.031 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.576 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 3.6 p90 -137.74 138.26 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.811 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' ARG . 7.0 m -98.82 159.58 14.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.177 -0.952 . . . . 0.0 110.858 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 91' ' ' ILE . 24.7 t -104.19 122.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -121.92 -76.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.085 -1.009 . . . . 0.0 110.953 -178.561 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 16.0 mm-40 -70.49 57.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.753 -1.217 . . . . 0.0 109.996 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -69.54 126.8 19.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.502 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.83 -54.1 3.62 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.2 Cg_endo -75.99 -40.99 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.875 1.46 . . . . 0.0 110.594 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 85' ' ' VAL . 36.0 mt -50.98 138.37 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.076 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.55 -94.55 1.83 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.82 -80.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 110.171 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.03 19.79 2.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 110.065 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.67 165.51 12.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.227 -0.92 . . . . 0.0 110.245 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.468 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 3.2 tp10 56.35 33.17 21.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 8.8 tttm -67.84 167.34 13.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.565 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.1 mt -143.93 127.86 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.42 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.468 ' HB3' ' CB ' ' A' ' 119' ' ' LYS . 12.9 t -115.1 112.31 22.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.576 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -105.85 152.39 23.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.873 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 30.9 mt-10 -145.24 129.27 17.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.785 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.44 ' HA ' HD11 ' A' ' 102' ' ' ILE . 19.5 mm -122.26 128.95 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.03 -1.044 . . . . 0.0 110.384 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 4.9 tttt -129.63 117.24 20.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 110.038 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.541 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 64.4 mt -110.66 109.2 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 110.72 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 106' ' ' ALA . 42.1 t -115.47 151.03 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.748 0.785 . . . . 0.0 109.595 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.531 ' N ' HG11 ' A' ' 105' ' ' VAL . . . -88.05 168.38 12.87 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.642 -0.662 . . . . 0.0 110.867 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.467 HG21 ' CD1' ' A' ' 113' ' ' ILE . 7.7 p . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -134.49 162.85 31.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 110.743 -179.496 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.467 ' CD1' HG21 ' A' ' 107' ' ' THR . 5.2 mt -110.37 117.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.396 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 21.6 mt -87.76 129.18 35.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.913 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 104.76 9.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 4.1 mp -105.04 122.27 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.094 -1.004 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.5 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -105.95 120.95 43.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.473 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.423 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -114.93 139.02 50.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.236 -179.784 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER -132.55 142.2 49.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -121.21 133.07 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.044 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.534 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 59.9 m-70 -111.57 129.41 56.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.23 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.521 ' CG2' ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.95 173.47 6.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.425 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.4 tttt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.331 -0.856 . . . . 0.0 110.203 179.792 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.521 ' HA ' ' CG2' ' A' ' 122' ' ' THR . 38.6 mt-10 . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.666 0.746 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.557 HG22 ' CD2' ' A' ' 120' ' ' TYR . 1.8 p -79.97 137.38 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.572 -0.705 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 126.71 31.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.611 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . . . -65.92 -57.24 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.931 -1.106 . . . . 0.0 111.249 -178.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -40.95 -26.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.889 -1.132 . . . . 0.0 110.143 -179.273 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -84.68 -42.88 14.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.175 -0.953 . . . . 0.0 109.164 178.509 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.611 ' CG1' ' HA ' ' A' ' 130' ' ' ALA . 8.0 p -78.98 -33.77 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.339 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' N ' HG11 ' A' ' 133' ' ' VAL . 2.9 ttpp -70.56 -23.6 62.63 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.242 -0.911 . . . . 0.0 109.277 178.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 131' ' ' GLU . . . -73.29 -20.9 60.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.829 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.7 t -71.94 -29.87 64.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 110.19 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -78.04 -47.15 19.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -45.95 -61.17 1.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -14.49 61.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -64.18 -54.41 30.25 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.535 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.4 tt0 -47.72 -36.95 12.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 100.0 m -66.8 -25.36 66.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.717 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 36.6 mt -74.75 -52.24 12.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.632 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.3 pp -66.79 -29.3 69.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.942 . . . . 0.0 109.657 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.423 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 11.0 tpt180 -78.0 -28.88 49.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -0.877 . . . . 0.0 109.511 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.503 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -68.83 -36.7 78.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.823 . . . . 0.0 109.732 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.489 HG13 ' CD1' ' A' ' 18' ' ' LEU . 40.2 t -73.09 -48.51 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.389 -0.82 . . . . 0.0 109.715 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.409 ' HA ' HG13 ' A' ' 13' ' ' ILE . 5.6 tt0 -53.4 -49.67 66.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 152' ' ' LEU . 0.9 OUTLIER -60.45 -45.39 93.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.684 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -48.31 -72.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 110.035 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.19 -36.12 5.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.421 ' HB3' ' O ' ' A' ' 149' ' ' SER . 16.1 tp -62.74 -55.71 24.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 -179.946 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.502 HG23 ' CG ' ' A' ' 121' ' ' HIS . 2.7 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.427 0.632 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -97.0 163.8 12.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.724 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -133.78 144.95 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 110.678 -179.662 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CD1' HG13 ' A' ' 133' ' ' VAL . 48.4 m-85 -154.85 56.44 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -0.771 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.535 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 2.2 pp20? -86.91 137.09 32.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 110.837 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -140.11 -175.66 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.674 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.28 152.16 25.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.056 -1.027 . . . . 0.0 110.589 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -135.35 -179.17 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 0.0 109.81 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 1.5 p -127.3 161.25 29.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.66 141.89 17.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.518 -0.739 . . . . 0.0 109.636 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.83 -12.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.32 -0.952 . . . . 0.0 108.559 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.626 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.3 mp -71.07 152.01 94.82 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.13 152.02 82.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.475 1.25 . . . . 0.0 110.886 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -76.86 -27.59 55.12 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.904 -178.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.22 -50.23 16.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.046 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -63.49 -43.15 98.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.785 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.73 -33.84 76.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.379 -0.825 . . . . 0.0 109.948 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 76' ' ' HIS . 37.2 t80 -61.57 -64.89 0.8 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 12.0 mttt -48.13 -47.25 34.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.482 -0.761 . . . . 0.0 110.39 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.47 78.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.317 -0.864 . . . . 0.0 111.012 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -90.08 -10.1 45.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 110.65 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -115.02 -60.19 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 109.932 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 15.1 mt -68.29 -48.97 63.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.111 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.71 20.7 18.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.033 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.42 -60.9 5.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.01 -24.66 10.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 0.0 110.218 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -84.67 -46.57 11.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.522 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.483 HD22 ' CG1' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -73.88 -28.22 61.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.478 -179.739 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.526 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m-30 -49.38 -57.47 11.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.456 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 45.6 Cg_endo -72.02 -7.61 21.36 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.987 1.52 . . . . 0.0 110.728 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -101.58 -54.43 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.344 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG1' HD22 ' A' ' 29' ' ' LEU . 5.5 m -80.31 -13.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 110.528 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.69 71.84 12.64 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 0.0 110.08 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.51 0.37 9.19 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.047 1.551 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.94 -20.08 19.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.455 ' O ' ' CD1' ' A' ' 58' ' ' PHE . . . -102.18 -38.9 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.82 136.8 53.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.65 -47.17 6.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.84 140.06 3.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.29 125.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 11.8 mt-10 -115.0 89.27 3.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 110.728 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 54' ' ' LYS . 10.9 t-20 -54.17 116.76 2.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.3 mm -87.75 -38.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.271 1.034 . . . . 0.0 108.574 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' O ' HG21 ' A' ' 52' ' ' THR . 24.4 tt0 . . . . . 0 C--N 1.295 -1.776 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.449 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.0 Cg_endo -73.54 120.52 6.52 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.981 1.516 . . . . 0.0 110.551 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.02 1.3 61.41 Favored Glycine 0 N--CA 1.48 1.606 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.561 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.2 m -67.21 152.93 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -1.191 . . . . 0.0 109.435 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.443 ' C ' ' HG3' ' A' ' 54' ' ' LYS . 8.6 mt -124.56 131.38 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.48 -179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -143.89 134.76 25.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 179.471 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 2.2 ttpt -82.17 98.65 8.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.7 mt -85.95 132.55 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.696 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.5 OUTLIER -109.43 145.67 35.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 110.795 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 37' ' ' ALA . 5.9 m-85 -109.46 140.72 22.37 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 109.987 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.542 . . . . 0.0 110.756 -179.738 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 3.4 p90 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 4.3 m -160.54 164.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 110.503 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -109.63 40.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 109.848 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 7.7 t70 -38.76 130.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.486 -0.759 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ttp-105 -103.96 151.42 23.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.077 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.561 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.6 t -78.44 147.71 6.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 84' ' ' SER . 10.3 m-20 -97.4 -72.38 0.65 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.452 0.644 . . . . 0.0 110.431 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.9 tt0 -138.52 136.62 36.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.578 -0.701 . . . . 0.0 110.129 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.8 t -125.07 125.35 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.919 . . . . 0.0 109.995 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -123.85 127.89 48.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 109.885 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.2 t60 -86.27 -20.02 29.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 0.0 111.075 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -106.19 -37.81 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.995 -1.066 . . . . 0.0 109.897 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -85.81 13.42 7.34 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.475 -0.766 . . . . 0.0 110.198 179.999 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 42.31 61.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.918 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -128.21 118.15 22.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 110.921 -179.329 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 52.7 t80 -133.83 98.03 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 32.3 m-20 -112.76 142.84 44.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 110.289 -179.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 10.9 p90 -142.2 138.43 31.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.342 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 35.6 m -104.45 165.12 11.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.082 -1.011 . . . . 0.0 111.062 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.544 HG13 ' CD1' ' A' ' 91' ' ' ILE . 47.2 t -108.42 127.36 64.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.63 -74.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 111.388 -178.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 2.3 mt-10 -82.8 97.87 8.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.828 -1.17 . . . . 0.0 110.227 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.415 ' HA2' HG11 ' A' ' 67' ' ' VAL . . . -128.48 155.5 20.5 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.526 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -45.38 -56.68 6.13 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -70.59 -41.44 3.22 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.866 1.456 . . . . 0.0 110.84 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.544 ' CD1' HG13 ' A' ' 85' ' ' VAL . 77.4 mt -77.46 165.32 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.196 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -148.18 -52.56 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.31 -83.08 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.373 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.9 t -143.06 11.15 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.22 151.04 22.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.262 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.525 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 7.7 tt0 55.83 35.07 24.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.764 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 6.2 tttt -75.44 158.3 32.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.39 -0.819 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.58 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.2 mt -135.71 131.1 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -0.99 . . . . 0.0 110.662 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 m -116.18 109.95 18.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 0.0 109.527 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.58 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 3.0 m120 -99.56 138.41 36.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.454 ' HG3' ' HB3' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -128.94 131.62 47.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.822 179.593 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.468 HD13 HG22 ' A' ' 116' ' ' ILE . 40.3 mm -122.15 119.15 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -122.11 109.26 14.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.096 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 1.9 mp -94.92 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.2 132.31 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.309 -0.87 . . . . 0.0 110.248 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.06 145.39 25.99 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.418 0.627 . . . . 0.0 110.969 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 111' ' ' GLY . 2.6 p . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -137.26 169.05 18.43 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.666 -0.902 . . . . 0.0 110.444 -179.414 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 23.0 mt -123.63 133.96 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 179.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.486 ' CD2' HG22 ' A' ' 104' ' ' ILE . 25.5 mt -97.9 142.37 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.81 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -127.86 97.16 4.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.316 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.468 HG22 HD13 ' A' ' 102' ' ' ILE . 3.0 mt -94.34 115.98 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.732 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.535 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 38.4 t -104.58 108.3 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.464 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 4.3 t-20 -101.36 149.52 23.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.226 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 141.04 38.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.013 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.58 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -117.72 122.16 42.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.814 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.525 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 25.2 m-70 -105.23 110.14 22.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.99 167.95 14.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.523 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.115 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.342 0.591 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 128' ' ' VAL . 3.3 p -108.27 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.396 -0.815 . . . . 0.0 111.062 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.1 142.1 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.953 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 131' ' ' GLU . . . -52.59 -26.86 14.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.093 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.5 mm-40 -42.39 -58.33 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.716 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -59.85 -34.08 72.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 108.978 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.571 HG13 ' CD1' ' A' ' 5' ' ' TYR . 15.7 t -67.11 -49.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.447 -0.783 . . . . 0.0 109.259 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.494 ' HE2' ' NZ ' ' A' ' 137' ' ' LYS . 2.3 mmtt -50.74 -35.36 31.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -23.85 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.6 t -70.9 -37.47 72.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.117 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.494 ' NZ ' ' HE2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -75.77 -31.2 59.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 109.91 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.62 -47.25 80.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.88 -45.06 29.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.855 . . . . 0.0 110.311 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.55 -47.24 52.22 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -56.67 -30.46 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -1.204 . . . . 0.0 110.425 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.404 ' O ' ' HB1' ' A' ' 146' ' ' ALA . 90.4 m -70.73 -28.81 65.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.091 . . . . 0.0 109.653 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.4 mt -71.81 -48.69 44.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 109.867 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.481 ' C ' ' CD1' ' A' ' 144' ' ' LEU . 1.1 pp -63.55 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.418 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -75.05 -35.19 61.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.661 179.502 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -68.59 -29.22 67.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.56 -47.01 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.875 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -59.37 -46.8 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -43.45 98.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 110.148 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -54.43 -71.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 110.389 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 150' ' ' TYR . 34.0 mt -39.65 -49.91 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.468 -0.77 . . . . 0.0 110.592 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.65 -61.63 2.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.274 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.109 179.97 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.455 0.645 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.52 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 0.7 OUTLIER -99.36 171.12 8.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 109.26 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.05 141.28 16.44 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.969 -1.082 . . . . 0.0 110.825 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CD2' ' CG1' ' A' ' 133' ' ' VAL . 8.3 m-85 -159.38 59.17 0.4 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.538 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 11.2 pt-20 -81.85 152.67 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.428 -0.795 . . . . 0.0 110.662 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.71 -175.92 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 109.91 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.69 157.73 30.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.081 -1.012 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 t -146.51 -179.1 6.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.102 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -116.81 160.82 20.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.254 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.07 137.03 11.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.85 -12.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 35.3 mm -68.6 148.49 98.08 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.51 150.43 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.38 1.2 . . . . 0.0 110.752 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB3' HG23 ' A' ' 104' ' ' ILE . . . -74.95 -25.62 59.01 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.29 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.39 -52.3 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 110.356 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 8.4 ttt-85 -63.45 -38.38 90.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.868 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.49 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 3.0 tm? -68.89 -34.35 75.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.967 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 45.9 t80 -64.11 -68.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 24' ' ' LEU . 8.7 tttt -45.84 -51.26 13.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.002 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.0 -38.77 79.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 110.054 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 15.1 t80 -84.72 -13.07 52.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.587 HD13 ' CG ' ' A' ' 81' ' ' TYR . 9.9 mm -118.9 -76.55 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.258 -0.901 . . . . 0.0 110.056 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' CB ' ' HG2' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -46.47 -56.3 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.033 179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -93.92 1.05 56.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 27' ' ' ASP . . . -46.91 -53.22 10.6 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 26' ' ' GLY . 3.3 p-10 -42.88 -29.94 0.36 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -1.134 . . . . 0.0 110.033 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 19.3 t30 -113.54 -11.36 13.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.003 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -83.63 -18.48 38.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.556 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.2 m-30 -75.43 -59.51 1.26 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.362 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.8 Cg_endo -71.19 -3.57 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.905 1.476 . . . . 0.0 110.492 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -91.97 -66.26 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.204 179.967 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.459 HG13 ' CG ' ' A' ' 150' ' ' TYR . 6.2 m -85.93 -11.13 11.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.426 -0.797 . . . . 0.0 110.312 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -143.05 61.39 10.35 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.932 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.23 -5.93 18.02 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.091 1.574 . . . . 0.0 110.584 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.72 -25.58 38.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB3' HD21 ' A' ' 139' ' ' LEU . . . -96.42 -55.99 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 110.311 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.453 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -100.57 137.97 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.906 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.494 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -103.24 -33.33 9.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.1 OUTLIER -160.1 149.24 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.0 110.796 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.414 HG13 ' HE2' ' A' ' 54' ' ' LYS . 6.3 t -128.08 136.2 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 0.0 109.337 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 29.0 mt-10 -139.86 153.11 46.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.039 -1.038 . . . . 0.0 111.151 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.5 113.12 26.5 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.806 0.812 . . . . 0.0 109.636 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' ILE . 19.2 mm -82.97 -39.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 122.185 0.993 . . . . 0.0 108.989 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 7.9 tp10 . . . . . 0 C--N 1.295 -1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 110.464 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.61 131.05 16.76 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.12 1.59 . . . . 0.0 110.476 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 -9.46 76.97 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.55 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 22.2 m -60.85 153.62 24.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.068 -1.254 . . . . 0.0 109.496 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' ILE . 6.8 mt -116.25 125.62 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -135.47 146.67 48.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 110.265 -179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HB2' HD13 ' A' ' 44' ' ' ILE . 30.5 ttpt -97.61 132.98 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.33 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.48 144.18 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.471 ' HB2' ' OG ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -114.56 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.124 -0.985 . . . . 0.0 110.221 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -121.18 133.4 24.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 48.7 Cg_endo . . . . . 0 C--N 1.307 -1.621 0 O-C-N 123.99 1.521 . . . . 0.0 110.487 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.423 ' O ' HG11 ' A' ' 67' ' ' VAL . 1.9 p90 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.186 0.517 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 66' ' ' TYR . 9.2 m -144.11 172.36 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.334 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -116.32 139.2 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.876 179.716 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 84' ' ' SER . 5.0 p-10 -133.2 133.47 42.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.0 ttm180 -96.26 146.42 24.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.55 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 3.4 t -73.94 145.12 11.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.836 -1.165 . . . . 0.0 110.404 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -94.07 -70.61 0.7 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.466 0.65 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -148.91 124.3 10.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 0.0 109.801 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 3.3 t -112.85 149.28 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.19 -0.944 . . . . 0.0 110.445 -179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 3.8 t0 -149.09 97.74 2.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -64.4 -7.92 11.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.895 -179.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -108.28 -46.22 3.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.016 -1.052 . . . . 0.0 109.765 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.36 13.54 4.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.735 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.564 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.7 m-30 47.42 50.87 14.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.059 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 6.3 tttt -123.77 117.28 24.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.993 -1.067 . . . . 0.0 110.779 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.587 ' CG ' HD13 ' A' ' 23' ' ' ILE . 17.3 t80 -134.44 103.75 5.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.344 -0.848 . . . . 0.0 109.779 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 31.2 m-20 -118.14 144.42 45.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.222 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 26.5 p90 -144.63 136.24 25.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' ARG . 74.5 m -96.77 171.09 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 111.209 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 91' ' ' ILE . 41.6 t -108.95 125.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.409 HG13 ' H ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -116.75 -70.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.021 -1.049 . . . . 0.0 111.648 -178.577 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -89.16 98.82 11.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.543 -1.348 . . . . 0.0 110.375 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -116.55 151.71 18.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.51 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.98 -57.69 4.65 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.8 Cg_endo -74.0 -47.68 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.976 1.514 . . . . 0.0 110.953 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.45 ' CD1' HG13 ' A' ' 85' ' ' VAL . 89.7 mt -55.28 157.75 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.004 . . . . 0.0 110.085 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.97 -71.54 0.19 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -111.38 -58.39 2.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -1.221 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.6 t -152.21 15.65 0.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.962 . . . . 0.0 110.538 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 123' ' ' LYS . 16.9 mt -91.28 147.86 22.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HA ' HG21 ' A' ' 122' ' ' THR . 4.9 mt-10 59.3 31.5 21.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 121' ' ' HIS . 4.6 mttt -70.55 151.36 45.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.591 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 4.5 mp -127.54 134.37 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.647 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.29 106.21 13.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.34 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 1.8 m120 -95.12 150.14 20.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.73 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 3.2 mp0 -143.18 142.06 31.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.772 . . . . 0.0 109.706 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.6 mt -138.6 119.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 110.567 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -118.15 121.87 41.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.58 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 44.8 mt -108.84 118.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.368 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -122.9 152.6 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.402 -0.811 . . . . 0.0 109.774 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -87.98 166.35 14.55 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.633 -0.667 . . . . 0.0 111.121 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.438 HG23 HG13 ' A' ' 113' ' ' ILE . 16.5 p . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.369 -0.832 . . . . 0.0 109.73 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.491 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -141.17 163.65 32.38 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -1.069 . . . . 0.0 110.596 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.438 HG13 HG23 ' A' ' 107' ' ' THR . 78.9 mt -112.31 124.41 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.782 . . . . 0.0 109.166 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 130.64 42.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.982 . . . . 0.0 110.827 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -121.23 114.87 22.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.544 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -105.62 128.33 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.531 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -111.55 110.36 20.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 110.03 179.761 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.74 135.89 45.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.171 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.37 137.35 45.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 110.212 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.591 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -112.33 144.73 41.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.872 . . . . 0.0 110.036 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 97' ' ' LYS . 31.8 m-70 -127.15 106.36 9.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 110.233 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -121.63 166.59 14.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.489 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.977 . . . . 0.0 110.61 -179.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 121.784 0.802 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.4 p -113.92 93.48 2.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.811 -0.555 . . . . 0.0 110.627 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.98 146.66 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.043 . . . . 0.0 109.799 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.424 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -62.48 -12.71 23.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -48.14 -69.94 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.973 -1.079 . . . . 0.0 109.861 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 136' ' ' SER . 0.8 OUTLIER -54.8 -27.49 42.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.516 179.598 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.593 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 16.1 t -71.07 -47.28 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 134' ' ' LYS . 22.8 ttpt -67.76 -31.8 71.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.089 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' O ' HD11 ' A' ' 139' ' ' LEU . . . -73.7 -39.04 64.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.786 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -67.23 -27.36 67.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -73.07 -42.15 63.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.91 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -63.8 -44.36 93.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -71.3 -33.16 69.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -55.36 -55.5 28.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.1 tm-20 -54.86 -44.96 74.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -1.154 . . . . 0.0 109.923 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 m -57.4 -32.77 67.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.831 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 43.9 mt -69.93 -53.4 18.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.022 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 4.6 pp -72.03 -22.33 61.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.159 -0.963 . . . . 0.0 109.474 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -83.14 -31.42 27.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 109.739 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.04 70.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.421 HG13 HD23 ' A' ' 18' ' ' LEU . 25.2 t -69.81 -44.3 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.473 -0.767 . . . . 0.0 109.738 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.439 ' HA ' HG13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -62.51 -47.98 81.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.618 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.425 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -68.97 -16.48 63.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 110.074 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.459 ' CG ' HG13 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -83.07 -34.19 26.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 179.932 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.478 HD11 ' CG2' ' A' ' 13' ' ' ILE . 10.8 mt -73.87 -56.19 5.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 110.171 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.47 -30.39 12.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 0.0 110.437 -179.781 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.522 HG12 ' ND1' ' A' ' 121' ' ' HIS . 5.1 m -94.05 -162.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -1.147 . . . . 0.0 110.292 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -108.89 158.45 17.66 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.736 -0.602 . . . . 0.0 109.717 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.68 140.09 51.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.024 -1.048 . . . . 0.0 110.894 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.575 ' CZ ' HG12 ' A' ' 133' ' ' VAL . 9.8 m-85 -146.52 61.99 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 12.9 pt-20 -87.59 157.48 19.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 111.129 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -156.64 174.93 14.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 0.0 109.944 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.71 150.38 19.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 110.231 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 m -145.29 168.15 21.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.295 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.91 164.29 12.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.218 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -157.68 144.46 18.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.426 -0.796 . . . . 0.0 109.855 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 15.1 t -79.8 -7.63 10.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.839 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.534 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 30.2 mm -78.85 146.87 69.44 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.93 145.94 81.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.659 1.347 . . . . 0.0 111.331 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -66.86 -28.41 68.32 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.54 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.95 2.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.943 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' HG3' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -58.53 -37.04 74.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.728 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 5.6 tt -68.44 -39.44 81.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.007 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CE1' HG12 ' A' ' 23' ' ' ILE . 80.8 t80 -60.84 -65.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 109.983 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -43.04 -49.26 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.24 96.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.873 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.95 -9.17 52.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.232 -0.917 . . . . 0.0 110.811 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.538 HG13 ' CG ' ' A' ' 81' ' ' TYR . 1.2 mp -118.16 -69.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.988 -1.07 . . . . 0.0 110.191 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 mt -60.69 -43.42 97.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.57 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.36 13.42 16.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.88 -59.66 10.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.447 ' O ' HG22 ' A' ' 41' ' ' VAL . 85.3 m-20 -52.21 -29.07 20.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -1.161 . . . . 0.0 110.304 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -86.29 -28.93 23.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.424 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.68 -21.73 25.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.312 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.536 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -54.02 -57.55 17.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.533 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -73.34 -0.07 8.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.95 1.5 . . . . 0.0 110.832 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.44 -59.12 1.76 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.436 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -90.7 12.91 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.356 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.448 ' HB2' ' HB1' ' A' ' 37' ' ' ALA . . . -159.77 75.87 3.0 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.297 -0.877 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.36 -7.97 21.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.008 1.53 . . . . 0.0 110.716 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -100.79 0.05 38.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 110.262 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.459 ' HA ' HD22 ' A' ' 139' ' ' LEU . . . -107.28 -69.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.167 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mt -119.14 135.13 60.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.868 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 -49.94 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.316 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.477 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -157.09 171.33 20.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 110.304 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 27' ' ' ASP . 40.6 t -129.81 140.52 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' CB ' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -133.28 84.27 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.406 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -50.4 117.74 2.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 0.0 110.283 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.532 HG22 HD11 ' A' ' 44' ' ' ILE . 12.5 mt -88.58 -37.83 10.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.271 1.034 . . . . 0.0 108.666 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 48.2 tt0 -153.78 174.41 14.58 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.335 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.554 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 66.79 159.96 0.92 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -104.8 32.17 4.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -1.104 . . . . 0.0 109.765 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.14 0.67 67.77 Favored Glycine 0 N--CA 1.48 1.574 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.37 -163.85 29.43 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.9 Cg_endo -73.09 129.43 14.13 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.028 1.541 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.62 -3.92 81.79 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.56 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.1 m -63.68 154.66 32.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -1.215 . . . . 0.0 109.255 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.494 HD12 ' NE ' ' A' ' 70' ' ' ARG . 8.7 mm -124.81 127.69 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -139.7 136.91 34.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.299 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HB3' ' CB ' ' A' ' 42' ' ' GLU . 22.1 tttt -80.5 98.41 7.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 110.297 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 56' ' ' ILE . 43.6 mm -86.7 134.81 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -103.76 145.94 29.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.199 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -118.33 131.55 24.17 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.213 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 44.9 Cg_endo -71.77 89.53 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.953 1.501 . . . . 0.0 110.574 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -138.51 -169.69 2.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.046 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.22 -15.88 4.08 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.439 ' CB ' ' HD2' ' A' ' 63' ' ' PRO . 0.9 OUTLIER -59.06 175.33 0.34 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.259 -1.142 . . . . 0.0 110.257 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 62' ' ' PHE . 44.5 Cg_endo -71.61 -45.47 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.971 1.511 . . . . 0.0 109.957 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 23.4 m-85 -116.43 127.76 54.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.425 -0.797 . . . . 0.0 109.852 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' CG ' ' N ' ' A' ' 66' ' ' TYR . 9.3 ptpt -142.09 -44.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -0.981 . . . . 0.0 110.42 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 57' ' ' SER . 20.3 p90 -65.42 -170.05 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.975 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -178.45 171.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.278 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -90.14 -61.76 1.61 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.513 -0.742 . . . . 0.0 109.598 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 68' ' ' LYS . 7.6 t70 59.2 124.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.494 ' NE ' HD12 ' A' ' 53' ' ' ILE . 1.8 ttt180 -110.78 147.85 33.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.56 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 3.5 t -67.02 152.03 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.481 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 7.7 t70 -99.95 -71.4 0.7 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.311 0.577 . . . . 0.0 110.459 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -145.85 104.19 3.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.439 -0.788 . . . . 0.0 109.985 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.57 HG23 ' CE1' ' A' ' 81' ' ' TYR . 18.6 t -92.78 149.88 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.265 -0.897 . . . . 0.0 110.324 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -148.42 101.62 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 109.927 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.462 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 m-70 -76.23 1.18 16.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.584 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -116.5 -44.61 2.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.058 -1.026 . . . . 0.0 110.041 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.13 15.06 9.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.435 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.504 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 20.0 m-30 51.49 54.43 11.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.911 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -126.62 126.55 43.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CE1' HG23 ' A' ' 74' ' ' VAL . 28.1 t80 -143.34 97.94 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.499 ' ND2' ' OE2' ' A' ' 101' ' ' GLU . 9.4 m-20 -114.37 146.48 40.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 23.6 p90 -142.22 139.96 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.864 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 50.5 m -106.04 164.91 11.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.095 -1.003 . . . . 0.0 110.928 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.533 HG13 ' CD1' ' A' ' 91' ' ' ILE . 24.4 t -103.06 130.2 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -126.96 -68.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.287 -178.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 1.4 tt0 -91.93 78.83 5.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.621 -1.3 . . . . 0.0 110.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -94.8 153.03 20.75 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.522 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.46 -57.99 4.83 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -72.44 -41.56 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.545 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.533 ' CD1' HG13 ' A' ' 85' ' ' VAL . 48.8 mt -61.62 134.3 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.23 -39.34 0.75 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -120.8 -84.14 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -1.091 . . . . 0.0 110.008 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 t -150.83 14.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 123' ' ' LYS . 18.5 mt -88.81 156.92 18.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -0.969 . . . . 0.0 110.077 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-10 54.56 34.28 20.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.12 -0.987 . . . . 0.0 109.48 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -77.02 170.3 16.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 -179.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.64 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 4.6 mp -143.11 125.15 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.478 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 11.2 t -117.35 109.86 17.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.57 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 3.1 t-20 -98.92 169.94 9.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 117' ' ' SER . 18.6 mt-10 -152.38 130.11 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.777 -0.577 . . . . 0.0 109.565 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.5 mt -121.14 132.41 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 110.459 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HD2' ' HD2' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -139.61 122.54 16.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.467 ' CG2' ' HB3' ' A' ' 15' ' ' ALA . 3.3 mp -108.92 144.23 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.363 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.423 HG21 ' C ' ' A' ' 104' ' ' ILE . 55.0 t -145.67 117.94 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.532 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -71.47 146.23 48.73 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.347 0.594 . . . . 0.0 110.554 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.46 153.87 72.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.024 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.5 55.59 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.962 1.507 . . . . 0.0 110.411 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -139.59 10.08 2.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 110.059 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.45 ' O ' HG11 ' A' ' 12' ' ' VAL . . . 87.77 24.16 36.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -167.89 -162.76 20.51 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 106' ' ' ALA . 7.6 t -141.78 -175.89 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.998 . . . . 0.0 110.525 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.418 ' N ' ' OG ' ' A' ' 112' ' ' SER . 19.9 mt -134.99 128.19 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 109.599 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 pp -108.81 139.39 43.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -123.79 113.92 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.77 115.13 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.797 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.524 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -103.4 135.92 44.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -126.71 144.25 50.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.144 -0.973 . . . . 0.0 110.815 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -126.55 150.9 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 109.884 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -131.57 105.65 7.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.522 ' ND1' HG12 ' A' ' 2' ' ' VAL . 24.1 m-70 -86.0 125.29 33.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 110.605 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.455 HG22 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.3 167.86 12.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.435 ' HB2' HD21 ' A' ' 95' ' ' LEU . 19.1 tptt -159.92 -170.09 2.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.33 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 42.55 -151.57 0.29 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.29 12.05 23.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -1.126 . . . . 0.0 110.154 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -82.92 172.5 12.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 110.13 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -153.53 -166.66 2.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.246 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 128' ' ' VAL . 2.1 t -121.8 99.5 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.434 -0.791 . . . . 0.0 109.89 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -64.46 125.81 25.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -42.57 -34.79 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.8 mp0 -39.83 -70.36 0.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.306 -0.871 . . . . 0.0 110.872 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -27.83 38.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.568 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.575 HG12 ' CZ ' ' A' ' 5' ' ' TYR . 21.4 t -74.91 -49.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -30.86 70.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.515 -0.741 . . . . 0.0 109.792 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.81 -30.42 61.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.623 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.0 t -73.39 -37.69 65.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.412 -0.805 . . . . 0.0 109.682 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -68.89 -38.31 79.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.6 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -68.0 -40.26 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 37' ' ' ALA . 1.1 tp -72.83 -40.42 65.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.827 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.43 97.77 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.5 mm-40 -65.95 -34.72 78.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -1.133 . . . . 0.0 109.917 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 75.2 m -67.98 -29.96 69.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.927 . . . . 0.0 109.723 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 71.9 mt -70.25 -46.54 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.497 ' HG ' ' N ' ' A' ' 145' ' ' ARG . 1.0 OUTLIER -67.3 -30.84 70.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.745 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.497 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 4.5 ttt180 -79.5 -32.93 42.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 0.0 109.938 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.67 98.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.85 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.27 -47.49 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 110.007 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -56.98 -43.3 81.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.5 t -60.72 -49.82 75.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.647 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.3 t80 -52.35 -70.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.838 . . . . 0.0 110.473 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.466 ' HB3' ' CD1' ' A' ' 13' ' ' ILE . 1.2 mt -40.6 -35.43 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 110.684 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -25.09 50.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.007 . . . . 0.0 110.498 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . -89.71 26.15 1.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 110.461 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.527 ' C ' ' CD2' ' A' ' 154' ' ' HIS . 3.9 p-80 -81.07 175.76 10.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 110.481 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 t -150.17 83.58 1.38 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 109.995 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.14 -15.35 14.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.46 163.04 33.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -108.12 -51.2 2.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.918 . . . . 0.0 110.297 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.257 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.565 HG23 ' CE1' ' A' ' 121' ' ' HIS . 2.7 t -59.09 142.6 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 110.289 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -100.91 137.5 39.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.384 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.24 146.8 44.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 110.91 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -152.29 56.63 0.82 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.472 0.654 . . . . 0.0 109.298 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.528 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 4.9 pt-20 -80.19 153.2 28.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 110.368 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -149.7 -175.6 5.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.882 . . . . 0.0 110.099 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -159.45 162.52 35.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.7 -176.24 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.07 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.453 HG21 HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -133.67 159.61 40.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.483 ' HB3' ' CG ' ' A' ' 148' ' ' GLU . 3.7 m -160.03 145.51 15.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 109.991 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.457 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 11.9 t -79.93 -7.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.41 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.544 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 41.7 mm -77.1 148.2 77.94 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.46 150.47 84.22 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 123.589 1.31 . . . . 0.0 111.063 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.438 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.15 -49.95 8.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.92 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.435 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 8.0 tpt180 -67.15 -34.33 77.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.712 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 5.8 tt -76.92 -35.41 57.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.47 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 75.2 t80 -61.12 -57.76 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.867 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 27.3 mttp -58.2 -41.21 83.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.828 . . . . 0.0 109.96 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 17' ' ' ARG . . . -70.68 -32.91 70.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 7.9 t80 -87.98 -15.82 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.883 . . . . 0.0 110.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 1.1 mp -120.15 -58.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.092 -1.005 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' CE1' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -63.05 -37.25 86.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.344 -0.848 . . . . 0.0 110.687 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -110.11 -0.81 17.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -46.0 -48.51 14.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -56.46 -17.21 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.307 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -113.1 -19.77 11.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.297 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.99 -33.76 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.736 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.549 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -63.25 -58.21 17.0 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.701 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -76.7 46.11 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.825 1.434 . . . . 0.0 111.347 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.32 -54.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.921 -1.112 . . . . 0.0 110.397 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 146' ' ' ALA . 9.9 p -84.85 -26.0 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.48 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.62 75.61 79.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.385 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.59 -3.98 14.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.389 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -91.21 -12.72 34.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.24 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.51 -72.65 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.908 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -105.78 154.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.439 -0.788 . . . . 0.0 109.5 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 8.1 t -100.85 -56.44 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 110.415 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 36.5 m -153.55 175.34 13.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 110.489 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 25.8 t -138.53 143.5 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.889 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -145.82 99.82 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.152 -0.967 . . . . 0.0 110.658 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.493 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 90.5 m-20 -58.36 117.33 4.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 42' ' ' GLU . 22.8 mm -85.87 -38.07 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.366 1.079 . . . . 0.0 108.301 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 61.5 tt0 -152.45 174.1 14.29 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.084 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 72.64 166.43 9.46 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -110.85 37.77 2.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -1.119 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' HG23 ' A' ' 52' ' ' THR . . . 82.14 2.07 90.49 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.55 -160.79 23.72 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.31 124.05 7.55 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.018 1.536 . . . . 0.0 110.437 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.74 -3.0 70.57 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.552 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.2 m -61.43 152.13 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -1.164 . . . . 0.0 109.787 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 10.4 mt -112.75 136.48 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 110.327 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 2.7 ptmt -153.13 139.18 18.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.229 -0.92 . . . . 0.0 110.305 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HG3' ' CD1' ' A' ' 66' ' ' TYR . 15.6 ttpp -91.67 109.28 20.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.457 HD11 ' OD1' ' A' ' 69' ' ' ASP . 96.7 mt -98.6 120.89 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.928 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 39' ' ' SER . 54.3 m -77.3 133.78 38.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.857 . . . . 0.0 110.46 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.29 140.05 22.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.025 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 60' ' ' GLU . 45.0 Cg_endo -72.25 77.47 2.04 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER 50.09 -178.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 110.462 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.63 -50.27 0.82 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -100.68 -179.22 0.78 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.288 -1.125 . . . . 0.0 109.682 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.584 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 42.9 Cg_endo -69.84 -27.71 25.78 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.718 1.378 . . . . 0.0 109.873 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.48 ' CB ' ' HA3' ' A' ' 89' ' ' GLY . 0.2 OUTLIER -115.41 137.27 52.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.394 -0.816 . . . . 0.0 109.635 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -55.18 -79.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.348 -0.845 . . . . 0.0 111.152 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' CD1' ' HG3' ' A' ' 55' ' ' LYS . 5.0 p90 -92.09 179.58 5.54 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.869 0.843 . . . . 0.0 112.065 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.568 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -148.54 175.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -123.48 50.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.795 -1.191 . . . . 0.0 111.124 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.457 ' OD1' HD11 ' A' ' 56' ' ' ILE . 11.8 p-10 -61.78 131.03 48.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.943 . . . . 0.0 109.99 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -96.61 -179.22 4.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.552 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 3.0 t -90.27 151.39 3.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 120.916 -1.115 . . . . 0.0 109.891 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -100.44 -73.23 0.65 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.524 0.678 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -137.44 132.59 33.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.126 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.463 HG22 HG13 ' A' ' 71' ' ' VAL . 2.6 t -119.14 146.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 0.0 110.117 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.529 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -150.09 110.9 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.907 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.479 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -76.64 -12.84 60.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -109.94 -39.78 4.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.028 -1.045 . . . . 0.0 109.836 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -88.2 15.93 6.89 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.302 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 19.6 m-85 42.23 57.21 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.2 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.73 115.68 21.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.982 . . . . 0.0 110.679 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.439 ' HB2' HG12 ' A' ' 23' ' ' ILE . 13.1 t80 -135.82 102.17 4.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.505 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 32.7 m-20 -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.099 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.631 ' CE2' ' CB ' ' A' ' 100' ' ' ASN . 2.8 p90 -137.93 145.16 41.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.6 m -105.38 155.43 19.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.277 -0.889 . . . . 0.0 111.451 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.511 HG13 ' CD1' ' A' ' 91' ' ' ILE . 38.2 t -100.07 122.13 51.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -120.98 -66.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 111.531 -178.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HB2' ' CB ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -80.5 52.66 1.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.674 -1.266 . . . . 0.0 109.917 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -63.65 125.64 33.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -38.58 -58.46 1.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -72.88 -26.6 15.39 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.866 1.456 . . . . 0.0 110.555 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.511 ' CD1' HG13 ' A' ' 85' ' ' VAL . 17.9 mt -69.75 161.69 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.75 -51.95 0.08 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.444 ' C ' ' HG ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -87.6 50.66 2.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.091 -1.241 . . . . 0.0 110.593 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 49.23 24.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.528 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.478 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -118.56 175.43 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.948 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.458 ' O ' HD12 ' A' ' 91' ' ' ILE . 4.0 mt-10 54.89 32.6 18.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -80.02 159.39 26.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.409 -0.807 . . . . 0.0 110.069 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 97' ' ' LYS . 17.1 mt -143.03 137.09 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.687 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.48 94.45 4.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.76 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.631 ' CB ' ' CE2' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -84.31 141.31 31.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 2.5 mt-10 -128.28 146.37 50.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 110.168 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.4 mt -137.15 125.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 0.0 110.236 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.516 ' HE3' ' CG2' ' A' ' 105' ' ' VAL . 11.9 tttt -124.89 157.43 35.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 10.5 mt -148.09 119.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 110.495 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.516 ' CG2' ' HE3' ' A' ' 103' ' ' LYS . 83.6 t -118.52 129.63 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.414 -0.804 . . . . 0.0 109.987 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.529 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -80.59 154.18 27.59 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.414 0.626 . . . . 0.0 110.767 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 6.8 p -114.51 167.14 10.14 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.868 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 48.0 Cg_endo -73.92 -2.48 12.31 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.882 1.464 . . . . 0.0 110.423 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -88.28 -12.43 43.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.3 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.94 -12.8 26.94 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . -105.74 -164.7 23.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 3.8 t -147.45 -174.86 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -1.031 . . . . 0.0 110.593 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 105' ' ' VAL . 68.4 mt -138.63 136.58 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.8 . . . . 0.0 109.383 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.505 ' N ' HD13 ' A' ' 114' ' ' LEU . 6.5 mp -105.19 136.29 44.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.08 104.23 8.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.438 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 5.4 mp -99.56 139.55 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.83 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -126.54 105.82 9.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.42 -0.8 . . . . 0.0 110.081 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -98.43 142.49 29.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.219 -0.925 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.0 OUTLIER -135.97 127.57 28.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CD2' HG23 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -111.8 123.41 50.18 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.151 -0.968 . . . . 0.0 110.014 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.565 ' CE1' HG23 ' A' ' 2' ' ' VAL . 43.9 m-70 -104.51 116.39 32.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.853 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.439 HG22 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -112.14 169.36 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 109.777 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -156.91 -169.11 2.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 110.243 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 44.16 -138.73 4.44 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.12 1.84 45.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -1.157 . . . . 0.0 110.484 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -73.92 167.78 20.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.209 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.421 ' CA ' HG23 ' A' ' 122' ' ' THR . 1.4 pm0 -150.72 -171.44 3.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 0.0 109.882 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.524 ' CG1' HG23 ' A' ' 133' ' ' VAL . 4.6 t -113.93 96.3 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -64.3 127.24 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.966 . . . . 0.0 109.385 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.73 -46.3 63.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.983 . . . . 0.0 110.458 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.456 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 6.9 tp10 -41.27 -47.68 3.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.012 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -70.3 -31.55 68.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 108.818 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 130' ' ' ALA . 14.5 t -74.05 -47.97 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 109.31 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -66.48 -30.78 71.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.197 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 131' ' ' GLU . . . -72.14 -27.92 62.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -72.78 -40.6 65.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 110.365 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -77.24 -22.07 52.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 0.0 110.254 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.64 -57.46 11.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.335 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 142' ' ' THR . 38.6 mt -70.88 -42.05 70.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.219 -0.926 . . . . 0.0 110.429 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 139' ' ' LEU . . . -41.53 -44.63 4.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.499 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.3 tt0 -57.75 -36.28 71.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -1.2 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 139' ' ' LEU . 92.8 m -67.97 -22.0 65.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 64.4 mt -76.39 -49.99 15.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.921 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.499 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.38 -23.81 65.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.25 -38.17 22.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.964 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.449 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . . . -60.77 -39.97 90.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -0.915 . . . . 0.0 109.514 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.47 ' O ' HD13 ' A' ' 151' ' ' LEU . 40.2 t -71.36 -52.77 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.483 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.412 -0.805 . . . . 0.0 109.571 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -50.95 69.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.54 -70.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.295 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.479 ' CB ' HD13 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.066 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -61.83 -43.81 98.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.86 -1.14 30.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -120.99 17.58 11.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.101 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.57 10.96 18.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.223 -0.923 . . . . 0.0 110.267 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.39 11.76 33.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.179 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.63 -172.89 2.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.135 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 158' ' ' TYR . 59.8 t80 -138.82 55.46 1.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.118 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 27.0 p30 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.208 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.456 HG23 ' CE1' ' A' ' 121' ' ' HIS . 2.4 t -79.99 143.14 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -1.149 . . . . 0.0 110.194 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.13 154.29 17.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.673 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -127.26 149.34 50.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.911 -1.118 . . . . 0.0 111.038 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 40.9 m-85 -158.29 61.31 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.668 -0.645 . . . . 0.0 109.438 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 19.5 pt-20 -85.62 148.63 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 110.948 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.48 173.87 13.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 0.0 109.63 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.2 pm0 -147.61 169.98 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 0.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 152.12 29.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.746 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.53 161.57 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 110.552 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.465 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 9.4 t -159.85 138.16 10.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.639 -0.663 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 t -80.04 -14.25 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.866 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 44.3 mm -72.01 148.02 91.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.4 Cg_endo -66.85 150.07 83.22 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.432 1.228 . . . . 0.0 111.112 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 19' ' ' PHE . . . -76.05 -29.42 58.02 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.405 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.81 -54.55 13.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.898 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.429 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 5.5 ttm180 -66.7 -35.69 80.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.437 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 11.3 tp -75.25 -32.9 61.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 0.0 109.984 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ALA . 55.3 t80 -64.2 -68.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -52.75 -38.62 61.18 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.514 -0.741 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 -37.37 69.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 47.7 t80 -82.64 -20.79 35.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 19' ' ' PHE . 1.1 mp -110.84 -69.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.834 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -49.24 -41.42 37.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 110.1 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.6 0.65 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.187 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.93 -52.69 29.61 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -47.86 -29.36 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -101.42 -29.64 11.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 0.0 110.269 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -80.56 -21.09 42.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.7 m-85 -66.1 -60.77 6.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.388 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -72.4 -0.11 8.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.989 1.521 . . . . 0.0 110.784 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -101.78 -48.74 4.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.035 -1.04 . . . . 0.0 110.562 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 29' ' ' LEU . 17.0 m -91.44 7.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 110.6 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 75.39 3.34 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.143 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.33 -9.65 24.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.082 1.569 . . . . 0.0 110.69 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -92.81 -8.08 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 110.232 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -102.5 -72.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.016 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.48 131.33 57.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.443 -0.786 . . . . 0.0 109.758 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.07 -34.9 37.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 110.208 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 p -178.09 157.77 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.44 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 60.5 t -117.49 152.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 109.982 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.9 tm-20 -139.05 89.68 2.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 15.9 t-20 -56.52 115.84 2.76 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.914 0.864 . . . . 0.0 110.532 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 53' ' ' ILE . 6.0 mt -87.55 -39.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.902 0.858 . . . . 0.0 109.081 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' O ' HG22 ' A' ' 52' ' ' THR . 14.1 mt-10 -130.32 176.48 8.09 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.833 0.825 . . . . 0.0 111.689 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 45' ' ' GLU . . . 33.83 -156.57 0.01 OUTLIER Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -123.46 -19.15 5.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.39 -1.065 . . . . 0.0 109.869 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 49' ' ' GLY . . . 161.88 -21.67 0.2 Allowed Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 48' ' ' GLY . . . -53.16 -171.55 0.04 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.3 Cg_endo -72.65 128.7 13.7 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.009 1.531 . . . . 0.0 110.529 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.21 -7.17 62.04 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.513 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 2.3 m -69.76 144.42 52.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -1.164 . . . . 0.0 109.886 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' ILE . 7.5 mt -114.55 141.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.936 -1.103 . . . . 0.0 109.264 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -153.38 134.43 14.01 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 110.069 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -86.49 116.78 24.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 111.041 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 56.0 mt -104.69 123.73 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.402 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 35.2 m -93.07 141.4 28.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 110.594 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.428 ' HB2' ' C ' ' A' ' 65' ' ' LYS . 2.5 m-85 -110.16 154.41 42.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.922 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.512 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 44.5 Cg_endo -71.83 168.04 24.93 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.0 1.526 . . . . 0.0 110.381 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -60.8 163.82 5.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.334 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.05 -44.64 0.77 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.51 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 1.3 m-85 -130.5 177.75 2.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.286 -1.126 . . . . 0.0 109.918 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 42.1 Cg_endo -67.76 -43.15 5.66 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.713 1.375 . . . . 0.0 110.562 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -98.93 130.77 45.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.839 . . . . 0.0 110.028 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.428 ' C ' ' HB2' ' A' ' 58' ' ' PHE . 8.6 mtmm -122.34 -81.8 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 110.528 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 6.4 p90 -58.01 167.99 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.972 0.892 . . . . 0.0 111.291 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 1.9 m -166.84 167.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HD2' ' CB ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -99.3 -64.75 1.01 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.613 -1.304 . . . . 0.0 110.017 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 68' ' ' LYS . 9.2 m-20 59.08 129.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.888 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -112.56 149.56 32.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 108.908 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.513 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 11.6 t -65.12 153.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.864 -1.147 . . . . 0.0 110.268 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.5 t70 -104.69 -75.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.407 0.622 . . . . 0.0 110.038 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -137.13 128.45 28.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.568 HG21 ' CD2' ' A' ' 81' ' ' TYR . 4.1 t -119.19 142.89 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -144.37 114.8 7.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -81.08 -10.58 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -108.93 -39.11 5.41 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.071 -1.018 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.64 9.27 27.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.518 -0.739 . . . . 0.0 109.997 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 48.32 51.41 15.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.185 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.92 117.54 24.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.269 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.568 ' CD2' HG21 ' A' ' 74' ' ' VAL . 45.9 t80 -137.83 106.16 5.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.773 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 35.2 m-20 -119.61 152.35 37.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.229 -0.919 . . . . 0.0 110.331 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 11.5 p90 -142.79 136.46 28.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' ARG . 50.4 m -95.6 168.13 10.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.117 -0.989 . . . . 0.0 111.132 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.531 HG13 ' CD1' ' A' ' 91' ' ' ILE . 53.8 t -107.98 123.94 63.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -74.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.815 -1.178 . . . . 0.0 111.451 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.538 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 2.8 mm-40 -91.87 71.65 5.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.195 . . . . 0.0 110.131 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.439 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . -151.24 161.54 29.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 52.55 -157.95 3.76 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.85 -0.86 10.96 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.032 1.543 . . . . 0.0 111.197 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' CD1' HG13 ' A' ' 85' ' ' VAL . 50.0 mt -51.13 156.35 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.48 -58.0 0.2 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.2 p-10 -146.23 -49.09 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -1.162 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 t -145.08 12.45 1.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.81 144.94 28.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.408 ' HA ' HG22 ' A' ' 122' ' ' THR . 2.7 tt0 55.99 33.4 21.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 109.859 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.492 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -70.48 150.43 46.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.639 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mt -132.62 134.43 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.364 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -118.78 107.64 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.043 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.496 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 18.4 m-80 -92.73 127.93 38.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.305 -0.872 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.475 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 4.1 mt-10 -121.22 143.9 48.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 116' ' ' ILE . 58.0 mt -137.63 129.59 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.469 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 ttpt -124.82 142.46 51.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.653 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.543 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 84.1 mt -130.65 103.98 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.471 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 106' ' ' ALA . 73.4 t -108.7 146.2 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.06 159.69 18.14 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.728 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 22.0 p -118.81 165.86 15.67 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 110.274 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 46.3 Cg_endo -73.29 -1.88 11.27 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.901 1.474 . . . . 0.0 110.401 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -92.96 -9.53 39.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.11 -8.43 35.91 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.49 -167.12 21.06 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -135.75 -176.52 4.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -1.089 . . . . 0.0 110.513 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 33.6 mt -136.5 117.55 18.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -88.63 124.31 33.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 110.626 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 7.0 ttmt -116.14 100.02 7.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.78 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 102' ' ' ILE . 28.7 mt -96.48 139.57 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.395 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.475 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -122.16 109.3 14.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.2 t-20 -98.17 131.34 44.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.993 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 138.09 49.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.639 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.51 141.41 43.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.492 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 49.2 m-70 -123.37 95.99 4.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.408 HG22 ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -118.06 172.15 7.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 124' ' ' GLY . 18.6 tttp -100.23 154.89 18.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 110.14 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.62 -29.6 0.78 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.5 -81.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -1.123 . . . . 0.0 110.136 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 126' ' ' HIS . 39.1 m170 -64.33 -178.08 0.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 110.06 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 126' ' ' HIS . 24.5 mt-10 -155.43 -173.49 4.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.889 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.559 HG22 ' CG ' ' A' ' 120' ' ' TYR . 4.4 t -116.68 99.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.165 -0.959 . . . . 0.0 110.449 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.483 ' CD ' ' HB2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -68.06 146.74 53.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.993 . . . . 0.0 109.498 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 134' ' ' LYS . . . -66.59 -9.66 37.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.971 -1.081 . . . . 0.0 110.808 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.483 ' HB2' ' CD ' ' A' ' 129' ' ' LYS . 12.9 mt-10 -68.0 -54.58 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.994 -1.066 . . . . 0.0 109.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.14 -23.7 63.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.89 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.48 ' CG2' ' CG1' ' A' ' 128' ' ' VAL . 17.5 t -80.85 -46.59 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 130' ' ' ALA . 27.8 tttt -64.27 -26.02 68.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.955 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.41 74.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.885 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -75.91 -40.41 54.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -47.5 -69.43 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.7 -22.74 63.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.169 -0.957 . . . . 0.0 109.902 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.17 -32.86 51.11 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 34.8 mt-10 -72.46 -61.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -1.095 . . . . 0.0 110.082 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 141' ' ' GLU . 3.0 m -45.62 -33.37 2.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.904 -1.123 . . . . 0.0 109.708 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.54 -59.38 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.856 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.8 pp -65.9 -24.64 66.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -81.96 -29.23 32.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.47 -38.44 77.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.675 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.47 -44.91 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -56.29 -46.08 79.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.573 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.4 OUTLIER -64.24 -49.76 70.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.733 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -47.71 -71.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 110.038 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.22 -37.21 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.379 -0.825 . . . . 0.0 110.298 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 149' ' ' SER . 5.3 mt -59.33 -23.66 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 110.507 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.81 -5.38 51.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -100.36 37.38 1.69 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.183 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.3 m -97.61 23.35 7.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.395 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -94.0 -27.4 16.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.025 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.75 178.62 4.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 110.034 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -96.9 -63.28 1.15 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.946 . . . . 0.0 110.382 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.257 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 3' ' ' PHE . 2.9 t -71.96 148.26 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -1.185 . . . . 0.0 110.371 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.471 ' N ' HG11 ' A' ' 2' ' ' VAL . 23.1 m-85 -95.28 155.01 16.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.626 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.64 140.97 51.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.718 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CE2' HG12 ' A' ' 133' ' ' VAL . 20.2 m-85 -149.32 61.53 1.03 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.398 -0.813 . . . . 0.0 109.723 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.0 148.44 26.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.862 . . . . 0.0 110.915 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 116' ' ' ILE . 3.1 p -151.8 175.24 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.793 . . . . 0.0 109.565 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 11.8 pt-20 -155.26 146.42 22.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.93 -1.106 . . . . 0.0 110.621 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 m -129.26 143.18 50.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 110.019 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -82.06 159.69 23.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.416 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 m -156.77 136.91 12.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 m -79.98 -16.37 12.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.09 -1.006 . . . . 0.0 108.66 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 26.0 mm -67.03 149.44 98.51 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.69 150.55 83.59 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.509 1.268 . . . . 0.0 110.875 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.51 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -76.81 -27.02 55.05 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.57 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.07 -52.57 9.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 0.0 109.396 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 9.8 tt -75.5 -42.45 52.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.523 -0.735 . . . . 0.0 109.829 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 79' ' ' PHE . 51.0 t80 -56.65 -62.23 1.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 0.0 110.17 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -53.41 -45.61 69.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.81 . . . . 0.0 110.277 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.49 65.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.459 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 5.8 t80 -88.13 -22.98 23.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.435 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.455 HD11 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -112.18 -58.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -60.23 -30.35 69.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.876 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -122.24 11.65 10.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.935 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.23 -54.52 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 36.2 p-10 -55.44 -25.55 36.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -1.179 . . . . 0.0 110.393 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.415 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 37.2 m-20 -92.99 -41.21 10.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -72.99 -31.31 64.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 110.524 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.0 m-85 -50.17 -61.96 3.14 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -72.4 -7.46 20.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.84 1.442 . . . . 0.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -93.42 -67.2 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.397 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 m -88.98 -0.29 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.339 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 35' ' ' PRO . . . -146.8 56.33 2.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 110.344 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 34' ' ' ALA . 45.4 Cg_endo -71.88 -23.19 22.48 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.335 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.84 -16.92 61.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.45 ' O ' ' HD3' ' A' ' 59' ' ' PRO . . . -96.66 -58.74 1.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.195 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.446 HD11 ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -110.47 137.78 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.969 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.15 -52.59 6.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 110.353 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.71 -179.23 7.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.192 -0.942 . . . . 0.0 110.453 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 p -159.94 112.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.3 145.68 44.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.896 . . . . 0.0 110.044 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.542 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 1.4 m120 -93.88 121.95 35.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.684 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 44' ' ' ILE . 25.4 mm -83.8 -37.59 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.345 1.069 . . . . 0.0 108.363 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 31.8 tt0 -153.57 174.3 14.62 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.289 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 66.4 173.31 5.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 47' ' ' ASN . 10.8 t-20 -124.92 45.12 2.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -1.049 . . . . 0.0 109.795 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.81 14.55 80.79 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.32 -168.4 34.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.8 Cg_endo -71.25 114.96 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.971 1.511 . . . . 0.0 110.315 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.14 -2.89 51.2 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.544 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.4 m -62.91 154.45 30.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.111 . . . . 0.0 109.815 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 44' ' ' ILE . 6.0 mt -125.35 136.1 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -154.48 139.32 17.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.915 . . . . 0.0 110.35 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -84.07 119.88 25.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.3 mt -103.24 118.04 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -85.75 140.49 30.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.54 ' CB ' ' HB3' ' A' ' 65' ' ' LYS . 19.4 m-85 -112.49 158.53 37.06 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 42.7 Cg_endo -70.55 -169.9 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.007 1.53 . . . . 0.0 110.908 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.8 -170.36 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.852 . . . . 0.0 110.645 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.89 -38.31 2.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.546 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.9 OUTLIER -135.24 177.09 2.4 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.335 -1.097 . . . . 0.0 110.007 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.546 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 44.6 Cg_endo -71.59 -54.87 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.958 1.504 . . . . 0.0 110.093 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.484 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 36.6 m-85 -111.64 129.58 56.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.851 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -144.07 -38.71 0.3 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.324 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 9.0 p90 -62.25 148.5 44.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.963 . . . . 0.0 109.632 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -157.52 172.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.098 -1.001 . . . . 0.0 110.662 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.565 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 2.5 mtpp -93.46 -65.02 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.662 -0.649 . . . . 0.0 109.811 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' HB2' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER 60.6 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ptm180 -106.37 167.22 9.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 4.6 t -82.18 152.32 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.88 -1.137 . . . . 0.0 110.348 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 48.5 t0 -101.2 -72.34 0.68 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.235 0.541 . . . . 0.0 109.878 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -146.82 124.58 11.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.361 -0.837 . . . . 0.0 110.124 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.61 149.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.479 ' CB ' ' HB3' ' A' ' 80' ' ' LYS . 5.3 t0 -151.94 115.06 4.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 109.908 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -85.86 3.14 43.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.647 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -110.34 -48.38 3.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.305 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -91.77 17.84 8.47 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.701 -0.624 . . . . 0.0 110.03 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 20.2 m-85 43.74 58.97 3.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.93 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 75' ' ' ASP . 28.1 tttt -122.18 119.44 31.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -135.51 109.16 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.526 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 51.4 m-20 -125.86 150.29 47.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 110.427 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 51.3 p90 -142.64 139.64 31.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.447 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' ARG . 3.1 m -96.16 155.87 16.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.973 -1.079 . . . . 0.0 110.808 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 54.7 t -99.91 124.43 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.61 -76.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 110.956 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.68 78.88 9.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.649 -1.282 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.424 ' C ' ' HD2' ' A' ' 90' ' ' PRO . . . -100.63 145.97 17.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.552 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.57 -50.01 8.44 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.5 Cg_endo -73.62 -48.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.636 1.335 . . . . 0.0 111.02 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 91' ' ' ILE . 33.7 mt -54.52 141.7 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.078 -1.014 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -108.73 -65.06 0.57 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 4.7 m-20 -114.3 -82.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -1.113 . . . . 0.0 110.0 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.9 p -134.27 12.2 3.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.975 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.529 HD11 ' CE1' ' A' ' 126' ' ' HIS . 37.2 mt -90.87 156.38 18.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.016 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 12.1 tt0 61.96 31.76 17.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.522 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.7 mtpt -65.25 161.56 19.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.552 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.556 HG12 ' CD1' ' A' ' 120' ' ' TYR . 87.6 mt -143.9 132.52 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 110.614 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 1.2 m -116.24 111.34 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 109.547 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 2.0 m-80 -103.06 142.17 34.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.526 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 4.2 mp0 -136.19 150.23 48.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.973 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.6 mt -140.63 125.55 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.509 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 2.4 ttpt -125.15 111.91 15.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 109.65 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.552 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 12.1 mt -102.96 112.59 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.43 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.78 142.32 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.827 . . . . 0.0 110.188 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.51 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -87.94 159.96 18.12 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.595 -0.691 . . . . 0.0 110.665 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 14.9 p -119.75 166.25 15.38 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 44.0 Cg_endo -71.18 -10.84 28.04 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.875 1.46 . . . . 0.0 110.409 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -79.0 -17.07 56.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 110.315 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.16 -17.23 12.76 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.71 -164.63 23.37 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -135.98 -174.17 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.407 -1.055 . . . . 0.0 110.511 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.406 HG13 ' CG2' ' A' ' 107' ' ' THR . 23.5 mt -137.59 109.39 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.0 108.982 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -84.42 129.19 34.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG2' ' CB ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -122.44 98.47 5.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 109.692 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.429 HG21 ' O ' ' A' ' 7' ' ' THR . 2.6 tt -94.82 120.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.509 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.451 ' HB3' ' OE1' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -102.04 116.26 32.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.051 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.454 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -103.08 158.62 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 1.8 ttmt -148.51 142.0 25.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.447 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.556 ' CD1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -123.52 133.48 54.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -0.931 . . . . 0.0 110.106 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.619 ' CD2' ' N ' ' A' ' 121' ' ' HIS . 4.4 m-70 -119.37 97.67 5.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.52 163.21 14.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.951 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.46 160.61 14.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.397 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -49.75 -24.96 6.45 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.48 -54.72 4.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.122 -1.222 . . . . 0.0 110.57 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 95' ' ' LEU . 51.7 m170 -79.64 175.92 10.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 110.269 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.491 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -160.11 137.34 9.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.701 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.6 p -98.46 89.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.514 -0.742 . . . . 0.0 110.223 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -50.16 155.31 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.118 -0.989 . . . . 0.0 110.145 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -64.76 -33.15 75.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.278 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -41.03 -59.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -27.31 65.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 109.274 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 5' ' ' TYR . 18.8 t -77.2 -49.47 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.425 -0.797 . . . . 0.0 109.372 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.43 65.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.857 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.02 -21.44 59.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t -76.44 -43.72 38.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.467 -0.77 . . . . 0.0 110.056 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.75 -30.29 68.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.942 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.97 -40.45 46.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.882 . . . . 0.0 110.125 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -50.03 -40.99 36.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 23.2 tt0 -60.88 -43.98 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -1.122 . . . . 0.0 109.699 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 38.7 m -62.43 -30.36 71.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.533 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 74.1 mt -64.85 -45.55 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' A' ' 145' ' ' ARG . 1.0 OUTLIER -66.64 -26.2 66.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.517 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -78.79 -39.66 35.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.82 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.59 88.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.579 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.92 -39.66 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.01 -50.86 69.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -17.25 63.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.448 -0.782 . . . . 0.0 110.749 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.53 ' CD2' ' HG ' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -79.81 -42.24 24.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.966 -1.084 . . . . 0.0 109.503 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.53 ' HG ' ' CD2' ' A' ' 150' ' ' TYR . 5.7 mt -67.48 -48.16 67.95 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.821 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -53.34 56.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.83 62.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.912 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.67 97.07 6.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 110.063 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 57.6 m -146.8 75.43 1.39 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.292 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' A' ' 157' ' ' ALA . 34.2 m-20 -85.12 -35.18 21.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.038 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 156' ' ' ASP . . . 68.38 178.18 0.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.211 -0.931 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -173.73 -49.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.069 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.147 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.578 HG23 ' CE1' ' A' ' 121' ' ' HIS . 5.1 t -54.78 151.21 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -1.168 . . . . 0.0 110.074 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -104.35 128.66 52.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 109.883 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.17 142.07 32.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.846 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CE2' HG13 ' A' ' 133' ' ' VAL . 27.8 m-85 -149.93 54.96 0.94 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.46 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 0.1 OUTLIER -83.16 158.0 22.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.529 -0.732 . . . . 0.0 110.878 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -154.44 153.84 32.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.677 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -138.5 146.71 42.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.539 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.54 -178.97 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -121.64 163.29 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.949 . . . . 0.0 110.664 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.404 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 2.7 t -159.29 136.86 10.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.78 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 16.6 t -80.03 -13.87 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.125 -0.984 . . . . 0.0 109.008 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.1 mp -71.89 153.97 92.83 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.4 Cg_endo -67.93 149.15 77.49 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.619 1.326 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . . . -75.08 -29.06 60.55 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.513 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -68.16 -55.07 13.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.444 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 16.3 mtt-85 -63.93 -36.63 84.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.462 HD21 HG22 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -71.79 -35.81 70.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.09 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 36.4 t80 -60.54 -58.73 7.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.921 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 16' ' ' ALA . 13.7 mtpt -50.69 -52.62 38.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.67 67.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.293 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -89.13 -12.06 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.556 HD12 ' CD2' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -124.45 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.742 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD22 ' CE1' ' A' ' 76' ' ' HIS . 0.3 OUTLIER -50.34 -56.2 12.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 2.5 m-20 -111.95 35.43 3.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 109.829 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.13 -58.91 2.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -53.03 -26.72 16.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 110.052 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -87.56 -34.8 18.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 13.9 mt -80.44 -38.75 29.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.316 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.514 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.0 m-30 -43.79 -57.72 5.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.619 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.8 Cg_endo -70.71 -18.89 32.21 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.884 1.465 . . . . 0.0 110.629 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.1 mtpp -86.15 -54.46 4.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 146' ' ' ALA . 5.5 p -83.76 -25.33 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.48 77.29 15.5 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.01 -4.73 15.89 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.082 1.569 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.93 -26.5 60.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.124 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -95.6 -70.34 0.72 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.861 . . . . 0.0 109.967 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.02 128.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.819 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -88.49 -44.69 10.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.29 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -159.5 139.96 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.476 ' CG1' HG12 ' A' ' 56' ' ' ILE . 3.8 t -119.04 130.87 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -135.61 101.82 4.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.686 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.5 m120 -50.64 118.86 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.22 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.503 ' CD1' ' HG2' ' A' ' 68' ' ' LYS . 12.8 mt -86.42 -37.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.336 1.065 . . . . 0.0 108.403 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 24.6 tt0 -143.61 174.43 10.79 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.072 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 57.4 160.49 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -103.88 1.73 31.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -1.203 . . . . 0.0 110.115 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.21 -1.4 4.52 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.86 -167.64 19.98 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.6 122.28 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.005 1.529 . . . . 0.0 110.293 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.73 59.9 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.4 m -54.85 158.72 2.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -1.167 . . . . 0.0 109.305 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 45.8 mt -125.79 142.57 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.048 -1.033 . . . . 0.0 110.559 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -145.32 150.39 36.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 14.7 ttpp -102.2 93.47 5.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.638 -0.664 . . . . 0.0 110.079 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.476 HG12 ' CG1' ' A' ' 41' ' ' VAL . 66.1 mt -87.92 122.47 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 110.055 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.513 ' CB ' ' OG ' ' A' ' 39' ' ' SER . 17.6 m -86.7 138.14 31.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.44 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -106.14 135.31 19.47 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 45.3 Cg_endo -72.8 121.11 7.08 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.936 1.493 . . . . 0.0 110.416 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -172.44 -171.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 62' ' ' PHE . . . -106.04 -52.89 0.77 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.461 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 15.2 m-85 -44.51 163.85 0.18 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.278 -1.131 . . . . 0.0 110.05 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 43.9 Cg_endo -71.36 -50.62 0.3 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.038 1.546 . . . . 0.0 110.846 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.415 ' CD2' ' HG2' ' A' ' 63' ' ' PRO . 26.2 m-85 -82.87 128.51 34.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.388 -0.82 . . . . 0.0 110.325 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.44 ' HD2' ' O ' ' A' ' 58' ' ' PHE . 9.8 pttp -164.63 -43.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 109.883 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.8 p90 -63.09 165.72 6.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.788 . . . . 0.0 109.951 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -144.33 167.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.403 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HG2' ' CD1' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -123.05 41.8 3.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.945 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 18.6 p-10 -41.84 136.21 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.9 ttm180 -97.46 151.84 19.58 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 4.1 t -75.75 149.06 6.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.67 -1.269 . . . . 0.0 110.459 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 46.2 t0 -101.87 -72.14 0.69 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.416 0.627 . . . . 0.0 110.306 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 122.47 11.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -0.855 . . . . 0.0 109.96 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 81' ' ' TYR . 5.1 t -108.7 154.22 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 110.265 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.488 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 2.1 t0 -156.48 121.85 4.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.887 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.505 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -87.54 -15.29 37.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.788 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -102.37 -45.13 5.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.126 -0.984 . . . . 0.0 109.356 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.13 7.48 15.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.546 -0.722 . . . . 0.0 110.091 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.4 m-30 46.25 58.46 4.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HG3' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.61 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CE2' HG23 ' A' ' 74' ' ' VAL . 38.9 t80 -127.95 100.08 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 109.804 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.507 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 6.7 m120 -109.58 139.77 44.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.466 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 39.7 p90 -136.14 136.29 39.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 70' ' ' ARG . 10.6 m -100.13 162.51 12.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 111.223 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 24.3 t -104.54 123.66 58.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.4 -72.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.303 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.75 88.27 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.268 . . . . 0.0 110.211 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -107.1 148.2 16.37 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.54 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.53 -51.91 5.44 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.9 Cg_endo -76.3 -46.96 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.934 1.492 . . . . 0.0 110.732 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' CD1' HG13 ' A' ' 85' ' ' VAL . 52.8 mt -56.51 164.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.107 -0.995 . . . . 0.0 110.459 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 91' ' ' ILE . . . -150.91 -69.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -86.4 -87.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -148.62 15.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -89.66 160.62 16.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 110.38 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.6 OUTLIER 58.16 35.63 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -75.28 147.73 39.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.646 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 4.9 mp -127.77 137.01 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.763 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.7 114.69 19.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.87 . . . . 0.0 109.661 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.571 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 1.1 m120 -110.04 141.14 43.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.448 ' CG ' ' CG ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -130.26 135.68 48.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.44 101.67 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.056 -1.027 . . . . 0.0 110.344 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -107.63 121.46 44.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.926 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.493 ' CG2' ' HB3' ' A' ' 15' ' ' ALA . 54.9 mt -110.48 139.35 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.6 t -138.77 135.78 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.372 -0.83 . . . . 0.0 109.816 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.16 145.92 25.66 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.486 0.66 . . . . 0.0 111.096 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.59 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.4 p -89.24 -167.04 0.12 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.271 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 46.0 Cg_endo -79.77 70.86 7.33 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.399 1.21 . . . . 0.0 110.281 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER 68.48 35.62 3.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.394 -0.816 . . . . 0.0 110.144 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.52 16.37 4.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 107' ' ' THR . . . 106.23 -159.76 14.92 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -140.4 163.46 32.74 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.549 -0.971 . . . . 0.0 110.676 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.85 127.33 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.53 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.492 ' CG ' ' O ' ' A' ' 114' ' ' LEU . 2.1 pp -105.79 112.87 26.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.001 -1.062 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -99.31 104.58 16.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.322 -0.861 . . . . 0.0 109.951 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 9.7 mt -89.56 125.38 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.485 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -112.63 112.51 24.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.126 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -106.39 155.63 19.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.8 mptt -147.21 131.02 17.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.511 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.646 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.21 128.28 55.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.742 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.578 ' CE1' HG23 ' A' ' 2' ' ' VAL . 23.0 m-70 -113.75 130.01 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.63 175.65 5.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 110.086 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.446 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -147.2 165.6 29.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 110.183 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 43.04 -124.55 4.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -111.8 10.76 20.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -1.121 . . . . 0.0 110.071 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 13.9 m-70 -69.02 168.05 14.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.293 -0.88 . . . . 0.0 109.878 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.522 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 5.7 mt-10 -155.75 150.96 26.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.179 -0.951 . . . . 0.0 109.442 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.49 HG22 ' CZ ' ' A' ' 120' ' ' TYR . 2.4 p -106.52 86.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 O-C-N 121.658 -0.651 . . . . 0.0 109.839 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 128' ' ' VAL . 1.3 mttp -39.56 144.66 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.508 -0.745 . . . . 0.0 110.603 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -57.31 -27.34 62.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 110.059 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ALA . 60.8 tt0 -41.57 -64.16 0.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -24.36 38.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.571 HG13 ' CE2' ' A' ' 5' ' ' TYR . 5.3 t -78.88 -50.95 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.365 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -24.55 67.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.465 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.58 -38.26 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.649 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 t -66.9 -31.94 72.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.316 -0.865 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -36.73 73.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.804 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.49 -48.08 79.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.844 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.88 -36.55 56.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.59 -50.25 61.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.1 tt0 -56.08 -33.21 64.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -1.194 . . . . 0.0 110.289 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.415 ' O ' HG21 ' A' ' 142' ' ' THR . 20.3 m -70.88 -24.76 62.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.514 HD12 ' CE2' ' A' ' 30' ' ' PHE . 21.3 mt -75.7 -47.31 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.993 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 144' ' ' LEU . 3.5 pp -70.66 -24.06 62.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.767 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -81.05 -32.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.519 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -70.37 -35.42 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 18' ' ' LEU . 47.0 t -73.5 -46.03 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.465 -0.772 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 49.6 tt0 -54.79 -50.87 67.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.33 -47.35 84.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -48.73 -70.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.436 HD11 HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -49.31 -23.64 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.452 -0.78 . . . . 0.0 110.242 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -81.11 -20.47 41.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.4 3.56 37.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.91 8.1 44.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.221 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 36.9 m -95.14 52.14 1.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 0.0 110.221 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.44 18.97 6.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.029 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.01 -37.21 75.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.353 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.34 70.31 0.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.184 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.25 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.466 HG21 ' ND1' ' A' ' 121' ' ' HIS . 4.8 t 57.72 153.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -1.108 . . . . 0.0 110.412 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.5 m-85 -112.0 163.82 13.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.679 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.09 137.52 32.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.106 . . . . 0.0 110.714 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 118' ' ' ASN . 46.6 m-85 -144.89 57.89 1.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.777 . . . . 0.0 109.556 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 1.2 tm-20 -80.03 154.52 28.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 110.783 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.68 -179.06 7.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.494 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -158.04 151.74 23.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.0 110.47 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 t -140.4 169.57 17.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.928 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.4 162.99 13.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 110.256 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -158.86 137.88 11.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.444 -0.785 . . . . 0.0 109.916 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.98 -3.02 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 36.1 mm -81.58 147.47 59.51 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.049 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.88 150.56 83.11 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.473 1.249 . . . . 0.0 111.091 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB3' HG23 ' A' ' 104' ' ' ILE . . . -75.18 -33.15 61.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.935 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.03 -47.81 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.469 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 5.1 ttt180 -68.64 -38.92 80.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 109.764 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 2.4 tp -72.69 -30.45 64.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.517 ' CD1' HD12 ' A' ' 23' ' ' ILE . 67.6 t80 -68.13 -63.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.368 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HA ' HD11 ' A' ' 24' ' ' LEU . 1.4 mptp? -53.24 -40.98 64.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -0.777 . . . . 0.0 110.512 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.76 -32.15 63.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.541 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.7 t80 -90.61 -8.72 49.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 19' ' ' PHE . 1.2 mp -118.83 -65.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -61.33 -46.73 89.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -97.05 -15.35 21.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 110.06 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -45.94 -42.51 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 4.6 m-20 -52.77 -27.98 20.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -113.31 -20.29 11.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.424 ' O ' HG21 ' A' ' 33' ' ' VAL . 2.6 tp -86.66 -27.79 23.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 110.106 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.526 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.0 m-85 -54.84 -53.76 57.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.406 -0.809 . . . . 0.0 110.657 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -74.31 -4.59 15.66 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.833 1.438 . . . . 0.0 111.101 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.5 -40.71 8.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.59 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 29' ' ' LEU . 13.5 m -86.03 -26.66 6.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 110.8 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.24 88.44 5.81 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.092 -1.005 . . . . 0.0 110.594 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 59' ' ' PRO . 49.3 Cg_endo -76.34 0.68 9.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.006 1.53 . . . . 0.0 110.489 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -29.75 23.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.282 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -92.4 -66.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.82 126.86 64.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.444 -0.785 . . . . 0.0 109.936 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 2.9 t -83.35 -53.35 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.285 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -149.6 146.99 27.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 5.8 t -121.45 127.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.63 108.95 8.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.093 -1.005 . . . . 0.0 110.838 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 2.7 m120 -62.4 118.39 7.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 44' ' ' ILE . 12.1 mt -87.36 -37.71 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.236 1.017 . . . . 0.0 108.585 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 23.8 tt0 -148.64 174.7 11.87 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.405 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 71.18 -174.92 40.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.77 43.21 3.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -1.197 . . . . 0.0 110.295 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.3 27.95 68.93 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.11 -158.97 12.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.7 Cg_endo -72.47 110.22 2.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.112 1.585 . . . . 0.0 110.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.82 47.41 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 2.4 m -60.72 152.65 26.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.181 -1.188 . . . . 0.0 109.728 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mt -119.43 133.95 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.452 ' HD3' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -141.08 150.84 43.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.533 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.41 101.44 13.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 109.751 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.452 HD13 ' HD3' ' A' ' 54' ' ' LYS . 4.4 mm -94.48 134.01 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.963 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.498 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -102.97 131.81 49.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.92 . . . . 0.0 110.337 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.14 117.73 62.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.911 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 48.7 Cg_endo -75.54 137.62 20.77 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.912 1.48 . . . . 0.0 110.638 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 10.2 tt0 -177.98 -72.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.215 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.02 -34.24 0.86 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -54.29 173.5 0.21 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.289 -1.124 . . . . 0.0 110.059 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.02 -55.26 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.997 1.525 . . . . 0.0 109.898 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 22.0 m-85 -96.51 167.52 11.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.952 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 165.81 -55.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.498 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 33.6 p90 -58.22 177.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.485 -0.759 . . . . 0.0 110.281 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.559 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 1.4 p -167.16 171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 110.657 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.559 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.7 tttt -106.89 46.42 0.93 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.715 -0.615 . . . . 0.0 109.912 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' CG2' ' A' ' 67' ' ' VAL . 48.5 m-20 -45.62 130.98 9.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.693 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttp180 -102.56 162.92 12.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 12.3 t -86.56 151.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.596 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 32.1 t70 -100.33 -68.01 0.83 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.194 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.3 mt-10 -143.77 137.86 28.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.414 -0.804 . . . . 0.0 110.205 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.5 t -123.97 144.22 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.158 -0.964 . . . . 0.0 110.101 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -147.43 114.06 6.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.476 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 12.3 m170 -82.56 -2.07 52.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.338 -0.851 . . . . 0.0 110.708 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -118.08 -42.45 2.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.037 -1.039 . . . . 0.0 109.891 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.452 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -90.26 18.85 5.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.516 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.2 m-85 42.17 64.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.111 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -131.11 117.14 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.442 ' OH ' ' NZ ' ' A' ' 54' ' ' LYS . 9.5 t80 -137.34 99.63 4.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.527 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 56.8 m-20 -113.81 147.01 39.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.495 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 36.2 p90 -140.99 142.48 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 70' ' ' ARG . 26.3 m -107.07 165.14 11.58 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.176 -0.953 . . . . 0.0 110.974 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 91' ' ' ILE . 71.4 t -108.06 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -123.06 -77.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.898 -1.126 . . . . 0.0 110.834 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -85.61 77.28 9.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.835 -1.166 . . . . 0.0 109.891 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.473 ' HA2' ' CB ' ' A' ' 67' ' ' VAL . . . -104.23 159.74 16.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.53 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.75 -54.84 5.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -71.06 -48.76 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.768 1.404 . . . . 0.0 111.013 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 86' ' ' ILE . 4.8 mt -64.89 164.59 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 91' ' ' ILE . . . -153.15 -40.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.3 -85.97 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -1.152 . . . . 0.0 110.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -139.26 6.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.47 ' O ' ' HB3' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -92.91 158.44 15.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 58.39 31.3 20.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 110.162 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -75.31 146.35 41.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.787 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.577 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.1 mp -132.29 127.82 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -0.951 . . . . 0.0 110.685 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.49 116.24 30.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 109.679 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.52 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 12.6 m-80 -104.35 156.34 18.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.937 . . . . 0.0 110.749 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 94.2 mt-10 -144.91 138.38 26.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.792 . . . . 0.0 109.815 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -128.76 128.67 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.521 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -129.17 132.29 47.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.937 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.516 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 1.3 mp -121.66 129.17 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.85 123.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 111.195 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -58.12 162.9 3.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.864 -0.523 . . . . 0.0 110.503 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.564 HG21 ' CD ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -160.0 -61.05 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 111.371 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.564 ' CD ' HG21 ' A' ' 107' ' ' THR . 49.4 Cg_endo -74.27 53.1 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.082 1.043 . . . . 0.0 111.099 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 108' ' ' PRO . 1.2 m-20 40.6 55.13 2.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.905 . . . . 0.0 110.549 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 146.63 -56.14 0.52 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -75.78 -169.05 26.39 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 11.3 t -157.19 -179.98 8.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.255 . . . . 0.0 111.218 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 107' ' ' THR . 4.9 mt -125.21 124.79 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 mp -99.09 114.67 27.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 110.952 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -103.83 106.48 17.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.334 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 101' ' ' GLU . 26.3 mt -101.99 127.27 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.679 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -105.43 143.44 33.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.801 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.52 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 2.0 m120 -131.07 153.15 49.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.413 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -146.26 132.65 19.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 110.375 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.577 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.07 131.5 55.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.81 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 97' ' ' LYS . 66.5 m-70 -118.28 109.15 15.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 110.371 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.48 173.07 6.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 125' ' ' ASP . 1.6 ttpm? -110.32 176.06 5.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 110.361 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.09 60.58 0.22 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 123' ' ' LYS . 42.8 t0 -175.29 -67.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.37 -1.076 . . . . 0.0 109.831 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -81.91 172.15 13.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.937 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -145.17 -164.14 1.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 110.266 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.488 HG23 ' CG ' ' A' ' 120' ' ' TYR . 1.8 t -122.82 105.38 15.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.499 -0.751 . . . . 0.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -78.22 126.76 31.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.371 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.57 -37.28 26.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.405 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -42.49 -48.85 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.024 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -70.51 -27.73 64.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 108.934 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 130' ' ' ALA . 16.9 t -76.5 -47.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.569 -0.707 . . . . 0.0 109.12 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -27.94 66.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.658 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.92 66.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.1 t -66.87 -31.32 71.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -45.34 54.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 110.046 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.84 -57.36 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.884 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 139' ' ' LEU . 4.0 mm? -75.37 -35.08 61.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.034 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.86 -49.5 22.69 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 40.7 tt0 -55.88 -44.51 78.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -1.14 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.457 ' O ' ' HB1' ' A' ' 146' ' ' ALA . 17.1 m -55.57 -34.15 64.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.0 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 17.4 mt -67.86 -49.36 62.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 0.9 OUTLIER -69.87 -27.11 64.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.086 -1.009 . . . . 0.0 109.83 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.402 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 3.4 ttm180 -81.47 -28.81 33.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.92 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 142' ' ' THR . . . -72.11 -43.53 64.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 109.918 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.22 -38.26 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.794 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.5 tt0 -65.06 -46.09 82.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -63.5 -40.73 97.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.586 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -73.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.977 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 154' ' ' HIS . 1.6 mt -50.11 -38.98 41.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.412 -0.805 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 3.9 mt -50.98 -26.77 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.808 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.56 -20.4 13.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.938 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 151' ' ' LEU . 22.4 t-160 -93.27 -40.09 10.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 110.064 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.2 m -92.67 17.3 10.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 0.0 110.243 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -66.69 -36.09 81.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.931 . . . . 0.0 110.082 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.83 -145.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.055 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -92.09 -28.07 17.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 0.0 110.142 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 29.5 p-10 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.29 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.583 HG13 ' CG ' ' A' ' 121' ' ' HIS . 8.6 m -109.94 -164.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.147 -1.207 . . . . 0.0 110.118 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.533 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 3.4 m-85 -107.81 164.33 12.34 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.628 -0.67 . . . . 0.0 109.714 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.99 138.49 42.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.053 -1.029 . . . . 0.0 110.848 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.428 ' CZ ' HG12 ' A' ' 133' ' ' VAL . 50.0 m-85 -146.57 53.89 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.3 pt-20 -81.66 144.43 31.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.766 . . . . 0.0 111.149 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -171.03 3.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.443 -0.786 . . . . 0.0 109.674 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -159.9 164.46 33.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 110.711 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.83 -169.92 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 110.048 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -129.52 160.94 31.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 110.35 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.98 135.3 8.14 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.622 -0.674 . . . . 0.0 109.834 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.96 -17.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 108.642 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 21.9 mm -68.24 150.35 97.76 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.2 Cg_endo -65.92 151.71 83.37 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.508 1.267 . . . . 0.0 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.61 -25.06 59.0 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -78.13 -47.6 17.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.45 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -69.61 -34.12 73.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.707 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 10.6 tp -74.38 -28.7 61.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 110.007 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' ILE . 50.6 t80 -70.44 -60.18 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -54.72 -45.79 74.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.43 70.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.63 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 8.2 t80 -91.54 -20.76 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.97 . . . . 0.0 110.461 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 81' ' ' TYR . 1.3 mp -114.08 -62.8 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.67 -35.19 20.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.871 . . . . 0.0 110.209 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.58 26.45 4.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -61.0 -44.97 97.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' HA ' HG12 ' A' ' 41' ' ' VAL . 26.9 m-20 -64.88 -8.13 14.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -1.203 . . . . 0.0 110.412 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 4.6 t30 -107.68 -38.79 5.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -80.64 -38.74 28.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -42.12 -59.27 2.77 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.449 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.2 Cg_endo -72.73 -10.65 25.27 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.637 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 6.6 tttm -90.78 -63.74 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -81.51 -17.4 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 110.741 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.85 64.37 62.24 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 110.383 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.7 -13.26 20.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.001 1.527 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -79.05 -23.61 44.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.434 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -89.07 -61.01 1.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.427 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -106.42 155.45 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 109.841 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.49 -61.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 110.177 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.65 135.17 16.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.519 ' CG2' HG12 ' A' ' 56' ' ' ILE . 1.7 p -124.04 128.77 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.125 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 2.9 mt-10 -130.77 159.61 36.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 110.344 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 54' ' ' LYS . 25.8 m120 -95.06 119.27 33.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.156 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' ILE . 19.2 mm -87.14 -36.84 10.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.315 1.055 . . . . 0.0 108.479 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.535 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 45.0 tt0 -145.51 174.0 11.54 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.444 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 62.73 166.01 0.58 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -114.39 41.62 2.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -1.14 . . . . 0.0 110.207 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.31 29.07 51.32 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.97 -162.8 18.07 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.426 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.7 Cg_endo -74.02 106.8 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.959 1.505 . . . . 0.0 110.27 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.98 5.48 33.08 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.1 m -69.74 157.16 37.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 109.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 6.3 mt -124.48 131.18 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -137.95 149.83 46.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.196 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 42' ' ' GLU . 1.6 tttp -98.34 109.62 22.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.565 -0.709 . . . . 0.0 110.758 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.519 HG12 ' CG2' ' A' ' 41' ' ' VAL . 72.9 mt -104.1 141.98 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.214 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -121.08 154.1 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 111.155 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.46 135.44 21.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 46.8 Cg_endo -73.67 97.58 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.847 1.446 . . . . 0.0 111.033 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.586 ' HG2' ' CE2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -165.13 -150.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 110.482 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.96 -42.99 1.46 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.586 ' CE2' ' HG2' ' A' ' 60' ' ' GLU . 8.8 p90 -60.12 138.26 91.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.114 -1.227 . . . . 0.0 110.401 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.34 -24.54 10.68 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.053 1.554 . . . . 0.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.566 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 4.9 m-85 -80.18 -162.44 0.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 110.432 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 80.37 -39.89 0.18 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.921 -0.487 . . . . 0.0 110.925 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 2.2 p90 -55.37 159.43 2.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.865 -1.147 . . . . 0.0 109.652 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 65' ' ' LYS . 18.3 m -151.51 156.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.566 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.6 mttt -111.43 46.67 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 109.724 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.461 ' OD2' HD11 ' A' ' 56' ' ' ILE . 4.2 p30 -39.35 140.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.947 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -99.44 154.1 18.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.4 t -76.81 147.43 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.678 -1.264 . . . . 0.0 109.72 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.519 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 64.6 t0 -97.28 -69.45 0.76 Allowed 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.719 -0.613 . . . . 0.0 110.461 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 mm-40 -154.8 106.69 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 110.463 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.26 149.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.129 -0.982 . . . . 0.0 109.706 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -139.2 112.54 8.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 110.48 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -87.75 1.52 53.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.584 -0.697 . . . . 0.0 110.123 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -113.14 -57.63 2.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.09 13.76 5.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.524 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 14.3 m-85 48.59 61.72 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -130.12 110.33 11.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.977 . . . . 0.0 110.699 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.482 ' CD2' HG13 ' A' ' 23' ' ' ILE . 4.0 t80 -120.13 96.98 5.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.496 -0.753 . . . . 0.0 109.602 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.519 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 7.1 m120 -102.75 138.89 39.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.6 p90 -136.63 137.92 40.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.2 m -104.02 152.81 21.59 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.106 -0.996 . . . . 0.0 111.365 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 91' ' ' ILE . 19.4 t -100.71 124.2 54.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.8 OUTLIER -124.92 -75.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.74 -178.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -65.1 70.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.758 -1.214 . . . . 0.0 109.793 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 86' ' ' ILE . . . -96.6 131.86 10.8 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.531 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.92 -56.87 3.05 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.0 Cg_endo -71.52 -27.74 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.782 1.412 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.519 ' CD1' HG13 ' A' ' 85' ' ' VAL . 59.1 mt -72.81 158.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.56 -58.04 0.37 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -56.63 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 0.0 109.838 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 t -146.34 18.28 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.939 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.3 149.78 22.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 52.42 33.98 14.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.373 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.511 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 9.9 tttt -67.38 164.68 18.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.451 -0.78 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.65 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -136.27 125.54 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.258 -0.901 . . . . 0.0 110.157 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.02 115.55 27.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.868 . . . . 0.0 109.488 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.586 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 1.6 m-80 -112.31 140.5 46.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.973 . . . . 0.0 110.709 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB2' ' OG ' ' A' ' 117' ' ' SER . 0.5 OUTLIER -127.35 132.3 50.24 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.444 -0.785 . . . . 0.0 109.59 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mt -120.45 105.39 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 110.625 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 32.6 tttm -104.44 117.41 34.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.524 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 3.8 mt -105.58 111.18 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.296 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.47 146.0 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.662 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.21 142.32 27.85 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.434 0.635 . . . . 0.0 111.066 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 8.2 p -96.32 169.48 8.89 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.436 -0.79 . . . . 0.0 109.496 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 45.6 Cg_endo -71.53 -0.35 8.1 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.674 1.355 . . . . 0.0 111.024 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -94.69 -2.49 51.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.028 -1.045 . . . . 0.0 110.238 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.8 -19.81 43.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.05 -164.12 33.7 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -143.53 157.86 44.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.303 -1.116 . . . . 0.0 111.418 -179.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 1.1 tt -107.2 129.61 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.03 136.61 33.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 110.588 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.35 105.71 9.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 109.654 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 4.4 mp -105.62 105.74 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -90.42 133.21 35.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.551 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.446 ' ND2' ' ND2' ' A' ' 100' ' ' ASN . 2.5 t-20 -127.45 140.66 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.758 -1.214 . . . . 0.0 110.59 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.87 149.6 52.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 109.872 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.65 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -126.46 107.25 10.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.101 -1.0 . . . . 0.0 109.439 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.583 ' CG ' HG13 ' A' ' 2' ' ' VAL . 17.5 m-70 -88.52 93.02 9.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.986 . . . . 0.0 110.531 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -117.33 167.58 11.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.994 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 124' ' ' GLY . 10.1 tptt -115.69 162.64 16.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.905 . . . . 0.0 110.193 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.57 -39.87 3.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.41 -85.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -1.188 . . . . 0.0 110.293 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.516 ' CD2' ' N ' ' A' ' 126' ' ' HIS . 14.6 m170 -67.66 -179.75 1.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -153.56 -172.13 4.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 110.435 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.475 ' O ' ' CG1' ' A' ' 128' ' ' VAL . 2.0 t -129.86 96.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.401 -0.812 . . . . 0.0 109.678 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -62.79 126.02 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.027 . . . . 0.0 109.612 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.22 -41.36 18.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 110.55 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.8 mt-10 -40.25 -58.62 1.46 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 110.244 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.97 -30.67 69.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.179 -0.95 . . . . 0.0 108.954 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 130' ' ' ALA . 22.7 t -72.7 -53.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 109.035 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -55.49 -28.62 55.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.191 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.14 -25.85 62.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 133' ' ' VAL . 26.9 t -68.6 -30.92 69.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -79.09 -49.56 12.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.92 -48.71 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.928 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.29 -39.75 53.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' A' ' 143' ' ' LEU . . . -54.07 -50.67 54.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.505 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 2.8 tt0 -57.78 -48.46 79.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -1.174 . . . . 0.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.6 -29.53 59.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.426 HD11 ' HA2' ' A' ' 140' ' ' GLY . 78.0 mt -72.78 -53.38 11.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.505 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -68.42 -22.17 64.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -81.88 -35.11 29.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.752 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.13 -40.96 91.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.12 -46.44 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.682 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.452 ' OE1' HD13 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -56.35 -45.8 80.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -25.3 64.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.843 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.553 ' CD1' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.53 -41.07 63.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' ' CD1' ' A' ' 150' ' ' TYR . 4.5 mt -66.86 -34.64 78.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.452 HD13 ' OE1' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -63.86 -34.12 77.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.865 . . . . 0.0 110.197 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.22 -13.32 60.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.65 84.7 1.74 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 110.418 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 38.7 t -144.57 38.35 1.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.917 . . . . 0.0 110.241 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.67 -39.07 0.19 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.055 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.26 159.91 41.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.74 53.4 0.68 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 110.183 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.0 t30 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.523 ' O ' ' CG2' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 1' ' ' GLY . 4.7 m 38.46 -160.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.598 -0.943 . . . . 0.0 110.756 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 7.4 m-85 -121.96 145.15 48.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 109.911 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.458 ' OD1' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -124.27 133.47 53.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 110.713 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.501 ' CD2' HG12 ' A' ' 133' ' ' VAL . 62.2 m-85 -139.42 57.13 1.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.526 -0.734 . . . . 0.0 109.447 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 3.1 tm-20 -80.2 153.81 28.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.585 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.04 176.1 13.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 109.719 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -158.54 152.18 23.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.002 -1.061 . . . . 0.0 110.572 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 10' ' ' THR . 1.8 t -134.72 -170.77 2.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -122.36 165.57 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 138.24 10.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.423 -0.798 . . . . 0.0 109.754 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.7 t -80.11 -14.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.685 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 31.0 mm -70.24 149.42 95.97 Favored Pre-proline 0 N--CA 1.487 1.421 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -68.2 148.25 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.317 1.167 . . . . 0.0 110.82 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.37 -33.82 65.25 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.977 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.15 35.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.487 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -66.74 -37.28 84.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.962 . . . . 0.0 109.847 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 18' ' ' LEU . 7.8 tt -73.94 -32.16 63.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 76' ' ' HIS . 30.7 t80 -63.21 -55.93 20.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -58.05 -45.03 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.45 -31.08 71.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' HB2' HD22 ' A' ' 18' ' ' LEU . 20.3 t80 -89.72 -23.96 21.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.577 HD11 ' CD2' ' A' ' 81' ' ' TYR . 7.3 mm -106.18 -65.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -51.92 -42.77 63.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.985 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 18.9 m-20 -115.39 23.54 12.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 110.193 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -62.83 -54.18 35.43 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 21.5 m-20 -59.72 -13.15 8.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -1.141 . . . . 0.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -104.15 -36.26 7.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -83.44 -23.48 32.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.566 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -56.43 -60.25 9.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.6 Cg_endo -73.91 -3.56 13.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.944 1.497 . . . . 0.0 110.286 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 20.7 tttm -103.29 -32.93 9.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 110.433 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 146' ' ' ALA . 1.6 p -101.68 -33.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.116 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.43 ' CB ' HD22 ' A' ' 143' ' ' LEU . . . -121.4 78.76 36.34 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.41 -0.806 . . . . 0.0 110.1 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 -18.98 31.17 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.99 1.521 . . . . 0.0 110.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.55 -4.29 57.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 110.276 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -107.5 -67.82 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.15 152.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.529 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -113.84 -27.88 7.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.021 -1.05 . . . . 0.0 110.83 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.82 162.14 34.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.076 -1.015 . . . . 0.0 110.832 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 27' ' ' ASP . 3.7 m -142.62 133.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.45 -0.781 . . . . 0.0 109.719 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -135.7 110.45 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.524 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.534 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -69.2 118.31 11.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 110.257 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.436 ' H ' ' HA ' ' A' ' 54' ' ' LYS . 11.6 mt -80.0 -39.98 20.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -97.13 -159.39 0.73 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.4 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.49 57.11 0.32 Allowed Glycine 0 C--N 1.296 -1.683 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.433 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 49.3 t30 -116.31 -26.88 7.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.361 -1.082 . . . . 0.0 109.808 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 54.46 20.04 15.27 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -126.65 -158.62 9.93 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.2 Cg_endo -71.64 96.18 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.913 1.481 . . . . 0.0 110.271 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.22 -0.74 6.08 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.562 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 88.4 m -67.69 160.58 27.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -1.159 . . . . 0.0 109.186 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 11.5 mt -130.38 142.55 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.833 -1.167 . . . . 0.0 111.017 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 19.1 pttt -159.87 136.88 9.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.569 -0.707 . . . . 0.0 110.196 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -87.91 113.54 23.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.411 HD13 ' CG ' ' A' ' 69' ' ' ASP . 47.9 mt -92.16 153.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.645 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -118.0 148.53 42.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 110.784 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 47.4 m-85 -126.76 118.51 22.57 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 109.625 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 39' ' ' SER . 48.6 Cg_endo -74.2 132.21 16.27 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.89 1.468 . . . . 0.0 111.034 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.629 ' CB ' ' CZ ' ' A' ' 62' ' ' PHE . 4.0 tt0 176.11 -151.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -129.45 -13.07 2.38 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.493 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CZ ' ' CB ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -45.02 170.87 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.879 -1.365 . . . . 0.0 110.46 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 41.8 Cg_endo -68.06 -35.91 18.71 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.486 1.256 . . . . 0.0 109.504 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 8.8 m-85 -87.56 -167.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.5 -0.75 . . . . 0.0 109.176 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 3.8 tttp -164.99 -76.69 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.093 -1.004 . . . . 0.0 110.7 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 20.4 p90 -92.05 -168.0 1.9 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 110.863 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -173.0 172.93 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.496 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.0 ttmt -112.41 122.65 48.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 110.069 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -118.93 129.39 55.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.789 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -100.28 145.41 28.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.227 -0.921 . . . . 0.0 108.86 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.562 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 4.0 t -76.5 147.22 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.881 -1.137 . . . . 0.0 110.668 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.459 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 6.8 t70 -99.1 -71.71 0.68 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.448 0.642 . . . . 0.0 109.966 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 3.1 tp10 -141.64 133.1 26.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.45 -0.782 . . . . 0.0 110.168 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG23 ' CE2' ' A' ' 81' ' ' TYR . 2.6 t -118.37 157.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -159.77 124.26 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 110.064 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 18.7 m170 -98.63 1.17 46.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -112.82 -46.81 3.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.34 10.91 27.82 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 109.966 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-85 51.09 64.0 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 110.445 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -129.7 123.16 30.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.577 ' CD2' HD11 ' A' ' 23' ' ' ILE . 28.0 t80 -144.11 103.77 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.475 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 77.5 m-20 -113.97 140.58 48.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.216 -0.927 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 22.9 p90 -137.25 137.22 38.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.488 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 53.8 m -103.76 166.54 10.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.022 -1.049 . . . . 0.0 110.915 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 91' ' ' ILE . 53.0 t -108.19 124.62 64.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -115.79 -67.89 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.899 -1.126 . . . . 0.0 112.0 -178.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HB2' ' CB ' ' A' ' 68' ' ' LYS . 0.5 OUTLIER -88.24 82.1 7.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 67' ' ' VAL . . . -100.54 141.13 15.25 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.513 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.71 -58.59 2.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.6 Cg_endo -71.78 -45.18 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.933 1.491 . . . . 0.0 110.393 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.534 ' CD1' HG13 ' A' ' 85' ' ' VAL . 50.4 mt -58.07 149.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.7 -114.73 2.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -70.03 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -1.166 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 3.2 t -143.93 15.06 1.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.069 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.05 152.55 22.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 109.99 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.535 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 56.33 34.82 24.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.58 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -68.36 157.36 35.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.386 -0.821 . . . . 0.0 110.112 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.581 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.7 mp -137.12 131.16 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.94 . . . . 0.0 110.402 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.84 114.8 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.785 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.577 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 5.7 m120 -106.62 138.02 43.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.152 -0.968 . . . . 0.0 110.411 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.498 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 26.2 mt-10 -127.53 132.27 49.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 110.191 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.32 121.82 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.33 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 3.9 mttt -128.36 126.39 40.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 109.91 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 12.5 mt -115.36 130.25 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.165 -0.96 . . . . 0.0 110.655 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.12 143.94 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 109.603 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.11 138.77 31.15 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 110.8 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 t -108.75 151.96 42.02 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.96 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.28 54.96 2.39 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.924 1.486 . . . . 0.0 110.452 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.32 11.25 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.025 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.7 19.82 50.12 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.5 -165.8 17.18 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -136.72 164.02 29.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.092 . . . . 0.0 110.702 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.48 127.55 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 109.353 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.52 143.45 29.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 0.0 110.955 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 8' ' ' GLU . 1.8 ttmt -135.13 105.01 6.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.465 -0.772 . . . . 0.0 109.795 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.8 mt -106.4 112.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.336 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.498 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -90.39 154.42 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -143.86 135.56 26.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HG3' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -125.56 153.48 43.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.581 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -135.04 101.88 5.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.079 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.535 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 21.3 m-70 -85.98 120.54 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.047 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.449 HG22 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -113.09 173.58 6.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 0.0 110.012 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.51 177.16 11.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.396 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.78 -138.92 7.96 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.19 -9.23 37.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -1.118 . . . . 0.0 110.356 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -53.61 174.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.397 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -158.62 -167.28 2.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 120' ' ' TYR . 2.3 t -121.5 93.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -58.69 129.57 42.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 109.562 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.43 -46.45 26.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.942 . . . . 0.0 110.541 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 130' ' ' ALA . 26.7 tt0 -40.18 -50.72 2.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.198 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -35.3 80.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.016 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 130' ' ' ALA . 15.9 t -72.55 -50.87 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.414 -0.804 . . . . 0.0 108.982 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -63.0 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.746 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.3 -44.23 72.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.628 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t -57.78 -33.01 68.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.19 12.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.888 . . . . 0.0 110.106 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -48.38 -52.9 19.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 110.285 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.9 mt -69.62 -44.52 70.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 143' ' ' LEU . . . -49.33 -46.52 35.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.526 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 30.8 tt0 -61.29 -30.23 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -30.75 68.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.475 ' CD1' ' HA2' ' A' ' 140' ' ' GLY . 3.0 mt -73.03 -47.46 44.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.1 pp -69.44 -22.51 63.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 109.904 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 149' ' ' SER . 2.9 ttp180 -83.78 -34.54 24.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -63.35 -44.43 94.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.379 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.91 -49.66 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.557 -0.714 . . . . 0.0 109.94 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 8.9 tt0 -56.53 -46.43 80.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.641 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 1.1 t -64.93 -43.92 91.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.456 -0.777 . . . . 0.0 109.872 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -50.99 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.099 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 154' ' ' HIS . 3.8 mt -44.97 -34.39 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -34.2 62.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.829 . . . . 0.0 110.131 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 150' ' ' TYR . . . -56.96 -23.26 44.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.206 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -137.17 154.18 50.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 110.282 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.3 m -109.75 115.47 29.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 109.834 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -75.79 -54.56 6.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.55 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.43 ' CB ' ' OD1' ' A' ' 159' ' ' ASN . . . -145.5 169.97 17.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.958 . . . . 0.0 110.58 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.89 -2.68 34.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.439 -0.788 . . . . 0.0 110.238 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.43 ' OD1' ' CB ' ' A' ' 157' ' ' ALA . 6.5 m120 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.182 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.473 HG23 ' CG ' ' A' ' 121' ' ' HIS . 2.6 t -126.02 144.52 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -1.144 . . . . 0.0 110.228 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -94.31 149.63 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -0.759 . . . . 0.0 109.427 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.497 ' ND2' ' HG3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -121.54 144.49 48.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.125 -0.984 . . . . 0.0 110.634 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 118' ' ' ASN . 34.1 m-85 -153.77 69.92 0.81 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.436 -0.79 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 10.7 pt-20 -100.59 135.81 41.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.758 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' HD2' ' A' ' 137' ' ' LYS . 0.2 OUTLIER -134.92 177.93 7.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.017 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -158.12 161.12 37.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 110.356 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -147.6 -175.88 5.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 110.097 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 p -122.19 160.98 24.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 110.308 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -157.93 136.84 11.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.768 . . . . 0.0 109.803 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.02 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.103 -0.998 . . . . 0.0 109.154 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 45.3 mm -77.75 149.22 77.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.5 Cg_endo -64.02 148.48 91.52 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.264 1.139 . . . . 0.0 111.187 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -73.46 -24.36 60.21 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.114 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.03 -50.96 11.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.277 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 3.0 tpm_? -64.57 -40.3 95.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.098 -1.001 . . . . 0.0 109.603 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 8.5 tt -71.23 -37.47 72.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.598 -0.689 . . . . 0.0 110.187 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.488 ' CE2' ' HA ' ' A' ' 76' ' ' HIS . 76.4 t80 -61.59 -69.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.314 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.15 -51.77 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.878 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.1 74.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.0 t80 -84.86 -10.08 57.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -124.78 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.902 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -51.96 -42.25 62.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.264 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -104.3 -1.51 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -47.95 -52.69 16.07 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' OD2' ' HB ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -48.05 -23.15 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -1.21 . . . . 0.0 110.06 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -112.55 -23.84 10.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -84.81 -27.94 26.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.141 -0.974 . . . . 0.0 110.045 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -64.51 -60.08 9.25 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -74.01 53.14 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.823 1.433 . . . . 0.0 110.254 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.84 -58.1 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG13 ' CE1' ' A' ' 150' ' ' TYR . 27.0 m -85.92 -16.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.373 -0.829 . . . . 0.0 110.45 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.56 71.18 5.46 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.48 -12.5 27.18 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.993 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.411 ' C ' ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -64.55 -21.15 66.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.467 -0.771 . . . . 0.0 110.115 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.9 -60.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.868 . . . . 0.0 110.02 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.471 HD11 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -113.56 145.01 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.747 . . . . 0.0 109.745 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.55 -57.69 2.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.7 t -155.3 157.51 37.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.554 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.465 ' HB ' ' OD2' ' A' ' 27' ' ' ASP . 59.0 t -114.4 138.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -129.35 87.24 2.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.895 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 6.2 m-20 -54.73 114.34 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.717 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.509 HG23 HD11 ' A' ' 44' ' ' ILE . 4.9 mt -82.54 -38.51 15.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.197 0.999 . . . . 0.0 108.676 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 23.1 tt0 -157.43 174.44 15.4 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.655 0.741 . . . . 0.0 110.176 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 75.77 155.97 5.81 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -103.33 43.22 1.1 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -1.101 . . . . 0.0 109.425 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.06 23.95 76.81 Favored Glycine 0 N--CA 1.48 1.572 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -96.72 -162.47 32.45 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.4 Cg_endo -72.95 101.54 1.33 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.048 1.552 . . . . 0.0 110.909 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 111.32 -1.25 28.08 Favored Glycine 0 N--CA 1.48 1.579 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -58.4 154.14 14.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -1.201 . . . . 0.0 109.585 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.418 HD13 ' HB3' ' A' ' 45' ' ' GLU . 18.2 mt -116.64 143.38 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -157.49 144.43 18.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 110.539 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -92.34 102.22 14.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.432 HD12 HG12 ' A' ' 41' ' ' VAL . 5.5 mm -82.76 130.09 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.86 . . . . 0.0 109.48 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.87 153.73 22.6 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.288 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 32.8 p90 -110.92 155.64 42.09 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 110.12 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.457 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 45.6 Cg_endo -72.72 175.46 10.23 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.032 1.543 . . . . 0.0 110.626 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.37 161.01 0.72 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.316 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.14 -85.33 0.15 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.567 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -101.47 -179.25 0.77 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.776 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 43.0 Cg_endo -70.26 -53.9 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.731 1.385 . . . . 0.0 109.753 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.553 ' CE2' ' HG2' ' A' ' 63' ' ' PRO . 1.5 p90 -123.27 165.98 16.03 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.472 -0.768 . . . . 0.0 110.025 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER 169.65 -28.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 109.861 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 29.6 p90 -52.56 158.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.427 -0.796 . . . . 0.0 109.815 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 65' ' ' LYS . 10.4 m -152.23 179.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 0.0 110.413 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 12.5 mttt -128.83 41.84 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.689 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 84' ' ' SER . 45.2 p-10 -39.17 138.94 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 110.816 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HB2' HD12 ' A' ' 86' ' ' ILE . 8.8 ttm180 -100.08 155.24 17.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.401 -0.812 . . . . 0.0 108.887 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.2 t -79.94 144.04 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.8 -1.188 . . . . 0.0 110.195 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.467 ' HB2' ' CB ' ' A' ' 82' ' ' ASN . 46.8 m-20 -96.32 -69.2 0.76 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.292 0.568 . . . . 0.0 110.159 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -146.76 132.29 18.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 1.1 m-20 -151.61 107.01 3.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.488 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -81.81 -10.38 59.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 110.398 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -108.82 -45.83 3.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.15 6.39 25.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.562 -0.711 . . . . 0.0 109.987 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-30 48.56 58.75 4.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.255 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.6 ttmt -134.09 110.38 9.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.469 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' A' ' 81' ' ' TYR . 13.2 t80 -126.82 122.1 33.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.881 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 73.1 m-20 -128.3 141.36 51.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 46.9 p90 -138.44 133.14 32.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.316 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 64.7 m -100.95 168.27 9.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.003 -1.061 . . . . 0.0 111.156 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.545 HG13 ' CD1' ' A' ' 91' ' ' ILE . 71.7 t -104.48 127.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -126.83 -75.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.97 -1.081 . . . . 0.0 111.196 -178.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -79.06 83.36 5.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.892 -1.13 . . . . 0.0 110.109 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -109.09 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.546 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.45 -54.0 3.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -73.33 -49.58 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.871 1.458 . . . . 0.0 110.826 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.545 ' CD1' HG13 ' A' ' 85' ' ' VAL . 42.3 mt -58.8 138.0 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.024 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.27 -60.98 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -97.6 -90.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.194 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 t -139.92 9.11 2.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -86.77 162.14 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.239 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 95' ' ' LEU . 6.5 mm-40 57.67 36.33 26.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.939 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -81.33 155.6 25.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.558 HG12 ' CD2' ' A' ' 120' ' ' TYR . 2.7 mp -138.64 129.05 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 110.516 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.07 120.47 41.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 1.9 m-20 -110.02 149.36 30.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.515 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 34.5 mt-10 -141.63 163.92 31.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.371 -0.831 . . . . 0.0 110.048 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.441 ' CG1' ' C ' ' A' ' 101' ' ' GLU . 19.4 mt -153.57 106.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.806 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -108.11 118.41 36.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.415 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 3.9 mp -110.35 133.52 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.055 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -137.43 134.06 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 0.0 110.487 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -82.15 148.31 28.57 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.703 -0.623 . . . . 0.0 110.718 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.583 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.3 p -92.02 -167.03 0.12 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.415 -0.803 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 47.4 Cg_endo -80.05 69.29 8.0 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.403 1.212 . . . . 0.0 110.699 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 9.8 t70 68.08 39.59 2.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 110.575 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.48 26.86 1.97 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 107' ' ' THR . . . 103.02 -161.03 16.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -135.17 -178.74 5.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.477 -1.014 . . . . 0.0 110.557 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.439 HG13 ' C ' ' A' ' 112' ' ' SER . 25.1 mt -134.41 124.6 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.67 135.83 39.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.008 . . . . 0.0 110.65 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -128.64 98.99 5.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.778 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.1 mt -87.57 145.67 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.497 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.441 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -129.65 108.38 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -0.874 . . . . 0.0 110.005 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -109.81 128.4 55.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.415 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.497 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -128.64 137.11 51.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.053 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.558 ' CD2' HG12 ' A' ' 98' ' ' ILE . 5.9 t80 -109.67 143.01 40.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.473 ' CG ' HG23 ' A' ' 2' ' ' VAL . 13.5 m-70 -120.81 131.54 54.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.407 ' CG2' ' HA ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -114.11 174.75 5.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -140.98 177.26 8.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.235 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 42.86 -126.26 4.74 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -119.49 15.24 12.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -1.16 . . . . 0.0 110.363 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -80.46 -178.71 6.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 110.059 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HA ' ' CG2' ' A' ' 122' ' ' THR . 0.0 OUTLIER -159.98 168.14 26.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.19 -0.943 . . . . 0.0 109.784 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 120' ' ' TYR . 2.4 p -112.98 108.55 25.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.369 0.604 . . . . 0.0 110.759 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 133.25 55.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.463 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -63.17 -9.44 11.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.734 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -55.21 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.171 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -54.84 -36.04 64.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.358 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.1 t -67.45 -47.79 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.541 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 1.4 mmtt -59.4 -34.48 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.428 -0.795 . . . . 0.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.89 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -74.74 -35.69 62.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.466 -0.771 . . . . 0.0 109.874 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HD2' HG22 ' A' ' 7' ' ' THR . 26.1 ttpp -72.46 -37.11 68.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.837 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -58.5 -42.68 88.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 140' ' ' GLY . 2.0 tp -75.17 -43.85 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 139' ' ' LEU . . . -45.27 -50.19 9.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.488 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.4 mt-10 -59.87 -31.35 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -1.159 . . . . 0.0 110.215 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.6 m -70.69 -27.48 64.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.012 -1.055 . . . . 0.0 109.649 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.8 mt -72.53 -49.38 33.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 110.061 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 2.3 pp -65.6 -25.4 67.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.015 . . . . 0.0 109.472 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.2 OUTLIER -78.92 -33.8 45.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.427 -0.796 . . . . 0.0 109.676 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.97 84.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.381 -0.825 . . . . 0.0 109.638 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.6 t -71.19 -46.97 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -54.18 -46.5 72.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.63 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 t -61.01 -50.35 73.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.656 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.457 ' CE1' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -48.07 -72.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 109.936 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 150' ' ' TYR . 5.4 mt -43.09 -43.72 4.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.002 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -61.38 -43.31 99.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.202 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.04 -12.96 21.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 110.381 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.56 -161.4 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.947 . . . . 0.0 110.181 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 60.7 m -138.7 89.88 2.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 110.041 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -93.21 -65.12 1.02 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.883 . . . . 0.0 110.242 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 156' ' ' ASP . . . -56.01 -163.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.292 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -72.18 -15.76 61.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 110.281 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.355 -179.872 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.87 139.85 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -1.149 . . . . 0.0 110.128 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.8 m-85 -94.36 138.59 32.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.51 -0.744 . . . . 0.0 109.916 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.07 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.054 . . . . 0.0 110.42 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -141.16 59.26 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.542 -0.723 . . . . 0.0 109.218 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.0 pt-20 -88.47 142.89 27.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.484 -0.76 . . . . 0.0 110.797 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.39 178.55 8.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.527 -0.733 . . . . 0.0 109.818 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.4 ' HB2' ' HG3' ' A' ' 115' ' ' LYS . 2.3 pp20? -150.61 143.15 24.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m -130.2 -174.76 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -119.95 159.43 24.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 110.614 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.467 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -154.26 135.58 14.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 17.7 m -79.91 -12.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.914 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 5.1 mm -71.31 150.44 94.24 Favored Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.31 150.77 86.89 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 123.293 1.154 . . . . 0.0 111.08 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -73.16 -29.85 63.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.88 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.26 -54.23 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 110.076 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.442 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -67.42 -30.97 70.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 109.771 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' A' ' 14' ' ' PRO . 29.1 tp -73.8 -29.19 62.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.959 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.563 ' CG ' HD11 ' A' ' 23' ' ' ILE . 71.8 t80 -71.71 -57.17 4.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 110.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 31.9 mtpt -54.34 -41.24 68.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.78 . . . . 0.0 110.298 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 17' ' ' ARG . . . -68.58 -33.79 74.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -91.6 -7.34 50.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.719 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.563 HD11 ' CG ' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -121.16 -56.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 8.4 mt -72.99 -25.25 60.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -130.03 14.53 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -58.69 -42.47 96.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -65.05 -27.19 68.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -1.14 . . . . 0.0 110.317 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.3 m-20 -92.14 -38.95 11.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.491 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.8 mp -76.13 -25.97 55.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -55.64 -59.69 10.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.914 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.5 Cg_endo -71.37 0.43 6.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.994 1.523 . . . . 0.0 111.256 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -105.58 -50.94 3.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.988 -1.07 . . . . 0.0 110.577 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 150' ' ' TYR . 35.9 m -87.33 -11.15 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.04 71.24 3.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.013 . . . . 0.0 110.396 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.73 -6.73 19.75 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.033 1.544 . . . . 0.0 110.504 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.503 ' O ' ' CG ' ' A' ' 59' ' ' PRO . 16.1 mt-30 -73.33 -30.01 63.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -89.52 -51.28 5.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.517 HD12 ' CD2' ' A' ' 30' ' ' PHE . 1.5 mp -112.32 141.39 28.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 110.031 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.423 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -109.74 -19.19 13.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.19 165.07 11.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.143 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.0 m -147.15 154.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.217 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 1.6 mt-10 -153.2 152.98 31.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.532 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.7 112.5 25.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.0 110.055 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.518 HG22 HD11 ' A' ' 44' ' ' ILE . 6.3 mt -80.2 -39.9 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.233 1.016 . . . . 0.0 108.346 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.43 -160.17 0.78 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.827 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.35 59.66 0.32 Allowed Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 48' ' ' GLY . 1.6 m-80 -125.29 -19.22 5.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -1.08 . . . . 0.0 110.268 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.542 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 44.21 42.78 7.02 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.24 -154.67 6.83 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.81 87.54 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.071 1.564 . . . . 0.0 110.602 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.89 -6.63 3.78 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.576 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 95.5 m -67.91 164.07 20.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -1.211 . . . . 0.0 109.32 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 53' ' ' ILE . 8.3 mt -137.13 149.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.729 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.515 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -155.21 141.6 18.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.393 -0.817 . . . . 0.0 110.561 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.5 tptm -90.39 113.03 24.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.663 -0.648 . . . . 0.0 110.508 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 56' ' ' ILE . 28.4 mt -101.49 139.88 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -102.53 159.93 15.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.64 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -136.82 136.99 22.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 0.0 109.857 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 36' ' ' GLN . 46.5 Cg_endo -73.06 129.57 14.34 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.888 1.467 . . . . 0.0 110.466 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 179.62 172.42 0.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.192 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.81 19.44 9.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.566 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -92.7 178.32 1.7 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.045 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.566 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 42.8 Cg_endo -68.35 -31.76 27.52 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.869 1.457 . . . . 0.0 110.376 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.493 ' CE1' ' HA2' ' A' ' 89' ' ' GLY . 0.2 OUTLIER -114.41 137.28 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 109.965 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' TYR . 6.4 mtpm? -138.16 -79.32 0.36 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.373 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.479 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 55.7 p90 -55.22 -165.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.802 . . . . 0.0 110.491 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -179.68 172.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.858 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -115.64 132.33 56.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.902 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 8.9 p-10 -133.29 131.04 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' CG ' ' HB2' ' A' ' 84' ' ' SER . 8.2 ptt180 -98.23 151.24 20.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.071 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.576 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 4.6 t -80.02 147.05 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.782 -1.199 . . . . 0.0 110.251 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.532 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 11.3 t0 -97.56 -62.35 1.26 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.099 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.3 tt0 -155.22 120.91 5.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.236 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.405 HG22 ' CG1' ' A' ' 71' ' ' VAL . 2.9 t -116.02 142.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.321 -0.862 . . . . 0.0 110.085 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.537 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -139.98 118.24 12.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.91 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -82.6 1.45 38.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.831 . . . . 0.0 110.796 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -119.86 -38.31 2.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.05 20.36 10.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 22.9 m-30 44.66 58.56 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -127.01 129.6 48.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.052 -1.03 . . . . 0.0 110.16 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.48 ' HB2' HG12 ' A' ' 23' ' ' ILE . 77.5 t80 -148.51 94.37 2.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.947 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.532 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 71.6 m-20 -109.98 137.78 47.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.195 -0.94 . . . . 0.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.7 p90 -137.89 143.48 40.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.9 . . . . 0.0 110.004 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.415 ' HB2' ' CG ' ' A' ' 70' ' ' ARG . 74.2 m -106.17 170.61 7.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.075 -1.015 . . . . 0.0 111.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.523 HG13 ' CD1' ' A' ' 91' ' ' ILE . 53.9 t -112.16 125.38 69.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -116.61 -72.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.856 -1.152 . . . . 0.0 111.735 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -87.78 85.64 7.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.269 . . . . 0.0 110.436 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.474 ' HA2' HG22 ' A' ' 67' ' ' VAL . . . -106.42 141.31 15.46 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.545 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.02 -53.39 2.57 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.7 Cg_endo -71.66 -40.34 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.744 1.391 . . . . 0.0 110.512 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.523 ' CD1' HG13 ' A' ' 85' ' ' VAL . 70.3 mt -70.57 140.19 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 0.0 110.025 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.59 -85.06 1.13 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -83.42 -80.04 0.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -1.172 . . . . 0.0 110.434 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -145.34 13.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.464 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.442 HD22 ' CB ' ' A' ' 123' ' ' LYS . 4.1 mp -87.7 153.73 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.051 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.4 tt0 61.34 36.05 17.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.481 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.4 OUTLIER -69.67 162.54 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.463 HG12 ' CD1' ' A' ' 120' ' ' TYR . 8.3 mt -145.89 136.02 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 110.565 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -120.97 117.27 26.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.656 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 7.0 m120 -101.37 141.27 34.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.76 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 0.9 OUTLIER -131.19 132.36 44.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.713 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 81' ' ' TYR . 43.0 mt -126.5 124.34 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.002 -1.061 . . . . 0.0 110.704 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -129.12 127.23 41.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.672 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.491 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 93.3 mt -116.72 125.46 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.718 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.5 t -127.3 136.47 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.425 -0.797 . . . . 0.0 109.716 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.499 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -88.1 143.55 27.01 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.552 0.691 . . . . 0.0 111.035 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.602 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 2.3 p -82.84 -163.08 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 45.4 Cg_endo -78.53 -28.64 4.24 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.094 1.05 . . . . 0.0 110.999 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.67 35.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.122 -0.986 . . . . 0.0 110.385 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.99 27.89 2.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.469 ' O ' HG22 ' A' ' 107' ' ' THR . . . 100.32 -154.79 19.46 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -133.27 155.99 48.39 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.724 -0.868 . . . . 0.0 110.774 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 6.0 tt -109.66 120.12 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.05 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -101.45 122.49 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.931 -1.105 . . . . 0.0 111.18 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 8' ' ' GLU . 4.8 mttt -102.23 111.09 23.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 7' ' ' THR . 55.4 mt -97.19 140.29 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.638 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -125.87 118.04 24.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.074 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.85 125.41 48.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.173 -0.954 . . . . 0.0 110.23 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 3.6 mtpp -116.35 138.2 51.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 110.466 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.497 ' CG ' HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -112.83 124.72 53.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.262 -0.899 . . . . 0.0 109.707 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 36.0 m-70 -106.22 113.12 26.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.985 . . . . 0.0 110.355 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.434 HG21 ' HG3' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -122.59 167.05 13.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.1 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.442 ' CB ' HD22 ' A' ' 95' ' ' LEU . 5.0 mmtp -104.51 155.09 19.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -43.79 -27.03 0.87 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.67 -65.42 0.9 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -1.218 . . . . 0.0 110.313 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -83.08 170.14 15.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 110.096 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -139.51 -167.15 2.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.16 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.497 HG23 ' CG ' ' A' ' 120' ' ' TYR . 3.8 t -118.92 88.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 110.117 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -59.73 127.81 33.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -44.82 -45.46 10.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.113 -0.992 . . . . 0.0 110.204 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.0 mm-40 -38.64 -59.1 0.97 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -29.1 69.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 130' ' ' ALA . 8.9 t -78.6 -49.64 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -63.21 -25.71 68.46 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.419 -0.801 . . . . 0.0 109.531 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.99 -39.56 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.542 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 t -65.46 -33.79 76.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 109.688 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -79.15 -46.09 18.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.769 . . . . 0.0 109.818 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' OG1' ' A' ' 142' ' ' THR . 1.7 mt-10 -43.25 -67.47 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 37' ' ' ALA . 2.5 mp -67.04 -30.2 70.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.91 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -55.82 -63.81 4.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.514 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -52.23 -32.13 35.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -69.78 -27.24 64.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.675 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 69.3 mt -72.15 -50.31 28.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.749 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.514 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.3 pp -68.14 -28.52 67.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.402 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.13 -34.53 43.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.794 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.22 77.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.882 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.65 -48.07 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.931 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 11' ' ' SER . 0.5 OUTLIER -50.59 -41.05 54.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.432 179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -66.34 -47.55 73.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.593 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.53 ' CE1' HG11 ' A' ' 33' ' ' VAL . 1.8 t80 -45.69 -67.6 0.27 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.469 -0.77 . . . . 0.0 110.563 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.443 HD11 ' CG2' ' A' ' 13' ' ' ILE . 10.3 mt -57.49 -39.03 75.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.362 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -49.2 -40.38 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.48 11.92 7.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.54 -6.67 20.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 110.113 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.94 39.0 0.94 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.895 . . . . 0.0 110.138 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -126.57 -36.5 2.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.203 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.01 175.5 9.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 110.084 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.46 43.64 2.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.322 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.1 t30 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.183 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG23 ' ND1' ' A' ' 121' ' ' HIS . 2.7 t 58.8 146.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.381 -1.07 . . . . 0.0 110.237 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 4.0 m-85 -93.33 167.63 11.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -138.25 144.23 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.994 . . . . 0.0 110.811 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 64.6 m-85 -156.12 57.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.74 . . . . 0.0 109.604 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 14.9 mt-10 -88.94 145.88 25.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.372 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -150.65 173.06 14.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 4.6 pt-20 -151.15 155.79 39.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 110.551 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -139.36 176.84 8.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.405 HG23 HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -112.75 163.65 14.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 110.581 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -159.93 136.46 9.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.648 -0.657 . . . . 0.0 109.454 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.19 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.806 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 42.0 mm -71.81 149.15 92.71 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -64.9 148.66 89.97 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.463 1.244 . . . . 0.0 111.282 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -66.48 -47.11 74.08 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.82 74.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -63.38 -37.97 89.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -72.25 -35.84 68.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.432 -0.792 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' ILE . 40.1 t80 -64.55 -63.84 1.03 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -48.57 -48.46 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.102 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -38.6 91.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 4.1 t80 -86.3 -11.11 53.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.215 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.568 HD11 ' CG ' ' A' ' 81' ' ' TYR . 12.0 mm -114.72 -74.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.178 -0.951 . . . . 0.0 110.491 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.3 mt -54.87 -51.76 64.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 110.471 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.99 8.73 36.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.17 -47.92 88.69 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 79.5 m-20 -58.51 -28.42 65.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -1.14 . . . . 0.0 110.252 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.412 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 m-20 -86.56 -46.79 9.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -35.79 80.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.222 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -48.97 -60.07 5.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.953 . . . . 0.0 110.046 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -73.5 53.77 2.74 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.048 1.552 . . . . 0.0 110.274 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -63.91 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 110.392 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 HG21 ' N ' ' A' ' 34' ' ' ALA . 33.2 m -82.96 -24.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 110.435 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.504 ' CB ' HD22 ' A' ' 143' ' ' LEU . . . -134.66 70.0 71.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.6 -14.58 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.995 1.524 . . . . 0.0 110.512 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -71.67 -24.19 61.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.37 -60.02 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.274 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -113.13 143.92 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -0.815 . . . . 0.0 109.888 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -47.56 8.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.266 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.4 133.89 2.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.273 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.518 ' CG1' ' HD3' ' A' ' 54' ' ' LYS . 94.6 t -100.46 142.01 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 53.9 mt-10 -140.88 99.28 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -61.52 117.78 6.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.517 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.4 mm -85.99 -37.59 11.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 108.425 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 46' ' ' GLY . 1.4 tm-20 -111.23 -151.11 0.47 Allowed 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.437 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 45' ' ' GLU . . . -40.78 168.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.7 16.97 1.97 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -1.188 . . . . 0.0 110.832 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 49' ' ' GLY . . . 142.07 -3.93 2.03 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.742 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 48' ' ' GLY . . . -45.74 171.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.97 99.19 0.65 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.807 1.425 . . . . 0.0 110.094 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 71' ' ' VAL . . . 109.48 9.39 25.34 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.546 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.1 m -65.39 166.75 9.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.407 -1.055 . . . . 0.0 109.364 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 14.6 mt -129.55 138.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 110.392 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' HD3' ' CG1' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.743 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 20.9 tttt -92.14 98.36 11.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.313 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.467 HD13 ' OD2' ' A' ' 69' ' ' ASP . 52.0 mt -87.88 120.55 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.633 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.93 143.3 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -0.963 . . . . 0.0 110.291 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.04 136.2 20.46 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.208 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.22 137.98 29.63 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.997 1.525 . . . . 0.0 110.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 48.98 -169.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -0.904 . . . . 0.0 110.248 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 92.87 77.67 1.38 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.619 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 41.47 -165.56 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.38 -1.071 . . . . 0.0 110.061 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.619 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 45.4 Cg_endo -77.29 -51.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.373 1.196 . . . . 0.0 110.625 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.478 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 3.4 m-85 -83.31 153.38 24.66 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 34.4 pttt 173.67 -41.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.221 -0.924 . . . . 0.0 110.389 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -63.83 -173.18 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 110.11 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER 178.98 172.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.3 ttmt -119.18 52.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.523 -0.736 . . . . 0.0 110.47 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.467 ' OD2' HD13 ' A' ' 56' ' ' ILE . 10.2 p-10 -46.09 137.81 5.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.106 -0.996 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttm180 -100.75 157.85 16.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.228 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.546 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.6 t -84.7 146.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.877 -1.14 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.3 t70 -94.51 -68.91 0.78 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.275 0.56 . . . . 0.0 110.491 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -144.61 143.72 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 0.0 110.377 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 48' ' ' GLY . 4.3 t -123.66 155.64 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.239 -0.913 . . . . 0.0 109.947 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -154.75 130.13 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 110.085 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -5.54 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 0.0 110.894 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -112.55 -40.6 4.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 109.884 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.468 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.88 16.21 16.6 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.337 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.7 m-85 46.74 69.01 0.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.78 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.49 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 6.2 tttt -131.19 127.14 37.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.568 ' CG ' HD11 ' A' ' 23' ' ' ILE . 34.1 t80 -150.67 88.66 1.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.459 -0.775 . . . . 0.0 109.39 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.508 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 86.3 m-20 -100.95 145.66 28.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.129 -0.982 . . . . 0.0 110.617 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 7.7 p90 -141.81 137.97 31.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.499 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ARG . 58.8 m -108.32 168.24 9.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.048 -1.032 . . . . 0.0 111.232 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 91' ' ' ILE . 45.1 t -105.86 131.18 56.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER -129.5 -77.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.942 -1.099 . . . . 0.0 110.583 -179.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -69.58 65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.838 -1.164 . . . . 0.0 109.997 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -87.86 136.68 13.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.535 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -41.66 -54.87 4.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.0 Cg_endo -72.01 -42.1 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.823 1.433 . . . . 0.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.518 ' CD1' HG13 ' A' ' 85' ' ' VAL . 69.8 mt -56.31 145.82 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.23 -76.0 0.26 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.33 -75.94 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -1.136 . . . . 0.0 110.083 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.1 p -144.61 9.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.06 161.91 14.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.13 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.9 OUTLIER 61.59 28.42 17.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.147 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 98' ' ' ILE . 10.5 ttmt -80.94 159.64 24.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.105 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.569 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.6 mp -141.13 133.0 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 110.641 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 m -114.79 115.64 27.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.58 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 19.3 m120 -104.77 142.76 34.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.631 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.508 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -130.6 128.63 41.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.807 . . . . 0.0 109.634 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.5 mm -120.34 113.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.659 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -125.37 139.79 53.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 109.648 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.431 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 7.2 mt -127.53 142.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.027 -1.046 . . . . 0.0 110.823 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.7 t -137.52 130.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 109.548 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.04 155.98 19.53 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.635 -0.665 . . . . 0.0 111.307 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.467 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -128.49 157.8 73.71 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 109.868 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 43.8 Cg_endo -70.51 -3.53 12.69 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.967 1.509 . . . . 0.0 110.487 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.43 -10.04 59.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 110.018 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.22 28.06 6.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 107' ' ' THR . . . -164.89 -168.08 26.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.485 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -141.25 162.97 34.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -1.087 . . . . 0.0 110.639 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 113' ' ' ILE . 49.0 mt -120.08 120.92 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 109.377 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.28 131.99 44.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 8' ' ' GLU . 19.8 mttt -112.4 110.97 21.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 7' ' ' THR . 29.0 mm -94.95 119.92 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -106.81 120.65 42.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.131 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -115.0 147.13 40.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -137.35 133.26 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.073 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.569 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -109.93 138.35 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.444 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.5 ' ND1' HG23 ' A' ' 2' ' ' VAL . 75.1 m-70 -123.69 102.37 7.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.92 165.35 12.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.943 . . . . 0.0 110.099 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -100.69 158.59 15.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -43.2 -29.69 1.04 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.76 -61.59 1.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -1.104 . . . . 0.0 110.23 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 123' ' ' LYS . 21.9 m-70 -84.94 164.63 18.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.955 . . . . 0.0 110.261 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -144.34 -170.29 3.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.232 -0.918 . . . . 0.0 109.951 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 128' ' ' VAL . 2.3 t -128.94 92.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.921 . . . . 0.0 110.023 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HE2' ' CB ' ' A' ' 131' ' ' GLU . 20.1 ptmt -69.4 131.19 44.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.312 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.455 ' O ' ' C ' ' A' ' 131' ' ' GLU . . . -40.47 -38.59 0.86 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 110.826 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.476 ' CB ' ' HE2' ' A' ' 129' ' ' LYS . 9.8 tp10 -39.16 -65.96 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.07 -29.93 61.26 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.558 HG12 ' CE1' ' A' ' 5' ' ' TYR . 12.9 t -74.01 -49.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 0.0 109.423 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.37 -32.72 73.57 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.23 -17.79 64.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.651 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -81.27 -33.38 32.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 109.845 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -28.51 60.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.893 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -60.61 -62.14 2.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.033 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.52 -30.68 66.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.25 -38.8 93.76 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.7 mt-10 -61.59 -38.5 87.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.151 -1.205 . . . . 0.0 110.254 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.5 m -66.83 -27.75 67.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.109 -0.994 . . . . 0.0 109.875 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.504 HD22 ' CB ' ' A' ' 34' ' ' ALA . 66.1 mt -73.33 -46.41 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.315 -0.866 . . . . 0.0 110.005 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -68.27 -30.01 68.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.005 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.431 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.65 -33.87 40.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.28 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.431 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -64.3 -46.97 81.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.29 -41.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.975 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.4 tm-20 -60.3 -48.37 82.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.64 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -44.19 93.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.462 -0.774 . . . . 0.0 110.002 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -50.55 -71.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 110.368 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.0 mt -49.4 -32.77 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 110.668 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -64.82 -34.49 78.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.084 -1.01 . . . . 0.0 110.404 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -58.85 -33.97 71.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -99.03 -174.65 2.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.432 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 155' ' ' SER . 3.0 t -141.08 51.57 1.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.4 t0 50.0 25.91 1.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.945 . . . . 0.0 109.679 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 61.94 -170.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.449 -0.782 . . . . 0.0 109.996 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.64 38.18 1.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.123 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.24 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.417 HG21 ' ND1' ' A' ' 121' ' ' HIS . 2.6 t -146.81 143.96 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -1.207 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -118.68 127.4 53.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 10.1 p-10 -131.93 124.97 30.52 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.857 -1.152 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.552 ' CZ ' HG13 ' A' ' 133' ' ' VAL . 93.9 m-85 -103.38 74.29 1.26 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -80.06 149.12 30.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.863 . . . . 0.0 110.528 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.512 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -160.07 -173.55 4.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.588 -0.695 . . . . 0.0 109.818 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -159.36 153.33 23.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 0.0 110.478 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 170.07 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.909 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.63 159.84 21.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.265 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.6 m -158.86 141.66 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.645 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.528 HG21 ' CD1' ' A' ' 13' ' ' ILE . 12.5 m -79.85 -10.97 12.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.607 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.61 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.2 mp -67.92 149.91 98.0 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.81 151.71 83.55 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.397 1.209 . . . . 0.0 110.796 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -74.42 -23.09 58.89 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.698 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.42 -56.57 3.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.941 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -59.84 -32.69 70.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.945 . . . . 0.0 109.798 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.442 ' CD1' HG13 ' A' ' 147' ' ' VAL . 19.3 tp -71.47 -41.73 69.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.252 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.556 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 41.4 t80 -60.89 -66.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -47.2 -42.85 20.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 110.29 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.59 69.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.449 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -89.88 -12.17 39.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.58 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.1 mp -124.11 -62.27 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.76 -34.78 54.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.878 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' GLY . 1.1 m-20 -125.0 -6.29 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.019 -1.05 . . . . 0.0 110.793 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -44.89 -45.67 9.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 15.3 p-10 -51.56 -33.41 32.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.309 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 21.8 t-20 -100.41 -33.35 10.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.46 ' HG ' HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -69.01 -41.89 77.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.561 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -45.04 -58.93 4.83 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.301 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.6 Cg_endo -72.04 -2.73 12.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.998 1.525 . . . . 0.0 110.621 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 4.8 mmtp -104.51 -60.61 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.46 HG12 ' HG ' ' A' ' 29' ' ' LEU . 26.7 m -84.69 -18.15 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.454 -0.779 . . . . 0.0 110.528 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.01 68.52 70.58 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.591 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.47 -1.4 11.28 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.036 1.545 . . . . 0.0 110.119 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.475 ' HB3' HD13 ' A' ' 139' ' ' LEU . 0.6 OUTLIER -87.62 -20.94 25.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 110.333 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.67 -58.21 1.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.459 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -104.1 129.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 110.093 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -83.85 -48.38 10.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.357 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -163.72 155.95 17.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.458 HG21 HD11 ' A' ' 56' ' ' ILE . 61.5 t -118.69 146.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.87 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -144.15 90.38 2.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.347 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 74.4 m-20 -56.38 119.35 5.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.454 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.518 ' CD1' ' HD3' ' A' ' 68' ' ' LYS . 15.2 mt -87.83 -37.81 11.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.232 1.015 . . . . 0.0 108.525 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.548 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 32.1 tt0 -145.45 174.65 10.96 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.379 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.548 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 61.71 167.6 0.54 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.04 21.09 17.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -1.041 . . . . 0.0 110.036 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.428 ' HA2' HG22 ' A' ' 52' ' ' THR . . . 99.85 12.83 39.09 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.63 -162.8 38.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -74.0 122.44 7.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.079 1.568 . . . . 0.0 110.376 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.6 0.66 62.5 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -71.01 156.54 39.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.464 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 44' ' ' ILE . 5.3 mt -119.83 135.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.934 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 6.7 ptmt -149.33 143.44 25.8 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 110.278 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -89.22 106.48 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.46 HD12 ' HG3' ' A' ' 54' ' ' LYS . 41.9 mm -89.55 122.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.882 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.47 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 52.1 m -84.15 142.0 30.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 110.38 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 0.5 OUTLIER -110.19 146.05 33.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.6 63.8 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.077 1.567 . . . . 0.0 110.563 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 47.05 -168.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.382 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.65 -40.92 2.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.511 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 1.1 m-85 -96.57 175.97 2.38 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.511 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 47.4 Cg_endo -73.95 -25.17 14.45 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.877 1.462 . . . . 0.0 110.207 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.455 ' HB2' ' HA2' ' A' ' 89' ' ' GLY . 2.1 m-85 -111.96 131.01 55.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.249 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -52.6 -82.58 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.288 -0.882 . . . . 0.0 109.831 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 4.3 p90 -92.02 -170.54 2.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.804 . . . . 0.0 110.471 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.475 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 19.6 m -156.79 140.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.473 -0.767 . . . . 0.0 109.768 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -83.83 127.48 33.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.023 . . . . 0.0 110.401 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 83' ' ' TYR . 12.1 t70 -126.24 124.44 40.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.824 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.9 ttp85 -98.73 144.08 28.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.0 109.031 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.549 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.3 t -75.26 146.3 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.819 -1.175 . . . . 0.0 110.126 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.442 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 22.6 t70 -98.68 -72.43 0.65 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.43 0.634 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -135.94 144.06 45.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 2.5 t -130.65 128.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 13.4 m-20 -135.97 104.03 5.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.458 ' CD2' ' N ' ' A' ' 76' ' ' HIS . 13.6 m-70 -79.37 -9.92 59.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.273 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -111.27 -37.81 5.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -89.66 3.22 53.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 110.045 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.556 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.6 m-30 55.7 59.67 3.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 75' ' ' ASP . 12.1 tttp -139.36 114.87 9.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 110.074 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.58 ' CG ' HG12 ' A' ' 23' ' ' ILE . 59.8 t80 -136.26 116.47 13.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.1 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.442 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 53.5 m-20 -127.47 151.08 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 27.2 p90 -145.28 136.63 25.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.877 . . . . 0.0 109.506 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.2 m -100.51 164.5 11.88 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.121 -0.987 . . . . 0.0 111.14 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.525 HG13 ' CD1' ' A' ' 91' ' ' ILE . 55.4 t -108.82 126.15 65.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -115.52 -74.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.767 -1.208 . . . . 0.0 111.869 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.89 59.34 3.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.655 -1.278 . . . . 0.0 110.274 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 148.95 16.95 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . 52.5 -157.18 4.05 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.35 6.71 4.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.067 1.561 . . . . 0.0 111.021 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' CD1' HG13 ' A' ' 85' ' ' VAL . 50.0 mt -51.47 148.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.63 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' THR . . . -152.88 141.96 8.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.87 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -1.173 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 16.7 p -147.61 14.72 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.408 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 1.6 pp -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.793 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-10 53.31 34.84 18.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.115 -0.991 . . . . 0.0 109.247 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -71.68 157.72 37.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.543 -0.723 . . . . 0.0 110.262 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.572 HG12 ' CD1' ' A' ' 120' ' ' TYR . 61.9 mt -142.18 125.35 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 110.628 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.63 108.55 13.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.539 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -97.03 142.96 28.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.707 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 102' ' ' ILE . 25.5 mt-10 -130.23 164.18 25.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -0.796 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 101' ' ' GLU . 23.1 mm -151.63 110.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -113.59 134.17 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.151 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.447 ' C ' ' CG2' ' A' ' 105' ' ' VAL . 52.9 mt -117.86 152.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.399 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.447 ' CG2' ' C ' ' A' ' 104' ' ' ILE . 27.0 t -153.22 119.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 109.856 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.523 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . . . -75.86 151.06 37.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.477 0.656 . . . . 0.0 111.037 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.59 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 3.1 p -90.43 -161.73 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 48.1 Cg_endo -79.01 -28.18 4.07 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 122.917 0.956 . . . . 0.0 110.692 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 3.8 t0 177.1 34.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.12 29.98 2.77 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 107' ' ' THR . . . 100.4 -156.0 19.46 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 120.995 -1.297 . . . . 0.0 110.04 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -135.57 168.71 18.74 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.705 -0.879 . . . . 0.0 110.505 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 113' ' ' ILE . 50.0 mt -127.92 124.36 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.194 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 1.6 pp -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 111.024 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -110.31 114.8 28.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.6 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 35.5 mt -90.89 131.95 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.366 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -118.31 105.58 11.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 110.258 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 4.6 t-20 -92.94 155.38 17.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.022 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -152.76 132.99 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.572 ' CD1' HG12 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -132.75 103.18 5.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 89.2 m-70 -82.2 142.38 32.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.984 -1.072 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 p -106.28 -170.29 1.7 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 0.0 109.887 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 1.2 ttmt -110.34 55.42 0.65 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 110.273 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 42.88 26.5 0.46 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -164.57 -63.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -1.086 . . . . 0.0 109.835 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 59.7 m-70 -57.5 -170.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.597 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 126' ' ' HIS . 27.0 mt-10 -154.23 -177.47 6.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.09 -1.006 . . . . 0.0 110.608 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.569 HG23 ' CG ' ' A' ' 120' ' ' TYR . 2.6 t -112.67 101.51 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 110.076 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.456 ' O ' HG22 ' A' ' 133' ' ' VAL . 1.6 mmtp -68.57 129.08 38.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.24 -49.12 61.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 111.071 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -38.4 -48.36 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -68.73 -34.09 75.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.079 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.552 HG13 ' CZ ' ' A' ' 5' ' ' TYR . 6.0 t -75.15 -47.46 35.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -61.1 -31.16 70.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.424 -0.797 . . . . 0.0 109.561 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.88 -49.48 51.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 t -65.83 -33.01 74.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 0.0 109.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -71.7 -34.86 69.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.052 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -49.95 -55.61 13.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' A' ' 36' ' ' GLN . 4.3 mm? -67.05 -36.0 81.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.015 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.1 -40.13 13.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -70.29 -63.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -1.072 . . . . 0.0 109.878 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.2 m -51.32 -22.33 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 13.2 mt -69.94 -54.25 14.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.985 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.474 ' HG ' ' N ' ' A' ' 145' ' ' ARG . 1.6 pp -57.63 -25.43 60.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.085 -1.01 . . . . 0.0 109.257 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.474 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -82.3 -33.58 28.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.98 85.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.449 -0.782 . . . . 0.0 109.743 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.472 HG11 HD13 ' A' ' 151' ' ' LEU . 70.2 t -76.21 -52.52 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.428 -0.795 . . . . 0.0 109.869 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 26.7 tt0 -51.73 -36.6 47.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.879 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 2.4 t -67.36 -54.45 20.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 110.026 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.423 ' CD1' HG13 ' A' ' 33' ' ' VAL . 1.3 t80 -48.74 -69.95 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 0.0 110.433 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.472 HD13 HG11 ' A' ' 147' ' ' VAL . 10.9 mt -41.56 -46.35 3.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.524 -0.735 . . . . 0.0 110.75 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.9 mt -70.34 -27.6 64.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.915 . . . . 0.0 110.549 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.29 70.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 110.198 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.6 150.25 21.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.869 . . . . 0.0 110.094 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.1 t -101.61 97.48 7.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.53 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 157' ' ' ALA . 11.4 t0 -129.75 31.91 4.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 156' ' ' ASP . . . 62.18 164.11 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.323 -0.861 . . . . 0.0 110.272 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' A' ' 159' ' ' ASN . 9.5 m-85 -79.93 -15.09 58.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 110.233 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.272 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -72.49 146.92 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -1.177 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.51 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 18.1 m-85 -100.7 161.79 13.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.421 -0.799 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -138.19 140.98 40.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 110.369 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 23.4 m-85 -152.18 59.18 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.855 . . . . 0.0 109.775 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.414 ' CG ' ' HA ' ' A' ' 117' ' ' SER . 4.5 tm-20 -80.98 153.22 27.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.525 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.4 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 1.4 p -149.93 163.27 38.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.684 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.38 164.45 34.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.669 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.14 -179.9 7.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -112.75 160.52 17.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 110.407 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.72 136.71 10.52 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.528 -0.732 . . . . 0.0 109.812 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 19.6 m -79.91 -16.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.139 -0.975 . . . . 0.0 108.57 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.544 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 24.9 mm -65.79 148.59 98.15 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.1 150.06 85.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.613 1.323 . . . . 0.0 110.917 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -74.27 -30.64 62.21 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.903 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.32 -49.32 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.083 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.532 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 1.2 tpt180 -66.57 -32.02 73.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.952 . . . . 0.0 109.709 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.5 tt -74.81 -37.63 62.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.564 ' CE1' HG13 ' A' ' 23' ' ' ILE . 6.1 t80 -64.05 -57.06 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.04 -52.85 59.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 110.292 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.84 69.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.698 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 36.2 t80 -91.96 -16.14 27.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.203 -0.936 . . . . 0.0 110.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.564 HG13 ' CE1' ' A' ' 19' ' ' PHE . 12.5 mm -109.21 -69.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.104 -0.997 . . . . 0.0 110.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 mt -59.03 -34.48 71.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.455 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.5 -14.17 16.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.88 -30.55 9.29 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.91 -36.83 77.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -1.131 . . . . 0.0 110.396 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 8.0 p-10 -109.13 -22.89 11.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -72.5 -42.54 64.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -47.44 -59.91 4.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.353 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -72.46 -1.26 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.04 1.548 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.3 mttt -99.41 -65.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.6 m -82.91 5.31 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 110.516 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.509 ' CB ' HD22 ' A' ' 143' ' ' LEU . . . -157.04 64.33 3.3 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.293 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.16 1.82 6.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.075 1.566 . . . . 0.0 110.738 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -89.44 -19.31 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.56 -69.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.512 HD11 ' N ' ' A' ' 38' ' ' ILE . 2.0 mp -94.42 149.55 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.326 -0.858 . . . . 0.0 109.504 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.424 ' HB3' ' CA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.93 -33.47 9.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 110.75 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.76 171.16 11.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.958 -1.088 . . . . 0.0 110.822 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.424 HG23 HD11 ' A' ' 56' ' ' ILE . 73.3 t -138.9 139.0 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.933 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -145.08 112.25 6.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 110.64 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -69.7 114.9 8.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 110.113 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mm -80.63 -38.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.275 1.036 . . . . 0.0 108.484 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 46' ' ' GLY . 6.4 tp10 -139.58 174.16 10.79 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.043 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 43.87 -158.98 0.12 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -128.63 -18.04 3.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 0.0 110.68 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 49' ' ' GLY . . . 155.49 -18.35 0.51 Allowed Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 48' ' ' GLY . . . -56.38 -169.39 0.09 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' HG13 ' A' ' 71' ' ' VAL . 49.8 Cg_endo -75.88 131.73 13.59 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.056 1.556 . . . . 0.0 110.354 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA2' ' HD3' ' A' ' 70' ' ' ARG . . . 90.74 -1.26 78.17 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.537 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.6 m -72.69 167.6 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.532 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 10.0 mt -127.04 131.17 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.804 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.51 ' CD ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -144.0 141.46 30.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 110.561 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -99.38 107.63 19.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 110.459 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.51 HD12 ' CD ' ' A' ' 54' ' ' LYS . 28.4 mm -88.22 128.04 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -92.59 156.04 17.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 67' ' ' VAL . 30.0 m-85 -132.93 141.46 41.1 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.119 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 112.6 3.51 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.037 1.546 . . . . 0.0 110.431 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -155.82 159.87 39.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.329 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.18 -27.56 15.56 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.468 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 1.4 m-85 -61.79 175.8 0.5 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.35 -1.088 . . . . 0.0 110.094 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 43.7 Cg_endo -71.12 -53.56 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.777 1.409 . . . . 0.0 110.177 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.473 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 19.5 m-85 -86.41 164.65 16.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.33 -0.856 . . . . 0.0 109.909 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 4.6 pttt 174.75 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 110.335 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 5.0 p90 -67.03 177.6 1.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.293 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 2.5 m -162.95 133.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 110.048 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 16.5 ttpt -91.67 141.25 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -0.957 . . . . 0.0 110.046 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.82 134.04 36.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 109.839 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 84' ' ' SER . 3.8 ttm180 -95.4 134.3 38.38 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.537 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.7 t -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.014 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 12.6 t0 -99.41 -72.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.445 0.64 . . . . 0.0 110.407 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 tt0 -137.39 138.25 39.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.526 -0.734 . . . . 0.0 110.175 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.581 ' CG2' ' CD2' ' A' ' 81' ' ' TYR . 2.1 t -124.69 143.34 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.725 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 m-20 -150.91 93.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -72.85 -1.66 17.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -110.34 -33.23 6.69 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.331 -0.856 . . . . 0.0 108.821 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.48 16.22 27.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.676 -0.64 . . . . 0.0 109.997 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.52 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.2 m-30 44.91 48.71 9.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 5.8 ttpt -126.42 113.6 17.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.109 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.581 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 42.1 t80 -138.31 117.62 12.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 110.191 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 29.2 t-20 -124.7 165.45 17.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.171 -0.956 . . . . 0.0 109.889 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 7.7 p90 -159.37 134.55 8.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 14.4 m -93.29 161.98 14.18 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.173 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.9 t -103.51 123.71 57.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -117.07 -72.92 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 111.61 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -82.91 89.63 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.596 -1.315 . . . . 0.0 110.49 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -109.08 152.04 17.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.462 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.14 -61.37 2.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.5 Cg_endo -71.69 -47.33 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.964 1.507 . . . . 0.0 110.64 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.469 HD13 HG13 ' A' ' 85' ' ' VAL . 29.0 mt -53.98 150.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.089 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.83 -72.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.71 -75.88 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.168 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.55 21.36 0.92 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.141 -0.975 . . . . 0.0 110.495 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.441 HD22 ' HB3' ' A' ' 123' ' ' LYS . 2.5 mp -96.69 158.94 15.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.947 . . . . 0.0 110.337 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.433 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 57.09 35.39 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.996 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -67.72 151.69 46.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.629 ' CD1' ' CE1' ' A' ' 120' ' ' TYR . 19.7 mt -139.54 129.26 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 t -119.29 111.55 18.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.397 -0.814 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 1.8 m-20 -103.52 144.4 31.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.69 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.523 ' HB3' ' CB ' ' A' ' 117' ' ' SER . 13.2 tm-20 -122.84 163.28 20.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.403 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.439 HG13 ' C ' ' A' ' 101' ' ' GLU . 92.5 mt -145.52 102.42 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.898 . . . . 0.0 110.043 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.41 128.31 55.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.503 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 15.8 mt -118.96 124.68 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 110.379 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.8 t -129.12 133.24 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.293 -0.88 . . . . 0.0 110.109 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.94 147.78 24.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.665 -0.647 . . . . 0.0 111.288 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.593 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.7 p -86.19 -165.38 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 0.0 109.022 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 48.0 Cg_endo -80.51 69.51 7.92 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.26 1.137 . . . . 0.0 110.625 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 15.8 t0 69.02 39.35 1.79 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.266 -0.896 . . . . 0.0 110.331 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.2 38.36 1.25 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.469 ' O ' HG22 ' A' ' 107' ' ' THR . . . 93.07 -161.97 25.84 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -140.79 167.49 22.05 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.577 -0.955 . . . . 0.0 110.552 -179.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.4 120.71 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.204 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.75 142.02 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.992 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -130.8 96.49 4.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.605 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.9 115.51 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.567 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.523 ' CB ' ' HB3' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -91.36 152.13 20.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.67 124.86 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.097 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.88 144.5 49.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.11 -0.994 . . . . 0.0 110.471 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.629 ' CE1' ' CD1' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -122.02 135.35 54.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.989 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.525 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 22.5 m-70 -117.42 120.05 36.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 110.467 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.45 167.3 10.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB3' HD22 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -141.82 170.81 15.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.492 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.37 -156.24 0.83 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -85.14 17.16 3.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -1.139 . . . . 0.0 110.225 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -81.58 175.68 10.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.207 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HA ' HG23 ' A' ' 122' ' ' THR . 10.0 pt-20 -159.97 170.43 21.36 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.235 -0.915 . . . . 0.0 109.765 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.3 p -113.35 95.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.675 -0.641 . . . . 0.0 110.631 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 128' ' ' VAL . 15.4 mttt -42.87 139.04 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 133' ' ' VAL . . . -64.8 -9.66 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 110.062 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -67.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.954 . . . . 0.0 109.887 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -53.7 -30.65 44.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.217 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.457 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 5.8 t -71.62 -52.07 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.496 -0.753 . . . . 0.0 109.486 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -61.84 -29.21 70.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.85 . . . . 0.0 109.792 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.88 60.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.788 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.3 t -71.66 -31.21 66.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.835 . . . . 0.0 110.097 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -74.89 -36.91 62.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -62.77 -46.62 87.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 110.072 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -38.85 58.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.2 -34.91 89.86 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.92 -50.68 65.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -1.142 . . . . 0.0 110.211 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -58.78 -24.57 61.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.509 HD22 ' CB ' ' A' ' 34' ' ' ALA . 36.0 mt -74.65 -42.79 57.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -67.58 -27.82 67.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.437 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -81.76 -32.03 31.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 109.831 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.66 93.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.783 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.2 -43.68 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.815 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 27.2 tt0 -59.43 -43.98 92.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.834 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -62.01 -42.41 99.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 109.57 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -57.14 -73.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 110.098 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 150' ' ' TYR . 1.4 mt -42.5 -33.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.142 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -58.98 -32.08 69.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.87 -13.83 55.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.336 -0.853 . . . . 0.0 110.172 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -85.98 -45.52 11.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 110.381 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.77 47.4 1.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.945 . . . . 0.0 110.479 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -89.98 -28.05 19.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.957 . . . . 0.0 110.032 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -164.07 -68.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.863 . . . . 0.0 110.269 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -165.67 -41.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 110.247 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.235 179.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.478 HG11 ' N ' ' A' ' 3' ' ' PHE . 2.8 t -138.24 148.0 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.145 . . . . 0.0 110.084 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.496 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 20.8 m-85 -107.47 169.09 8.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 109.865 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -149.21 143.18 25.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.569 ' CD2' ' CG1' ' A' ' 133' ' ' VAL . 55.5 m-85 -154.86 60.57 0.66 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 109.581 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -80.16 150.93 30.0 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.587 0.708 . . . . 0.0 110.501 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.438 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -147.75 174.5 11.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.486 -0.759 . . . . 0.0 109.712 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -158.7 163.54 36.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.434 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 12.0 m -159.91 154.99 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 110.213 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.49 163.37 13.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -158.47 138.92 12.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.489 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 76.2 t -80.0 -14.01 13.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.136 -0.978 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.543 HG22 HD11 ' A' ' 13' ' ' ILE . 22.0 mm -67.52 150.3 97.92 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.3 Cg_endo -67.09 149.95 82.33 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.503 1.265 . . . . 0.0 110.701 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.92 -25.2 58.74 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.892 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 -54.79 6.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 14.5 mtp180 -65.8 -31.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.722 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.409 HD21 HG22 ' A' ' 104' ' ' ILE . 30.0 tp -71.29 -32.39 68.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.811 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CD2' HD11 ' A' ' 23' ' ' ILE . 6.3 t80 -70.45 -64.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -46.67 -42.55 16.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 110.481 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -70.68 -36.04 73.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.517 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 17.4 t80 -91.96 -11.3 36.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.816 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.57 HD11 ' CD2' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -118.75 -62.19 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 109.982 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.493 ' N ' HG21 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -72.87 -23.43 60.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.833 . . . . 0.0 110.109 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.7 t70 -128.85 3.13 5.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -59.85 -37.81 93.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -59.61 -25.45 64.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -1.101 . . . . 0.0 110.262 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -98.67 -22.62 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.45 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -93.04 -22.89 18.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.548 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -58.13 -58.08 21.36 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 109.932 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 49.4 Cg_endo -75.36 2.9 6.29 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.065 1.56 . . . . 0.0 110.679 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 1.2 mtpt -105.27 -60.09 1.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.016 -1.052 . . . . 0.0 110.76 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.4 m -82.73 -18.88 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB2' ' CD2' ' A' ' 143' ' ' LEU . . . -138.41 72.08 44.78 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.79 -16.8 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.03 1.542 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -74.78 -16.22 60.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.85 -63.74 1.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 110.053 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.62 144.14 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.486 -0.758 . . . . 0.0 110.305 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.03 -40.26 6.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.02 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.482 ' HB2' ' CB ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -166.93 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.472 HG13 HD11 ' A' ' 56' ' ' ILE . 3.7 m -134.55 153.48 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.91 104.37 1.92 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 111.297 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.66 117.74 7.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.645 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 53' ' ' ILE . 14.2 mm -84.26 -38.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.231 1.015 . . . . 0.0 108.779 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 47.1 tt0 -153.55 175.04 13.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.245 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 67.9 163.93 2.54 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -107.47 35.49 3.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -1.107 . . . . 0.0 110.099 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.1 8.92 83.18 Favored Glycine 0 N--CA 1.48 1.613 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.28 -159.68 34.27 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -76.08 119.23 5.26 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.054 1.555 . . . . 0.0 110.438 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.99 2.26 59.45 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.56 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.1 m -67.87 156.78 36.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.171 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 44' ' ' ILE . 10.9 mt -121.86 131.15 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.222 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.45 140.63 30.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 11.7 ttmt -93.78 119.01 32.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 HD11 HG13 ' A' ' 41' ' ' VAL . 7.9 mm -102.34 128.03 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.089 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' A' ' 40' ' ' SER . 0.7 OUTLIER -90.01 153.75 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.333 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -119.56 134.95 23.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.153 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.31 113.26 3.55 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.991 1.521 . . . . 0.0 110.146 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.97 173.8 8.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 110.28 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.51 8.45 28.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.49 ' CG ' ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -89.96 178.13 2.08 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.202 -1.175 . . . . 0.0 110.197 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 62' ' ' PHE . 46.7 Cg_endo -72.72 -55.71 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.102 1.58 . . . . 0.0 110.719 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 9.8 p90 -98.32 148.01 24.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 0.0 110.527 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -174.94 -41.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.716 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.444 ' O ' ' CB ' ' A' ' 67' ' ' VAL . 12.8 p90 -63.46 -168.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 110.014 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.555 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER 173.16 171.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 110.377 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.47 137.83 52.26 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.594 -0.691 . . . . 0.0 109.746 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD1' HG21 ' A' ' 85' ' ' VAL . 94.1 m-20 -125.22 125.78 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 110.656 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -94.07 133.59 37.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.56 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.4 t -72.58 144.38 13.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.825 -1.172 . . . . 0.0 110.743 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 82' ' ' ASN . 86.4 m-20 -92.87 -68.92 0.77 Allowed 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.339 0.59 . . . . 0.0 110.193 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.8 tp10 -143.35 134.67 26.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.177 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 HG23 ' CD2' ' A' ' 81' ' ' TYR . 3.8 t -117.29 147.79 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.897 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.35 105.0 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -80.47 -4.42 53.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -108.12 -33.2 7.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.182 -0.949 . . . . 0.0 109.305 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.66 4.52 43.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.665 -0.647 . . . . 0.0 110.109 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.503 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 22.9 m-85 53.56 46.71 25.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.07 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.39 109.97 15.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.149 -0.97 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.427 ' CD2' HG23 ' A' ' 74' ' ' VAL . 44.5 t80 -127.62 107.47 9.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.897 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.503 ' CB ' ' HB2' ' A' ' 72' ' ' ASP . 7.8 m120 -114.23 140.57 48.47 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.091 -1.005 . . . . 0.0 109.999 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 100' ' ' ASN . 48.8 p90 -143.16 138.62 29.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.7 m -103.97 172.17 6.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 111.376 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.52 HG13 ' CD1' ' A' ' 91' ' ' ILE . 42.4 t -111.21 126.57 68.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -120.94 -76.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.818 -1.176 . . . . 0.0 111.518 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.6 102.42 7.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.818 -1.176 . . . . 0.0 110.652 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -129.42 145.43 16.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.529 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.59 -57.28 3.93 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.6 Cg_endo -71.21 -30.58 15.72 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.394 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.52 ' CD1' HG13 ' A' ' 85' ' ' VAL . 73.9 mt -78.64 147.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.81 -36.32 0.73 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.07 -74.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.1 t -137.3 4.52 2.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.928 . . . . 0.0 110.416 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 5.6 mp -84.37 150.88 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.935 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.9 34.25 21.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.59 162.53 29.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 110.253 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.585 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.0 mp -136.5 131.42 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 119' ' ' LYS . 1.8 m -118.75 119.73 35.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.364 -0.835 . . . . 0.0 109.603 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 13.9 m-80 -112.17 160.6 17.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 110.721 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.474 ' CG ' ' CG ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -150.84 132.1 14.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.11 125.67 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.027 -1.046 . . . . 0.0 110.564 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 69.5 tttt -129.7 119.22 23.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.858 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.501 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 70.5 mt -118.42 112.49 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.763 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.0 t -112.01 141.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.414 -0.804 . . . . 0.0 109.879 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.0 147.08 25.18 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.499 -0.75 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.596 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 2.7 p -86.38 -162.86 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 0.0 109.089 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 45.1 Cg_endo -79.59 -27.72 3.93 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.011 1.006 . . . . 0.0 110.952 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 6.9 p-10 178.36 33.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 110.362 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.79 21.59 3.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . 106.21 -151.69 17.01 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.161 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -136.87 163.04 31.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.755 -0.85 . . . . 0.0 110.644 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.466 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 1.7 tt -112.16 126.81 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.166 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 2.0 pp -106.14 135.72 47.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.869 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -124.52 106.55 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 0.0 109.712 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.22 112.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.47 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -97.8 114.02 25.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.27 135.37 48.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 99' ' ' SER . 4.7 mttt -126.22 155.74 41.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.371 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.585 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -132.04 130.21 41.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 71.8 m-70 -113.11 140.2 48.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.159 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.491 HG23 ' CA ' ' A' ' 127' ' ' GLU . 0.3 OUTLIER -129.78 170.71 13.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.974 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 126' ' ' HIS . 0.7 OUTLIER -159.68 -177.95 6.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 125' ' ' ASP . . . 45.95 40.9 10.08 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 124' ' ' GLY . 9.2 m-20 61.79 15.69 7.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -1.139 . . . . 0.0 110.333 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.471 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 63.7 m170 -82.34 175.28 10.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.394 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.491 ' CA ' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER -159.99 136.66 9.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.487 -0.758 . . . . 0.0 109.146 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.1 p -87.12 108.78 18.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 121.475 -0.765 . . . . 0.0 110.291 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.47 ' O ' HG22 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -50.61 156.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -79.57 -7.46 58.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -50.4 -73.27 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -22.92 6.12 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.569 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 11.5 t -76.09 -48.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.845 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -26.76 65.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.392 -0.817 . . . . 0.0 109.58 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -38.74 63.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.859 . . . . 0.0 109.366 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -60.52 -35.97 77.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.688 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -68.49 -48.14 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.869 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -52.43 -58.72 5.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.925 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 0.3 OUTLIER -72.37 -33.06 66.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.08 -42.52 31.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.6 tp10 -63.11 -47.69 81.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -1.187 . . . . 0.0 109.975 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.1 m -59.89 -26.86 66.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.085 -1.009 . . . . 0.0 109.747 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 17.3 mt -67.68 -49.98 59.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.981 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.3 pp -66.97 -23.21 65.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.01 -1.056 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.441 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 2.0 tmm_? -80.9 -35.85 31.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.067 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 150' ' ' TYR . . . -65.32 -44.23 88.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.733 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.83 -45.26 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.514 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.47 ' HA ' HG13 ' A' ' 13' ' ' ILE . 1.1 tt0 -60.35 -56.24 23.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.51 47.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.552 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -83.24 -25.52 31.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.552 ' CD2' ' CE2' ' A' ' 150' ' ' TYR . 43.1 mt -88.8 -25.12 22.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -22.64 33.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -61.08 -26.01 67.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.423 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.22 22.03 16.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 110.416 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.43 -0.82 56.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.0 110.1 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -92.44 2.74 56.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.27 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.09 167.44 14.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.933 . . . . 0.0 110.193 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.42 -49.07 13.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.917 . . . . 0.0 110.262 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.124 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.441 HG11 ' N ' ' A' ' 3' ' ' PHE . 2.9 t -125.17 150.91 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -1.1 . . . . 0.0 109.999 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.462 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 3.2 m-85 -101.4 152.89 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.753 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.76 142.65 51.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.042 -1.036 . . . . 0.0 110.843 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -154.12 53.7 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.645 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.492 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 1.9 pt-20 -81.61 160.0 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 110.557 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 116' ' ' ILE . 3.5 p -159.8 172.26 17.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.857 . . . . 0.0 109.874 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 12.7 pt-20 -146.34 141.88 27.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.017 . . . . 0.0 110.381 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.7 m -131.69 166.95 20.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -102.23 164.01 11.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.336 -0.853 . . . . 0.0 110.425 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -159.84 134.8 7.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 m -80.03 -14.06 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.556 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 36.2 mm -73.56 148.7 88.07 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.551 -0.718 . . . . 0.0 109.146 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.91 150.59 85.56 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.55 1.29 . . . . 0.0 110.965 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -70.09 -35.09 73.93 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.942 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.55 -56.44 6.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER -62.31 -36.29 81.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 14' ' ' PRO . 4.4 tt -74.13 -33.94 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.407 -0.808 . . . . 0.0 110.241 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 32.5 t80 -60.81 -61.06 2.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.957 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttt -57.08 -36.87 71.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 110.058 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.51 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.91 -11.29 36.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.457 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.0 OUTLIER -121.69 -64.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -58.13 -48.38 80.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -105.01 7.55 34.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.155 -0.966 . . . . 0.0 110.463 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.85 -48.65 65.53 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' HB2' HG23 ' A' ' 41' ' ' VAL . 5.3 p-10 -57.67 -26.54 61.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.236 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -99.34 -30.93 11.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.649 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -81.54 -35.62 30.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.301 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.542 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.4 m-30 -44.8 -59.15 4.41 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 110.348 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -71.79 -10.45 26.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.877 1.462 . . . . 0.0 110.774 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.64 -57.26 2.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.984 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -94.18 -2.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 110.988 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.42 71.27 9.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.92 -1.112 . . . . 0.0 110.76 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.26 -20.11 16.67 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.005 1.529 . . . . 0.0 110.026 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -80.55 -29.06 37.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 110.092 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.02 -55.92 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 110.133 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.2 151.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.453 -0.78 . . . . 0.0 110.318 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -98.7 -46.49 5.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.865 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.406 ' O ' HG11 ' A' ' 41' ' ' VAL . 22.1 t -162.37 174.07 13.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 110.099 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 24.7 m -147.71 146.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -144.26 151.06 38.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.447 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -100.09 116.73 32.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 44' ' ' ILE . 19.6 mm -86.12 -37.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.19 0.995 . . . . 0.0 108.679 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 27.5 tt0 -157.08 173.64 16.7 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.701 0.763 . . . . 0.0 110.734 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.531 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 75.97 -173.35 53.76 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -128.65 43.94 3.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -1.073 . . . . 0.0 110.1 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 52' ' ' THR . . . 69.02 7.52 56.67 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.96 -156.26 32.31 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.03 117.8 5.03 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.019 1.536 . . . . 0.0 110.744 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.14 2.02 56.95 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.53 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.3 m -69.79 149.42 47.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.039 -1.271 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.444 HG12 ' HG3' ' A' ' 70' ' ' ARG . 4.7 mt -115.31 128.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.548 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -137.03 148.87 47.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.92 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 42' ' ' GLU . 8.6 tttt -94.13 95.07 8.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.822 -0.549 . . . . 0.0 109.988 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 66' ' ' TYR . 13.7 mt -84.04 137.0 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.439 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -109.03 133.3 53.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.622 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.97 144.35 29.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 109.842 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.26 95.17 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.972 1.511 . . . . 0.0 110.475 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.47 163.34 32.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.396 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -90.17 -37.29 6.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.477 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 2.5 m-30 -46.9 172.75 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.313 -1.11 . . . . 0.0 110.325 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 43.0 Cg_endo -69.72 -48.76 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.911 1.48 . . . . 0.0 109.798 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 11.9 m-85 -99.49 166.72 11.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.453 -0.78 . . . . 0.0 109.785 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER 173.71 -36.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 110.148 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 18.3 p90 -71.17 172.02 9.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.378 -0.826 . . . . 0.0 110.261 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 18.2 m -154.47 154.38 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 25.8 ttmt -105.39 48.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -48.19 132.07 16.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 84' ' ' SER . 38.0 ttt180 -96.43 151.09 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 108.637 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.5 t -76.55 147.81 7.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.619 -1.301 . . . . 0.0 110.375 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 29.5 t0 -101.55 -74.07 0.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.373 0.606 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.32 146.6 36.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.209 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.9 t -137.37 127.95 38.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -124.64 113.65 18.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 109.747 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.413 ' CE1' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -75.68 -13.45 60.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 111.105 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -106.68 -35.49 6.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.017 -1.052 . . . . 0.0 109.672 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.462 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.31 14.88 19.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.549 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 41.68 48.26 3.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.382 -0.824 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -116.65 113.7 23.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.217 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.457 ' CG ' HG12 ' A' ' 23' ' ' ILE . 41.1 t80 -133.04 120.29 21.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.383 -0.823 . . . . 0.0 110.071 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 42.6 t-20 -130.69 162.42 29.49 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 110.194 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.604 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 23.7 p90 -153.94 140.86 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.2 m -98.08 154.01 18.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.475 HG13 HD13 ' A' ' 91' ' ' ILE . 39.1 t -99.39 123.05 51.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -125.09 -77.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 111.041 -178.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.528 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 3.9 tm-20 -71.97 65.62 0.55 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -86.36 140.72 17.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.528 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.18 -53.83 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.9 Cg_endo -74.59 -45.26 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.784 1.412 . . . . 0.0 110.704 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.475 HD13 HG13 ' A' ' 85' ' ' VAL . 49.2 mt -59.51 172.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.012 . . . . 0.0 110.189 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.401 ' N ' ' CG2' ' A' ' 91' ' ' ILE . . . -152.42 -65.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.475 ' O ' HG21 ' A' ' 94' ' ' THR . 2.4 m-20 -99.56 -85.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 110.107 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 93' ' ' ASP . 64.6 p -140.12 19.2 2.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 110.35 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -94.28 153.83 17.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.557 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 36.2 mt-10 57.14 36.02 27.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.396 -0.815 . . . . 0.0 109.932 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.452 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.6 mttt -69.2 153.26 43.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.915 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.57 HG12 ' CE1' ' A' ' 120' ' ' TYR . 12.6 mt -138.93 132.0 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.722 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.6 m -121.91 110.36 15.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.623 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.604 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 5.0 m120 -104.03 125.89 50.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -110.18 167.13 10.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 102' ' ' ILE . 12.2 mt -155.39 118.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.479 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 5.9 tttt -119.46 114.19 21.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.509 ' CG1' ' HG ' ' A' ' 114' ' ' LEU . 2.7 mp -103.28 125.43 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 112' ' ' SER . 42.6 t -131.21 145.71 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.246 -0.909 . . . . 0.0 110.542 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.96 153.43 21.3 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.777 -0.577 . . . . 0.0 110.218 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.551 ' CG2' ' HD3' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -130.08 -56.49 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.064 -1.022 . . . . 0.0 111.331 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.551 ' HD3' ' CG2' ' A' ' 107' ' ' THR . 45.5 Cg_endo -88.35 43.11 0.75 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.076 1.04 . . . . 0.0 110.793 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 108' ' ' PRO . 0.6 OUTLIER 42.7 28.18 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.91 . . . . 0.0 110.244 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 108' ' ' PRO . . . -163.75 -36.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -111.89 -174.65 19.73 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -157.14 170.63 22.07 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.407 HG23 HD11 ' A' ' 113' ' ' ILE . 48.4 mt -122.76 120.58 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.509 ' HG ' ' CG1' ' A' ' 104' ' ' ILE . 1.4 mp -86.95 122.05 30.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.667 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -104.27 97.48 7.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.8 mt -85.67 144.59 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.861 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.492 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -128.05 120.58 27.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.55 123.93 51.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.015 -1.053 . . . . 0.0 110.612 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -120.76 128.43 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.746 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.57 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -109.31 143.5 38.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -0.985 . . . . 0.0 110.243 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 66.9 m-70 -128.11 129.64 46.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.058 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -113.85 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -145.33 164.37 31.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.384 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 41.59 -126.12 3.61 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -103.39 14.74 30.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -1.107 . . . . 0.0 109.975 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.488 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 9.4 m170 -70.39 165.81 21.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.321 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.488 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -160.16 137.7 9.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.307 -0.871 . . . . 0.0 109.28 179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.7 p -100.05 98.15 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.372 -0.83 . . . . 0.0 110.527 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 128' ' ' VAL . 3.8 mttm -54.94 -172.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.49 16.73 16.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.85 -72.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.875 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -30.49 38.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 109.201 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.553 ' CG2' ' CE2' ' A' ' 120' ' ' TYR . 11.3 t -70.88 -48.83 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.463 -0.773 . . . . 0.0 109.531 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -65.46 -36.31 83.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 0.0 110.173 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.52 72.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.661 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 t -66.4 -38.36 87.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.752 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -64.22 -43.8 93.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.993 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -51.18 -53.79 31.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.32 -24.35 62.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -57.63 -44.03 94.1 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.481 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 15.8 mt-10 -64.43 -57.51 9.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -1.161 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.8 m -46.27 -29.94 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 20.2 mt -70.61 -59.33 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.847 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 2.3 pp -66.72 -17.89 65.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.172 -0.955 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 149' ' ' SER . 0.0 OUTLIER -84.12 -33.64 24.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.798 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.11 -44.05 73.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.907 . . . . 0.0 109.438 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.7 t -67.95 -43.97 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.679 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.5 OUTLIER -61.2 -36.74 80.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.249 -0.907 . . . . 0.0 109.374 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.9 OUTLIER -68.08 -52.87 30.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 0.0 109.755 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -47.46 -69.92 0.11 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 110.312 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 154' ' ' HIS . 2.3 mt -46.21 -36.53 6.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.394 -0.817 . . . . 0.0 110.403 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -71.3 -56.41 6.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.084 -1.01 . . . . 0.0 110.297 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -56.6 -27.56 58.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.933 . . . . 0.0 110.241 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -118.56 117.8 29.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.9 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.7 t -101.12 -26.72 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 110.521 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 157' ' ' ALA . 46.1 m-20 -129.16 1.47 5.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.101 -1.0 . . . . 0.0 110.323 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 156' ' ' ASP . . . 50.31 -177.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -0.932 . . . . 0.0 110.087 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -151.49 50.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 110.392 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.215 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.53 HG13 ' ND1' ' A' ' 121' ' ' HIS . 4.2 m -74.37 -165.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.429 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -107.31 153.04 23.32 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.261 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 143.8 48.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.971 -1.08 . . . . 0.0 111.183 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CD2' HG12 ' A' ' 133' ' ' VAL . 10.8 m-85 -153.59 58.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 0.0 109.151 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 9.9 pt-20 -84.94 145.07 27.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 110.807 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -146.78 167.53 23.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -147.42 166.87 25.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.99 . . . . 0.0 110.369 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.12 -168.4 2.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 p -130.35 160.81 32.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.461 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . 41.5 m -159.95 139.26 11.03 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 14.8 p -79.83 -6.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.203 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 9.9 mm -74.27 148.96 86.64 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.0 150.25 88.33 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.561 1.296 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -67.04 -36.99 83.29 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.457 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.66 -54.16 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.565 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.525 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 12.0 ttt180 -57.83 -39.5 77.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 1.4 tt -67.32 -39.1 85.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CZ ' ' O ' ' A' ' 75' ' ' ASP . 61.9 t80 -61.23 -71.0 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 0.0 110.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -47.4 -45.67 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.144 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 0.0 110.496 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 16.2 t80 -90.86 -7.09 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -121.42 -64.9 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.978 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.472 ' N ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -61.82 -48.27 81.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 110.299 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.431 ' OD2' HD12 ' A' ' 29' ' ' LEU . 29.9 t0 -110.82 16.7 21.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 110.313 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.72 -61.18 6.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -45.89 -23.88 0.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -1.125 . . . . 0.0 110.711 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -89.74 -32.51 16.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 0.0 110.518 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.431 HD12 ' OD2' ' A' ' 25' ' ' ASP . 3.8 mp -84.4 -18.08 37.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -62.49 -61.81 6.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.675 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -72.72 53.76 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.841 1.443 . . . . 0.0 110.981 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -151.64 -63.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.119 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.534 HG12 ' CE1' ' A' ' 150' ' ' TYR . 17.0 m -86.18 -19.93 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.44 66.12 35.52 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 110.264 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.66 -10.77 21.97 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.003 1.528 . . . . 0.0 110.397 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -22.91 64.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.285 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.459 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -95.19 -55.91 2.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.49 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.4 mp -107.72 137.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 110.112 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.19 -29.33 14.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.987 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -178.61 145.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.012 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 2.3 p -126.99 119.21 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.167 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -115.01 119.68 37.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.3 m-20 -65.54 117.59 8.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.493 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 55' ' ' LYS . 20.8 mm -79.91 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.36 1.076 . . . . 0.0 108.422 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.2 mm-40 -100.15 -161.38 0.86 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.064 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.31 53.83 0.34 Allowed Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -116.3 -24.83 7.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -1.053 . . . . 0.0 110.003 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.529 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 50.77 78.16 0.11 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 71' ' ' VAL . . . 166.66 -160.19 33.74 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 43.8 Cg_endo -70.72 83.68 0.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.05 1.553 . . . . 0.0 110.286 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.86 -8.69 2.25 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 32.7 m -67.69 165.54 17.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.965 -1.315 . . . . 0.0 109.257 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 19.5 mt -138.03 143.37 33.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.961 -1.087 . . . . 0.0 111.056 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -154.9 136.9 14.63 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.569 ' HE2' ' CD1' ' A' ' 66' ' ' TYR . 1.1 ttpm? -95.56 112.48 24.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 111.404 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.49 ' CG2' HG12 ' A' ' 38' ' ' ILE . 15.1 mt -98.17 122.33 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 109.266 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.48 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -84.08 150.89 25.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.691 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -111.19 137.06 20.87 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.198 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.459 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 48.6 Cg_endo -75.23 76.27 3.54 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.994 1.523 . . . . 0.0 110.529 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -125.67 179.57 5.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.149 -0.969 . . . . 0.0 110.346 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -99.56 -45.33 2.15 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.463 ' O ' ' O ' ' A' ' 61' ' ' GLY . 1.9 m-85 -42.92 166.01 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.272 -1.134 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.09 -59.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.933 1.491 . . . . 0.0 110.434 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -84.07 144.3 29.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.859 . . . . 0.0 109.834 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -174.07 -49.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.986 . . . . 0.0 110.554 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.569 ' CD1' ' HE2' ' A' ' 55' ' ' LYS . 21.5 p90 -64.06 162.79 13.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.258 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 66' ' ' TYR . 4.2 m -143.09 175.74 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.177 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.9 ttpt -122.46 37.93 4.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 4.6 p-10 -42.24 138.57 1.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.618 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.0 ptt180 -102.81 167.26 9.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 108.947 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 16.3 t -77.85 152.34 5.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.94 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 34.2 t70 -104.71 -66.34 0.97 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -144.7 130.09 18.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.251 -0.906 . . . . 0.0 110.742 -179.736 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 5.4 t -116.12 150.83 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.578 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -158.33 111.23 2.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.221 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -21.25 51.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -104.77 -40.32 6.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.19 -0.944 . . . . 0.0 109.756 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.41 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -84.48 7.22 20.56 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.762 . . . . 0.0 110.274 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.526 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 8.0 m-85 46.25 59.26 3.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.29 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -131.27 107.94 9.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.965 -1.084 . . . . 0.0 110.741 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.534 ' CD2' HD11 ' A' ' 102' ' ' ILE . 13.9 t80 -125.99 104.1 8.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.521 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 37.3 m-20 -121.02 149.1 43.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.2 p90 -139.04 138.38 37.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' ARG . 5.7 m -101.89 159.94 14.92 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.906 -1.121 . . . . 0.0 111.008 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 69' ' ' ASP . 55.5 t -106.98 121.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.16 -75.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.067 -1.021 . . . . 0.0 110.873 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' CA ' ' OE1' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -74.04 95.24 2.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.72 -1.238 . . . . 0.0 110.101 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -122.79 138.31 11.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.536 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.4 -54.36 3.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.4 Cg_endo -72.47 -48.43 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.831 1.437 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 91' ' ' ILE . 64.4 mt -54.5 160.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.178 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.469 ' N ' HG21 ' A' ' 91' ' ' ILE . . . -155.59 -70.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.467 ' O ' ' OG1' ' A' ' 94' ' ' THR . 0.5 OUTLIER -103.31 74.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 110.198 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 46.6 p 43.7 24.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 96' ' ' GLU . 3.6 pp -96.96 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 0.0 110.126 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER 56.45 34.66 24.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -67.95 151.48 47.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.301 -0.874 . . . . 0.0 110.018 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.654 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -126.79 120.67 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.612 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.45 ' O ' ' OE1' ' A' ' 101' ' ' GLU . 1.0 OUTLIER -108.83 104.23 13.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.541 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -96.25 145.43 25.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.782 -179.249 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.521 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 1.2 mp0 -136.11 139.73 43.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.437 -0.79 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.534 HD11 ' CD2' ' A' ' 81' ' ' TYR . 3.0 mp -130.21 100.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 110.476 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 59.3 tttt -104.76 124.47 49.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.01 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 50.0 mt -110.45 138.63 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.895 . . . . 0.0 110.377 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 t -139.2 138.87 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.05 -1.031 . . . . 0.0 109.912 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.08 144.08 26.7 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.497 0.665 . . . . 0.0 110.479 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.598 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.9 p -79.86 -163.71 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.81 . . . . 0.0 108.924 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 44.3 Cg_endo -78.06 -32.19 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.008 1.004 . . . . 0.0 110.543 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 108' ' ' PRO . 1.7 m-20 -173.68 35.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.3 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.77 61.75 0.46 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.638 -1.267 . . . . 0.0 110.301 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 107' ' ' THR . . . 73.09 -154.53 49.68 Favored Glycine 0 N--CA 1.491 2.358 0 O-C-N 121.223 -1.163 . . . . 0.0 110.332 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -134.51 163.56 29.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.785 -0.832 . . . . 0.0 110.538 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.1 mt -109.49 133.25 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 109.349 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -97.88 133.93 41.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.976 -1.078 . . . . 0.0 110.803 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -129.55 98.66 4.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.413 -0.804 . . . . 0.0 109.642 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.494 ' CD1' HD21 ' A' ' 114' ' ' LEU . 1.5 mp -101.02 136.86 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.933 . . . . 0.0 110.421 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -113.33 125.44 54.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.374 -0.829 . . . . 0.0 110.232 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.78 134.0 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 0.7 OUTLIER -125.82 143.59 51.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.956 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.654 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -125.56 104.02 8.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.97 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.53 ' ND1' HG13 ' A' ' 2' ' ' VAL . 33.2 m-70 -83.42 101.44 11.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.88 . . . . 0.0 110.409 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.5 166.98 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.804 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 124' ' ' GLY . 5.6 ttpt -107.44 145.75 32.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.325 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.87 -30.11 0.93 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.0 -55.77 5.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -1.222 . . . . 0.0 110.403 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.445 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 96.6 m-70 -78.83 179.15 7.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -159.99 136.52 9.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 109.897 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 128' ' ' VAL . 3.0 p -104.79 86.62 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -48.48 150.29 1.39 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -60.46 -27.34 67.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.959 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 130' ' ' ALA . 28.5 mt-10 -41.71 -64.59 0.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 110.046 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -55.12 -29.7 58.23 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.577 HG12 ' CD2' ' A' ' 5' ' ' TYR . 9.3 t -72.88 -50.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.415 -0.803 . . . . 0.0 109.442 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.2 -21.4 60.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.198 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 -32.29 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.122 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -35.58 37.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -49.36 -60.57 2.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 110.004 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -76.94 -31.7 56.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 110.116 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.52 -55.03 14.38 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -50.06 -40.3 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.154 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.06 -24.91 67.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.987 . . . . 0.0 109.695 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 54.7 mt -73.81 -51.49 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.94 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.4 pp -64.54 -22.01 66.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 tpt85 -81.66 -43.08 19.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.444 -0.785 . . . . 0.0 109.682 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -57.75 -36.72 72.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.3 t -73.22 -53.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 109.603 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 11' ' ' SER . 50.7 tt0 -53.48 -53.15 55.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -36.3 73.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.128 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.534 ' CE1' HG12 ' A' ' 33' ' ' VAL . 1.2 t80 -48.93 -71.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.573 -0.704 . . . . 0.0 109.823 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.488 ' CB ' ' CD1' ' A' ' 13' ' ' ILE . 1.9 mp -56.45 -26.53 54.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.725 . . . . 0.0 110.071 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -77.74 -14.38 59.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.32 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -119.32 18.05 12.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -99.74 119.51 38.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.065 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.52 112.68 25.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.267 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -70.0 -20.35 63.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.17 -152.14 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 110.088 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.08 -60.62 1.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.296 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 1' ' ' GLY . 4.5 t 57.3 155.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -1.111 . . . . 0.0 110.11 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -111.24 151.31 28.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.33 135.61 49.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 110.363 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD2' HG12 ' A' ' 133' ' ' VAL . 28.2 m-85 -148.39 70.68 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.445 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -95.19 154.21 17.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 6' ' ' GLU . 2.1 p -158.15 -169.77 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.507 -0.746 . . . . 0.0 109.844 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.9 pt-20 -159.96 150.93 19.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.748 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.424 ' CG2' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -132.17 153.39 50.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.402 -0.811 . . . . 0.0 109.77 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.403 ' CG2' ' CD1' ' A' ' 113' ' ' ILE . 1.8 p -92.93 160.2 15.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.741 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.48 ' OG ' ' CD1' ' A' ' 114' ' ' LEU . 17.3 m -158.07 137.78 12.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 109.673 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' O ' HG11 ' A' ' 12' ' ' VAL . 56.7 t -80.05 -11.0 12.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.611 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.0 OUTLIER -75.85 150.73 84.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.083 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.3 Cg_endo -66.71 150.74 83.52 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.716 1.377 . . . . 0.0 111.145 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.73 -19.57 60.76 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.497 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.8 -54.87 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.471 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 14.4 ttp180 -64.15 -38.35 90.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.759 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 18' ' ' LEU . 6.4 tt -71.29 -33.48 69.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.569 ' CD2' HD11 ' A' ' 23' ' ' ILE . 33.8 t80 -62.26 -65.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.115 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -51.64 -47.82 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 110.266 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 17' ' ' ARG . . . -64.26 -32.29 73.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 25.9 t80 -91.73 -13.01 32.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.569 HD11 ' CD2' ' A' ' 19' ' ' PHE . 1.1 mp -114.98 -71.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.192 -0.942 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' N ' HG23 ' A' ' 23' ' ' ILE . 8.1 mt -62.22 -34.2 76.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.845 . . . . 0.0 110.766 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.4 m-20 -118.0 23.8 11.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.156 -0.965 . . . . 0.0 110.444 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.56 -38.22 33.19 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 41' ' ' VAL . 1.9 p30 -56.49 -30.57 63.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -1.152 . . . . 0.0 110.408 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 25' ' ' ASP . 4.9 p-10 -96.02 -18.81 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 tp -82.21 -39.75 22.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 110.341 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.588 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -53.05 -62.04 3.99 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.224 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.8 Cg_endo -73.27 54.89 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.813 1.428 . . . . 0.0 110.476 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.7 -67.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 110.564 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.479 HG13 ' CD1' ' A' ' 150' ' ' TYR . 30.6 m -80.14 -15.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.512 -0.742 . . . . 0.0 110.449 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.447 ' HB2' HD22 ' A' ' 143' ' ' LEU . . . -156.25 76.87 4.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.346 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.0 -2.19 11.64 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.044 1.549 . . . . 0.0 110.214 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -72.72 -28.31 62.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -86.42 -61.66 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.961 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.532 HD11 ' CG ' ' A' ' 30' ' ' PHE . 1.2 mp -105.8 128.91 59.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.402 -0.811 . . . . 0.0 109.699 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.451 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -91.33 -25.3 19.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.18 -0.95 . . . . 0.0 110.485 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.39 141.02 0.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.693 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 27' ' ' ASP . 2.1 p -127.47 139.88 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mm-40 -142.23 158.74 43.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.973 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -103.87 115.73 31.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.465 -0.772 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.431 HD13 ' HG3' ' A' ' 68' ' ' LYS . 10.0 mt -81.23 -39.01 17.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.8 tp10 -99.13 -157.77 0.63 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.708 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.25 61.51 0.26 Allowed Glycine 0 N--CA 1.482 1.715 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.82 -23.33 5.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -1.12 . . . . 0.0 109.845 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 48.13 89.26 0.01 OUTLIER Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . 151.48 -158.87 27.96 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.32 89.34 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.6 -3.03 3.17 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.189 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.564 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 33.5 m -78.48 161.34 27.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.319 . . . . 0.0 109.697 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 14.0 mt -130.9 144.91 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.911 -1.118 . . . . 0.0 110.619 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -152.47 144.45 23.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.778 . . . . 0.0 109.784 179.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -93.52 117.45 30.1 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.434 -0.791 . . . . 0.0 110.757 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.5 mm -102.73 141.76 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -112.19 142.72 44.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.048 -1.032 . . . . 0.0 110.437 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 14.2 m-85 -118.2 123.2 29.61 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 49.3 Cg_endo -76.6 126.67 9.1 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.855 1.45 . . . . 0.0 110.383 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -172.99 -145.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.052 -1.03 . . . . 0.0 110.396 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -130.28 -19.58 1.36 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.496 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.655 ' CZ ' ' CB ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -45.25 170.89 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.812 -1.405 . . . . 0.0 110.544 -179.557 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 43.8 Cg_endo -71.79 -33.63 9.92 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.59 1.31 . . . . 0.0 109.133 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 32.6 m-85 -84.21 -163.99 0.87 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.596 -0.69 . . . . 0.0 109.209 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 3.5 ttmt -168.39 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.712 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 40.6 p90 -92.04 -165.74 1.41 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.855 0.836 . . . . 0.0 111.172 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.556 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -173.91 172.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.556 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -107.95 128.68 54.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.161 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.464 ' OD1' HG21 ' A' ' 85' ' ' VAL . 17.0 m-20 -127.19 130.67 50.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 2.4 ttp180 -101.15 145.26 29.02 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 0.0 108.935 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.564 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 9.7 t -67.9 149.79 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.965 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t70 -101.33 -68.95 0.79 Allowed 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.403 0.621 . . . . 0.0 110.386 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.1 tt0 -145.8 121.94 10.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 110.339 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.7 t -108.91 151.6 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 1.2 m-20 -152.08 113.77 4.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -88.89 2.13 54.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 110.144 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -117.43 -40.84 3.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.692 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.1 11.77 28.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.219 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.508 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 50.35 57.79 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 3.8 mtpt -129.61 126.27 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.498 ' OH ' ' NZ ' ' A' ' 54' ' ' LYS . 16.4 t80 -143.63 106.62 4.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 62.7 t-20 -117.0 165.99 12.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.631 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.3 p90 -161.17 137.76 8.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.818 . . . . 0.0 109.467 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 69.8 m -106.85 168.53 9.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.581 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 91' ' ' ILE . 39.8 t -106.58 127.87 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -114.8 -70.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 111.879 -178.462 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.544 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -90.48 98.09 11.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.492 -1.38 . . . . 0.0 110.147 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -111.33 141.53 16.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.03 -58.7 3.63 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.0 Cg_endo -74.06 -31.46 7.88 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.986 1.519 . . . . 0.0 110.461 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.519 ' CD1' HG13 ' A' ' 85' ' ' VAL . 54.0 mt -67.66 145.61 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.306 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.433 ' N ' HG21 ' A' ' 91' ' ' ILE . . . -107.11 -92.21 2.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.58 -72.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.9 p -132.06 15.11 4.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.47 146.67 23.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 110.315 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.429 ' HA ' HG21 ' A' ' 122' ' ' THR . 16.6 tt0 62.33 33.05 16.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.972 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -79.08 149.66 32.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.56 HD12 ' CE1' ' A' ' 120' ' ' TYR . 11.0 mt -127.69 153.93 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.816 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 63.3 m -145.64 105.39 3.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.489 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 7.7 m120 -101.19 124.4 46.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.147 -0.971 . . . . 0.0 110.889 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.525 ' HG3' ' ND2' ' A' ' 82' ' ' ASN . 1.9 tt0 -106.71 152.41 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.545 -0.722 . . . . 0.0 109.776 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.442 HG13 ' C ' ' A' ' 101' ' ' GLU . 13.5 mt -137.6 144.44 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.206 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.405 ' C ' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -143.98 132.42 22.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.473 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 7.3 mm -119.94 119.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 109.908 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 112' ' ' SER . 14.4 t -133.49 126.15 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 110.918 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -72.96 158.17 35.99 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.149 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.59 ' CG2' ' HD3' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -137.37 -61.15 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.026 -1.046 . . . . 0.0 111.22 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.59 ' HD3' ' CG2' ' A' ' 107' ' ' THR . 51.1 Cg_endo -82.88 41.09 1.04 Allowed 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 122.775 0.882 . . . . 0.0 110.781 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 108' ' ' PRO . 5.1 t70 42.19 31.48 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.033 -1.042 . . . . 0.0 110.396 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.15 -37.54 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . -115.64 -166.91 14.97 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 13.7 t -159.99 -178.86 7.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 111.274 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.403 ' CD1' ' CG2' ' A' ' 10' ' ' THR . 39.1 mm -130.0 117.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.48 ' CD1' ' OG ' ' A' ' 11' ' ' SER . 3.4 mp -87.2 121.12 29.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.966 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -104.34 106.83 17.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.662 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 1.2 tt -105.63 132.17 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 40.7 t -121.1 115.18 22.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -99.25 134.71 41.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 134.3 50.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.56 ' CE1' HD12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -116.75 131.93 56.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.87 . . . . 0.0 109.998 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 86.9 m-70 -116.25 101.51 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.038 . . . . 0.0 110.29 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.463 HG22 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -118.28 167.15 11.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.201 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 124' ' ' GLY . 4.1 ttmt -104.64 164.54 11.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 110.367 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -44.71 -40.1 6.42 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.5 -74.42 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -1.164 . . . . 0.0 110.157 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 30.2 m170 -67.67 178.92 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.298 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 126' ' ' HIS . 55.0 mt-10 -156.61 -170.07 3.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.205 -0.934 . . . . 0.0 110.438 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 122' ' ' THR . 2.1 t -132.09 103.43 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 110.092 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -75.95 139.91 41.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.496 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -61.76 -10.17 8.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.989 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.42 -52.88 41.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.875 -1.141 . . . . 0.0 109.878 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -28.91 68.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 108.881 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.567 HG12 ' CD2' ' A' ' 5' ' ' TYR . 22.1 t -76.98 -49.97 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.5 -0.75 . . . . 0.0 109.12 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 15.6 tptt -66.58 -27.33 67.64 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.722 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.96 -33.47 63.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.762 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.6 t -67.07 -34.69 78.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.106 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -29.57 66.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.24 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.23 -66.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -17.91 62.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.43 -41.12 86.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.8 tt0 -67.62 -42.2 82.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 110.109 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -61.47 -29.01 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.495 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 34' ' ' ALA . 18.1 mt -68.85 -54.5 15.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.409 -0.807 . . . . 0.0 109.908 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.495 ' HG ' ' N ' ' A' ' 145' ' ' ARG . 1.1 pp -61.48 -29.43 69.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.495 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -72.86 -34.05 66.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.429 -0.794 . . . . 0.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -65.56 -43.21 90.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.426 HG11 HD13 ' A' ' 151' ' ' LEU . 21.6 t -64.98 -40.86 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.609 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 2.8 tt0 -54.66 -48.9 71.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.842 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t -59.53 -50.36 74.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.479 ' CD1' HG13 ' A' ' 33' ' ' VAL . 1.6 t80 -47.18 -70.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.66 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.426 HD13 HG11 ' A' ' 147' ' ' VAL . 8.5 mt -47.59 -45.17 27.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -50.92 -46.25 60.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 110.277 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -89.58 -15.75 32.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -89.58 -1.95 58.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.952 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.76 55.37 1.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.315 -0.866 . . . . 0.0 110.406 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -93.2 -32.98 14.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.301 -0.874 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.99 -30.79 70.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -65.03 -9.6 23.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.0 110.181 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.215 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.545 HG13 ' ND1' ' A' ' 121' ' ' HIS . 13.1 m -126.41 -165.84 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -1.099 . . . . 0.0 110.531 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.478 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 31.9 m-85 -117.62 141.58 48.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.996 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.6 141.14 46.72 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.022 . . . . 0.0 110.258 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.47 ' CE1' HG13 ' A' ' 133' ' ' VAL . 42.8 m-85 -147.16 55.63 1.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.725 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.67 148.85 30.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.787 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.61 -0.681 . . . . 0.0 109.78 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.81 158.03 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 -171.4 3.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.586 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.81 162.16 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -159.2 143.36 15.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 0.0 109.936 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.493 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 7.2 p -79.94 -12.85 13.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.618 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.585 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.2 mp -69.95 149.28 96.42 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.28 149.59 85.09 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.437 1.23 . . . . 0.0 111.157 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 112' ' ' SER . . . -74.63 -25.91 59.54 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.53 -53.53 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.918 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.501 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -66.1 -34.2 77.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.8 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.51 ' HB2' ' CG2' ' A' ' 13' ' ' ILE . 7.0 tt -74.95 -30.99 61.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.615 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CE1' HG13 ' A' ' 23' ' ' ILE . 59.3 t80 -67.92 -71.82 0.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -50.45 -42.68 54.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.853 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 17' ' ' ARG . . . -66.21 -36.16 82.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.493 -0.754 . . . . 0.0 110.294 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 25.8 t80 -91.98 -10.93 37.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.578 HG13 ' CE1' ' A' ' 19' ' ' PHE . 7.7 mm -100.35 -74.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.211 -0.931 . . . . 0.0 110.157 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.478 ' CD1' ' HG2' ' A' ' 20' ' ' LYS . 19.8 mt -68.0 -40.99 82.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.44 -0.788 . . . . 0.0 109.796 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -85.39 -18.79 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 110.026 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.52 -40.43 62.19 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 9.5 m-20 -55.74 -26.04 43.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -1.157 . . . . 0.0 110.11 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 67.6 m-20 -109.19 -23.32 11.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mp -85.33 -28.48 25.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.219 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.564 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.6 m-30 -54.2 -59.79 9.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.6 Cg_endo -73.41 0.19 8.38 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.99 1.521 . . . . 0.0 110.556 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -96.25 -69.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.685 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.2 m -81.81 7.27 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.396 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.16 2.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.325 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.33 -2.03 11.49 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.979 1.515 . . . . 0.0 110.653 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -90.62 -3.49 57.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.274 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' O ' ' HD3' ' A' ' 59' ' ' PRO . . . -110.88 -71.56 0.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.13 138.59 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.453 -0.78 . . . . 0.0 110.162 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.2 t -81.57 -48.82 11.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -163.65 176.75 9.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.296 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 27' ' ' ASP . 2.6 m -135.45 147.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 1.1 tt0 -136.44 161.29 36.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.84 110.16 20.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.481 ' HB ' ' HB ' ' A' ' 53' ' ' ILE . 15.5 mm -82.04 -39.45 16.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 122.231 1.015 . . . . 0.0 108.414 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.0 tm-20 -105.77 -159.71 0.72 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.166 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.73 59.77 0.33 Allowed Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' GLY . 0.7 OUTLIER -123.53 -19.26 5.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -1.182 . . . . 0.0 110.272 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.529 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 45.12 70.98 0.54 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.487 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . 164.11 -159.12 31.9 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.28 94.84 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.876 1.461 . . . . 0.0 110.221 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.38 -6.92 4.64 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.581 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 38.1 m -80.25 162.74 24.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -1.112 . . . . 0.0 109.53 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.481 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 31.5 mt -137.41 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.099 -1.001 . . . . 0.0 110.37 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -148.79 142.7 25.76 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.267 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HB2' HD13 ' A' ' 44' ' ' ILE . 25.0 tttp -91.77 117.24 29.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.532 -0.73 . . . . 0.0 110.197 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.5 HD13 ' CD ' ' A' ' 54' ' ' LYS . 39.7 mm -97.15 119.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.244 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.472 ' HB2' ' N ' ' A' ' 40' ' ' SER . 3.7 m -82.54 130.68 35.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.869 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.538 ' CD1' HG23 ' A' ' 67' ' ' VAL . 2.3 m-85 -108.24 163.63 16.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 110.617 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 45.2 Cg_endo -74.18 -165.87 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.238 1.652 . . . . 0.0 110.726 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.52 155.8 21.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.892 . . . . 0.0 110.828 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.74 -93.3 0.13 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.53 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 6.5 p90 -64.51 168.99 5.6 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.363 -1.081 . . . . 0.0 109.85 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 38.8 Cg_endo -64.13 -26.52 65.2 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.54 1.284 . . . . 0.0 110.305 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -81.82 179.37 7.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.185 178.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 22.6 mttt -129.32 -73.32 0.57 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.108 -0.995 . . . . 0.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.463 ' O ' HG11 ' A' ' 67' ' ' VAL . 8.3 p90 -92.06 177.77 6.07 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.765 0.793 . . . . 0.0 111.057 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' A' ' 58' ' ' PHE . 29.2 m -152.21 150.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.534 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 11.6 mtmt -110.48 139.91 45.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.95 -1.094 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 20.2 p-10 -134.73 133.58 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 110.276 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 84' ' ' SER . 7.4 ttt180 -100.07 139.65 35.43 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.581 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 14.1 t -61.31 153.92 5.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.541 -1.349 . . . . 0.0 111.039 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 18.4 t0 -106.32 -73.6 0.68 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.874 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.31 112.63 7.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.385 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.502 HG23 ' CZ ' ' A' ' 81' ' ' TYR . 2.6 t -102.89 141.5 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' LYS . 16.8 t0 -142.63 120.55 12.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.64 1.33 57.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 110.383 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -115.39 -35.63 4.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.089 -1.007 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -102.14 20.81 15.97 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.488 -0.758 . . . . 0.0 110.503 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.8 m-30 43.21 56.72 4.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 75' ' ' ASP . 25.7 tttt -125.99 123.16 37.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.53 ' CD2' HG22 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -142.48 105.09 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.087 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.48 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 47.3 m-20 -121.0 144.01 48.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 110.185 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 31.1 p90 -135.49 137.37 42.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.848 . . . . 0.0 109.379 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.5 m -94.66 161.66 14.1 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 110.977 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.539 HG13 ' CD1' ' A' ' 91' ' ' ILE . 25.2 t -102.69 128.22 55.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -119.33 -74.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.06 -1.025 . . . . 0.0 111.349 -178.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -92.11 64.84 4.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.638 -1.289 . . . . 0.0 109.881 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . -131.77 159.67 23.3 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 44.98 -157.08 0.24 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.83 1.57 6.9 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.024 1.539 . . . . 0.0 110.782 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.539 ' CD1' HG13 ' A' ' 85' ' ' VAL . 75.9 mt -51.63 155.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.052 . . . . 0.0 110.321 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.1 -107.08 0.24 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.476 ' HB2' HD22 ' A' ' 95' ' ' LEU . 18.4 m-20 -47.7 -86.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.933 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.419 ' CG2' ' C ' ' A' ' 93' ' ' ASP . 30.6 p -148.23 12.34 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -92.82 157.85 16.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 110.239 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.4 mm-40 59.51 33.04 22.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.902 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.497 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.2 ttpm? -76.55 159.36 30.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.622 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mp -142.02 127.59 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.875 . . . . 0.0 110.228 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t -116.42 112.9 22.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.603 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -99.24 136.62 38.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 110.495 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.518 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 90.2 mt-10 -125.97 144.28 50.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.794 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.4 mt -136.08 113.6 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.352 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.45 124.66 48.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 3.2 mt -118.2 127.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.0 t -132.56 141.59 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -87.93 144.45 26.55 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.393 0.616 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.577 ' HB ' ' CD ' ' A' ' 108' ' ' PRO . 4.4 p -79.91 -165.01 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.577 ' CD ' ' HB ' ' A' ' 107' ' ' THR . 46.3 Cg_endo -80.94 -23.67 5.32 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.187 1.098 . . . . 0.0 110.956 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.33 31.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.105 -0.997 . . . . 0.0 110.242 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -141.78 42.72 1.13 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.314 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . 88.69 -153.46 23.98 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.52 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -133.6 163.59 29.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.813 -0.816 . . . . 0.0 110.671 -179.3 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.3 mt -108.32 131.6 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.42 -0.8 . . . . 0.0 109.022 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.01 135.29 47.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.937 -1.102 . . . . 0.0 110.504 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.45 111.12 11.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' THR . 3.2 mt -102.84 125.61 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 110.587 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.518 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -109.55 119.39 39.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.807 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -118.26 141.66 48.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.319 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -124.9 151.73 44.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 109.993 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.622 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -130.26 99.8 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 109.759 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.545 ' ND1' HG13 ' A' ' 2' ' ' VAL . 14.7 m-70 -86.01 105.83 16.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.804 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.468 HG22 ' CG2' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -113.02 172.94 6.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 8.1 tttt -108.42 154.03 22.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.866 . . . . 0.0 110.386 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -43.95 -47.59 7.87 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -54.07 -61.87 2.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -1.177 . . . . 0.0 110.466 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.464 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 68.4 m-70 -83.06 176.75 8.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.909 . . . . 0.0 110.631 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 126' ' ' HIS . 3.4 mt-10 -146.36 -171.18 3.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.793 . . . . 0.0 109.682 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.5 ' O ' ' CG1' ' A' ' 128' ' ' VAL . 2.4 t -122.36 89.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -60.18 132.03 52.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.615 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.9 -16.84 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.018 . . . . 0.0 110.632 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.22 -59.01 5.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.898 -1.126 . . . . 0.0 109.495 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -63.59 -30.2 71.34 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 109.061 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.47 HG13 ' CE1' ' A' ' 5' ' ' TYR . 16.1 t -71.74 -47.25 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -65.07 -30.67 71.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.773 . . . . 0.0 110.048 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.44 -19.94 61.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.0 t -72.43 -43.47 63.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 110.092 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 138' ' ' GLU . 21.9 ptmt -79.91 -37.71 34.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 137' ' ' LYS . 6.5 tt0 -51.8 -57.58 8.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 -25.94 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -60.44 -46.49 94.25 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.462 ' HA ' HD22 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -62.26 -44.11 97.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.26 -1.141 . . . . 0.0 110.453 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.465 ' O ' ' HB1' ' A' ' 146' ' ' ALA . 56.6 m -62.67 -22.82 66.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.003 -1.06 . . . . 0.0 109.775 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 19.6 mt -74.32 -52.66 11.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 110.041 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.64 -27.32 66.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.602 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.454 ' HG2' HD13 ' A' ' 144' ' ' LEU . 27.0 mmt180 -77.17 -29.26 54.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.878 . . . . 0.0 109.492 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 142' ' ' THR . . . -67.41 -49.64 62.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.3 -41.55 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.694 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -63.38 -50.67 69.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.678 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.33 -16.78 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.676 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.45 ' CD2' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -83.53 -38.45 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.6 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.45 ' HG ' ' CD2' ' A' ' 150' ' ' TYR . 8.7 mt -68.72 -55.29 11.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 110.285 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.63 -27.31 1.83 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.936 . . . . 0.0 109.994 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.25 22.28 8.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 110.018 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 151' ' ' LEU . 40.8 t-80 -94.01 -59.0 2.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.0 110.362 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.5 m -145.64 40.94 1.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.957 . . . . 0.0 110.266 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -138.68 -48.06 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.939 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.68 -63.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 110.124 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 60.72 35.93 19.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 110.105 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.284 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.459 HG23 ' ND1' ' A' ' 121' ' ' HIS . 2.4 t -120.33 138.81 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -1.125 . . . . 0.0 110.127 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.483 ' CD2' ' HB ' ' A' ' 128' ' ' VAL . 1.2 m-85 -91.4 164.27 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -143.95 143.56 31.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.504 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 68.2 m-85 -155.49 65.83 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.587 -0.695 . . . . 0.0 109.291 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 1.8 pp20? -85.15 153.1 22.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 110.888 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.43 176.45 9.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.972 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 2.0 pt-20 -158.44 149.38 20.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.127 -0.983 . . . . 0.0 110.483 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 -170.04 2.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -125.95 168.37 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.442 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -158.81 138.26 11.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.553 -0.717 . . . . 0.0 109.595 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 13' ' ' ILE . 4.0 p -79.89 -14.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.559 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.596 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.0 OUTLIER -72.39 152.16 92.03 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.73 150.3 86.27 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 123.505 1.266 . . . . 0.0 111.132 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -74.25 -22.07 59.49 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.642 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.24 -57.31 3.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.436 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 3.4 ttt-85 -60.38 -29.49 68.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.482 HD13 ' CG1' ' A' ' 147' ' ' VAL . 4.3 tp -74.28 -42.19 59.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 42.4 t80 -59.52 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 110.166 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.0 ttpt -53.49 -45.29 69.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 17' ' ' ARG . . . -70.83 -28.6 64.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.868 . . . . 0.0 110.588 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 42.1 t80 -92.03 -17.55 24.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.915 . . . . 0.0 110.486 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.558 HG12 ' CD2' ' A' ' 81' ' ' TYR . 1.6 mt -117.64 -63.55 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -48.14 -47.89 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 110.265 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.1 m-20 -107.15 -12.03 15.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 30' ' ' PHE . . . -41.8 -30.49 0.64 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.63 -59.49 4.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -1.179 . . . . 0.0 110.048 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -87.89 -17.26 31.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.1 tp -75.72 -45.39 36.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 110.131 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 26' ' ' GLY . 1.6 m-85 -43.46 -57.72 5.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 110.457 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.2 Cg_endo -70.05 -8.91 24.77 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.914 1.481 . . . . 0.0 110.608 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 29' ' ' LEU . 6.0 ttmm -95.57 -46.2 6.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.91 -8.11 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.381 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.09 81.05 3.35 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.82 -6.32 18.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.975 1.513 . . . . 0.0 110.298 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.18 -18.43 27.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.269 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -97.39 -71.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -99.69 152.58 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.546 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.414 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -114.39 -33.15 5.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.537 -179.675 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.07 146.79 6.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.089 -1.007 . . . . 0.0 110.596 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.47 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 47.5 t -133.5 139.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 84.6 tt0 -152.48 158.74 43.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.441 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.49 117.88 35.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 110.377 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.422 ' HA ' HD11 ' A' ' 44' ' ' ILE . 21.6 mm -83.16 -38.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.301 1.048 . . . . 0.0 108.335 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.568 ' HG3' ' N ' ' A' ' 46' ' ' GLY . 25.3 tp10 -148.25 173.55 12.9 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.099 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.568 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 63.41 169.62 1.35 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -116.25 37.34 3.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 110.09 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.06 37.52 9.95 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -111.42 -168.62 18.64 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.48 100.86 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.858 1.452 . . . . 0.0 110.243 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' O ' HD12 ' A' ' 53' ' ' ILE . . . 111.39 1.32 27.91 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.1 m -61.12 155.81 19.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -1.117 . . . . 0.0 109.5 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 11.7 mm -112.94 133.14 59.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.943 . . . . 0.0 109.775 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.507 ' CG ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -145.34 144.5 30.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.102 -0.999 . . . . 0.0 110.285 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -92.83 112.67 24.7 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.619 -0.676 . . . . 0.0 110.608 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.507 HD12 ' CG ' ' A' ' 54' ' ' LYS . 38.8 mm -103.85 138.77 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 109.347 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.45 141.67 47.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 110.757 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 1.9 m-85 -116.67 135.03 22.85 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.94 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo -75.4 135.4 18.32 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.93 1.49 . . . . 0.0 110.784 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 51.53 178.06 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 0.0 110.682 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 104.09 79.67 1.35 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CG ' ' CD ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 42.27 -164.43 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.367 -1.078 . . . . 0.0 109.686 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.637 ' CD ' ' CG ' ' A' ' 62' ' ' PHE . 45.4 Cg_endo -80.37 -32.38 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.228 1.12 . . . . 0.0 110.285 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 21.8 p90 -90.56 128.51 36.59 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.228 -0.92 . . . . 0.0 109.956 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 58' ' ' PHE . 1.5 pttp -161.6 -41.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 110.392 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.487 ' O ' ' CB ' ' A' ' 67' ' ' VAL . 6.7 p90 -80.73 -175.33 5.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 110.085 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.572 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER 168.81 171.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.367 -0.833 . . . . 0.0 110.586 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.572 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -106.03 54.36 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.642 -0.662 . . . . 0.0 109.938 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.463 ' OD2' HG21 ' A' ' 85' ' ' VAL . 5.2 m-20 -41.83 129.41 3.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.338 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -98.14 150.65 21.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 108.896 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.551 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.3 t -81.03 144.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.71 -1.243 . . . . 0.0 110.219 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 36.3 t0 -98.42 -71.0 0.7 Allowed 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.367 0.603 . . . . 0.0 110.004 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -143.84 113.01 6.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 0.0 110.047 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 4.9 t -104.17 136.21 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.267 -0.896 . . . . 0.0 109.932 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 74' ' ' VAL . 83.4 m-20 -141.07 113.03 7.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -82.51 -3.02 55.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -110.42 -36.68 5.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.201 -0.937 . . . . 0.0 109.653 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.39 15.24 20.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.549 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 m-30 45.86 51.97 10.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 110.34 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -129.21 124.54 34.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.973 -1.079 . . . . 0.0 110.751 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.558 ' CD2' HG12 ' A' ' 23' ' ' ILE . 2.2 t80 -139.44 101.6 4.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.421 -0.799 . . . . 0.0 109.861 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.506 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 74.0 m-20 -113.87 136.04 53.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.0 p90 -134.71 133.04 39.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.582 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' ARG . 68.3 m -99.41 170.58 8.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 111.433 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.463 HG21 ' OD2' ' A' ' 69' ' ' ASP . 48.9 t -106.71 131.27 56.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.39 -79.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.899 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 68' ' ' LYS . 1.1 tt0 -91.87 106.52 18.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.941 -1.099 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 164.13 175.74 35.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 47.27 -159.81 0.41 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.92 -7.76 21.7 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.135 1.597 . . . . 0.0 110.691 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 91' ' ' ILE . 47.7 mt -51.55 154.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.35 -58.1 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -121.33 -69.2 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.252 . . . . 0.0 110.645 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 t -147.31 9.14 0.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 0.0 110.748 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.7 155.74 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 0.0 110.091 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 57.84 36.33 26.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -78.82 159.35 27.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 110.408 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.479 HG13 ' CD1' ' A' ' 120' ' ' TYR . 2.3 mt -139.82 137.69 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.528 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 m -123.46 112.72 17.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.33 -0.856 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 13.7 m120 -99.39 130.03 45.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.506 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 2.6 mt-10 -123.76 139.74 53.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.852 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 102' ' ' ILE . 16.9 mt -135.59 114.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.369 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -114.53 124.22 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.862 . . . . 0.0 109.878 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.49 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 4.3 mp -111.92 134.79 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.416 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -140.58 137.94 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 0.0 110.417 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.0 146.62 25.41 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.78 -0.575 . . . . 0.0 110.968 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.593 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.5 p -84.92 -164.9 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.352 -0.843 . . . . 0.0 108.957 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 46.1 Cg_endo -80.05 70.12 7.65 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.267 1.14 . . . . 0.0 110.247 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 0.7 OUTLIER 67.66 33.85 4.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.19 38.64 1.68 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 107' ' ' THR . . . 91.67 -161.91 27.49 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -137.34 166.38 23.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.477 -1.013 . . . . 0.0 111.13 -179.087 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.5 mt -118.86 126.0 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 109.103 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.12 146.08 25.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 0.0 110.863 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 13.4 mttt -141.58 109.97 5.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.525 -0.734 . . . . 0.0 109.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 101' ' ' GLU . 19.0 mt -105.92 135.45 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.6 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.519 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -116.7 115.78 26.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.129 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -103.88 126.1 50.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.392 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -115.5 130.14 56.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.316 -0.865 . . . . 0.0 109.959 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.479 ' CD1' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -116.72 117.21 29.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.453 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.459 ' ND1' HG23 ' A' ' 2' ' ' VAL . 25.3 m-70 -94.26 130.64 40.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.457 ' CG2' HG22 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -114.96 169.24 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 110.088 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' ASP . 0.7 OUTLIER -101.39 63.99 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 48.45 -91.32 0.01 OUTLIER Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -40.34 -55.55 2.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -1.104 . . . . 0.0 110.576 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.453 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 77.2 m-70 -66.29 176.8 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 0.0 110.435 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 126' ' ' HIS . 72.1 mt-10 -154.44 -171.93 4.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 110.17 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.483 ' HB ' ' CD2' ' A' ' 3' ' ' PHE . 2.3 t -121.14 116.11 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -80.16 132.4 35.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.731 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.96 -48.41 52.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 110.913 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.9 mt-10 -36.98 -55.97 0.9 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 110.907 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.48 77.05 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 130' ' ' ALA . 7.2 t -74.68 -48.3 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 109.315 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -67.42 -30.22 69.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.531 -0.73 . . . . 0.0 109.824 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.54 60.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -35.1 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -79.74 -23.93 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.23 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -53.86 -52.81 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 4.6 mt -75.15 -28.75 60.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.468 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -55.49 -46.57 80.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 33.5 tt0 -56.34 -52.53 64.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -1.205 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.3 m -57.61 -28.86 64.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.201 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.511 HD23 ' CB ' ' A' ' 37' ' ' ALA . 84.7 mt -69.48 -46.08 67.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 110.358 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.1 pp -68.77 -26.13 65.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.779 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.461 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -81.93 -41.0 21.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -56.1 -50.37 71.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.37 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.482 ' CG1' HD13 ' A' ' 18' ' ' LEU . 3.6 t -62.4 -48.84 86.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.475 -0.765 . . . . 0.0 108.954 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 36.5 tt0 -53.03 -46.83 68.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.8 t -67.43 -51.27 53.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 1.8 t80 -44.9 -69.38 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.809 . . . . 0.0 110.392 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.9 mt -49.17 -37.1 21.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.503 -0.748 . . . . 0.0 110.629 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.2 mt -77.1 -18.84 57.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.048 -1.033 . . . . 0.0 110.373 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.56 -12.35 17.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.935 . . . . 0.0 110.071 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.432 ' CD2' ' O ' ' A' ' 154' ' ' HIS . 17.8 t60 -119.69 102.54 8.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 110.205 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 40.8 t -115.07 3.54 14.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.246 -0.909 . . . . 0.0 110.563 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.06 -70.42 0.15 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.487 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.39 -162.33 1.31 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.602 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -85.04 8.42 17.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -0.842 . . . . 0.0 110.312 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.573 HG22 ' CG ' ' A' ' 121' ' ' HIS . 9.3 p -176.44 154.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -1.16 . . . . 0.0 110.466 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.513 ' N ' HG21 ' A' ' 2' ' ' VAL . 25.5 m-85 -101.89 -178.93 3.86 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.67 138.39 34.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.861 -1.149 . . . . 0.0 111.018 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -144.44 54.83 1.27 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 9.0 pt-20 -80.1 152.55 29.24 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.543 0.687 . . . . 0.0 110.962 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.74 172.72 13.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -157.84 153.54 26.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.402 ' OG1' HD13 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -144.03 -169.14 3.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 110.12 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -132.14 167.64 19.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.349 -0.845 . . . . 0.0 110.391 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.899 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 17.3 t -79.92 -17.25 12.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 17.8 mm -70.42 149.31 95.71 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.6 Cg_endo -65.72 146.75 84.68 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.143 1.075 . . . . 0.0 111.053 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 112' ' ' SER . . . -71.86 -30.13 65.11 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.45 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.54 -56.85 10.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.937 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -35.15 79.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -69.78 -38.31 76.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.485 -0.76 . . . . 0.0 109.418 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CZ ' ' O ' ' A' ' 75' ' ' ASP . 41.9 t80 -62.2 -59.1 5.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.895 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -49.76 -48.42 50.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 110.314 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.84 76.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.6 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.2 t80 -88.43 -14.01 39.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.614 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.512 HD12 ' CD2' ' A' ' 19' ' ' PHE . 1.3 mp -114.62 -48.9 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.95 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -72.12 -48.56 42.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 110.036 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' HB3' ' CD1' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -115.99 20.81 14.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.993 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.02 -58.18 14.97 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' HB3' HG13 ' A' ' 41' ' ' VAL . 21.8 m-20 -56.71 -19.08 14.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -1.174 . . . . 0.0 110.213 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.82 -37.03 10.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.9 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 3.9 mp -79.97 -20.84 44.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 0.0 110.163 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.518 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.1 m-85 -58.37 -57.03 29.33 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.552 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.7 Cg_endo -73.0 -13.62 26.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.054 1.555 . . . . 0.0 110.945 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.17 -43.38 11.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.989 . . . . 0.0 110.58 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 29' ' ' LEU . 26.8 m -89.68 -24.76 5.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 110.315 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HB2' HD22 ' A' ' 143' ' ' LEU . . . -150.36 78.84 7.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.48 -31.31 7.26 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.093 1.575 . . . . 0.0 110.63 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.37 -18.65 11.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.062 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.422 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . . . -96.83 -48.0 5.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.221 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -123.29 146.49 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 109.923 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.423 ' C ' ' OG ' ' A' ' 40' ' ' SER . 1.6 t -92.56 -53.05 4.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -162.32 172.51 15.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 0.0 110.634 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 27' ' ' ASP . 12.6 t -145.83 138.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.311 -0.868 . . . . 0.0 109.886 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mt-10 -137.62 163.89 30.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.723 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.7 116.56 32.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 44' ' ' ILE . 23.9 mm -83.63 -37.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.345 1.069 . . . . 0.0 108.372 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' A' ' 46' ' ' GLY . 6.1 tp10 -149.61 173.24 13.86 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.059 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 61.86 173.55 1.54 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -123.37 33.71 5.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 110.257 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.0 -7.01 60.33 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.94 -172.5 26.34 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 45.4 Cg_endo -71.72 118.35 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.939 1.494 . . . . 0.0 110.249 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.75 54.68 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.56 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.4 m -68.41 154.46 41.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -1.183 . . . . 0.0 109.348 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.526 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 9.3 mt -116.96 133.39 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.011 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 1.4 ptpt -143.28 147.54 34.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.661 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB2' HD13 ' A' ' 44' ' ' ILE . 12.7 tttp -105.35 118.27 36.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.688 -0.633 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.0 mt -107.26 147.83 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.082 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -107.25 139.49 41.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.127 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 14.7 m-85 -112.58 125.63 29.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 60' ' ' GLU . 50.1 Cg_endo -77.87 125.32 7.3 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.852 1.448 . . . . 0.0 110.557 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 1.7 tt0 171.25 -157.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.135 -0.978 . . . . 0.0 110.292 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -129.9 -8.09 3.52 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.773 -1.204 . . . . 0.0 110.351 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -44.94 171.79 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.033 -1.275 . . . . 0.0 110.551 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 39.5 Cg_endo -65.11 -48.12 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.386 1.203 . . . . 0.0 110.016 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.583 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 19.6 p90 -86.84 140.33 29.79 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.333 -0.855 . . . . 0.0 109.258 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -106.75 -75.67 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.996 -1.065 . . . . 0.0 110.993 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -91.7 -171.45 2.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.147 -0.971 . . . . 0.0 110.956 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -170.57 172.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 0.0 109.801 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.571 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.25 151.51 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.161 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 84' ' ' SER . 6.8 p-10 -148.41 135.39 20.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 110.357 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 84' ' ' SER . 14.6 ttp-105 -99.02 141.22 32.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.394 -0.816 . . . . 0.0 108.849 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.56 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 3.4 t -72.56 147.14 10.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.847 -1.158 . . . . 0.0 110.199 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 84' ' ' SER . 4.7 m-20 -93.04 -70.09 0.72 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.404 0.621 . . . . 0.0 109.98 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.5 tt0 -149.91 131.28 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.74 146.68 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.528 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 35.2 m-20 -145.63 119.98 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -88.9 0.19 56.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -116.67 -35.96 4.05 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.75 8.74 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.46 -0.775 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.512 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.5 m-30 53.62 69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 5.4 tttt -136.79 133.1 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.377 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.403 ' HB2' HG12 ' A' ' 23' ' ' ILE . 9.7 t80 -149.86 94.58 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.883 . . . . 0.0 110.071 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.524 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 33.2 m-20 -116.78 145.2 43.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.568 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 36.3 p90 -146.76 137.38 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 70' ' ' ARG . 62.2 m -98.78 170.83 8.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 111.232 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.538 HG13 ' CD1' ' A' ' 91' ' ' ILE . 41.5 t -108.35 127.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -116.96 -70.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 111.272 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -85.05 95.6 9.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.594 -1.316 . . . . 0.0 110.052 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -116.93 139.82 15.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.515 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.11 -57.12 2.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.2 Cg_endo -71.91 -38.34 4.17 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.922 1.485 . . . . 0.0 110.308 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.538 ' CD1' HG13 ' A' ' 85' ' ' VAL . 46.5 mt -68.16 170.53 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.503 ' N ' ' CG2' ' A' ' 91' ' ' ILE . . . -162.66 -77.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.92 -90.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -1.196 . . . . 0.0 110.297 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.1 t -146.94 18.39 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.2 164.76 12.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 110.105 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.92 34.43 22.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 121' ' ' HIS . 1.1 ttmt -76.42 150.95 36.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.233 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.651 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 56.2 mt -128.39 132.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 t -119.17 102.41 8.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.579 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.568 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 3.4 m120 -87.08 135.51 33.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.524 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 52.1 mt-10 -131.45 134.6 46.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 110.095 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.7 mt -128.33 126.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.031 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 15' ' ' ALA . 4.5 mp -134.45 141.09 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.752 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.5 t -141.9 144.16 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 109.546 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.06 162.7 16.64 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.395 -0.815 . . . . 0.0 111.09 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.5 p -108.86 -166.91 0.1 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.501 -0.749 . . . . 0.0 109.245 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 47.1 Cg_endo -80.45 70.02 7.7 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.413 1.217 . . . . 0.0 110.311 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 23.0 t0 67.32 40.87 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.39 -0.819 . . . . 0.0 110.186 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.92 40.77 1.11 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.477 ' O ' HG21 ' A' ' 107' ' ' THR . . . 86.54 -159.11 31.7 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.48 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -142.44 159.98 41.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.708 -0.878 . . . . 0.0 110.627 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.45 ' O ' HG21 ' A' ' 113' ' ' ILE . 19.7 tt -109.19 142.0 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.945 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 116' ' ' ILE . 1.0 OUTLIER -121.72 150.49 41.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 110.181 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.15 124.29 18.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 2.4 mt -111.19 117.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -102.05 111.8 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.33 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.05 123.49 47.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.121 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.56 151.54 35.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.354 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.651 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -131.6 99.72 4.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.834 . . . . 0.0 110.193 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.573 ' CG ' HG22 ' A' ' 2' ' ' VAL . 85.5 m-70 -79.8 113.69 18.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.37 172.47 6.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.979 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -145.5 -177.03 5.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.604 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 43.25 -153.14 0.27 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.22 9.12 21.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -1.116 . . . . 0.0 110.245 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -76.68 167.74 21.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 110.131 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.424 ' HA ' HG23 ' A' ' 122' ' ' THR . 4.1 mt-10 -152.95 -168.97 3.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -0.96 . . . . 0.0 110.429 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.563 HG12 ' CD2' ' A' ' 120' ' ' TYR . 2.8 t -116.08 101.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -54.75 125.19 19.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.027 -1.045 . . . . 0.0 109.501 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -53.16 -48.06 68.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 110.396 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.1 mt-10 -35.63 -55.22 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.58 -0.7 . . . . 0.0 110.661 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -42.35 92.85 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 108.998 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 130' ' ' ALA . 14.1 t -68.03 -48.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.248 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -59.86 -31.46 69.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.529 -0.732 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.89 -47.72 61.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -24.08 67.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.173 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.44 -36.09 45.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.88 . . . . 0.0 110.184 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -44.67 83.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.12 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 37' ' ' ALA . 3.1 mp -73.47 -31.54 63.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 110.019 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -65.72 -41.1 96.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.4 mm-40 -56.67 -37.05 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -1.203 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.8 m -70.15 -18.86 63.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 98.0 mt -77.13 -44.82 28.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 0.0 109.896 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.6 pp -66.93 -29.94 69.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.459 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 17.2 ttp180 -77.64 -36.4 51.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.765 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.12 67.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.785 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.0 t -60.23 -47.26 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.444 -0.785 . . . . 0.0 109.781 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 35.8 tt0 -51.64 -48.91 63.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 -43.67 85.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.948 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -52.03 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.159 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.487 ' CD1' HG23 ' A' ' 13' ' ' ILE . 35.5 mt -42.62 -51.82 5.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -48.72 -25.21 1.69 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.074 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . -105.87 1.74 27.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.33 -55.36 3.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.153 -0.967 . . . . 0.0 110.132 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.4 m -130.28 11.72 5.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 110.061 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.64 26.69 9.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -172.4 -83.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.908 . . . . 0.0 110.177 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.4 t80 52.28 84.98 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.169 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.23 -179.933 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 3.3 t 58.11 151.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -1.08 . . . . 0.0 110.333 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.553 ' CD1' HG13 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -106.54 161.93 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.949 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.79 139.21 50.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.942 . . . . 0.0 110.156 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.564 ' CE2' HG12 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -146.84 56.21 1.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.025 179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 7' ' ' THR . 0.3 OUTLIER -82.83 153.7 25.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.38 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 6' ' ' GLU . 1.4 p -156.14 169.06 25.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.814 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 15.2 pt-20 -158.8 138.37 11.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 110.619 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 t -133.15 -172.6 2.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.316 -0.865 . . . . 0.0 109.928 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -117.97 159.52 23.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.7 t -152.67 136.75 16.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.689 -0.632 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.96 -12.17 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.017 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 41.2 mm -69.86 148.4 96.39 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.0 Cg_endo -65.58 151.23 85.37 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.503 1.265 . . . . 0.0 111.007 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.68 -29.16 61.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.035 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.6 -48.46 16.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.287 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.481 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -68.14 -37.54 81.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.994 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' CD1' HG13 ' A' ' 147' ' ' VAL . 25.7 tp -74.79 -26.24 59.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.185 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.539 ' CE1' HG13 ' A' ' 23' ' ' ILE . 75.2 t80 -69.69 -59.69 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 110.046 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -57.18 -39.95 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.387 -0.821 . . . . 0.0 110.128 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -72.54 -31.99 65.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.846 . . . . 0.0 110.546 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -91.9 -18.25 24.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.539 HG13 ' CE1' ' A' ' 19' ' ' PHE . 9.3 mm -104.06 -67.33 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.49 -27.54 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -109.38 -5.06 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.356 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.42 -56.54 24.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.98 -23.84 1.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 110.556 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -100.37 -39.79 7.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 110.305 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 1.9 tp -71.18 -38.01 72.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.0 m-30 -48.21 -61.02 3.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 110.55 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.0 Cg_endo -71.65 -2.09 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.972 1.512 . . . . 0.0 110.715 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -104.28 -36.11 7.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 110.469 -179.756 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.503 ' CG2' ' HB2' ' A' ' 146' ' ' ALA . 7.2 p -96.67 -26.08 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.959 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.24 78.61 8.58 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.78 2.75 6.16 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.117 1.588 . . . . 0.0 110.964 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.05 -38.36 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 110.481 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.55 -49.4 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.229 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.43 146.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.987 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.508 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -100.95 -32.3 10.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.212 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.5 168.11 2.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.601 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 t -138.51 141.27 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.598 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -144.62 110.94 5.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.067 -1.021 . . . . 0.0 110.757 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.6 116.89 5.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.214 -0.929 . . . . 0.0 110.419 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' ILE . 12.3 mt -84.97 -39.64 14.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 122.172 0.987 . . . . 0.0 108.556 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.543 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 22.3 tt0 -145.43 174.3 11.26 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 48.16 -172.32 0.05 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -124.64 -13.57 6.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -1.144 . . . . 0.0 110.22 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' GLY . . . 156.86 -23.02 0.47 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' GLY . . . -52.06 -174.77 0.03 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.3 Cg_endo -72.83 118.04 5.39 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.026 1.54 . . . . 0.0 110.381 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 -1.65 40.88 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.565 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 7.0 m -67.35 154.64 40.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.252 . . . . 0.0 109.226 179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' ILE . 9.9 mt -121.97 135.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 110.512 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -142.38 138.71 31.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.99 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -92.43 101.08 13.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.574 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.433 HD13 ' CG ' ' A' ' 69' ' ' ASP . 22.3 mt -88.97 129.09 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.533 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.1 m -93.24 141.22 28.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.473 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 1.2 m-85 -112.18 131.27 22.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.863 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 39' ' ' SER . 47.3 Cg_endo -73.01 127.41 12.11 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.874 1.46 . . . . 0.0 110.663 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER 177.28 -160.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.198 179.832 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -125.46 -30.92 0.87 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.519 ' O ' ' CD ' ' A' ' 65' ' ' LYS . 3.7 m-85 -47.16 170.98 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.203 -1.174 . . . . 0.0 110.002 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 44.1 Cg_endo -72.34 -59.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.948 1.499 . . . . 0.0 110.494 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -90.37 130.53 36.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.342 -0.849 . . . . 0.0 110.157 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' CD ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -149.07 -48.93 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.148 -0.97 . . . . 0.0 110.51 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.533 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 32.8 p90 -70.71 -178.65 1.91 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 0.0 110.207 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.574 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -170.35 172.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.191 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.574 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -121.25 62.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.477 -0.765 . . . . 0.0 110.468 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.433 ' CG ' HD13 ' A' ' 56' ' ' ILE . 7.4 p-10 -52.97 133.08 38.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.906 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -97.81 142.86 29.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.937 . . . . 0.0 108.716 179.491 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.565 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 3.5 t -69.73 149.56 10.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.645 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.3 t70 -101.29 -74.42 0.62 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.434 0.635 . . . . 0.0 110.044 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.2 tt0 -135.39 136.13 41.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.109 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 48' ' ' GLY . 2.8 t -120.78 147.32 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -152.57 101.32 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -75.14 -9.42 58.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.736 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -102.78 -34.09 9.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 108.638 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.75 11.26 39.15 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.342 0.591 . . . . 0.0 109.752 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 23.4 m-30 44.36 43.85 6.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 110.191 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 5.7 tttm -118.09 114.21 22.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.267 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 8.3 t80 -131.48 109.36 10.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 6.9 m120 -112.4 145.97 39.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 110.031 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.576 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 3.6 p90 -137.74 138.26 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.811 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' ARG . 7.0 m -98.82 159.58 14.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.177 -0.952 . . . . 0.0 110.858 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 91' ' ' ILE . 24.7 t -104.19 122.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -121.92 -76.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.085 -1.009 . . . . 0.0 110.953 -178.561 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 16.0 mm-40 -70.49 57.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.753 -1.217 . . . . 0.0 109.996 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -69.54 126.8 19.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.502 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.83 -54.1 3.62 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.2 Cg_endo -75.99 -40.99 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.875 1.46 . . . . 0.0 110.594 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 85' ' ' VAL . 36.0 mt -50.98 138.37 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.076 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.55 -94.55 1.83 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.82 -80.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 110.171 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.03 19.79 2.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 110.065 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.67 165.51 12.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.227 -0.92 . . . . 0.0 110.245 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.468 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 3.2 tp10 56.35 33.17 21.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 8.8 tttm -67.84 167.34 13.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.565 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.1 mt -143.93 127.86 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.42 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.468 ' HB3' ' CB ' ' A' ' 119' ' ' LYS . 12.9 t -115.1 112.31 22.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.576 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -105.85 152.39 23.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.873 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 30.9 mt-10 -145.24 129.27 17.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.785 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.44 ' HA ' HD11 ' A' ' 102' ' ' ILE . 19.5 mm -122.26 128.95 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.03 -1.044 . . . . 0.0 110.384 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 4.9 tttt -129.63 117.24 20.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 110.038 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.541 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 64.4 mt -110.66 109.2 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 110.72 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 106' ' ' ALA . 42.1 t -115.47 151.03 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.748 0.785 . . . . 0.0 109.595 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.531 ' N ' HG11 ' A' ' 105' ' ' VAL . . . -88.05 168.38 12.87 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.642 -0.662 . . . . 0.0 110.867 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 7.7 p -124.21 167.81 14.56 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 45.5 Cg_endo -71.11 -6.0 18.25 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.784 1.412 . . . . 0.0 110.258 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.48 -17.84 25.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.381 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 121.25 -27.93 6.21 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -90.63 -169.73 43.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -134.49 162.85 31.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 110.743 -179.496 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.467 ' CD1' HG21 ' A' ' 107' ' ' THR . 5.2 mt -110.37 117.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.396 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 21.6 mt -87.76 129.18 35.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.913 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 104.76 9.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 4.1 mp -105.04 122.27 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.094 -1.004 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.5 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -105.95 120.95 43.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.473 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.423 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -114.93 139.02 50.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.236 -179.784 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER -132.55 142.2 49.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -121.21 133.07 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.044 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.534 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 59.9 m-70 -111.57 129.41 56.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.23 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.521 ' CG2' ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.95 173.47 6.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.425 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' GLY . 3.4 tttt -136.47 -172.29 3.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.331 -0.856 . . . . 0.0 110.203 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 43.9 -134.95 5.78 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.92 -0.82 12.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -1.126 . . . . 0.0 110.303 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 0.4 OUTLIER -78.6 -166.8 0.93 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.99 179.885 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.521 ' HA ' ' CG2' ' A' ' 122' ' ' THR . 38.6 mt-10 -153.43 179.47 8.76 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 109.299 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.557 HG22 ' CD2' ' A' ' 120' ' ' TYR . 1.8 p -79.97 137.38 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.572 -0.705 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 126.71 31.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.611 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . . . -65.92 -57.24 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.931 -1.106 . . . . 0.0 111.249 -178.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -40.95 -26.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.889 -1.132 . . . . 0.0 110.143 -179.273 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -84.68 -42.88 14.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.175 -0.953 . . . . 0.0 109.164 178.509 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.611 ' CG1' ' HA ' ' A' ' 130' ' ' ALA . 8.0 p -78.98 -33.77 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.339 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' N ' HG11 ' A' ' 133' ' ' VAL . 2.9 ttpp -70.56 -23.6 62.63 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.242 -0.911 . . . . 0.0 109.277 178.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 131' ' ' GLU . . . -73.29 -20.9 60.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.829 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.7 t -71.94 -29.87 64.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 110.19 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -78.04 -47.15 19.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -45.95 -61.17 1.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -14.49 61.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -64.18 -54.41 30.25 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.535 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.4 tt0 -47.72 -36.95 12.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 100.0 m -66.8 -25.36 66.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.717 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 36.6 mt -74.75 -52.24 12.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.632 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.3 pp -66.79 -29.3 69.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.942 . . . . 0.0 109.657 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.423 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 11.0 tpt180 -78.0 -28.88 49.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -0.877 . . . . 0.0 109.511 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.503 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -68.83 -36.7 78.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.823 . . . . 0.0 109.732 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.489 HG13 ' CD1' ' A' ' 18' ' ' LEU . 40.2 t -73.09 -48.51 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.389 -0.82 . . . . 0.0 109.715 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.409 ' HA ' HG13 ' A' ' 13' ' ' ILE . 5.6 tt0 -53.4 -49.67 66.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 152' ' ' LEU . 0.9 OUTLIER -60.45 -45.39 93.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.684 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.534 ' CE2' ' CE1' ' A' ' 154' ' ' HIS . 1.3 t80 -48.31 -72.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 110.035 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.19 -36.12 5.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.421 ' HB3' ' O ' ' A' ' 149' ' ' SER . 16.1 tp -62.74 -55.71 24.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -81.44 1.72 31.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.534 ' CE1' ' CE2' ' A' ' 150' ' ' TYR . 3.8 m-70 -104.45 98.62 8.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.47 80.57 1.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 110.062 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -72.23 -22.79 61.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 110.166 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.97 -173.58 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 110.305 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.542 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 75.9 t80 -99.4 5.67 46.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.375 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.291 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.502 HG23 ' CG ' ' A' ' 121' ' ' HIS . 2.7 t -79.59 152.96 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -1.125 . . . . 0.0 110.329 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -97.0 163.8 12.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.724 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -133.78 144.95 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 110.678 -179.662 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CD1' HG13 ' A' ' 133' ' ' VAL . 48.4 m-85 -154.85 56.44 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -0.771 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.535 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 2.2 pp20? -86.91 137.09 32.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 110.837 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -140.11 -175.66 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.674 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.28 152.16 25.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.056 -1.027 . . . . 0.0 110.589 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -135.35 -179.17 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 0.0 109.81 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 1.5 p -127.3 161.25 29.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.66 141.89 17.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.518 -0.739 . . . . 0.0 109.636 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.83 -12.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.32 -0.952 . . . . 0.0 108.559 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.626 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 1.3 mp -71.07 152.01 94.82 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.13 152.02 82.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.475 1.25 . . . . 0.0 110.886 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB1' ' CB ' ' A' ' 106' ' ' ALA . . . -76.86 -27.59 55.12 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.904 -178.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.22 -50.23 16.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.046 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -63.49 -43.15 98.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.785 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.73 -33.84 76.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.379 -0.825 . . . . 0.0 109.948 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 76' ' ' HIS . 37.2 t80 -61.57 -64.89 0.8 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 12.0 mttt -48.13 -47.25 34.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.482 -0.761 . . . . 0.0 110.39 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.47 78.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.317 -0.864 . . . . 0.0 111.012 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -90.08 -10.1 45.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 110.65 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -115.02 -60.19 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 109.932 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 15.1 mt -68.29 -48.97 63.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.111 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.71 20.7 18.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.033 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.42 -60.9 5.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.01 -24.66 10.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 0.0 110.218 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -84.67 -46.57 11.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.522 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.483 HD22 ' CG1' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -73.88 -28.22 61.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.478 -179.739 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.526 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m-30 -49.38 -57.47 11.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.456 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 45.6 Cg_endo -72.02 -7.61 21.36 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.987 1.52 . . . . 0.0 110.728 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -101.58 -54.43 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.344 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG1' HD22 ' A' ' 29' ' ' LEU . 5.5 m -80.31 -13.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 110.528 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.69 71.84 12.64 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 0.0 110.08 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.51 0.37 9.19 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.047 1.551 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.94 -20.08 19.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' O ' ' CD1' ' A' ' 58' ' ' PHE . . . -102.18 -38.9 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.82 136.8 53.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.65 -47.17 6.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.84 140.06 3.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.29 125.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 11.8 mt-10 -115.0 89.27 3.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 110.728 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 54' ' ' LYS . 10.9 t-20 -54.17 116.76 2.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.3 mm -87.75 -38.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.271 1.034 . . . . 0.0 108.574 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 24.4 tt0 -151.66 174.05 13.95 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.449 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 63.79 159.92 0.3 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -106.19 29.62 6.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.399 -1.059 . . . . 0.0 110.192 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 52' ' ' THR . . . 96.16 -0.46 62.13 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.3 -161.96 22.78 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.0 Cg_endo -73.54 120.52 6.52 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.981 1.516 . . . . 0.0 110.551 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.02 1.3 61.41 Favored Glycine 0 N--CA 1.48 1.606 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.561 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 1.2 m -67.21 152.93 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -1.191 . . . . 0.0 109.435 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.443 ' C ' ' HG3' ' A' ' 54' ' ' LYS . 8.6 mt -124.56 131.38 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.48 -179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -143.89 134.76 25.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 179.471 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 2.2 ttpt -82.17 98.65 8.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.7 mt -85.95 132.55 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.696 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.5 OUTLIER -109.43 145.67 35.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 110.795 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 5.9 m-85 -109.46 140.72 22.37 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 109.987 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.28 133.31 19.14 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.542 . . . . 0.0 110.756 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.35 158.16 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 110.449 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 114.71 81.27 0.97 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 41.92 -166.04 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 121.385 -1.067 . . . . 0.0 109.885 179.436 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.622 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 46.9 Cg_endo -83.21 -44.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.393 1.207 . . . . 0.0 110.069 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -89.72 136.22 33.16 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.891 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' CG ' ' HB2' ' A' ' 58' ' ' PHE . 4.2 tptp -171.14 -40.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.182 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 3.4 p90 -54.22 177.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 4.3 m -160.54 164.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 110.503 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -109.63 40.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 109.848 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 7.7 t70 -38.76 130.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.486 -0.759 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ttp-105 -103.96 151.42 23.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.077 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.561 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 2.6 t -78.44 147.71 6.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 84' ' ' SER . 10.3 m-20 -97.4 -72.38 0.65 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.452 0.644 . . . . 0.0 110.431 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.9 tt0 -138.52 136.62 36.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.578 -0.701 . . . . 0.0 110.129 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.8 t -125.07 125.35 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.919 . . . . 0.0 109.995 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -123.85 127.89 48.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 109.885 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.2 t60 -86.27 -20.02 29.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 0.0 111.075 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -106.19 -37.81 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.995 -1.066 . . . . 0.0 109.897 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -85.81 13.42 7.34 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.475 -0.766 . . . . 0.0 110.198 179.999 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 42.31 61.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.918 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -128.21 118.15 22.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 110.921 -179.329 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 52.7 t80 -133.83 98.03 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 32.3 m-20 -112.76 142.84 44.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 110.289 -179.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 10.9 p90 -142.2 138.43 31.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.342 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 35.6 m -104.45 165.12 11.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.082 -1.011 . . . . 0.0 111.062 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.544 HG13 ' CD1' ' A' ' 91' ' ' ILE . 47.2 t -108.42 127.36 64.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.63 -74.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 111.388 -178.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 2.3 mt-10 -82.8 97.87 8.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.828 -1.17 . . . . 0.0 110.227 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.415 ' HA2' HG11 ' A' ' 67' ' ' VAL . . . -128.48 155.5 20.5 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.526 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -45.38 -56.68 6.13 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -70.59 -41.44 3.22 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.866 1.456 . . . . 0.0 110.84 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.544 ' CD1' HG13 ' A' ' 85' ' ' VAL . 77.4 mt -77.46 165.32 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.196 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -148.18 -52.56 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.31 -83.08 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.373 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.9 t -143.06 11.15 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.22 151.04 22.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.262 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.525 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 7.7 tt0 55.83 35.07 24.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.764 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 6.2 tttt -75.44 158.3 32.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.39 -0.819 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.58 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.2 mt -135.71 131.1 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -0.99 . . . . 0.0 110.662 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 m -116.18 109.95 18.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 0.0 109.527 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.58 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 3.0 m120 -99.56 138.41 36.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.454 ' HG3' ' HB3' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -128.94 131.62 47.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.822 179.593 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.468 HD13 HG22 ' A' ' 116' ' ' ILE . 40.3 mm -122.15 119.15 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -122.11 109.26 14.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.096 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 1.9 mp -94.92 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.2 132.31 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.309 -0.87 . . . . 0.0 110.248 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.06 145.39 25.99 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.418 0.627 . . . . 0.0 110.969 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.583 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 2.6 p -80.1 -163.5 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 45.9 Cg_endo -78.45 -23.53 8.51 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.106 1.056 . . . . 0.0 111.024 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 0.4 OUTLIER 174.42 33.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.016 -1.052 . . . . 0.0 110.156 179.98 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.62 35.41 2.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 107' ' ' THR . . . 94.97 -153.86 20.99 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -137.26 169.05 18.43 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.666 -0.902 . . . . 0.0 110.444 -179.414 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 23.0 mt -123.63 133.96 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 179.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.486 ' CD2' HG22 ' A' ' 104' ' ' ILE . 25.5 mt -97.9 142.37 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.81 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -127.86 97.16 4.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.316 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.468 HG22 HD13 ' A' ' 102' ' ' ILE . 3.0 mt -94.34 115.98 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.732 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.535 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 38.4 t -104.58 108.3 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.464 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 4.3 t-20 -101.36 149.52 23.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.226 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 141.04 38.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.013 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.58 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -117.72 122.16 42.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.814 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.525 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 25.2 m-70 -105.23 110.14 22.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.99 167.95 14.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.523 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -102.31 152.75 20.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.115 179.842 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.04 -40.12 3.18 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.73 -66.98 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -1.16 . . . . 0.0 110.176 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.49 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 10.9 m170 -69.24 169.95 11.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.49 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 0.2 OUTLIER -159.98 137.9 9.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 109.581 179.857 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 128' ' ' VAL . 3.3 p -108.27 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.396 -0.815 . . . . 0.0 111.062 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.1 142.1 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.953 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 131' ' ' GLU . . . -52.59 -26.86 14.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.093 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.5 mm-40 -42.39 -58.33 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.716 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -59.85 -34.08 72.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 108.978 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.571 HG13 ' CD1' ' A' ' 5' ' ' TYR . 15.7 t -67.11 -49.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.447 -0.783 . . . . 0.0 109.259 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.494 ' HE2' ' NZ ' ' A' ' 137' ' ' LYS . 2.3 mmtt -50.74 -35.36 31.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -23.85 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.6 t -70.9 -37.47 72.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.117 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.494 ' NZ ' ' HE2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -75.77 -31.2 59.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 109.91 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.62 -47.25 80.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.88 -45.06 29.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.855 . . . . 0.0 110.311 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.55 -47.24 52.22 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -56.67 -30.46 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -1.204 . . . . 0.0 110.425 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.404 ' O ' ' HB1' ' A' ' 146' ' ' ALA . 90.4 m -70.73 -28.81 65.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.091 . . . . 0.0 109.653 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.4 mt -71.81 -48.69 44.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 109.867 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.481 ' C ' ' CD1' ' A' ' 144' ' ' LEU . 1.1 pp -63.55 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.418 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -75.05 -35.19 61.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.661 179.502 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -68.59 -29.22 67.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.56 -47.01 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.875 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -59.37 -46.8 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -43.45 98.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 110.148 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -54.43 -71.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 110.389 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 150' ' ' TYR . 34.0 mt -39.65 -49.91 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.468 -0.77 . . . . 0.0 110.592 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.65 -61.63 2.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.274 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -55.51 -37.58 68.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.78 92.03 3.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.0 109.942 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -96.52 -21.64 17.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 110.645 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -106.1 20.16 19.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.99 . . . . 0.0 110.458 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.31 -170.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.168 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.45 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 0.1 OUTLIER -168.04 72.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 110.059 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 35.6 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t -109.22 154.87 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.355 -1.085 . . . . 0.0 110.091 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.52 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 0.7 OUTLIER -99.36 171.12 8.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 109.26 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.05 141.28 16.44 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.969 -1.082 . . . . 0.0 110.825 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CD2' ' CG1' ' A' ' 133' ' ' VAL . 8.3 m-85 -159.38 59.17 0.4 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.538 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 11.2 pt-20 -81.85 152.67 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.428 -0.795 . . . . 0.0 110.662 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.71 -175.92 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 109.91 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.69 157.73 30.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.081 -1.012 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 t -146.51 -179.1 6.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.102 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -116.81 160.82 20.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.254 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.07 137.03 11.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.85 -12.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 35.3 mm -68.6 148.49 98.08 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.51 150.43 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.38 1.2 . . . . 0.0 110.752 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB3' HG23 ' A' ' 104' ' ' ILE . . . -74.95 -25.62 59.01 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.29 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.39 -52.3 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 110.356 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 8.4 ttt-85 -63.45 -38.38 90.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.868 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.49 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 3.0 tm? -68.89 -34.35 75.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.967 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 45.9 t80 -64.11 -68.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 24' ' ' LEU . 8.7 tttt -45.84 -51.26 13.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.002 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.0 -38.77 79.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 110.054 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 15.1 t80 -84.72 -13.07 52.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.587 HD13 ' CG ' ' A' ' 81' ' ' TYR . 9.9 mm -118.9 -76.55 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.258 -0.901 . . . . 0.0 110.056 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' CB ' ' HG2' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -46.47 -56.3 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.033 179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -93.92 1.05 56.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 27' ' ' ASP . . . -46.91 -53.22 10.6 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 26' ' ' GLY . 3.3 p-10 -42.88 -29.94 0.36 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -1.134 . . . . 0.0 110.033 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 19.3 t30 -113.54 -11.36 13.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.003 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -83.63 -18.48 38.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.556 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.2 m-30 -75.43 -59.51 1.26 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.362 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.8 Cg_endo -71.19 -3.57 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.905 1.476 . . . . 0.0 110.492 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -91.97 -66.26 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.204 179.967 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.459 HG13 ' CG ' ' A' ' 150' ' ' TYR . 6.2 m -85.93 -11.13 11.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.426 -0.797 . . . . 0.0 110.312 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -143.05 61.39 10.35 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.932 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.23 -5.93 18.02 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.091 1.574 . . . . 0.0 110.584 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.72 -25.58 38.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB3' HD21 ' A' ' 139' ' ' LEU . . . -96.42 -55.99 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 110.311 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.453 ' CD1' ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -100.57 137.97 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.906 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.494 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -103.24 -33.33 9.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.1 OUTLIER -160.1 149.24 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.0 110.796 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.414 HG13 ' HE2' ' A' ' 54' ' ' LYS . 6.3 t -128.08 136.2 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 0.0 109.337 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 29.0 mt-10 -139.86 153.11 46.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.039 -1.038 . . . . 0.0 111.151 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.5 113.12 26.5 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.806 0.812 . . . . 0.0 109.636 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' ILE . 19.2 mm -82.97 -39.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 122.185 0.993 . . . . 0.0 108.989 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 46' ' ' GLY . 7.9 tp10 -153.58 173.04 16.28 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 110.464 -179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.56 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 71.81 171.0 14.14 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -109.74 35.71 3.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.377 -1.072 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.25 6.57 87.79 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.85 -159.44 35.03 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.61 131.05 16.76 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.12 1.59 . . . . 0.0 110.476 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 -9.46 76.97 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.55 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 22.2 m -60.85 153.62 24.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.068 -1.254 . . . . 0.0 109.496 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' ILE . 6.8 mt -116.25 125.62 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -135.47 146.67 48.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 110.265 -179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HB2' HD13 ' A' ' 44' ' ' ILE . 30.5 ttpt -97.61 132.98 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.33 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.48 144.18 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.471 ' HB2' ' OG ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -114.56 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.124 -0.985 . . . . 0.0 110.221 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -121.18 133.4 24.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 48.7 Cg_endo -75.31 144.09 28.87 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.99 1.521 . . . . 0.0 110.487 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 50.01 -166.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.108 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 88.79 78.91 1.3 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.602 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 43.11 -167.94 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.375 -1.073 . . . . 0.0 109.873 179.368 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 45.6 Cg_endo -75.62 -41.13 0.61 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.264 1.139 . . . . 0.0 110.278 -179.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.1 m-85 -89.53 129.16 36.05 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 109.634 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -152.04 -46.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 110.13 -179.812 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' O ' HG11 ' A' ' 67' ' ' VAL . 1.9 p90 -65.38 140.64 58.67 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 110.029 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 66' ' ' TYR . 9.2 m -144.11 172.36 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.334 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -116.32 139.2 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.876 179.716 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 84' ' ' SER . 5.0 p-10 -133.2 133.47 42.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.0 ttm180 -96.26 146.42 24.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.55 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 3.4 t -73.94 145.12 11.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.836 -1.165 . . . . 0.0 110.404 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -94.07 -70.61 0.7 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.466 0.65 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -148.91 124.3 10.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 0.0 109.801 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 3.3 t -112.85 149.28 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.19 -0.944 . . . . 0.0 110.445 -179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 3.8 t0 -149.09 97.74 2.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -64.4 -7.92 11.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.895 -179.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -108.28 -46.22 3.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.016 -1.052 . . . . 0.0 109.765 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.36 13.54 4.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.735 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.564 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.7 m-30 47.42 50.87 14.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.059 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 6.3 tttt -123.77 117.28 24.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.993 -1.067 . . . . 0.0 110.779 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.587 ' CG ' HD13 ' A' ' 23' ' ' ILE . 17.3 t80 -134.44 103.75 5.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.344 -0.848 . . . . 0.0 109.779 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 31.2 m-20 -118.14 144.42 45.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.222 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 26.5 p90 -144.63 136.24 25.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' ARG . 74.5 m -96.77 171.09 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 111.209 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 91' ' ' ILE . 41.6 t -108.95 125.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.409 HG13 ' H ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -116.75 -70.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.021 -1.049 . . . . 0.0 111.648 -178.577 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -89.16 98.82 11.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.543 -1.348 . . . . 0.0 110.375 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -116.55 151.71 18.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.51 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.98 -57.69 4.65 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.8 Cg_endo -74.0 -47.68 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.976 1.514 . . . . 0.0 110.953 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.45 ' CD1' HG13 ' A' ' 85' ' ' VAL . 89.7 mt -55.28 157.75 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.004 . . . . 0.0 110.085 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.97 -71.54 0.19 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -111.38 -58.39 2.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -1.221 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.6 t -152.21 15.65 0.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.962 . . . . 0.0 110.538 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 123' ' ' LYS . 16.9 mt -91.28 147.86 22.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HA ' HG21 ' A' ' 122' ' ' THR . 4.9 mt-10 59.3 31.5 21.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 121' ' ' HIS . 4.6 mttt -70.55 151.36 45.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.591 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 4.5 mp -127.54 134.37 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.647 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.29 106.21 13.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.34 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 1.8 m120 -95.12 150.14 20.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.73 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 3.2 mp0 -143.18 142.06 31.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.772 . . . . 0.0 109.706 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.6 mt -138.6 119.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 110.567 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -118.15 121.87 41.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.58 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 44.8 mt -108.84 118.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.368 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -122.9 152.6 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.402 -0.811 . . . . 0.0 109.774 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -87.98 166.35 14.55 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.633 -0.667 . . . . 0.0 111.121 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 16.5 p -116.53 167.18 10.99 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.369 -0.832 . . . . 0.0 109.73 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 45.0 Cg_endo -71.59 -2.08 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.641 1.337 . . . . 0.0 110.612 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.37 -10.27 19.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.317 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.03 -35.64 3.85 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -77.22 -166.99 27.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.491 ' HB3' ' HA ' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -141.17 163.65 32.38 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -1.069 . . . . 0.0 110.596 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.438 HG13 HG23 ' A' ' 107' ' ' THR . 78.9 mt -112.31 124.41 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.782 . . . . 0.0 109.166 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 130.64 42.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.982 . . . . 0.0 110.827 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -121.23 114.87 22.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.544 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -105.62 128.33 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.531 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -111.55 110.36 20.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 110.03 179.761 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.74 135.89 45.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.171 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.37 137.35 45.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 110.212 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.591 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -112.33 144.73 41.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.872 . . . . 0.0 110.036 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 97' ' ' LYS . 31.8 m-70 -127.15 106.36 9.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 110.233 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -121.63 166.59 14.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.489 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -86.93 153.12 21.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.977 . . . . 0.0 110.61 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -47.75 -25.36 3.44 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.17 -50.83 6.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -1.196 . . . . 0.0 110.125 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -78.69 176.66 9.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.147 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -160.08 160.38 33.02 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.4 p -113.92 93.48 2.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.811 -0.555 . . . . 0.0 110.627 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.98 146.66 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.043 . . . . 0.0 109.799 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.424 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -62.48 -12.71 23.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -48.14 -69.94 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.973 -1.079 . . . . 0.0 109.861 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 136' ' ' SER . 0.8 OUTLIER -54.8 -27.49 42.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.516 179.598 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.593 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 16.1 t -71.07 -47.28 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 134' ' ' LYS . 22.8 ttpt -67.76 -31.8 71.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.089 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' O ' HD11 ' A' ' 139' ' ' LEU . . . -73.7 -39.04 64.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.786 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -67.23 -27.36 67.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -73.07 -42.15 63.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.91 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -63.8 -44.36 93.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -71.3 -33.16 69.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -55.36 -55.5 28.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.1 tm-20 -54.86 -44.96 74.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -1.154 . . . . 0.0 109.923 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 m -57.4 -32.77 67.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.831 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 43.9 mt -69.93 -53.4 18.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.022 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 4.6 pp -72.03 -22.33 61.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.159 -0.963 . . . . 0.0 109.474 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -83.14 -31.42 27.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 109.739 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.04 70.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.421 HG13 HD23 ' A' ' 18' ' ' LEU . 25.2 t -69.81 -44.3 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.473 -0.767 . . . . 0.0 109.738 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.439 ' HA ' HG13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -62.51 -47.98 81.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.618 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.425 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -68.97 -16.48 63.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 110.074 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.459 ' CG ' HG13 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -83.07 -34.19 26.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 179.932 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.478 HD11 ' CG2' ' A' ' 13' ' ' ILE . 10.8 mt -73.87 -56.19 5.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 110.171 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.47 -30.39 12.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.39 -8.72 55.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 0.0 110.437 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -105.22 92.07 4.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.124 -0.985 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.9 p -138.24 29.66 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.284 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -109.34 -31.33 7.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.9 . . . . 0.0 109.932 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 47.64 -163.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.376 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -78.43 -17.6 56.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.282 -0.886 . . . . 0.0 110.286 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.292 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.869 HG11 ' ND1' ' A' ' 121' ' ' HIS . 5.1 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.748 0.785 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -108.89 158.45 17.66 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.736 -0.602 . . . . 0.0 109.717 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.68 140.09 51.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.024 -1.048 . . . . 0.0 110.894 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 9.8 m-85 -146.52 61.99 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 7' ' ' THR . 12.9 pt-20 -87.59 157.48 19.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 111.129 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.4 p -156.64 174.93 14.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 0.0 109.944 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . 9.9 pt-20 -159.71 150.38 19.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 110.231 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 m -145.29 168.15 21.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.295 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.76 HG22 HG12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -106.91 164.29 12.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.218 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -157.68 144.46 18.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.426 -0.796 . . . . 0.0 109.855 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.491 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 15.1 t -79.8 -7.63 10.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.839 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.826 HG21 HD13 ' A' ' 151' ' ' LEU . 30.2 mm -78.85 146.87 69.44 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.656 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.93 145.94 81.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.659 1.347 . . . . 0.0 111.331 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.802 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -66.86 -28.41 68.32 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.54 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.95 2.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.943 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.478 ' HG3' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -58.53 -37.04 74.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.728 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.6 tt -68.44 -39.44 81.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.007 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CE2' HG21 ' A' ' 23' ' ' ILE . 80.8 t80 -60.84 -65.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 109.983 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -43.04 -49.26 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.24 96.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.873 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -88.95 -9.17 52.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.232 -0.917 . . . . 0.0 110.811 -179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 24' ' ' LEU . 1.2 mp -118.16 -69.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.988 -1.07 . . . . 0.0 110.191 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.586 ' N ' HG22 ' A' ' 23' ' ' ILE . 6.0 mt -60.69 -43.42 97.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.57 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.596 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -115.36 13.42 16.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.349 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.88 -59.66 10.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.62 ' HB3' HG11 ' A' ' 41' ' ' VAL . 85.3 m-20 -52.21 -29.07 20.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -1.161 . . . . 0.0 110.304 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -86.29 -28.93 23.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.424 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.805 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -87.68 -21.73 25.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.312 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.764 ' HE1' HD13 ' A' ' 143' ' ' LEU . 0.5 OUTLIER -54.02 -57.55 17.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.533 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -73.34 -0.07 8.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.95 1.5 . . . . 0.0 110.832 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -103.44 -59.12 1.76 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.436 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 29' ' ' LEU . 33.6 m -90.7 12.91 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.356 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -159.77 75.87 3.0 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.297 -0.877 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.36 -7.97 21.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.008 1.53 . . . . 0.0 110.716 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -100.79 0.05 38.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 110.262 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.477 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -107.28 -69.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.167 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.406 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.1 mt -119.14 135.13 60.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.868 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 -49.94 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.316 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.467 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -157.09 171.33 20.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 110.304 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.792 HG13 ' CD1' ' A' ' 56' ' ' ILE . 40.6 t -129.81 140.52 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' CB ' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -133.28 84.27 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.406 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -50.4 117.74 2.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 0.0 110.283 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.615 HD12 HG22 ' A' ' 53' ' ' ILE . 12.5 mt -88.58 -37.83 10.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.271 1.034 . . . . 0.0 108.666 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.468 ' O ' HG23 ' A' ' 52' ' ' THR . 48.2 tt0 . . . . . 0 C--N 1.294 -1.813 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.335 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.591 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.9 Cg_endo -73.09 129.43 14.13 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.028 1.541 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.62 -3.92 81.79 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.74 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -63.68 154.66 32.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -1.215 . . . . 0.0 109.255 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 44' ' ' ILE . 8.7 mm -124.81 127.69 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -139.7 136.91 34.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.299 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HB3' ' CB ' ' A' ' 42' ' ' GLU . 22.1 tttt -80.5 98.41 7.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 110.297 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.792 ' CD1' HG13 ' A' ' 41' ' ' VAL . 43.6 mm -86.7 134.81 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -103.76 145.94 29.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.199 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -118.33 131.55 24.17 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.213 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 44.9 Cg_endo . . . . . 0 C--N 1.306 -1.668 0 O-C-N 123.953 1.501 . . . . 0.0 110.574 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' C ' HG12 ' A' ' 67' ' ' VAL . 20.3 p90 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.26 0.552 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -178.45 171.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.278 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -90.14 -61.76 1.61 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.513 -0.742 . . . . 0.0 109.598 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 68' ' ' LYS . 7.6 t70 59.2 124.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.481 ' NE ' HD11 ' A' ' 53' ' ' ILE . 1.8 ttt180 -110.78 147.85 33.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.5 t -67.02 152.03 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 7.7 t70 -99.95 -71.4 0.7 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.311 0.577 . . . . 0.0 110.459 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -145.85 104.19 3.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.439 -0.788 . . . . 0.0 109.985 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 81' ' ' TYR . 18.6 t -92.78 149.88 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.265 -0.897 . . . . 0.0 110.324 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -148.42 101.62 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 109.927 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 m-70 -76.23 1.18 16.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.584 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -116.5 -44.61 2.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.058 -1.026 . . . . 0.0 110.041 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.13 15.06 9.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.435 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.552 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 20.0 m-30 51.49 54.43 11.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.911 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -126.62 126.55 43.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.561 ' CG ' HG13 ' A' ' 23' ' ' ILE . 28.1 t80 -143.34 97.94 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.499 ' ND2' ' OE2' ' A' ' 101' ' ' GLU . 9.4 m-20 -114.37 146.48 40.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 23.6 p90 -142.22 139.96 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.864 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 50.5 m -106.04 164.91 11.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.095 -1.003 . . . . 0.0 110.928 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 91' ' ' ILE . 24.4 t -103.06 130.2 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.499 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -126.96 -68.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.287 -178.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 1.4 tt0 -91.93 78.83 5.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.621 -1.3 . . . . 0.0 110.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -94.8 153.03 20.75 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.529 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.46 -57.99 4.83 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -72.44 -41.56 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.545 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 86' ' ' ILE . 48.8 mt -61.62 134.3 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.23 -39.34 0.75 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -120.8 -84.14 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -1.091 . . . . 0.0 110.008 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 t -150.83 14.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.59 HD22 ' CB ' ' A' ' 123' ' ' LYS . 18.5 mt -88.81 156.92 18.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -0.969 . . . . 0.0 110.077 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-10 54.56 34.28 20.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.12 -0.987 . . . . 0.0 109.48 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -77.02 170.3 16.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 -179.59 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.64 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 4.6 mp -143.11 125.15 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.478 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 11.2 t -117.35 109.86 17.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.57 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 3.1 t-20 -98.92 169.94 9.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 117' ' ' SER . 18.6 mt-10 -152.38 130.11 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.777 -0.577 . . . . 0.0 109.565 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.452 HD12 ' HD2' ' A' ' 81' ' ' TYR . 27.5 mt -121.14 132.41 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 110.459 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HD2' ' HD2' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -139.61 122.54 16.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.802 HG22 ' HB1' ' A' ' 15' ' ' ALA . 3.3 mp -108.92 144.23 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.363 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -145.67 117.94 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.751 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -71.47 146.23 48.73 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.347 0.594 . . . . 0.0 110.554 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 112' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.024 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.675 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 7.6 t -141.78 -175.89 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.998 . . . . 0.0 110.525 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.76 HG12 HG22 ' A' ' 10' ' ' THR . 19.9 mt -134.99 128.19 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 109.599 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.53 ' C ' HD12 ' A' ' 114' ' ' LEU . 3.8 pp -108.81 139.39 43.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 8' ' ' GLU . 10.2 mttt -123.79 113.92 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.507 HG23 HD21 ' A' ' 100' ' ' ASN . 72.3 mt -107.77 115.13 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.797 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.53 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -103.4 135.92 44.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -126.71 144.25 50.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.144 -0.973 . . . . 0.0 110.815 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -126.55 150.9 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 109.884 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -131.57 105.65 7.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.869 ' ND1' HG11 ' A' ' 2' ' ' VAL . 24.1 m-70 -86.0 125.29 33.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 110.605 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.3 167.86 12.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.59 ' CB ' HD22 ' A' ' 95' ' ' LEU . 19.1 tptt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.33 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.364 0.602 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.662 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.1 t -121.8 99.5 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.434 -0.791 . . . . 0.0 109.89 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -64.46 125.81 25.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -42.57 -34.79 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.8 mp0 -39.83 -70.36 0.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.306 -0.871 . . . . 0.0 110.872 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -27.83 38.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.568 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.565 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 21.4 t -74.91 -49.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.2 -30.86 70.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.515 -0.741 . . . . 0.0 109.792 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.81 -30.42 61.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.623 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.0 t -73.39 -37.69 65.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.412 -0.805 . . . . 0.0 109.682 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -68.89 -38.31 79.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.6 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -68.0 -40.26 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 1.1 tp -72.83 -40.42 65.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.827 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.43 97.77 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.689 ' HA ' HD23 ' A' ' 144' ' ' LEU . 1.5 mm-40 -65.95 -34.72 78.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -1.133 . . . . 0.0 109.917 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 75.2 m -67.98 -29.96 69.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.927 . . . . 0.0 109.723 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.764 HD13 ' HE1' ' A' ' 30' ' ' PHE . 71.9 mt -70.25 -46.54 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -67.3 -30.84 70.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.745 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.5 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 4.5 ttt180 -79.5 -32.93 42.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 0.0 109.938 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 33' ' ' VAL . . . -63.41 -42.67 98.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.85 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.27 -47.49 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 110.007 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -56.98 -43.3 81.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.5 t -60.72 -49.82 75.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.647 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.3 t80 -52.35 -70.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.838 . . . . 0.0 110.473 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.826 HD13 HG21 ' A' ' 13' ' ' ILE . 1.2 mt -40.6 -35.43 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 110.684 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -25.09 50.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.007 . . . . 0.0 110.498 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 110.461 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.494 0.664 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.2 m-85 -100.91 137.5 39.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.384 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.24 146.8 44.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 110.91 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -152.29 56.63 0.82 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.472 0.654 . . . . 0.0 109.298 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 4.9 pt-20 -80.19 153.2 28.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 110.368 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -149.7 -175.6 5.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.882 . . . . 0.0 110.099 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -159.45 162.52 35.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.7 -176.24 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.07 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.469 HG22 HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -133.67 159.61 40.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.482 ' HB3' ' CG ' ' A' ' 148' ' ' GLU . 3.7 m -160.03 145.51 15.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 109.991 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.483 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 11.9 t -79.93 -7.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.41 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.661 HD12 ' HB3' ' A' ' 151' ' ' LEU . 41.7 mm -77.1 148.2 77.94 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.661 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.46 150.47 84.22 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 123.589 1.31 . . . . 0.0 111.063 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.804 ' HB3' ' HB2' ' A' ' 106' ' ' ALA . . . -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.438 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.15 -49.95 8.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.92 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 8.0 tpt180 -67.15 -34.33 77.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.712 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 5.8 tt -76.92 -35.41 57.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.655 ' CD1' HD13 ' A' ' 23' ' ' ILE . 75.2 t80 -61.12 -57.76 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.867 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 27.3 mttp -58.2 -41.21 83.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.828 . . . . 0.0 109.96 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.68 -32.91 70.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.67 ' CD1' HG21 ' A' ' 147' ' ' VAL . 7.9 t80 -87.98 -15.82 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.883 . . . . 0.0 110.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.655 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -120.15 -58.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.092 -1.005 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.529 HD11 ' CE1' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -63.05 -37.25 86.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.344 -0.848 . . . . 0.0 110.687 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -110.11 -0.81 17.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -46.0 -48.51 14.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -56.46 -17.21 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.307 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -113.1 -19.77 11.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.297 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.8 tp -93.99 -33.76 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.736 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.567 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -63.25 -58.21 17.0 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.701 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -76.7 46.11 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.825 1.434 . . . . 0.0 111.347 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.32 -54.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.921 -1.112 . . . . 0.0 110.397 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.565 ' CG2' ' HB1' ' A' ' 146' ' ' ALA . 9.9 p -84.85 -26.0 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.48 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.62 75.61 79.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.385 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.59 -3.98 14.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.389 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -91.21 -12.72 34.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.24 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.51 -72.65 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.908 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.444 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.3 mp -105.78 154.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.439 -0.788 . . . . 0.0 109.5 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 8.1 t -100.85 -56.44 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 110.415 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 36.5 m -153.55 175.34 13.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 110.489 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 56' ' ' ILE . 25.8 t -138.53 143.5 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.889 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.82 99.82 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.152 -0.967 . . . . 0.0 110.658 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.484 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 90.5 m-20 -58.36 117.33 4.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 54' ' ' LYS . 22.8 mm -85.87 -38.07 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.366 1.079 . . . . 0.0 108.301 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 53' ' ' ILE . 61.5 tt0 . . . . . 0 C--N 1.295 -1.772 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.084 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.68 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.31 124.05 7.55 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.018 1.536 . . . . 0.0 110.437 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.74 -3.0 70.57 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.68 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.2 m -61.43 152.13 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -1.164 . . . . 0.0 109.787 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 10.4 mt -112.75 136.48 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 110.327 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 54' ' ' LYS . 2.7 ptmt -153.13 139.18 18.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.229 -0.92 . . . . 0.0 110.305 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HG3' ' CD1' ' A' ' 66' ' ' TYR . 15.6 ttpp -91.67 109.28 20.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.499 HD12 ' OD1' ' A' ' 69' ' ' ASP . 96.7 mt -98.6 120.89 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.928 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 39' ' ' SER . 54.3 m -77.3 133.78 38.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.857 . . . . 0.0 110.46 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.29 140.05 22.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.025 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.72 -179.841 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' HG3' ' A' ' 55' ' ' LYS . 5.0 p90 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.869 0.843 . . . . 0.0 112.065 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.568 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -148.54 175.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -123.48 50.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.795 -1.191 . . . . 0.0 111.124 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' A' ' 56' ' ' ILE . 11.8 p-10 -61.78 131.03 48.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.943 . . . . 0.0 109.99 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -96.61 -179.22 4.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.625 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.0 t -90.27 151.39 3.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 120.916 -1.115 . . . . 0.0 109.891 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -100.44 -73.23 0.65 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.524 0.678 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -137.44 132.59 33.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.126 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.6 t -119.14 146.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 0.0 110.117 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.553 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -150.09 110.9 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.907 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -76.64 -12.84 60.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -109.94 -39.78 4.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.028 -1.045 . . . . 0.0 109.836 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -88.2 15.93 6.89 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.302 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 19.6 m-85 42.23 57.21 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.2 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.553 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.73 115.68 21.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.982 . . . . 0.0 110.679 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' A' ' 23' ' ' ILE . 13.1 t80 -135.82 102.17 4.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 32.7 m-20 -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.099 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.631 ' CE2' ' CB ' ' A' ' 100' ' ' ASN . 2.8 p90 -137.93 145.16 41.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.6 m -105.38 155.43 19.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.277 -0.889 . . . . 0.0 111.451 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 38.2 t -100.07 122.13 51.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -120.98 -66.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 111.531 -178.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -80.5 52.66 1.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.674 -1.266 . . . . 0.0 109.917 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.665 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -63.65 125.64 33.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.501 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -38.58 -58.46 1.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -72.88 -26.6 15.39 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.866 1.456 . . . . 0.0 110.555 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.665 HD12 ' HA3' ' A' ' 88' ' ' GLY . 17.9 mt -69.75 161.69 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.75 -51.95 0.08 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.456 ' C ' ' HG ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -87.6 50.66 2.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.091 -1.241 . . . . 0.0 110.593 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 49.23 24.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.528 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.576 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -118.56 175.43 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.948 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.615 ' O ' HD11 ' A' ' 91' ' ' ILE . 4.0 mt-10 54.89 32.6 18.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -80.02 159.39 26.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.409 -0.807 . . . . 0.0 110.069 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 120' ' ' TYR . 17.1 mt -143.03 137.09 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.687 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.48 94.45 4.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.76 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.631 ' CB ' ' CE2' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -84.31 141.31 31.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 2.5 mt-10 -128.28 146.37 50.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 110.168 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.4 mt -137.15 125.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 0.0 110.236 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.533 ' HE3' ' CG2' ' A' ' 105' ' ' VAL . 11.9 tttt -124.89 157.43 35.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 10.5 mt -148.09 119.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 110.495 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.533 ' CG2' ' HE3' ' A' ' 103' ' ' LYS . 83.6 t -118.52 129.63 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.414 -0.804 . . . . 0.0 109.987 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -80.59 154.18 27.59 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.414 0.626 . . . . 0.0 110.767 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.505 HG23 ' HA ' ' A' ' 112' ' ' SER . 6.8 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.868 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.632 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 3.8 t -147.45 -174.86 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -1.031 . . . . 0.0 110.593 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 68.4 mt -138.63 136.58 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.8 . . . . 0.0 109.383 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 114' ' ' LEU . 6.5 mp -105.19 136.29 44.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.08 104.23 8.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.438 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 116' ' ' ILE . 5.4 mp -99.56 139.55 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.83 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -126.54 105.82 9.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.42 -0.8 . . . . 0.0 110.081 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -98.43 142.49 29.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.219 -0.925 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.0 OUTLIER -135.97 127.57 28.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -111.8 123.41 50.18 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.151 -0.968 . . . . 0.0 110.014 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -104.51 116.39 32.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.853 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.14 169.36 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 109.777 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 110.243 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.115 0.483 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 128' ' ' VAL . 4.6 t -113.93 96.3 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.649 ' O ' HG23 ' A' ' 133' ' ' VAL . 14.4 mttm -64.3 127.24 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.966 . . . . 0.0 109.385 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.73 -46.3 63.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.983 . . . . 0.0 110.458 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' ALA . 6.9 tp10 -41.27 -47.68 3.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.012 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -70.3 -31.55 68.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 108.818 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 129' ' ' LYS . 14.5 t -74.05 -47.97 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 109.31 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 7.0 tmtt? -66.48 -30.78 71.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.197 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.14 -27.92 62.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -72.78 -40.6 65.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 110.365 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 134' ' ' LYS . 13.6 ptmt -77.24 -22.07 52.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 0.0 110.254 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.64 -57.46 11.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.335 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 142' ' ' THR . 38.6 mt -70.88 -42.05 70.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.219 -0.926 . . . . 0.0 110.429 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 139' ' ' LEU . . . -41.53 -44.63 4.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.3 tt0 -57.75 -36.28 71.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -1.2 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 139' ' ' LEU . 92.8 m -67.97 -22.0 65.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.477 HD13 ' CZ ' ' A' ' 30' ' ' PHE . 64.4 mt -76.39 -49.99 15.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.921 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.38 -23.81 65.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -83.25 -38.17 22.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.964 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.565 ' HB1' ' CG2' ' A' ' 33' ' ' VAL . . . -60.77 -39.97 90.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -0.915 . . . . 0.0 109.514 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 22' ' ' PHE . 40.2 t -71.36 -52.77 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.482 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.412 -0.805 . . . . 0.0 109.571 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -50.95 69.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.54 -70.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.295 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.661 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.066 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -61.83 -43.81 98.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.447 0.642 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.9 m-85 -97.13 154.29 17.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.673 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -127.26 149.34 50.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.911 -1.118 . . . . 0.0 111.038 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 40.9 m-85 -158.29 61.31 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.668 -0.645 . . . . 0.0 109.438 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 19.5 pt-20 -85.62 148.63 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 110.948 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.48 173.87 13.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 0.0 109.63 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.2 pm0 -147.61 169.98 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 0.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 152.12 29.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.746 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.53 161.57 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 110.552 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.465 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 9.4 t -159.85 138.16 10.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.639 -0.663 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 t -80.04 -14.25 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.866 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 44.3 mm -72.01 148.02 91.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.4 Cg_endo -66.85 150.07 83.22 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.432 1.228 . . . . 0.0 111.112 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.916 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -76.05 -29.42 58.02 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.405 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.81 -54.55 13.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.898 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 5.5 ttm180 -66.7 -35.69 80.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.437 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 114' ' ' LEU . 11.3 tp -75.25 -32.9 61.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 0.0 109.984 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.664 ' CD1' HD13 ' A' ' 23' ' ' ILE . 55.3 t80 -64.2 -68.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -52.75 -38.62 61.18 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.514 -0.741 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 -37.37 69.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 47.7 t80 -82.64 -20.79 35.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.664 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -110.84 -69.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.834 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.511 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -49.24 -41.42 37.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 110.1 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.565 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -108.6 0.65 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.187 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.93 -52.69 29.61 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -47.86 -29.36 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 20.8 t-20 -101.42 -29.64 11.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 0.0 110.269 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.035 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -80.56 -21.09 42.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.7 m-85 -66.1 -60.77 6.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.388 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -72.4 -0.11 8.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.989 1.521 . . . . 0.0 110.784 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 13.7 ttpt -101.78 -48.74 4.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.035 -1.04 . . . . 0.0 110.562 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.035 HG22 ' O ' ' A' ' 29' ' ' LEU . 17.0 m -91.44 7.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 110.6 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 75.39 3.34 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.143 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.33 -9.65 24.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.082 1.569 . . . . 0.0 110.69 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -92.81 -8.08 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 110.232 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -102.5 -72.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.016 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.48 131.33 57.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.443 -0.786 . . . . 0.0 109.758 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.5 OUTLIER -80.07 -34.9 37.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 110.208 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 39' ' ' SER . 2.0 p -178.09 157.77 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.44 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 60.5 t -117.49 152.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 109.982 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.9 tm-20 -139.05 89.68 2.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 15.9 t-20 -56.52 115.84 2.76 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.914 0.864 . . . . 0.0 110.532 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.726 HD12 HG22 ' A' ' 53' ' ' ILE . 6.0 mt -87.55 -39.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.902 0.858 . . . . 0.0 109.081 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 52' ' ' THR . 14.1 mt-10 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.833 0.825 . . . . 0.0 111.689 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.3 Cg_endo -72.65 128.7 13.7 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.009 1.531 . . . . 0.0 110.529 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.21 -7.17 62.04 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.663 ' HB ' HG21 ' A' ' 71' ' ' VAL . 2.3 m -69.76 144.42 52.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -1.164 . . . . 0.0 109.886 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.726 HG22 HD12 ' A' ' 44' ' ' ILE . 7.5 mt -114.55 141.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.936 -1.103 . . . . 0.0 109.264 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -153.38 134.43 14.01 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 110.069 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -86.49 116.78 24.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 111.041 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.467 HD11 ' HE2' ' A' ' 54' ' ' LYS . 56.0 mt -104.69 123.73 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.402 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 35.2 m -93.07 141.4 28.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 110.594 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -110.16 154.41 42.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.922 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.512 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 44.5 Cg_endo . . . . . 0 C--N 1.304 -1.813 0 O-C-N 124.0 1.526 . . . . 0.0 110.381 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.843 ' O ' HG13 ' A' ' 67' ' ' VAL . 6.4 p90 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.972 0.892 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 66' ' ' TYR . 1.9 m -166.84 167.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.553 ' HD2' ' CB ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -99.3 -64.75 1.01 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.613 -1.304 . . . . 0.0 110.017 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.528 ' OD1' HG13 ' A' ' 85' ' ' VAL . 9.2 m-20 59.08 129.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.888 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -112.56 149.56 32.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 108.908 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG21 ' HB ' ' A' ' 52' ' ' THR . 11.6 t -65.12 153.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.864 -1.147 . . . . 0.0 110.268 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.5 t70 -104.69 -75.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.407 0.622 . . . . 0.0 110.038 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -137.13 128.45 28.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.838 HG22 ' CD2' ' A' ' 81' ' ' TYR . 4.1 t -119.19 142.89 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -144.37 114.8 7.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.507 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -81.08 -10.58 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -108.93 -39.11 5.41 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.071 -1.018 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.64 9.27 27.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.518 -0.739 . . . . 0.0 109.997 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 48.32 51.41 15.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.185 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.92 117.54 24.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.269 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.838 ' CD2' HG22 ' A' ' 74' ' ' VAL . 45.9 t80 -137.83 106.16 5.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.773 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 35.2 m-20 -119.61 152.35 37.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.229 -0.919 . . . . 0.0 110.331 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 11.5 p90 -142.79 136.46 28.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' ARG . 50.4 m -95.6 168.13 10.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.117 -0.989 . . . . 0.0 111.132 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.528 HG13 ' OD1' ' A' ' 69' ' ' ASP . 53.8 t -107.98 123.94 63.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -74.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.815 -1.178 . . . . 0.0 111.451 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 2.8 mm-40 -91.87 71.65 5.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.195 . . . . 0.0 110.131 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.8 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . -151.24 161.54 29.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 52.55 -157.95 3.76 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.85 -0.86 10.96 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.032 1.543 . . . . 0.0 111.197 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CD1' HG12 ' A' ' 85' ' ' VAL . 50.0 mt -51.13 156.35 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.48 -58.0 0.2 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.2 p-10 -146.23 -49.09 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -1.162 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 t -145.08 12.45 1.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.81 144.94 28.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.492 ' HA ' HG23 ' A' ' 122' ' ' THR . 2.7 tt0 55.99 33.4 21.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 109.859 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -70.48 150.43 46.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.639 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mt -132.62 134.43 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.364 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -118.78 107.64 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.043 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.496 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 18.4 m-80 -92.73 127.93 38.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.305 -0.872 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 82' ' ' ASN . 4.1 mt-10 -121.22 143.9 48.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 116' ' ' ILE . 58.0 mt -137.63 129.59 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.469 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 ttpt -124.82 142.46 51.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.653 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.916 HG22 ' HB1' ' A' ' 15' ' ' ALA . 84.1 mt -130.65 103.98 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.471 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 113' ' ' ILE . 73.4 t -108.7 146.2 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.06 159.69 18.14 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.728 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 112' ' ' SER . 22.0 p . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 110.274 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -135.75 -176.52 4.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -1.089 . . . . 0.0 110.513 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 105' ' ' VAL . 33.6 mt -136.5 117.55 18.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.552 HD11 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -88.63 124.31 33.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 110.626 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 7.0 ttmt -116.14 100.02 7.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.78 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 102' ' ' ILE . 28.7 mt -96.48 139.57 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.395 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -122.16 109.3 14.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.2 t-20 -98.17 131.34 44.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.993 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 138.09 49.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.639 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.51 141.41 43.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 49.2 m-70 -123.37 95.99 4.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.492 HG23 ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -118.06 172.15 7.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 tttp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 110.14 -179.906 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.109 0.48 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.581 HG21 ' CG ' ' A' ' 120' ' ' TYR . 4.4 t -116.68 99.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.165 -0.959 . . . . 0.0 110.449 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.741 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -68.06 146.74 53.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.993 . . . . 0.0 109.498 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . . . -66.59 -9.66 37.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.971 -1.081 . . . . 0.0 110.808 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.505 ' HB2' ' CD ' ' A' ' 129' ' ' LYS . 12.9 mt-10 -68.0 -54.58 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.994 -1.066 . . . . 0.0 109.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.14 -23.7 63.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.89 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 129' ' ' LYS . 17.5 t -80.85 -46.59 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 130' ' ' ALA . 27.8 tttt -64.27 -26.02 68.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.955 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.41 74.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.885 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -75.91 -40.41 54.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -47.5 -69.43 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.7 -22.74 63.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.169 -0.957 . . . . 0.0 109.902 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.17 -32.86 51.11 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.503 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 34.8 mt-10 -72.46 -61.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -1.095 . . . . 0.0 110.082 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 146' ' ' ALA . 3.0 m -45.62 -33.37 2.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.904 -1.123 . . . . 0.0 109.708 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.54 -59.38 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.856 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.8 pp -65.9 -24.64 66.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -81.96 -29.23 32.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.47 -38.44 77.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.675 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.47 -44.91 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -56.29 -46.08 79.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.573 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.4 OUTLIER -64.24 -49.76 70.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.733 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -47.71 -71.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 110.038 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -46.22 -37.21 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.379 -0.825 . . . . 0.0 110.298 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 149' ' ' SER . 5.3 mt -59.33 -23.66 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 110.507 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.403 0.62 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.439 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 23.1 m-85 -95.28 155.01 16.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.626 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.64 140.97 51.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.718 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.403 ' CE2' HG11 ' A' ' 133' ' ' VAL . 20.2 m-85 -149.32 61.53 1.03 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.398 -0.813 . . . . 0.0 109.723 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 4.2 pt-20 -84.0 148.44 26.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.862 . . . . 0.0 110.915 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLU . 3.1 p -151.8 175.24 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.793 . . . . 0.0 109.565 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 11.8 pt-20 -155.26 146.42 22.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.93 -1.106 . . . . 0.0 110.621 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 m -129.26 143.18 50.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 110.019 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -82.06 159.69 23.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.416 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 m -156.77 136.91 12.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 12.1 m -79.98 -16.37 12.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.09 -1.006 . . . . 0.0 108.66 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.865 HG21 HD13 ' A' ' 151' ' ' LEU . 26.0 mm -67.03 149.44 98.51 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.74 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.69 150.55 83.59 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.509 1.268 . . . . 0.0 110.875 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -76.81 -27.02 55.05 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.57 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.07 -52.57 9.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 0.0 109.396 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.588 HD22 HG21 ' A' ' 104' ' ' ILE . 9.8 tt -75.5 -42.45 52.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.523 -0.735 . . . . 0.0 109.829 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.752 ' CD1' HD13 ' A' ' 23' ' ' ILE . 51.0 t80 -56.65 -62.23 1.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 0.0 110.17 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.477 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -53.41 -45.61 69.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.81 . . . . 0.0 110.277 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.49 65.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.459 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.718 ' HD2' HG11 ' A' ' 147' ' ' VAL . 5.8 t80 -88.13 -22.98 23.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.435 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.752 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -112.18 -58.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' CG ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -60.23 -30.35 69.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.876 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -122.24 11.65 10.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.935 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.23 -54.52 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 36.2 p-10 -55.44 -25.55 36.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -1.179 . . . . 0.0 110.393 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 37.2 m-20 -92.99 -41.21 10.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.676 HD21 ' CE2' ' A' ' 150' ' ' TYR . 0.6 OUTLIER -72.99 -31.31 64.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 110.524 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.762 ' CD2' HD13 ' A' ' 38' ' ' ILE . 2.0 m-85 -50.17 -61.96 3.14 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -72.4 -7.46 20.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.84 1.442 . . . . 0.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -93.42 -67.2 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.397 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 29' ' ' LEU . 24.3 m -88.98 -0.29 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.339 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -146.8 56.33 2.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 110.344 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 34' ' ' ALA . 45.4 Cg_endo -71.88 -23.19 22.48 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.335 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.84 -16.92 61.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.584 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -96.66 -58.74 1.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.195 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.762 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -110.47 137.78 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.969 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.15 -52.59 6.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 110.353 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.71 -179.23 7.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.192 -0.942 . . . . 0.0 110.453 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 41' ' ' VAL . 2.4 p -159.94 112.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.3 145.68 44.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.896 . . . . 0.0 110.044 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -93.88 121.95 35.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.684 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 54' ' ' LYS . 25.4 mm -83.8 -37.59 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.345 1.069 . . . . 0.0 108.363 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--N 1.295 -1.792 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.289 -179.866 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.75 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.8 Cg_endo -71.25 114.96 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.971 1.511 . . . . 0.0 110.315 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.14 -2.89 51.2 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.75 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.4 m -62.91 154.45 30.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.111 . . . . 0.0 109.815 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 44' ' ' ILE . 6.0 mt -125.35 136.1 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -154.48 139.32 17.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.915 . . . . 0.0 110.35 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -84.07 119.88 25.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.3 mt -103.24 118.04 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -85.75 140.49 30.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.49 158.53 37.06 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 42.7 Cg_endo . . . . . 0 C--N 1.304 -1.788 0 O-C-N 124.007 1.53 . . . . 0.0 110.908 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 9.0 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -157.52 172.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.098 -1.001 . . . . 0.0 110.662 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.565 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 2.5 mtpp -93.46 -65.02 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.662 -0.649 . . . . 0.0 109.811 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER 60.6 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ptm180 -106.37 167.22 9.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.672 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.6 t -82.18 152.32 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.88 -1.137 . . . . 0.0 110.348 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 48.5 t0 -101.2 -72.34 0.68 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.235 0.541 . . . . 0.0 109.878 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -146.82 124.58 11.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.361 -0.837 . . . . 0.0 110.124 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.61 149.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 5.3 t0 -151.94 115.06 4.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 109.908 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -85.86 3.14 43.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.647 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -110.34 -48.38 3.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.305 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -91.77 17.84 8.47 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.701 -0.624 . . . . 0.0 110.03 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 20.2 m-85 43.74 58.97 3.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.93 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 28.1 tttt -122.18 119.44 31.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -135.51 109.16 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 51.4 m-20 -125.86 150.29 47.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 110.427 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 51.3 p90 -142.64 139.64 31.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.447 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' ARG . 3.1 m -96.16 155.87 16.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.973 -1.079 . . . . 0.0 110.808 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' OD2' ' A' ' 69' ' ' ASP . 54.7 t -99.91 124.43 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.61 -76.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 110.956 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.525 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.68 78.88 9.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.649 -1.282 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.441 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -100.63 145.97 17.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.57 -50.01 8.44 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.5 Cg_endo -73.62 -48.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.636 1.335 . . . . 0.0 111.02 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 85' ' ' VAL . 33.7 mt -54.52 141.7 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.078 -1.014 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -108.73 -65.06 0.57 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 4.7 m-20 -114.3 -82.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -1.113 . . . . 0.0 110.0 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.9 p -134.27 12.2 3.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.975 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.752 HD22 ' HB2' ' A' ' 123' ' ' LYS . 37.2 mt -90.87 156.38 18.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.016 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.515 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 12.1 tt0 61.96 31.76 17.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.7 mtpt -65.25 161.56 19.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.552 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.588 HD11 ' HE1' ' A' ' 120' ' ' TYR . 87.6 mt -143.9 132.52 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 110.614 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 1.2 m -116.24 111.34 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 109.547 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 2.0 m-80 -103.06 142.17 34.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.548 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 4.2 mp0 -136.19 150.23 48.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.973 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.446 HG12 HD12 ' A' ' 116' ' ' ILE . 45.6 mt -140.63 125.55 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.509 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 2.4 ttpt -125.15 111.91 15.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 109.65 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.588 HG21 HD22 ' A' ' 18' ' ' LEU . 12.1 mt -102.96 112.59 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.43 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.78 142.32 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.827 . . . . 0.0 110.188 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.94 159.96 18.12 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.595 -0.691 . . . . 0.0 110.665 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.581 HG23 ' HA ' ' A' ' 112' ' ' SER . 14.9 p . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.823 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -135.98 -174.17 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.407 -1.055 . . . . 0.0 110.511 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' CG2' ' A' ' 107' ' ' THR . 23.5 mt -137.59 109.39 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.0 108.982 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -84.42 129.19 34.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG2' ' CB ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -122.44 98.47 5.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 109.692 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 116' ' ' ILE . 2.6 tt -94.82 120.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.509 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.472 ' HB3' ' OE1' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -102.04 116.26 32.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.051 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.454 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -103.08 158.62 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 1.8 ttmt -148.51 142.0 25.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.447 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.61 ' CD2' HG21 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -123.52 133.48 54.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -0.931 . . . . 0.0 110.106 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.619 ' CD2' ' N ' ' A' ' 121' ' ' HIS . 4.4 m-70 -119.37 97.67 5.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.52 163.21 14.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.951 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.752 ' HB2' HD22 ' A' ' 95' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.397 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.476 0.655 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.61 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.6 p -98.46 89.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.514 -0.742 . . . . 0.0 110.223 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.16 155.31 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.118 -0.989 . . . . 0.0 110.145 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -64.76 -33.15 75.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.278 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -41.03 -59.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -27.31 65.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 109.274 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 130' ' ' ALA . 18.8 t -77.2 -49.47 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.425 -0.797 . . . . 0.0 109.372 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.43 65.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.857 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.02 -21.44 59.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t -76.44 -43.72 38.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.467 -0.77 . . . . 0.0 110.056 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.75 -30.29 68.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.942 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.97 -40.45 46.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.882 . . . . 0.0 110.125 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.669 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -50.03 -40.99 36.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.871 ' HA ' HD23 ' A' ' 144' ' ' LEU . 23.2 tt0 -60.88 -43.98 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -1.122 . . . . 0.0 109.699 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 38.7 m -62.43 -30.36 71.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.533 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.669 HD12 ' HA2' ' A' ' 140' ' ' GLY . 74.1 mt -64.85 -45.55 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -66.64 -26.2 66.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.524 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -78.79 -39.66 35.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.82 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.59 88.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.579 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.718 HG11 ' HD2' ' A' ' 22' ' ' PHE . 60.0 t -69.92 -39.66 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.01 -50.86 69.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -17.25 63.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.448 -0.782 . . . . 0.0 110.749 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.676 ' CE2' HD21 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -79.81 -42.24 24.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.966 -1.084 . . . . 0.0 109.503 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.865 HD13 HG21 ' A' ' 13' ' ' ILE . 5.7 mt -67.48 -48.16 67.95 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.821 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -53.34 56.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.912 179.809 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.446 HG21 ' CE1' ' A' ' 121' ' ' HIS . 5.1 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.431 0.634 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -104.35 128.66 52.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 109.883 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.17 142.07 32.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.846 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.767 ' CE2' HG11 ' A' ' 133' ' ' VAL . 27.8 m-85 -149.93 54.96 0.94 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.46 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.496 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 0.1 OUTLIER -83.16 158.0 22.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.529 -0.732 . . . . 0.0 110.878 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -154.44 153.84 32.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.677 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -138.5 146.71 42.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.539 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.54 -178.97 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.43 HG22 HG12 ' A' ' 113' ' ' ILE . 1.6 p -121.64 163.29 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.949 . . . . 0.0 110.664 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 2.7 t -159.29 136.86 10.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.78 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.514 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 16.6 t -80.03 -13.87 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.125 -0.984 . . . . 0.0 109.008 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.863 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.1 mp -71.89 153.97 92.83 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.863 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.4 Cg_endo -67.93 149.15 77.49 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.619 1.326 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -75.08 -29.06 60.55 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.513 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -68.16 -55.07 13.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 16.3 mtt-85 -63.93 -36.63 84.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.568 HD23 HD13 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -71.79 -35.81 70.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.09 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.615 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 36.4 t80 -60.54 -58.73 7.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.921 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.484 ' HD3' ' O ' ' A' ' 16' ' ' ALA . 13.7 mtpt -50.69 -52.62 38.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.67 67.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.293 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -89.13 -12.06 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -124.45 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.742 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.616 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -50.34 -56.2 12.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.43 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 2.5 m-20 -111.95 35.43 3.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 109.829 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.13 -58.91 2.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.59 ' HB2' HG11 ' A' ' 41' ' ' VAL . 7.0 p-10 -53.03 -26.72 16.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 110.052 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -87.56 -34.8 18.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.568 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 13.9 mt -80.44 -38.75 29.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.316 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.635 ' HD2' HD13 ' A' ' 38' ' ' ILE . 2.0 m-30 -43.79 -57.72 5.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.619 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.8 Cg_endo -70.71 -18.89 32.21 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.884 1.465 . . . . 0.0 110.629 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.1 mtpp -86.15 -54.46 4.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.93 HG22 ' HB1' ' A' ' 146' ' ' ALA . 5.5 p -83.76 -25.33 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.48 77.29 15.5 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.01 -4.73 15.89 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.082 1.569 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.93 -26.5 60.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.124 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -95.6 -70.34 0.72 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.861 . . . . 0.0 109.967 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.635 HD13 ' HD2' ' A' ' 30' ' ' PHE . 1.7 mp -99.02 128.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.819 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -88.49 -44.69 10.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.29 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -159.5 139.96 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.974 HG13 HG12 ' A' ' 56' ' ' ILE . 3.8 t -119.04 130.87 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -135.61 101.82 4.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.686 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 8.6 m-80 -50.64 118.86 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.22 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.526 ' CD1' ' HG2' ' A' ' 68' ' ' LYS . 12.8 mt -86.42 -37.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.336 1.065 . . . . 0.0 108.403 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 53' ' ' ILE . 24.6 tt0 . . . . . 0 C--N 1.296 -1.734 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.072 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.661 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.6 122.28 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.005 1.529 . . . . 0.0 110.293 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.73 59.9 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.661 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.4 m -54.85 158.72 2.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -1.167 . . . . 0.0 109.305 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 45.8 mt -125.79 142.57 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.048 -1.033 . . . . 0.0 110.559 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -145.32 150.39 36.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 14.7 ttpp -102.2 93.47 5.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.638 -0.664 . . . . 0.0 110.079 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.974 HG12 HG13 ' A' ' 41' ' ' VAL . 66.1 mt -87.92 122.47 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 110.055 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.513 ' CB ' ' OG ' ' A' ' 39' ' ' SER . 17.6 m -86.7 138.14 31.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.14 135.31 19.47 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 45.3 Cg_endo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.936 1.493 . . . . 0.0 110.416 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.8 p90 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.26 0.552 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -144.33 167.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.403 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.526 ' HG2' ' CD1' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -123.05 41.8 3.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.945 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 18.6 p-10 -41.84 136.21 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.9 ttm180 -97.46 151.84 19.58 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.659 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.1 t -75.75 149.06 6.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.67 -1.269 . . . . 0.0 110.459 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 46.2 t0 -101.87 -72.14 0.69 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.416 0.627 . . . . 0.0 110.306 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 122.47 11.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -0.855 . . . . 0.0 109.96 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.793 HG22 ' CD2' ' A' ' 81' ' ' TYR . 5.1 t -108.7 154.22 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 110.265 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.488 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 2.1 t0 -156.48 121.85 4.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.887 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.505 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -87.54 -15.29 37.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.788 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -102.37 -45.13 5.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.126 -0.984 . . . . 0.0 109.356 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.13 7.48 15.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.546 -0.722 . . . . 0.0 110.091 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.615 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.4 m-30 46.25 58.46 4.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.493 ' HG3' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.61 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.793 ' CD2' HG22 ' A' ' 74' ' ' VAL . 38.9 t80 -127.95 100.08 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 109.804 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.606 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 61.8 m-20 -109.58 139.77 44.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.466 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.598 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 39.7 p90 -136.14 136.29 39.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 70' ' ' ARG . 10.6 m -100.13 162.51 12.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 111.223 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.735 HG11 HD13 ' A' ' 98' ' ' ILE . 24.3 t -104.54 123.66 58.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -123.4 -72.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.303 -179.11 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.75 88.27 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.268 . . . . 0.0 110.211 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -107.1 148.2 16.37 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.53 -51.91 5.44 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.9 Cg_endo -76.3 -46.96 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.934 1.492 . . . . 0.0 110.732 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 92' ' ' GLY . 52.8 mt -56.51 164.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.107 -0.995 . . . . 0.0 110.459 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -150.91 -69.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -86.4 -87.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -148.62 15.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.467 ' HB3' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -89.66 160.62 16.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 110.38 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 58.16 35.63 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.28 147.73 39.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.735 HD13 HG11 ' A' ' 85' ' ' VAL . 4.9 mp -127.77 137.01 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.763 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.7 114.69 19.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.87 . . . . 0.0 109.661 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.598 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 4.9 m-20 -110.04 141.14 43.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.606 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -130.26 135.68 48.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.44 101.67 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.056 -1.027 . . . . 0.0 110.344 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HE3' ' HG3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -107.63 121.46 44.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.926 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.735 HG22 ' HB1' ' A' ' 15' ' ' ALA . 54.9 mt -110.48 139.35 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.6 t -138.77 135.78 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.372 -0.83 . . . . 0.0 109.816 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.16 145.92 25.66 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.486 0.66 . . . . 0.0 111.096 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.4 p . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.271 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.854 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -140.4 163.46 32.74 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.549 -0.971 . . . . 0.0 110.676 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 10' ' ' THR . 71.4 mt -119.85 127.33 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.53 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 114' ' ' LEU . 2.1 pp -105.79 112.87 26.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.001 -1.062 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -99.31 104.58 16.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.322 -0.861 . . . . 0.0 109.951 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.489 HG13 HD12 ' A' ' 114' ' ' LEU . 9.7 mt -89.56 125.38 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.496 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -112.63 112.51 24.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.126 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -106.39 155.63 19.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.8 mptt -147.21 131.02 17.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.511 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.646 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.21 128.28 55.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.742 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.446 ' CE1' HG21 ' A' ' 2' ' ' VAL . 23.0 m-70 -113.75 130.01 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -110.63 175.65 5.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 110.086 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 110.183 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.609 ' HA ' HG21 ' A' ' 122' ' ' THR . 5.7 mt-10 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.603 HG21 ' CE2' ' A' ' 120' ' ' TYR . 2.4 p -106.52 86.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 O-C-N 121.658 -0.651 . . . . 0.0 109.839 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 128' ' ' VAL . 1.3 mttp -39.56 144.66 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.508 -0.745 . . . . 0.0 110.603 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.504 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -57.31 -27.34 62.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 110.059 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ALA . 60.8 tt0 -41.57 -64.16 0.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -56.03 -24.36 38.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.767 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.3 t -78.88 -50.95 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.365 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -24.55 67.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.465 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.58 -38.26 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.649 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 t -66.9 -31.94 72.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.316 -0.865 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -36.73 73.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.804 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.49 -48.08 79.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.844 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.88 -36.55 56.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.59 -50.25 61.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.1 tt0 -56.08 -33.21 64.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -1.194 . . . . 0.0 110.289 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.3 m -70.88 -24.76 62.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.565 ' O ' HG23 ' A' ' 147' ' ' VAL . 21.3 mt -75.7 -47.31 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.993 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.5 pp -70.66 -24.06 62.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.767 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.474 ' N ' HD12 ' A' ' 144' ' ' LEU . 15.0 tpt180 -81.05 -32.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.93 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -70.37 -35.42 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 143' ' ' LEU . 47.0 t -73.5 -46.03 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.465 -0.772 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 49.6 tt0 -54.79 -50.87 67.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.33 -47.35 84.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -48.73 -70.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.621 HD13 HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -49.31 -23.64 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.452 -0.78 . . . . 0.0 110.242 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -81.11 -20.47 41.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.528 HG22 ' ND1' ' A' ' 121' ' ' HIS . 4.8 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.382 0.61 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.5 m-85 -112.0 163.82 13.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.679 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.09 137.52 32.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.106 . . . . 0.0 110.714 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.479 ' O ' ' HB2' ' A' ' 118' ' ' ASN . 46.6 m-85 -144.89 57.89 1.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.777 . . . . 0.0 109.556 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 7' ' ' THR . 1.2 tm-20 -80.03 154.52 28.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 110.783 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -155.68 -179.06 7.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.494 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -158.04 151.74 23.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.0 110.47 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 t -140.4 169.57 17.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.928 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.4 162.99 13.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 110.256 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.403 ' OG ' ' HG3' ' A' ' 148' ' ' GLU . 3.6 t -158.86 137.88 11.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.444 -0.785 . . . . 0.0 109.916 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.98 -3.02 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.594 HG21 HD13 ' A' ' 151' ' ' LEU . 36.1 mm -81.58 147.47 59.51 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.049 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.88 150.56 83.11 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.473 1.249 . . . . 0.0 111.091 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -75.18 -33.15 61.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.935 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.03 -47.81 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.49 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 5.1 ttt180 -68.64 -38.92 80.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 109.764 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.74 ' CD2' HD21 ' A' ' 114' ' ' LEU . 2.4 tp -72.69 -30.45 64.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 76' ' ' HIS . 67.6 t80 -68.13 -63.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.368 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HG3' HD13 ' A' ' 24' ' ' LEU . 1.4 mptp? -53.24 -40.98 64.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -0.777 . . . . 0.0 110.512 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.76 -32.15 63.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.541 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.7 t80 -90.61 -8.72 49.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 1.2 mp -118.83 -65.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.691 HD11 ' NE2' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -61.33 -46.73 89.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 29' ' ' LEU . 1.1 t0 -97.05 -15.35 21.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -45.94 -42.51 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 4.6 m-20 -52.77 -27.98 20.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -113.31 -20.29 11.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.6 tp -86.66 -27.79 23.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 110.106 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.542 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.0 m-85 -54.84 -53.76 57.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.406 -0.809 . . . . 0.0 110.657 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -74.31 -4.59 15.66 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.833 1.438 . . . . 0.0 111.101 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.5 -40.71 8.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.59 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 29' ' ' LEU . 13.5 m -86.03 -26.66 6.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 110.8 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.24 88.44 5.81 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.092 -1.005 . . . . 0.0 110.594 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 59' ' ' PRO . 49.3 Cg_endo -76.34 0.68 9.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.006 1.53 . . . . 0.0 110.489 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -29.75 23.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.282 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -92.4 -66.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.445 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.2 mp -107.82 126.86 64.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.444 -0.785 . . . . 0.0 109.936 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 31' ' ' PRO . 2.9 t -83.35 -53.35 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.285 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -149.6 146.99 27.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.018 HG13 HD12 ' A' ' 56' ' ' ILE . 5.8 t -121.45 127.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.63 108.95 8.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.093 -1.005 . . . . 0.0 110.838 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 2.7 m120 -62.4 118.39 7.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 44' ' ' ILE . 12.1 mt -87.36 -37.71 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.236 1.017 . . . . 0.0 108.585 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HB3' HD12 ' A' ' 53' ' ' ILE . 23.8 tt0 . . . . . 0 C--N 1.296 -1.755 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.405 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.918 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.7 Cg_endo -72.47 110.22 2.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.112 1.585 . . . . 0.0 110.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.82 47.41 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.918 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 2.4 m -60.72 152.65 26.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.181 -1.188 . . . . 0.0 109.728 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.42 HG21 ' HE2' ' A' ' 68' ' ' LYS . 7.3 mt -119.43 133.95 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.455 ' HD3' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -141.08 150.84 43.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.533 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.48 ' C ' HD13 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -96.41 101.44 13.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 109.751 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 HG13 ' A' ' 41' ' ' VAL . 4.4 mm -94.48 134.01 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.963 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -102.97 131.81 49.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.92 . . . . 0.0 110.337 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.14 117.73 62.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.911 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.484 ' HG3' ' O ' ' A' ' 35' ' ' PRO . 48.7 Cg_endo . . . . . 0 C--N 1.307 -1.654 0 O-C-N 123.912 1.48 . . . . 0.0 110.638 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 33.6 p90 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.218 0.532 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 68' ' ' LYS . 1.4 p -167.16 171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 110.657 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' N ' HG22 ' A' ' 67' ' ' VAL . 8.7 tttt -106.89 46.42 0.93 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.715 -0.615 . . . . 0.0 109.912 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' CG2' ' A' ' 67' ' ' VAL . 48.5 m-20 -45.62 130.98 9.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.693 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttp180 -102.56 162.92 12.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.603 HG21 ' HB ' ' A' ' 52' ' ' THR . 12.3 t -86.56 151.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.596 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 32.1 t70 -100.33 -68.01 0.83 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.194 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.3 mt-10 -143.77 137.86 28.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.414 -0.804 . . . . 0.0 110.205 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 4.5 t -123.97 144.22 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.158 -0.964 . . . . 0.0 110.101 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -147.43 114.06 6.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.691 ' NE2' HD11 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -82.56 -2.07 52.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.338 -0.851 . . . . 0.0 110.708 -179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -118.08 -42.45 2.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.037 -1.039 . . . . 0.0 109.891 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.477 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -90.26 18.85 5.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.516 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.2 m-85 42.17 64.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.111 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.503 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -131.11 117.14 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.442 ' OH ' ' NZ ' ' A' ' 54' ' ' LYS . 9.5 t80 -137.34 99.63 4.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.536 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 56.8 m-20 -113.81 147.01 39.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 36.2 p90 -140.99 142.48 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 70' ' ' ARG . 26.3 m -107.07 165.14 11.58 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.176 -0.953 . . . . 0.0 110.974 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.696 HG12 HD13 ' A' ' 91' ' ' ILE . 71.4 t -108.06 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.499 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -123.06 -77.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.898 -1.126 . . . . 0.0 110.834 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -85.61 77.28 9.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.835 -1.166 . . . . 0.0 109.891 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.494 ' HA2' ' CB ' ' A' ' 67' ' ' VAL . . . -104.23 159.74 16.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.546 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.75 -54.84 5.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -71.06 -48.76 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.768 1.404 . . . . 0.0 111.013 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.696 HD13 HG12 ' A' ' 85' ' ' VAL . 4.8 mt -64.89 164.59 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.479 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -153.15 -40.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.3 -85.97 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -1.152 . . . . 0.0 110.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -139.26 6.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -92.91 158.44 15.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 58.39 31.3 20.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 110.162 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -75.31 146.35 41.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.787 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.599 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.1 mp -132.29 127.82 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -0.951 . . . . 0.0 110.685 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.49 116.24 30.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 109.679 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.52 ' ND2' ' OD1' ' A' ' 118' ' ' ASN . 10.1 m120 -104.35 156.34 18.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.937 . . . . 0.0 110.749 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 94.2 mt-10 -144.91 138.38 26.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.792 . . . . 0.0 109.815 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -128.76 128.67 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.521 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -129.17 132.29 47.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.937 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.516 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 1.3 mp -121.66 129.17 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.85 123.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 111.195 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -58.12 162.9 3.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.864 -0.523 . . . . 0.0 110.503 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.521 HG22 ' C ' ' A' ' 106' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 111.371 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 11.3 t -157.19 -179.98 8.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.255 . . . . 0.0 111.218 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.468 HG13 HG21 ' A' ' 107' ' ' THR . 4.9 mt -125.21 124.79 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.74 HD21 ' CD2' ' A' ' 18' ' ' LEU . 2.1 mp -99.09 114.67 27.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 110.952 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -103.83 106.48 17.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.334 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 26.3 mt -101.99 127.27 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.679 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -105.43 143.44 33.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.801 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.52 ' OD1' ' ND2' ' A' ' 100' ' ' ASN . 6.8 m-80 -131.07 153.15 49.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.413 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -146.26 132.65 19.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 110.375 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.671 ' CG ' HG21 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -110.07 131.5 55.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.81 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.528 ' ND1' HG22 ' A' ' 2' ' ' VAL . 66.5 m-70 -118.28 109.15 15.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 110.371 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.555 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -107.48 173.07 6.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 110.361 -179.859 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.555 ' HA ' HG21 ' A' ' 122' ' ' THR . 1.3 mm-40 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.466 0.65 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.671 HG21 ' CG ' ' A' ' 120' ' ' TYR . 1.8 t -122.82 105.38 15.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.499 -0.751 . . . . 0.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -78.22 126.76 31.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.371 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.57 -37.28 26.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.405 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -42.49 -48.85 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.024 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -70.51 -27.73 64.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 108.934 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 130' ' ' ALA . 16.9 t -76.5 -47.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.569 -0.707 . . . . 0.0 109.12 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -59.51 -27.94 66.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.658 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.92 66.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.1 t -66.87 -31.32 71.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -45.34 54.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 110.046 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.84 -57.36 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.884 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' ' HB ' ' A' ' 142' ' ' THR . 4.0 mm? -75.37 -35.08 61.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.034 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.86 -49.5 22.69 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.495 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 40.7 tt0 -55.88 -44.51 78.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -1.14 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 139' ' ' LEU . 17.1 m -55.57 -34.15 64.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.0 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 143' ' ' LEU . 17.4 mt -67.86 -49.36 62.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 144' ' ' LEU . 0.9 OUTLIER -69.87 -27.11 64.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.086 -1.009 . . . . 0.0 109.83 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.405 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 3.4 ttm180 -81.47 -28.81 33.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.92 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.11 -43.53 64.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 109.918 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 22' ' ' PHE . 77.8 t -72.22 -38.26 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.794 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.5 tt0 -65.06 -46.09 82.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -63.5 -40.73 97.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.586 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -73.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.977 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 13' ' ' ILE . 1.6 mt -50.11 -38.98 41.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.412 -0.805 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 3.9 mt -50.98 -26.77 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.808 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.938 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.764 HG11 ' ND1' ' A' ' 121' ' ' HIS . 8.6 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.687 0.755 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.562 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 3.4 m-85 -107.81 164.33 12.34 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.628 -0.67 . . . . 0.0 109.714 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.99 138.49 42.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.053 -1.029 . . . . 0.0 110.848 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.42 ' CE1' HG11 ' A' ' 133' ' ' VAL . 50.0 m-85 -146.57 53.89 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.3 pt-20 -81.66 144.43 31.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.766 . . . . 0.0 111.149 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -171.03 3.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.443 -0.786 . . . . 0.0 109.674 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -159.9 164.46 33.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 110.711 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -144.83 -169.92 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 110.048 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.592 ' H ' HG22 ' A' ' 9' ' ' THR . 3.1 p -129.52 160.94 31.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 110.35 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.98 135.3 8.14 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.622 -0.674 . . . . 0.0 109.834 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.96 -17.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 108.642 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.007 HG21 HD13 ' A' ' 151' ' ' LEU . 21.9 mm -68.24 150.35 97.76 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -65.92 151.71 83.37 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.508 1.267 . . . . 0.0 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.61 -25.06 59.0 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -78.13 -47.6 17.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.473 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -69.61 -34.12 73.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.707 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 104' ' ' ILE . 10.6 tp -74.38 -28.7 61.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 110.007 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' ILE . 50.6 t80 -70.44 -60.18 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -54.72 -45.79 74.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.43 70.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.63 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.459 ' HB3' HD12 ' A' ' 23' ' ' ILE . 8.2 t80 -91.54 -20.76 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.97 . . . . 0.0 110.461 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.499 HG13 ' CD2' ' A' ' 81' ' ' TYR . 1.3 mp -114.08 -62.8 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.67 -35.19 20.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.871 . . . . 0.0 110.209 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.58 26.45 4.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -61.0 -44.97 97.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' OD1' HG21 ' A' ' 41' ' ' VAL . 26.9 m-20 -64.88 -8.13 14.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -1.203 . . . . 0.0 110.412 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 4.6 t30 -107.68 -38.79 5.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.469 HD21 ' CZ ' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -80.64 -38.74 28.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -42.12 -59.27 2.77 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.449 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.2 Cg_endo -72.73 -10.65 25.27 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.637 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 6.6 tttm -90.78 -63.74 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 29' ' ' LEU . 11.1 m -81.51 -17.4 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 110.741 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.85 64.37 62.24 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 110.383 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.7 -13.26 20.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.001 1.527 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -79.05 -23.61 44.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -89.07 -61.01 1.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.428 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -106.42 155.45 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 109.841 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.49 -61.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 110.177 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.65 135.17 16.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 56' ' ' ILE . 1.7 p -124.04 128.77 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.125 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 2.9 mt-10 -130.77 159.61 36.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 110.344 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 71.6 m-20 -95.06 119.27 33.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.156 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.2 mm -87.14 -36.84 10.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.315 1.055 . . . . 0.0 108.479 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 53' ' ' ILE . 45.0 tt0 . . . . . 0 C--N 1.295 -1.8 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.444 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.822 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.7 Cg_endo -74.02 106.8 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.959 1.505 . . . . 0.0 110.27 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.98 5.48 33.08 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.822 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.1 m -69.74 157.16 37.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 109.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.483 HD11 HH21 ' A' ' 70' ' ' ARG . 6.3 mt -124.48 131.18 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -137.95 149.83 46.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.196 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HB2' HD11 ' A' ' 44' ' ' ILE . 1.6 tttp -98.34 109.62 22.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.565 -0.709 . . . . 0.0 110.758 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.725 HD12 ' OD2' ' A' ' 69' ' ' ASP . 72.9 mt -104.1 141.98 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.214 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -121.08 154.1 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 111.155 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.46 135.44 21.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 46.8 Cg_endo . . . . . 0 C--N 1.304 -1.787 0 O-C-N 123.847 1.446 . . . . 0.0 111.033 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 2.2 p90 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.597 HG12 ' HA2' ' A' ' 88' ' ' GLY . 18.3 m -151.51 156.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.566 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.6 mttt -111.43 46.67 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 109.724 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.725 ' OD2' HD12 ' A' ' 56' ' ' ILE . 4.2 p30 -39.35 140.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.947 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.483 HH21 HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -99.44 154.1 18.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.652 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.4 t -76.81 147.43 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.678 -1.264 . . . . 0.0 109.72 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 64.6 t0 -97.28 -69.45 0.76 Allowed 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.719 -0.613 . . . . 0.0 110.461 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 mm-40 -154.8 106.69 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 110.463 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 74' ' ' VAL . 4.3 p -83.26 149.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.129 -0.982 . . . . 0.0 109.706 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -139.2 112.54 8.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 110.48 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -87.75 1.52 53.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.584 -0.697 . . . . 0.0 110.123 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -113.14 -57.63 2.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.09 13.76 5.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.524 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 14.3 m-85 48.59 61.72 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -130.12 110.33 11.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.977 . . . . 0.0 110.699 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.499 ' CD2' HG13 ' A' ' 23' ' ' ILE . 4.0 t80 -120.13 96.98 5.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.496 -0.753 . . . . 0.0 109.602 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.527 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 69.9 m-20 -102.75 138.89 39.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.6 p90 -136.63 137.92 40.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 70' ' ' ARG . 1.2 m -104.02 152.81 21.59 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.106 -0.996 . . . . 0.0 111.365 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 19.4 t -100.71 124.2 54.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.8 OUTLIER -124.92 -75.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.74 -178.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -65.1 70.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.758 -1.214 . . . . 0.0 109.793 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -96.6 131.86 10.8 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.92 -56.87 3.05 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.0 Cg_endo -71.52 -27.74 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.782 1.412 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.468 ' CD1' HG12 ' A' ' 85' ' ' VAL . 59.1 mt -72.81 158.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.56 -58.04 0.37 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -56.63 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 0.0 109.838 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 t -146.34 18.28 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.939 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 123' ' ' LYS . 1.2 mt -98.3 149.78 22.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.791 ' HA ' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER 52.42 33.98 14.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.373 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 9.9 tttt -67.38 164.68 18.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.451 -0.78 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.65 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -136.27 125.54 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.258 -0.901 . . . . 0.0 110.157 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.02 115.55 27.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.868 . . . . 0.0 109.488 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -112.31 140.5 46.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.973 . . . . 0.0 110.709 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -127.35 132.3 50.24 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.444 -0.785 . . . . 0.0 109.59 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mt -120.45 105.39 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 110.625 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 32.6 tttm -104.44 117.41 34.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.582 HG21 HD23 ' A' ' 18' ' ' LEU . 3.8 mt -105.58 111.18 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.296 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.47 146.0 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.662 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.21 142.32 27.85 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.434 0.635 . . . . 0.0 111.066 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.563 HG23 ' HA ' ' A' ' 112' ' ' SER . 8.2 p . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.436 -0.79 . . . . 0.0 109.496 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.652 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -143.53 157.86 44.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.303 -1.116 . . . . 0.0 111.418 -179.002 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 113' ' ' ILE . 1.1 tt -107.2 129.61 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.498 HD11 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -93.03 136.61 33.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 110.588 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -125.35 105.71 9.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 109.654 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.698 ' N ' HD12 ' A' ' 116' ' ' ILE . 4.4 mp -105.62 105.74 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -90.42 133.21 35.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.551 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 5' ' ' TYR . 47.2 t30 -127.45 140.66 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.758 -1.214 . . . . 0.0 110.59 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -132.87 149.6 52.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 109.872 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.65 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -126.46 107.25 10.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.101 -1.0 . . . . 0.0 109.439 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.764 ' ND1' HG11 ' A' ' 2' ' ' VAL . 17.5 m-70 -88.52 93.02 9.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.986 . . . . 0.0 110.531 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -117.33 167.58 11.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.994 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HB2' HD23 ' A' ' 95' ' ' LEU . 10.1 tptt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.905 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.379 0.609 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.732 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.0 t -129.86 96.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.401 -0.812 . . . . 0.0 109.678 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -62.79 126.02 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.027 . . . . 0.0 109.612 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.22 -41.36 18.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 110.55 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.8 mt-10 -40.25 -58.62 1.46 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 110.244 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.97 -30.67 69.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.179 -0.95 . . . . 0.0 108.954 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 130' ' ' ALA . 22.7 t -72.7 -53.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 109.035 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -55.49 -28.62 55.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.191 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.14 -25.85 62.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 133' ' ' VAL . 26.9 t -68.6 -30.92 69.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -79.09 -49.56 12.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.92 -48.71 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.928 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.29 -39.75 53.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -54.07 -50.67 54.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.529 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 2.8 tt0 -57.78 -48.46 79.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -1.174 . . . . 0.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.6 -29.53 59.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.536 HD12 ' HA2' ' A' ' 140' ' ' GLY . 78.0 mt -72.78 -53.38 11.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -68.42 -22.17 64.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -81.88 -35.11 29.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.752 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.13 -40.96 91.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.12 -46.44 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.682 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -45.8 80.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -25.3 64.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.843 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.561 ' CD1' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.53 -41.07 63.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.007 HD13 HG21 ' A' ' 13' ' ' ILE . 4.5 mt -66.86 -34.64 78.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.86 -34.12 77.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.865 . . . . 0.0 110.197 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.72 HG11 ' ND1' ' A' ' 121' ' ' HIS . 4.7 m . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.754 0.787 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 7.4 m-85 -121.96 145.15 48.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 109.911 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.456 ' OD1' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -124.27 133.47 53.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 110.713 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.439 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 62.2 m-85 -139.42 57.13 1.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.526 -0.734 . . . . 0.0 109.447 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 7' ' ' THR . 3.1 tm-20 -80.2 153.81 28.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.585 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -156.04 176.1 13.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 109.719 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.474 ' HB3' ' HG3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -158.54 152.18 23.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.002 -1.061 . . . . 0.0 110.572 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.465 HG21 HD22 ' A' ' 144' ' ' LEU . 1.8 t -134.72 -170.77 2.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -122.36 165.57 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 138.24 10.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.423 -0.798 . . . . 0.0 109.754 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.425 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 61.7 t -80.11 -14.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.685 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.801 HG21 HD13 ' A' ' 151' ' ' LEU . 31.0 mm -70.24 149.42 95.97 Favored Pre-proline 0 N--CA 1.487 1.421 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -68.2 148.25 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.317 1.167 . . . . 0.0 110.82 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.37 -33.82 65.25 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.977 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.15 35.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.487 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -66.74 -37.28 84.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.962 . . . . 0.0 109.847 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.623 ' O ' HD23 ' A' ' 18' ' ' LEU . 7.8 tt -73.94 -32.16 63.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 76' ' ' HIS . 30.7 t80 -63.21 -55.93 20.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.727 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -58.05 -45.03 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.45 -31.08 71.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 20.3 t80 -89.72 -23.96 21.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.705 HD12 ' CD2' ' A' ' 81' ' ' TYR . 7.3 mm -106.18 -65.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.727 HD13 ' CG ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -51.92 -42.77 63.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.985 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 18.9 m-20 -115.39 23.54 12.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 110.193 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -62.83 -54.18 35.43 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.883 ' O ' HG21 ' A' ' 41' ' ' VAL . 21.5 m-20 -59.72 -13.15 8.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -1.141 . . . . 0.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -104.15 -36.26 7.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -83.44 -23.48 32.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.597 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -56.43 -60.25 9.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.6 Cg_endo -73.91 -3.56 13.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.944 1.497 . . . . 0.0 110.286 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 20.7 tttm -103.29 -32.93 9.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 110.433 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.053 HG22 ' HB1' ' A' ' 146' ' ' ALA . 1.6 p -101.68 -33.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.116 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB3' HD23 ' A' ' 143' ' ' LEU . . . -121.4 78.76 36.34 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.41 -0.806 . . . . 0.0 110.1 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 -18.98 31.17 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.99 1.521 . . . . 0.0 110.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.55 -4.29 57.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 110.276 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -107.5 -67.82 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.597 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.2 mp -112.15 152.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.544 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -113.84 -27.88 7.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.021 -1.05 . . . . 0.0 110.83 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.82 162.14 34.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.076 -1.015 . . . . 0.0 110.832 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.883 HG21 ' O ' ' A' ' 27' ' ' ASP . 3.7 m -142.62 133.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.45 -0.781 . . . . 0.0 109.719 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 55' ' ' LYS . 1.7 tt0 -135.7 110.45 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.524 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -69.2 118.31 11.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 110.257 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.676 HD12 HG22 ' A' ' 53' ' ' ILE . 11.6 mt -80.0 -39.98 20.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' OE1' HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.4 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.662 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.2 Cg_endo -71.64 96.18 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.913 1.481 . . . . 0.0 110.271 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.22 -0.74 6.08 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.704 ' HB ' HG21 ' A' ' 71' ' ' VAL . 88.4 m -67.69 160.58 27.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -1.159 . . . . 0.0 109.186 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.676 HG22 HD12 ' A' ' 44' ' ' ILE . 11.5 mt -130.38 142.55 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.833 -1.167 . . . . 0.0 111.017 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 19.1 pttt -159.87 136.88 9.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.569 -0.707 . . . . 0.0 110.196 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' GLU . 14.8 ttpt -87.91 113.54 23.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.9 mt -92.16 153.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.645 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -118.0 148.53 42.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 110.784 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -126.76 118.51 22.57 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 109.625 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 39' ' ' SER . 48.6 Cg_endo . . . . . 0 C--N 1.306 -1.669 0 O-C-N 123.89 1.468 . . . . 0.0 111.034 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 20.4 p90 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -173.0 172.93 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.496 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.0 ttmt -112.41 122.65 48.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 110.069 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -118.93 129.39 55.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.789 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -100.28 145.41 28.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.227 -0.921 . . . . 0.0 108.86 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.704 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.0 t -76.5 147.22 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.881 -1.137 . . . . 0.0 110.668 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 6.8 t70 -99.1 -71.71 0.68 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.448 0.642 . . . . 0.0 109.966 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 3.1 tp10 -141.64 133.1 26.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.45 -0.782 . . . . 0.0 110.168 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.798 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.6 t -118.37 157.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.531 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -159.77 124.26 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 110.064 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -98.63 1.17 46.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -112.82 -46.81 3.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.34 10.91 27.82 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 109.966 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-85 51.09 64.0 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 110.445 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -129.7 123.16 30.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.798 ' CD2' HG22 ' A' ' 74' ' ' VAL . 28.0 t80 -144.11 103.77 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 77.5 m-20 -113.97 140.58 48.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.216 -0.927 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 22.9 p90 -137.25 137.22 38.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.488 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 53.8 m -103.76 166.54 10.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.022 -1.049 . . . . 0.0 110.915 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 53.0 t -108.19 124.62 64.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -115.79 -67.89 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.899 -1.126 . . . . 0.0 112.0 -178.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.5 OUTLIER -88.24 82.1 7.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 67' ' ' VAL . . . -100.54 141.13 15.25 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.521 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.71 -58.59 2.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.6 Cg_endo -71.78 -45.18 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.933 1.491 . . . . 0.0 110.393 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.787 HD11 ' CD1' ' A' ' 98' ' ' ILE . 50.4 mt -58.07 149.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.7 -114.73 2.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -70.03 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -1.166 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.486 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 3.2 t -143.93 15.06 1.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.069 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.05 152.55 22.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 109.99 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.535 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 56.33 34.82 24.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.58 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -68.36 157.36 35.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.386 -0.821 . . . . 0.0 110.112 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.787 ' CD1' HD11 ' A' ' 91' ' ' ILE . 2.7 mp -137.12 131.16 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.94 . . . . 0.0 110.402 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.84 114.8 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.785 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.599 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 5.7 m120 -106.62 138.02 43.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.152 -0.968 . . . . 0.0 110.411 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.517 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 26.2 mt-10 -127.53 132.27 49.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 110.191 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.32 121.82 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.33 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 3.9 mttt -128.36 126.39 40.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 109.91 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 12.5 mt -115.36 130.25 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.165 -0.96 . . . . 0.0 110.655 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.12 143.94 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 109.603 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.11 138.77 31.15 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 110.8 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 112' ' ' SER . 1.7 t . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.96 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.802 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -136.72 164.02 29.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.092 . . . . 0.0 110.702 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.48 127.55 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 109.353 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.52 143.45 29.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 0.0 110.955 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 1.8 ttmt -135.13 105.01 6.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.465 -0.772 . . . . 0.0 109.795 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.8 mt -106.4 112.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.336 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -90.39 154.42 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -143.86 135.56 26.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -125.56 153.48 43.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.605 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -135.04 101.88 5.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.079 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.72 ' ND1' HG11 ' A' ' 2' ' ' VAL . 21.3 m-70 -85.98 120.54 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.047 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.09 173.58 6.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 0.0 110.012 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.396 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.33 0.586 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.716 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.3 t -121.5 93.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -58.69 129.57 42.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 109.562 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.43 -46.45 26.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.942 . . . . 0.0 110.541 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 130' ' ' ALA . 26.7 tt0 -40.18 -50.72 2.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.198 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -35.3 80.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.016 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 130' ' ' ALA . 15.9 t -72.55 -50.87 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.414 -0.804 . . . . 0.0 108.982 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 130' ' ' ALA . 3.2 ttpt -63.0 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.746 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.3 -44.23 72.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.628 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t -57.78 -33.01 68.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.19 12.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.888 . . . . 0.0 110.106 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -48.38 -52.9 19.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 110.285 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.9 mt -69.62 -44.52 70.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.845 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -49.33 -46.52 35.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.552 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 30.8 tt0 -61.29 -30.23 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -30.75 68.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.845 HD12 ' HA2' ' A' ' 140' ' ' GLY . 3.0 mt -73.03 -47.46 44.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.738 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.1 pp -69.44 -22.51 63.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 109.904 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' SER . 2.9 ttp180 -83.78 -34.54 24.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.053 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -63.35 -44.43 94.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.379 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.91 -49.66 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.557 -0.714 . . . . 0.0 109.94 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 8.9 tt0 -56.53 -46.43 80.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.641 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 1.1 t -64.93 -43.92 91.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.456 -0.777 . . . . 0.0 109.872 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -50.99 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.099 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 13' ' ' ILE . 3.8 mt -44.97 -34.39 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -34.2 62.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.829 . . . . 0.0 110.131 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.206 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.412 HG22 ' CG ' ' A' ' 121' ' ' HIS . 2.6 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.412 0.625 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -94.31 149.63 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -0.759 . . . . 0.0 109.427 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.54 144.49 48.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.125 -0.984 . . . . 0.0 110.634 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HG11 ' A' ' 133' ' ' VAL . 34.1 m-85 -153.77 69.92 0.81 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.436 -0.79 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 10.7 pt-20 -100.59 135.81 41.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.758 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.427 HG21 ' HD2' ' A' ' 137' ' ' LYS . 0.2 OUTLIER -134.92 177.93 7.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.017 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -158.12 161.12 37.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 110.356 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 10' ' ' THR . 3.1 m -147.6 -175.88 5.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 110.097 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.648 ' H ' HG22 ' A' ' 9' ' ' THR . 1.8 p -122.19 160.98 24.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 110.308 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -157.93 136.84 11.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.768 . . . . 0.0 109.803 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 34.6 m -80.02 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.103 -0.998 . . . . 0.0 109.154 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 151' ' ' LEU . 45.3 mm -77.75 149.22 77.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.5 Cg_endo -64.02 148.48 91.52 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.264 1.139 . . . . 0.0 111.187 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.46 -24.36 60.21 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.114 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.03 -50.96 11.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.277 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 3.0 tpm_? -64.57 -40.3 95.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.098 -1.001 . . . . 0.0 109.603 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 18' ' ' LEU . 8.5 tt -71.23 -37.47 72.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.598 -0.689 . . . . 0.0 110.187 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.715 ' CD1' HD13 ' A' ' 23' ' ' ILE . 76.4 t80 -61.59 -69.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.314 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.15 -51.77 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.878 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.1 74.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.0 t80 -84.86 -10.08 57.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.715 HD13 ' CD1' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -124.78 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.902 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.693 HD23 ' NE2' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -51.96 -42.25 62.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.264 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -104.3 -1.51 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -47.95 -52.69 16.07 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.475 ' OD2' ' HB ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -48.05 -23.15 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -1.21 . . . . 0.0 110.06 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -112.55 -23.84 10.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -84.81 -27.94 26.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.141 -0.974 . . . . 0.0 110.045 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.894 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -64.51 -60.08 9.25 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -74.01 53.14 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.823 1.433 . . . . 0.0 110.254 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.84 -58.1 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 29' ' ' LEU . 27.0 m -85.92 -16.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.373 -0.829 . . . . 0.0 110.45 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.56 71.18 5.46 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.48 -12.5 27.18 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.993 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.44 ' C ' ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -64.55 -21.15 66.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.467 -0.771 . . . . 0.0 110.115 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.9 -60.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.868 . . . . 0.0 110.02 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.894 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -113.56 145.01 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.747 . . . . 0.0 109.745 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.55 -57.69 2.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.7 t -155.3 157.51 37.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.554 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' A' ' 56' ' ' ILE . 59.0 t -114.4 138.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -129.35 87.24 2.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.895 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 6.2 m-20 -54.73 114.34 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.717 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 54' ' ' LYS . 4.9 mt -82.54 -38.51 15.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.197 0.999 . . . . 0.0 108.676 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.442 ' HB3' HD12 ' A' ' 53' ' ' ILE . 23.1 tt0 . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 121.655 0.741 . . . . 0.0 110.176 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.76 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.4 Cg_endo -72.95 101.54 1.33 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.048 1.552 . . . . 0.0 110.909 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 111.32 -1.25 28.08 Favored Glycine 0 N--CA 1.48 1.579 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.76 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.0 OUTLIER -58.4 154.14 14.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -1.201 . . . . 0.0 109.585 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 45' ' ' GLU . 18.2 mt -116.64 143.38 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -157.49 144.43 18.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 110.539 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -92.34 102.22 14.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' A' ' 41' ' ' VAL . 5.5 mm -82.76 130.09 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.86 . . . . 0.0 109.48 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.87 153.73 22.6 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.288 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 32.8 p90 -110.92 155.64 42.09 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 110.12 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.457 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 45.6 Cg_endo . . . . . 0 C--N 1.304 -1.782 0 O-C-N 124.032 1.543 . . . . 0.0 110.626 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 29.6 p90 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.066 0.46 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG13 ' C ' ' A' ' 66' ' ' TYR . 10.4 m -152.23 179.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 0.0 110.413 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.532 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 12.5 mttt -128.83 41.84 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.689 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' SER . 45.2 p-10 -39.17 138.94 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 110.816 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 84' ' ' SER . 8.8 ttm180 -100.08 155.24 17.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.401 -0.812 . . . . 0.0 108.887 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.654 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.2 t -79.94 144.04 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.8 -1.188 . . . . 0.0 110.195 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 46.8 m-20 -96.32 -69.2 0.76 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.292 0.568 . . . . 0.0 110.159 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -146.76 132.29 18.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 81' ' ' TYR . 2.0 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 1.1 m-20 -151.61 107.01 3.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.693 ' NE2' HD23 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -81.81 -10.38 59.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 110.398 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -108.82 -45.83 3.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.15 6.39 25.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.562 -0.711 . . . . 0.0 109.987 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-30 48.56 58.75 4.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.255 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.6 ttmt -134.09 110.38 9.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.469 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.559 ' HD2' HG22 ' A' ' 74' ' ' VAL . 13.2 t80 -126.82 122.1 33.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.881 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 73.1 m-20 -128.3 141.36 51.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 46.9 p90 -138.44 133.14 32.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.316 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 64.7 m -100.95 168.27 9.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.003 -1.061 . . . . 0.0 111.156 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -104.48 127.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -126.83 -75.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.97 -1.081 . . . . 0.0 111.196 -178.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -79.06 83.36 5.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.892 -1.13 . . . . 0.0 110.109 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -109.09 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.45 -54.0 3.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -73.33 -49.58 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.871 1.458 . . . . 0.0 110.826 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 86' ' ' ILE . 42.3 mt -58.8 138.0 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.024 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.27 -60.98 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -97.6 -90.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.194 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 t -139.92 9.11 2.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -86.77 162.14 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.239 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.655 ' HG3' HD12 ' A' ' 95' ' ' LEU . 6.5 mm-40 57.67 36.33 26.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.939 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -81.33 155.6 25.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.582 HG12 ' CD2' ' A' ' 120' ' ' TYR . 2.7 mp -138.64 129.05 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 110.516 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.07 120.47 41.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 1.9 m-20 -110.02 149.36 30.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.515 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 34.5 mt-10 -141.63 163.92 31.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.371 -0.831 . . . . 0.0 110.048 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.564 HG22 HD11 ' A' ' 104' ' ' ILE . 19.4 mt -153.57 106.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.806 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -108.11 118.41 36.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.415 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 104' ' ' ILE . 3.9 mp -110.35 133.52 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.055 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 113' ' ' ILE . 25.0 t -137.43 134.06 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 0.0 110.487 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -82.15 148.31 28.57 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.703 -0.623 . . . . 0.0 110.718 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.3 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.415 -0.803 . . . . 0.0 109.437 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.816 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -135.17 -178.74 5.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.477 -1.014 . . . . 0.0 110.557 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.446 HG13 ' C ' ' A' ' 112' ' ' SER . 25.1 mt -134.41 124.6 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.67 135.83 39.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.008 . . . . 0.0 110.65 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -128.64 98.99 5.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.778 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.1 mt -87.57 145.67 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.497 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -129.65 108.38 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -0.874 . . . . 0.0 110.005 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -109.81 128.4 55.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.415 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 137.11 51.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.053 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.595 ' CD2' HG21 ' A' ' 128' ' ' VAL . 5.9 t80 -109.67 143.01 40.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.412 ' CG ' HG22 ' A' ' 2' ' ' VAL . 16.1 m80 -120.81 131.54 54.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.877 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -114.11 174.75 5.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.235 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.877 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 121.651 0.739 . . . . 0.0 109.784 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.4 p -112.98 108.55 25.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.369 0.604 . . . . 0.0 110.759 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 133.25 55.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.463 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -63.17 -9.44 11.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.734 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -55.21 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.171 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -54.84 -36.04 64.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.358 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG11 ' CD2' ' A' ' 5' ' ' TYR . 12.1 t -67.45 -47.79 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.541 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 1.4 mmtt -59.4 -34.48 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.428 -0.795 . . . . 0.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.89 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -74.74 -35.69 62.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.466 -0.771 . . . . 0.0 109.874 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.427 ' HD2' HG21 ' A' ' 7' ' ' THR . 26.1 ttpp -72.46 -37.11 68.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.837 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -58.5 -42.68 88.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 140' ' ' GLY . 2.0 tp -75.17 -43.85 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.631 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -45.27 -50.19 9.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.4 mt-10 -59.87 -31.35 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -1.159 . . . . 0.0 110.215 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.6 m -70.69 -27.48 64.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.012 -1.055 . . . . 0.0 109.649 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.631 HD12 ' HA2' ' A' ' 140' ' ' GLY . 50.8 mt -72.53 -49.38 33.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 110.061 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.679 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -65.6 -25.4 67.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.015 . . . . 0.0 109.472 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.2 OUTLIER -78.92 -33.8 45.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.427 -0.796 . . . . 0.0 109.676 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.97 84.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.381 -0.825 . . . . 0.0 109.638 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.6 t -71.19 -46.97 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -54.18 -46.5 72.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.63 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 t -61.01 -50.35 73.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.656 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.429 ' CE1' HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -48.07 -72.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 109.936 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.636 HD13 HG21 ' A' ' 13' ' ' ILE . 5.4 mt -43.09 -43.72 4.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.002 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -61.38 -43.31 99.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.202 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 110.381 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.391 0.615 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.8 m-85 -94.36 138.59 32.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.51 -0.744 . . . . 0.0 109.916 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.07 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.054 . . . . 0.0 110.42 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.513 ' CE2' HG11 ' A' ' 133' ' ' VAL . 17.6 m-85 -141.16 59.26 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.542 -0.723 . . . . 0.0 109.218 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.0 pt-20 -88.47 142.89 27.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.484 -0.76 . . . . 0.0 110.797 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.39 178.55 8.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.527 -0.733 . . . . 0.0 109.818 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HB2' ' HG3' ' A' ' 115' ' ' LYS . 2.3 pp20? -150.61 143.15 24.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 10' ' ' THR . 1.6 m -130.2 -174.76 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.599 ' H ' HG22 ' A' ' 9' ' ' THR . 1.2 p -119.95 159.43 24.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 110.614 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.495 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -154.26 135.58 14.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' OE2' ' A' ' 148' ' ' GLU . 17.7 m -79.91 -12.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.914 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.788 HG23 ' HD2' ' A' ' 14' ' ' PRO . 5.1 mm -71.31 150.44 94.24 Favored Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.788 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.31 150.77 86.89 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 123.293 1.154 . . . . 0.0 111.08 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.94 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.16 -29.85 63.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.88 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.26 -54.23 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 110.076 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -67.42 -30.97 70.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 109.771 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.574 ' HB2' HG22 ' A' ' 13' ' ' ILE . 29.1 tp -73.8 -29.19 62.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.959 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.746 ' CD1' HD13 ' A' ' 23' ' ' ILE . 71.8 t80 -71.71 -57.17 4.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 110.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 31.9 mtpt -54.34 -41.24 68.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.78 . . . . 0.0 110.298 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.58 -33.79 74.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -91.6 -7.34 50.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.719 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.746 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -121.16 -56.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 24' ' ' LEU . 8.4 mt -72.99 -25.25 60.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -130.03 14.53 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -58.69 -42.47 96.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' O ' HG21 ' A' ' 41' ' ' VAL . 55.6 m-20 -65.05 -27.19 68.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -1.14 . . . . 0.0 110.317 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.3 m-20 -92.14 -38.95 11.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.491 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.004 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.8 mp -76.13 -25.97 55.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -55.64 -59.69 10.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.914 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.5 Cg_endo -71.37 0.43 6.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.994 1.523 . . . . 0.0 111.256 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -105.58 -50.94 3.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.988 -1.07 . . . . 0.0 110.577 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.004 HG22 ' O ' ' A' ' 29' ' ' LEU . 35.9 m -87.33 -11.15 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -160.04 71.24 3.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.013 . . . . 0.0 110.396 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.73 -6.73 19.75 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.033 1.544 . . . . 0.0 110.504 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.503 ' O ' ' CG ' ' A' ' 59' ' ' PRO . 16.1 mt-30 -73.33 -30.01 63.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.558 ' CB ' HD23 ' A' ' 139' ' ' LEU . . . -89.52 -51.28 5.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.617 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.5 mp -112.32 141.39 28.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 110.031 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.444 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -109.74 -19.19 13.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.19 165.07 11.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.143 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.481 HG12 HG23 ' A' ' 56' ' ' ILE . 20.0 m -147.15 154.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.217 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 1.6 mt-10 -153.2 152.98 31.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.532 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.7 112.5 25.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.0 110.055 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.67 HD12 HG22 ' A' ' 53' ' ' ILE . 6.3 mt -80.2 -39.9 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.233 1.016 . . . . 0.0 108.346 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.827 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.908 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.81 87.54 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.071 1.564 . . . . 0.0 110.602 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.89 -6.63 3.78 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.908 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 95.5 m -67.91 164.07 20.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -1.211 . . . . 0.0 109.32 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.67 HG22 HD12 ' A' ' 44' ' ' ILE . 8.3 mt -137.13 149.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.729 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.515 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -155.21 141.6 18.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.393 -0.817 . . . . 0.0 110.561 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.5 tptm -90.39 113.03 24.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.663 -0.648 . . . . 0.0 110.508 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.481 HG23 HG12 ' A' ' 41' ' ' VAL . 28.4 mt -101.49 139.88 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.475 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -102.53 159.93 15.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.64 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -136.82 136.99 22.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 0.0 109.857 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 36' ' ' GLN . 46.5 Cg_endo . . . . . 0 C--N 1.304 -1.807 0 O-C-N 123.888 1.467 . . . . 0.0 110.466 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.524 ' C ' HG12 ' A' ' 67' ' ' VAL . 55.7 p90 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.609 0.719 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -179.68 172.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.858 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -115.64 132.33 56.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.902 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 8.9 p-10 -133.29 131.04 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' CG ' ' HB2' ' A' ' 84' ' ' SER . 8.2 ptt180 -98.23 151.24 20.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.071 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.741 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.6 t -80.02 147.05 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.782 -1.199 . . . . 0.0 110.251 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 11.3 t0 -97.56 -62.35 1.26 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.099 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.3 tt0 -155.22 120.91 5.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.236 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 81' ' ' TYR . 2.9 t -116.02 142.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.321 -0.862 . . . . 0.0 110.085 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -139.98 118.24 12.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.91 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -82.6 1.45 38.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.831 . . . . 0.0 110.796 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -119.86 -38.31 2.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.05 20.36 10.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.501 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 22.9 m-30 44.66 58.56 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.555 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -127.01 129.6 48.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.052 -1.03 . . . . 0.0 110.16 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.722 ' CD1' HG22 ' A' ' 74' ' ' VAL . 77.5 t80 -148.51 94.37 2.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.947 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 71.6 m-20 -109.98 137.78 47.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.195 -0.94 . . . . 0.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.7 p90 -137.89 143.48 40.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.9 . . . . 0.0 110.004 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 70' ' ' ARG . 74.2 m -106.17 170.61 7.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.075 -1.015 . . . . 0.0 111.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.428 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 53.9 t -112.16 125.38 69.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -116.61 -72.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.856 -1.152 . . . . 0.0 111.735 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -87.78 85.64 7.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.269 . . . . 0.0 110.436 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.478 ' HA2' HG23 ' A' ' 67' ' ' VAL . . . -106.42 141.31 15.46 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.558 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.02 -53.39 2.57 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.7 Cg_endo -71.66 -40.34 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.744 1.391 . . . . 0.0 110.512 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.57 140.19 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 0.0 110.025 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.59 -85.06 1.13 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -83.42 -80.04 0.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -1.172 . . . . 0.0 110.434 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -145.34 13.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.464 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.647 HD23 ' HB2' ' A' ' 123' ' ' LYS . 4.1 mp -87.7 153.73 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.051 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.4 tt0 61.34 36.05 17.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 0.4 OUTLIER -69.67 162.54 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.482 HG12 ' CD1' ' A' ' 120' ' ' TYR . 8.3 mt -145.89 136.02 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 110.565 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -120.97 117.27 26.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.656 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 1.9 m-80 -101.37 141.27 34.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.76 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.521 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 0.9 OUTLIER -131.19 132.36 44.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.713 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.657 HD12 ' HD2' ' A' ' 81' ' ' TYR . 43.0 mt -126.5 124.34 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.002 -1.061 . . . . 0.0 110.704 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -129.12 127.23 41.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.672 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.559 HG22 ' HB1' ' A' ' 15' ' ' ALA . 93.3 mt -116.72 125.46 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.718 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.5 t -127.3 136.47 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.425 -0.797 . . . . 0.0 109.716 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.1 143.55 27.01 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.552 0.691 . . . . 0.0 111.035 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.3 p . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.647 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.94 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -133.27 155.99 48.39 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.724 -0.868 . . . . 0.0 110.774 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 113' ' ' ILE . 6.0 tt -109.66 120.12 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.05 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -101.45 122.49 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.931 -1.105 . . . . 0.0 111.18 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 8' ' ' GLU . 4.8 mttt -102.23 111.09 23.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 7' ' ' THR . 55.4 mt -97.19 140.29 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.638 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -125.87 118.04 24.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.074 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -119.85 125.41 48.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.173 -0.954 . . . . 0.0 110.23 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 3.6 mtpp -116.35 138.2 51.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 110.466 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.482 ' CD1' HG12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -112.83 124.72 53.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.262 -0.899 . . . . 0.0 109.707 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 36.0 m-70 -106.22 113.12 26.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.985 . . . . 0.0 110.355 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.559 HG21 HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -122.59 167.05 13.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.1 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.647 ' HB2' HD23 ' A' ' 95' ' ' LEU . 5.0 mmtp . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.6 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.721 ' O ' HG12 ' A' ' 128' ' ' VAL . 3.8 t -118.92 88.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 110.117 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -59.73 127.81 33.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -44.82 -45.46 10.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.113 -0.992 . . . . 0.0 110.204 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.0 mm-40 -38.64 -59.1 0.97 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -29.1 69.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.513 HG11 ' CE2' ' A' ' 5' ' ' TYR . 8.9 t -78.6 -49.64 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 130' ' ' ALA . 12.6 mttt -63.21 -25.71 68.46 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.419 -0.801 . . . . 0.0 109.531 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.99 -39.56 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.542 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 t -65.46 -33.79 76.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 109.688 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -79.15 -46.09 18.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.769 . . . . 0.0 109.818 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' OG1' ' A' ' 142' ' ' THR . 1.7 mt-10 -43.25 -67.47 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.558 HD23 ' CB ' ' A' ' 37' ' ' ALA . 2.5 mp -67.04 -30.2 70.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.91 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.82 -63.81 4.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.534 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -52.23 -32.13 35.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -69.78 -27.24 64.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.675 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 69.3 mt -72.15 -50.31 28.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.749 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.601 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -68.14 -28.52 67.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.406 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.13 -34.53 43.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.794 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.22 77.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.882 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.65 -48.07 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.931 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -50.59 -41.05 54.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.432 179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -66.34 -47.55 73.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.593 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.895 ' CD1' HG12 ' A' ' 33' ' ' VAL . 1.8 t80 -45.69 -67.6 0.27 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.469 -0.77 . . . . 0.0 110.563 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 13' ' ' ILE . 10.3 mt -57.49 -39.03 75.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.362 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -49.2 -40.38 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.49 HG22 ' ND1' ' A' ' 121' ' ' HIS . 2.7 t . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.482 0.658 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 4.0 m-85 -93.33 167.63 11.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -138.25 144.23 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.994 . . . . 0.0 110.811 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 64.6 m-85 -156.12 57.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.74 . . . . 0.0 109.604 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 14.9 mt-10 -88.94 145.88 25.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.372 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -150.65 173.06 14.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 4.6 pt-20 -151.15 155.79 39.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 110.551 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.509 HG22 ' H ' ' A' ' 10' ' ' THR . 3.1 m -139.36 176.84 8.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -112.75 163.65 14.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 110.581 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -159.93 136.46 9.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.648 -0.657 . . . . 0.0 109.454 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 9.9 p -80.19 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.806 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.842 HG21 HD13 ' A' ' 151' ' ' LEU . 42.0 mm -71.81 149.15 92.71 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.662 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -64.9 148.66 89.97 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.463 1.244 . . . . 0.0 111.282 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -66.48 -47.11 74.08 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.82 74.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.499 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -63.38 -37.97 89.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -72.25 -35.84 68.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.432 -0.792 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' ILE . 40.1 t80 -64.55 -63.84 1.03 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -48.57 -48.46 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.102 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -38.6 91.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 4.1 t80 -86.3 -11.11 53.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.215 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.812 HD12 ' CG ' ' A' ' 81' ' ' TYR . 12.0 mm -114.72 -74.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.178 -0.951 . . . . 0.0 110.491 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 24' ' ' LEU . 20.3 mt -54.87 -51.76 64.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 110.471 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.99 8.73 36.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.17 -47.92 88.69 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 79.5 m-20 -58.51 -28.42 65.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -1.14 . . . . 0.0 110.252 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.411 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 m-20 -86.56 -46.79 9.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -35.79 80.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.222 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.707 ' CD2' HD13 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -48.97 -60.07 5.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.953 . . . . 0.0 110.046 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -73.5 53.77 2.74 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.048 1.552 . . . . 0.0 110.274 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -63.91 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 110.392 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 33' ' ' VAL . 33.2 m -82.96 -24.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 110.435 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -134.66 70.0 71.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.6 -14.58 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.995 1.524 . . . . 0.0 110.512 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -71.67 -24.19 61.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.37 -60.02 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.274 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.707 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -113.13 143.92 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -0.815 . . . . 0.0 109.888 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -47.56 8.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.266 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.4 133.89 2.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.273 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG1' ' HD3' ' A' ' 54' ' ' LYS . 94.6 t -100.46 142.01 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 53.9 mt-10 -140.88 99.28 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -61.52 117.78 6.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.517 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.4 mm -85.99 -37.59 11.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 108.425 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 1.4 tm-20 . . . . . 0 C--N 1.294 -1.806 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.437 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.816 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.97 99.19 0.65 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.807 1.425 . . . . 0.0 110.094 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 71' ' ' VAL . . . 109.48 9.39 25.34 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.816 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.1 m -65.39 166.75 9.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.407 -1.055 . . . . 0.0 109.364 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 14.6 mt -129.55 138.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 110.392 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HD3' ' CG1' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.743 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HB2' HD11 ' A' ' 44' ' ' ILE . 20.9 tttt -92.14 98.36 11.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.313 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.744 HD12 ' OD1' ' A' ' 69' ' ' ASP . 52.0 mt -87.88 120.55 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.633 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.93 143.3 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -0.963 . . . . 0.0 110.291 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.04 136.2 20.46 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.208 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--N 1.304 -1.763 0 O-C-N 123.997 1.525 . . . . 0.0 110.463 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.491 ' C ' HG12 ' A' ' 67' ' ' VAL . 27.9 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.268 0.556 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER 178.98 172.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.3 ttmt -119.18 52.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.523 -0.736 . . . . 0.0 110.47 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.744 ' OD1' HD12 ' A' ' 56' ' ' ILE . 10.2 p-10 -46.09 137.81 5.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.106 -0.996 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttm180 -100.75 157.85 16.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.228 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.582 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.6 t -84.7 146.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.877 -1.14 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.3 t70 -94.51 -68.91 0.78 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.275 0.56 . . . . 0.0 110.491 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -144.61 143.72 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 0.0 110.377 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 4.3 t -123.66 155.64 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.239 -0.913 . . . . 0.0 109.947 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.516 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -154.75 130.13 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 110.085 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -5.54 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 0.0 110.894 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -112.55 -40.6 4.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 109.884 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.88 16.21 16.6 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.337 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.7 m-85 46.74 69.01 0.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.78 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.516 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 6.2 tttt -131.19 127.14 37.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.812 ' CG ' HD12 ' A' ' 23' ' ' ILE . 34.1 t80 -150.67 88.66 1.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.459 -0.775 . . . . 0.0 109.39 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 86.3 m-20 -100.95 145.66 28.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.129 -0.982 . . . . 0.0 110.617 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.652 ' CE1' ' ND2' ' A' ' 100' ' ' ASN . 7.7 p90 -141.81 137.97 31.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.499 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ARG . 58.8 m -108.32 168.24 9.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.048 -1.032 . . . . 0.0 111.232 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.484 HG12 ' CD1' ' A' ' 91' ' ' ILE . 45.1 t -105.86 131.18 56.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER -129.5 -77.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.942 -1.099 . . . . 0.0 110.583 -179.484 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -69.58 65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.838 -1.164 . . . . 0.0 109.997 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.733 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -87.86 136.68 13.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.545 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -41.66 -54.87 4.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.0 Cg_endo -72.01 -42.1 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.823 1.433 . . . . 0.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.733 HD12 ' HA3' ' A' ' 88' ' ' GLY . 69.8 mt -56.31 145.82 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.23 -76.0 0.26 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.33 -75.94 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -1.136 . . . . 0.0 110.083 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.1 p -144.61 9.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.434 ' HB3' ' HE3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -93.06 161.91 14.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.13 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' OE1' HG13 ' A' ' 91' ' ' ILE . 0.9 OUTLIER 61.59 28.42 17.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.147 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 98' ' ' ILE . 10.5 ttmt -80.94 159.64 24.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.105 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.6 mp -141.13 133.0 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 110.641 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 m -114.79 115.64 27.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.652 ' ND2' ' CE1' ' A' ' 83' ' ' TYR . 32.2 m-80 -104.77 142.76 34.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.631 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.533 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -130.6 128.63 41.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.807 . . . . 0.0 109.634 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 116' ' ' ILE . 17.5 mm -120.34 113.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.659 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 9.8 mtmm -125.37 139.79 53.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 109.648 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.431 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 7.2 mt -127.53 142.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.027 -1.046 . . . . 0.0 110.823 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.7 t -137.52 130.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 109.548 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.04 155.98 19.53 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.635 -0.665 . . . . 0.0 111.307 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 109.868 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -141.25 162.97 34.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -1.087 . . . . 0.0 110.639 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 10' ' ' THR . 49.0 mt -120.08 120.92 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 109.377 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.5 pp -98.28 131.99 44.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 8' ' ' GLU . 19.8 mttt -112.4 110.97 21.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 7' ' ' THR . 29.0 mm -94.95 119.92 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -106.81 120.65 42.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.131 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -115.0 147.13 40.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -137.35 133.26 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.073 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.592 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -109.93 138.35 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.444 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.49 ' ND1' HG22 ' A' ' 2' ' ' VAL . 75.1 m-70 -123.69 102.37 7.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.477 HG21 HG23 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -114.92 165.35 12.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.943 . . . . 0.0 110.099 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 95' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.417 ' C ' HG21 ' A' ' 122' ' ' THR . 11.2 mt-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.123 0.487 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.3 t -128.94 92.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.921 . . . . 0.0 110.023 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HG3' ' HB3' ' A' ' 131' ' ' GLU . 20.1 ptmt -69.4 131.19 44.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.312 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 134' ' ' LYS . . . -40.47 -38.59 0.86 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 110.826 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.478 ' HB3' ' HG3' ' A' ' 129' ' ' LYS . 9.8 tp10 -39.16 -65.96 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.07 -29.93 61.26 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.556 HG11 ' CE1' ' A' ' 5' ' ' TYR . 12.9 t -74.01 -49.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 0.0 109.423 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -62.37 -32.72 73.57 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.23 -17.79 64.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.651 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -81.27 -33.38 32.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 109.845 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -28.51 60.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.893 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -60.61 -62.14 2.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.033 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.52 -30.68 66.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.705 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -59.25 -38.8 93.76 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.571 ' HA ' HD23 ' A' ' 144' ' ' LEU . 2.7 mt-10 -61.59 -38.5 87.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.151 -1.205 . . . . 0.0 110.254 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.5 m -66.83 -27.75 67.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.109 -0.994 . . . . 0.0 109.875 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.705 HD12 ' HA2' ' A' ' 140' ' ' GLY . 66.1 mt -73.33 -46.41 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.315 -0.866 . . . . 0.0 110.005 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -68.27 -30.01 68.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.005 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.431 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.65 -33.87 40.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.28 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -64.3 -46.97 81.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.29 -41.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.975 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.4 tm-20 -60.3 -48.37 82.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.64 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -44.19 93.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.462 -0.774 . . . . 0.0 110.002 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 1.2 t80 -50.55 -71.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 110.368 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.842 HD13 HG21 ' A' ' 13' ' ' ILE . 13.0 mt -49.4 -32.77 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 110.668 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -64.82 -34.49 78.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.084 -1.01 . . . . 0.0 110.404 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.704 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.47 HG22 ' ND1' ' A' ' 121' ' ' HIS . 2.6 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.374 0.607 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -118.68 127.4 53.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 10.1 p-10 -131.93 124.97 30.52 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.857 -1.152 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.616 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 93.9 m-85 -103.38 74.29 1.26 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -80.06 149.12 30.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.863 . . . . 0.0 110.528 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -160.07 -173.55 4.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.588 -0.695 . . . . 0.0 109.818 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -159.36 153.33 23.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 0.0 110.478 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 170.07 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.909 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.478 HG22 HG12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -116.63 159.84 21.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.265 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.6 m -158.86 141.66 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.645 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.494 HG23 HD12 ' A' ' 13' ' ' ILE . 12.5 m -79.85 -10.97 12.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.607 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.71 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.2 mp -67.92 149.91 98.0 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.71 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.81 151.71 83.55 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.397 1.209 . . . . 0.0 110.796 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.846 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.42 -23.09 58.89 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.698 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.42 -56.57 3.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.941 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -59.84 -32.69 70.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.945 . . . . 0.0 109.798 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -71.47 -41.73 69.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.252 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 41.4 t80 -60.89 -66.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 37.8 mttt -47.2 -42.85 20.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 110.29 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.59 69.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.449 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' HB3' HD12 ' A' ' 23' ' ' ILE . 7.9 t80 -89.88 -12.17 39.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.607 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.1 mp -124.11 -62.27 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -52.76 -34.78 54.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.878 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' GLY . 1.1 m-20 -125.0 -6.29 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.019 -1.05 . . . . 0.0 110.793 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -44.89 -45.67 9.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 15.3 p-10 -51.56 -33.41 32.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.309 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 21.8 t-20 -100.41 -33.35 10.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.759 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -69.01 -41.89 77.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.728 ' CD1' HD13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -45.04 -58.93 4.83 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.301 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.6 Cg_endo -72.04 -2.73 12.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.998 1.525 . . . . 0.0 110.621 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 4.8 mmtp -104.51 -60.61 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.7 m -84.69 -18.15 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.454 -0.779 . . . . 0.0 110.528 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HB1' ' CD2' ' A' ' 143' ' ' LEU . . . -135.01 68.52 70.58 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.591 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.47 -1.4 11.28 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.036 1.545 . . . . 0.0 110.119 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.62 -20.94 25.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 110.333 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -104.67 -58.21 1.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.459 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.728 HD13 ' CD1' ' A' ' 30' ' ' PHE . 1.2 mp -104.1 129.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 110.093 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -83.85 -48.38 10.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.357 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -163.72 155.95 17.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 56' ' ' ILE . 61.5 t -118.69 146.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.87 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -144.15 90.38 2.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.347 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 74.4 m-20 -56.38 119.35 5.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.454 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.532 ' CD1' ' HD3' ' A' ' 68' ' ' LYS . 15.2 mt -87.83 -37.81 11.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.232 1.015 . . . . 0.0 108.525 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 52' ' ' THR . 32.1 tt0 . . . . . 0 C--N 1.294 -1.821 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.379 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.564 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -74.0 122.44 7.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.079 1.568 . . . . 0.0 110.376 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.6 0.66 62.5 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.674 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -71.01 156.54 39.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.464 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 44' ' ' ILE . 5.3 mt -119.83 135.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.934 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HA ' HG13 ' A' ' 44' ' ' ILE . 6.7 ptmt -149.33 143.44 25.8 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 110.278 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -89.22 106.48 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' CD1' HG13 ' A' ' 41' ' ' VAL . 41.9 mm -89.55 122.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.882 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.461 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 52.1 m -84.15 142.0 30.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 110.38 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.19 146.05 33.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 124.077 1.567 . . . . 0.0 110.563 -179.737 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' VAL . 4.3 p90 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.386 0.612 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 66' ' ' TYR . 19.6 m -156.79 140.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.473 -0.767 . . . . 0.0 109.768 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -83.83 127.48 33.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.023 . . . . 0.0 110.401 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 83' ' ' TYR . 12.1 t70 -126.24 124.44 40.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.824 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.9 ttp85 -98.73 144.08 28.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.0 109.031 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -75.26 146.3 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.819 -1.175 . . . . 0.0 110.126 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 22.6 t70 -98.68 -72.43 0.65 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.43 0.634 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -135.94 144.06 45.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.718 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.5 t -130.65 128.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 13.4 m-20 -135.97 104.03 5.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.458 ' CD2' ' N ' ' A' ' 76' ' ' HIS . 13.6 m-70 -79.37 -9.92 59.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.273 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -111.27 -37.81 5.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -89.66 3.22 53.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 110.045 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.609 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.6 m-30 55.7 59.67 3.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 75' ' ' ASP . 12.1 tttp -139.36 114.87 9.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 110.074 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.718 ' CD2' HG22 ' A' ' 74' ' ' VAL . 59.8 t80 -136.26 116.47 13.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.1 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.448 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 53.5 m-20 -127.47 151.08 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 27.2 p90 -145.28 136.63 25.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.877 . . . . 0.0 109.506 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.2 m -100.51 164.5 11.88 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.121 -0.987 . . . . 0.0 111.14 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG22 ' OD2' ' A' ' 69' ' ' ASP . 55.4 t -108.82 126.15 65.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -115.52 -74.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.767 -1.208 . . . . 0.0 111.869 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.89 59.34 3.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.655 -1.278 . . . . 0.0 110.274 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 148.95 16.95 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 52.5 -157.18 4.05 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.35 6.71 4.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.067 1.561 . . . . 0.0 111.021 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.0 mt -51.47 148.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.63 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' THR . . . -152.88 141.96 8.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.87 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -1.173 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 16.7 p -147.61 14.72 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.408 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 96' ' ' GLU . 1.6 pp -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.793 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.787 ' HB2' HD12 ' A' ' 95' ' ' LEU . 1.6 mt-10 53.31 34.84 18.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.115 -0.991 . . . . 0.0 109.247 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -71.68 157.72 37.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.543 -0.723 . . . . 0.0 110.262 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 120' ' ' TYR . 61.9 mt -142.18 125.35 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 110.628 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.63 108.55 13.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.539 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -97.03 142.96 28.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.707 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 102' ' ' ILE . 25.5 mt-10 -130.23 164.18 25.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -0.796 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 101' ' ' GLU . 23.1 mm -151.63 110.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -113.59 134.17 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.151 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.556 ' C ' HG23 ' A' ' 105' ' ' VAL . 52.9 mt -117.86 152.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.399 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.556 HG23 ' C ' ' A' ' 104' ' ' ILE . 27.0 t -153.22 119.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 109.856 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -75.86 151.06 37.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.477 0.656 . . . . 0.0 111.037 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 111' ' ' GLY . 3.1 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.654 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.846 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -135.57 168.71 18.74 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.705 -0.879 . . . . 0.0 110.505 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.478 HG12 HG22 ' A' ' 10' ' ' THR . 50.0 mt -127.92 124.36 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.194 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 1.6 pp -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 111.024 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -110.31 114.8 28.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.6 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.473 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 35.5 mt -90.89 131.95 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.366 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -118.31 105.58 11.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 110.258 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 4.6 t-20 -92.94 155.38 17.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.022 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -152.76 132.99 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -132.75 103.18 5.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 89.2 m-70 -82.2 142.38 32.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.984 -1.072 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 p -106.28 -170.29 1.7 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 0.0 109.887 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 1.2 ttmt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 110.273 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.39 0.614 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.604 HG21 ' HB3' ' A' ' 120' ' ' TYR . 2.6 t -112.67 101.51 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 110.076 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 133' ' ' VAL . 1.6 mmtp -68.57 129.08 38.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.24 -49.12 61.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 111.071 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -38.4 -48.36 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -68.73 -34.09 75.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.079 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.616 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 6.0 t -75.15 -47.46 35.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 130' ' ' ALA . 9.5 tttp -61.1 -31.16 70.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.424 -0.797 . . . . 0.0 109.561 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.88 -49.48 51.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 t -65.83 -33.01 74.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 0.0 109.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -71.7 -34.86 69.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.052 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -49.95 -55.61 13.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 37' ' ' ALA . 4.3 mm? -67.05 -36.0 81.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.015 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.1 -40.13 13.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.64 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.4 OUTLIER -70.29 -63.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -1.072 . . . . 0.0 109.878 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.2 m -51.32 -22.33 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 13.2 mt -69.94 -54.25 14.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.985 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -57.63 -25.43 60.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.085 -1.01 . . . . 0.0 109.257 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -82.3 -33.58 28.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.98 85.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.449 -0.782 . . . . 0.0 109.743 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.21 -52.52 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.428 -0.795 . . . . 0.0 109.869 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 26.7 tt0 -51.73 -36.6 47.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.879 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 2.4 t -67.36 -54.45 20.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 110.026 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 151' ' ' LEU . 1.3 t80 -48.74 -69.95 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 0.0 110.433 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 13' ' ' ILE . 10.9 mt -41.56 -46.35 3.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.524 -0.735 . . . . 0.0 110.75 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.9 mt -70.34 -27.6 64.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.915 . . . . 0.0 110.549 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 110.198 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.402 0.62 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.531 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 18.1 m-85 -100.7 161.79 13.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.421 -0.799 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -138.19 140.98 40.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 110.369 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.748 ' CE2' HG11 ' A' ' 133' ' ' VAL . 23.4 m-85 -152.18 59.18 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.855 . . . . 0.0 109.775 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 4.5 tm-20 -80.98 153.22 27.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.525 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -149.93 163.27 38.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.684 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.38 164.45 34.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.669 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.14 -179.9 7.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -112.75 160.52 17.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 110.407 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.72 136.71 10.52 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.528 -0.732 . . . . 0.0 109.812 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.473 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 19.6 m -79.91 -16.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.139 -0.975 . . . . 0.0 108.57 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.758 HG21 HD13 ' A' ' 151' ' ' LEU . 24.9 mm -65.79 148.59 98.15 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.1 150.06 85.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.613 1.323 . . . . 0.0 110.917 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.717 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.27 -30.64 62.21 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.903 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.32 -49.32 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.083 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.553 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 1.2 tpt180 -66.57 -32.02 73.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.952 . . . . 0.0 109.709 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 114' ' ' LEU . 1.5 tt -74.81 -37.63 62.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CE1' HG13 ' A' ' 23' ' ' ILE . 6.1 t80 -64.05 -57.06 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.04 -52.85 59.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 110.292 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.84 69.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.698 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 36.2 t80 -91.96 -16.14 27.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.203 -0.936 . . . . 0.0 110.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.573 HG13 ' CE1' ' A' ' 19' ' ' PHE . 12.5 mm -109.21 -69.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.104 -0.997 . . . . 0.0 110.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HA ' HD23 ' A' ' 24' ' ' LEU . 9.2 mt -59.03 -34.48 71.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.455 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.5 -14.17 16.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.88 -30.55 9.29 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.91 -36.83 77.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -1.131 . . . . 0.0 110.396 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 8.0 p-10 -109.13 -22.89 11.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -72.5 -42.54 64.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -47.44 -59.91 4.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.353 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -72.46 -1.26 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.04 1.548 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.3 mttt -99.41 -65.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 29' ' ' LEU . 35.6 m -82.91 5.31 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 110.516 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -157.04 64.33 3.3 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.293 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.16 1.82 6.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.075 1.566 . . . . 0.0 110.738 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -89.44 -19.31 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.56 -69.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.0 mp -94.42 149.55 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.326 -0.858 . . . . 0.0 109.504 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.437 ' HB3' ' CA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.93 -33.47 9.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 110.75 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.76 171.16 11.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.958 -1.088 . . . . 0.0 110.822 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.3 t -138.9 139.0 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.933 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -145.08 112.25 6.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 110.64 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -69.7 114.9 8.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 110.113 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 55' ' ' LYS . 16.6 mm -80.63 -38.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.275 1.036 . . . . 0.0 108.484 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 6.4 tp10 . . . . . 0 C--N 1.294 -1.815 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.043 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG11 ' A' ' 71' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 49.8 Cg_endo -75.88 131.73 13.59 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.056 1.556 . . . . 0.0 110.354 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' A' ' 70' ' ' ARG . . . 90.74 -1.26 78.17 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.649 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.6 m -72.69 167.6 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.545 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 10.0 mt -127.04 131.17 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.804 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.945 ' CE ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -144.0 141.46 30.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 110.561 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HB2' HD11 ' A' ' 44' ' ' ILE . 13.9 tptt -99.38 107.63 19.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 110.459 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.945 HD11 ' CE ' ' A' ' 54' ' ' LYS . 28.4 mm -88.22 128.04 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -92.59 156.04 17.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 67' ' ' VAL . 30.0 m-85 -132.93 141.46 41.1 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.119 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 124.037 1.546 . . . . 0.0 110.431 -179.839 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.781 ' O ' HG13 ' A' ' 67' ' ' VAL . 5.0 p90 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 66' ' ' TYR . 2.5 m -162.95 133.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 110.048 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 16.5 ttpt -91.67 141.25 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -0.957 . . . . 0.0 110.046 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.82 134.04 36.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 109.839 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.496 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 3.8 ttm180 -95.4 134.3 38.38 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.649 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.7 t -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.014 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 12.6 t0 -99.41 -72.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.445 0.64 . . . . 0.0 110.407 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 tt0 -137.39 138.25 39.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.526 -0.734 . . . . 0.0 110.175 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.024 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.1 t -124.69 143.34 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.725 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 m-20 -150.91 93.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -72.85 -1.66 17.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -110.34 -33.23 6.69 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.331 -0.856 . . . . 0.0 108.821 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.48 16.22 27.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.676 -0.64 . . . . 0.0 109.997 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.564 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.2 m-30 44.91 48.71 9.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 5.8 ttpt -126.42 113.6 17.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.109 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 1.024 ' CD2' HG22 ' A' ' 74' ' ' VAL . 42.1 t80 -138.31 117.62 12.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 110.191 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 29.2 t-20 -124.7 165.45 17.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.171 -0.956 . . . . 0.0 109.889 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 7.7 p90 -159.37 134.55 8.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 14.4 m -93.29 161.98 14.18 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.173 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.9 t -103.51 123.71 57.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG22 ' HZ1' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -117.07 -72.92 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 111.61 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -82.91 89.63 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.596 -1.315 . . . . 0.0 110.49 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.489 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -109.08 152.04 17.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.14 -61.37 2.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.5 Cg_endo -71.69 -47.33 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.964 1.507 . . . . 0.0 110.64 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.0 mt -53.98 150.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.089 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.83 -72.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.71 -75.88 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.168 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.55 21.36 0.92 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.141 -0.975 . . . . 0.0 110.495 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.587 HD23 ' CB ' ' A' ' 123' ' ' LYS . 2.5 mp -96.69 158.94 15.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.947 . . . . 0.0 110.337 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 57.09 35.39 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.996 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -67.72 151.69 46.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.817 HD11 ' CE1' ' A' ' 120' ' ' TYR . 19.7 mt -139.54 129.26 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 t -119.29 111.55 18.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.397 -0.814 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.575 ' OD1' HG22 ' A' ' 98' ' ' ILE . 1.8 m-20 -103.52 144.4 31.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.69 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 117' ' ' SER . 13.2 tm-20 -122.84 163.28 20.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.403 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.447 HG13 ' C ' ' A' ' 101' ' ' GLU . 92.5 mt -145.52 102.42 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.898 . . . . 0.0 110.043 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -111.41 128.31 55.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.652 HG22 ' HB1' ' A' ' 15' ' ' ALA . 15.8 mt -118.96 124.68 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 110.379 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.8 t -129.12 133.24 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.293 -0.88 . . . . 0.0 110.109 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.94 147.78 24.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.665 -0.647 . . . . 0.0 111.288 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.7 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 0.0 109.022 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.717 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -140.79 167.49 22.05 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.577 -0.955 . . . . 0.0 110.552 -179.334 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 107' ' ' THR . 3.5 mt -117.4 120.71 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.204 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -91.75 142.02 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.992 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -130.8 96.49 4.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.605 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.9 115.51 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.567 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.545 ' CB ' ' HB3' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -91.36 152.13 20.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -146.67 124.86 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.097 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.88 144.5 49.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.11 -0.994 . . . . 0.0 110.471 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.817 ' CE1' HD11 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -122.02 135.35 54.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.989 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.54 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 22.5 m-70 -117.42 120.05 36.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 110.467 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.711 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.45 167.3 10.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.587 ' CB ' HD23 ' A' ' 95' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.492 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.711 ' HA ' HG21 ' A' ' 122' ' ' THR . 10.0 pt-20 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.719 0.771 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 128' ' ' VAL . 2.3 p -113.35 95.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.675 -0.641 . . . . 0.0 110.631 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 128' ' ' VAL . 15.4 mttt -42.87 139.04 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.8 -9.66 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 110.062 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -67.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.954 . . . . 0.0 109.887 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -53.7 -30.65 44.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.217 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.748 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.8 t -71.62 -52.07 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.496 -0.753 . . . . 0.0 109.486 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -61.84 -29.21 70.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.85 . . . . 0.0 109.792 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.88 60.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.788 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.3 t -71.66 -31.21 66.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.835 . . . . 0.0 110.097 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -74.89 -36.91 62.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -62.77 -46.62 87.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 110.072 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -38.85 58.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.2 -34.91 89.86 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.673 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.92 -50.68 65.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -1.142 . . . . 0.0 110.211 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -58.78 -24.57 61.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.424 HD23 ' CB ' ' A' ' 34' ' ' ALA . 36.0 mt -74.65 -42.79 57.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -67.58 -27.82 67.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 149' ' ' SER . 0.0 OUTLIER -81.76 -32.03 31.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 109.831 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.66 93.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.783 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' A' ' 22' ' ' PHE . 60.9 t -73.2 -43.68 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.815 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 27.2 tt0 -59.43 -43.98 92.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.834 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -62.01 -42.41 99.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 109.57 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -57.14 -73.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 110.098 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.758 HD13 HG21 ' A' ' 13' ' ' ILE . 1.4 mt -42.5 -33.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.142 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -58.98 -32.08 69.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.336 -0.853 . . . . 0.0 110.172 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.354 0.597 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.518 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 20.8 m-85 -107.47 169.09 8.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 109.865 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -149.21 143.18 25.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.798 ' CE2' HG11 ' A' ' 133' ' ' VAL . 55.5 m-85 -154.86 60.57 0.66 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 109.581 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -80.16 150.93 30.0 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.587 0.708 . . . . 0.0 110.501 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.428 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -147.75 174.5 11.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.486 -0.759 . . . . 0.0 109.712 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -158.7 163.54 36.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.724 ' HB ' HD21 ' A' ' 114' ' ' LEU . 12.0 m -159.91 154.99 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 110.213 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.49 163.37 13.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.478 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -158.47 138.92 12.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 76.2 t -80.0 -14.01 13.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.136 -0.978 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.918 HG21 HD12 ' A' ' 151' ' ' LEU . 22.0 mm -67.52 150.3 97.92 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.766 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.3 Cg_endo -67.09 149.95 82.33 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.503 1.265 . . . . 0.0 110.701 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.92 -25.2 58.74 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.892 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 -54.79 6.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.476 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 14.5 mtp180 -65.8 -31.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.722 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.526 HD23 HG21 ' A' ' 104' ' ' ILE . 30.0 tp -71.29 -32.39 68.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.811 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.848 ' CD2' HD13 ' A' ' 23' ' ' ILE . 6.3 t80 -70.45 -64.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -46.67 -42.55 16.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 110.481 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . . . -70.68 -36.04 73.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.517 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 17.4 t80 -91.96 -11.3 36.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.816 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.848 HD13 ' CD2' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -118.75 -62.19 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 109.982 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -72.87 -23.43 60.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.833 . . . . 0.0 110.109 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.526 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . 1.7 t70 -128.85 3.13 5.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -59.85 -37.81 93.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.697 ' O ' HG21 ' A' ' 41' ' ' VAL . 76.4 m-20 -59.61 -25.45 64.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -1.101 . . . . 0.0 110.262 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -98.67 -22.62 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.45 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.888 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -93.04 -22.89 18.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -58.13 -58.08 21.36 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 109.932 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 49.4 Cg_endo -75.36 2.9 6.29 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.065 1.56 . . . . 0.0 110.679 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 1.2 mtpt -105.27 -60.09 1.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.016 -1.052 . . . . 0.0 110.76 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 29' ' ' LEU . 23.4 m -82.73 -18.88 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 143' ' ' LEU . . . -138.41 72.08 44.78 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.79 -16.8 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.03 1.542 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -74.78 -16.22 60.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.665 ' HB2' HD23 ' A' ' 139' ' ' LEU . . . -103.85 -63.74 1.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 110.053 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 38' ' ' ILE . 1.8 mp -93.62 144.14 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.486 -0.758 . . . . 0.0 110.305 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 0.1 OUTLIER -103.03 -40.26 6.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.02 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.499 ' HB2' ' CB ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -166.93 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 27' ' ' ASP . 3.7 m -134.55 153.48 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -157.91 104.37 1.92 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 111.297 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.66 117.74 7.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.645 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 55' ' ' LYS . 14.2 mm -84.26 -38.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.231 1.015 . . . . 0.0 108.779 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 52' ' ' THR . 47.1 tt0 . . . . . 0 C--N 1.295 -1.764 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.245 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.687 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -76.08 119.23 5.26 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.054 1.555 . . . . 0.0 110.438 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.99 2.26 59.45 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.693 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -67.87 156.78 36.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.171 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 44' ' ' ILE . 10.9 mt -121.86 131.15 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.222 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.45 140.63 30.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' C ' HD13 ' A' ' 56' ' ' ILE . 11.7 ttmt -93.78 119.01 32.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.569 HD12 HG12 ' A' ' 41' ' ' VAL . 7.9 mm -102.34 128.03 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.089 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 40' ' ' SER . 0.7 OUTLIER -90.01 153.75 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.333 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -119.56 134.95 23.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.153 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.304 -1.782 0 O-C-N 123.991 1.521 . . . . 0.0 110.146 179.662 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.612 ' C ' HG12 ' A' ' 67' ' ' VAL . 12.8 p90 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.296 0.57 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER 173.16 171.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 110.377 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.47 137.83 52.26 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.594 -0.691 . . . . 0.0 109.746 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 85' ' ' VAL . 94.1 m-20 -125.22 125.78 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 110.656 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 52' ' ' THR . 1.4 ttt180 -94.07 133.59 37.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.693 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.4 t -72.58 144.38 13.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.825 -1.172 . . . . 0.0 110.743 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 86.4 m-20 -92.87 -68.92 0.77 Allowed 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.339 0.59 . . . . 0.0 110.193 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.8 tp10 -143.35 134.67 26.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.177 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 81' ' ' TYR . 3.8 t -117.29 147.79 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.897 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.35 105.0 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -80.47 -4.42 53.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -108.12 -33.2 7.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.182 -0.949 . . . . 0.0 109.305 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.66 4.52 43.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.665 -0.647 . . . . 0.0 110.109 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.55 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 22.9 m-85 53.56 46.71 25.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.07 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.39 109.97 15.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.149 -0.97 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.501 ' CD2' HG22 ' A' ' 74' ' ' VAL . 44.5 t80 -127.62 107.47 9.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.897 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 59.7 m-20 -114.23 140.57 48.47 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.091 -1.005 . . . . 0.0 109.999 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 100' ' ' ASN . 48.8 p90 -143.16 138.62 29.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.7 m -103.97 172.17 6.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 111.376 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.817 HG11 HD13 ' A' ' 98' ' ' ILE . 42.4 t -111.21 126.57 68.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.574 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -120.94 -76.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.818 -1.176 . . . . 0.0 111.518 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.6 102.42 7.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.818 -1.176 . . . . 0.0 110.652 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -129.42 145.43 16.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.54 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.59 -57.28 3.93 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.6 Cg_endo -71.21 -30.58 15.72 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.394 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.574 HG21 ' O ' ' A' ' 86' ' ' ILE . 73.9 mt -78.64 147.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.81 -36.32 0.73 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.07 -74.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.493 ' H ' HD12 ' A' ' 95' ' ' LEU . 14.1 t -137.3 4.52 2.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.928 . . . . 0.0 110.416 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 95' ' ' LEU . 5.6 mp -84.37 150.88 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.935 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.9 34.25 21.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.59 162.53 29.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 110.253 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.817 HD13 HG11 ' A' ' 85' ' ' VAL . 4.0 mp -136.5 131.42 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 119' ' ' LYS . 1.8 m -118.75 119.73 35.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.364 -0.835 . . . . 0.0 109.603 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 9.4 m120 -112.17 160.6 17.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 110.721 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.474 ' CG ' ' CG ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -150.84 132.1 14.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.11 125.67 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.027 -1.046 . . . . 0.0 110.564 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 69.5 tttt -129.7 119.22 23.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.858 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.526 HG21 HD23 ' A' ' 18' ' ' LEU . 70.5 mt -118.42 112.49 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.763 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.0 t -112.01 141.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.414 -0.804 . . . . 0.0 109.879 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.0 147.08 25.18 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.499 -0.75 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.7 p . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 0.0 109.089 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.861 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -136.87 163.04 31.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.755 -0.85 . . . . 0.0 110.644 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 113' ' ' ILE . 1.7 tt -112.16 126.81 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.166 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 9' ' ' THR . 2.0 pp -106.14 135.72 47.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.869 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -124.52 106.55 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 0.0 109.712 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 67.5 mt -97.22 112.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.47 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -97.8 114.02 25.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.49 ' CG ' HD21 ' A' ' 100' ' ' ASN . 1.5 m-20 -107.27 135.37 48.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 99' ' ' SER . 4.7 mttt -126.22 155.74 41.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.371 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.612 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -132.04 130.21 41.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 71.8 m-70 -113.11 140.2 48.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.159 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.96 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.3 OUTLIER -129.78 170.71 13.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.974 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.96 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 120' ' ' TYR . 2.1 p -87.12 108.78 18.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 121.475 -0.765 . . . . 0.0 110.291 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -50.61 156.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -79.57 -7.46 58.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -50.4 -73.27 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -22.92 6.12 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 5' ' ' TYR . 11.5 t -76.09 -48.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.845 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -26.76 65.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.392 -0.817 . . . . 0.0 109.58 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -38.74 63.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.859 . . . . 0.0 109.366 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -60.52 -35.97 77.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.688 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -68.49 -48.14 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.869 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -52.43 -58.72 5.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.925 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -72.37 -33.06 66.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.08 -42.52 31.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.662 ' HA ' HD23 ' A' ' 144' ' ' LEU . 2.6 tp10 -63.11 -47.69 81.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -1.187 . . . . 0.0 109.975 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.1 m -59.89 -26.86 66.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.085 -1.009 . . . . 0.0 109.747 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.533 HD13 ' HE1' ' A' ' 30' ' ' PHE . 17.3 mt -67.68 -49.98 59.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.981 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.3 pp -66.97 -23.21 65.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.01 -1.056 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.446 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 2.0 tmm_? -80.9 -35.85 31.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.067 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 150' ' ' TYR . . . -65.32 -44.23 88.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.733 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.83 -45.26 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.514 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' A' ' 13' ' ' ILE . 1.1 tt0 -60.35 -56.24 23.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.51 47.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.585 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.24 -25.52 31.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.918 HD12 HG21 ' A' ' 13' ' ' ILE . 43.1 mt -88.8 -25.12 22.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -22.64 33.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.423 -179.824 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 120' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.368 0.604 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.506 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.2 m-85 -101.4 152.89 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.753 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.76 142.65 51.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.042 -1.036 . . . . 0.0 110.843 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.76 ' CD2' HG11 ' A' ' 133' ' ' VAL . 1.1 m-85 -154.12 53.7 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.645 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 7' ' ' THR . 1.9 pt-20 -81.61 160.0 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 110.557 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 6' ' ' GLU . 3.5 p -159.8 172.26 17.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.857 . . . . 0.0 109.874 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 12.7 pt-20 -146.34 141.88 27.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.017 . . . . 0.0 110.381 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 10' ' ' THR . 78.7 m -131.69 166.95 20.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 9' ' ' THR . 1.5 p -102.23 164.01 11.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.336 -0.853 . . . . 0.0 110.425 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 10' ' ' THR . 3.6 m -159.84 134.8 7.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.514 ' CG2' HD11 ' A' ' 152' ' ' LEU . 21.3 m -80.03 -14.06 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.61 HG23 ' HD2' ' A' ' 14' ' ' PRO . 36.2 mm -73.56 148.7 88.07 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.551 -0.718 . . . . 0.0 109.146 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.91 150.59 85.56 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.55 1.29 . . . . 0.0 110.965 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -70.09 -35.09 73.93 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.942 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.55 -56.44 6.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER -62.31 -36.29 81.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.909 HD22 HG21 ' A' ' 104' ' ' ILE . 4.4 tt -74.13 -33.94 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.407 -0.808 . . . . 0.0 110.241 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 32.5 t80 -60.81 -61.06 2.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.957 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttt -57.08 -36.87 71.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 110.058 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.51 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.403 ' CD1' HG21 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -91.91 -11.29 36.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.483 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.0 OUTLIER -121.69 -64.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -58.13 -48.38 80.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -105.01 7.55 34.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.155 -0.966 . . . . 0.0 110.463 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.85 -48.65 65.53 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB2' HG21 ' A' ' 41' ' ' VAL . 5.3 p-10 -57.67 -26.54 61.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.236 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -99.34 -30.93 11.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.649 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.673 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -81.54 -35.62 30.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.301 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.553 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 2.4 m-30 -44.8 -59.15 4.41 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 110.348 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -71.79 -10.45 26.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.877 1.462 . . . . 0.0 110.774 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -92.64 -57.26 2.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.984 . . . . 0.0 110.739 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 29' ' ' LEU . 27.1 m -94.18 -2.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 110.988 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -149.42 71.27 9.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.92 -1.112 . . . . 0.0 110.76 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.26 -20.11 16.67 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.005 1.529 . . . . 0.0 110.026 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -80.55 -29.06 37.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 110.092 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.02 -55.92 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 110.133 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.2 151.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.453 -0.78 . . . . 0.0 110.318 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 1.3 t -98.7 -46.49 5.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.865 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.426 ' C ' HG13 ' A' ' 41' ' ' VAL . 22.1 t -162.37 174.07 13.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 110.099 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 27' ' ' ASP . 24.7 m -147.71 146.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -144.26 151.06 38.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.447 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -100.09 116.73 32.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.868 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.6 mm -86.12 -37.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.19 0.995 . . . . 0.0 108.679 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 52' ' ' THR . 27.5 tt0 . . . . . 0 C--N 1.295 -1.798 0 CA-C-O 121.701 0.763 . . . . 0.0 110.734 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.66 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.8 Cg_endo -75.03 117.8 5.03 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.019 1.536 . . . . 0.0 110.744 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.14 2.02 56.95 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.66 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.3 m -69.79 149.42 47.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.039 -1.271 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.462 HG12 ' HG3' ' A' ' 70' ' ' ARG . 4.7 mt -115.31 128.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.548 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -137.03 148.87 47.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.92 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.868 ' HB2' HD11 ' A' ' 44' ' ' ILE . 8.6 tttt -94.13 95.07 8.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.822 -0.549 . . . . 0.0 109.988 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 66' ' ' TYR . 13.7 mt -84.04 137.0 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -109.03 133.3 53.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.622 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.97 144.35 29.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 109.842 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--N 1.306 -1.676 0 O-C-N 123.972 1.511 . . . . 0.0 110.475 -179.717 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' C ' HG13 ' A' ' 67' ' ' VAL . 18.3 p90 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.274 0.559 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.505 HG13 ' C ' ' A' ' 66' ' ' TYR . 18.2 m -154.47 154.38 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 25.8 ttmt -105.39 48.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -48.19 132.07 16.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 84' ' ' SER . 38.0 ttt180 -96.43 151.09 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 108.637 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.64 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.5 t -76.55 147.81 7.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.619 -1.301 . . . . 0.0 110.375 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 29.5 t0 -101.55 -74.07 0.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.373 0.606 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 mm-40 -141.32 146.6 36.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.209 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.763 HG22 ' HD1' ' A' ' 81' ' ' TYR . 2.9 t -137.37 127.95 38.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -124.64 113.65 18.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 109.747 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -13.45 60.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 111.105 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -106.68 -35.49 6.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.017 -1.052 . . . . 0.0 109.672 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.486 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.31 14.88 19.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.597 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 41.68 48.26 3.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.382 -0.824 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -116.65 113.7 23.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.217 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.763 ' HD1' HG22 ' A' ' 74' ' ' VAL . 41.1 t80 -133.04 120.29 21.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.383 -0.823 . . . . 0.0 110.071 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 42.6 t-20 -130.69 162.42 29.49 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 110.194 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 100' ' ' ASN . 23.7 p90 -153.94 140.86 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.2 m -98.08 154.01 18.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 98' ' ' ILE . 39.1 t -99.39 123.05 51.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.492 HD11 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -125.09 -77.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 111.041 -178.778 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.556 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 3.9 tm-20 -71.97 65.62 0.55 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -86.36 140.72 17.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.18 -53.83 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.9 Cg_endo -74.59 -45.26 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.784 1.412 . . . . 0.0 110.704 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 92' ' ' GLY . 49.2 mt -59.51 172.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.012 . . . . 0.0 110.189 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -152.42 -65.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.56 -85.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 110.107 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.6 p -140.12 19.2 2.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 110.35 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -94.28 153.83 17.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.557 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 36.2 mt-10 57.14 36.02 27.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.396 -0.815 . . . . 0.0 109.932 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.469 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.6 mttt -69.2 153.26 43.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.915 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.56 HG12 ' CE1' ' A' ' 120' ' ' TYR . 12.6 mt -138.93 132.0 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.722 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.6 m -121.91 110.36 15.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.623 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 5.0 m120 -104.03 125.89 50.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -110.18 167.13 10.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.457 ' CG1' ' O ' ' A' ' 101' ' ' GLU . 12.2 mt -155.39 118.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.479 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 5.9 tttt -119.46 114.19 21.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.909 HG21 HD22 ' A' ' 18' ' ' LEU . 2.7 mp -103.28 125.43 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 112' ' ' SER . 42.6 t -131.21 145.71 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.246 -0.909 . . . . 0.0 110.542 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.96 153.43 21.3 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.777 -0.577 . . . . 0.0 110.218 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.501 HG21 HG13 ' A' ' 113' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.064 -1.022 . . . . 0.0 111.331 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -157.14 170.63 22.07 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.501 HG13 HG21 ' A' ' 107' ' ' THR . 48.4 mt -122.76 120.58 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.517 ' HG ' ' CG1' ' A' ' 104' ' ' ILE . 1.4 mp -86.95 122.05 30.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.667 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -104.27 97.48 7.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.8 mt -85.67 144.59 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.861 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.512 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -128.05 120.58 27.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -113.55 123.93 51.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.015 -1.053 . . . . 0.0 110.612 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -120.76 128.43 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.746 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 1.031 ' CE2' HG22 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -109.31 143.5 38.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -0.985 . . . . 0.0 110.243 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 66.9 m-70 -128.11 129.64 46.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.058 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -113.85 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.384 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.748 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 128' ' ' VAL . 2.7 p -100.05 98.15 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.372 -0.83 . . . . 0.0 110.527 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 128' ' ' VAL . 3.8 mttm -54.94 -172.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.49 16.73 16.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.85 -72.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.875 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -30.49 38.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 109.201 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.031 HG22 ' CE2' ' A' ' 120' ' ' TYR . 11.3 t -70.88 -48.83 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.463 -0.773 . . . . 0.0 109.531 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -65.46 -36.31 83.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 0.0 110.173 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.52 72.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.661 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 t -66.4 -38.36 87.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.752 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -64.22 -43.8 93.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.993 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -51.18 -53.79 31.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.32 -24.35 62.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -57.63 -44.03 94.1 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 15.8 mt-10 -64.43 -57.51 9.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -1.161 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.8 m -46.27 -29.94 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 143' ' ' LEU . 20.2 mt -70.61 -59.33 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.847 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -66.72 -17.89 65.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.172 -0.955 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' SER . 0.0 OUTLIER -84.12 -33.64 24.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.798 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 33' ' ' VAL . . . -69.11 -44.05 73.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.907 . . . . 0.0 109.438 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 22' ' ' PHE . 41.7 t -67.95 -43.97 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.679 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -61.2 -36.74 80.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.249 -0.907 . . . . 0.0 109.374 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.9 OUTLIER -68.08 -52.87 30.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 0.0 109.755 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -47.46 -69.92 0.11 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 110.312 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 13' ' ' ILE . 2.3 mt -46.21 -36.53 6.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.394 -0.817 . . . . 0.0 110.403 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.514 HD11 ' CG2' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -71.3 -56.41 6.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.084 -1.01 . . . . 0.0 110.297 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.933 . . . . 0.0 110.241 -179.876 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.754 HG11 ' ND1' ' A' ' 121' ' ' HIS . 4.2 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.729 0.776 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -107.31 153.04 23.32 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.261 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 143.8 48.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.971 -1.08 . . . . 0.0 111.183 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.854 ' CE2' HG11 ' A' ' 133' ' ' VAL . 10.8 m-85 -153.59 58.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 0.0 109.151 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 9.9 pt-20 -84.94 145.07 27.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 110.807 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -146.78 167.53 23.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 3.5 pm0 -147.42 166.87 25.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.99 . . . . 0.0 110.369 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.12 -168.4 2.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 p -130.35 160.81 32.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.461 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.449 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . 41.5 m -159.95 139.26 11.03 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 14.8 p -79.83 -6.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.203 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.731 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.9 mm -74.27 148.96 86.64 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.731 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.0 150.25 88.33 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.561 1.296 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -67.04 -36.99 83.29 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.457 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.66 -54.16 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.565 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.542 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 12.0 ttt180 -57.83 -39.5 77.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 1.4 tt -67.32 -39.1 85.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.705 ' CD1' HD13 ' A' ' 23' ' ' ILE . 61.9 t80 -61.23 -71.0 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 0.0 110.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -47.4 -45.67 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.144 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 0.0 110.496 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 16.2 t80 -90.86 -7.09 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.705 HD13 ' CD1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -121.42 -64.9 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.978 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.483 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -61.82 -48.27 81.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 110.299 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 28' ' ' ASN . 29.9 t0 -110.82 16.7 21.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 110.313 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.72 -61.18 6.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -45.89 -23.88 0.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -1.125 . . . . 0.0 110.711 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.412 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 29.3 t-20 -89.74 -32.51 16.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 0.0 110.518 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mp -84.4 -18.08 37.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -62.49 -61.81 6.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.675 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -72.72 53.76 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.841 1.443 . . . . 0.0 110.981 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -151.64 -63.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.119 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.519 HG11 ' CE1' ' A' ' 150' ' ' TYR . 17.0 m -86.18 -19.93 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.44 66.12 35.52 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 110.264 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.66 -10.77 21.97 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.003 1.528 . . . . 0.0 110.397 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -22.91 64.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.285 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.459 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -95.19 -55.91 2.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.536 HG12 HG21 ' A' ' 56' ' ' ILE . 1.4 mp -107.72 137.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 110.112 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.19 -29.33 14.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.987 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.5 m -178.61 145.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.012 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 2.3 p -126.99 119.21 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.167 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -115.01 119.68 37.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.3 m-20 -65.54 117.59 8.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.493 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.733 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.8 mm -79.91 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.36 1.076 . . . . 0.0 108.422 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.2 mm-40 . . . . . 0 C--N 1.295 -1.761 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.064 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.884 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 43.8 Cg_endo -70.72 83.68 0.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.05 1.553 . . . . 0.0 110.286 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.86 -8.69 2.25 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.884 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 32.7 m -67.69 165.54 17.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.965 -1.315 . . . . 0.0 109.257 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 19.5 mt -138.03 143.37 33.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.961 -1.087 . . . . 0.0 111.056 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -154.9 136.9 14.63 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.328 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.733 ' HB2' HD11 ' A' ' 44' ' ' ILE . 1.1 ttpm? -95.56 112.48 24.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 111.404 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.536 HG21 HG12 ' A' ' 38' ' ' ILE . 15.1 mt -98.17 122.33 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 109.266 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.488 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -84.08 150.89 25.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.691 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -111.19 137.06 20.87 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.198 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.459 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 48.6 Cg_endo . . . . . 0 C--N 1.304 -1.765 0 O-C-N 123.994 1.523 . . . . 0.0 110.529 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.595 ' CD1' ' HE2' ' A' ' 55' ' ' LYS . 21.5 p90 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.227 0.537 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 ' OD1' ' A' ' 69' ' ' ASP . 4.2 m -143.09 175.74 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.177 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.9 ttpt -122.46 37.93 4.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 84' ' ' SER . 4.6 p-10 -42.24 138.57 1.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.618 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.0 ptt180 -102.81 167.26 9.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 108.947 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.696 HG21 ' HB ' ' A' ' 52' ' ' THR . 16.3 t -77.85 152.34 5.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.94 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 34.2 t70 -104.71 -66.34 0.97 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -144.7 130.09 18.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.251 -0.906 . . . . 0.0 110.742 -179.736 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 5.4 t -116.12 150.83 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.578 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -158.33 111.23 2.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.221 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -21.25 51.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -104.77 -40.32 6.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.19 -0.944 . . . . 0.0 109.756 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -84.48 7.22 20.56 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.762 . . . . 0.0 110.274 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.526 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 8.0 m-85 46.25 59.26 3.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.29 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -131.27 107.94 9.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.965 -1.084 . . . . 0.0 110.741 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.672 ' O ' HD12 ' A' ' 102' ' ' ILE . 13.9 t80 -125.99 104.1 8.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.54 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 37.3 m-20 -121.02 149.1 43.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.2 p90 -139.04 138.38 37.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' ARG . 5.7 m -101.89 159.94 14.92 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.906 -1.121 . . . . 0.0 111.008 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 55.5 t -106.98 121.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.16 -75.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.067 -1.021 . . . . 0.0 110.873 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' CA ' ' OE1' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -74.04 95.24 2.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.72 -1.238 . . . . 0.0 110.101 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -122.79 138.31 11.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.551 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.4 -54.36 3.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.4 Cg_endo -72.47 -48.43 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.831 1.437 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.415 ' CD1' HG12 ' A' ' 85' ' ' VAL . 64.4 mt -54.5 160.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.178 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.59 -70.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.592 ' H ' HD23 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -103.31 74.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 110.198 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 46.6 p 43.7 24.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.592 HD23 ' H ' ' A' ' 93' ' ' ASP . 3.6 pp -96.96 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 0.0 110.126 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.585 ' CB ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER 56.45 34.66 24.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -67.95 151.48 47.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.301 -0.874 . . . . 0.0 110.018 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.654 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -126.79 120.67 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.612 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -108.83 104.23 13.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.56 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -96.25 145.43 25.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.782 -179.249 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.54 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 1.2 mp0 -136.11 139.73 43.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.437 -0.79 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 81' ' ' TYR . 3.0 mp -130.21 100.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 110.476 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 59.3 tttt -104.76 124.47 49.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.01 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 50.0 mt -110.45 138.63 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.895 . . . . 0.0 110.377 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 t -139.2 138.87 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.05 -1.031 . . . . 0.0 109.912 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.08 144.08 26.7 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.497 0.665 . . . . 0.0 110.479 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.9 p . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.81 . . . . 0.0 108.924 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -134.51 163.56 29.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.785 -0.832 . . . . 0.0 110.538 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.46 HG13 HG22 ' A' ' 107' ' ' THR . 9.1 mt -109.49 133.25 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 109.349 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.471 HD23 HD11 ' A' ' 116' ' ' ILE . 0.0 OUTLIER -97.88 133.93 41.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.976 -1.078 . . . . 0.0 110.803 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -129.55 98.66 4.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.413 -0.804 . . . . 0.0 109.642 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 1.5 mp -101.02 136.86 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.933 . . . . 0.0 110.421 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -113.33 125.44 54.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.374 -0.829 . . . . 0.0 110.232 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -111.78 134.0 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.633 ' HG2' HG21 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -125.82 143.59 51.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.956 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.654 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -125.56 104.02 8.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.97 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.754 ' ND1' HG11 ' A' ' 2' ' ' VAL . 33.2 m-70 -83.42 101.44 11.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.88 . . . . 0.0 110.409 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.5 166.98 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.804 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.325 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.551 0.691 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.638 HG21 ' CD2' ' A' ' 120' ' ' TYR . 3.0 p -104.79 86.62 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -48.48 150.29 1.39 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -60.46 -27.34 67.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.959 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 130' ' ' ALA . 28.5 mt-10 -41.71 -64.59 0.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 110.046 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -55.12 -29.7 58.23 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.854 HG11 ' CE2' ' A' ' 5' ' ' TYR . 9.3 t -72.88 -50.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.415 -0.803 . . . . 0.0 109.442 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.2 -21.4 60.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.198 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 -32.29 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.122 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -35.58 37.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -49.36 -60.57 2.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 110.004 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -76.94 -31.7 56.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 110.116 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.52 -55.03 14.38 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.586 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -50.06 -40.3 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.154 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.06 -24.91 67.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.987 . . . . 0.0 109.695 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 54.7 mt -73.81 -51.49 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.94 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.4 pp -64.54 -22.01 66.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 149' ' ' SER . 17.4 tpt85 -81.66 -43.08 19.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.444 -0.785 . . . . 0.0 109.682 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -57.75 -36.72 72.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.3 t -73.22 -53.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 109.603 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.449 ' OE2' ' HA ' ' A' ' 11' ' ' SER . 50.7 tt0 -53.48 -53.15 55.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -58.6 -36.3 73.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.128 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.519 ' CE1' HG11 ' A' ' 33' ' ' VAL . 1.2 t80 -48.93 -71.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.573 -0.704 . . . . 0.0 109.823 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.634 HD22 HG23 ' A' ' 13' ' ' ILE . 1.9 mp -56.45 -26.53 54.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.725 . . . . 0.0 110.071 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -77.74 -14.38 59.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.32 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -179.875 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 120' ' ' TYR . 4.5 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.427 0.632 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.6 m-85 -111.24 151.31 28.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.33 135.61 49.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 110.363 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.683 ' CE2' HG11 ' A' ' 133' ' ' VAL . 28.2 m-85 -148.39 70.68 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.445 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -95.19 154.21 17.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 6' ' ' GLU . 2.1 p -158.15 -169.77 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.507 -0.746 . . . . 0.0 109.844 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.9 pt-20 -159.96 150.93 19.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.748 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.706 HG21 HD21 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -132.17 153.39 50.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.402 -0.811 . . . . 0.0 109.77 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.892 HG22 ' CD1' ' A' ' 113' ' ' ILE . 1.8 p -92.93 160.2 15.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.741 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.48 ' OG ' ' CD1' ' A' ' 114' ' ' LEU . 17.3 m -158.07 137.78 12.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 109.673 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.425 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 56.7 t -80.05 -11.0 12.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.795 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.0 OUTLIER -75.85 150.73 84.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.083 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.795 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.3 Cg_endo -66.71 150.74 83.52 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.716 1.377 . . . . 0.0 111.145 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 104' ' ' ILE . . . -73.73 -19.57 60.76 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.497 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.8 -54.87 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 14.4 ttp180 -64.15 -38.35 90.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.759 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.622 ' HB2' HG22 ' A' ' 13' ' ' ILE . 6.4 tt -71.29 -33.48 69.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.703 ' CD2' HD13 ' A' ' 23' ' ' ILE . 33.8 t80 -62.26 -65.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.115 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -51.64 -47.82 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 110.266 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.29 73.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 25.9 t80 -91.73 -13.01 32.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.703 HD13 ' CD2' ' A' ' 19' ' ' PHE . 1.1 mp -114.98 -71.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.192 -0.942 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.576 ' N ' HG22 ' A' ' 23' ' ' ILE . 8.1 mt -62.22 -34.2 76.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.845 . . . . 0.0 110.766 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.4 m-20 -118.0 23.8 11.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.156 -0.965 . . . . 0.0 110.444 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.56 -38.22 33.19 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.506 ' O ' HG11 ' A' ' 41' ' ' VAL . 1.9 p30 -56.49 -30.57 63.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -1.152 . . . . 0.0 110.408 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 25' ' ' ASP . 4.9 p-10 -96.02 -18.81 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 tp -82.21 -39.75 22.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 110.341 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.588 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -53.05 -62.04 3.99 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.224 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.8 Cg_endo -73.27 54.89 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.813 1.428 . . . . 0.0 110.476 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.7 -67.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 110.564 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.14 -15.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.512 -0.742 . . . . 0.0 110.449 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.25 76.87 4.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.346 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.0 -2.19 11.64 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.044 1.549 . . . . 0.0 110.214 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -72.72 -28.31 62.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.624 ' CB ' HD11 ' A' ' 143' ' ' LEU . . . -86.42 -61.66 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.961 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.586 HD13 ' CG ' ' A' ' 30' ' ' PHE . 1.2 mp -105.8 128.91 59.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.402 -0.811 . . . . 0.0 109.699 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -91.33 -25.3 19.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.18 -0.95 . . . . 0.0 110.485 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.39 141.02 0.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.693 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.641 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.1 p -127.47 139.88 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mm-40 -142.23 158.74 43.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.973 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -103.87 115.73 31.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.465 -0.772 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.436 HD11 ' HG3' ' A' ' 68' ' ' LYS . 10.0 mt -81.23 -39.01 17.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.811 ' OE1' HD12 ' A' ' 53' ' ' ILE . 2.8 tp10 . . . . . 0 C--N 1.296 -1.739 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.708 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.735 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.32 89.34 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.6 -3.03 3.17 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.189 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.735 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 33.5 m -78.48 161.34 27.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.319 . . . . 0.0 109.697 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.811 HD12 ' OE1' ' A' ' 45' ' ' GLU . 14.0 mt -130.9 144.91 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.911 -1.118 . . . . 0.0 110.619 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -152.47 144.45 23.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.778 . . . . 0.0 109.784 179.139 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -93.52 117.45 30.1 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.434 -0.791 . . . . 0.0 110.757 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.641 ' CD1' HG23 ' A' ' 41' ' ' VAL . 16.5 mm -102.73 141.76 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -112.19 142.72 44.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.048 -1.032 . . . . 0.0 110.437 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -118.2 123.2 29.61 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 O-C-N 123.855 1.45 . . . . 0.0 110.383 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.456 ' C ' HG12 ' A' ' 67' ' ' VAL . 40.6 p90 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.855 0.836 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.556 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -173.91 172.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.569 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -107.95 128.68 54.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.161 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' A' ' 85' ' ' VAL . 17.0 m-20 -127.19 130.67 50.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 2.4 ttp180 -101.15 145.26 29.02 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 0.0 108.935 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.735 HG21 ' HB ' ' A' ' 52' ' ' THR . 9.7 t -67.9 149.79 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.965 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t70 -101.33 -68.95 0.79 Allowed 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.403 0.621 . . . . 0.0 110.386 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.1 tt0 -145.8 121.94 10.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 110.339 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.683 HG22 ' HD1' ' A' ' 81' ' ' TYR . 3.7 t -108.91 151.6 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 1.2 m-20 -152.08 113.77 4.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -88.89 2.13 54.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 110.144 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -117.43 -40.84 3.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.692 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.1 11.77 28.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.219 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.547 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 50.35 57.79 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.547 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 3.8 mtpt -129.61 126.27 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.683 ' HD1' HG22 ' A' ' 74' ' ' VAL . 16.4 t80 -143.63 106.62 4.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 62.7 t-20 -117.0 165.99 12.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.631 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.3 p90 -161.17 137.76 8.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.818 . . . . 0.0 109.467 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 69.8 m -106.85 168.53 9.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.581 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' A' ' 69' ' ' ASP . 39.8 t -106.58 127.87 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -114.8 -70.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 111.879 -178.462 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.569 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -90.48 98.09 11.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.492 -1.38 . . . . 0.0 110.147 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -111.33 141.53 16.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.03 -58.7 3.63 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.0 Cg_endo -74.06 -31.46 7.88 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.986 1.519 . . . . 0.0 110.461 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 91' ' ' ILE . 54.0 mt -67.66 145.61 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.306 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.11 -92.21 2.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.58 -72.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.9 p -132.06 15.11 4.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.47 146.67 23.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 110.315 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 62.33 33.05 16.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.972 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -79.08 149.66 32.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.519 HG12 ' CE1' ' A' ' 120' ' ' TYR . 11.0 mt -127.69 153.93 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.816 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.3 m -145.64 105.39 3.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.489 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 7.7 m120 -101.19 124.4 46.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.147 -0.971 . . . . 0.0 110.889 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.531 ' HG3' ' ND2' ' A' ' 82' ' ' ASN . 1.9 tt0 -106.71 152.41 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.545 -0.722 . . . . 0.0 109.776 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.442 HG13 ' C ' ' A' ' 101' ' ' GLU . 13.5 mt -137.6 144.44 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.206 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.711 ' O ' HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -143.98 132.42 22.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 103' ' ' LYS . 7.3 mm -119.94 119.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 109.908 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 112' ' ' SER . 14.4 t -133.49 126.15 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 110.918 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -72.96 158.17 35.99 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.149 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.534 HG21 HG12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.026 -1.046 . . . . 0.0 111.22 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 13.7 t -159.99 -178.86 7.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 111.274 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.892 ' CD1' HG22 ' A' ' 10' ' ' THR . 39.1 mm -130.0 117.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.48 ' CD1' ' OG ' ' A' ' 11' ' ' SER . 3.4 mp -87.2 121.12 29.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.966 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -104.34 106.83 17.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.662 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 116' ' ' ILE . 1.2 tt -105.63 132.17 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 40.7 t -121.1 115.18 22.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 5' ' ' TYR . 38.2 t30 -99.25 134.71 41.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 134.3 50.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.519 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -116.75 131.93 56.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.87 . . . . 0.0 109.998 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 86.9 m-70 -116.25 101.51 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.038 . . . . 0.0 110.29 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.28 167.15 11.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.201 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 110.367 -179.875 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.262 0.553 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.1 t -132.09 103.43 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 110.092 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -75.95 139.91 41.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.496 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -61.76 -10.17 8.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.989 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.42 -52.88 41.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.875 -1.141 . . . . 0.0 109.878 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -28.91 68.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 108.881 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.683 HG11 ' CE2' ' A' ' 5' ' ' TYR . 22.1 t -76.98 -49.97 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.5 -0.75 . . . . 0.0 109.12 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 15.6 tptt -66.58 -27.33 67.64 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.722 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.96 -33.47 63.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.762 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.6 t -67.07 -34.69 78.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.106 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -29.57 66.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.24 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.23 -66.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -17.91 62.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.43 -41.12 86.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.621 ' HA ' HD23 ' A' ' 144' ' ' LEU . 1.8 tt0 -67.62 -42.2 82.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 110.109 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -61.47 -29.01 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.495 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.624 HD11 ' CB ' ' A' ' 37' ' ' ALA . 18.1 mt -68.85 -54.5 15.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.409 -0.807 . . . . 0.0 109.908 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 9' ' ' THR . 1.1 pp -61.48 -29.43 69.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.499 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -72.86 -34.05 66.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.429 -0.794 . . . . 0.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.56 -43.21 90.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.98 -40.86 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.609 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 2.8 tt0 -54.66 -48.9 71.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.842 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t -59.53 -50.36 74.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -47.18 -70.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.66 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.7 HD13 HG21 ' A' ' 13' ' ' ILE . 8.5 mt -47.59 -45.17 27.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -50.92 -46.25 60.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 110.277 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.786 HG11 ' ND1' ' A' ' 121' ' ' HIS . 13.1 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.618 0.723 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 31.9 m-85 -117.62 141.58 48.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.996 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.6 141.14 46.72 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.022 . . . . 0.0 110.258 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CE1' HG11 ' A' ' 133' ' ' VAL . 42.8 m-85 -147.16 55.63 1.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.725 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.67 148.85 30.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.787 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.61 -0.681 . . . . 0.0 109.78 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.81 158.03 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 -171.4 3.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.586 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.81 162.16 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.407 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 20.1 m -159.2 143.36 15.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 0.0 109.936 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.607 HG13 HD12 ' A' ' 13' ' ' ILE . 7.2 p -79.94 -12.85 13.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.618 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.69 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.2 mp -69.95 149.28 96.42 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.28 149.59 85.09 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.437 1.23 . . . . 0.0 111.157 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.821 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.63 -25.91 59.54 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.53 -53.53 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.918 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.523 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -66.1 -34.2 77.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.8 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.605 ' HB2' HG22 ' A' ' 13' ' ' ILE . 7.0 tt -74.95 -30.99 61.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.615 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.599 ' CE1' HG13 ' A' ' 23' ' ' ILE . 59.3 t80 -67.92 -71.82 0.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.995 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -50.45 -42.68 54.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.853 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -66.21 -36.16 82.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.493 -0.754 . . . . 0.0 110.294 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 25.8 t80 -91.98 -10.93 37.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.599 HG13 ' CE1' ' A' ' 19' ' ' PHE . 7.7 mm -100.35 -74.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.211 -0.931 . . . . 0.0 110.157 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.995 HD12 ' HG2' ' A' ' 20' ' ' LYS . 19.8 mt -68.0 -40.99 82.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.44 -0.788 . . . . 0.0 109.796 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -85.39 -18.79 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 110.026 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.52 -40.43 62.19 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.79 ' O ' HG21 ' A' ' 41' ' ' VAL . 9.5 m-20 -55.74 -26.04 43.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -1.157 . . . . 0.0 110.11 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 67.6 m-20 -109.19 -23.32 11.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.591 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.6 mp -85.33 -28.48 25.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.219 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.564 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.6 m-30 -54.2 -59.79 9.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.6 Cg_endo -73.41 0.19 8.38 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.99 1.521 . . . . 0.0 110.556 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -96.25 -69.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.685 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 29' ' ' LEU . 25.2 m -81.81 7.27 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.396 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.16 2.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.325 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.33 -2.03 11.49 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.979 1.515 . . . . 0.0 110.653 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -90.62 -3.49 57.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.274 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' HD3' ' A' ' 59' ' ' PRO . . . -110.88 -71.56 0.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 38' ' ' ILE . 1.6 mp -99.13 138.59 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.453 -0.78 . . . . 0.0 110.162 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 1.2 t -81.57 -48.82 11.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -163.65 176.75 9.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.296 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.79 HG21 ' O ' ' A' ' 27' ' ' ASP . 2.6 m -135.45 147.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 1.1 tt0 -136.44 161.29 36.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.84 110.16 20.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.937 HD11 ' HB2' ' A' ' 55' ' ' LYS . 15.5 mm -82.04 -39.45 16.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 122.231 1.015 . . . . 0.0 108.414 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.0 tm-20 . . . . . 0 C--N 1.296 -1.752 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.166 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.701 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.28 94.84 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.876 1.461 . . . . 0.0 110.221 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.38 -6.92 4.64 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.758 ' HB ' HG21 ' A' ' 71' ' ' VAL . 38.1 m -80.25 162.74 24.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -1.112 . . . . 0.0 109.53 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 31.5 mt -137.41 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.099 -1.001 . . . . 0.0 110.37 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.632 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -148.79 142.7 25.76 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.267 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 44' ' ' ILE . 25.0 tttp -91.77 117.24 29.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.532 -0.73 . . . . 0.0 110.197 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.687 ' CD1' HG12 ' A' ' 41' ' ' VAL . 39.7 mm -97.15 119.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.244 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 39' ' ' SER . 3.7 m -82.54 130.68 35.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.869 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.455 ' CD2' ' HD2' ' A' ' 59' ' ' PRO . 2.3 m-85 -108.24 163.63 16.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 110.617 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 45.2 Cg_endo . . . . . 0 C--N 1.304 -1.769 0 O-C-N 124.238 1.652 . . . . 0.0 110.726 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.466 ' C ' HG13 ' A' ' 67' ' ' VAL . 8.3 p90 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.765 0.793 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.466 HG13 ' C ' ' A' ' 66' ' ' TYR . 29.2 m -152.21 150.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 11.6 mtmt -110.48 139.91 45.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.95 -1.094 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 20.2 p-10 -134.73 133.58 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 110.276 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 84' ' ' SER . 7.4 ttt180 -100.07 139.65 35.43 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.758 HG21 ' HB ' ' A' ' 52' ' ' THR . 14.1 t -61.31 153.92 5.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.541 -1.349 . . . . 0.0 111.039 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 18.4 t0 -106.32 -73.6 0.68 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.874 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.31 112.63 7.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.385 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.552 HG22 ' CE2' ' A' ' 81' ' ' TYR . 2.6 t -102.89 141.5 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' LYS . 16.8 t0 -142.63 120.55 12.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.64 1.33 57.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 110.383 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -115.39 -35.63 4.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.089 -1.007 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -102.14 20.81 15.97 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.488 -0.758 . . . . 0.0 110.503 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.8 m-30 43.21 56.72 4.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 75' ' ' ASP . 25.7 tttt -125.99 123.16 37.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -142.48 105.09 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.087 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 47.3 m-20 -121.0 144.01 48.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 110.185 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 31.1 p90 -135.49 137.37 42.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.848 . . . . 0.0 109.379 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.5 m -94.66 161.66 14.1 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 110.977 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.515 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 25.2 t -102.69 128.22 55.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -119.33 -74.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.06 -1.025 . . . . 0.0 111.349 -178.578 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.546 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -92.11 64.84 4.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.638 -1.289 . . . . 0.0 109.881 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . -131.77 159.67 23.3 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 44.98 -157.08 0.24 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.83 1.57 6.9 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.024 1.539 . . . . 0.0 110.782 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.542 HD11 HD13 ' A' ' 98' ' ' ILE . 75.9 mt -51.63 155.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.052 . . . . 0.0 110.321 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.1 -107.08 0.24 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.45 ' C ' HG23 ' A' ' 94' ' ' THR . 18.4 m-20 -47.7 -86.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.933 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.45 HG23 ' C ' ' A' ' 93' ' ' ASP . 30.6 p -148.23 12.34 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -92.82 157.85 16.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 110.239 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.4 mm-40 59.51 33.04 22.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.902 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.522 ' C ' HD12 ' A' ' 98' ' ' ILE . 1.2 ttpm? -76.55 159.36 30.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.622 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mp -142.02 127.59 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.875 . . . . 0.0 110.228 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t -116.42 112.9 22.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.603 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -99.24 136.62 38.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 110.495 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 90.2 mt-10 -125.97 144.28 50.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.794 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.4 mt -136.08 113.6 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.352 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.45 124.66 48.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.692 HG22 ' HB1' ' A' ' 15' ' ' ALA . 3.2 mt -118.2 127.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.0 t -132.56 141.59 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.93 144.45 26.55 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.393 0.616 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 111' ' ' GLY . 4.4 p . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.493 2.496 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -133.6 163.59 29.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.813 -0.816 . . . . 0.0 110.671 -179.3 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 113' ' ' ILE . 29.3 mt -108.32 131.6 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.42 -0.8 . . . . 0.0 109.022 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -106.01 135.29 47.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.937 -1.102 . . . . 0.0 110.504 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.45 111.12 11.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' THR . 3.2 mt -102.84 125.61 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 110.587 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.535 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -109.55 119.39 39.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.807 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -118.26 141.66 48.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.319 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.3 mtpp -124.9 151.73 44.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 109.993 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.622 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -130.26 99.8 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 109.759 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.786 ' ND1' HG11 ' A' ' 2' ' ' VAL . 14.7 m-70 -86.01 105.83 16.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.804 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.642 HG21 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -113.02 172.94 6.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.1 tttt . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.866 . . . . 0.0 110.386 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.758 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.4 t -122.36 89.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.442 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -60.18 132.03 52.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.615 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . . . -54.9 -16.84 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.018 . . . . 0.0 110.632 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.22 -59.01 5.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.898 -1.126 . . . . 0.0 109.495 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -63.59 -30.2 71.34 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 109.061 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG11 ' CE1' ' A' ' 5' ' ' TYR . 16.1 t -71.74 -47.25 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 8.3 ttpp -65.07 -30.67 71.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.773 . . . . 0.0 110.048 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.44 -19.94 61.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.0 t -72.43 -43.47 63.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 110.092 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 138' ' ' GLU . 21.9 ptmt -79.91 -37.71 34.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 137' ' ' LYS . 6.5 tt0 -51.8 -57.58 8.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 -25.94 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -60.44 -46.49 94.25 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -62.26 -44.11 97.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.26 -1.141 . . . . 0.0 110.453 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.6 m -62.67 -22.82 66.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.003 -1.06 . . . . 0.0 109.775 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 143' ' ' LEU . 19.6 mt -74.32 -52.66 11.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 110.041 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.64 -27.32 66.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.602 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 27.0 mmt180 -77.17 -29.26 54.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.878 . . . . 0.0 109.492 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 150' ' ' TYR . . . -67.41 -49.64 62.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 22' ' ' PHE . 92.9 t -62.3 -41.55 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.694 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -63.38 -50.67 69.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.678 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -67.33 -16.78 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.676 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.46 ' CD2' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -83.53 -38.45 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.6 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 13' ' ' ILE . 8.7 mt -68.72 -55.29 11.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 110.285 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.63 -27.31 1.83 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.936 . . . . 0.0 109.994 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 110.018 179.797 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.523 0.677 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.488 ' CD2' ' HB ' ' A' ' 128' ' ' VAL . 1.2 m-85 -91.4 164.27 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -143.95 143.56 31.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CD2' HG11 ' A' ' 133' ' ' VAL . 68.2 m-85 -155.49 65.83 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.587 -0.695 . . . . 0.0 109.291 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 1.8 pp20? -85.15 153.1 22.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 110.888 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.43 176.45 9.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.972 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 2.0 pt-20 -158.44 149.38 20.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.127 -0.983 . . . . 0.0 110.483 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 -170.04 2.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -125.95 168.37 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.442 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -158.81 138.26 11.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.553 -0.717 . . . . 0.0 109.595 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 13' ' ' ILE . 4.0 p -79.89 -14.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.559 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.836 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.0 OUTLIER -72.39 152.16 92.03 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.236 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.73 150.3 86.27 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 123.505 1.266 . . . . 0.0 111.132 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.25 -22.07 59.49 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.642 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.24 -57.31 3.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt-85 -60.38 -29.49 68.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.571 ' CD2' HD11 ' A' ' 114' ' ' LEU . 4.3 tp -74.28 -42.19 59.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 23' ' ' ILE . 42.4 t80 -59.52 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 110.166 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.0 ttpt -53.49 -45.29 69.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.556 ' O ' HD22 ' A' ' 29' ' ' LEU . . . -70.83 -28.6 64.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.868 . . . . 0.0 110.588 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 42.1 t80 -92.03 -17.55 24.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.915 . . . . 0.0 110.486 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.62 HD13 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -117.64 -63.55 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.497 ' HA ' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -48.14 -47.89 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 110.265 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.1 m-20 -107.15 -12.03 15.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 30' ' ' PHE . . . -41.8 -30.49 0.64 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.63 -59.49 4.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -1.179 . . . . 0.0 110.048 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -87.89 -17.26 31.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.689 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.1 tp -75.72 -45.39 36.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 110.131 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.528 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.6 m-85 -43.46 -57.72 5.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 110.457 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.2 Cg_endo -70.05 -8.91 24.77 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.914 1.481 . . . . 0.0 110.608 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 6.0 ttmm -95.57 -46.2 6.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 29' ' ' LEU . 28.0 m -91.91 -8.11 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.381 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.09 81.05 3.35 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.82 -6.32 18.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.975 1.513 . . . . 0.0 110.298 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.18 -18.43 27.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.269 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.813 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -97.39 -71.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 30' ' ' PHE . 1.1 mp -99.69 152.58 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.546 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.39 -33.15 5.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.537 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.07 146.79 6.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.089 -1.007 . . . . 0.0 110.596 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.995 HG13 ' CD1' ' A' ' 56' ' ' ILE . 47.5 t -133.5 139.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 84.6 tt0 -152.48 158.74 43.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.441 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -104.49 117.88 35.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 110.377 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.74 HD11 ' HB2' ' A' ' 55' ' ' LYS . 21.6 mm -83.16 -38.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.301 1.048 . . . . 0.0 108.335 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.541 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 25.3 tp10 . . . . . 0 C--N 1.296 -1.741 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.099 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.956 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.48 100.86 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.858 1.452 . . . . 0.0 110.243 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 111.39 1.32 27.91 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.956 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.1 m -61.12 155.81 19.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -1.117 . . . . 0.0 109.5 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 11.7 mm -112.94 133.14 59.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.943 . . . . 0.0 109.775 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.837 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -145.34 144.5 30.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.102 -0.999 . . . . 0.0 110.285 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.74 ' HB2' HD11 ' A' ' 44' ' ' ILE . 5.6 tttm -92.83 112.67 24.7 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.619 -0.676 . . . . 0.0 110.608 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.995 ' CD1' HG13 ' A' ' 41' ' ' VAL . 38.8 mm -103.85 138.77 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 109.347 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.45 141.67 47.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 110.757 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -116.67 135.03 22.85 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.94 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo . . . . . 0 C--N 1.304 -1.787 0 O-C-N 123.93 1.49 . . . . 0.0 110.784 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.674 ' C ' HG12 ' A' ' 67' ' ' VAL . 6.7 p90 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.195 0.521 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.747 HG21 HG13 ' A' ' 85' ' ' VAL . 0.8 OUTLIER 168.81 171.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.367 -0.833 . . . . 0.0 110.586 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.572 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -106.03 54.36 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.642 -0.662 . . . . 0.0 109.938 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD1' HG13 ' A' ' 67' ' ' VAL . 5.2 m-20 -41.83 129.41 3.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.338 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -98.14 150.65 21.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 108.896 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.643 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -81.03 144.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.71 -1.243 . . . . 0.0 110.219 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 36.3 t0 -98.42 -71.0 0.7 Allowed 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.367 0.603 . . . . 0.0 110.004 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -143.84 113.01 6.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 0.0 110.047 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 4.9 t -104.17 136.21 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.267 -0.896 . . . . 0.0 109.932 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 74' ' ' VAL . 83.4 m-20 -141.07 113.03 7.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -82.51 -3.02 55.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -110.42 -36.68 5.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.201 -0.937 . . . . 0.0 109.653 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.39 15.24 20.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.598 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 m-30 45.86 51.97 10.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 110.34 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -129.21 124.54 34.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.973 -1.079 . . . . 0.0 110.751 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' CD2' HG12 ' A' ' 23' ' ' ILE . 2.2 t80 -139.44 101.6 4.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.421 -0.799 . . . . 0.0 109.861 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.516 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 74.0 m-20 -113.87 136.04 53.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.0 p90 -134.71 133.04 39.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.582 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' ARG . 68.3 m -99.41 170.58 8.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 111.433 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.747 HG13 HG21 ' A' ' 67' ' ' VAL . 48.9 t -106.71 131.27 56.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.39 -79.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.899 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 68' ' ' LYS . 1.1 tt0 -91.87 106.52 18.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.941 -1.099 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 67' ' ' VAL . . . 164.13 175.74 35.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 47.27 -159.81 0.41 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.92 -7.76 21.7 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.135 1.597 . . . . 0.0 110.691 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.537 ' CD1' HG12 ' A' ' 85' ' ' VAL . 47.7 mt -51.55 154.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.35 -58.1 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -121.33 -69.2 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.252 . . . . 0.0 110.645 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 t -147.31 9.14 0.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 0.0 110.748 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -92.7 155.74 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 0.0 110.091 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' HB2' HD12 ' A' ' 95' ' ' LEU . 1.9 mt-10 57.84 36.33 26.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -78.82 159.35 27.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 110.408 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.498 HG13 ' CD1' ' A' ' 120' ' ' TYR . 2.3 mt -139.82 137.69 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.528 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 m -123.46 112.72 17.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.33 -0.856 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 13.7 m120 -99.39 130.03 45.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.516 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 2.6 mt-10 -123.76 139.74 53.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.852 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.604 HG23 HG12 ' A' ' 116' ' ' ILE . 16.9 mt -135.59 114.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.369 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -114.53 124.22 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.862 . . . . 0.0 109.878 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.3 mp -111.92 134.79 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.416 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -140.58 137.94 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 0.0 110.417 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.67 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.0 146.62 25.41 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.78 -0.575 . . . . 0.0 110.968 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.5 p . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.352 -0.843 . . . . 0.0 108.957 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.817 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -137.34 166.38 23.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.477 -1.013 . . . . 0.0 111.13 -179.087 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.5 mt -118.86 126.0 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 109.103 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -97.12 146.08 25.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 0.0 110.863 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 13.4 mttt -141.58 109.97 5.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.525 -0.734 . . . . 0.0 109.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.604 HG12 HG23 ' A' ' 102' ' ' ILE . 19.0 mt -105.92 135.45 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.6 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.509 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -116.7 115.78 26.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.129 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -103.88 126.1 50.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.392 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -115.5 130.14 56.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.316 -0.865 . . . . 0.0 109.959 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.498 ' CD1' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -116.72 117.21 29.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.453 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.424 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 25.3 m-70 -94.26 130.64 40.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.629 HG23 HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -114.96 169.24 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 110.088 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.514 ' HA ' HG21 ' A' ' 122' ' ' THR . 72.1 mt-10 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.19 0.519 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.629 HG23 HG23 ' A' ' 122' ' ' THR . 2.3 t -121.14 116.11 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 133' ' ' VAL . 11.0 mttt -80.16 132.4 35.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.731 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.96 -48.41 52.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 110.913 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.9 mt-10 -36.98 -55.97 0.9 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 110.907 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.48 77.05 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.618 HG11 ' CD2' ' A' ' 5' ' ' TYR . 7.2 t -74.68 -48.3 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 109.315 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 130' ' ' ALA . 14.2 tptt -67.42 -30.22 69.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.531 -0.73 . . . . 0.0 109.824 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.54 60.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -35.1 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -79.74 -23.93 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.23 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -53.86 -52.81 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 4.6 mt -75.15 -28.75 60.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.468 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.666 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -55.49 -46.57 80.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.639 ' HA ' HD23 ' A' ' 144' ' ' LEU . 33.5 tt0 -56.34 -52.53 64.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -1.205 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.3 m -57.61 -28.86 64.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.201 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 37' ' ' ALA . 84.7 mt -69.48 -46.08 67.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 110.358 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.1 pp -68.77 -26.13 65.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.779 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -81.93 -41.0 21.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -56.1 -50.37 71.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.37 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.4 -48.84 86.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.475 -0.765 . . . . 0.0 108.954 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 36.5 tt0 -53.03 -46.83 68.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.8 t -67.43 -51.27 53.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.423 ' CE1' HG12 ' A' ' 33' ' ' VAL . 1.8 t80 -44.9 -69.38 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.809 . . . . 0.0 110.392 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 151' ' ' LEU . 29.9 mt -49.17 -37.1 21.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.503 -0.748 . . . . 0.0 110.629 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.2 mt -77.1 -18.84 57.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.048 -1.033 . . . . 0.0 110.373 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.935 . . . . 0.0 110.071 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.998 HG23 ' C ' ' A' ' 120' ' ' TYR . 9.3 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.586 0.708 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.89 -178.93 3.86 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -140.67 138.39 34.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.861 -1.149 . . . . 0.0 111.018 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.526 ' CD1' HG11 ' A' ' 133' ' ' VAL . 65.0 m-85 -144.44 54.83 1.27 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 9.0 pt-20 -80.1 152.55 29.24 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.543 0.687 . . . . 0.0 110.962 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.74 172.72 13.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -157.84 153.54 26.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.03 -169.14 3.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 110.12 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -132.14 167.64 19.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.349 -0.845 . . . . 0.0 110.391 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.899 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 17.3 t -79.92 -17.25 12.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.712 HG21 HD13 ' A' ' 151' ' ' LEU . 17.8 mm -70.42 149.31 95.71 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.6 Cg_endo -65.72 146.75 84.68 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.143 1.075 . . . . 0.0 111.053 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.836 ' HB2' ' CB ' ' A' ' 112' ' ' SER . . . -71.86 -30.13 65.11 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.45 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.54 -56.85 10.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.937 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -35.15 79.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -69.78 -38.31 76.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.485 -0.76 . . . . 0.0 109.418 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 41.9 t80 -62.2 -59.1 5.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.895 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -49.76 -48.42 50.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 110.314 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.84 76.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.6 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.2 t80 -88.43 -14.01 39.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.614 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' PHE . 1.3 mp -114.62 -48.9 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.95 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -72.12 -48.56 42.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 110.036 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.973 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -115.99 20.81 14.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.993 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.02 -58.18 14.97 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.663 ' OD1' HG11 ' A' ' 41' ' ' VAL . 21.8 m-20 -56.71 -19.08 14.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -1.174 . . . . 0.0 110.213 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.82 -37.03 10.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.9 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.034 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.9 mp -79.97 -20.84 44.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 0.0 110.163 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.52 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 1.1 m-85 -58.37 -57.03 29.33 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.552 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 48.7 Cg_endo -73.0 -13.62 26.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.054 1.555 . . . . 0.0 110.945 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.17 -43.38 11.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.989 . . . . 0.0 110.58 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.034 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.8 m -89.68 -24.76 5.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 110.315 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.36 78.84 7.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.48 -31.31 7.26 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.093 1.575 . . . . 0.0 110.63 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -56.37 -18.65 11.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.062 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.779 ' HA ' HD23 ' A' ' 139' ' ' LEU . . . -96.83 -48.0 5.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.221 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -123.29 146.49 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 109.923 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.423 ' C ' ' OG ' ' A' ' 40' ' ' SER . 1.6 t -92.56 -53.05 4.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -162.32 172.51 15.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 0.0 110.634 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.964 HG13 HG12 ' A' ' 56' ' ' ILE . 12.6 t -145.83 138.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.311 -0.868 . . . . 0.0 109.886 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mt-10 -137.62 163.89 30.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.723 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.7 116.56 32.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.724 HD11 ' HB2' ' A' ' 55' ' ' LYS . 23.9 mm -83.63 -37.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.345 1.069 . . . . 0.0 108.372 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 6.1 tp10 . . . . . 0 C--N 1.293 -1.857 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.679 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 45.4 Cg_endo -71.72 118.35 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.939 1.494 . . . . 0.0 110.249 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.75 54.68 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.703 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.4 m -68.41 154.46 41.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -1.183 . . . . 0.0 109.348 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 9.3 mt -116.96 133.39 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.011 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 1.4 ptpt -143.28 147.54 34.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.661 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.724 ' HB2' HD11 ' A' ' 44' ' ' ILE . 12.7 tttp -105.35 118.27 36.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.688 -0.633 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.964 HG12 HG13 ' A' ' 41' ' ' VAL . 23.0 mt -107.26 147.83 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.082 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -107.25 139.49 41.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.127 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -112.58 125.63 29.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.307 -1.63 0 O-C-N 123.852 1.448 . . . . 0.0 110.557 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.5 p90 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.551 0.691 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -170.57 172.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 0.0 109.801 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.571 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.25 151.51 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.161 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 84' ' ' SER . 6.8 p-10 -148.41 135.39 20.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 110.357 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 84' ' ' SER . 14.6 ttp-105 -99.02 141.22 32.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.394 -0.816 . . . . 0.0 108.849 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.703 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.4 t -72.56 147.14 10.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.847 -1.158 . . . . 0.0 110.199 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 82' ' ' ASN . 4.7 m-20 -93.04 -70.09 0.72 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.404 0.621 . . . . 0.0 109.98 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.5 tt0 -149.91 131.28 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.74 146.68 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 35.2 m-20 -145.63 119.98 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -88.9 0.19 56.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -116.67 -35.96 4.05 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.75 8.74 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.46 -0.775 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.56 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.5 m-30 53.62 69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 5.4 tttt -136.79 133.1 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.377 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.437 ' HB2' HG12 ' A' ' 23' ' ' ILE . 9.7 t80 -149.86 94.58 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.883 . . . . 0.0 110.071 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.51 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 33.2 m-20 -116.78 145.2 43.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.568 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 36.3 p90 -146.76 137.38 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.494 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 62.2 m -98.78 170.83 8.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 111.232 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 41.5 t -108.35 127.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.96 -70.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 111.272 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -85.05 95.6 9.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.594 -1.316 . . . . 0.0 110.052 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -116.93 139.82 15.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.53 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.11 -57.12 2.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.2 Cg_endo -71.91 -38.34 4.17 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.922 1.485 . . . . 0.0 110.308 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' N ' ' A' ' 92' ' ' GLY . 46.5 mt -68.16 170.53 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.573 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -162.66 -77.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.92 -90.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -1.196 . . . . 0.0 110.297 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.1 t -146.94 18.39 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.2 164.76 12.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 110.105 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.92 34.43 22.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 121' ' ' HIS . 1.1 ttmt -76.42 150.95 36.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.233 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.651 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 56.2 mt -128.39 132.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 t -119.17 102.41 8.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.579 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.568 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 3.4 m120 -87.08 135.51 33.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 52.1 mt-10 -131.45 134.6 46.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 110.095 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.542 HG22 HD11 ' A' ' 104' ' ' ILE . 12.7 mt -128.33 126.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.031 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.684 HG22 ' HB1' ' A' ' 15' ' ' ALA . 4.5 mp -134.45 141.09 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.752 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.5 t -141.9 144.16 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 109.546 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.06 162.7 16.64 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.395 -0.815 . . . . 0.0 111.09 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.5 p . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.501 -0.749 . . . . 0.0 109.245 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.836 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -142.44 159.98 41.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.708 -0.878 . . . . 0.0 110.627 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.7 tt -109.19 142.0 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.945 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.72 150.49 41.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 110.181 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.15 124.29 18.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 2.4 mt -111.19 117.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -102.05 111.8 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.33 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -105.05 123.49 47.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.121 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -116.56 151.54 35.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.354 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.998 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -131.6 99.72 4.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.834 . . . . 0.0 110.193 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.781 ' N ' HG23 ' A' ' 2' ' ' VAL . 85.5 m-70 -79.8 113.69 18.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.37 172.47 6.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.979 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.604 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.461 ' HA ' HG21 ' A' ' 122' ' ' THR . 4.1 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.355 0.598 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.762 HG21 ' CG ' ' A' ' 120' ' ' TYR . 2.8 t -116.08 101.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -54.75 125.19 19.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.027 -1.045 . . . . 0.0 109.501 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -53.16 -48.06 68.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 110.396 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.1 mt-10 -35.63 -55.22 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.58 -0.7 . . . . 0.0 110.661 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -42.35 92.85 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 108.998 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 5' ' ' TYR . 14.1 t -68.03 -48.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.248 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -59.86 -31.46 69.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.529 -0.732 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.89 -47.72 61.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -24.08 67.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.173 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.44 -36.09 45.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.88 . . . . 0.0 110.184 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -44.67 83.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.12 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.779 HD23 ' HA ' ' A' ' 37' ' ' ALA . 3.1 mp -73.47 -31.54 63.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 110.019 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.822 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -65.72 -41.1 96.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.601 ' HA ' HD23 ' A' ' 144' ' ' LEU . 5.4 mm-40 -56.67 -37.05 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -1.203 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.8 m -70.15 -18.86 63.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.822 HD12 ' HA2' ' A' ' 140' ' ' GLY . 98.0 mt -77.13 -44.82 28.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 0.0 109.896 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.601 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -66.93 -29.94 69.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 17.2 ttp180 -77.64 -36.4 51.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.765 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.12 67.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.785 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.0 t -60.23 -47.26 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.444 -0.785 . . . . 0.0 109.781 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 35.8 tt0 -51.64 -48.91 63.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 -43.67 85.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.948 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -52.03 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.159 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.712 HD13 HG21 ' A' ' 13' ' ' ILE . 35.5 mt -42.62 -51.82 5.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -48.72 -25.21 1.69 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.074 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.418 0.628 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.413 ' CD1' ' CG1' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -106.54 161.93 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.949 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.79 139.21 50.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.942 . . . . 0.0 110.156 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.84 56.21 1.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.025 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -82.83 153.7 25.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.38 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.4 p -156.14 169.06 25.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.814 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 15.2 pt-20 -158.8 138.37 11.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 110.619 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 t -133.15 -172.6 2.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.316 -0.865 . . . . 0.0 109.928 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -117.97 159.52 23.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.7 t -152.67 136.75 16.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.689 -0.632 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 27.2 m -79.96 -12.17 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.017 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.668 HG23 ' HD2' ' A' ' 14' ' ' PRO . 41.2 mm -69.86 148.4 96.39 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.668 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.0 Cg_endo -65.58 151.23 85.37 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.503 1.265 . . . . 0.0 111.007 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.68 -29.16 61.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.035 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.6 -48.46 16.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.287 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.526 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -68.14 -37.54 81.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.994 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' HB2' HG22 ' A' ' 13' ' ' ILE . 25.7 tp -74.79 -26.24 59.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.185 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' CE1' HG13 ' A' ' 23' ' ' ILE . 75.2 t80 -69.69 -59.69 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 110.046 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -57.18 -39.95 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.387 -0.821 . . . . 0.0 110.128 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -72.54 -31.99 65.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.846 . . . . 0.0 110.546 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.444 ' CD1' HG21 ' A' ' 147' ' ' VAL . 33.8 t80 -91.9 -18.25 24.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.558 HG13 ' CE1' ' A' ' 19' ' ' PHE . 9.3 mm -104.06 -67.33 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.49 -27.54 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' OD1' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -109.38 -5.06 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.356 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.42 -56.54 24.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.98 -23.84 1.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 110.556 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -100.37 -39.79 7.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 110.305 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 1.9 tp -71.18 -38.01 72.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.0 m-30 -48.21 -61.02 3.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 110.55 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.0 Cg_endo -71.65 -2.09 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.972 1.512 . . . . 0.0 110.715 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -104.28 -36.11 7.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 110.469 -179.756 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.754 HG22 ' HB1' ' A' ' 146' ' ' ALA . 7.2 p -96.67 -26.08 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.959 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.24 78.61 8.58 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.78 2.75 6.16 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.117 1.588 . . . . 0.0 110.964 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.05 -38.36 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 110.481 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.55 -49.4 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.229 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.43 146.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.987 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.519 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -100.95 -32.3 10.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.212 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.5 168.11 2.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.601 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 56' ' ' ILE . 4.7 t -138.51 141.27 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.598 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -144.62 110.94 5.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.067 -1.021 . . . . 0.0 110.757 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.6 116.89 5.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.214 -0.929 . . . . 0.0 110.419 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.722 HD12 HG22 ' A' ' 53' ' ' ILE . 12.3 mt -84.97 -39.64 14.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 122.172 0.987 . . . . 0.0 108.556 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 52' ' ' THR . 22.3 tt0 . . . . . 0 C--N 1.296 -1.731 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.537 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.3 Cg_endo -72.83 118.04 5.39 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.026 1.54 . . . . 0.0 110.381 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 -1.65 40.88 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.694 ' HB ' HG21 ' A' ' 71' ' ' VAL . 7.0 m -67.35 154.64 40.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.252 . . . . 0.0 109.226 179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.722 HG22 HD12 ' A' ' 44' ' ' ILE . 9.9 mt -121.97 135.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 110.512 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.559 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -142.38 138.71 31.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.99 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -92.43 101.08 13.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.574 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.507 HG12 HG13 ' A' ' 41' ' ' VAL . 22.3 mt -88.97 129.09 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.542 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.1 m -93.24 141.22 28.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.473 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.18 131.27 22.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.863 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 39' ' ' SER . 47.3 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 O-C-N 123.874 1.46 . . . . 0.0 110.663 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 32.8 p90 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.269 0.557 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.574 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -170.35 172.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.191 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.587 ' O ' HD11 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -121.25 62.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.477 -0.765 . . . . 0.0 110.468 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -52.97 133.08 38.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.906 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -97.81 142.86 29.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.937 . . . . 0.0 108.716 179.491 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.694 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.5 t -69.73 149.56 10.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.645 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.3 t70 -101.29 -74.42 0.62 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.434 0.635 . . . . 0.0 110.044 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.2 tt0 -135.39 136.13 41.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.109 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.443 HG22 ' HD2' ' A' ' 81' ' ' TYR . 2.8 t -120.78 147.32 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -152.57 101.32 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -75.14 -9.42 58.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.736 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -102.78 -34.09 9.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 108.638 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.75 11.26 39.15 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.342 0.591 . . . . 0.0 109.752 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 23.4 m-30 44.36 43.85 6.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 110.191 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 5.7 tttm -118.09 114.21 22.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.267 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 8.3 t80 -131.48 109.36 10.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 40.1 m-20 -112.4 145.97 39.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 110.031 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 3.6 p90 -137.74 138.26 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.811 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' ARG . 7.0 m -98.82 159.58 14.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.177 -0.952 . . . . 0.0 110.858 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 98' ' ' ILE . 24.7 t -104.19 122.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.587 HD11 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -121.92 -76.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.085 -1.009 . . . . 0.0 110.953 -178.561 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 16.0 mm-40 -70.49 57.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.753 -1.217 . . . . 0.0 109.996 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -69.54 126.8 19.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.51 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.83 -54.1 3.62 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.2 Cg_endo -75.99 -40.99 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.875 1.46 . . . . 0.0 110.594 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.567 HD12 ' HA3' ' A' ' 88' ' ' GLY . 36.0 mt -50.98 138.37 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.076 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.55 -94.55 1.83 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.82 -80.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 110.171 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.03 19.79 2.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 110.065 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.411 ' CB ' ' HB2' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -94.67 165.51 12.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.227 -0.92 . . . . 0.0 110.245 -179.888 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 3.2 tp10 56.35 33.17 21.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 8.8 tttm -67.84 167.34 13.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.564 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.1 mt -143.93 127.86 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.42 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.48 ' HB3' ' CB ' ' A' ' 119' ' ' LYS . 12.9 t -115.1 112.31 22.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.599 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -105.85 152.39 23.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.873 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.513 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 30.9 mt-10 -145.24 129.27 17.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.785 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.823 ' CD1' HG23 ' A' ' 116' ' ' ILE . 19.5 mm -122.26 128.95 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.03 -1.044 . . . . 0.0 110.384 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 4.9 tttt -129.63 117.24 20.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 110.038 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.701 HG23 ' CD2' ' A' ' 114' ' ' LEU . 64.4 mt -110.66 109.2 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 110.72 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 112' ' ' SER . 42.1 t -115.47 151.03 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.748 0.785 . . . . 0.0 109.595 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.05 168.38 12.87 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.642 -0.662 . . . . 0.0 110.867 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.703 HG22 ' CD1' ' A' ' 113' ' ' ILE . 7.7 p . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -134.49 162.85 31.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 110.743 -179.496 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.703 ' CD1' HG22 ' A' ' 107' ' ' THR . 5.2 mt -110.37 117.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.396 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.701 ' CD2' HG23 ' A' ' 104' ' ' ILE . 21.6 mt -87.76 129.18 35.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.913 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 104.76 9.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.823 HG23 ' CD1' ' A' ' 102' ' ' ILE . 4.1 mp -105.04 122.27 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.094 -1.004 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -105.95 120.95 43.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.473 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -114.93 139.02 50.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.236 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER -132.55 142.2 49.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.564 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -121.21 133.07 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.044 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.55 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 59.9 m-70 -111.57 129.41 56.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.23 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.978 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.95 173.47 6.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.425 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HB2' ' CB ' ' A' ' 95' ' ' LEU . 3.4 tttt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.331 -0.856 . . . . 0.0 110.203 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.978 ' HA ' HG21 ' A' ' 122' ' ' THR . 38.6 mt-10 . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.666 0.746 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.554 HG21 ' CD2' ' A' ' 120' ' ' TYR . 1.8 p -79.97 137.38 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.572 -0.705 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 126.71 31.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.973 ' HA ' HG12 ' A' ' 133' ' ' VAL . . . -65.92 -57.24 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.931 -1.106 . . . . 0.0 111.249 -178.5 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -40.95 -26.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.889 -1.132 . . . . 0.0 110.143 -179.273 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -84.68 -42.88 14.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.175 -0.953 . . . . 0.0 109.164 178.509 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.973 HG12 ' HA ' ' A' ' 130' ' ' ALA . 8.0 p -78.98 -33.77 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.339 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -70.56 -23.6 62.63 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.242 -0.911 . . . . 0.0 109.277 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -73.29 -20.9 60.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.829 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.7 t -71.94 -29.87 64.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 110.19 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -78.04 -47.15 19.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -45.95 -61.17 1.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -14.49 61.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -64.18 -54.41 30.25 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.562 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.4 tt0 -47.72 -36.95 12.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 100.0 m -66.8 -25.36 66.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.717 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.6 mt -74.75 -52.24 12.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.632 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.3 pp -66.79 -29.3 69.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.942 . . . . 0.0 109.657 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.429 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 11.0 tpt180 -78.0 -28.88 49.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -0.877 . . . . 0.0 109.511 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.754 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -68.83 -36.7 78.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.823 . . . . 0.0 109.732 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.444 HG21 ' CD1' ' A' ' 22' ' ' PHE . 40.2 t -73.09 -48.51 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.389 -0.82 . . . . 0.0 109.715 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 13' ' ' ILE . 5.6 tt0 -53.4 -49.67 66.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 152' ' ' LEU . 0.9 OUTLIER -60.45 -45.39 93.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.684 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -48.31 -72.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 110.035 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.19 -36.12 5.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 149' ' ' SER . 16.1 tp -62.74 -55.71 24.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 -179.946 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.562 HG22 ' HA ' ' A' ' 121' ' ' HIS . 2.7 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.427 0.632 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -97.0 163.8 12.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.724 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -133.78 144.95 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 110.678 -179.662 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CG ' HG11 ' A' ' 133' ' ' VAL . 48.4 m-85 -154.85 56.44 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -0.771 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 2.2 pp20? -86.91 137.09 32.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 110.837 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -140.11 -175.66 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.674 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.28 152.16 25.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.056 -1.027 . . . . 0.0 110.589 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 10' ' ' THR . 1.5 m -135.35 -179.17 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 0.0 109.81 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 9' ' ' THR . 1.5 p -127.3 161.25 29.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.66 141.89 17.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.518 -0.739 . . . . 0.0 109.636 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.83 -12.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.32 -0.952 . . . . 0.0 108.559 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.811 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.3 mp -71.07 152.01 94.82 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.534 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.13 152.02 82.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.475 1.25 . . . . 0.0 110.886 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.798 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -76.86 -27.59 55.12 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.904 -178.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.22 -50.23 16.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.046 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -63.49 -43.15 98.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.785 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.73 -33.84 76.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.379 -0.825 . . . . 0.0 109.948 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.61 ' CD1' HD13 ' A' ' 23' ' ' ILE . 37.2 t80 -61.57 -64.89 0.8 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 12.0 mttt -48.13 -47.25 34.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.482 -0.761 . . . . 0.0 110.39 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.47 78.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.317 -0.864 . . . . 0.0 111.012 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -90.08 -10.1 45.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 110.65 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.61 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -115.02 -60.19 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 109.932 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 15.1 mt -68.29 -48.97 63.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.111 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.71 20.7 18.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.033 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.42 -60.9 5.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.01 -24.66 10.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 0.0 110.218 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -84.67 -46.57 11.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.522 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.807 HD23 HG11 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -73.88 -28.22 61.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.478 -179.739 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.526 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m-30 -49.38 -57.47 11.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.456 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 45.6 Cg_endo -72.02 -7.61 21.36 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.987 1.52 . . . . 0.0 110.728 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -101.58 -54.43 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.344 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.807 HG11 HD23 ' A' ' 29' ' ' LEU . 5.5 m -80.31 -13.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 110.528 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.69 71.84 12.64 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 0.0 110.08 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.51 0.37 9.19 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.047 1.551 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.94 -20.08 19.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -102.18 -38.9 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.82 136.8 53.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.65 -47.17 6.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.84 140.06 3.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.29 125.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 11.8 mt-10 -115.0 89.27 3.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 110.728 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 10.9 t-20 -54.17 116.76 2.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.449 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.3 mm -87.75 -38.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.271 1.034 . . . . 0.0 108.574 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 52' ' ' THR . 24.4 tt0 . . . . . 0 C--N 1.295 -1.776 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.449 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.679 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.0 Cg_endo -73.54 120.52 6.52 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.981 1.516 . . . . 0.0 110.551 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.02 1.3 61.41 Favored Glycine 0 N--CA 1.48 1.606 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.679 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.2 m -67.21 152.93 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -1.191 . . . . 0.0 109.435 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' ILE . 8.6 mt -124.56 131.38 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.48 -179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -143.89 134.76 25.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 179.471 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 2.2 ttpt -82.17 98.65 8.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.7 mt -85.95 132.55 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.696 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.5 OUTLIER -109.43 145.67 35.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 110.795 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 37' ' ' ALA . 5.9 m-85 -109.46 140.72 22.37 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 109.987 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.542 . . . . 0.0 110.756 -179.738 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.741 ' O ' HG13 ' A' ' 67' ' ' VAL . 3.4 p90 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 66' ' ' TYR . 4.3 m -160.54 164.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 110.503 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -109.63 40.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 109.848 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 7.7 t70 -38.76 130.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.486 -0.759 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ttp-105 -103.96 151.42 23.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.077 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.672 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.6 t -78.44 147.71 6.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 10.3 m-20 -97.4 -72.38 0.65 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.452 0.644 . . . . 0.0 110.431 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.9 tt0 -138.52 136.62 36.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.578 -0.701 . . . . 0.0 110.129 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.8 t -125.07 125.35 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.919 . . . . 0.0 109.995 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -123.85 127.89 48.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 109.885 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 5.4 t-80 -86.27 -20.02 29.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 0.0 111.075 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -106.19 -37.81 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.995 -1.066 . . . . 0.0 109.897 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -85.81 13.42 7.34 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.475 -0.766 . . . . 0.0 110.198 179.999 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 42.31 61.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.918 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -128.21 118.15 22.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 110.921 -179.329 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 52.7 t80 -133.83 98.03 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 32.3 m-20 -112.76 142.84 44.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 110.289 -179.468 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 10.9 p90 -142.2 138.43 31.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.342 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 35.6 m -104.45 165.12 11.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.082 -1.011 . . . . 0.0 111.062 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 69' ' ' ASP . 47.2 t -108.42 127.36 64.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.63 -74.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 111.388 -178.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 2.3 mt-10 -82.8 97.87 8.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.828 -1.17 . . . . 0.0 110.227 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.575 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . -128.48 155.5 20.5 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.538 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -45.38 -56.68 6.13 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -70.59 -41.44 3.22 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.866 1.456 . . . . 0.0 110.84 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 92' ' ' GLY . 77.4 mt -77.46 165.32 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.196 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -148.18 -52.56 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.31 -83.08 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.373 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.9 t -143.06 11.15 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.22 151.04 22.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.262 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.525 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 7.7 tt0 55.83 35.07 24.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.764 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 6.2 tttt -75.44 158.3 32.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.39 -0.819 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.2 mt -135.71 131.1 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -0.99 . . . . 0.0 110.662 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 m -116.18 109.95 18.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 0.0 109.527 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.601 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 3.0 m120 -99.56 138.41 36.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -128.94 131.62 47.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.822 179.593 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.657 ' CD1' HG23 ' A' ' 116' ' ' ILE . 40.3 mm -122.15 119.15 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 32.9 mttt -122.11 109.26 14.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.744 HG23 HD23 ' A' ' 114' ' ' LEU . 1.9 mp -94.92 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.2 132.31 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.309 -0.87 . . . . 0.0 110.248 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.06 145.39 25.99 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.418 0.627 . . . . 0.0 110.969 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.6 p . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.798 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -137.26 169.05 18.43 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.666 -0.902 . . . . 0.0 110.444 -179.414 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 10' ' ' THR . 23.0 mt -123.63 133.96 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 179.401 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.744 HD23 HG23 ' A' ' 104' ' ' ILE . 25.5 mt -97.9 142.37 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.81 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -127.86 97.16 4.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.316 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.657 HG23 ' CD1' ' A' ' 102' ' ' ILE . 3.0 mt -94.34 115.98 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.732 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.539 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 38.4 t -104.58 108.3 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -101.36 149.52 23.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.226 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 141.04 38.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.013 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.594 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -117.72 122.16 42.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.814 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.562 ' HA ' HG22 ' A' ' 2' ' ' VAL . 25.2 m-70 -105.23 110.14 22.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.99 167.95 14.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.523 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.115 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.342 0.591 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.5 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.3 p -108.27 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.396 -0.815 . . . . 0.0 111.062 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.1 142.1 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.953 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.472 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -52.59 -26.86 14.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.093 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.5 mm-40 -42.39 -58.33 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.716 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -59.85 -34.08 72.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 108.978 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.565 HG11 ' CG ' ' A' ' 5' ' ' TYR . 15.7 t -67.11 -49.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.447 -0.783 . . . . 0.0 109.259 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.5 ' HE2' ' NZ ' ' A' ' 137' ' ' LYS . 2.3 mmtt -50.74 -35.36 31.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -23.85 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.6 t -70.9 -37.47 72.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.117 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.5 ' NZ ' ' HE2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -75.77 -31.2 59.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 109.91 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.62 -47.25 80.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 37' ' ' ALA . 3.2 mm? -76.88 -45.06 29.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.855 . . . . 0.0 110.311 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.55 -47.24 52.22 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.607 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -56.67 -30.46 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -1.204 . . . . 0.0 110.425 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.4 m -70.73 -28.81 65.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.091 . . . . 0.0 109.653 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.4 mt -71.81 -48.69 44.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 109.867 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 144' ' ' LEU . 1.1 pp -63.55 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.421 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -75.05 -35.19 61.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.661 179.502 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -68.59 -29.22 67.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.56 -47.01 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.875 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -59.37 -46.8 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -62.26 -43.45 98.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 110.148 179.813 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -54.43 -71.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 110.389 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 13' ' ' ILE . 34.0 mt -39.65 -49.91 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.468 -0.77 . . . . 0.0 110.592 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.65 -61.63 2.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.274 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.109 179.97 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.455 0.645 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 0.7 OUTLIER -99.36 171.12 8.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 109.26 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.05 141.28 16.44 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.969 -1.082 . . . . 0.0 110.825 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.85 ' CD2' HG11 ' A' ' 133' ' ' VAL . 8.3 m-85 -159.38 59.17 0.4 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.538 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.483 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 11.2 pt-20 -81.85 152.67 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.428 -0.795 . . . . 0.0 110.662 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.71 -175.92 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 109.91 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.69 157.73 30.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.081 -1.012 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.497 HG21 HD22 ' A' ' 144' ' ' LEU . 1.1 t -146.51 -179.1 6.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.102 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -116.81 160.82 20.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.254 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.07 137.03 11.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.85 -12.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.673 HG23 ' HD2' ' A' ' 14' ' ' PRO . 35.3 mm -68.6 148.49 98.08 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.673 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.51 150.43 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.38 1.2 . . . . 0.0 110.752 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.746 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.95 -25.62 59.01 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.29 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.39 -52.3 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 110.356 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 8.4 ttt-85 -63.45 -38.38 90.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.868 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.899 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.0 tm? -68.89 -34.35 75.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.967 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 45.9 t80 -64.11 -68.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.485 ' HG2' ' CB ' ' A' ' 24' ' ' LEU . 8.7 tttt -45.84 -51.26 13.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.002 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.0 -38.77 79.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 110.054 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 15.1 t80 -84.72 -13.07 52.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.75 HD12 ' CD2' ' A' ' 81' ' ' TYR . 9.9 mm -118.9 -76.55 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.258 -0.901 . . . . 0.0 110.056 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' CB ' ' HG2' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -46.47 -56.3 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.033 179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.816 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -93.92 1.05 56.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 27' ' ' ASP . . . -46.91 -53.22 10.6 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 26' ' ' GLY . 3.3 p-10 -42.88 -29.94 0.36 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -1.134 . . . . 0.0 110.033 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 19.3 t30 -113.54 -11.36 13.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.003 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -83.63 -18.48 38.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.742 ' CD2' HD13 ' A' ' 38' ' ' ILE . 2.2 m-30 -75.43 -59.51 1.26 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.362 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.8 Cg_endo -71.19 -3.57 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.905 1.476 . . . . 0.0 110.492 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -91.97 -66.26 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.204 179.967 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 29' ' ' LEU . 6.2 m -85.93 -11.13 11.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.426 -0.797 . . . . 0.0 110.312 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -143.05 61.39 10.35 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.932 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.23 -5.93 18.02 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.091 1.574 . . . . 0.0 110.584 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.72 -25.58 38.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.42 -55.99 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 110.311 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -100.57 137.97 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.906 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.479 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -103.24 -33.33 9.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.1 OUTLIER -160.1 149.24 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.0 110.796 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.528 HG12 ' HE2' ' A' ' 54' ' ' LYS . 6.3 t -128.08 136.2 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 0.0 109.337 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 29.0 mt-10 -139.86 153.11 46.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.039 -1.038 . . . . 0.0 111.151 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.5 113.12 26.5 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.806 0.812 . . . . 0.0 109.636 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.2 mm -82.97 -39.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 122.185 0.993 . . . . 0.0 108.989 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' THR . 7.9 tp10 . . . . . 0 C--N 1.295 -1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 110.464 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.792 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.0 Cg_endo -72.61 131.05 16.76 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.12 1.59 . . . . 0.0 110.476 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 -9.46 76.97 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 45' ' ' GLU . 22.2 m -60.85 153.62 24.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.068 -1.254 . . . . 0.0 109.496 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 45' ' ' GLU . 6.8 mt -116.25 125.62 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HE2' HG12 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -135.47 146.67 48.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 110.265 -179.955 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.735 ' HB2' HD11 ' A' ' 44' ' ' ILE . 30.5 ttpt -97.61 132.98 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.33 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.48 144.18 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.478 ' HB2' ' OG ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -114.56 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.124 -0.985 . . . . 0.0 110.221 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -121.18 133.4 24.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 48.7 Cg_endo . . . . . 0 C--N 1.307 -1.621 0 O-C-N 123.99 1.521 . . . . 0.0 110.487 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.186 0.517 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.574 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.2 m -144.11 172.36 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.334 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.32 139.2 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.876 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 84' ' ' SER . 5.0 p-10 -133.2 133.47 42.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.0 ttm180 -96.26 146.42 24.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.701 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.4 t -73.94 145.12 11.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.836 -1.165 . . . . 0.0 110.404 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -94.07 -70.61 0.7 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.466 0.65 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.8 mt-10 -148.91 124.3 10.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 0.0 109.801 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 3.3 t -112.85 149.28 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.19 -0.944 . . . . 0.0 110.445 -179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 3.8 t0 -149.09 97.74 2.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -64.4 -7.92 11.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.895 -179.348 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -108.28 -46.22 3.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.016 -1.052 . . . . 0.0 109.765 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.36 13.54 4.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.735 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.7 m-30 47.42 50.87 14.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.059 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 6.3 tttt -123.77 117.28 24.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.993 -1.067 . . . . 0.0 110.779 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.75 ' CD2' HD12 ' A' ' 23' ' ' ILE . 17.3 t80 -134.44 103.75 5.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.344 -0.848 . . . . 0.0 109.779 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 31.2 m-20 -118.14 144.42 45.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.222 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 26.5 p90 -144.63 136.24 25.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' ARG . 74.5 m -96.77 171.09 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 111.209 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.515 HG11 HD13 ' A' ' 98' ' ' ILE . 41.6 t -108.95 125.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.75 -70.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.021 -1.049 . . . . 0.0 111.648 -178.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.16 98.82 11.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.543 -1.348 . . . . 0.0 110.375 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.574 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -116.55 151.71 18.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.519 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.98 -57.69 4.65 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.8 Cg_endo -74.0 -47.68 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.976 1.514 . . . . 0.0 110.953 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.28 157.75 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.004 . . . . 0.0 110.085 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.97 -71.54 0.19 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -111.38 -58.39 2.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -1.221 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.6 t -152.21 15.65 0.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.962 . . . . 0.0 110.538 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 123' ' ' LYS . 16.9 mt -91.28 147.86 22.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HG3' HG22 ' A' ' 122' ' ' THR . 4.9 mt-10 59.3 31.5 21.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 121' ' ' HIS . 4.6 mttt -70.55 151.36 45.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.5 mp -127.54 134.37 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.647 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.29 106.21 13.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.34 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -95.12 150.14 20.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.73 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 3.2 mp0 -143.18 142.06 31.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.772 . . . . 0.0 109.706 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 101' ' ' GLU . 61.6 mt -138.6 119.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 110.567 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 56.6 tttt -118.15 121.87 41.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.58 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 44.8 mt -108.84 118.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.368 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -122.9 152.6 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.402 -0.811 . . . . 0.0 109.774 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.98 166.35 14.55 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.633 -0.667 . . . . 0.0 111.121 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.765 HG23 ' HA ' ' A' ' 112' ' ' SER . 16.5 p . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.369 -0.832 . . . . 0.0 109.73 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.765 ' HA ' HG23 ' A' ' 107' ' ' THR . 0.2 OUTLIER -141.17 163.65 32.38 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -1.069 . . . . 0.0 110.596 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.502 HG13 HG22 ' A' ' 107' ' ' THR . 78.9 mt -112.31 124.41 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.782 . . . . 0.0 109.166 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 130.64 42.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.982 . . . . 0.0 110.827 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -121.23 114.87 22.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.544 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -105.62 128.33 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -111.55 110.36 20.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 110.03 179.761 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.74 135.89 45.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.171 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.37 137.35 45.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 110.212 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.613 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -112.33 144.73 41.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.872 . . . . 0.0 110.036 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 97' ' ' LYS . 31.8 m-70 -127.15 106.36 9.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 110.233 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -121.63 166.59 14.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.977 . . . . 0.0 110.61 -179.581 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 121.784 0.802 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.4 p -113.92 93.48 2.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.811 -0.555 . . . . 0.0 110.627 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.98 146.66 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.043 . . . . 0.0 109.799 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.467 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -62.48 -12.71 23.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -48.14 -69.94 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.973 -1.079 . . . . 0.0 109.861 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 136' ' ' SER . 0.8 OUTLIER -54.8 -27.49 42.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.516 179.598 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.85 HG11 ' CD2' ' A' ' 5' ' ' TYR . 16.1 t -71.07 -47.28 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 134' ' ' LYS . 22.8 ttpt -67.76 -31.8 71.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.089 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 139' ' ' LEU . . . -73.7 -39.04 64.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.786 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -67.23 -27.36 67.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -73.07 -42.15 63.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.91 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -63.8 -44.36 93.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -71.3 -33.16 69.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -55.36 -55.5 28.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.1 tm-20 -54.86 -44.96 74.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -1.154 . . . . 0.0 109.923 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 m -57.4 -32.77 67.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.831 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.678 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.9 mt -69.93 -53.4 18.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.022 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 144' ' ' LEU . 4.6 pp -72.03 -22.33 61.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.159 -0.963 . . . . 0.0 109.474 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.711 ' N ' HD12 ' A' ' 144' ' ' LEU . 30.8 ttt180 -83.14 -31.42 27.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 109.739 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.04 70.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 143' ' ' LEU . 25.2 t -69.81 -44.3 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.473 -0.767 . . . . 0.0 109.738 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.475 ' HA ' HG13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -62.51 -47.98 81.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.618 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.425 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -68.97 -16.48 63.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 110.074 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.07 -34.19 26.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 13' ' ' ILE . 10.8 mt -73.87 -56.19 5.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 110.171 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.47 -30.39 12.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 0.0 110.437 -179.781 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.869 HG11 ' ND1' ' A' ' 121' ' ' HIS . 5.1 m -94.05 -162.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -1.147 . . . . 0.0 110.292 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -108.89 158.45 17.66 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.736 -0.602 . . . . 0.0 109.717 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.68 140.09 51.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.024 -1.048 . . . . 0.0 110.894 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 9.8 m-85 -146.52 61.99 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 7' ' ' THR . 12.9 pt-20 -87.59 157.48 19.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 111.129 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.4 p -156.64 174.93 14.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 0.0 109.944 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . 9.9 pt-20 -159.71 150.38 19.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 110.231 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 m -145.29 168.15 21.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.295 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.76 HG22 HG12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -106.91 164.29 12.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.218 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -157.68 144.46 18.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.426 -0.796 . . . . 0.0 109.855 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.491 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 15.1 t -79.8 -7.63 10.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.839 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.826 HG21 HD13 ' A' ' 151' ' ' LEU . 30.2 mm -78.85 146.87 69.44 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.656 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.93 145.94 81.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.659 1.347 . . . . 0.0 111.331 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.802 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -66.86 -28.41 68.32 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.54 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.95 2.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.943 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.478 ' HG3' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -58.53 -37.04 74.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.728 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.6 tt -68.44 -39.44 81.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.007 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CE2' HG21 ' A' ' 23' ' ' ILE . 80.8 t80 -60.84 -65.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 109.983 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -43.04 -49.26 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.24 96.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.873 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -88.95 -9.17 52.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.232 -0.917 . . . . 0.0 110.811 -179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 24' ' ' LEU . 1.2 mp -118.16 -69.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.988 -1.07 . . . . 0.0 110.191 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.586 ' N ' HG22 ' A' ' 23' ' ' ILE . 6.0 mt -60.69 -43.42 97.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.57 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.596 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -115.36 13.42 16.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.349 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.88 -59.66 10.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.62 ' HB3' HG11 ' A' ' 41' ' ' VAL . 85.3 m-20 -52.21 -29.07 20.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -1.161 . . . . 0.0 110.304 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -86.29 -28.93 23.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.424 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.805 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -87.68 -21.73 25.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.312 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.764 ' HE1' HD13 ' A' ' 143' ' ' LEU . 0.5 OUTLIER -54.02 -57.55 17.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.533 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -73.34 -0.07 8.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.95 1.5 . . . . 0.0 110.832 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -103.44 -59.12 1.76 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.436 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 29' ' ' LEU . 33.6 m -90.7 12.91 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.356 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -159.77 75.87 3.0 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.297 -0.877 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.36 -7.97 21.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.008 1.53 . . . . 0.0 110.716 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -100.79 0.05 38.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 110.262 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.477 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -107.28 -69.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.167 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.406 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.1 mt -119.14 135.13 60.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.868 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 -49.94 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.316 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.467 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -157.09 171.33 20.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 110.304 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.792 HG13 ' CD1' ' A' ' 56' ' ' ILE . 40.6 t -129.81 140.52 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' CB ' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -133.28 84.27 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.406 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -50.4 117.74 2.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 0.0 110.283 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.615 HD12 HG22 ' A' ' 53' ' ' ILE . 12.5 mt -88.58 -37.83 10.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.271 1.034 . . . . 0.0 108.666 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 48.2 tt0 -153.78 174.41 14.58 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.335 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.554 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 66.79 159.96 0.92 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -104.8 32.17 4.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -1.104 . . . . 0.0 109.765 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' HG21 ' A' ' 74' ' ' VAL . . . 93.14 0.67 67.77 Favored Glycine 0 N--CA 1.48 1.574 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.37 -163.85 29.43 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.9 Cg_endo -73.09 129.43 14.13 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.028 1.541 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.62 -3.92 81.79 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.74 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -63.68 154.66 32.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -1.215 . . . . 0.0 109.255 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 44' ' ' ILE . 8.7 mm -124.81 127.69 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -139.7 136.91 34.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.299 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HB3' ' CB ' ' A' ' 42' ' ' GLU . 22.1 tttt -80.5 98.41 7.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 110.297 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.792 ' CD1' HG13 ' A' ' 41' ' ' VAL . 43.6 mm -86.7 134.81 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -103.76 145.94 29.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.199 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -118.33 131.55 24.17 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.213 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 44.9 Cg_endo -71.77 89.53 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.953 1.501 . . . . 0.0 110.574 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -138.51 -169.69 2.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.046 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.22 -15.88 4.08 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.445 ' CB ' ' HD2' ' A' ' 63' ' ' PRO . 0.9 OUTLIER -59.06 175.33 0.34 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.259 -1.142 . . . . 0.0 110.257 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 62' ' ' PHE . 44.5 Cg_endo -71.61 -45.47 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.971 1.511 . . . . 0.0 109.957 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.484 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 23.4 m-85 -116.43 127.76 54.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.425 -0.797 . . . . 0.0 109.852 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 66' ' ' TYR . 9.3 ptpt -142.09 -44.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -0.981 . . . . 0.0 110.42 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' C ' HG12 ' A' ' 67' ' ' VAL . 20.3 p90 -65.42 -170.05 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.975 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -178.45 171.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.278 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -90.14 -61.76 1.61 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.513 -0.742 . . . . 0.0 109.598 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 68' ' ' LYS . 7.6 t70 59.2 124.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.481 ' NE ' HD11 ' A' ' 53' ' ' ILE . 1.8 ttt180 -110.78 147.85 33.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.5 t -67.02 152.03 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 7.7 t70 -99.95 -71.4 0.7 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.311 0.577 . . . . 0.0 110.459 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -145.85 104.19 3.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.439 -0.788 . . . . 0.0 109.985 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 81' ' ' TYR . 18.6 t -92.78 149.88 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.265 -0.897 . . . . 0.0 110.324 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -148.42 101.62 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 109.927 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 m-70 -76.23 1.18 16.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.584 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -116.5 -44.61 2.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.058 -1.026 . . . . 0.0 110.041 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.13 15.06 9.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.435 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.552 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 20.0 m-30 51.49 54.43 11.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.911 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -126.62 126.55 43.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.561 ' CG ' HG13 ' A' ' 23' ' ' ILE . 28.1 t80 -143.34 97.94 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.499 ' ND2' ' OE2' ' A' ' 101' ' ' GLU . 9.4 m-20 -114.37 146.48 40.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 23.6 p90 -142.22 139.96 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.864 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 50.5 m -106.04 164.91 11.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.095 -1.003 . . . . 0.0 110.928 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 91' ' ' ILE . 24.4 t -103.06 130.2 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.499 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -126.96 -68.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.287 -178.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 1.4 tt0 -91.93 78.83 5.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.621 -1.3 . . . . 0.0 110.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -94.8 153.03 20.75 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.529 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.46 -57.99 4.83 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -72.44 -41.56 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.545 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 86' ' ' ILE . 48.8 mt -61.62 134.3 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.23 -39.34 0.75 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -120.8 -84.14 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -1.091 . . . . 0.0 110.008 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 t -150.83 14.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.59 HD22 ' CB ' ' A' ' 123' ' ' LYS . 18.5 mt -88.81 156.92 18.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -0.969 . . . . 0.0 110.077 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-10 54.56 34.28 20.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.12 -0.987 . . . . 0.0 109.48 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -77.02 170.3 16.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 -179.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.64 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 4.6 mp -143.11 125.15 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.478 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 11.2 t -117.35 109.86 17.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.57 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 3.1 t-20 -98.92 169.94 9.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 117' ' ' SER . 18.6 mt-10 -152.38 130.11 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.777 -0.577 . . . . 0.0 109.565 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.452 HD12 ' HD2' ' A' ' 81' ' ' TYR . 27.5 mt -121.14 132.41 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 110.459 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HD2' ' HD2' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -139.61 122.54 16.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.802 HG22 ' HB1' ' A' ' 15' ' ' ALA . 3.3 mp -108.92 144.23 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.363 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -145.67 117.94 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.751 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -71.47 146.23 48.73 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.347 0.594 . . . . 0.0 110.554 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 112' ' ' SER . 0.6 OUTLIER -125.46 153.87 72.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.024 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.5 55.59 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.962 1.507 . . . . 0.0 110.411 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -139.59 10.08 2.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 110.059 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.77 24.16 36.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -167.89 -162.76 20.51 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.675 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 7.6 t -141.78 -175.89 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.998 . . . . 0.0 110.525 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.76 HG12 HG22 ' A' ' 10' ' ' THR . 19.9 mt -134.99 128.19 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 109.599 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.53 ' C ' HD12 ' A' ' 114' ' ' LEU . 3.8 pp -108.81 139.39 43.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 8' ' ' GLU . 10.2 mttt -123.79 113.92 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.507 HG23 HD21 ' A' ' 100' ' ' ASN . 72.3 mt -107.77 115.13 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.797 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.53 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -103.4 135.92 44.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -126.71 144.25 50.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.144 -0.973 . . . . 0.0 110.815 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -126.55 150.9 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 109.884 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -131.57 105.65 7.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.869 ' ND1' HG11 ' A' ' 2' ' ' VAL . 24.1 m-70 -86.0 125.29 33.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 110.605 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.3 167.86 12.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.59 ' CB ' HD22 ' A' ' 95' ' ' LEU . 19.1 tptt -159.92 -170.09 2.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.33 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 42.55 -151.57 0.29 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.29 12.05 23.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -1.126 . . . . 0.0 110.154 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -82.92 172.5 12.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 110.13 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -153.53 -166.66 2.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.246 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.662 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.1 t -121.8 99.5 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.434 -0.791 . . . . 0.0 109.89 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -64.46 125.81 25.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -42.57 -34.79 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.8 mp0 -39.83 -70.36 0.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.306 -0.871 . . . . 0.0 110.872 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -27.83 38.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.568 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.565 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 21.4 t -74.91 -49.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.2 -30.86 70.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.515 -0.741 . . . . 0.0 109.792 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.81 -30.42 61.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.623 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.0 t -73.39 -37.69 65.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.412 -0.805 . . . . 0.0 109.682 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -68.89 -38.31 79.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.6 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -68.0 -40.26 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 1.1 tp -72.83 -40.42 65.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.827 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.43 97.77 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.689 ' HA ' HD23 ' A' ' 144' ' ' LEU . 1.5 mm-40 -65.95 -34.72 78.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -1.133 . . . . 0.0 109.917 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 75.2 m -67.98 -29.96 69.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.927 . . . . 0.0 109.723 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.764 HD13 ' HE1' ' A' ' 30' ' ' PHE . 71.9 mt -70.25 -46.54 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -67.3 -30.84 70.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.745 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.5 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 4.5 ttt180 -79.5 -32.93 42.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 0.0 109.938 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 33' ' ' VAL . . . -63.41 -42.67 98.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.85 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.27 -47.49 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 110.007 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -56.98 -43.3 81.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.5 t -60.72 -49.82 75.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.647 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.3 t80 -52.35 -70.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.838 . . . . 0.0 110.473 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.826 HD13 HG21 ' A' ' 13' ' ' ILE . 1.2 mt -40.6 -35.43 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 110.684 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -25.09 50.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.007 . . . . 0.0 110.498 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . -89.71 26.15 1.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 110.461 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.527 ' C ' ' CD2' ' A' ' 154' ' ' HIS . 3.9 p-80 -81.07 175.76 10.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 110.481 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 t -150.17 83.58 1.38 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 109.995 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.14 -15.35 14.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.46 163.04 33.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -108.12 -51.2 2.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.918 . . . . 0.0 110.297 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.257 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t -59.09 142.6 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 110.289 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.2 m-85 -100.91 137.5 39.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.384 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.24 146.8 44.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 110.91 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -152.29 56.63 0.82 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.472 0.654 . . . . 0.0 109.298 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 4.9 pt-20 -80.19 153.2 28.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 110.368 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -149.7 -175.6 5.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.882 . . . . 0.0 110.099 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -159.45 162.52 35.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.7 -176.24 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.07 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.469 HG22 HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -133.67 159.61 40.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.482 ' HB3' ' CG ' ' A' ' 148' ' ' GLU . 3.7 m -160.03 145.51 15.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 109.991 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.483 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 11.9 t -79.93 -7.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.41 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.661 HD12 ' HB3' ' A' ' 151' ' ' LEU . 41.7 mm -77.1 148.2 77.94 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.661 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.46 150.47 84.22 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 123.589 1.31 . . . . 0.0 111.063 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.804 ' HB3' ' HB2' ' A' ' 106' ' ' ALA . . . -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.438 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.15 -49.95 8.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.92 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 8.0 tpt180 -67.15 -34.33 77.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.712 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 5.8 tt -76.92 -35.41 57.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.655 ' CD1' HD13 ' A' ' 23' ' ' ILE . 75.2 t80 -61.12 -57.76 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.867 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 27.3 mttp -58.2 -41.21 83.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.828 . . . . 0.0 109.96 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.68 -32.91 70.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.67 ' CD1' HG21 ' A' ' 147' ' ' VAL . 7.9 t80 -87.98 -15.82 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.883 . . . . 0.0 110.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.655 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -120.15 -58.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.092 -1.005 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.529 HD11 ' CE1' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -63.05 -37.25 86.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.344 -0.848 . . . . 0.0 110.687 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -110.11 -0.81 17.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -46.0 -48.51 14.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -56.46 -17.21 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.307 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -113.1 -19.77 11.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.297 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.8 tp -93.99 -33.76 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.736 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.567 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -63.25 -58.21 17.0 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.701 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -76.7 46.11 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.825 1.434 . . . . 0.0 111.347 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.32 -54.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.921 -1.112 . . . . 0.0 110.397 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.565 ' CG2' ' HB1' ' A' ' 146' ' ' ALA . 9.9 p -84.85 -26.0 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.48 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.62 75.61 79.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.385 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.59 -3.98 14.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.389 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -91.21 -12.72 34.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.24 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.51 -72.65 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.908 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.444 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.3 mp -105.78 154.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.439 -0.788 . . . . 0.0 109.5 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 8.1 t -100.85 -56.44 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 110.415 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 36.5 m -153.55 175.34 13.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 110.489 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 56' ' ' ILE . 25.8 t -138.53 143.5 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.889 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.82 99.82 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.152 -0.967 . . . . 0.0 110.658 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.484 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 90.5 m-20 -58.36 117.33 4.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 54' ' ' LYS . 22.8 mm -85.87 -38.07 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.366 1.079 . . . . 0.0 108.301 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 61.5 tt0 -152.45 174.1 14.29 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.084 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 72.64 166.43 9.46 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -110.85 37.77 2.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -1.119 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 82.14 2.07 90.49 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.55 -160.79 23.72 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.31 124.05 7.55 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.018 1.536 . . . . 0.0 110.437 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.74 -3.0 70.57 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.625 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.2 m -61.43 152.13 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -1.164 . . . . 0.0 109.787 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 10.4 mt -112.75 136.48 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 110.327 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 54' ' ' LYS . 2.7 ptmt -153.13 139.18 18.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.229 -0.92 . . . . 0.0 110.305 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HG3' ' CD1' ' A' ' 66' ' ' TYR . 15.6 ttpp -91.67 109.28 20.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.499 HD12 ' OD1' ' A' ' 69' ' ' ASP . 96.7 mt -98.6 120.89 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.928 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 39' ' ' SER . 54.3 m -77.3 133.78 38.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.857 . . . . 0.0 110.46 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.29 140.05 22.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.025 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 60' ' ' GLU . 45.0 Cg_endo -72.25 77.47 2.04 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER 50.09 -178.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 110.462 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.63 -50.27 0.82 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.61 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -100.68 -179.22 0.78 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.288 -1.125 . . . . 0.0 109.682 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.61 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 42.9 Cg_endo -69.84 -27.71 25.78 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.718 1.378 . . . . 0.0 109.873 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CB ' ' HA3' ' A' ' 89' ' ' GLY . 0.2 OUTLIER -115.41 137.27 52.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.394 -0.816 . . . . 0.0 109.635 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -55.18 -79.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.348 -0.845 . . . . 0.0 111.152 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' HG3' ' A' ' 55' ' ' LYS . 5.0 p90 -92.09 179.58 5.54 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.869 0.843 . . . . 0.0 112.065 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.568 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -148.54 175.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -123.48 50.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.795 -1.191 . . . . 0.0 111.124 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' A' ' 56' ' ' ILE . 11.8 p-10 -61.78 131.03 48.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.943 . . . . 0.0 109.99 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -96.61 -179.22 4.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.625 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.0 t -90.27 151.39 3.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 120.916 -1.115 . . . . 0.0 109.891 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -100.44 -73.23 0.65 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.524 0.678 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -137.44 132.59 33.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.126 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.6 t -119.14 146.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 0.0 110.117 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.553 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -150.09 110.9 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.907 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -76.64 -12.84 60.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -109.94 -39.78 4.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.028 -1.045 . . . . 0.0 109.836 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -88.2 15.93 6.89 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.302 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 19.6 m-85 42.23 57.21 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.2 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.553 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.73 115.68 21.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.982 . . . . 0.0 110.679 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' A' ' 23' ' ' ILE . 13.1 t80 -135.82 102.17 4.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 32.7 m-20 -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.099 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.631 ' CE2' ' CB ' ' A' ' 100' ' ' ASN . 2.8 p90 -137.93 145.16 41.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.6 m -105.38 155.43 19.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.277 -0.889 . . . . 0.0 111.451 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 38.2 t -100.07 122.13 51.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -120.98 -66.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 111.531 -178.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -80.5 52.66 1.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.674 -1.266 . . . . 0.0 109.917 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.665 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -63.65 125.64 33.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.501 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -38.58 -58.46 1.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -72.88 -26.6 15.39 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.866 1.456 . . . . 0.0 110.555 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.665 HD12 ' HA3' ' A' ' 88' ' ' GLY . 17.9 mt -69.75 161.69 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.75 -51.95 0.08 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' C ' ' HG ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -87.6 50.66 2.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.091 -1.241 . . . . 0.0 110.593 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 49.23 24.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.528 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.576 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -118.56 175.43 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.948 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.615 ' O ' HD11 ' A' ' 91' ' ' ILE . 4.0 mt-10 54.89 32.6 18.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -80.02 159.39 26.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.409 -0.807 . . . . 0.0 110.069 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 120' ' ' TYR . 17.1 mt -143.03 137.09 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.687 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.48 94.45 4.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.76 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.631 ' CB ' ' CE2' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -84.31 141.31 31.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 2.5 mt-10 -128.28 146.37 50.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 110.168 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.4 mt -137.15 125.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 0.0 110.236 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.533 ' HE3' ' CG2' ' A' ' 105' ' ' VAL . 11.9 tttt -124.89 157.43 35.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 10.5 mt -148.09 119.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 110.495 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.533 ' CG2' ' HE3' ' A' ' 103' ' ' LYS . 83.6 t -118.52 129.63 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.414 -0.804 . . . . 0.0 109.987 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -80.59 154.18 27.59 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.414 0.626 . . . . 0.0 110.767 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.505 HG23 ' HA ' ' A' ' 112' ' ' SER . 6.8 p -114.51 167.14 10.14 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.868 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 48.0 Cg_endo -73.92 -2.48 12.31 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.882 1.464 . . . . 0.0 110.423 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -88.28 -12.43 43.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.3 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.94 -12.8 26.94 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . -105.74 -164.7 23.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.632 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 3.8 t -147.45 -174.86 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -1.031 . . . . 0.0 110.593 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 68.4 mt -138.63 136.58 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.8 . . . . 0.0 109.383 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 114' ' ' LEU . 6.5 mp -105.19 136.29 44.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.08 104.23 8.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.438 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 116' ' ' ILE . 5.4 mp -99.56 139.55 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.83 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -126.54 105.82 9.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.42 -0.8 . . . . 0.0 110.081 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -98.43 142.49 29.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.219 -0.925 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.0 OUTLIER -135.97 127.57 28.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -111.8 123.41 50.18 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.151 -0.968 . . . . 0.0 110.014 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -104.51 116.39 32.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.853 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.14 169.36 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 109.777 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -156.91 -169.11 2.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 110.243 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 44.16 -138.73 4.44 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.12 1.84 45.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -1.157 . . . . 0.0 110.484 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -73.92 167.78 20.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.209 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -150.72 -171.44 3.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 0.0 109.882 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 128' ' ' VAL . 4.6 t -113.93 96.3 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.649 ' O ' HG23 ' A' ' 133' ' ' VAL . 14.4 mttm -64.3 127.24 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.966 . . . . 0.0 109.385 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.73 -46.3 63.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.983 . . . . 0.0 110.458 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' ALA . 6.9 tp10 -41.27 -47.68 3.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.012 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -70.3 -31.55 68.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 108.818 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 129' ' ' LYS . 14.5 t -74.05 -47.97 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 109.31 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 7.0 tmtt? -66.48 -30.78 71.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.197 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.14 -27.92 62.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -72.78 -40.6 65.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 110.365 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 134' ' ' LYS . 13.6 ptmt -77.24 -22.07 52.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 0.0 110.254 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.64 -57.46 11.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.335 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 142' ' ' THR . 38.6 mt -70.88 -42.05 70.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.219 -0.926 . . . . 0.0 110.429 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 139' ' ' LEU . . . -41.53 -44.63 4.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.3 tt0 -57.75 -36.28 71.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -1.2 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 139' ' ' LEU . 92.8 m -67.97 -22.0 65.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.477 HD13 ' CZ ' ' A' ' 30' ' ' PHE . 64.4 mt -76.39 -49.99 15.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.921 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.38 -23.81 65.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -83.25 -38.17 22.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.964 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.565 ' HB1' ' CG2' ' A' ' 33' ' ' VAL . . . -60.77 -39.97 90.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -0.915 . . . . 0.0 109.514 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 22' ' ' PHE . 40.2 t -71.36 -52.77 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.482 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.412 -0.805 . . . . 0.0 109.571 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -50.95 69.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.54 -70.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.295 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.661 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.066 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -61.83 -43.81 98.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.86 -1.14 30.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -120.99 17.58 11.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.101 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.57 10.96 18.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.223 -0.923 . . . . 0.0 110.267 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.39 11.76 33.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.179 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.63 -172.89 2.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.135 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 158' ' ' TYR . 59.8 t80 -138.82 55.46 1.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.118 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 27.0 p30 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.208 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.99 143.14 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -1.149 . . . . 0.0 110.194 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.9 m-85 -97.13 154.29 17.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.673 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -127.26 149.34 50.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.911 -1.118 . . . . 0.0 111.038 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 40.9 m-85 -158.29 61.31 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.668 -0.645 . . . . 0.0 109.438 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 19.5 pt-20 -85.62 148.63 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 110.948 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.48 173.87 13.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 0.0 109.63 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.2 pm0 -147.61 169.98 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 0.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 152.12 29.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.746 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.53 161.57 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 110.552 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.465 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 9.4 t -159.85 138.16 10.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.639 -0.663 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 t -80.04 -14.25 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.866 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 44.3 mm -72.01 148.02 91.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.4 Cg_endo -66.85 150.07 83.22 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.432 1.228 . . . . 0.0 111.112 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.916 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -76.05 -29.42 58.02 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.405 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.81 -54.55 13.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.898 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 5.5 ttm180 -66.7 -35.69 80.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.437 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 114' ' ' LEU . 11.3 tp -75.25 -32.9 61.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 0.0 109.984 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.664 ' CD1' HD13 ' A' ' 23' ' ' ILE . 55.3 t80 -64.2 -68.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -52.75 -38.62 61.18 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.514 -0.741 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 -37.37 69.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 47.7 t80 -82.64 -20.79 35.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.664 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -110.84 -69.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.834 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -49.24 -41.42 37.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 110.1 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.565 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -108.6 0.65 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.187 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.93 -52.69 29.61 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -47.86 -29.36 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 20.8 t-20 -101.42 -29.64 11.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 0.0 110.269 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.035 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -80.56 -21.09 42.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.7 m-85 -66.1 -60.77 6.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.388 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -72.4 -0.11 8.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.989 1.521 . . . . 0.0 110.784 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 13.7 ttpt -101.78 -48.74 4.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.035 -1.04 . . . . 0.0 110.562 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.035 HG22 ' O ' ' A' ' 29' ' ' LEU . 17.0 m -91.44 7.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 110.6 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 75.39 3.34 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.143 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.33 -9.65 24.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.082 1.569 . . . . 0.0 110.69 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -92.81 -8.08 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 110.232 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -102.5 -72.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.016 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.48 131.33 57.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.443 -0.786 . . . . 0.0 109.758 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.5 OUTLIER -80.07 -34.9 37.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 110.208 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 39' ' ' SER . 2.0 p -178.09 157.77 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.44 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 60.5 t -117.49 152.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 109.982 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.9 tm-20 -139.05 89.68 2.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 15.9 t-20 -56.52 115.84 2.76 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.914 0.864 . . . . 0.0 110.532 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.726 HD12 HG22 ' A' ' 53' ' ' ILE . 6.0 mt -87.55 -39.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.902 0.858 . . . . 0.0 109.081 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 52' ' ' THR . 14.1 mt-10 -130.32 176.48 8.09 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.833 0.825 . . . . 0.0 111.689 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 45' ' ' GLU . . . 33.83 -156.57 0.01 OUTLIER Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -123.46 -19.15 5.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.39 -1.065 . . . . 0.0 109.869 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 49' ' ' GLY . . . 161.88 -21.67 0.2 Allowed Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 48' ' ' GLY . . . -53.16 -171.55 0.04 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.3 Cg_endo -72.65 128.7 13.7 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.009 1.531 . . . . 0.0 110.529 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.21 -7.17 62.04 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.663 ' HB ' HG21 ' A' ' 71' ' ' VAL . 2.3 m -69.76 144.42 52.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -1.164 . . . . 0.0 109.886 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.726 HG22 HD12 ' A' ' 44' ' ' ILE . 7.5 mt -114.55 141.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.936 -1.103 . . . . 0.0 109.264 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -153.38 134.43 14.01 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 110.069 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -86.49 116.78 24.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 111.041 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.467 HD11 ' HE2' ' A' ' 54' ' ' LYS . 56.0 mt -104.69 123.73 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.402 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 35.2 m -93.07 141.4 28.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 110.594 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.437 ' HB2' ' C ' ' A' ' 65' ' ' LYS . 2.5 m-85 -110.16 154.41 42.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.922 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.512 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 44.5 Cg_endo -71.83 168.04 24.93 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.0 1.526 . . . . 0.0 110.381 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 61' ' ' GLY . 63.9 tt0 -60.8 163.82 5.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.334 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' N ' ' HG2' ' A' ' 60' ' ' GLU . . . 148.05 -44.64 0.77 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.495 ' CB ' ' HD2' ' A' ' 63' ' ' PRO . 1.3 m-85 -130.5 177.75 2.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.286 -1.126 . . . . 0.0 109.918 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 62' ' ' PHE . 42.1 Cg_endo -67.76 -43.15 5.66 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.713 1.375 . . . . 0.0 110.562 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -98.93 130.77 45.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.839 . . . . 0.0 110.028 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' C ' ' HB2' ' A' ' 58' ' ' PHE . 8.6 mtmm -122.34 -81.8 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 110.528 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.843 ' O ' HG13 ' A' ' 67' ' ' VAL . 6.4 p90 -58.01 167.99 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.972 0.892 . . . . 0.0 111.291 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 66' ' ' TYR . 1.9 m -166.84 167.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.553 ' HD2' ' CB ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -99.3 -64.75 1.01 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.613 -1.304 . . . . 0.0 110.017 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.528 ' OD1' HG13 ' A' ' 85' ' ' VAL . 9.2 m-20 59.08 129.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.888 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -112.56 149.56 32.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 108.908 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG21 ' HB ' ' A' ' 52' ' ' THR . 11.6 t -65.12 153.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.864 -1.147 . . . . 0.0 110.268 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.5 t70 -104.69 -75.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.407 0.622 . . . . 0.0 110.038 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -137.13 128.45 28.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.838 HG22 ' CD2' ' A' ' 81' ' ' TYR . 4.1 t -119.19 142.89 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -144.37 114.8 7.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.507 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -81.08 -10.58 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -108.93 -39.11 5.41 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.071 -1.018 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.64 9.27 27.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.518 -0.739 . . . . 0.0 109.997 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 48.32 51.41 15.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.185 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.92 117.54 24.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.269 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.838 ' CD2' HG22 ' A' ' 74' ' ' VAL . 45.9 t80 -137.83 106.16 5.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.773 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 35.2 m-20 -119.61 152.35 37.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.229 -0.919 . . . . 0.0 110.331 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 11.5 p90 -142.79 136.46 28.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' ARG . 50.4 m -95.6 168.13 10.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.117 -0.989 . . . . 0.0 111.132 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.528 HG13 ' OD1' ' A' ' 69' ' ' ASP . 53.8 t -107.98 123.94 63.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -74.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.815 -1.178 . . . . 0.0 111.451 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 2.8 mm-40 -91.87 71.65 5.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.195 . . . . 0.0 110.131 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.8 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . -151.24 161.54 29.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 52.55 -157.95 3.76 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.85 -0.86 10.96 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.032 1.543 . . . . 0.0 111.197 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CD1' HG12 ' A' ' 85' ' ' VAL . 50.0 mt -51.13 156.35 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.48 -58.0 0.2 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.2 p-10 -146.23 -49.09 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -1.162 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 t -145.08 12.45 1.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.81 144.94 28.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.492 ' HA ' HG23 ' A' ' 122' ' ' THR . 2.7 tt0 55.99 33.4 21.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 109.859 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -70.48 150.43 46.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.639 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mt -132.62 134.43 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.364 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -118.78 107.64 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.043 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.496 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 18.4 m-80 -92.73 127.93 38.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.305 -0.872 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 82' ' ' ASN . 4.1 mt-10 -121.22 143.9 48.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 116' ' ' ILE . 58.0 mt -137.63 129.59 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.469 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 ttpt -124.82 142.46 51.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.653 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.916 HG22 ' HB1' ' A' ' 15' ' ' ALA . 84.1 mt -130.65 103.98 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.471 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 113' ' ' ILE . 73.4 t -108.7 146.2 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.06 159.69 18.14 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.728 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 112' ' ' SER . 22.0 p -118.81 165.86 15.67 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 110.274 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 46.3 Cg_endo -73.29 -1.88 11.27 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.901 1.474 . . . . 0.0 110.401 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -92.96 -9.53 39.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.11 -8.43 35.91 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.49 -167.12 21.06 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -135.75 -176.52 4.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -1.089 . . . . 0.0 110.513 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 105' ' ' VAL . 33.6 mt -136.5 117.55 18.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.552 HD11 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -88.63 124.31 33.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 110.626 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 7.0 ttmt -116.14 100.02 7.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.78 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 102' ' ' ILE . 28.7 mt -96.48 139.57 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.395 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -122.16 109.3 14.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.2 t-20 -98.17 131.34 44.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.993 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 138.09 49.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.639 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.51 141.41 43.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 49.2 m-70 -123.37 95.99 4.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.492 HG23 ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -118.06 172.15 7.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 124' ' ' GLY . 18.6 tttp -100.23 154.89 18.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 110.14 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.62 -29.6 0.78 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.5 -81.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -1.123 . . . . 0.0 110.136 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 2.9 m-70 -64.33 -178.08 0.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 110.06 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 126' ' ' HIS . 24.5 mt-10 -155.43 -173.49 4.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.889 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.581 HG21 ' CG ' ' A' ' 120' ' ' TYR . 4.4 t -116.68 99.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.165 -0.959 . . . . 0.0 110.449 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.741 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -68.06 146.74 53.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.993 . . . . 0.0 109.498 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . . . -66.59 -9.66 37.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.971 -1.081 . . . . 0.0 110.808 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.505 ' HB2' ' CD ' ' A' ' 129' ' ' LYS . 12.9 mt-10 -68.0 -54.58 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.994 -1.066 . . . . 0.0 109.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.14 -23.7 63.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.89 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 129' ' ' LYS . 17.5 t -80.85 -46.59 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 130' ' ' ALA . 27.8 tttt -64.27 -26.02 68.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.955 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.41 74.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.885 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -75.91 -40.41 54.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -47.5 -69.43 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.7 -22.74 63.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.169 -0.957 . . . . 0.0 109.902 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.17 -32.86 51.11 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.503 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 34.8 mt-10 -72.46 -61.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -1.095 . . . . 0.0 110.082 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 146' ' ' ALA . 3.0 m -45.62 -33.37 2.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.904 -1.123 . . . . 0.0 109.708 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.54 -59.38 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.856 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.8 pp -65.9 -24.64 66.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -81.96 -29.23 32.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.47 -38.44 77.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.675 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.47 -44.91 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -56.29 -46.08 79.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.573 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.4 OUTLIER -64.24 -49.76 70.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.733 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -47.71 -71.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 110.038 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -46.22 -37.21 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.379 -0.825 . . . . 0.0 110.298 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 149' ' ' SER . 5.3 mt -59.33 -23.66 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 110.507 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.81 -5.38 51.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -100.36 37.38 1.69 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.183 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.3 m -97.61 23.35 7.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.395 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -94.0 -27.4 16.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.025 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.75 178.62 4.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 110.034 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -96.9 -63.28 1.15 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.946 . . . . 0.0 110.382 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.257 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.96 148.26 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -1.185 . . . . 0.0 110.371 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.439 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 23.1 m-85 -95.28 155.01 16.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.626 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.64 140.97 51.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.718 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.403 ' CE2' HG11 ' A' ' 133' ' ' VAL . 20.2 m-85 -149.32 61.53 1.03 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.398 -0.813 . . . . 0.0 109.723 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 4.2 pt-20 -84.0 148.44 26.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.862 . . . . 0.0 110.915 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLU . 3.1 p -151.8 175.24 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.793 . . . . 0.0 109.565 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 11.8 pt-20 -155.26 146.42 22.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.93 -1.106 . . . . 0.0 110.621 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 m -129.26 143.18 50.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 110.019 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -82.06 159.69 23.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.416 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 m -156.77 136.91 12.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 12.1 m -79.98 -16.37 12.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.09 -1.006 . . . . 0.0 108.66 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.865 HG21 HD13 ' A' ' 151' ' ' LEU . 26.0 mm -67.03 149.44 98.51 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.74 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.69 150.55 83.59 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.509 1.268 . . . . 0.0 110.875 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -76.81 -27.02 55.05 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.57 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.07 -52.57 9.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 0.0 109.396 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.588 HD22 HG21 ' A' ' 104' ' ' ILE . 9.8 tt -75.5 -42.45 52.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.523 -0.735 . . . . 0.0 109.829 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.752 ' CD1' HD13 ' A' ' 23' ' ' ILE . 51.0 t80 -56.65 -62.23 1.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 0.0 110.17 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.477 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -53.41 -45.61 69.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.81 . . . . 0.0 110.277 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.49 65.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.459 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.718 ' HD2' HG11 ' A' ' 147' ' ' VAL . 5.8 t80 -88.13 -22.98 23.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.435 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.752 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -112.18 -58.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' CG ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -60.23 -30.35 69.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.876 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -122.24 11.65 10.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.935 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.23 -54.52 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 36.2 p-10 -55.44 -25.55 36.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -1.179 . . . . 0.0 110.393 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 37.2 m-20 -92.99 -41.21 10.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.676 HD21 ' CE2' ' A' ' 150' ' ' TYR . 0.6 OUTLIER -72.99 -31.31 64.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 110.524 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.762 ' CD2' HD13 ' A' ' 38' ' ' ILE . 2.0 m-85 -50.17 -61.96 3.14 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -72.4 -7.46 20.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.84 1.442 . . . . 0.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -93.42 -67.2 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.397 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 29' ' ' LEU . 24.3 m -88.98 -0.29 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.339 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -146.8 56.33 2.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 110.344 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 34' ' ' ALA . 45.4 Cg_endo -71.88 -23.19 22.48 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.335 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.84 -16.92 61.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.584 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -96.66 -58.74 1.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.195 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.762 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -110.47 137.78 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.969 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.15 -52.59 6.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 110.353 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.71 -179.23 7.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.192 -0.942 . . . . 0.0 110.453 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 41' ' ' VAL . 2.4 p -159.94 112.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.3 145.68 44.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.896 . . . . 0.0 110.044 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -93.88 121.95 35.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.684 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 54' ' ' LYS . 25.4 mm -83.8 -37.59 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.345 1.069 . . . . 0.0 108.363 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 31.8 tt0 -153.57 174.3 14.62 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.289 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 66.4 173.31 5.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 47' ' ' ASN . 10.8 t-20 -124.92 45.12 2.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -1.049 . . . . 0.0 109.795 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.539 ' H ' HG21 ' A' ' 52' ' ' THR . . . 79.81 14.55 80.79 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.32 -168.4 34.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.8 Cg_endo -71.25 114.96 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.971 1.511 . . . . 0.0 110.315 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.14 -2.89 51.2 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.672 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.4 m -62.91 154.45 30.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.111 . . . . 0.0 109.815 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 44' ' ' ILE . 6.0 mt -125.35 136.1 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -154.48 139.32 17.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.915 . . . . 0.0 110.35 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -84.07 119.88 25.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.3 mt -103.24 118.04 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -85.75 140.49 30.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CB ' ' HB3' ' A' ' 65' ' ' LYS . 19.4 m-85 -112.49 158.53 37.06 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 42.7 Cg_endo -70.55 -169.9 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.007 1.53 . . . . 0.0 110.908 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.8 -170.36 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.852 . . . . 0.0 110.645 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.89 -38.31 2.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.9 OUTLIER -135.24 177.09 2.4 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.335 -1.097 . . . . 0.0 110.007 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.571 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 44.6 Cg_endo -71.59 -54.87 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.958 1.504 . . . . 0.0 110.093 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 36.6 m-85 -111.64 129.58 56.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.851 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.553 ' HB3' ' CB ' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -144.07 -38.71 0.3 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.324 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 9.0 p90 -62.25 148.5 44.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.963 . . . . 0.0 109.632 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -157.52 172.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.098 -1.001 . . . . 0.0 110.662 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.565 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 2.5 mtpp -93.46 -65.02 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.662 -0.649 . . . . 0.0 109.811 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER 60.6 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ptm180 -106.37 167.22 9.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.672 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.6 t -82.18 152.32 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.88 -1.137 . . . . 0.0 110.348 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 48.5 t0 -101.2 -72.34 0.68 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.235 0.541 . . . . 0.0 109.878 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -146.82 124.58 11.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.361 -0.837 . . . . 0.0 110.124 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.61 149.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 5.3 t0 -151.94 115.06 4.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 109.908 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -85.86 3.14 43.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.647 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -110.34 -48.38 3.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.305 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -91.77 17.84 8.47 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.701 -0.624 . . . . 0.0 110.03 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 20.2 m-85 43.74 58.97 3.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.93 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 28.1 tttt -122.18 119.44 31.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -135.51 109.16 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 51.4 m-20 -125.86 150.29 47.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 110.427 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 51.3 p90 -142.64 139.64 31.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.447 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' ARG . 3.1 m -96.16 155.87 16.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.973 -1.079 . . . . 0.0 110.808 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' OD2' ' A' ' 69' ' ' ASP . 54.7 t -99.91 124.43 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.61 -76.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 110.956 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.68 78.88 9.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.649 -1.282 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.441 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -100.63 145.97 17.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.57 -50.01 8.44 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.5 Cg_endo -73.62 -48.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.636 1.335 . . . . 0.0 111.02 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 85' ' ' VAL . 33.7 mt -54.52 141.7 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.078 -1.014 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -108.73 -65.06 0.57 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 4.7 m-20 -114.3 -82.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -1.113 . . . . 0.0 110.0 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.9 p -134.27 12.2 3.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.975 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.752 HD22 ' HB2' ' A' ' 123' ' ' LYS . 37.2 mt -90.87 156.38 18.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.016 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 12.1 tt0 61.96 31.76 17.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.7 mtpt -65.25 161.56 19.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.552 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.588 HD11 ' HE1' ' A' ' 120' ' ' TYR . 87.6 mt -143.9 132.52 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 110.614 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 1.2 m -116.24 111.34 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 109.547 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 2.0 m-80 -103.06 142.17 34.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.548 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 4.2 mp0 -136.19 150.23 48.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.973 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.446 HG12 HD12 ' A' ' 116' ' ' ILE . 45.6 mt -140.63 125.55 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.509 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 2.4 ttpt -125.15 111.91 15.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 109.65 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.588 HG21 HD22 ' A' ' 18' ' ' LEU . 12.1 mt -102.96 112.59 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.43 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.78 142.32 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.827 . . . . 0.0 110.188 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.94 159.96 18.12 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.595 -0.691 . . . . 0.0 110.665 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.581 HG23 ' HA ' ' A' ' 112' ' ' SER . 14.9 p -119.75 166.25 15.38 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 44.0 Cg_endo -71.18 -10.84 28.04 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.875 1.46 . . . . 0.0 110.409 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -79.0 -17.07 56.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 110.315 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.16 -17.23 12.76 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -105.71 -164.63 23.37 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.823 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -135.98 -174.17 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.407 -1.055 . . . . 0.0 110.511 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' CG2' ' A' ' 107' ' ' THR . 23.5 mt -137.59 109.39 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.0 108.982 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -84.42 129.19 34.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG2' ' CB ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -122.44 98.47 5.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 109.692 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 116' ' ' ILE . 2.6 tt -94.82 120.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.509 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.472 ' HB3' ' OE1' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -102.04 116.26 32.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.051 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.454 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -103.08 158.62 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 1.8 ttmt -148.51 142.0 25.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.447 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.61 ' CD2' HG21 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -123.52 133.48 54.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -0.931 . . . . 0.0 110.106 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.619 ' CD2' ' N ' ' A' ' 121' ' ' HIS . 4.4 m-70 -119.37 97.67 5.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.52 163.21 14.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.951 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.752 ' HB2' HD22 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -101.46 160.61 14.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.397 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -49.75 -24.96 6.45 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.48 -54.72 4.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.122 -1.222 . . . . 0.0 110.57 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.491 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 51.7 m170 -79.64 175.92 10.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 110.269 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.491 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -160.11 137.34 9.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.701 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.61 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.6 p -98.46 89.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.514 -0.742 . . . . 0.0 110.223 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.16 155.31 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.118 -0.989 . . . . 0.0 110.145 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -64.76 -33.15 75.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.278 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -41.03 -59.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -27.31 65.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 109.274 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 130' ' ' ALA . 18.8 t -77.2 -49.47 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.425 -0.797 . . . . 0.0 109.372 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.43 65.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.857 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.02 -21.44 59.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t -76.44 -43.72 38.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.467 -0.77 . . . . 0.0 110.056 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.75 -30.29 68.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.942 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.97 -40.45 46.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.882 . . . . 0.0 110.125 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.669 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -50.03 -40.99 36.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.871 ' HA ' HD23 ' A' ' 144' ' ' LEU . 23.2 tt0 -60.88 -43.98 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -1.122 . . . . 0.0 109.699 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 38.7 m -62.43 -30.36 71.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.533 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.669 HD12 ' HA2' ' A' ' 140' ' ' GLY . 74.1 mt -64.85 -45.55 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -66.64 -26.2 66.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.524 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -78.79 -39.66 35.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.82 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.59 88.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.579 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.718 HG11 ' HD2' ' A' ' 22' ' ' PHE . 60.0 t -69.92 -39.66 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.01 -50.86 69.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -17.25 63.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.448 -0.782 . . . . 0.0 110.749 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.676 ' CE2' HD21 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -79.81 -42.24 24.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.966 -1.084 . . . . 0.0 109.503 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.865 HD13 HG21 ' A' ' 13' ' ' ILE . 5.7 mt -67.48 -48.16 67.95 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.821 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -53.34 56.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.83 62.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.912 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.67 97.07 6.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 110.063 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 57.6 m -146.8 75.43 1.39 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.292 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 34.2 m-20 -85.12 -35.18 21.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.038 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 156' ' ' ASP . . . 68.38 178.18 0.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.211 -0.931 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -173.73 -49.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.069 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.147 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.446 HG21 ' CE1' ' A' ' 121' ' ' HIS . 5.1 t -54.78 151.21 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -1.168 . . . . 0.0 110.074 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -104.35 128.66 52.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 109.883 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.17 142.07 32.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.846 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.767 ' CE2' HG11 ' A' ' 133' ' ' VAL . 27.8 m-85 -149.93 54.96 0.94 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.46 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.496 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 0.1 OUTLIER -83.16 158.0 22.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.529 -0.732 . . . . 0.0 110.878 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -154.44 153.84 32.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.677 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -138.5 146.71 42.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.539 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.54 -178.97 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.43 HG22 HG12 ' A' ' 113' ' ' ILE . 1.6 p -121.64 163.29 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.949 . . . . 0.0 110.664 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 2.7 t -159.29 136.86 10.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.78 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.514 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 16.6 t -80.03 -13.87 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.125 -0.984 . . . . 0.0 109.008 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.863 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.1 mp -71.89 153.97 92.83 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.863 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.4 Cg_endo -67.93 149.15 77.49 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.619 1.326 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -75.08 -29.06 60.55 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.513 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -68.16 -55.07 13.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 16.3 mtt-85 -63.93 -36.63 84.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.568 HD23 HD13 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -71.79 -35.81 70.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.09 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.615 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 36.4 t80 -60.54 -58.73 7.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.921 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' HD3' ' O ' ' A' ' 16' ' ' ALA . 13.7 mtpt -50.69 -52.62 38.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.67 67.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.293 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -89.13 -12.06 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -124.45 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.742 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.616 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -50.34 -56.2 12.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.43 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 2.5 m-20 -111.95 35.43 3.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 109.829 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.13 -58.91 2.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.59 ' HB2' HG11 ' A' ' 41' ' ' VAL . 7.0 p-10 -53.03 -26.72 16.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 110.052 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -87.56 -34.8 18.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.568 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 13.9 mt -80.44 -38.75 29.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.316 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.635 ' HD2' HD13 ' A' ' 38' ' ' ILE . 2.0 m-30 -43.79 -57.72 5.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.619 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.8 Cg_endo -70.71 -18.89 32.21 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.884 1.465 . . . . 0.0 110.629 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.1 mtpp -86.15 -54.46 4.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.93 HG22 ' HB1' ' A' ' 146' ' ' ALA . 5.5 p -83.76 -25.33 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.48 77.29 15.5 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.01 -4.73 15.89 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.082 1.569 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.93 -26.5 60.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.124 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -95.6 -70.34 0.72 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.861 . . . . 0.0 109.967 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.635 HD13 ' HD2' ' A' ' 30' ' ' PHE . 1.7 mp -99.02 128.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.819 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -88.49 -44.69 10.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.29 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -159.5 139.96 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.974 HG13 HG12 ' A' ' 56' ' ' ILE . 3.8 t -119.04 130.87 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -135.61 101.82 4.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.686 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 8.6 m-80 -50.64 118.86 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.22 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.526 ' CD1' ' HG2' ' A' ' 68' ' ' LYS . 12.8 mt -86.42 -37.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.336 1.065 . . . . 0.0 108.403 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 24.6 tt0 -143.61 174.43 10.79 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.072 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 57.4 160.49 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -103.88 1.73 31.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -1.203 . . . . 0.0 110.115 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.21 -1.4 4.52 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.86 -167.64 19.98 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.6 122.28 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.005 1.529 . . . . 0.0 110.293 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.73 59.9 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.659 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.4 m -54.85 158.72 2.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -1.167 . . . . 0.0 109.305 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 45.8 mt -125.79 142.57 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.048 -1.033 . . . . 0.0 110.559 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -145.32 150.39 36.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 14.7 ttpp -102.2 93.47 5.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.638 -0.664 . . . . 0.0 110.079 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.974 HG12 HG13 ' A' ' 41' ' ' VAL . 66.1 mt -87.92 122.47 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 110.055 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.513 ' CB ' ' OG ' ' A' ' 39' ' ' SER . 17.6 m -86.7 138.14 31.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -106.14 135.31 19.47 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 45.3 Cg_endo -72.8 121.11 7.08 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.936 1.493 . . . . 0.0 110.416 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -172.44 -171.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 62' ' ' PHE . . . -106.04 -52.89 0.77 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 15.2 m-85 -44.51 163.85 0.18 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.278 -1.131 . . . . 0.0 110.05 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 43.9 Cg_endo -71.36 -50.62 0.3 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.038 1.546 . . . . 0.0 110.846 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.427 ' CD2' ' HG2' ' A' ' 63' ' ' PRO . 26.2 m-85 -82.87 128.51 34.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.388 -0.82 . . . . 0.0 110.325 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 58' ' ' PHE . 9.8 pttp -164.63 -43.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 109.883 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.8 p90 -63.09 165.72 6.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.788 . . . . 0.0 109.951 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -144.33 167.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.403 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.526 ' HG2' ' CD1' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -123.05 41.8 3.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.945 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 18.6 p-10 -41.84 136.21 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.9 ttm180 -97.46 151.84 19.58 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.659 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.1 t -75.75 149.06 6.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.67 -1.269 . . . . 0.0 110.459 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 46.2 t0 -101.87 -72.14 0.69 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.416 0.627 . . . . 0.0 110.306 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 122.47 11.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -0.855 . . . . 0.0 109.96 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.793 HG22 ' CD2' ' A' ' 81' ' ' TYR . 5.1 t -108.7 154.22 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 110.265 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.488 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 2.1 t0 -156.48 121.85 4.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.887 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.505 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -87.54 -15.29 37.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.788 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -102.37 -45.13 5.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.126 -0.984 . . . . 0.0 109.356 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.13 7.48 15.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.546 -0.722 . . . . 0.0 110.091 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.615 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.4 m-30 46.25 58.46 4.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.493 ' HG3' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.61 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.793 ' CD2' HG22 ' A' ' 74' ' ' VAL . 38.9 t80 -127.95 100.08 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 109.804 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.606 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 61.8 m-20 -109.58 139.77 44.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.466 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.598 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 39.7 p90 -136.14 136.29 39.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 70' ' ' ARG . 10.6 m -100.13 162.51 12.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 111.223 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.735 HG11 HD13 ' A' ' 98' ' ' ILE . 24.3 t -104.54 123.66 58.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -123.4 -72.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.303 -179.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.75 88.27 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.268 . . . . 0.0 110.211 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -107.1 148.2 16.37 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.53 -51.91 5.44 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.9 Cg_endo -76.3 -46.96 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.934 1.492 . . . . 0.0 110.732 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 92' ' ' GLY . 52.8 mt -56.51 164.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.107 -0.995 . . . . 0.0 110.459 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -150.91 -69.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -86.4 -87.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -148.62 15.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.467 ' HB3' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -89.66 160.62 16.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 110.38 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 58.16 35.63 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.28 147.73 39.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.735 HD13 HG11 ' A' ' 85' ' ' VAL . 4.9 mp -127.77 137.01 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.763 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.7 114.69 19.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.87 . . . . 0.0 109.661 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.598 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 4.9 m-20 -110.04 141.14 43.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.606 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -130.26 135.68 48.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.44 101.67 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.056 -1.027 . . . . 0.0 110.344 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HE3' ' HG3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -107.63 121.46 44.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.926 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.735 HG22 ' HB1' ' A' ' 15' ' ' ALA . 54.9 mt -110.48 139.35 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.6 t -138.77 135.78 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.372 -0.83 . . . . 0.0 109.816 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.16 145.92 25.66 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.486 0.66 . . . . 0.0 111.096 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.4 p -89.24 -167.04 0.12 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.271 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 46.0 Cg_endo -79.77 70.86 7.33 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.399 1.21 . . . . 0.0 110.281 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER 68.48 35.62 3.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.394 -0.816 . . . . 0.0 110.144 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.52 16.37 4.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 107' ' ' THR . . . 106.23 -159.76 14.92 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.854 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -140.4 163.46 32.74 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.549 -0.971 . . . . 0.0 110.676 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 10' ' ' THR . 71.4 mt -119.85 127.33 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.53 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 114' ' ' LEU . 2.1 pp -105.79 112.87 26.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.001 -1.062 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -99.31 104.58 16.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.322 -0.861 . . . . 0.0 109.951 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.489 HG13 HD12 ' A' ' 114' ' ' LEU . 9.7 mt -89.56 125.38 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.496 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -112.63 112.51 24.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.126 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -106.39 155.63 19.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.8 mptt -147.21 131.02 17.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.511 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.646 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.21 128.28 55.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.742 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.446 ' CE1' HG21 ' A' ' 2' ' ' VAL . 23.0 m-70 -113.75 130.01 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -110.63 175.65 5.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 110.086 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -147.2 165.6 29.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 110.183 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 43.04 -124.55 4.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -111.8 10.76 20.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -1.121 . . . . 0.0 110.071 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 13.9 m-70 -69.02 168.05 14.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.293 -0.88 . . . . 0.0 109.878 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.609 ' HA ' HG21 ' A' ' 122' ' ' THR . 5.7 mt-10 -155.75 150.96 26.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.179 -0.951 . . . . 0.0 109.442 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.603 HG21 ' CE2' ' A' ' 120' ' ' TYR . 2.4 p -106.52 86.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 O-C-N 121.658 -0.651 . . . . 0.0 109.839 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 128' ' ' VAL . 1.3 mttp -39.56 144.66 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.508 -0.745 . . . . 0.0 110.603 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.504 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -57.31 -27.34 62.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 110.059 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ALA . 60.8 tt0 -41.57 -64.16 0.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -56.03 -24.36 38.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.767 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.3 t -78.88 -50.95 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.365 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -24.55 67.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.465 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.58 -38.26 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.649 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 t -66.9 -31.94 72.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.316 -0.865 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -36.73 73.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.804 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.49 -48.08 79.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.844 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.88 -36.55 56.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.59 -50.25 61.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.1 tt0 -56.08 -33.21 64.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -1.194 . . . . 0.0 110.289 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.3 m -70.88 -24.76 62.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.565 ' O ' HG23 ' A' ' 147' ' ' VAL . 21.3 mt -75.7 -47.31 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.993 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.5 pp -70.66 -24.06 62.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.767 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.474 ' N ' HD12 ' A' ' 144' ' ' LEU . 15.0 tpt180 -81.05 -32.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.93 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -70.37 -35.42 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 143' ' ' LEU . 47.0 t -73.5 -46.03 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.465 -0.772 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 49.6 tt0 -54.79 -50.87 67.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.33 -47.35 84.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -48.73 -70.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.621 HD13 HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -49.31 -23.64 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.452 -0.78 . . . . 0.0 110.242 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -81.11 -20.47 41.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.4 3.56 37.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.91 8.1 44.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.221 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 36.9 m -95.14 52.14 1.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 0.0 110.221 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.44 18.97 6.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.029 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.01 -37.21 75.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.353 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.34 70.31 0.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.184 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.25 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.528 HG22 ' ND1' ' A' ' 121' ' ' HIS . 4.8 t 57.72 153.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -1.108 . . . . 0.0 110.412 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.5 m-85 -112.0 163.82 13.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.679 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.09 137.52 32.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.106 . . . . 0.0 110.714 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.479 ' O ' ' HB2' ' A' ' 118' ' ' ASN . 46.6 m-85 -144.89 57.89 1.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.777 . . . . 0.0 109.556 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 7' ' ' THR . 1.2 tm-20 -80.03 154.52 28.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 110.783 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -155.68 -179.06 7.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.494 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -158.04 151.74 23.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.0 110.47 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 t -140.4 169.57 17.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.928 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.4 162.99 13.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 110.256 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.403 ' OG ' ' HG3' ' A' ' 148' ' ' GLU . 3.6 t -158.86 137.88 11.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.444 -0.785 . . . . 0.0 109.916 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.98 -3.02 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.594 HG21 HD13 ' A' ' 151' ' ' LEU . 36.1 mm -81.58 147.47 59.51 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.049 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.88 150.56 83.11 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.473 1.249 . . . . 0.0 111.091 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -75.18 -33.15 61.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.935 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.03 -47.81 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.49 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 5.1 ttt180 -68.64 -38.92 80.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 109.764 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.74 ' CD2' HD21 ' A' ' 114' ' ' LEU . 2.4 tp -72.69 -30.45 64.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 76' ' ' HIS . 67.6 t80 -68.13 -63.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.368 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HG3' HD13 ' A' ' 24' ' ' LEU . 1.4 mptp? -53.24 -40.98 64.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -0.777 . . . . 0.0 110.512 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.76 -32.15 63.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.541 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.7 t80 -90.61 -8.72 49.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 1.2 mp -118.83 -65.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.691 HD11 ' NE2' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -61.33 -46.73 89.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 29' ' ' LEU . 1.1 t0 -97.05 -15.35 21.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -45.94 -42.51 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 4.6 m-20 -52.77 -27.98 20.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -113.31 -20.29 11.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.6 tp -86.66 -27.79 23.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 110.106 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.542 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.0 m-85 -54.84 -53.76 57.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.406 -0.809 . . . . 0.0 110.657 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -74.31 -4.59 15.66 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.833 1.438 . . . . 0.0 111.101 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.5 -40.71 8.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.59 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 29' ' ' LEU . 13.5 m -86.03 -26.66 6.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 110.8 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.24 88.44 5.81 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.092 -1.005 . . . . 0.0 110.594 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 59' ' ' PRO . 49.3 Cg_endo -76.34 0.68 9.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.006 1.53 . . . . 0.0 110.489 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -29.75 23.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.282 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -92.4 -66.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.445 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.2 mp -107.82 126.86 64.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.444 -0.785 . . . . 0.0 109.936 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 31' ' ' PRO . 2.9 t -83.35 -53.35 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.285 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -149.6 146.99 27.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.018 HG13 HD12 ' A' ' 56' ' ' ILE . 5.8 t -121.45 127.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.63 108.95 8.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.093 -1.005 . . . . 0.0 110.838 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 2.7 m120 -62.4 118.39 7.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 44' ' ' ILE . 12.1 mt -87.36 -37.71 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.236 1.017 . . . . 0.0 108.585 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 23.8 tt0 -148.64 174.7 11.87 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.405 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 71.18 -174.92 40.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.77 43.21 3.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -1.197 . . . . 0.0 110.295 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' H ' HG21 ' A' ' 52' ' ' THR . . . 72.3 27.95 68.93 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.11 -158.97 12.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.7 Cg_endo -72.47 110.22 2.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.112 1.585 . . . . 0.0 110.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.82 47.41 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.603 ' HB ' HG21 ' A' ' 71' ' ' VAL . 2.4 m -60.72 152.65 26.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.181 -1.188 . . . . 0.0 109.728 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.42 HG21 ' HE2' ' A' ' 68' ' ' LYS . 7.3 mt -119.43 133.95 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' HD3' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -141.08 150.84 43.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.533 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.48 ' C ' HD13 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -96.41 101.44 13.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 109.751 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 HG13 ' A' ' 41' ' ' VAL . 4.4 mm -94.48 134.01 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.963 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -102.97 131.81 49.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.92 . . . . 0.0 110.337 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.418 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -100.14 117.73 62.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.911 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.484 ' HG3' ' O ' ' A' ' 35' ' ' PRO . 48.7 Cg_endo -75.54 137.62 20.77 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.912 1.48 . . . . 0.0 110.638 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 10.2 tt0 -177.98 -72.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.215 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.02 -34.24 0.86 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.401 ' CB ' ' HD2' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -54.29 173.5 0.21 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.289 -1.124 . . . . 0.0 110.059 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 62' ' ' PHE . 43.8 Cg_endo -71.02 -55.26 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.997 1.525 . . . . 0.0 109.898 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 22.0 m-85 -96.51 167.52 11.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.952 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 165.81 -55.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 33.6 p90 -58.22 177.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.485 -0.759 . . . . 0.0 110.281 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 68' ' ' LYS . 1.4 p -167.16 171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 110.657 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' N ' HG22 ' A' ' 67' ' ' VAL . 8.7 tttt -106.89 46.42 0.93 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.715 -0.615 . . . . 0.0 109.912 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' CG2' ' A' ' 67' ' ' VAL . 48.5 m-20 -45.62 130.98 9.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.693 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttp180 -102.56 162.92 12.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.603 HG21 ' HB ' ' A' ' 52' ' ' THR . 12.3 t -86.56 151.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.596 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 32.1 t70 -100.33 -68.01 0.83 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.194 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.3 mt-10 -143.77 137.86 28.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.414 -0.804 . . . . 0.0 110.205 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 4.5 t -123.97 144.22 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.158 -0.964 . . . . 0.0 110.101 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -147.43 114.06 6.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.691 ' NE2' HD11 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -82.56 -2.07 52.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.338 -0.851 . . . . 0.0 110.708 -179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -118.08 -42.45 2.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.037 -1.039 . . . . 0.0 109.891 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.477 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -90.26 18.85 5.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.516 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.2 m-85 42.17 64.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.111 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.503 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -131.11 117.14 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.442 ' OH ' ' NZ ' ' A' ' 54' ' ' LYS . 9.5 t80 -137.34 99.63 4.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.536 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 56.8 m-20 -113.81 147.01 39.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 36.2 p90 -140.99 142.48 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 70' ' ' ARG . 26.3 m -107.07 165.14 11.58 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.176 -0.953 . . . . 0.0 110.974 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.696 HG12 HD13 ' A' ' 91' ' ' ILE . 71.4 t -108.06 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.499 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -123.06 -77.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.898 -1.126 . . . . 0.0 110.834 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -85.61 77.28 9.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.835 -1.166 . . . . 0.0 109.891 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.494 ' HA2' ' CB ' ' A' ' 67' ' ' VAL . . . -104.23 159.74 16.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.546 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.75 -54.84 5.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -71.06 -48.76 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.768 1.404 . . . . 0.0 111.013 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.696 HD13 HG12 ' A' ' 85' ' ' VAL . 4.8 mt -64.89 164.59 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.479 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -153.15 -40.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.3 -85.97 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -1.152 . . . . 0.0 110.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -139.26 6.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -92.91 158.44 15.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 58.39 31.3 20.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 110.162 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -75.31 146.35 41.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.787 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.599 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.1 mp -132.29 127.82 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -0.951 . . . . 0.0 110.685 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.49 116.24 30.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 109.679 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.52 ' ND2' ' OD1' ' A' ' 118' ' ' ASN . 10.1 m120 -104.35 156.34 18.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.937 . . . . 0.0 110.749 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 94.2 mt-10 -144.91 138.38 26.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.792 . . . . 0.0 109.815 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -128.76 128.67 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.521 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -129.17 132.29 47.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.937 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.516 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 1.3 mp -121.66 129.17 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.85 123.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 111.195 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -58.12 162.9 3.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.864 -0.523 . . . . 0.0 110.503 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.73 HG23 ' CD ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -160.0 -61.05 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 111.371 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.73 ' CD ' HG23 ' A' ' 107' ' ' THR . 49.4 Cg_endo -74.27 53.1 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.082 1.043 . . . . 0.0 111.099 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 108' ' ' PRO . 1.2 m-20 40.6 55.13 2.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.905 . . . . 0.0 110.549 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 146.63 -56.14 0.52 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -75.78 -169.05 26.39 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 11.3 t -157.19 -179.98 8.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.255 . . . . 0.0 111.218 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.468 HG13 HG21 ' A' ' 107' ' ' THR . 4.9 mt -125.21 124.79 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.74 HD21 ' CD2' ' A' ' 18' ' ' LEU . 2.1 mp -99.09 114.67 27.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 110.952 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -103.83 106.48 17.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.334 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 26.3 mt -101.99 127.27 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.679 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -105.43 143.44 33.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.801 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.52 ' OD1' ' ND2' ' A' ' 100' ' ' ASN . 6.8 m-80 -131.07 153.15 49.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.413 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -146.26 132.65 19.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 110.375 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.671 ' CG ' HG21 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -110.07 131.5 55.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.81 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.528 ' ND1' HG22 ' A' ' 2' ' ' VAL . 66.5 m-70 -118.28 109.15 15.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 110.371 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.555 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -107.48 173.07 6.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' ASP . 1.6 ttpm? -110.32 176.06 5.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 110.361 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.09 60.58 0.22 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' LYS . 42.8 t0 -175.29 -67.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.37 -1.076 . . . . 0.0 109.831 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -81.91 172.15 13.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.937 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.555 ' HA ' HG21 ' A' ' 122' ' ' THR . 1.3 mm-40 -145.17 -164.14 1.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 110.266 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.671 HG21 ' CG ' ' A' ' 120' ' ' TYR . 1.8 t -122.82 105.38 15.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.499 -0.751 . . . . 0.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -78.22 126.76 31.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.371 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.57 -37.28 26.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.405 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -42.49 -48.85 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.024 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -70.51 -27.73 64.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 108.934 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 130' ' ' ALA . 16.9 t -76.5 -47.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.569 -0.707 . . . . 0.0 109.12 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -59.51 -27.94 66.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.658 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.92 66.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.1 t -66.87 -31.32 71.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -45.34 54.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 110.046 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.84 -57.36 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.884 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' ' HB ' ' A' ' 142' ' ' THR . 4.0 mm? -75.37 -35.08 61.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.034 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.86 -49.5 22.69 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.495 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 40.7 tt0 -55.88 -44.51 78.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -1.14 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 139' ' ' LEU . 17.1 m -55.57 -34.15 64.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.0 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 143' ' ' LEU . 17.4 mt -67.86 -49.36 62.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 144' ' ' LEU . 0.9 OUTLIER -69.87 -27.11 64.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.086 -1.009 . . . . 0.0 109.83 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.405 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 3.4 ttm180 -81.47 -28.81 33.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.92 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.11 -43.53 64.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 109.918 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 22' ' ' PHE . 77.8 t -72.22 -38.26 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.794 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.5 tt0 -65.06 -46.09 82.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -63.5 -40.73 97.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.586 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -73.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.977 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 13' ' ' ILE . 1.6 mt -50.11 -38.98 41.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.412 -0.805 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 3.9 mt -50.98 -26.77 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.808 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.56 -20.4 13.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.938 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 151' ' ' LEU . 1.2 t60 -93.27 -40.09 10.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 110.064 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.2 m -92.67 17.3 10.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 0.0 110.243 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -66.69 -36.09 81.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.931 . . . . 0.0 110.082 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.83 -145.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.055 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -92.09 -28.07 17.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 0.0 110.142 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 29.5 p-10 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.29 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.764 HG11 ' ND1' ' A' ' 121' ' ' HIS . 8.6 m -109.94 -164.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.147 -1.207 . . . . 0.0 110.118 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.562 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 3.4 m-85 -107.81 164.33 12.34 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.628 -0.67 . . . . 0.0 109.714 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.99 138.49 42.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.053 -1.029 . . . . 0.0 110.848 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.42 ' CE1' HG11 ' A' ' 133' ' ' VAL . 50.0 m-85 -146.57 53.89 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.3 pt-20 -81.66 144.43 31.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.766 . . . . 0.0 111.149 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -171.03 3.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.443 -0.786 . . . . 0.0 109.674 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -159.9 164.46 33.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 110.711 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -144.83 -169.92 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 110.048 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.592 ' H ' HG22 ' A' ' 9' ' ' THR . 3.1 p -129.52 160.94 31.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 110.35 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.98 135.3 8.14 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.622 -0.674 . . . . 0.0 109.834 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.96 -17.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 108.642 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.007 HG21 HD13 ' A' ' 151' ' ' LEU . 21.9 mm -68.24 150.35 97.76 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -65.92 151.71 83.37 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.508 1.267 . . . . 0.0 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.61 -25.06 59.0 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -78.13 -47.6 17.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.473 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -69.61 -34.12 73.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.707 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 104' ' ' ILE . 10.6 tp -74.38 -28.7 61.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 110.007 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' ILE . 50.6 t80 -70.44 -60.18 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -54.72 -45.79 74.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.43 70.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.63 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.459 ' HB3' HD12 ' A' ' 23' ' ' ILE . 8.2 t80 -91.54 -20.76 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.97 . . . . 0.0 110.461 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.499 HG13 ' CD2' ' A' ' 81' ' ' TYR . 1.3 mp -114.08 -62.8 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.67 -35.19 20.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.871 . . . . 0.0 110.209 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.58 26.45 4.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -61.0 -44.97 97.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' OD1' HG21 ' A' ' 41' ' ' VAL . 26.9 m-20 -64.88 -8.13 14.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -1.203 . . . . 0.0 110.412 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 4.6 t30 -107.68 -38.79 5.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.469 HD21 ' CZ ' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -80.64 -38.74 28.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -42.12 -59.27 2.77 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.449 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.2 Cg_endo -72.73 -10.65 25.27 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.637 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 6.6 tttm -90.78 -63.74 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 29' ' ' LEU . 11.1 m -81.51 -17.4 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 110.741 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.85 64.37 62.24 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 110.383 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.7 -13.26 20.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.001 1.527 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -79.05 -23.61 44.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -89.07 -61.01 1.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.428 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -106.42 155.45 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 109.841 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.49 -61.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 110.177 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.65 135.17 16.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 56' ' ' ILE . 1.7 p -124.04 128.77 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.125 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 2.9 mt-10 -130.77 159.61 36.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 110.344 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 71.6 m-20 -95.06 119.27 33.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.156 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.2 mm -87.14 -36.84 10.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.315 1.055 . . . . 0.0 108.479 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.535 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 45.0 tt0 -145.51 174.0 11.54 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.444 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 62.73 166.01 0.58 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -114.39 41.62 2.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -1.14 . . . . 0.0 110.207 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.31 29.07 51.32 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.97 -162.8 18.07 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.7 Cg_endo -74.02 106.8 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.959 1.505 . . . . 0.0 110.27 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.98 5.48 33.08 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.652 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -69.74 157.16 37.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 109.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.483 HD11 HH21 ' A' ' 70' ' ' ARG . 6.3 mt -124.48 131.18 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -137.95 149.83 46.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.196 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HB2' HD11 ' A' ' 44' ' ' ILE . 1.6 tttp -98.34 109.62 22.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.565 -0.709 . . . . 0.0 110.758 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.725 HD12 ' OD2' ' A' ' 69' ' ' ASP . 72.9 mt -104.1 141.98 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.214 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -121.08 154.1 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 111.155 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.46 135.44 21.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 46.8 Cg_endo -73.67 97.58 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.847 1.446 . . . . 0.0 111.033 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.573 ' HG2' ' CE2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -165.13 -150.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 110.482 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.96 -42.99 1.46 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.573 ' CE2' ' HG2' ' A' ' 60' ' ' GLU . 8.8 p90 -60.12 138.26 91.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.114 -1.227 . . . . 0.0 110.401 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.34 -24.54 10.68 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.053 1.554 . . . . 0.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.566 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 4.9 m-85 -80.18 -162.44 0.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 110.432 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 80.37 -39.89 0.18 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.921 -0.487 . . . . 0.0 110.925 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 2.2 p90 -55.37 159.43 2.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.865 -1.147 . . . . 0.0 109.652 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.597 HG12 ' HA2' ' A' ' 88' ' ' GLY . 18.3 m -151.51 156.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.566 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.6 mttt -111.43 46.67 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 109.724 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.725 ' OD2' HD12 ' A' ' 56' ' ' ILE . 4.2 p30 -39.35 140.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.947 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.483 HH21 HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -99.44 154.1 18.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.652 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.4 t -76.81 147.43 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.678 -1.264 . . . . 0.0 109.72 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 64.6 t0 -97.28 -69.45 0.76 Allowed 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.719 -0.613 . . . . 0.0 110.461 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 mm-40 -154.8 106.69 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 110.463 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 74' ' ' VAL . 4.3 p -83.26 149.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.129 -0.982 . . . . 0.0 109.706 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -139.2 112.54 8.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 110.48 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -87.75 1.52 53.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.584 -0.697 . . . . 0.0 110.123 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -113.14 -57.63 2.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.09 13.76 5.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.524 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 14.3 m-85 48.59 61.72 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -130.12 110.33 11.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.977 . . . . 0.0 110.699 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.499 ' CD2' HG13 ' A' ' 23' ' ' ILE . 4.0 t80 -120.13 96.98 5.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.496 -0.753 . . . . 0.0 109.602 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.527 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 69.9 m-20 -102.75 138.89 39.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.6 p90 -136.63 137.92 40.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 70' ' ' ARG . 1.2 m -104.02 152.81 21.59 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.106 -0.996 . . . . 0.0 111.365 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 19.4 t -100.71 124.2 54.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.8 OUTLIER -124.92 -75.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.74 -178.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -65.1 70.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.758 -1.214 . . . . 0.0 109.793 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -96.6 131.86 10.8 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.92 -56.87 3.05 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.0 Cg_endo -71.52 -27.74 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.782 1.412 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.468 ' CD1' HG12 ' A' ' 85' ' ' VAL . 59.1 mt -72.81 158.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.56 -58.04 0.37 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -56.63 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 0.0 109.838 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 t -146.34 18.28 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.939 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 123' ' ' LYS . 1.2 mt -98.3 149.78 22.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.791 ' HA ' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER 52.42 33.98 14.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.373 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 9.9 tttt -67.38 164.68 18.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.451 -0.78 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.65 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -136.27 125.54 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.258 -0.901 . . . . 0.0 110.157 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.02 115.55 27.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.868 . . . . 0.0 109.488 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -112.31 140.5 46.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.973 . . . . 0.0 110.709 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -127.35 132.3 50.24 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.444 -0.785 . . . . 0.0 109.59 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mt -120.45 105.39 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 110.625 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 32.6 tttm -104.44 117.41 34.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.582 HG21 HD23 ' A' ' 18' ' ' LEU . 3.8 mt -105.58 111.18 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.296 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.47 146.0 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.662 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.21 142.32 27.85 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.434 0.635 . . . . 0.0 111.066 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.563 HG23 ' HA ' ' A' ' 112' ' ' SER . 8.2 p -96.32 169.48 8.89 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.436 -0.79 . . . . 0.0 109.496 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 45.6 Cg_endo -71.53 -0.35 8.1 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.674 1.355 . . . . 0.0 111.024 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -94.69 -2.49 51.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.028 -1.045 . . . . 0.0 110.238 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.8 -19.81 43.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.05 -164.12 33.7 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.652 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -143.53 157.86 44.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.303 -1.116 . . . . 0.0 111.418 -179.002 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 113' ' ' ILE . 1.1 tt -107.2 129.61 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.498 HD11 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -93.03 136.61 33.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 110.588 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -125.35 105.71 9.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 109.654 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.698 ' N ' HD12 ' A' ' 116' ' ' ILE . 4.4 mp -105.62 105.74 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -90.42 133.21 35.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.551 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 5' ' ' TYR . 47.2 t30 -127.45 140.66 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.758 -1.214 . . . . 0.0 110.59 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -132.87 149.6 52.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 109.872 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.65 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -126.46 107.25 10.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.101 -1.0 . . . . 0.0 109.439 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.764 ' ND1' HG11 ' A' ' 2' ' ' VAL . 17.5 m-70 -88.52 93.02 9.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.986 . . . . 0.0 110.531 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -117.33 167.58 11.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.994 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HB2' HD23 ' A' ' 95' ' ' LEU . 10.1 tptt -115.69 162.64 16.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.905 . . . . 0.0 110.193 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.57 -39.87 3.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.41 -85.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -1.188 . . . . 0.0 110.293 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -179.75 1.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -153.56 -172.13 4.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 110.435 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.732 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.0 t -129.86 96.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.401 -0.812 . . . . 0.0 109.678 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -62.79 126.02 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.027 . . . . 0.0 109.612 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.22 -41.36 18.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 110.55 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.8 mt-10 -40.25 -58.62 1.46 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 110.244 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.97 -30.67 69.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.179 -0.95 . . . . 0.0 108.954 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 130' ' ' ALA . 22.7 t -72.7 -53.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 109.035 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -55.49 -28.62 55.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.191 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.14 -25.85 62.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 133' ' ' VAL . 26.9 t -68.6 -30.92 69.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -79.09 -49.56 12.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.92 -48.71 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.928 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.29 -39.75 53.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -54.07 -50.67 54.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.529 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 2.8 tt0 -57.78 -48.46 79.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -1.174 . . . . 0.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.6 -29.53 59.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.536 HD12 ' HA2' ' A' ' 140' ' ' GLY . 78.0 mt -72.78 -53.38 11.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -68.42 -22.17 64.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -81.88 -35.11 29.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.752 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.13 -40.96 91.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.12 -46.44 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.682 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -45.8 80.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -25.3 64.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.843 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.561 ' CD1' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.53 -41.07 63.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.007 HD13 HG21 ' A' ' 13' ' ' ILE . 4.5 mt -66.86 -34.64 78.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.86 -34.12 77.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.865 . . . . 0.0 110.197 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.22 -13.32 60.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.65 84.7 1.74 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 110.418 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 38.7 t -144.57 38.35 1.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.917 . . . . 0.0 110.241 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.67 -39.07 0.19 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.055 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.26 159.91 41.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.74 53.4 0.68 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 110.183 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.0 t30 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.669 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.72 HG11 ' ND1' ' A' ' 121' ' ' HIS . 4.7 m 38.46 -160.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.598 -0.943 . . . . 0.0 110.756 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 7.4 m-85 -121.96 145.15 48.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 109.911 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.456 ' OD1' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -124.27 133.47 53.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 110.713 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.439 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 62.2 m-85 -139.42 57.13 1.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.526 -0.734 . . . . 0.0 109.447 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 7' ' ' THR . 3.1 tm-20 -80.2 153.81 28.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.585 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -156.04 176.1 13.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 109.719 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.474 ' HB3' ' HG3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -158.54 152.18 23.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.002 -1.061 . . . . 0.0 110.572 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.465 HG21 HD22 ' A' ' 144' ' ' LEU . 1.8 t -134.72 -170.77 2.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -122.36 165.57 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 138.24 10.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.423 -0.798 . . . . 0.0 109.754 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.425 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 61.7 t -80.11 -14.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.685 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.801 HG21 HD13 ' A' ' 151' ' ' LEU . 31.0 mm -70.24 149.42 95.97 Favored Pre-proline 0 N--CA 1.487 1.421 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -68.2 148.25 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.317 1.167 . . . . 0.0 110.82 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.37 -33.82 65.25 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.977 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.15 35.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.487 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -66.74 -37.28 84.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.962 . . . . 0.0 109.847 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.623 ' O ' HD23 ' A' ' 18' ' ' LEU . 7.8 tt -73.94 -32.16 63.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 76' ' ' HIS . 30.7 t80 -63.21 -55.93 20.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.727 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -58.05 -45.03 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.45 -31.08 71.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 20.3 t80 -89.72 -23.96 21.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.705 HD12 ' CD2' ' A' ' 81' ' ' TYR . 7.3 mm -106.18 -65.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.727 HD13 ' CG ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -51.92 -42.77 63.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.985 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 18.9 m-20 -115.39 23.54 12.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 110.193 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -62.83 -54.18 35.43 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.883 ' O ' HG21 ' A' ' 41' ' ' VAL . 21.5 m-20 -59.72 -13.15 8.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -1.141 . . . . 0.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -104.15 -36.26 7.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -83.44 -23.48 32.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.597 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -56.43 -60.25 9.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.6 Cg_endo -73.91 -3.56 13.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.944 1.497 . . . . 0.0 110.286 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 20.7 tttm -103.29 -32.93 9.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 110.433 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.053 HG22 ' HB1' ' A' ' 146' ' ' ALA . 1.6 p -101.68 -33.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.116 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB3' HD23 ' A' ' 143' ' ' LEU . . . -121.4 78.76 36.34 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.41 -0.806 . . . . 0.0 110.1 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 -18.98 31.17 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.99 1.521 . . . . 0.0 110.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.55 -4.29 57.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 110.276 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -107.5 -67.82 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.597 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.2 mp -112.15 152.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.544 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -113.84 -27.88 7.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.021 -1.05 . . . . 0.0 110.83 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.82 162.14 34.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.076 -1.015 . . . . 0.0 110.832 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.883 HG21 ' O ' ' A' ' 27' ' ' ASP . 3.7 m -142.62 133.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.45 -0.781 . . . . 0.0 109.719 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 55' ' ' LYS . 1.7 tt0 -135.7 110.45 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.524 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -69.2 118.31 11.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 110.257 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.676 HD12 HG22 ' A' ' 53' ' ' ILE . 11.6 mt -80.0 -39.98 20.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' OE1' HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -97.13 -159.39 0.73 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.4 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.49 57.11 0.32 Allowed Glycine 0 C--N 1.296 -1.683 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.429 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 49.3 t30 -116.31 -26.88 7.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.361 -1.082 . . . . 0.0 109.808 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 54.46 20.04 15.27 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' H ' ' HG1' ' A' ' 52' ' ' THR . . . -126.65 -158.62 9.93 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.2 Cg_endo -71.64 96.18 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.913 1.481 . . . . 0.0 110.271 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.22 -0.74 6.08 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.704 ' HB ' HG21 ' A' ' 71' ' ' VAL . 88.4 m -67.69 160.58 27.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -1.159 . . . . 0.0 109.186 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.676 HG22 HD12 ' A' ' 44' ' ' ILE . 11.5 mt -130.38 142.55 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.833 -1.167 . . . . 0.0 111.017 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 19.1 pttt -159.87 136.88 9.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.569 -0.707 . . . . 0.0 110.196 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' GLU . 14.8 ttpt -87.91 113.54 23.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.9 mt -92.16 153.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.645 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -118.0 148.53 42.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 110.784 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 47.4 m-85 -126.76 118.51 22.57 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 109.625 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 39' ' ' SER . 48.6 Cg_endo -74.2 132.21 16.27 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.89 1.468 . . . . 0.0 111.034 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.629 ' CB ' ' CZ ' ' A' ' 62' ' ' PHE . 4.0 tt0 176.11 -151.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -129.45 -13.07 2.38 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.493 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CZ ' ' CB ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -45.02 170.87 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.879 -1.365 . . . . 0.0 110.46 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 41.8 Cg_endo -68.06 -35.91 18.71 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.486 1.256 . . . . 0.0 109.504 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 8.8 m-85 -87.56 -167.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.5 -0.75 . . . . 0.0 109.176 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 3.8 tttp -164.99 -76.69 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.093 -1.004 . . . . 0.0 110.7 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 20.4 p90 -92.05 -168.0 1.9 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 110.863 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -173.0 172.93 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.496 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.0 ttmt -112.41 122.65 48.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 110.069 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -118.93 129.39 55.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.789 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -100.28 145.41 28.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.227 -0.921 . . . . 0.0 108.86 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.704 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.0 t -76.5 147.22 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.881 -1.137 . . . . 0.0 110.668 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 6.8 t70 -99.1 -71.71 0.68 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.448 0.642 . . . . 0.0 109.966 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 3.1 tp10 -141.64 133.1 26.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.45 -0.782 . . . . 0.0 110.168 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.798 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.6 t -118.37 157.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.531 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -159.77 124.26 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 110.064 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -98.63 1.17 46.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -112.82 -46.81 3.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.34 10.91 27.82 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 109.966 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-85 51.09 64.0 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 110.445 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -129.7 123.16 30.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.798 ' CD2' HG22 ' A' ' 74' ' ' VAL . 28.0 t80 -144.11 103.77 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 77.5 m-20 -113.97 140.58 48.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.216 -0.927 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 22.9 p90 -137.25 137.22 38.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.488 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 53.8 m -103.76 166.54 10.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.022 -1.049 . . . . 0.0 110.915 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 53.0 t -108.19 124.62 64.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -115.79 -67.89 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.899 -1.126 . . . . 0.0 112.0 -178.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.5 OUTLIER -88.24 82.1 7.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 67' ' ' VAL . . . -100.54 141.13 15.25 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.521 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.71 -58.59 2.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.6 Cg_endo -71.78 -45.18 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.933 1.491 . . . . 0.0 110.393 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.787 HD11 ' CD1' ' A' ' 98' ' ' ILE . 50.4 mt -58.07 149.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.7 -114.73 2.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -70.03 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -1.166 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.486 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 3.2 t -143.93 15.06 1.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.069 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.05 152.55 22.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 109.99 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.535 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 56.33 34.82 24.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.58 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -68.36 157.36 35.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.386 -0.821 . . . . 0.0 110.112 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.787 ' CD1' HD11 ' A' ' 91' ' ' ILE . 2.7 mp -137.12 131.16 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.94 . . . . 0.0 110.402 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.84 114.8 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.785 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.599 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 5.7 m120 -106.62 138.02 43.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.152 -0.968 . . . . 0.0 110.411 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.517 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 26.2 mt-10 -127.53 132.27 49.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 110.191 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.32 121.82 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.33 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 3.9 mttt -128.36 126.39 40.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 109.91 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 12.5 mt -115.36 130.25 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.165 -0.96 . . . . 0.0 110.655 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.12 143.94 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 109.603 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.11 138.77 31.15 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 110.8 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 112' ' ' SER . 1.7 t -108.75 151.96 42.02 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.96 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.28 54.96 2.39 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.924 1.486 . . . . 0.0 110.452 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.32 11.25 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.025 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.7 19.82 50.12 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 107' ' ' THR . . . -159.5 -165.8 17.18 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.802 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -136.72 164.02 29.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.092 . . . . 0.0 110.702 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.48 127.55 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 109.353 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.52 143.45 29.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 0.0 110.955 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 1.8 ttmt -135.13 105.01 6.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.465 -0.772 . . . . 0.0 109.795 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.8 mt -106.4 112.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.336 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -90.39 154.42 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -143.86 135.56 26.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -125.56 153.48 43.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.605 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -135.04 101.88 5.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.079 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.72 ' ND1' HG11 ' A' ' 2' ' ' VAL . 21.3 m-70 -85.98 120.54 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.047 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.09 173.58 6.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 0.0 110.012 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.51 177.16 11.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.396 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.78 -138.92 7.96 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.19 -9.23 37.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -1.118 . . . . 0.0 110.356 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -53.61 174.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.397 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -158.62 -167.28 2.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.716 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.3 t -121.5 93.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -58.69 129.57 42.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 109.562 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.43 -46.45 26.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.942 . . . . 0.0 110.541 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 130' ' ' ALA . 26.7 tt0 -40.18 -50.72 2.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.198 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -35.3 80.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.016 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 130' ' ' ALA . 15.9 t -72.55 -50.87 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.414 -0.804 . . . . 0.0 108.982 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 130' ' ' ALA . 3.2 ttpt -63.0 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.746 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.3 -44.23 72.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.628 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t -57.78 -33.01 68.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.19 12.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.888 . . . . 0.0 110.106 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -48.38 -52.9 19.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 110.285 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.9 mt -69.62 -44.52 70.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.845 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -49.33 -46.52 35.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.552 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 30.8 tt0 -61.29 -30.23 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -30.75 68.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.845 HD12 ' HA2' ' A' ' 140' ' ' GLY . 3.0 mt -73.03 -47.46 44.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.738 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.1 pp -69.44 -22.51 63.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 109.904 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' SER . 2.9 ttp180 -83.78 -34.54 24.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.053 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -63.35 -44.43 94.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.379 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.91 -49.66 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.557 -0.714 . . . . 0.0 109.94 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 8.9 tt0 -56.53 -46.43 80.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.641 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 1.1 t -64.93 -43.92 91.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.456 -0.777 . . . . 0.0 109.872 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -50.99 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.099 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 13' ' ' ILE . 3.8 mt -44.97 -34.39 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -34.2 62.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.829 . . . . 0.0 110.131 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -56.96 -23.26 44.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.206 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -137.17 154.18 50.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 110.282 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.3 m -109.75 115.47 29.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 109.834 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -75.79 -54.56 6.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.55 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.445 ' HB1' ' OD1' ' A' ' 159' ' ' ASN . . . -145.5 169.97 17.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.958 . . . . 0.0 110.58 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.89 -2.68 34.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.439 -0.788 . . . . 0.0 110.238 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.445 ' OD1' ' HB1' ' A' ' 157' ' ' ALA . 6.5 m120 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.182 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.412 HG22 ' CG ' ' A' ' 121' ' ' HIS . 2.6 t -126.02 144.52 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -1.144 . . . . 0.0 110.228 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -94.31 149.63 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -0.759 . . . . 0.0 109.427 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.54 144.49 48.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.125 -0.984 . . . . 0.0 110.634 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HG11 ' A' ' 133' ' ' VAL . 34.1 m-85 -153.77 69.92 0.81 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.436 -0.79 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 10.7 pt-20 -100.59 135.81 41.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.758 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.427 HG21 ' HD2' ' A' ' 137' ' ' LYS . 0.2 OUTLIER -134.92 177.93 7.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.017 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -158.12 161.12 37.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 110.356 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 10' ' ' THR . 3.1 m -147.6 -175.88 5.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 110.097 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.648 ' H ' HG22 ' A' ' 9' ' ' THR . 1.8 p -122.19 160.98 24.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 110.308 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -157.93 136.84 11.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.768 . . . . 0.0 109.803 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 34.6 m -80.02 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.103 -0.998 . . . . 0.0 109.154 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 151' ' ' LEU . 45.3 mm -77.75 149.22 77.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.5 Cg_endo -64.02 148.48 91.52 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.264 1.139 . . . . 0.0 111.187 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.46 -24.36 60.21 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.114 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.03 -50.96 11.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.277 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 3.0 tpm_? -64.57 -40.3 95.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.098 -1.001 . . . . 0.0 109.603 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 18' ' ' LEU . 8.5 tt -71.23 -37.47 72.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.598 -0.689 . . . . 0.0 110.187 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.715 ' CD1' HD13 ' A' ' 23' ' ' ILE . 76.4 t80 -61.59 -69.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.314 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.15 -51.77 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.878 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.1 74.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.0 t80 -84.86 -10.08 57.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.715 HD13 ' CD1' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -124.78 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.902 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.693 HD23 ' NE2' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -51.96 -42.25 62.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.264 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -104.3 -1.51 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -47.95 -52.69 16.07 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' OD2' ' HB ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -48.05 -23.15 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -1.21 . . . . 0.0 110.06 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -112.55 -23.84 10.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -84.81 -27.94 26.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.141 -0.974 . . . . 0.0 110.045 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.894 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -64.51 -60.08 9.25 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -74.01 53.14 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.823 1.433 . . . . 0.0 110.254 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.84 -58.1 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 29' ' ' LEU . 27.0 m -85.92 -16.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.373 -0.829 . . . . 0.0 110.45 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.56 71.18 5.46 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.48 -12.5 27.18 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.993 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.44 ' C ' ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -64.55 -21.15 66.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.467 -0.771 . . . . 0.0 110.115 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.9 -60.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.868 . . . . 0.0 110.02 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.894 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -113.56 145.01 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.747 . . . . 0.0 109.745 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.55 -57.69 2.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.7 t -155.3 157.51 37.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.554 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' A' ' 56' ' ' ILE . 59.0 t -114.4 138.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -129.35 87.24 2.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.895 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 6.2 m-20 -54.73 114.34 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.717 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 54' ' ' LYS . 4.9 mt -82.54 -38.51 15.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.197 0.999 . . . . 0.0 108.676 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.541 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 23.1 tt0 -157.43 174.44 15.4 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.655 0.741 . . . . 0.0 110.176 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.541 ' N ' ' HG2' ' A' ' 45' ' ' GLU . . . 75.77 155.97 5.81 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -103.33 43.22 1.1 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -1.101 . . . . 0.0 109.425 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.43 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 70.06 23.95 76.81 Favored Glycine 0 N--CA 1.48 1.572 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -96.72 -162.47 32.45 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.4 Cg_endo -72.95 101.54 1.33 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.048 1.552 . . . . 0.0 110.909 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 111.32 -1.25 28.08 Favored Glycine 0 N--CA 1.48 1.579 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.654 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -58.4 154.14 14.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -1.201 . . . . 0.0 109.585 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 45' ' ' GLU . 18.2 mt -116.64 143.38 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -157.49 144.43 18.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 110.539 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -92.34 102.22 14.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' A' ' 41' ' ' VAL . 5.5 mm -82.76 130.09 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.86 . . . . 0.0 109.48 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.87 153.73 22.6 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.288 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 32.8 p90 -110.92 155.64 42.09 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 110.12 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.457 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 45.6 Cg_endo -72.72 175.46 10.23 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.032 1.543 . . . . 0.0 110.626 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.37 161.01 0.72 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.316 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.14 -85.33 0.15 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.593 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -101.47 -179.25 0.77 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.776 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.593 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 43.0 Cg_endo -70.26 -53.9 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.731 1.385 . . . . 0.0 109.753 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.575 ' CE2' ' HG2' ' A' ' 63' ' ' PRO . 1.5 p90 -123.27 165.98 16.03 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.472 -0.768 . . . . 0.0 110.025 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.547 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER 169.65 -28.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 109.861 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 29.6 p90 -52.56 158.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.427 -0.796 . . . . 0.0 109.815 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 65' ' ' LYS . 10.4 m -152.23 179.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 0.0 110.413 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.532 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 12.5 mttt -128.83 41.84 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.689 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' SER . 45.2 p-10 -39.17 138.94 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 110.816 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 84' ' ' SER . 8.8 ttm180 -100.08 155.24 17.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.401 -0.812 . . . . 0.0 108.887 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.654 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.2 t -79.94 144.04 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.8 -1.188 . . . . 0.0 110.195 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 46.8 m-20 -96.32 -69.2 0.76 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.292 0.568 . . . . 0.0 110.159 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -146.76 132.29 18.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 81' ' ' TYR . 2.0 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 1.1 m-20 -151.61 107.01 3.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.693 ' NE2' HD23 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -81.81 -10.38 59.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 110.398 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -108.82 -45.83 3.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.15 6.39 25.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.562 -0.711 . . . . 0.0 109.987 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-30 48.56 58.75 4.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.255 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.6 ttmt -134.09 110.38 9.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.469 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.559 ' HD2' HG22 ' A' ' 74' ' ' VAL . 13.2 t80 -126.82 122.1 33.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.881 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 73.1 m-20 -128.3 141.36 51.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 46.9 p90 -138.44 133.14 32.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.316 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 64.7 m -100.95 168.27 9.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.003 -1.061 . . . . 0.0 111.156 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -104.48 127.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -126.83 -75.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.97 -1.081 . . . . 0.0 111.196 -178.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -79.06 83.36 5.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.892 -1.13 . . . . 0.0 110.109 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -109.09 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.45 -54.0 3.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -73.33 -49.58 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.871 1.458 . . . . 0.0 110.826 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 86' ' ' ILE . 42.3 mt -58.8 138.0 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.024 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.27 -60.98 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -97.6 -90.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.194 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 t -139.92 9.11 2.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -86.77 162.14 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.239 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.655 ' HG3' HD12 ' A' ' 95' ' ' LEU . 6.5 mm-40 57.67 36.33 26.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.939 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -81.33 155.6 25.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.582 HG12 ' CD2' ' A' ' 120' ' ' TYR . 2.7 mp -138.64 129.05 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 110.516 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.07 120.47 41.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 1.9 m-20 -110.02 149.36 30.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.515 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 34.5 mt-10 -141.63 163.92 31.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.371 -0.831 . . . . 0.0 110.048 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.564 HG22 HD11 ' A' ' 104' ' ' ILE . 19.4 mt -153.57 106.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.806 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -108.11 118.41 36.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.415 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 104' ' ' ILE . 3.9 mp -110.35 133.52 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.055 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 113' ' ' ILE . 25.0 t -137.43 134.06 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 0.0 110.487 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -82.15 148.31 28.57 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.703 -0.623 . . . . 0.0 110.718 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.3 p -92.02 -167.03 0.12 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.415 -0.803 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 47.4 Cg_endo -80.05 69.29 8.0 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.403 1.212 . . . . 0.0 110.699 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 9.8 t70 68.08 39.59 2.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 110.575 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.48 26.86 1.97 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 107' ' ' THR . . . 103.02 -161.03 16.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.816 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -135.17 -178.74 5.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.477 -1.014 . . . . 0.0 110.557 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.446 HG13 ' C ' ' A' ' 112' ' ' SER . 25.1 mt -134.41 124.6 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.67 135.83 39.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.008 . . . . 0.0 110.65 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -128.64 98.99 5.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.778 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.1 mt -87.57 145.67 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.497 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -129.65 108.38 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -0.874 . . . . 0.0 110.005 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -109.81 128.4 55.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.415 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 137.11 51.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.053 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.595 ' CD2' HG21 ' A' ' 128' ' ' VAL . 5.9 t80 -109.67 143.01 40.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.412 ' CG ' HG22 ' A' ' 2' ' ' VAL . 16.1 m80 -120.81 131.54 54.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.877 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -114.11 174.75 5.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -140.98 177.26 8.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.235 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 42.86 -126.26 4.74 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -119.49 15.24 12.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -1.16 . . . . 0.0 110.363 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -80.46 -178.71 6.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 110.059 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.877 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -159.98 168.14 26.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.19 -0.943 . . . . 0.0 109.784 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.4 p -112.98 108.55 25.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.369 0.604 . . . . 0.0 110.759 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 133.25 55.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.463 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -63.17 -9.44 11.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.734 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -55.21 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.171 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -54.84 -36.04 64.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.358 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG11 ' CD2' ' A' ' 5' ' ' TYR . 12.1 t -67.45 -47.79 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.541 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 1.4 mmtt -59.4 -34.48 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.428 -0.795 . . . . 0.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.89 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -74.74 -35.69 62.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.466 -0.771 . . . . 0.0 109.874 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.427 ' HD2' HG21 ' A' ' 7' ' ' THR . 26.1 ttpp -72.46 -37.11 68.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.837 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -58.5 -42.68 88.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 140' ' ' GLY . 2.0 tp -75.17 -43.85 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.631 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -45.27 -50.19 9.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.4 mt-10 -59.87 -31.35 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -1.159 . . . . 0.0 110.215 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.6 m -70.69 -27.48 64.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.012 -1.055 . . . . 0.0 109.649 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.631 HD12 ' HA2' ' A' ' 140' ' ' GLY . 50.8 mt -72.53 -49.38 33.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 110.061 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.679 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -65.6 -25.4 67.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.015 . . . . 0.0 109.472 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.2 OUTLIER -78.92 -33.8 45.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.427 -0.796 . . . . 0.0 109.676 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.97 84.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.381 -0.825 . . . . 0.0 109.638 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.6 t -71.19 -46.97 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -54.18 -46.5 72.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.63 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 t -61.01 -50.35 73.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.656 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.429 ' CE1' HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -48.07 -72.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 109.936 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.636 HD13 HG21 ' A' ' 13' ' ' ILE . 5.4 mt -43.09 -43.72 4.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.002 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -61.38 -43.31 99.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.202 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.04 -12.96 21.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 110.381 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.56 -161.4 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.947 . . . . 0.0 110.181 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 60.7 m -138.7 89.88 2.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 110.041 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -93.21 -65.12 1.02 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.883 . . . . 0.0 110.242 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 156' ' ' ASP . . . -56.01 -163.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.292 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -72.18 -15.76 61.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 110.281 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.355 -179.872 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.87 139.85 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -1.149 . . . . 0.0 110.128 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.8 m-85 -94.36 138.59 32.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.51 -0.744 . . . . 0.0 109.916 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.07 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.054 . . . . 0.0 110.42 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.513 ' CE2' HG11 ' A' ' 133' ' ' VAL . 17.6 m-85 -141.16 59.26 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.542 -0.723 . . . . 0.0 109.218 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.0 pt-20 -88.47 142.89 27.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.484 -0.76 . . . . 0.0 110.797 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.39 178.55 8.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.527 -0.733 . . . . 0.0 109.818 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HB2' ' HG3' ' A' ' 115' ' ' LYS . 2.3 pp20? -150.61 143.15 24.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 10' ' ' THR . 1.6 m -130.2 -174.76 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.599 ' H ' HG22 ' A' ' 9' ' ' THR . 1.2 p -119.95 159.43 24.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 110.614 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.495 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -154.26 135.58 14.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' OE2' ' A' ' 148' ' ' GLU . 17.7 m -79.91 -12.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.914 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.788 HG23 ' HD2' ' A' ' 14' ' ' PRO . 5.1 mm -71.31 150.44 94.24 Favored Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.788 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.31 150.77 86.89 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 123.293 1.154 . . . . 0.0 111.08 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.94 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.16 -29.85 63.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.88 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.26 -54.23 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 110.076 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -67.42 -30.97 70.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 109.771 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.574 ' HB2' HG22 ' A' ' 13' ' ' ILE . 29.1 tp -73.8 -29.19 62.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.959 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.746 ' CD1' HD13 ' A' ' 23' ' ' ILE . 71.8 t80 -71.71 -57.17 4.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 110.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 31.9 mtpt -54.34 -41.24 68.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.78 . . . . 0.0 110.298 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.58 -33.79 74.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -91.6 -7.34 50.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.719 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.746 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -121.16 -56.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 24' ' ' LEU . 8.4 mt -72.99 -25.25 60.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -130.03 14.53 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -58.69 -42.47 96.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' O ' HG21 ' A' ' 41' ' ' VAL . 55.6 m-20 -65.05 -27.19 68.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -1.14 . . . . 0.0 110.317 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.3 m-20 -92.14 -38.95 11.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.491 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.004 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.8 mp -76.13 -25.97 55.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -55.64 -59.69 10.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.914 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.5 Cg_endo -71.37 0.43 6.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.994 1.523 . . . . 0.0 111.256 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -105.58 -50.94 3.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.988 -1.07 . . . . 0.0 110.577 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.004 HG22 ' O ' ' A' ' 29' ' ' LEU . 35.9 m -87.33 -11.15 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -160.04 71.24 3.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.013 . . . . 0.0 110.396 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.73 -6.73 19.75 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.033 1.544 . . . . 0.0 110.504 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.503 ' O ' ' CG ' ' A' ' 59' ' ' PRO . 16.1 mt-30 -73.33 -30.01 63.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.558 ' CB ' HD23 ' A' ' 139' ' ' LEU . . . -89.52 -51.28 5.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.617 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.5 mp -112.32 141.39 28.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 110.031 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.444 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -109.74 -19.19 13.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.19 165.07 11.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.143 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.481 HG12 HG23 ' A' ' 56' ' ' ILE . 20.0 m -147.15 154.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.217 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 1.6 mt-10 -153.2 152.98 31.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.532 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.7 112.5 25.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.0 110.055 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.67 HD12 HG22 ' A' ' 53' ' ' ILE . 6.3 mt -80.2 -39.9 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.233 1.016 . . . . 0.0 108.346 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.43 -160.17 0.78 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.827 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.35 59.66 0.32 Allowed Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 48' ' ' GLY . 1.6 m-80 -125.29 -19.22 5.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -1.08 . . . . 0.0 110.268 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.542 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 44.21 42.78 7.02 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.514 ' H ' ' HG1' ' A' ' 52' ' ' THR . . . -153.24 -154.67 6.83 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.81 87.54 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.071 1.564 . . . . 0.0 110.602 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.89 -6.63 3.78 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.741 ' HB ' HG21 ' A' ' 71' ' ' VAL . 95.5 m -67.91 164.07 20.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -1.211 . . . . 0.0 109.32 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.67 HG22 HD12 ' A' ' 44' ' ' ILE . 8.3 mt -137.13 149.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.729 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.515 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -155.21 141.6 18.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.393 -0.817 . . . . 0.0 110.561 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.5 tptm -90.39 113.03 24.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.663 -0.648 . . . . 0.0 110.508 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.481 HG23 HG12 ' A' ' 41' ' ' VAL . 28.4 mt -101.49 139.88 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.475 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -102.53 159.93 15.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.64 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -136.82 136.99 22.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 0.0 109.857 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 36' ' ' GLN . 46.5 Cg_endo -73.06 129.57 14.34 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.888 1.467 . . . . 0.0 110.466 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 179.62 172.42 0.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.192 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.81 19.44 9.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.593 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -92.7 178.32 1.7 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.045 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.593 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 42.8 Cg_endo -68.35 -31.76 27.52 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.869 1.457 . . . . 0.0 110.376 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.515 ' CE1' ' HA2' ' A' ' 89' ' ' GLY . 0.2 OUTLIER -114.41 137.28 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 109.965 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' TYR . 6.4 mtpm? -138.16 -79.32 0.36 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.373 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.524 ' C ' HG12 ' A' ' 67' ' ' VAL . 55.7 p90 -55.22 -165.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.802 . . . . 0.0 110.491 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -179.68 172.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.858 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -115.64 132.33 56.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.902 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 8.9 p-10 -133.29 131.04 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' CG ' ' HB2' ' A' ' 84' ' ' SER . 8.2 ptt180 -98.23 151.24 20.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.071 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.741 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.6 t -80.02 147.05 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.782 -1.199 . . . . 0.0 110.251 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 11.3 t0 -97.56 -62.35 1.26 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.099 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.3 tt0 -155.22 120.91 5.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.236 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 81' ' ' TYR . 2.9 t -116.02 142.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.321 -0.862 . . . . 0.0 110.085 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -139.98 118.24 12.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.91 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -82.6 1.45 38.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.831 . . . . 0.0 110.796 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -119.86 -38.31 2.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.05 20.36 10.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.501 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 22.9 m-30 44.66 58.56 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.555 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -127.01 129.6 48.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.052 -1.03 . . . . 0.0 110.16 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.722 ' CD1' HG22 ' A' ' 74' ' ' VAL . 77.5 t80 -148.51 94.37 2.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.947 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 71.6 m-20 -109.98 137.78 47.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.195 -0.94 . . . . 0.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.7 p90 -137.89 143.48 40.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.9 . . . . 0.0 110.004 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 70' ' ' ARG . 74.2 m -106.17 170.61 7.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.075 -1.015 . . . . 0.0 111.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.428 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 53.9 t -112.16 125.38 69.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -116.61 -72.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.856 -1.152 . . . . 0.0 111.735 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -87.78 85.64 7.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.269 . . . . 0.0 110.436 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.478 ' HA2' HG23 ' A' ' 67' ' ' VAL . . . -106.42 141.31 15.46 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.558 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.02 -53.39 2.57 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.7 Cg_endo -71.66 -40.34 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.744 1.391 . . . . 0.0 110.512 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.57 140.19 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 0.0 110.025 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.59 -85.06 1.13 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -83.42 -80.04 0.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -1.172 . . . . 0.0 110.434 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -145.34 13.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.464 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.647 HD23 ' HB2' ' A' ' 123' ' ' LYS . 4.1 mp -87.7 153.73 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.051 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.4 tt0 61.34 36.05 17.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 0.4 OUTLIER -69.67 162.54 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.482 HG12 ' CD1' ' A' ' 120' ' ' TYR . 8.3 mt -145.89 136.02 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 110.565 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -120.97 117.27 26.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.656 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 1.9 m-80 -101.37 141.27 34.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.76 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.521 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 0.9 OUTLIER -131.19 132.36 44.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.713 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.657 HD12 ' HD2' ' A' ' 81' ' ' TYR . 43.0 mt -126.5 124.34 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.002 -1.061 . . . . 0.0 110.704 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -129.12 127.23 41.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.672 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.559 HG22 ' HB1' ' A' ' 15' ' ' ALA . 93.3 mt -116.72 125.46 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.718 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.5 t -127.3 136.47 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.425 -0.797 . . . . 0.0 109.716 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.1 143.55 27.01 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.552 0.691 . . . . 0.0 111.035 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.3 p -82.84 -163.08 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 45.4 Cg_endo -78.53 -28.64 4.24 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.094 1.05 . . . . 0.0 110.999 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.67 35.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.122 -0.986 . . . . 0.0 110.385 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.99 27.89 2.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.647 ' O ' HG23 ' A' ' 107' ' ' THR . . . 100.32 -154.79 19.46 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.94 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -133.27 155.99 48.39 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.724 -0.868 . . . . 0.0 110.774 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 113' ' ' ILE . 6.0 tt -109.66 120.12 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.05 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -101.45 122.49 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.931 -1.105 . . . . 0.0 111.18 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 8' ' ' GLU . 4.8 mttt -102.23 111.09 23.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 7' ' ' THR . 55.4 mt -97.19 140.29 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.638 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -125.87 118.04 24.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.074 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -119.85 125.41 48.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.173 -0.954 . . . . 0.0 110.23 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 3.6 mtpp -116.35 138.2 51.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 110.466 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.482 ' CD1' HG12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -112.83 124.72 53.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.262 -0.899 . . . . 0.0 109.707 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 36.0 m-70 -106.22 113.12 26.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.985 . . . . 0.0 110.355 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.559 HG21 HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -122.59 167.05 13.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.1 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.647 ' HB2' HD23 ' A' ' 95' ' ' LEU . 5.0 mmtp -104.51 155.09 19.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -43.79 -27.03 0.87 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.67 -65.42 0.9 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -1.218 . . . . 0.0 110.313 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -83.08 170.14 15.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 110.096 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -139.51 -167.15 2.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.16 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.721 ' O ' HG12 ' A' ' 128' ' ' VAL . 3.8 t -118.92 88.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 110.117 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -59.73 127.81 33.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -44.82 -45.46 10.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.113 -0.992 . . . . 0.0 110.204 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.0 mm-40 -38.64 -59.1 0.97 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -29.1 69.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.513 HG11 ' CE2' ' A' ' 5' ' ' TYR . 8.9 t -78.6 -49.64 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 130' ' ' ALA . 12.6 mttt -63.21 -25.71 68.46 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.419 -0.801 . . . . 0.0 109.531 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.99 -39.56 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.542 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 t -65.46 -33.79 76.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 109.688 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -79.15 -46.09 18.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.769 . . . . 0.0 109.818 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' OG1' ' A' ' 142' ' ' THR . 1.7 mt-10 -43.25 -67.47 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.558 HD23 ' CB ' ' A' ' 37' ' ' ALA . 2.5 mp -67.04 -30.2 70.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.91 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.82 -63.81 4.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.534 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -52.23 -32.13 35.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -69.78 -27.24 64.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.675 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 69.3 mt -72.15 -50.31 28.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.749 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.601 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -68.14 -28.52 67.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.406 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.13 -34.53 43.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.794 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.22 77.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.882 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.65 -48.07 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.931 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -50.59 -41.05 54.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.432 179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -66.34 -47.55 73.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.593 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.895 ' CD1' HG12 ' A' ' 33' ' ' VAL . 1.8 t80 -45.69 -67.6 0.27 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.469 -0.77 . . . . 0.0 110.563 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 13' ' ' ILE . 10.3 mt -57.49 -39.03 75.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.362 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -49.2 -40.38 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.48 11.92 7.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -104.54 -6.67 20.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 110.113 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.94 39.0 0.94 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.895 . . . . 0.0 110.138 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -126.57 -36.5 2.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.203 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.01 175.5 9.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 110.084 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.46 43.64 2.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.322 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.1 t30 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.183 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 2.7 t 58.8 146.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.381 -1.07 . . . . 0.0 110.237 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 4.0 m-85 -93.33 167.63 11.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -138.25 144.23 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.994 . . . . 0.0 110.811 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 64.6 m-85 -156.12 57.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.74 . . . . 0.0 109.604 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 14.9 mt-10 -88.94 145.88 25.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.372 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -150.65 173.06 14.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 4.6 pt-20 -151.15 155.79 39.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 110.551 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.509 HG22 ' H ' ' A' ' 10' ' ' THR . 3.1 m -139.36 176.84 8.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -112.75 163.65 14.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 110.581 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -159.93 136.46 9.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.648 -0.657 . . . . 0.0 109.454 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 9.9 p -80.19 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.806 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.842 HG21 HD13 ' A' ' 151' ' ' LEU . 42.0 mm -71.81 149.15 92.71 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.662 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -64.9 148.66 89.97 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.463 1.244 . . . . 0.0 111.282 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -66.48 -47.11 74.08 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.82 74.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.499 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -63.38 -37.97 89.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -72.25 -35.84 68.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.432 -0.792 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' ILE . 40.1 t80 -64.55 -63.84 1.03 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -48.57 -48.46 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.102 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -38.6 91.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 4.1 t80 -86.3 -11.11 53.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.215 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.812 HD12 ' CG ' ' A' ' 81' ' ' TYR . 12.0 mm -114.72 -74.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.178 -0.951 . . . . 0.0 110.491 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 24' ' ' LEU . 20.3 mt -54.87 -51.76 64.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 110.471 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.99 8.73 36.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.17 -47.92 88.69 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 79.5 m-20 -58.51 -28.42 65.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -1.14 . . . . 0.0 110.252 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.411 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 m-20 -86.56 -46.79 9.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -35.79 80.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.222 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.707 ' CD2' HD13 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -48.97 -60.07 5.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.953 . . . . 0.0 110.046 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -73.5 53.77 2.74 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.048 1.552 . . . . 0.0 110.274 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -63.91 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 110.392 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 33' ' ' VAL . 33.2 m -82.96 -24.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 110.435 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -134.66 70.0 71.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.6 -14.58 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.995 1.524 . . . . 0.0 110.512 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -71.67 -24.19 61.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.37 -60.02 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.274 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.707 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -113.13 143.92 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -0.815 . . . . 0.0 109.888 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -47.56 8.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.266 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.4 133.89 2.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.273 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG1' ' HD3' ' A' ' 54' ' ' LYS . 94.6 t -100.46 142.01 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 53.9 mt-10 -140.88 99.28 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -61.52 117.78 6.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.517 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.4 mm -85.99 -37.59 11.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 108.425 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 46' ' ' GLY . 1.4 tm-20 -111.23 -151.11 0.47 Allowed 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.437 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 45' ' ' GLU . . . -40.78 168.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.7 16.97 1.97 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -1.188 . . . . 0.0 110.832 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.52 ' O ' HG21 ' A' ' 74' ' ' VAL . . . 142.07 -3.93 2.03 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.742 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 48' ' ' GLY . . . -45.74 171.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.97 99.19 0.65 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.807 1.425 . . . . 0.0 110.094 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 71' ' ' VAL . . . 109.48 9.39 25.34 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.582 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -65.39 166.75 9.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.407 -1.055 . . . . 0.0 109.364 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 14.6 mt -129.55 138.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 110.392 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HD3' ' CG1' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.743 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HB2' HD11 ' A' ' 44' ' ' ILE . 20.9 tttt -92.14 98.36 11.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.313 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.744 HD12 ' OD1' ' A' ' 69' ' ' ASP . 52.0 mt -87.88 120.55 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.633 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.93 143.3 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -0.963 . . . . 0.0 110.291 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.04 136.2 20.46 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.208 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.22 137.98 29.63 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.997 1.525 . . . . 0.0 110.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 48.98 -169.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -0.904 . . . . 0.0 110.248 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 92.87 77.67 1.38 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.663 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 41.47 -165.56 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.38 -1.071 . . . . 0.0 110.061 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.663 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 45.4 Cg_endo -77.29 -51.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.373 1.196 . . . . 0.0 110.625 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 3.4 m-85 -83.31 153.38 24.66 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 34.4 pttt 173.67 -41.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.221 -0.924 . . . . 0.0 110.389 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.491 ' C ' HG12 ' A' ' 67' ' ' VAL . 27.9 p90 -63.83 -173.18 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 110.11 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER 178.98 172.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.3 ttmt -119.18 52.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.523 -0.736 . . . . 0.0 110.47 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.744 ' OD1' HD12 ' A' ' 56' ' ' ILE . 10.2 p-10 -46.09 137.81 5.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.106 -0.996 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttm180 -100.75 157.85 16.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.228 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.6 t -84.7 146.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.877 -1.14 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.3 t70 -94.51 -68.91 0.78 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.275 0.56 . . . . 0.0 110.491 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -144.61 143.72 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 0.0 110.377 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 48' ' ' GLY . 4.3 t -123.66 155.64 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.239 -0.913 . . . . 0.0 109.947 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.516 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -154.75 130.13 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 110.085 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -5.54 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 0.0 110.894 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -112.55 -40.6 4.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 109.884 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.88 16.21 16.6 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.337 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.7 m-85 46.74 69.01 0.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.78 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.516 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 6.2 tttt -131.19 127.14 37.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.812 ' CG ' HD12 ' A' ' 23' ' ' ILE . 34.1 t80 -150.67 88.66 1.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.459 -0.775 . . . . 0.0 109.39 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 86.3 m-20 -100.95 145.66 28.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.129 -0.982 . . . . 0.0 110.617 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.652 ' CE1' ' ND2' ' A' ' 100' ' ' ASN . 7.7 p90 -141.81 137.97 31.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.499 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ARG . 58.8 m -108.32 168.24 9.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.048 -1.032 . . . . 0.0 111.232 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.484 HG12 ' CD1' ' A' ' 91' ' ' ILE . 45.1 t -105.86 131.18 56.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER -129.5 -77.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.942 -1.099 . . . . 0.0 110.583 -179.484 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -69.58 65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.838 -1.164 . . . . 0.0 109.997 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.733 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -87.86 136.68 13.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.545 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -41.66 -54.87 4.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.0 Cg_endo -72.01 -42.1 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.823 1.433 . . . . 0.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.733 HD12 ' HA3' ' A' ' 88' ' ' GLY . 69.8 mt -56.31 145.82 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.23 -76.0 0.26 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.33 -75.94 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -1.136 . . . . 0.0 110.083 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.1 p -144.61 9.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.434 ' HB3' ' HE3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -93.06 161.91 14.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.13 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' OE1' HG13 ' A' ' 91' ' ' ILE . 0.9 OUTLIER 61.59 28.42 17.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.147 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 98' ' ' ILE . 10.5 ttmt -80.94 159.64 24.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.105 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.6 mp -141.13 133.0 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 110.641 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 m -114.79 115.64 27.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.652 ' ND2' ' CE1' ' A' ' 83' ' ' TYR . 32.2 m-80 -104.77 142.76 34.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.631 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.533 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -130.6 128.63 41.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.807 . . . . 0.0 109.634 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 116' ' ' ILE . 17.5 mm -120.34 113.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.659 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 9.8 mtmm -125.37 139.79 53.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 109.648 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.431 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 7.2 mt -127.53 142.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.027 -1.046 . . . . 0.0 110.823 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.7 t -137.52 130.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 109.548 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.04 155.98 19.53 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.635 -0.665 . . . . 0.0 111.307 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.46 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -128.49 157.8 73.71 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 109.868 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 43.8 Cg_endo -70.51 -3.53 12.69 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.967 1.509 . . . . 0.0 110.487 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.43 -10.04 59.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 110.018 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.22 28.06 6.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 107' ' ' THR . . . -164.89 -168.08 26.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -141.25 162.97 34.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -1.087 . . . . 0.0 110.639 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 10' ' ' THR . 49.0 mt -120.08 120.92 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 109.377 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.5 pp -98.28 131.99 44.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 8' ' ' GLU . 19.8 mttt -112.4 110.97 21.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 7' ' ' THR . 29.0 mm -94.95 119.92 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -106.81 120.65 42.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.131 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -115.0 147.13 40.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -137.35 133.26 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.073 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.592 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -109.93 138.35 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.444 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.49 ' ND1' HG22 ' A' ' 2' ' ' VAL . 75.1 m-70 -123.69 102.37 7.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.477 HG21 HG23 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -114.92 165.35 12.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.943 . . . . 0.0 110.099 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -100.69 158.59 15.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -43.2 -29.69 1.04 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.76 -61.59 1.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -1.104 . . . . 0.0 110.23 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 123' ' ' LYS . 14.4 m80 -84.94 164.63 18.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.955 . . . . 0.0 110.261 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.417 ' C ' HG21 ' A' ' 122' ' ' THR . 11.2 mt-10 -144.34 -170.29 3.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.232 -0.918 . . . . 0.0 109.951 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.3 t -128.94 92.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.921 . . . . 0.0 110.023 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HG3' ' HB3' ' A' ' 131' ' ' GLU . 20.1 ptmt -69.4 131.19 44.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.312 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 134' ' ' LYS . . . -40.47 -38.59 0.86 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 110.826 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.478 ' HB3' ' HG3' ' A' ' 129' ' ' LYS . 9.8 tp10 -39.16 -65.96 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.07 -29.93 61.26 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.556 HG11 ' CE1' ' A' ' 5' ' ' TYR . 12.9 t -74.01 -49.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 0.0 109.423 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -62.37 -32.72 73.57 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.23 -17.79 64.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.651 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -81.27 -33.38 32.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 109.845 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -28.51 60.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.893 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -60.61 -62.14 2.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.033 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.52 -30.68 66.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.705 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -59.25 -38.8 93.76 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.571 ' HA ' HD23 ' A' ' 144' ' ' LEU . 2.7 mt-10 -61.59 -38.5 87.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.151 -1.205 . . . . 0.0 110.254 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.5 m -66.83 -27.75 67.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.109 -0.994 . . . . 0.0 109.875 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.705 HD12 ' HA2' ' A' ' 140' ' ' GLY . 66.1 mt -73.33 -46.41 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.315 -0.866 . . . . 0.0 110.005 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -68.27 -30.01 68.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.005 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.431 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.65 -33.87 40.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.28 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -64.3 -46.97 81.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.29 -41.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.975 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.4 tm-20 -60.3 -48.37 82.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.64 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -44.19 93.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.462 -0.774 . . . . 0.0 110.002 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 1.2 t80 -50.55 -71.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 110.368 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.842 HD13 HG21 ' A' ' 13' ' ' ILE . 13.0 mt -49.4 -32.77 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 110.668 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -64.82 -34.49 78.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.084 -1.01 . . . . 0.0 110.404 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -58.85 -33.97 71.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -99.03 -174.65 2.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.432 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 155' ' ' SER . 3.0 t -141.08 51.57 1.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.567 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 10.4 t0 50.0 25.91 1.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.945 . . . . 0.0 109.679 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 156' ' ' ASP . . . 61.94 -170.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.449 -0.782 . . . . 0.0 109.996 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.64 38.18 1.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.123 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.24 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.47 HG22 ' ND1' ' A' ' 121' ' ' HIS . 2.6 t -146.81 143.96 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -1.207 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -118.68 127.4 53.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 10.1 p-10 -131.93 124.97 30.52 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.857 -1.152 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.616 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 93.9 m-85 -103.38 74.29 1.26 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -80.06 149.12 30.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.863 . . . . 0.0 110.528 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -160.07 -173.55 4.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.588 -0.695 . . . . 0.0 109.818 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -159.36 153.33 23.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 0.0 110.478 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 170.07 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.909 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.478 HG22 HG12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -116.63 159.84 21.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.265 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.6 m -158.86 141.66 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.645 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.494 HG23 HD12 ' A' ' 13' ' ' ILE . 12.5 m -79.85 -10.97 12.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.607 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.71 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.2 mp -67.92 149.91 98.0 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.71 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.81 151.71 83.55 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.397 1.209 . . . . 0.0 110.796 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.846 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.42 -23.09 58.89 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.698 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.42 -56.57 3.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.941 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -59.84 -32.69 70.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.945 . . . . 0.0 109.798 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -71.47 -41.73 69.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.252 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 41.4 t80 -60.89 -66.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 37.8 mttt -47.2 -42.85 20.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 110.29 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.59 69.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.449 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' HB3' HD12 ' A' ' 23' ' ' ILE . 7.9 t80 -89.88 -12.17 39.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.607 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.1 mp -124.11 -62.27 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -52.76 -34.78 54.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.878 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' GLY . 1.1 m-20 -125.0 -6.29 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.019 -1.05 . . . . 0.0 110.793 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -44.89 -45.67 9.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 15.3 p-10 -51.56 -33.41 32.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.309 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 21.8 t-20 -100.41 -33.35 10.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.759 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -69.01 -41.89 77.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.728 ' CD1' HD13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -45.04 -58.93 4.83 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.301 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.6 Cg_endo -72.04 -2.73 12.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.998 1.525 . . . . 0.0 110.621 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 4.8 mmtp -104.51 -60.61 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.7 m -84.69 -18.15 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.454 -0.779 . . . . 0.0 110.528 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HB1' ' CD2' ' A' ' 143' ' ' LEU . . . -135.01 68.52 70.58 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.591 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.47 -1.4 11.28 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.036 1.545 . . . . 0.0 110.119 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.62 -20.94 25.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 110.333 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -104.67 -58.21 1.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.459 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.728 HD13 ' CD1' ' A' ' 30' ' ' PHE . 1.2 mp -104.1 129.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 110.093 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -83.85 -48.38 10.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.357 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -163.72 155.95 17.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 56' ' ' ILE . 61.5 t -118.69 146.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.87 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -144.15 90.38 2.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.347 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 74.4 m-20 -56.38 119.35 5.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.454 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.532 ' CD1' ' HD3' ' A' ' 68' ' ' LYS . 15.2 mt -87.83 -37.81 11.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.232 1.015 . . . . 0.0 108.525 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.548 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 32.1 tt0 -145.45 174.65 10.96 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.379 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.548 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 61.71 167.6 0.54 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.04 21.09 17.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -1.041 . . . . 0.0 110.036 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.518 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 99.85 12.83 39.09 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -89.63 -162.8 38.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -74.0 122.44 7.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.079 1.568 . . . . 0.0 110.376 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.6 0.66 62.5 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.674 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -71.01 156.54 39.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.464 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 44' ' ' ILE . 5.3 mt -119.83 135.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.934 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HA ' HG13 ' A' ' 44' ' ' ILE . 6.7 ptmt -149.33 143.44 25.8 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 110.278 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -89.22 106.48 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' CD1' HG13 ' A' ' 41' ' ' VAL . 41.9 mm -89.55 122.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.882 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.461 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 52.1 m -84.15 142.0 30.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 110.38 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 0.5 OUTLIER -110.19 146.05 33.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.6 63.8 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.077 1.567 . . . . 0.0 110.563 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 47.05 -168.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.382 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.65 -40.92 2.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.538 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 1.1 m-85 -96.57 175.97 2.38 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 47.4 Cg_endo -73.95 -25.17 14.45 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.877 1.462 . . . . 0.0 110.207 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' HB2' ' HA2' ' A' ' 89' ' ' GLY . 2.1 m-85 -111.96 131.01 55.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.249 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -52.6 -82.58 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.288 -0.882 . . . . 0.0 109.831 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' VAL . 4.3 p90 -92.02 -170.54 2.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.804 . . . . 0.0 110.471 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 66' ' ' TYR . 19.6 m -156.79 140.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.473 -0.767 . . . . 0.0 109.768 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -83.83 127.48 33.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.023 . . . . 0.0 110.401 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 83' ' ' TYR . 12.1 t70 -126.24 124.44 40.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.824 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.9 ttp85 -98.73 144.08 28.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.0 109.031 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -75.26 146.3 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.819 -1.175 . . . . 0.0 110.126 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 22.6 t70 -98.68 -72.43 0.65 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.43 0.634 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -135.94 144.06 45.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.718 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.5 t -130.65 128.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 13.4 m-20 -135.97 104.03 5.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.458 ' CD2' ' N ' ' A' ' 76' ' ' HIS . 13.6 m-70 -79.37 -9.92 59.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.273 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -111.27 -37.81 5.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -89.66 3.22 53.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 110.045 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.609 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.6 m-30 55.7 59.67 3.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 75' ' ' ASP . 12.1 tttp -139.36 114.87 9.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 110.074 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.718 ' CD2' HG22 ' A' ' 74' ' ' VAL . 59.8 t80 -136.26 116.47 13.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.1 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.448 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 53.5 m-20 -127.47 151.08 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 27.2 p90 -145.28 136.63 25.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.877 . . . . 0.0 109.506 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.2 m -100.51 164.5 11.88 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.121 -0.987 . . . . 0.0 111.14 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG22 ' OD2' ' A' ' 69' ' ' ASP . 55.4 t -108.82 126.15 65.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -115.52 -74.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.767 -1.208 . . . . 0.0 111.869 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.89 59.34 3.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.655 -1.278 . . . . 0.0 110.274 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 148.95 16.95 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . 52.5 -157.18 4.05 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.35 6.71 4.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.067 1.561 . . . . 0.0 111.021 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.0 mt -51.47 148.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.63 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' THR . . . -152.88 141.96 8.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.87 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -1.173 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 16.7 p -147.61 14.72 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.408 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 96' ' ' GLU . 1.6 pp -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.793 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.787 ' HB2' HD12 ' A' ' 95' ' ' LEU . 1.6 mt-10 53.31 34.84 18.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.115 -0.991 . . . . 0.0 109.247 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -71.68 157.72 37.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.543 -0.723 . . . . 0.0 110.262 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 120' ' ' TYR . 61.9 mt -142.18 125.35 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 110.628 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.63 108.55 13.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.539 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -97.03 142.96 28.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.707 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 102' ' ' ILE . 25.5 mt-10 -130.23 164.18 25.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -0.796 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 101' ' ' GLU . 23.1 mm -151.63 110.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -113.59 134.17 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.151 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.556 ' C ' HG23 ' A' ' 105' ' ' VAL . 52.9 mt -117.86 152.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.399 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.556 HG23 ' C ' ' A' ' 104' ' ' ILE . 27.0 t -153.22 119.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 109.856 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -75.86 151.06 37.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.477 0.656 . . . . 0.0 111.037 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 111' ' ' GLY . 3.1 p -90.43 -161.73 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 48.1 Cg_endo -79.01 -28.18 4.07 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 122.917 0.956 . . . . 0.0 110.692 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 3.8 t0 177.1 34.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.12 29.98 2.77 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.654 ' O ' HG23 ' A' ' 107' ' ' THR . . . 100.4 -156.0 19.46 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 120.995 -1.297 . . . . 0.0 110.04 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.846 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -135.57 168.71 18.74 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.705 -0.879 . . . . 0.0 110.505 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.478 HG12 HG22 ' A' ' 10' ' ' THR . 50.0 mt -127.92 124.36 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.194 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 114' ' ' LEU . 1.6 pp -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 111.024 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -110.31 114.8 28.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.6 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.473 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 35.5 mt -90.89 131.95 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.366 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -118.31 105.58 11.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 110.258 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 4.6 t-20 -92.94 155.38 17.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.022 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -152.76 132.99 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -132.75 103.18 5.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 89.2 m-70 -82.2 142.38 32.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.984 -1.072 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 p -106.28 -170.29 1.7 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 0.0 109.887 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 1.2 ttmt -110.34 55.42 0.65 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 110.273 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 42.88 26.5 0.46 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -164.57 -63.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -1.086 . . . . 0.0 109.835 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 34.2 m80 -57.5 -170.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.597 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 126' ' ' HIS . 27.0 mt-10 -154.23 -177.47 6.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.09 -1.006 . . . . 0.0 110.608 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.604 HG21 ' HB3' ' A' ' 120' ' ' TYR . 2.6 t -112.67 101.51 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 110.076 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 133' ' ' VAL . 1.6 mmtp -68.57 129.08 38.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.24 -49.12 61.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 111.071 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -38.4 -48.36 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -68.73 -34.09 75.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.079 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.616 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 6.0 t -75.15 -47.46 35.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 130' ' ' ALA . 9.5 tttp -61.1 -31.16 70.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.424 -0.797 . . . . 0.0 109.561 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.88 -49.48 51.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 t -65.83 -33.01 74.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 0.0 109.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -71.7 -34.86 69.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.052 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -49.95 -55.61 13.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 37' ' ' ALA . 4.3 mm? -67.05 -36.0 81.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.015 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.1 -40.13 13.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.64 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.4 OUTLIER -70.29 -63.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -1.072 . . . . 0.0 109.878 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.2 m -51.32 -22.33 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 13.2 mt -69.94 -54.25 14.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.985 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -57.63 -25.43 60.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.085 -1.01 . . . . 0.0 109.257 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -82.3 -33.58 28.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.98 85.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.449 -0.782 . . . . 0.0 109.743 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.21 -52.52 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.428 -0.795 . . . . 0.0 109.869 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 26.7 tt0 -51.73 -36.6 47.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.879 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 2.4 t -67.36 -54.45 20.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 110.026 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 151' ' ' LEU . 1.3 t80 -48.74 -69.95 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 0.0 110.433 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 13' ' ' ILE . 10.9 mt -41.56 -46.35 3.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.524 -0.735 . . . . 0.0 110.75 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.9 mt -70.34 -27.6 64.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.915 . . . . 0.0 110.549 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.29 70.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 110.198 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.6 150.25 21.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.869 . . . . 0.0 110.094 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.1 t -101.61 97.48 7.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.53 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.582 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 11.4 t0 -129.75 31.91 4.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 156' ' ' ASP . . . 62.18 164.11 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.323 -0.861 . . . . 0.0 110.272 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' A' ' 159' ' ' ASN . 9.5 m-85 -79.93 -15.09 58.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 110.233 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.272 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -72.49 146.92 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -1.177 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.531 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 18.1 m-85 -100.7 161.79 13.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.421 -0.799 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -138.19 140.98 40.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 110.369 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.748 ' CE2' HG11 ' A' ' 133' ' ' VAL . 23.4 m-85 -152.18 59.18 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.855 . . . . 0.0 109.775 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 4.5 tm-20 -80.98 153.22 27.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.525 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -149.93 163.27 38.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.684 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.38 164.45 34.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.669 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.14 -179.9 7.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -112.75 160.52 17.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 110.407 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.72 136.71 10.52 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.528 -0.732 . . . . 0.0 109.812 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.473 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 19.6 m -79.91 -16.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.139 -0.975 . . . . 0.0 108.57 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.758 HG21 HD13 ' A' ' 151' ' ' LEU . 24.9 mm -65.79 148.59 98.15 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.1 150.06 85.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.613 1.323 . . . . 0.0 110.917 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.717 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.27 -30.64 62.21 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.903 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.32 -49.32 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.083 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.553 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 1.2 tpt180 -66.57 -32.02 73.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.952 . . . . 0.0 109.709 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 114' ' ' LEU . 1.5 tt -74.81 -37.63 62.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CE1' HG13 ' A' ' 23' ' ' ILE . 6.1 t80 -64.05 -57.06 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.04 -52.85 59.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 110.292 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.84 69.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.698 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 36.2 t80 -91.96 -16.14 27.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.203 -0.936 . . . . 0.0 110.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.573 HG13 ' CE1' ' A' ' 19' ' ' PHE . 12.5 mm -109.21 -69.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.104 -0.997 . . . . 0.0 110.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HA ' HD23 ' A' ' 24' ' ' LEU . 9.2 mt -59.03 -34.48 71.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.455 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.5 -14.17 16.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.88 -30.55 9.29 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.91 -36.83 77.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -1.131 . . . . 0.0 110.396 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 8.0 p-10 -109.13 -22.89 11.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -72.5 -42.54 64.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -47.44 -59.91 4.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.353 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -72.46 -1.26 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.04 1.548 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.3 mttt -99.41 -65.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 29' ' ' LEU . 35.6 m -82.91 5.31 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 110.516 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -157.04 64.33 3.3 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.293 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.16 1.82 6.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.075 1.566 . . . . 0.0 110.738 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -89.44 -19.31 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.56 -69.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.0 mp -94.42 149.55 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.326 -0.858 . . . . 0.0 109.504 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.437 ' HB3' ' CA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.93 -33.47 9.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 110.75 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.76 171.16 11.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.958 -1.088 . . . . 0.0 110.822 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.3 t -138.9 139.0 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.933 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -145.08 112.25 6.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 110.64 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -69.7 114.9 8.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 110.113 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 55' ' ' LYS . 16.6 mm -80.63 -38.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.275 1.036 . . . . 0.0 108.484 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 6.4 tp10 -139.58 174.16 10.79 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.043 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.533 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 43.87 -158.98 0.12 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -128.63 -18.04 3.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 0.0 110.68 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.408 ' N ' HG21 ' A' ' 52' ' ' THR . . . 155.49 -18.35 0.51 Allowed Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG11 ' A' ' 71' ' ' VAL . . . -56.38 -169.39 0.09 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 49.8 Cg_endo -75.88 131.73 13.59 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.056 1.556 . . . . 0.0 110.354 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' A' ' 70' ' ' ARG . . . 90.74 -1.26 78.17 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.649 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.6 m -72.69 167.6 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.545 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 10.0 mt -127.04 131.17 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.804 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.945 ' CE ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -144.0 141.46 30.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 110.561 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HB2' HD11 ' A' ' 44' ' ' ILE . 13.9 tptt -99.38 107.63 19.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 110.459 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.945 HD11 ' CE ' ' A' ' 54' ' ' LYS . 28.4 mm -88.22 128.04 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -92.59 156.04 17.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 67' ' ' VAL . 30.0 m-85 -132.93 141.46 41.1 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.119 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 112.6 3.51 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.037 1.546 . . . . 0.0 110.431 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -155.82 159.87 39.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.329 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.18 -27.56 15.56 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 1.4 m-85 -61.79 175.8 0.5 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.35 -1.088 . . . . 0.0 110.094 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 43.7 Cg_endo -71.12 -53.56 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.777 1.409 . . . . 0.0 110.177 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.457 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 19.5 m-85 -86.41 164.65 16.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.33 -0.856 . . . . 0.0 109.909 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 4.6 pttt 174.75 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 110.335 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.781 ' O ' HG13 ' A' ' 67' ' ' VAL . 5.0 p90 -67.03 177.6 1.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.293 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 66' ' ' TYR . 2.5 m -162.95 133.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 110.048 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 16.5 ttpt -91.67 141.25 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -0.957 . . . . 0.0 110.046 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.82 134.04 36.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 109.839 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.496 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 3.8 ttm180 -95.4 134.3 38.38 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.649 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.7 t -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.014 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 12.6 t0 -99.41 -72.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.445 0.64 . . . . 0.0 110.407 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 tt0 -137.39 138.25 39.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.526 -0.734 . . . . 0.0 110.175 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.024 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.1 t -124.69 143.34 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.725 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 m-20 -150.91 93.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -72.85 -1.66 17.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -110.34 -33.23 6.69 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.331 -0.856 . . . . 0.0 108.821 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.48 16.22 27.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.676 -0.64 . . . . 0.0 109.997 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.564 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.2 m-30 44.91 48.71 9.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 5.8 ttpt -126.42 113.6 17.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.109 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 1.024 ' CD2' HG22 ' A' ' 74' ' ' VAL . 42.1 t80 -138.31 117.62 12.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 110.191 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 29.2 t-20 -124.7 165.45 17.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.171 -0.956 . . . . 0.0 109.889 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 7.7 p90 -159.37 134.55 8.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 14.4 m -93.29 161.98 14.18 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.173 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.9 t -103.51 123.71 57.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG22 ' HZ1' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -117.07 -72.92 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 111.61 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -82.91 89.63 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.596 -1.315 . . . . 0.0 110.49 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.489 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -109.08 152.04 17.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.14 -61.37 2.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.5 Cg_endo -71.69 -47.33 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.964 1.507 . . . . 0.0 110.64 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.0 mt -53.98 150.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.089 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.83 -72.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.71 -75.88 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.168 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.55 21.36 0.92 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.141 -0.975 . . . . 0.0 110.495 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.587 HD23 ' CB ' ' A' ' 123' ' ' LYS . 2.5 mp -96.69 158.94 15.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.947 . . . . 0.0 110.337 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 57.09 35.39 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.996 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -67.72 151.69 46.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.817 HD11 ' CE1' ' A' ' 120' ' ' TYR . 19.7 mt -139.54 129.26 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 t -119.29 111.55 18.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.397 -0.814 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.575 ' OD1' HG22 ' A' ' 98' ' ' ILE . 1.8 m-20 -103.52 144.4 31.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.69 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 117' ' ' SER . 13.2 tm-20 -122.84 163.28 20.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.403 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.447 HG13 ' C ' ' A' ' 101' ' ' GLU . 92.5 mt -145.52 102.42 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.898 . . . . 0.0 110.043 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -111.41 128.31 55.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.652 HG22 ' HB1' ' A' ' 15' ' ' ALA . 15.8 mt -118.96 124.68 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 110.379 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.8 t -129.12 133.24 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.293 -0.88 . . . . 0.0 110.109 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.94 147.78 24.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.665 -0.647 . . . . 0.0 111.288 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.593 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.7 p -86.19 -165.38 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 0.0 109.022 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 48.0 Cg_endo -80.51 69.51 7.92 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.26 1.137 . . . . 0.0 110.625 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 15.8 t0 69.02 39.35 1.79 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.266 -0.896 . . . . 0.0 110.331 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.2 38.36 1.25 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . 93.07 -161.97 25.84 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.717 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -140.79 167.49 22.05 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.577 -0.955 . . . . 0.0 110.552 -179.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 107' ' ' THR . 3.5 mt -117.4 120.71 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.204 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -91.75 142.02 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.992 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -130.8 96.49 4.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.605 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.9 115.51 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.567 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.545 ' CB ' ' HB3' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -91.36 152.13 20.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -146.67 124.86 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.097 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.88 144.5 49.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.11 -0.994 . . . . 0.0 110.471 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.817 ' CE1' HD11 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -122.02 135.35 54.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.989 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.54 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 22.5 m-70 -117.42 120.05 36.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 110.467 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.711 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.45 167.3 10.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.587 ' CB ' HD23 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -141.82 170.81 15.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.492 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.37 -156.24 0.83 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -85.14 17.16 3.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -1.139 . . . . 0.0 110.225 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -81.58 175.68 10.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.207 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.711 ' HA ' HG21 ' A' ' 122' ' ' THR . 10.0 pt-20 -159.97 170.43 21.36 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.235 -0.915 . . . . 0.0 109.765 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 128' ' ' VAL . 2.3 p -113.35 95.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.675 -0.641 . . . . 0.0 110.631 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 128' ' ' VAL . 15.4 mttt -42.87 139.04 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.8 -9.66 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 110.062 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -67.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.954 . . . . 0.0 109.887 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -53.7 -30.65 44.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.217 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.748 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.8 t -71.62 -52.07 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.496 -0.753 . . . . 0.0 109.486 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -61.84 -29.21 70.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.85 . . . . 0.0 109.792 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.88 60.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.788 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.3 t -71.66 -31.21 66.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.835 . . . . 0.0 110.097 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -74.89 -36.91 62.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -62.77 -46.62 87.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 110.072 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -38.85 58.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.2 -34.91 89.86 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.673 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.92 -50.68 65.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -1.142 . . . . 0.0 110.211 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -58.78 -24.57 61.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.424 HD23 ' CB ' ' A' ' 34' ' ' ALA . 36.0 mt -74.65 -42.79 57.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -67.58 -27.82 67.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 149' ' ' SER . 0.0 OUTLIER -81.76 -32.03 31.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 109.831 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.66 93.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.783 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' A' ' 22' ' ' PHE . 60.9 t -73.2 -43.68 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.815 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 27.2 tt0 -59.43 -43.98 92.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.834 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -62.01 -42.41 99.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 109.57 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -57.14 -73.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 110.098 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.758 HD13 HG21 ' A' ' 13' ' ' ILE . 1.4 mt -42.5 -33.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.142 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -58.98 -32.08 69.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.87 -13.83 55.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.336 -0.853 . . . . 0.0 110.172 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -85.98 -45.52 11.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 110.381 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.77 47.4 1.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.945 . . . . 0.0 110.479 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -89.98 -28.05 19.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.957 . . . . 0.0 110.032 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -164.07 -68.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.863 . . . . 0.0 110.269 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -165.67 -41.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 110.247 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.235 179.881 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.24 148.0 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.145 . . . . 0.0 110.084 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.518 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 20.8 m-85 -107.47 169.09 8.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 109.865 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -149.21 143.18 25.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.798 ' CE2' HG11 ' A' ' 133' ' ' VAL . 55.5 m-85 -154.86 60.57 0.66 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 109.581 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -80.16 150.93 30.0 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.587 0.708 . . . . 0.0 110.501 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.428 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -147.75 174.5 11.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.486 -0.759 . . . . 0.0 109.712 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -158.7 163.54 36.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.724 ' HB ' HD21 ' A' ' 114' ' ' LEU . 12.0 m -159.91 154.99 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 110.213 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.49 163.37 13.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.478 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -158.47 138.92 12.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 76.2 t -80.0 -14.01 13.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.136 -0.978 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.918 HG21 HD12 ' A' ' 151' ' ' LEU . 22.0 mm -67.52 150.3 97.92 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.766 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.3 Cg_endo -67.09 149.95 82.33 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.503 1.265 . . . . 0.0 110.701 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.92 -25.2 58.74 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.892 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 -54.79 6.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 14.5 mtp180 -65.8 -31.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.722 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.526 HD23 HG21 ' A' ' 104' ' ' ILE . 30.0 tp -71.29 -32.39 68.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.811 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.848 ' CD2' HD13 ' A' ' 23' ' ' ILE . 6.3 t80 -70.45 -64.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -46.67 -42.55 16.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 110.481 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . . . -70.68 -36.04 73.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.517 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 17.4 t80 -91.96 -11.3 36.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.816 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.848 HD13 ' CD2' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -118.75 -62.19 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 109.982 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -72.87 -23.43 60.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.833 . . . . 0.0 110.109 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.526 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . 1.7 t70 -128.85 3.13 5.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -59.85 -37.81 93.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.697 ' O ' HG21 ' A' ' 41' ' ' VAL . 76.4 m-20 -59.61 -25.45 64.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -1.101 . . . . 0.0 110.262 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -98.67 -22.62 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.45 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.888 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -93.04 -22.89 18.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -58.13 -58.08 21.36 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 109.932 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 49.4 Cg_endo -75.36 2.9 6.29 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.065 1.56 . . . . 0.0 110.679 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 1.2 mtpt -105.27 -60.09 1.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.016 -1.052 . . . . 0.0 110.76 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 29' ' ' LEU . 23.4 m -82.73 -18.88 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 143' ' ' LEU . . . -138.41 72.08 44.78 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.79 -16.8 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.03 1.542 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -74.78 -16.22 60.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.665 ' HB2' HD23 ' A' ' 139' ' ' LEU . . . -103.85 -63.74 1.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 110.053 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 38' ' ' ILE . 1.8 mp -93.62 144.14 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.486 -0.758 . . . . 0.0 110.305 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 0.1 OUTLIER -103.03 -40.26 6.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.02 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.499 ' HB2' ' CB ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -166.93 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 27' ' ' ASP . 3.7 m -134.55 153.48 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -157.91 104.37 1.92 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 111.297 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.66 117.74 7.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.645 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 55' ' ' LYS . 14.2 mm -84.26 -38.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.231 1.015 . . . . 0.0 108.779 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 47.1 tt0 -153.55 175.04 13.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.245 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 67.9 163.93 2.54 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -107.47 35.49 3.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -1.107 . . . . 0.0 110.099 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.447 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 84.1 8.92 83.18 Favored Glycine 0 N--CA 1.48 1.613 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.28 -159.68 34.27 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -76.08 119.23 5.26 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.054 1.555 . . . . 0.0 110.438 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.99 2.26 59.45 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.693 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -67.87 156.78 36.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.171 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 44' ' ' ILE . 10.9 mt -121.86 131.15 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.222 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.45 140.63 30.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' C ' HD13 ' A' ' 56' ' ' ILE . 11.7 ttmt -93.78 119.01 32.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.569 HD12 HG12 ' A' ' 41' ' ' VAL . 7.9 mm -102.34 128.03 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.089 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 40' ' ' SER . 0.7 OUTLIER -90.01 153.75 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.333 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.403 ' HB2' ' C ' ' A' ' 65' ' ' LYS . 4.1 m-85 -119.56 134.95 23.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.153 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.31 113.26 3.55 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.991 1.521 . . . . 0.0 110.146 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.97 173.8 8.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 110.28 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.51 8.45 28.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.513 ' CG ' ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -89.96 178.13 2.08 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.202 -1.175 . . . . 0.0 110.197 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.513 ' HD2' ' CG ' ' A' ' 62' ' ' PHE . 46.7 Cg_endo -72.72 -55.71 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.102 1.58 . . . . 0.0 110.719 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 9.8 p90 -98.32 148.01 24.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 0.0 110.527 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' C ' ' HB2' ' A' ' 58' ' ' PHE . 6.2 pttt -174.94 -41.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.716 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.612 ' C ' HG12 ' A' ' 67' ' ' VAL . 12.8 p90 -63.46 -168.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 110.014 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER 173.16 171.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 110.377 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.47 137.83 52.26 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.594 -0.691 . . . . 0.0 109.746 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 85' ' ' VAL . 94.1 m-20 -125.22 125.78 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 110.656 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 52' ' ' THR . 1.4 ttt180 -94.07 133.59 37.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.693 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.4 t -72.58 144.38 13.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.825 -1.172 . . . . 0.0 110.743 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 86.4 m-20 -92.87 -68.92 0.77 Allowed 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.339 0.59 . . . . 0.0 110.193 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.8 tp10 -143.35 134.67 26.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.177 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 81' ' ' TYR . 3.8 t -117.29 147.79 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.897 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.35 105.0 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -80.47 -4.42 53.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -108.12 -33.2 7.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.182 -0.949 . . . . 0.0 109.305 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.66 4.52 43.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.665 -0.647 . . . . 0.0 110.109 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.55 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 22.9 m-85 53.56 46.71 25.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.07 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.39 109.97 15.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.149 -0.97 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.501 ' CD2' HG22 ' A' ' 74' ' ' VAL . 44.5 t80 -127.62 107.47 9.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.897 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 59.7 m-20 -114.23 140.57 48.47 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.091 -1.005 . . . . 0.0 109.999 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 100' ' ' ASN . 48.8 p90 -143.16 138.62 29.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.7 m -103.97 172.17 6.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 111.376 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.817 HG11 HD13 ' A' ' 98' ' ' ILE . 42.4 t -111.21 126.57 68.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.574 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -120.94 -76.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.818 -1.176 . . . . 0.0 111.518 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.6 102.42 7.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.818 -1.176 . . . . 0.0 110.652 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -129.42 145.43 16.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.54 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.59 -57.28 3.93 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.6 Cg_endo -71.21 -30.58 15.72 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.394 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.574 HG21 ' O ' ' A' ' 86' ' ' ILE . 73.9 mt -78.64 147.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.81 -36.32 0.73 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.07 -74.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.493 ' H ' HD12 ' A' ' 95' ' ' LEU . 14.1 t -137.3 4.52 2.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.928 . . . . 0.0 110.416 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 95' ' ' LEU . 5.6 mp -84.37 150.88 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.935 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.9 34.25 21.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.59 162.53 29.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 110.253 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.817 HD13 HG11 ' A' ' 85' ' ' VAL . 4.0 mp -136.5 131.42 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 119' ' ' LYS . 1.8 m -118.75 119.73 35.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.364 -0.835 . . . . 0.0 109.603 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 9.4 m120 -112.17 160.6 17.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 110.721 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.474 ' CG ' ' CG ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -150.84 132.1 14.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.11 125.67 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.027 -1.046 . . . . 0.0 110.564 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 69.5 tttt -129.7 119.22 23.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.858 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.526 HG21 HD23 ' A' ' 18' ' ' LEU . 70.5 mt -118.42 112.49 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.763 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.0 t -112.01 141.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.414 -0.804 . . . . 0.0 109.879 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.0 147.08 25.18 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.499 -0.75 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.7 p -86.38 -162.86 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 0.0 109.089 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 45.1 Cg_endo -79.59 -27.72 3.93 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.011 1.006 . . . . 0.0 110.952 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 6.9 p-10 178.36 33.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 110.362 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.79 21.59 3.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 107' ' ' THR . . . 106.21 -151.69 17.01 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.161 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.861 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -136.87 163.04 31.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.755 -0.85 . . . . 0.0 110.644 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 113' ' ' ILE . 1.7 tt -112.16 126.81 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.166 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 9' ' ' THR . 2.0 pp -106.14 135.72 47.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.869 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -124.52 106.55 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 0.0 109.712 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 67.5 mt -97.22 112.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.47 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -97.8 114.02 25.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.49 ' CG ' HD21 ' A' ' 100' ' ' ASN . 1.5 m-20 -107.27 135.37 48.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 99' ' ' SER . 4.7 mttt -126.22 155.74 41.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.371 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.612 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -132.04 130.21 41.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 71.8 m-70 -113.11 140.2 48.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.159 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.96 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.3 OUTLIER -129.78 170.71 13.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.974 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 126' ' ' HIS . 0.7 OUTLIER -159.68 -177.95 6.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 125' ' ' ASP . . . 45.95 40.9 10.08 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 124' ' ' GLY . 9.2 m-20 61.79 15.69 7.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -1.139 . . . . 0.0 110.333 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.471 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 63.7 m170 -82.34 175.28 10.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.394 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.96 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER -159.99 136.66 9.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.487 -0.758 . . . . 0.0 109.146 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 120' ' ' TYR . 2.1 p -87.12 108.78 18.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 121.475 -0.765 . . . . 0.0 110.291 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -50.61 156.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -79.57 -7.46 58.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -50.4 -73.27 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -22.92 6.12 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 5' ' ' TYR . 11.5 t -76.09 -48.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.845 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -26.76 65.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.392 -0.817 . . . . 0.0 109.58 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -38.74 63.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.859 . . . . 0.0 109.366 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -60.52 -35.97 77.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.688 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -68.49 -48.14 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.869 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -52.43 -58.72 5.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.925 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -72.37 -33.06 66.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.08 -42.52 31.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.662 ' HA ' HD23 ' A' ' 144' ' ' LEU . 2.6 tp10 -63.11 -47.69 81.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -1.187 . . . . 0.0 109.975 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.1 m -59.89 -26.86 66.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.085 -1.009 . . . . 0.0 109.747 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.533 HD13 ' HE1' ' A' ' 30' ' ' PHE . 17.3 mt -67.68 -49.98 59.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.981 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.3 pp -66.97 -23.21 65.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.01 -1.056 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.446 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 2.0 tmm_? -80.9 -35.85 31.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.067 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 150' ' ' TYR . . . -65.32 -44.23 88.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.733 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.83 -45.26 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.514 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' A' ' 13' ' ' ILE . 1.1 tt0 -60.35 -56.24 23.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.51 47.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.585 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.24 -25.52 31.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.918 HD12 HG21 ' A' ' 13' ' ' ILE . 43.1 mt -88.8 -25.12 22.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -22.64 33.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -61.08 -26.01 67.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.423 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.22 22.03 16.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 110.416 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.43 -0.82 56.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.0 110.1 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -92.44 2.74 56.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.27 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.09 167.44 14.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.933 . . . . 0.0 110.193 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.42 -49.07 13.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.917 . . . . 0.0 110.262 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.124 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 120' ' ' TYR . 2.9 t -125.17 150.91 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -1.1 . . . . 0.0 109.999 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.506 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.2 m-85 -101.4 152.89 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.753 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.76 142.65 51.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.042 -1.036 . . . . 0.0 110.843 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.76 ' CD2' HG11 ' A' ' 133' ' ' VAL . 1.1 m-85 -154.12 53.7 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.645 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 7' ' ' THR . 1.9 pt-20 -81.61 160.0 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 110.557 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 6' ' ' GLU . 3.5 p -159.8 172.26 17.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.857 . . . . 0.0 109.874 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 12.7 pt-20 -146.34 141.88 27.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.017 . . . . 0.0 110.381 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 10' ' ' THR . 78.7 m -131.69 166.95 20.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 9' ' ' THR . 1.5 p -102.23 164.01 11.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.336 -0.853 . . . . 0.0 110.425 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 10' ' ' THR . 3.6 m -159.84 134.8 7.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.514 ' CG2' HD11 ' A' ' 152' ' ' LEU . 21.3 m -80.03 -14.06 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.61 HG23 ' HD2' ' A' ' 14' ' ' PRO . 36.2 mm -73.56 148.7 88.07 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.551 -0.718 . . . . 0.0 109.146 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.91 150.59 85.56 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.55 1.29 . . . . 0.0 110.965 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -70.09 -35.09 73.93 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.942 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.55 -56.44 6.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER -62.31 -36.29 81.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.909 HD22 HG21 ' A' ' 104' ' ' ILE . 4.4 tt -74.13 -33.94 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.407 -0.808 . . . . 0.0 110.241 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 32.5 t80 -60.81 -61.06 2.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.957 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttt -57.08 -36.87 71.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 110.058 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.51 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.403 ' CD1' HG21 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -91.91 -11.29 36.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.483 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.0 OUTLIER -121.69 -64.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -58.13 -48.38 80.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -105.01 7.55 34.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.155 -0.966 . . . . 0.0 110.463 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.85 -48.65 65.53 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB2' HG21 ' A' ' 41' ' ' VAL . 5.3 p-10 -57.67 -26.54 61.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.236 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -99.34 -30.93 11.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.649 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.673 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -81.54 -35.62 30.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.301 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.553 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 2.4 m-30 -44.8 -59.15 4.41 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 110.348 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -71.79 -10.45 26.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.877 1.462 . . . . 0.0 110.774 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -92.64 -57.26 2.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.984 . . . . 0.0 110.739 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 29' ' ' LEU . 27.1 m -94.18 -2.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 110.988 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -149.42 71.27 9.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.92 -1.112 . . . . 0.0 110.76 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.26 -20.11 16.67 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.005 1.529 . . . . 0.0 110.026 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -80.55 -29.06 37.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 110.092 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.02 -55.92 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 110.133 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.2 151.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.453 -0.78 . . . . 0.0 110.318 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 1.3 t -98.7 -46.49 5.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.865 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.426 ' C ' HG13 ' A' ' 41' ' ' VAL . 22.1 t -162.37 174.07 13.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 110.099 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 27' ' ' ASP . 24.7 m -147.71 146.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -144.26 151.06 38.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.447 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -100.09 116.73 32.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.868 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.6 mm -86.12 -37.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.19 0.995 . . . . 0.0 108.679 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.532 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 27.5 tt0 -157.08 173.64 16.7 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.701 0.763 . . . . 0.0 110.734 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' N ' ' HG2' ' A' ' 45' ' ' GLU . . . 75.97 -173.35 53.76 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -128.65 43.94 3.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -1.073 . . . . 0.0 110.1 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 69.02 7.52 56.67 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.96 -156.26 32.31 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.8 Cg_endo -75.03 117.8 5.03 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.019 1.536 . . . . 0.0 110.744 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.14 2.02 56.95 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.64 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.3 m -69.79 149.42 47.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.039 -1.271 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.462 HG12 ' HG3' ' A' ' 70' ' ' ARG . 4.7 mt -115.31 128.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.548 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -137.03 148.87 47.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.92 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.868 ' HB2' HD11 ' A' ' 44' ' ' ILE . 8.6 tttt -94.13 95.07 8.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.822 -0.549 . . . . 0.0 109.988 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 66' ' ' TYR . 13.7 mt -84.04 137.0 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -109.03 133.3 53.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.622 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.97 144.35 29.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 109.842 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.26 95.17 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.972 1.511 . . . . 0.0 110.475 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.47 163.34 32.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.396 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -90.17 -37.29 6.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.456 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 2.5 m-30 -46.9 172.75 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.313 -1.11 . . . . 0.0 110.325 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 43.0 Cg_endo -69.72 -48.76 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.911 1.48 . . . . 0.0 109.798 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 11.9 m-85 -99.49 166.72 11.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.453 -0.78 . . . . 0.0 109.785 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER 173.71 -36.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 110.148 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' C ' HG13 ' A' ' 67' ' ' VAL . 18.3 p90 -71.17 172.02 9.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.378 -0.826 . . . . 0.0 110.261 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.505 HG13 ' C ' ' A' ' 66' ' ' TYR . 18.2 m -154.47 154.38 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 25.8 ttmt -105.39 48.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -48.19 132.07 16.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 84' ' ' SER . 38.0 ttt180 -96.43 151.09 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 108.637 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.64 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.5 t -76.55 147.81 7.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.619 -1.301 . . . . 0.0 110.375 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 29.5 t0 -101.55 -74.07 0.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.373 0.606 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 mm-40 -141.32 146.6 36.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.209 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.763 HG22 ' HD1' ' A' ' 81' ' ' TYR . 2.9 t -137.37 127.95 38.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -124.64 113.65 18.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 109.747 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -13.45 60.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 111.105 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -106.68 -35.49 6.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.017 -1.052 . . . . 0.0 109.672 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.486 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.31 14.88 19.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.597 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 41.68 48.26 3.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.382 -0.824 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -116.65 113.7 23.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.217 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.763 ' HD1' HG22 ' A' ' 74' ' ' VAL . 41.1 t80 -133.04 120.29 21.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.383 -0.823 . . . . 0.0 110.071 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 42.6 t-20 -130.69 162.42 29.49 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 110.194 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 100' ' ' ASN . 23.7 p90 -153.94 140.86 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.2 m -98.08 154.01 18.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 98' ' ' ILE . 39.1 t -99.39 123.05 51.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.492 HD11 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -125.09 -77.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 111.041 -178.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.556 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 3.9 tm-20 -71.97 65.62 0.55 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -86.36 140.72 17.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.18 -53.83 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.9 Cg_endo -74.59 -45.26 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.784 1.412 . . . . 0.0 110.704 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 92' ' ' GLY . 49.2 mt -59.51 172.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.012 . . . . 0.0 110.189 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -152.42 -65.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.56 -85.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 110.107 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.6 p -140.12 19.2 2.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 110.35 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -94.28 153.83 17.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.557 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 36.2 mt-10 57.14 36.02 27.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.396 -0.815 . . . . 0.0 109.932 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.469 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.6 mttt -69.2 153.26 43.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.915 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.56 HG12 ' CE1' ' A' ' 120' ' ' TYR . 12.6 mt -138.93 132.0 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.722 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.6 m -121.91 110.36 15.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.623 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 5.0 m120 -104.03 125.89 50.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -110.18 167.13 10.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.457 ' CG1' ' O ' ' A' ' 101' ' ' GLU . 12.2 mt -155.39 118.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.479 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 5.9 tttt -119.46 114.19 21.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.909 HG21 HD22 ' A' ' 18' ' ' LEU . 2.7 mp -103.28 125.43 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 112' ' ' SER . 42.6 t -131.21 145.71 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.246 -0.909 . . . . 0.0 110.542 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.96 153.43 21.3 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.777 -0.577 . . . . 0.0 110.218 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.705 HG23 ' HD3' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -130.08 -56.49 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.064 -1.022 . . . . 0.0 111.331 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.705 ' HD3' HG23 ' A' ' 107' ' ' THR . 45.5 Cg_endo -88.35 43.11 0.75 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.076 1.04 . . . . 0.0 110.793 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 108' ' ' PRO . 0.6 OUTLIER 42.7 28.18 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.91 . . . . 0.0 110.244 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 108' ' ' PRO . . . -163.75 -36.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -111.89 -174.65 19.73 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -157.14 170.63 22.07 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.501 HG13 HG21 ' A' ' 107' ' ' THR . 48.4 mt -122.76 120.58 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.517 ' HG ' ' CG1' ' A' ' 104' ' ' ILE . 1.4 mp -86.95 122.05 30.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.667 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -104.27 97.48 7.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.8 mt -85.67 144.59 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.861 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.512 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -128.05 120.58 27.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -113.55 123.93 51.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.015 -1.053 . . . . 0.0 110.612 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -120.76 128.43 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.746 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 1.031 ' CE2' HG22 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -109.31 143.5 38.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -0.985 . . . . 0.0 110.243 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 66.9 m-70 -128.11 129.64 46.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.058 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -113.85 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -145.33 164.37 31.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.384 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 41.59 -126.12 3.61 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -103.39 14.74 30.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -1.107 . . . . 0.0 109.975 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.488 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 9.4 m170 -70.39 165.81 21.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.321 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.748 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER -160.16 137.7 9.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.307 -0.871 . . . . 0.0 109.28 179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 128' ' ' VAL . 2.7 p -100.05 98.15 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.372 -0.83 . . . . 0.0 110.527 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 128' ' ' VAL . 3.8 mttm -54.94 -172.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.49 16.73 16.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.85 -72.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.875 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -30.49 38.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 109.201 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.031 HG22 ' CE2' ' A' ' 120' ' ' TYR . 11.3 t -70.88 -48.83 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.463 -0.773 . . . . 0.0 109.531 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -65.46 -36.31 83.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 0.0 110.173 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.52 72.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.661 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 t -66.4 -38.36 87.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.752 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -64.22 -43.8 93.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.993 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -51.18 -53.79 31.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.32 -24.35 62.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -57.63 -44.03 94.1 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 15.8 mt-10 -64.43 -57.51 9.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -1.161 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.8 m -46.27 -29.94 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 143' ' ' LEU . 20.2 mt -70.61 -59.33 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.847 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -66.72 -17.89 65.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.172 -0.955 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' SER . 0.0 OUTLIER -84.12 -33.64 24.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.798 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 33' ' ' VAL . . . -69.11 -44.05 73.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.907 . . . . 0.0 109.438 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 22' ' ' PHE . 41.7 t -67.95 -43.97 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.679 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -61.2 -36.74 80.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.249 -0.907 . . . . 0.0 109.374 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.9 OUTLIER -68.08 -52.87 30.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 0.0 109.755 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -47.46 -69.92 0.11 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 110.312 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 13' ' ' ILE . 2.3 mt -46.21 -36.53 6.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.394 -0.817 . . . . 0.0 110.403 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.514 HD11 ' CG2' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -71.3 -56.41 6.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.084 -1.01 . . . . 0.0 110.297 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -56.6 -27.56 58.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.933 . . . . 0.0 110.241 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -118.56 117.8 29.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.9 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.7 t -101.12 -26.72 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 110.521 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 157' ' ' ALA . 46.1 m-20 -129.16 1.47 5.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.101 -1.0 . . . . 0.0 110.323 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 156' ' ' ASP . . . 50.31 -177.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -0.932 . . . . 0.0 110.087 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -151.49 50.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 110.392 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.215 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.754 HG11 ' ND1' ' A' ' 121' ' ' HIS . 4.2 m -74.37 -165.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.429 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -107.31 153.04 23.32 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.261 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 143.8 48.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.971 -1.08 . . . . 0.0 111.183 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.854 ' CE2' HG11 ' A' ' 133' ' ' VAL . 10.8 m-85 -153.59 58.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 0.0 109.151 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 9.9 pt-20 -84.94 145.07 27.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 110.807 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -146.78 167.53 23.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 3.5 pm0 -147.42 166.87 25.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.99 . . . . 0.0 110.369 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.12 -168.4 2.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 p -130.35 160.81 32.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.461 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.449 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . 41.5 m -159.95 139.26 11.03 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 14.8 p -79.83 -6.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.203 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.731 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.9 mm -74.27 148.96 86.64 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.731 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.0 150.25 88.33 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.561 1.296 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -67.04 -36.99 83.29 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.457 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.66 -54.16 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.565 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.542 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 12.0 ttt180 -57.83 -39.5 77.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 1.4 tt -67.32 -39.1 85.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.705 ' CD1' HD13 ' A' ' 23' ' ' ILE . 61.9 t80 -61.23 -71.0 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 0.0 110.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -47.4 -45.67 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.144 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 0.0 110.496 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 16.2 t80 -90.86 -7.09 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.705 HD13 ' CD1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -121.42 -64.9 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.978 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.483 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -61.82 -48.27 81.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 110.299 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 28' ' ' ASN . 29.9 t0 -110.82 16.7 21.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 110.313 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.72 -61.18 6.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -45.89 -23.88 0.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -1.125 . . . . 0.0 110.711 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.412 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 29.3 t-20 -89.74 -32.51 16.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 0.0 110.518 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mp -84.4 -18.08 37.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -62.49 -61.81 6.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.675 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -72.72 53.76 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.841 1.443 . . . . 0.0 110.981 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -151.64 -63.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.119 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.519 HG11 ' CE1' ' A' ' 150' ' ' TYR . 17.0 m -86.18 -19.93 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.44 66.12 35.52 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 110.264 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.66 -10.77 21.97 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.003 1.528 . . . . 0.0 110.397 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -22.91 64.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.285 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.459 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -95.19 -55.91 2.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.536 HG12 HG21 ' A' ' 56' ' ' ILE . 1.4 mp -107.72 137.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 110.112 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.19 -29.33 14.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.987 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.5 m -178.61 145.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.012 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 2.3 p -126.99 119.21 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.167 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -115.01 119.68 37.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.3 m-20 -65.54 117.59 8.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.493 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.733 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.8 mm -79.91 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.36 1.076 . . . . 0.0 108.422 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.2 mm-40 -100.15 -161.38 0.86 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.064 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.31 53.83 0.34 Allowed Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -116.3 -24.83 7.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -1.053 . . . . 0.0 110.003 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.529 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 50.77 78.16 0.11 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . 166.66 -160.19 33.74 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 43.8 Cg_endo -70.72 83.68 0.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.05 1.553 . . . . 0.0 110.286 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.86 -8.69 2.25 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.696 ' HB ' HG21 ' A' ' 71' ' ' VAL . 32.7 m -67.69 165.54 17.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.965 -1.315 . . . . 0.0 109.257 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 19.5 mt -138.03 143.37 33.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.961 -1.087 . . . . 0.0 111.056 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -154.9 136.9 14.63 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.328 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.733 ' HB2' HD11 ' A' ' 44' ' ' ILE . 1.1 ttpm? -95.56 112.48 24.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 111.404 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.536 HG21 HG12 ' A' ' 38' ' ' ILE . 15.1 mt -98.17 122.33 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 109.266 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.488 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -84.08 150.89 25.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.691 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -111.19 137.06 20.87 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.198 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.459 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 48.6 Cg_endo -75.23 76.27 3.54 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.994 1.523 . . . . 0.0 110.529 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -125.67 179.57 5.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.149 -0.969 . . . . 0.0 110.346 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -99.56 -45.33 2.15 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.463 ' O ' ' O ' ' A' ' 61' ' ' GLY . 1.9 m-85 -42.92 166.01 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.272 -1.134 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.09 -59.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.933 1.491 . . . . 0.0 110.434 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -84.07 144.3 29.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.859 . . . . 0.0 109.834 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -174.07 -49.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.986 . . . . 0.0 110.554 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.595 ' CD1' ' HE2' ' A' ' 55' ' ' LYS . 21.5 p90 -64.06 162.79 13.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.258 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 ' OD1' ' A' ' 69' ' ' ASP . 4.2 m -143.09 175.74 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.177 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.9 ttpt -122.46 37.93 4.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 84' ' ' SER . 4.6 p-10 -42.24 138.57 1.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.618 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.0 ptt180 -102.81 167.26 9.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 108.947 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.696 HG21 ' HB ' ' A' ' 52' ' ' THR . 16.3 t -77.85 152.34 5.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.94 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 34.2 t70 -104.71 -66.34 0.97 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -144.7 130.09 18.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.251 -0.906 . . . . 0.0 110.742 -179.736 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 5.4 t -116.12 150.83 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.578 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -158.33 111.23 2.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.221 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -21.25 51.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -104.77 -40.32 6.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.19 -0.944 . . . . 0.0 109.756 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -84.48 7.22 20.56 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.762 . . . . 0.0 110.274 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.526 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 8.0 m-85 46.25 59.26 3.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.29 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -131.27 107.94 9.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.965 -1.084 . . . . 0.0 110.741 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.672 ' O ' HD12 ' A' ' 102' ' ' ILE . 13.9 t80 -125.99 104.1 8.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.54 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 37.3 m-20 -121.02 149.1 43.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.2 p90 -139.04 138.38 37.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' ARG . 5.7 m -101.89 159.94 14.92 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.906 -1.121 . . . . 0.0 111.008 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 55.5 t -106.98 121.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.16 -75.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.067 -1.021 . . . . 0.0 110.873 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' CA ' ' OE1' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -74.04 95.24 2.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.72 -1.238 . . . . 0.0 110.101 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -122.79 138.31 11.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.551 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.4 -54.36 3.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.4 Cg_endo -72.47 -48.43 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.831 1.437 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.415 ' CD1' HG12 ' A' ' 85' ' ' VAL . 64.4 mt -54.5 160.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.178 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.59 -70.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.592 ' H ' HD23 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -103.31 74.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 110.198 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 46.6 p 43.7 24.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.592 HD23 ' H ' ' A' ' 93' ' ' ASP . 3.6 pp -96.96 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 0.0 110.126 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.585 ' CB ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER 56.45 34.66 24.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -67.95 151.48 47.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.301 -0.874 . . . . 0.0 110.018 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.654 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -126.79 120.67 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.612 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -108.83 104.23 13.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.56 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -96.25 145.43 25.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.782 -179.249 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.54 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 1.2 mp0 -136.11 139.73 43.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.437 -0.79 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 81' ' ' TYR . 3.0 mp -130.21 100.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 110.476 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 59.3 tttt -104.76 124.47 49.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.01 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 50.0 mt -110.45 138.63 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.895 . . . . 0.0 110.377 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 t -139.2 138.87 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.05 -1.031 . . . . 0.0 109.912 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.08 144.08 26.7 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.497 0.665 . . . . 0.0 110.479 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.598 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.9 p -79.86 -163.71 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.81 . . . . 0.0 108.924 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 44.3 Cg_endo -78.06 -32.19 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.008 1.004 . . . . 0.0 110.543 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 108' ' ' PRO . 1.7 m-20 -173.68 35.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.3 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.77 61.75 0.46 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.638 -1.267 . . . . 0.0 110.301 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 107' ' ' THR . . . 73.09 -154.53 49.68 Favored Glycine 0 N--CA 1.491 2.358 0 O-C-N 121.223 -1.163 . . . . 0.0 110.332 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -134.51 163.56 29.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.785 -0.832 . . . . 0.0 110.538 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.46 HG13 HG22 ' A' ' 107' ' ' THR . 9.1 mt -109.49 133.25 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 109.349 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.471 HD23 HD11 ' A' ' 116' ' ' ILE . 0.0 OUTLIER -97.88 133.93 41.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.976 -1.078 . . . . 0.0 110.803 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -129.55 98.66 4.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.413 -0.804 . . . . 0.0 109.642 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 1.5 mp -101.02 136.86 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.933 . . . . 0.0 110.421 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -113.33 125.44 54.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.374 -0.829 . . . . 0.0 110.232 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -111.78 134.0 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.633 ' HG2' HG21 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -125.82 143.59 51.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.956 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.654 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -125.56 104.02 8.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.97 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.754 ' ND1' HG11 ' A' ' 2' ' ' VAL . 33.2 m-70 -83.42 101.44 11.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.88 . . . . 0.0 110.409 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.5 166.98 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.804 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 124' ' ' GLY . 5.6 ttpt -107.44 145.75 32.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.325 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.87 -30.11 0.93 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.0 -55.77 5.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -1.222 . . . . 0.0 110.403 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.445 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 96.6 m-70 -78.83 179.15 7.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -159.99 136.52 9.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 109.897 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.638 HG21 ' CD2' ' A' ' 120' ' ' TYR . 3.0 p -104.79 86.62 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -48.48 150.29 1.39 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -60.46 -27.34 67.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.959 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 130' ' ' ALA . 28.5 mt-10 -41.71 -64.59 0.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 110.046 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -55.12 -29.7 58.23 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.854 HG11 ' CE2' ' A' ' 5' ' ' TYR . 9.3 t -72.88 -50.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.415 -0.803 . . . . 0.0 109.442 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.2 -21.4 60.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.198 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 -32.29 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.122 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -35.58 37.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -49.36 -60.57 2.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 110.004 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -76.94 -31.7 56.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 110.116 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.52 -55.03 14.38 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.586 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -50.06 -40.3 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.154 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.06 -24.91 67.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.987 . . . . 0.0 109.695 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 54.7 mt -73.81 -51.49 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.94 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.4 pp -64.54 -22.01 66.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 149' ' ' SER . 17.4 tpt85 -81.66 -43.08 19.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.444 -0.785 . . . . 0.0 109.682 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -57.75 -36.72 72.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.3 t -73.22 -53.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 109.603 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.449 ' OE2' ' HA ' ' A' ' 11' ' ' SER . 50.7 tt0 -53.48 -53.15 55.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -58.6 -36.3 73.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.128 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.519 ' CE1' HG11 ' A' ' 33' ' ' VAL . 1.2 t80 -48.93 -71.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.573 -0.704 . . . . 0.0 109.823 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.634 HD22 HG23 ' A' ' 13' ' ' ILE . 1.9 mp -56.45 -26.53 54.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.725 . . . . 0.0 110.071 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -77.74 -14.38 59.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.32 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -119.32 18.05 12.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -99.74 119.51 38.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.065 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.52 112.68 25.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.267 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -70.0 -20.35 63.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.17 -152.14 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 110.088 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.08 -60.62 1.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.296 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 4.5 t 57.3 155.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -1.111 . . . . 0.0 110.11 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.6 m-85 -111.24 151.31 28.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.33 135.61 49.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 110.363 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.683 ' CE2' HG11 ' A' ' 133' ' ' VAL . 28.2 m-85 -148.39 70.68 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.445 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -95.19 154.21 17.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 6' ' ' GLU . 2.1 p -158.15 -169.77 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.507 -0.746 . . . . 0.0 109.844 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.9 pt-20 -159.96 150.93 19.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.748 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.706 HG21 HD21 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -132.17 153.39 50.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.402 -0.811 . . . . 0.0 109.77 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.892 HG22 ' CD1' ' A' ' 113' ' ' ILE . 1.8 p -92.93 160.2 15.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.741 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.48 ' OG ' ' CD1' ' A' ' 114' ' ' LEU . 17.3 m -158.07 137.78 12.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 109.673 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.425 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 56.7 t -80.05 -11.0 12.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.795 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.0 OUTLIER -75.85 150.73 84.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.083 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.795 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.3 Cg_endo -66.71 150.74 83.52 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.716 1.377 . . . . 0.0 111.145 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 104' ' ' ILE . . . -73.73 -19.57 60.76 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.497 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.8 -54.87 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 14.4 ttp180 -64.15 -38.35 90.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.759 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.622 ' HB2' HG22 ' A' ' 13' ' ' ILE . 6.4 tt -71.29 -33.48 69.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.703 ' CD2' HD13 ' A' ' 23' ' ' ILE . 33.8 t80 -62.26 -65.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.115 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -51.64 -47.82 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 110.266 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.29 73.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 25.9 t80 -91.73 -13.01 32.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.703 HD13 ' CD2' ' A' ' 19' ' ' PHE . 1.1 mp -114.98 -71.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.192 -0.942 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.576 ' N ' HG22 ' A' ' 23' ' ' ILE . 8.1 mt -62.22 -34.2 76.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.845 . . . . 0.0 110.766 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.4 m-20 -118.0 23.8 11.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.156 -0.965 . . . . 0.0 110.444 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.56 -38.22 33.19 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.506 ' O ' HG11 ' A' ' 41' ' ' VAL . 1.9 p30 -56.49 -30.57 63.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -1.152 . . . . 0.0 110.408 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 25' ' ' ASP . 4.9 p-10 -96.02 -18.81 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 tp -82.21 -39.75 22.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 110.341 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.588 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -53.05 -62.04 3.99 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.224 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.8 Cg_endo -73.27 54.89 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.813 1.428 . . . . 0.0 110.476 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.7 -67.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 110.564 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.14 -15.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.512 -0.742 . . . . 0.0 110.449 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.25 76.87 4.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.346 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.0 -2.19 11.64 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.044 1.549 . . . . 0.0 110.214 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -72.72 -28.31 62.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.624 ' CB ' HD11 ' A' ' 143' ' ' LEU . . . -86.42 -61.66 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.961 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.586 HD13 ' CG ' ' A' ' 30' ' ' PHE . 1.2 mp -105.8 128.91 59.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.402 -0.811 . . . . 0.0 109.699 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -91.33 -25.3 19.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.18 -0.95 . . . . 0.0 110.485 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.39 141.02 0.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.693 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.641 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.1 p -127.47 139.88 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mm-40 -142.23 158.74 43.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.973 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -103.87 115.73 31.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.465 -0.772 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.436 HD11 ' HG3' ' A' ' 68' ' ' LYS . 10.0 mt -81.23 -39.01 17.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.811 ' OE1' HD12 ' A' ' 53' ' ' ILE . 2.8 tp10 -99.13 -157.77 0.63 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.708 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.25 61.51 0.26 Allowed Glycine 0 N--CA 1.482 1.715 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.475 ' H ' HG23 ' A' ' 52' ' ' THR . 0.6 OUTLIER -120.82 -23.33 5.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -1.12 . . . . 0.0 109.845 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 48.13 89.26 0.01 OUTLIER Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . 151.48 -158.87 27.96 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.32 89.34 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.6 -3.03 3.17 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.189 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.735 ' HB ' HG21 ' A' ' 71' ' ' VAL . 33.5 m -78.48 161.34 27.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.319 . . . . 0.0 109.697 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.811 HD12 ' OE1' ' A' ' 45' ' ' GLU . 14.0 mt -130.9 144.91 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.911 -1.118 . . . . 0.0 110.619 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -152.47 144.45 23.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.778 . . . . 0.0 109.784 179.139 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -93.52 117.45 30.1 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.434 -0.791 . . . . 0.0 110.757 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.641 ' CD1' HG23 ' A' ' 41' ' ' VAL . 16.5 mm -102.73 141.76 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -112.19 142.72 44.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.048 -1.032 . . . . 0.0 110.437 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 14.2 m-85 -118.2 123.2 29.61 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 49.3 Cg_endo -76.6 126.67 9.1 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.855 1.45 . . . . 0.0 110.383 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -172.99 -145.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.052 -1.03 . . . . 0.0 110.396 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -130.28 -19.58 1.36 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.496 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.655 ' CZ ' ' CB ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -45.25 170.89 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.812 -1.405 . . . . 0.0 110.544 -179.557 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 43.8 Cg_endo -71.79 -33.63 9.92 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.59 1.31 . . . . 0.0 109.133 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 32.6 m-85 -84.21 -163.99 0.87 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.596 -0.69 . . . . 0.0 109.209 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.561 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 3.5 ttmt -168.39 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.712 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.456 ' C ' HG12 ' A' ' 67' ' ' VAL . 40.6 p90 -92.04 -165.74 1.41 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.855 0.836 . . . . 0.0 111.172 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.556 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -173.91 172.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.569 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -107.95 128.68 54.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.161 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' A' ' 85' ' ' VAL . 17.0 m-20 -127.19 130.67 50.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 2.4 ttp180 -101.15 145.26 29.02 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 0.0 108.935 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.735 HG21 ' HB ' ' A' ' 52' ' ' THR . 9.7 t -67.9 149.79 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.965 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t70 -101.33 -68.95 0.79 Allowed 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.403 0.621 . . . . 0.0 110.386 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.1 tt0 -145.8 121.94 10.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 110.339 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.683 HG22 ' HD1' ' A' ' 81' ' ' TYR . 3.7 t -108.91 151.6 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 1.2 m-20 -152.08 113.77 4.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -88.89 2.13 54.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 110.144 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -117.43 -40.84 3.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.692 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.1 11.77 28.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.219 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.547 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 50.35 57.79 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.547 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 3.8 mtpt -129.61 126.27 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.683 ' HD1' HG22 ' A' ' 74' ' ' VAL . 16.4 t80 -143.63 106.62 4.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 62.7 t-20 -117.0 165.99 12.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.631 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.3 p90 -161.17 137.76 8.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.818 . . . . 0.0 109.467 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 69.8 m -106.85 168.53 9.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.581 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' A' ' 69' ' ' ASP . 39.8 t -106.58 127.87 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -114.8 -70.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 111.879 -178.462 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.569 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -90.48 98.09 11.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.492 -1.38 . . . . 0.0 110.147 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -111.33 141.53 16.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.03 -58.7 3.63 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.0 Cg_endo -74.06 -31.46 7.88 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.986 1.519 . . . . 0.0 110.461 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 91' ' ' ILE . 54.0 mt -67.66 145.61 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.306 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.11 -92.21 2.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.58 -72.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.9 p -132.06 15.11 4.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.47 146.67 23.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 110.315 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 62.33 33.05 16.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.972 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -79.08 149.66 32.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.519 HG12 ' CE1' ' A' ' 120' ' ' TYR . 11.0 mt -127.69 153.93 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.816 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.3 m -145.64 105.39 3.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.489 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 7.7 m120 -101.19 124.4 46.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.147 -0.971 . . . . 0.0 110.889 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.531 ' HG3' ' ND2' ' A' ' 82' ' ' ASN . 1.9 tt0 -106.71 152.41 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.545 -0.722 . . . . 0.0 109.776 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.442 HG13 ' C ' ' A' ' 101' ' ' GLU . 13.5 mt -137.6 144.44 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.206 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.711 ' O ' HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -143.98 132.42 22.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 103' ' ' LYS . 7.3 mm -119.94 119.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 109.908 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 112' ' ' SER . 14.4 t -133.49 126.15 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 110.918 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -72.96 158.17 35.99 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.149 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.771 HG23 ' HD3' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -137.37 -61.15 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.026 -1.046 . . . . 0.0 111.22 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.771 ' HD3' HG23 ' A' ' 107' ' ' THR . 51.1 Cg_endo -82.88 41.09 1.04 Allowed 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 122.775 0.882 . . . . 0.0 110.781 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 108' ' ' PRO . 5.1 t70 42.19 31.48 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.033 -1.042 . . . . 0.0 110.396 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.15 -37.54 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . -115.64 -166.91 14.97 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 13.7 t -159.99 -178.86 7.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 111.274 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.892 ' CD1' HG22 ' A' ' 10' ' ' THR . 39.1 mm -130.0 117.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.48 ' CD1' ' OG ' ' A' ' 11' ' ' SER . 3.4 mp -87.2 121.12 29.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.966 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -104.34 106.83 17.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.662 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 116' ' ' ILE . 1.2 tt -105.63 132.17 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 40.7 t -121.1 115.18 22.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 5' ' ' TYR . 38.2 t30 -99.25 134.71 41.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 134.3 50.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.519 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -116.75 131.93 56.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.87 . . . . 0.0 109.998 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 86.9 m-70 -116.25 101.51 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.038 . . . . 0.0 110.29 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.28 167.15 11.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.201 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 124' ' ' GLY . 4.1 ttmt -104.64 164.54 11.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 110.367 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -44.71 -40.1 6.42 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.5 -74.42 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -1.164 . . . . 0.0 110.157 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 30.2 m170 -67.67 178.92 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.298 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 126' ' ' HIS . 55.0 mt-10 -156.61 -170.07 3.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.205 -0.934 . . . . 0.0 110.438 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.1 t -132.09 103.43 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 110.092 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -75.95 139.91 41.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.496 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -61.76 -10.17 8.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.989 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.42 -52.88 41.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.875 -1.141 . . . . 0.0 109.878 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -28.91 68.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 108.881 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.683 HG11 ' CE2' ' A' ' 5' ' ' TYR . 22.1 t -76.98 -49.97 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.5 -0.75 . . . . 0.0 109.12 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 15.6 tptt -66.58 -27.33 67.64 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.722 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.96 -33.47 63.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.762 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.6 t -67.07 -34.69 78.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.106 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -29.57 66.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.24 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.23 -66.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -17.91 62.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.43 -41.12 86.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.621 ' HA ' HD23 ' A' ' 144' ' ' LEU . 1.8 tt0 -67.62 -42.2 82.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 110.109 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -61.47 -29.01 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.495 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.624 HD11 ' CB ' ' A' ' 37' ' ' ALA . 18.1 mt -68.85 -54.5 15.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.409 -0.807 . . . . 0.0 109.908 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 9' ' ' THR . 1.1 pp -61.48 -29.43 69.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.499 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -72.86 -34.05 66.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.429 -0.794 . . . . 0.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.56 -43.21 90.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.98 -40.86 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.609 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 2.8 tt0 -54.66 -48.9 71.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.842 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t -59.53 -50.36 74.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 154' ' ' HIS . 1.6 t80 -47.18 -70.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.66 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.7 HD13 HG21 ' A' ' 13' ' ' ILE . 8.5 mt -47.59 -45.17 27.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -50.92 -46.25 60.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 110.277 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -89.58 -15.75 32.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -89.58 -1.95 58.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.952 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.76 55.37 1.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.315 -0.866 . . . . 0.0 110.406 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -93.2 -32.98 14.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.301 -0.874 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.99 -30.79 70.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -65.03 -9.6 23.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.0 110.181 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.215 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.786 HG11 ' ND1' ' A' ' 121' ' ' HIS . 13.1 m -126.41 -165.84 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -1.099 . . . . 0.0 110.531 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 31.9 m-85 -117.62 141.58 48.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.996 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.6 141.14 46.72 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.022 . . . . 0.0 110.258 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CE1' HG11 ' A' ' 133' ' ' VAL . 42.8 m-85 -147.16 55.63 1.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.725 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.67 148.85 30.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.787 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.61 -0.681 . . . . 0.0 109.78 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.81 158.03 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 -171.4 3.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.586 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.81 162.16 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.407 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 20.1 m -159.2 143.36 15.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 0.0 109.936 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.607 HG13 HD12 ' A' ' 13' ' ' ILE . 7.2 p -79.94 -12.85 13.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.618 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.69 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.2 mp -69.95 149.28 96.42 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.28 149.59 85.09 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.437 1.23 . . . . 0.0 111.157 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.821 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.63 -25.91 59.54 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.53 -53.53 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.918 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -66.1 -34.2 77.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.8 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.605 ' HB2' HG22 ' A' ' 13' ' ' ILE . 7.0 tt -74.95 -30.99 61.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.615 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.599 ' CE1' HG13 ' A' ' 23' ' ' ILE . 59.3 t80 -67.92 -71.82 0.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.995 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -50.45 -42.68 54.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.853 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -66.21 -36.16 82.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.493 -0.754 . . . . 0.0 110.294 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 25.8 t80 -91.98 -10.93 37.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.599 HG13 ' CE1' ' A' ' 19' ' ' PHE . 7.7 mm -100.35 -74.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.211 -0.931 . . . . 0.0 110.157 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.995 HD12 ' HG2' ' A' ' 20' ' ' LYS . 19.8 mt -68.0 -40.99 82.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.44 -0.788 . . . . 0.0 109.796 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -85.39 -18.79 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 110.026 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.52 -40.43 62.19 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.79 ' O ' HG21 ' A' ' 41' ' ' VAL . 9.5 m-20 -55.74 -26.04 43.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -1.157 . . . . 0.0 110.11 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 67.6 m-20 -109.19 -23.32 11.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.591 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.6 mp -85.33 -28.48 25.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.219 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.564 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.6 m-30 -54.2 -59.79 9.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.6 Cg_endo -73.41 0.19 8.38 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.99 1.521 . . . . 0.0 110.556 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -96.25 -69.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.685 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 29' ' ' LEU . 25.2 m -81.81 7.27 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.396 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.16 2.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.325 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.33 -2.03 11.49 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.979 1.515 . . . . 0.0 110.653 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -90.62 -3.49 57.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.274 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' HD3' ' A' ' 59' ' ' PRO . . . -110.88 -71.56 0.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 38' ' ' ILE . 1.6 mp -99.13 138.59 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.453 -0.78 . . . . 0.0 110.162 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 1.2 t -81.57 -48.82 11.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -163.65 176.75 9.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.296 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.79 HG21 ' O ' ' A' ' 27' ' ' ASP . 2.6 m -135.45 147.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 1.1 tt0 -136.44 161.29 36.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.84 110.16 20.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.937 HD11 ' HB2' ' A' ' 55' ' ' LYS . 15.5 mm -82.04 -39.45 16.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 122.231 1.015 . . . . 0.0 108.414 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.0 tm-20 -105.77 -159.71 0.72 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.166 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.73 59.77 0.33 Allowed Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.467 ' H ' HG23 ' A' ' 52' ' ' THR . 0.7 OUTLIER -123.53 -19.26 5.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -1.182 . . . . 0.0 110.272 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.529 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 45.12 70.98 0.54 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . 164.11 -159.12 31.9 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.28 94.84 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.876 1.461 . . . . 0.0 110.221 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.38 -6.92 4.64 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.758 ' HB ' HG21 ' A' ' 71' ' ' VAL . 38.1 m -80.25 162.74 24.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -1.112 . . . . 0.0 109.53 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 31.5 mt -137.41 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.099 -1.001 . . . . 0.0 110.37 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.632 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -148.79 142.7 25.76 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.267 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 44' ' ' ILE . 25.0 tttp -91.77 117.24 29.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.532 -0.73 . . . . 0.0 110.197 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.687 ' CD1' HG12 ' A' ' 41' ' ' VAL . 39.7 mm -97.15 119.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.244 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 39' ' ' SER . 3.7 m -82.54 130.68 35.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.869 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 2.3 m-85 -108.24 163.63 16.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 110.617 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 45.2 Cg_endo -74.18 -165.87 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.238 1.652 . . . . 0.0 110.726 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.52 155.8 21.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.892 . . . . 0.0 110.828 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.74 -93.3 0.13 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.541 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 6.5 p90 -64.51 168.99 5.6 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.363 -1.081 . . . . 0.0 109.85 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 38.8 Cg_endo -64.13 -26.52 65.2 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.54 1.284 . . . . 0.0 110.305 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -81.82 179.37 7.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.185 178.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 22.6 mttt -129.32 -73.32 0.57 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.108 -0.995 . . . . 0.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.466 ' C ' HG13 ' A' ' 67' ' ' VAL . 8.3 p90 -92.06 177.77 6.07 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.765 0.793 . . . . 0.0 111.057 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.466 HG13 ' C ' ' A' ' 66' ' ' TYR . 29.2 m -152.21 150.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 11.6 mtmt -110.48 139.91 45.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.95 -1.094 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 20.2 p-10 -134.73 133.58 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 110.276 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 84' ' ' SER . 7.4 ttt180 -100.07 139.65 35.43 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.758 HG21 ' HB ' ' A' ' 52' ' ' THR . 14.1 t -61.31 153.92 5.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.541 -1.349 . . . . 0.0 111.039 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 18.4 t0 -106.32 -73.6 0.68 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.874 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.31 112.63 7.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.385 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.552 HG22 ' CE2' ' A' ' 81' ' ' TYR . 2.6 t -102.89 141.5 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' LYS . 16.8 t0 -142.63 120.55 12.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.64 1.33 57.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 110.383 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -115.39 -35.63 4.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.089 -1.007 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -102.14 20.81 15.97 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.488 -0.758 . . . . 0.0 110.503 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.8 m-30 43.21 56.72 4.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 75' ' ' ASP . 25.7 tttt -125.99 123.16 37.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -142.48 105.09 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.087 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 47.3 m-20 -121.0 144.01 48.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 110.185 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 31.1 p90 -135.49 137.37 42.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.848 . . . . 0.0 109.379 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.5 m -94.66 161.66 14.1 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 110.977 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.515 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 25.2 t -102.69 128.22 55.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -119.33 -74.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.06 -1.025 . . . . 0.0 111.349 -178.578 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.546 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -92.11 64.84 4.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.638 -1.289 . . . . 0.0 109.881 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . -131.77 159.67 23.3 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 44.98 -157.08 0.24 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.83 1.57 6.9 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.024 1.539 . . . . 0.0 110.782 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.542 HD11 HD13 ' A' ' 98' ' ' ILE . 75.9 mt -51.63 155.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.052 . . . . 0.0 110.321 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.1 -107.08 0.24 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.45 ' C ' HG23 ' A' ' 94' ' ' THR . 18.4 m-20 -47.7 -86.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.933 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.45 HG23 ' C ' ' A' ' 93' ' ' ASP . 30.6 p -148.23 12.34 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -92.82 157.85 16.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 110.239 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.4 mm-40 59.51 33.04 22.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.902 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.522 ' C ' HD12 ' A' ' 98' ' ' ILE . 1.2 ttpm? -76.55 159.36 30.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.622 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mp -142.02 127.59 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.875 . . . . 0.0 110.228 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t -116.42 112.9 22.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.603 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -99.24 136.62 38.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 110.495 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 90.2 mt-10 -125.97 144.28 50.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.794 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.4 mt -136.08 113.6 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.352 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.45 124.66 48.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.692 HG22 ' HB1' ' A' ' 15' ' ' ALA . 3.2 mt -118.2 127.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.0 t -132.56 141.59 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.93 144.45 26.55 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.393 0.616 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 111' ' ' GLY . 4.4 p -79.91 -165.01 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.588 ' CD ' ' HB ' ' A' ' 107' ' ' THR . 46.3 Cg_endo -80.94 -23.67 5.32 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.187 1.098 . . . . 0.0 110.956 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.33 31.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.105 -0.997 . . . . 0.0 110.242 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -141.78 42.72 1.13 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.314 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 107' ' ' THR . . . 88.69 -153.46 23.98 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.52 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -133.6 163.59 29.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.813 -0.816 . . . . 0.0 110.671 -179.3 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 113' ' ' ILE . 29.3 mt -108.32 131.6 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.42 -0.8 . . . . 0.0 109.022 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -106.01 135.29 47.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.937 -1.102 . . . . 0.0 110.504 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.45 111.12 11.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' THR . 3.2 mt -102.84 125.61 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 110.587 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.535 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -109.55 119.39 39.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.807 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -118.26 141.66 48.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.319 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.3 mtpp -124.9 151.73 44.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 109.993 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.622 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -130.26 99.8 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 109.759 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.786 ' ND1' HG11 ' A' ' 2' ' ' VAL . 14.7 m-70 -86.01 105.83 16.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.804 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.642 HG21 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -113.02 172.94 6.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 8.1 tttt -108.42 154.03 22.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.866 . . . . 0.0 110.386 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -43.95 -47.59 7.87 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -54.07 -61.87 2.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -1.177 . . . . 0.0 110.466 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.465 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 68.4 m-70 -83.06 176.75 8.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.909 . . . . 0.0 110.631 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 126' ' ' HIS . 3.4 mt-10 -146.36 -171.18 3.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.793 . . . . 0.0 109.682 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.758 ' O ' HG12 ' A' ' 128' ' ' VAL . 2.4 t -122.36 89.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.442 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -60.18 132.03 52.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.615 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . . . -54.9 -16.84 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.018 . . . . 0.0 110.632 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.22 -59.01 5.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.898 -1.126 . . . . 0.0 109.495 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -63.59 -30.2 71.34 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 109.061 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG11 ' CE1' ' A' ' 5' ' ' TYR . 16.1 t -71.74 -47.25 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 8.3 ttpp -65.07 -30.67 71.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.773 . . . . 0.0 110.048 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.44 -19.94 61.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.0 t -72.43 -43.47 63.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 110.092 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 138' ' ' GLU . 21.9 ptmt -79.91 -37.71 34.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 137' ' ' LYS . 6.5 tt0 -51.8 -57.58 8.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 -25.94 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -60.44 -46.49 94.25 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -62.26 -44.11 97.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.26 -1.141 . . . . 0.0 110.453 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.6 m -62.67 -22.82 66.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.003 -1.06 . . . . 0.0 109.775 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 143' ' ' LEU . 19.6 mt -74.32 -52.66 11.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 110.041 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.64 -27.32 66.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.602 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 27.0 mmt180 -77.17 -29.26 54.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.878 . . . . 0.0 109.492 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 150' ' ' TYR . . . -67.41 -49.64 62.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 22' ' ' PHE . 92.9 t -62.3 -41.55 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.694 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -63.38 -50.67 69.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.678 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -67.33 -16.78 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.676 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.46 ' CD2' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -83.53 -38.45 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.6 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 13' ' ' ILE . 8.7 mt -68.72 -55.29 11.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 110.285 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.63 -27.31 1.83 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.936 . . . . 0.0 109.994 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.25 22.28 8.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 110.018 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 151' ' ' LEU . 40.8 t-80 -94.01 -59.0 2.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.0 110.362 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.5 m -145.64 40.94 1.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.957 . . . . 0.0 110.266 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -138.68 -48.06 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.939 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.68 -63.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 110.124 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 60.72 35.93 19.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 110.105 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.284 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.33 138.81 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -1.125 . . . . 0.0 110.127 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.488 ' CD2' ' HB ' ' A' ' 128' ' ' VAL . 1.2 m-85 -91.4 164.27 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -143.95 143.56 31.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CD2' HG11 ' A' ' 133' ' ' VAL . 68.2 m-85 -155.49 65.83 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.587 -0.695 . . . . 0.0 109.291 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 1.8 pp20? -85.15 153.1 22.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 110.888 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.43 176.45 9.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.972 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 2.0 pt-20 -158.44 149.38 20.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.127 -0.983 . . . . 0.0 110.483 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 -170.04 2.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -125.95 168.37 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.442 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -158.81 138.26 11.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.553 -0.717 . . . . 0.0 109.595 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 13' ' ' ILE . 4.0 p -79.89 -14.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.559 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.836 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.0 OUTLIER -72.39 152.16 92.03 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.73 150.3 86.27 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 123.505 1.266 . . . . 0.0 111.132 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.25 -22.07 59.49 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.642 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.24 -57.31 3.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt-85 -60.38 -29.49 68.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.571 ' CD2' HD11 ' A' ' 114' ' ' LEU . 4.3 tp -74.28 -42.19 59.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 23' ' ' ILE . 42.4 t80 -59.52 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 110.166 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.0 ttpt -53.49 -45.29 69.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.556 ' O ' HD22 ' A' ' 29' ' ' LEU . . . -70.83 -28.6 64.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.868 . . . . 0.0 110.588 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 42.1 t80 -92.03 -17.55 24.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.915 . . . . 0.0 110.486 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.62 HD13 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -117.64 -63.55 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.497 ' HA ' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -48.14 -47.89 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 110.265 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.1 m-20 -107.15 -12.03 15.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 30' ' ' PHE . . . -41.8 -30.49 0.64 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.63 -59.49 4.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -1.179 . . . . 0.0 110.048 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -87.89 -17.26 31.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.689 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.1 tp -75.72 -45.39 36.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 110.131 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.528 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.6 m-85 -43.46 -57.72 5.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 110.457 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.2 Cg_endo -70.05 -8.91 24.77 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.914 1.481 . . . . 0.0 110.608 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 6.0 ttmm -95.57 -46.2 6.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 29' ' ' LEU . 28.0 m -91.91 -8.11 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.381 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.09 81.05 3.35 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.82 -6.32 18.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.975 1.513 . . . . 0.0 110.298 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.18 -18.43 27.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.269 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.813 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -97.39 -71.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 30' ' ' PHE . 1.1 mp -99.69 152.58 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.546 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.39 -33.15 5.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.537 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.07 146.79 6.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.089 -1.007 . . . . 0.0 110.596 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.995 HG13 ' CD1' ' A' ' 56' ' ' ILE . 47.5 t -133.5 139.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 84.6 tt0 -152.48 158.74 43.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.441 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -104.49 117.88 35.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 110.377 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.74 HD11 ' HB2' ' A' ' 55' ' ' LYS . 21.6 mm -83.16 -38.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.301 1.048 . . . . 0.0 108.335 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.563 ' HG3' ' N ' ' A' ' 46' ' ' GLY . 25.3 tp10 -148.25 173.55 12.9 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.099 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.563 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 63.41 169.62 1.35 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -116.25 37.34 3.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 110.09 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.06 37.52 9.95 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -111.42 -168.62 18.64 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.48 100.86 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.858 1.452 . . . . 0.0 110.243 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 111.39 1.32 27.91 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.643 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -61.12 155.81 19.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -1.117 . . . . 0.0 109.5 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 11.7 mm -112.94 133.14 59.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.943 . . . . 0.0 109.775 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.837 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -145.34 144.5 30.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.102 -0.999 . . . . 0.0 110.285 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.74 ' HB2' HD11 ' A' ' 44' ' ' ILE . 5.6 tttm -92.83 112.67 24.7 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.619 -0.676 . . . . 0.0 110.608 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.995 ' CD1' HG13 ' A' ' 41' ' ' VAL . 38.8 mm -103.85 138.77 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 109.347 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.45 141.67 47.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 110.757 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.459 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 1.9 m-85 -116.67 135.03 22.85 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.94 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo -75.4 135.4 18.32 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.93 1.49 . . . . 0.0 110.784 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 51.53 178.06 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 0.0 110.682 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 104.09 79.67 1.35 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.676 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 42.27 -164.43 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.367 -1.078 . . . . 0.0 109.686 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.676 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 45.4 Cg_endo -80.37 -32.38 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.228 1.12 . . . . 0.0 110.285 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 21.8 p90 -90.56 128.51 36.59 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.228 -0.92 . . . . 0.0 109.956 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 58' ' ' PHE . 1.5 pttp -161.6 -41.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 110.392 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.674 ' C ' HG12 ' A' ' 67' ' ' VAL . 6.7 p90 -80.73 -175.33 5.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 110.085 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.747 HG21 HG13 ' A' ' 85' ' ' VAL . 0.8 OUTLIER 168.81 171.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.367 -0.833 . . . . 0.0 110.586 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.572 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -106.03 54.36 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.642 -0.662 . . . . 0.0 109.938 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD1' HG13 ' A' ' 67' ' ' VAL . 5.2 m-20 -41.83 129.41 3.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.338 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -98.14 150.65 21.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 108.896 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.643 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -81.03 144.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.71 -1.243 . . . . 0.0 110.219 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 36.3 t0 -98.42 -71.0 0.7 Allowed 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.367 0.603 . . . . 0.0 110.004 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -143.84 113.01 6.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 0.0 110.047 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 4.9 t -104.17 136.21 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.267 -0.896 . . . . 0.0 109.932 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 74' ' ' VAL . 83.4 m-20 -141.07 113.03 7.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -82.51 -3.02 55.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -110.42 -36.68 5.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.201 -0.937 . . . . 0.0 109.653 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.39 15.24 20.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.598 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 m-30 45.86 51.97 10.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 110.34 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -129.21 124.54 34.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.973 -1.079 . . . . 0.0 110.751 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' CD2' HG12 ' A' ' 23' ' ' ILE . 2.2 t80 -139.44 101.6 4.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.421 -0.799 . . . . 0.0 109.861 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.516 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 74.0 m-20 -113.87 136.04 53.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.0 p90 -134.71 133.04 39.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.582 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' ARG . 68.3 m -99.41 170.58 8.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 111.433 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.747 HG13 HG21 ' A' ' 67' ' ' VAL . 48.9 t -106.71 131.27 56.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.39 -79.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.899 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 68' ' ' LYS . 1.1 tt0 -91.87 106.52 18.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.941 -1.099 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 67' ' ' VAL . . . 164.13 175.74 35.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . 47.27 -159.81 0.41 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.92 -7.76 21.7 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.135 1.597 . . . . 0.0 110.691 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' CD1' HG12 ' A' ' 85' ' ' VAL . 47.7 mt -51.55 154.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.35 -58.1 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -121.33 -69.2 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.252 . . . . 0.0 110.645 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 t -147.31 9.14 0.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 0.0 110.748 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -92.7 155.74 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 0.0 110.091 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.431 ' HB2' HD12 ' A' ' 95' ' ' LEU . 1.9 mt-10 57.84 36.33 26.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -78.82 159.35 27.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 110.408 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.498 HG13 ' CD1' ' A' ' 120' ' ' TYR . 2.3 mt -139.82 137.69 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.528 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 m -123.46 112.72 17.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.33 -0.856 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 13.7 m120 -99.39 130.03 45.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.516 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 2.6 mt-10 -123.76 139.74 53.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.852 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.604 HG23 HG12 ' A' ' 116' ' ' ILE . 16.9 mt -135.59 114.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.369 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -114.53 124.22 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.862 . . . . 0.0 109.878 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.3 mp -111.92 134.79 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.416 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -140.58 137.94 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 0.0 110.417 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.67 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.0 146.62 25.41 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.78 -0.575 . . . . 0.0 110.968 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.593 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.5 p -84.92 -164.9 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.352 -0.843 . . . . 0.0 108.957 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 46.1 Cg_endo -80.05 70.12 7.65 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.267 1.14 . . . . 0.0 110.247 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 0.7 OUTLIER 67.66 33.85 4.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.19 38.64 1.68 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 107' ' ' THR . . . 91.67 -161.91 27.49 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.817 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -137.34 166.38 23.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.477 -1.013 . . . . 0.0 111.13 -179.087 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.5 mt -118.86 126.0 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 109.103 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -97.12 146.08 25.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 0.0 110.863 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 13.4 mttt -141.58 109.97 5.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.525 -0.734 . . . . 0.0 109.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.604 HG12 HG23 ' A' ' 102' ' ' ILE . 19.0 mt -105.92 135.45 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.6 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.509 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -116.7 115.78 26.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.129 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -103.88 126.1 50.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.392 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -115.5 130.14 56.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.316 -0.865 . . . . 0.0 109.959 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.498 ' CD1' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -116.72 117.21 29.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.453 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.424 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 25.3 m-70 -94.26 130.64 40.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.629 HG23 HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -114.96 169.24 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 110.088 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' ASP . 0.7 OUTLIER -101.39 63.99 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 48.45 -91.32 0.01 OUTLIER Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -40.34 -55.55 2.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -1.104 . . . . 0.0 110.576 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.471 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 76.3 m80 -66.29 176.8 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 0.0 110.435 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.514 ' HA ' HG21 ' A' ' 122' ' ' THR . 72.1 mt-10 -154.44 -171.93 4.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 110.17 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.629 HG23 HG23 ' A' ' 122' ' ' THR . 2.3 t -121.14 116.11 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 133' ' ' VAL . 11.0 mttt -80.16 132.4 35.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.731 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.96 -48.41 52.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 110.913 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.9 mt-10 -36.98 -55.97 0.9 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 110.907 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.48 77.05 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.618 HG11 ' CD2' ' A' ' 5' ' ' TYR . 7.2 t -74.68 -48.3 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 109.315 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 130' ' ' ALA . 14.2 tptt -67.42 -30.22 69.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.531 -0.73 . . . . 0.0 109.824 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.54 60.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -35.1 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -79.74 -23.93 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.23 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -53.86 -52.81 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 4.6 mt -75.15 -28.75 60.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.468 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.666 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -55.49 -46.57 80.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.639 ' HA ' HD23 ' A' ' 144' ' ' LEU . 33.5 tt0 -56.34 -52.53 64.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -1.205 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.3 m -57.61 -28.86 64.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.201 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 37' ' ' ALA . 84.7 mt -69.48 -46.08 67.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 110.358 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.1 pp -68.77 -26.13 65.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.779 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -81.93 -41.0 21.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -56.1 -50.37 71.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.37 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.4 -48.84 86.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.475 -0.765 . . . . 0.0 108.954 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 36.5 tt0 -53.03 -46.83 68.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.8 t -67.43 -51.27 53.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.423 ' CE1' HG12 ' A' ' 33' ' ' VAL . 1.8 t80 -44.9 -69.38 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.809 . . . . 0.0 110.392 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 151' ' ' LEU . 29.9 mt -49.17 -37.1 21.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.503 -0.748 . . . . 0.0 110.629 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.2 mt -77.1 -18.84 57.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.048 -1.033 . . . . 0.0 110.373 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.56 -12.35 17.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.935 . . . . 0.0 110.071 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -119.69 102.54 8.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 110.205 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 40.8 t -115.07 3.54 14.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.246 -0.909 . . . . 0.0 110.563 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.06 -70.42 0.15 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.487 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.39 -162.33 1.31 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.602 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -85.04 8.42 17.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -0.842 . . . . 0.0 110.312 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.998 HG23 ' C ' ' A' ' 120' ' ' TYR . 9.3 p -176.44 154.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -1.16 . . . . 0.0 110.466 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.89 -178.93 3.86 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -140.67 138.39 34.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.861 -1.149 . . . . 0.0 111.018 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.526 ' CD1' HG11 ' A' ' 133' ' ' VAL . 65.0 m-85 -144.44 54.83 1.27 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 9.0 pt-20 -80.1 152.55 29.24 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.543 0.687 . . . . 0.0 110.962 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.74 172.72 13.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -157.84 153.54 26.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.03 -169.14 3.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 110.12 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -132.14 167.64 19.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.349 -0.845 . . . . 0.0 110.391 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.899 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 17.3 t -79.92 -17.25 12.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.712 HG21 HD13 ' A' ' 151' ' ' LEU . 17.8 mm -70.42 149.31 95.71 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.6 Cg_endo -65.72 146.75 84.68 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.143 1.075 . . . . 0.0 111.053 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.836 ' HB2' ' CB ' ' A' ' 112' ' ' SER . . . -71.86 -30.13 65.11 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.45 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.54 -56.85 10.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.937 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -35.15 79.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -69.78 -38.31 76.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.485 -0.76 . . . . 0.0 109.418 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 41.9 t80 -62.2 -59.1 5.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.895 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -49.76 -48.42 50.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 110.314 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.84 76.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.6 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.2 t80 -88.43 -14.01 39.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.614 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' PHE . 1.3 mp -114.62 -48.9 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.95 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -72.12 -48.56 42.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 110.036 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.973 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -115.99 20.81 14.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.993 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.02 -58.18 14.97 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.663 ' OD1' HG11 ' A' ' 41' ' ' VAL . 21.8 m-20 -56.71 -19.08 14.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -1.174 . . . . 0.0 110.213 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.82 -37.03 10.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.9 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.034 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.9 mp -79.97 -20.84 44.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 0.0 110.163 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.52 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 1.1 m-85 -58.37 -57.03 29.33 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.552 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 48.7 Cg_endo -73.0 -13.62 26.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.054 1.555 . . . . 0.0 110.945 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.17 -43.38 11.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.989 . . . . 0.0 110.58 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.034 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.8 m -89.68 -24.76 5.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 110.315 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.36 78.84 7.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.48 -31.31 7.26 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.093 1.575 . . . . 0.0 110.63 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -56.37 -18.65 11.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.062 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.779 ' HA ' HD23 ' A' ' 139' ' ' LEU . . . -96.83 -48.0 5.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.221 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -123.29 146.49 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 109.923 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.423 ' C ' ' OG ' ' A' ' 40' ' ' SER . 1.6 t -92.56 -53.05 4.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -162.32 172.51 15.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 0.0 110.634 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.964 HG13 HG12 ' A' ' 56' ' ' ILE . 12.6 t -145.83 138.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.311 -0.868 . . . . 0.0 109.886 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mt-10 -137.62 163.89 30.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.723 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.7 116.56 32.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.724 HD11 ' HB2' ' A' ' 55' ' ' LYS . 23.9 mm -83.63 -37.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.345 1.069 . . . . 0.0 108.372 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 6.1 tp10 -149.61 173.24 13.86 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.059 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 61.86 173.55 1.54 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.37 33.71 5.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 110.257 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' H ' HG21 ' A' ' 52' ' ' THR . . . 99.0 -7.01 60.33 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.94 -172.5 26.34 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 45.4 Cg_endo -71.72 118.35 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.939 1.494 . . . . 0.0 110.249 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.75 54.68 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.703 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.4 m -68.41 154.46 41.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -1.183 . . . . 0.0 109.348 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 9.3 mt -116.96 133.39 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.011 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 1.4 ptpt -143.28 147.54 34.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.661 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.724 ' HB2' HD11 ' A' ' 44' ' ' ILE . 12.7 tttp -105.35 118.27 36.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.688 -0.633 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.964 HG12 HG13 ' A' ' 41' ' ' VAL . 23.0 mt -107.26 147.83 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.082 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -107.25 139.49 41.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.127 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 14.7 m-85 -112.58 125.63 29.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 60' ' ' GLU . 50.1 Cg_endo -77.87 125.32 7.3 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.852 1.448 . . . . 0.0 110.557 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 1.7 tt0 171.25 -157.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.135 -0.978 . . . . 0.0 110.292 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -129.9 -8.09 3.52 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.773 -1.204 . . . . 0.0 110.351 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -44.94 171.79 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.033 -1.275 . . . . 0.0 110.551 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 39.5 Cg_endo -65.11 -48.12 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.386 1.203 . . . . 0.0 110.016 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.583 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 19.6 p90 -86.84 140.33 29.79 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.333 -0.855 . . . . 0.0 109.258 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -106.75 -75.67 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.996 -1.065 . . . . 0.0 110.993 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -91.7 -171.45 2.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.147 -0.971 . . . . 0.0 110.956 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -170.57 172.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 0.0 109.801 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.571 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.25 151.51 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.161 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 84' ' ' SER . 6.8 p-10 -148.41 135.39 20.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 110.357 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 84' ' ' SER . 14.6 ttp-105 -99.02 141.22 32.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.394 -0.816 . . . . 0.0 108.849 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.703 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.4 t -72.56 147.14 10.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.847 -1.158 . . . . 0.0 110.199 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 82' ' ' ASN . 4.7 m-20 -93.04 -70.09 0.72 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.404 0.621 . . . . 0.0 109.98 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.5 tt0 -149.91 131.28 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.74 146.68 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 35.2 m-20 -145.63 119.98 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -88.9 0.19 56.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -116.67 -35.96 4.05 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.75 8.74 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.46 -0.775 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.56 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.5 m-30 53.62 69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 5.4 tttt -136.79 133.1 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.377 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.437 ' HB2' HG12 ' A' ' 23' ' ' ILE . 9.7 t80 -149.86 94.58 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.883 . . . . 0.0 110.071 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.51 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 33.2 m-20 -116.78 145.2 43.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.568 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 36.3 p90 -146.76 137.38 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.494 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 62.2 m -98.78 170.83 8.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 111.232 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 41.5 t -108.35 127.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.96 -70.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 111.272 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -85.05 95.6 9.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.594 -1.316 . . . . 0.0 110.052 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -116.93 139.82 15.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.53 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.11 -57.12 2.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.2 Cg_endo -71.91 -38.34 4.17 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.922 1.485 . . . . 0.0 110.308 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' N ' ' A' ' 92' ' ' GLY . 46.5 mt -68.16 170.53 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.573 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -162.66 -77.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.92 -90.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -1.196 . . . . 0.0 110.297 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.1 t -146.94 18.39 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.2 164.76 12.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 110.105 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.92 34.43 22.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 121' ' ' HIS . 1.1 ttmt -76.42 150.95 36.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.233 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.651 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 56.2 mt -128.39 132.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 t -119.17 102.41 8.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.579 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.568 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 3.4 m120 -87.08 135.51 33.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 52.1 mt-10 -131.45 134.6 46.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 110.095 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.542 HG22 HD11 ' A' ' 104' ' ' ILE . 12.7 mt -128.33 126.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.031 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.684 HG22 ' HB1' ' A' ' 15' ' ' ALA . 4.5 mp -134.45 141.09 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.752 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.5 t -141.9 144.16 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 109.546 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.06 162.7 16.64 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.395 -0.815 . . . . 0.0 111.09 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.5 p -108.86 -166.91 0.1 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.501 -0.749 . . . . 0.0 109.245 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 47.1 Cg_endo -80.45 70.02 7.7 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.413 1.217 . . . . 0.0 110.311 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 23.0 t0 67.32 40.87 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.39 -0.819 . . . . 0.0 110.186 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.92 40.77 1.11 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 107' ' ' THR . . . 86.54 -159.11 31.7 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.836 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -142.44 159.98 41.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.708 -0.878 . . . . 0.0 110.627 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.7 tt -109.19 142.0 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.945 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.72 150.49 41.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 110.181 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.15 124.29 18.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 2.4 mt -111.19 117.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -102.05 111.8 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.33 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -105.05 123.49 47.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.121 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -116.56 151.54 35.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.354 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.998 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -131.6 99.72 4.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.834 . . . . 0.0 110.193 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.781 ' N ' HG23 ' A' ' 2' ' ' VAL . 85.5 m-70 -79.8 113.69 18.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.37 172.47 6.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.979 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -145.5 -177.03 5.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.604 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 43.25 -153.14 0.27 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.22 9.12 21.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -1.116 . . . . 0.0 110.245 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -76.68 167.74 21.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 110.131 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.461 ' HA ' HG21 ' A' ' 122' ' ' THR . 4.1 mt-10 -152.95 -168.97 3.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -0.96 . . . . 0.0 110.429 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.762 HG21 ' CG ' ' A' ' 120' ' ' TYR . 2.8 t -116.08 101.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -54.75 125.19 19.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.027 -1.045 . . . . 0.0 109.501 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -53.16 -48.06 68.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 110.396 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.1 mt-10 -35.63 -55.22 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.58 -0.7 . . . . 0.0 110.661 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -42.35 92.85 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 108.998 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 5' ' ' TYR . 14.1 t -68.03 -48.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.248 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -59.86 -31.46 69.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.529 -0.732 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.89 -47.72 61.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -24.08 67.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.173 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.44 -36.09 45.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.88 . . . . 0.0 110.184 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -44.67 83.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.12 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.779 HD23 ' HA ' ' A' ' 37' ' ' ALA . 3.1 mp -73.47 -31.54 63.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 110.019 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.822 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -65.72 -41.1 96.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.601 ' HA ' HD23 ' A' ' 144' ' ' LEU . 5.4 mm-40 -56.67 -37.05 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -1.203 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.8 m -70.15 -18.86 63.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.822 HD12 ' HA2' ' A' ' 140' ' ' GLY . 98.0 mt -77.13 -44.82 28.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 0.0 109.896 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.601 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -66.93 -29.94 69.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 17.2 ttp180 -77.64 -36.4 51.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.765 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.12 67.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.785 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.0 t -60.23 -47.26 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.444 -0.785 . . . . 0.0 109.781 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 35.8 tt0 -51.64 -48.91 63.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 -43.67 85.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.948 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -52.03 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.159 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.712 HD13 HG21 ' A' ' 13' ' ' ILE . 35.5 mt -42.62 -51.82 5.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -48.72 -25.21 1.69 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.074 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . -105.87 1.74 27.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.33 -55.36 3.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.153 -0.967 . . . . 0.0 110.132 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.4 m -130.28 11.72 5.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 110.061 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.64 26.69 9.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -172.4 -83.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.908 . . . . 0.0 110.177 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.4 t80 52.28 84.98 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.169 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.23 -179.933 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 3.3 t 58.11 151.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -1.08 . . . . 0.0 110.333 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.413 ' CD1' ' CG1' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -106.54 161.93 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.949 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.79 139.21 50.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.942 . . . . 0.0 110.156 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.84 56.21 1.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.025 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -82.83 153.7 25.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.38 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.4 p -156.14 169.06 25.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.814 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 15.2 pt-20 -158.8 138.37 11.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 110.619 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 t -133.15 -172.6 2.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.316 -0.865 . . . . 0.0 109.928 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -117.97 159.52 23.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.7 t -152.67 136.75 16.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.689 -0.632 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 27.2 m -79.96 -12.17 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.017 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.668 HG23 ' HD2' ' A' ' 14' ' ' PRO . 41.2 mm -69.86 148.4 96.39 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.668 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.0 Cg_endo -65.58 151.23 85.37 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.503 1.265 . . . . 0.0 111.007 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.68 -29.16 61.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.035 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.6 -48.46 16.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.287 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.526 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -68.14 -37.54 81.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.994 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' HB2' HG22 ' A' ' 13' ' ' ILE . 25.7 tp -74.79 -26.24 59.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.185 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' CE1' HG13 ' A' ' 23' ' ' ILE . 75.2 t80 -69.69 -59.69 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 110.046 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -57.18 -39.95 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.387 -0.821 . . . . 0.0 110.128 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -72.54 -31.99 65.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.846 . . . . 0.0 110.546 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.444 ' CD1' HG21 ' A' ' 147' ' ' VAL . 33.8 t80 -91.9 -18.25 24.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.558 HG13 ' CE1' ' A' ' 19' ' ' PHE . 9.3 mm -104.06 -67.33 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.49 -27.54 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' OD1' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -109.38 -5.06 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.356 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.42 -56.54 24.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.98 -23.84 1.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 110.556 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -100.37 -39.79 7.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 110.305 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 1.9 tp -71.18 -38.01 72.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.0 m-30 -48.21 -61.02 3.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 110.55 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.0 Cg_endo -71.65 -2.09 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.972 1.512 . . . . 0.0 110.715 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -104.28 -36.11 7.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 110.469 -179.756 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.754 HG22 ' HB1' ' A' ' 146' ' ' ALA . 7.2 p -96.67 -26.08 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.959 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.24 78.61 8.58 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.78 2.75 6.16 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.117 1.588 . . . . 0.0 110.964 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.05 -38.36 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 110.481 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.55 -49.4 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.229 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.43 146.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.987 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.519 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -100.95 -32.3 10.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.212 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.5 168.11 2.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.601 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 56' ' ' ILE . 4.7 t -138.51 141.27 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.598 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -144.62 110.94 5.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.067 -1.021 . . . . 0.0 110.757 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.6 116.89 5.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.214 -0.929 . . . . 0.0 110.419 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.722 HD12 HG22 ' A' ' 53' ' ' ILE . 12.3 mt -84.97 -39.64 14.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 122.172 0.987 . . . . 0.0 108.556 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 52' ' ' THR . 22.3 tt0 -145.43 174.3 11.26 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 48.16 -172.32 0.05 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -124.64 -13.57 6.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -1.144 . . . . 0.0 110.22 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 74' ' ' VAL . . . 156.86 -23.02 0.47 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' GLY . . . -52.06 -174.77 0.03 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.3 Cg_endo -72.83 118.04 5.39 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.026 1.54 . . . . 0.0 110.381 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 -1.65 40.88 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.694 ' HB ' HG21 ' A' ' 71' ' ' VAL . 7.0 m -67.35 154.64 40.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.252 . . . . 0.0 109.226 179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.722 HG22 HD12 ' A' ' 44' ' ' ILE . 9.9 mt -121.97 135.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 110.512 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -142.38 138.71 31.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.99 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -92.43 101.08 13.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.574 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.507 HG12 HG13 ' A' ' 41' ' ' VAL . 22.3 mt -88.97 129.09 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.542 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.1 m -93.24 141.22 28.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.473 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 1.2 m-85 -112.18 131.27 22.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.863 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 39' ' ' SER . 47.3 Cg_endo -73.01 127.41 12.11 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.874 1.46 . . . . 0.0 110.663 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER 177.28 -160.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.198 179.832 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -125.46 -30.92 0.87 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.519 ' O ' ' CD ' ' A' ' 65' ' ' LYS . 3.7 m-85 -47.16 170.98 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.203 -1.174 . . . . 0.0 110.002 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 44.1 Cg_endo -72.34 -59.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.948 1.499 . . . . 0.0 110.494 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -90.37 130.53 36.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.342 -0.849 . . . . 0.0 110.157 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' CD ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -149.07 -48.93 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.148 -0.97 . . . . 0.0 110.51 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 32.8 p90 -70.71 -178.65 1.91 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 0.0 110.207 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.574 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -170.35 172.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.191 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.587 ' O ' HD11 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -121.25 62.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.477 -0.765 . . . . 0.0 110.468 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -52.97 133.08 38.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.906 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -97.81 142.86 29.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.937 . . . . 0.0 108.716 179.491 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.694 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.5 t -69.73 149.56 10.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.645 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.3 t70 -101.29 -74.42 0.62 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.434 0.635 . . . . 0.0 110.044 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.2 tt0 -135.39 136.13 41.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.109 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 48' ' ' GLY . 2.8 t -120.78 147.32 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -152.57 101.32 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -75.14 -9.42 58.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.736 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -102.78 -34.09 9.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 108.638 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.75 11.26 39.15 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.342 0.591 . . . . 0.0 109.752 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 23.4 m-30 44.36 43.85 6.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 110.191 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 5.7 tttm -118.09 114.21 22.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.267 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 8.3 t80 -131.48 109.36 10.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 40.1 m-20 -112.4 145.97 39.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 110.031 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 3.6 p90 -137.74 138.26 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.811 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' ARG . 7.0 m -98.82 159.58 14.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.177 -0.952 . . . . 0.0 110.858 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 98' ' ' ILE . 24.7 t -104.19 122.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.587 HD11 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -121.92 -76.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.085 -1.009 . . . . 0.0 110.953 -178.561 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 16.0 mm-40 -70.49 57.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.753 -1.217 . . . . 0.0 109.996 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -69.54 126.8 19.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.51 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.83 -54.1 3.62 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.2 Cg_endo -75.99 -40.99 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.875 1.46 . . . . 0.0 110.594 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.567 HD12 ' HA3' ' A' ' 88' ' ' GLY . 36.0 mt -50.98 138.37 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.076 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.55 -94.55 1.83 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.82 -80.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 110.171 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.03 19.79 2.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 110.065 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.411 ' CB ' ' HB2' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -94.67 165.51 12.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.227 -0.92 . . . . 0.0 110.245 -179.888 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 3.2 tp10 56.35 33.17 21.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 8.8 tttm -67.84 167.34 13.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.564 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.1 mt -143.93 127.86 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.42 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.48 ' HB3' ' CB ' ' A' ' 119' ' ' LYS . 12.9 t -115.1 112.31 22.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.599 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -105.85 152.39 23.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.873 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.513 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 30.9 mt-10 -145.24 129.27 17.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.785 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.823 ' CD1' HG23 ' A' ' 116' ' ' ILE . 19.5 mm -122.26 128.95 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.03 -1.044 . . . . 0.0 110.384 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 4.9 tttt -129.63 117.24 20.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 110.038 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.701 HG23 ' CD2' ' A' ' 114' ' ' LEU . 64.4 mt -110.66 109.2 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 110.72 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 112' ' ' SER . 42.1 t -115.47 151.03 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.748 0.785 . . . . 0.0 109.595 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.05 168.38 12.87 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.642 -0.662 . . . . 0.0 110.867 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.703 HG22 ' CD1' ' A' ' 113' ' ' ILE . 7.7 p -124.21 167.81 14.56 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 45.5 Cg_endo -71.11 -6.0 18.25 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.784 1.412 . . . . 0.0 110.258 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.48 -17.84 25.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.381 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 121.25 -27.93 6.21 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -90.63 -169.73 43.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -134.49 162.85 31.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 110.743 -179.496 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.703 ' CD1' HG22 ' A' ' 107' ' ' THR . 5.2 mt -110.37 117.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.396 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.701 ' CD2' HG23 ' A' ' 104' ' ' ILE . 21.6 mt -87.76 129.18 35.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.913 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 104.76 9.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.823 HG23 ' CD1' ' A' ' 102' ' ' ILE . 4.1 mp -105.04 122.27 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.094 -1.004 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -105.95 120.95 43.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.473 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -114.93 139.02 50.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.236 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER -132.55 142.2 49.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.564 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -121.21 133.07 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.044 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.55 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 59.9 m-70 -111.57 129.41 56.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.23 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.978 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.95 173.47 6.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.425 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HB2' ' CB ' ' A' ' 95' ' ' LEU . 3.4 tttt -136.47 -172.29 3.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.331 -0.856 . . . . 0.0 110.203 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 43.9 -134.95 5.78 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.92 -0.82 12.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -1.126 . . . . 0.0 110.303 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 0.4 OUTLIER -78.6 -166.8 0.93 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.99 179.885 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.978 ' HA ' HG21 ' A' ' 122' ' ' THR . 38.6 mt-10 -153.43 179.47 8.76 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 109.299 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.554 HG21 ' CD2' ' A' ' 120' ' ' TYR . 1.8 p -79.97 137.38 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.572 -0.705 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 126.71 31.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.973 ' HA ' HG12 ' A' ' 133' ' ' VAL . . . -65.92 -57.24 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.931 -1.106 . . . . 0.0 111.249 -178.5 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -40.95 -26.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.889 -1.132 . . . . 0.0 110.143 -179.273 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -84.68 -42.88 14.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.175 -0.953 . . . . 0.0 109.164 178.509 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.973 HG12 ' HA ' ' A' ' 130' ' ' ALA . 8.0 p -78.98 -33.77 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.339 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -70.56 -23.6 62.63 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.242 -0.911 . . . . 0.0 109.277 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -73.29 -20.9 60.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.829 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.7 t -71.94 -29.87 64.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 110.19 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -78.04 -47.15 19.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -45.95 -61.17 1.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -14.49 61.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -64.18 -54.41 30.25 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.562 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.4 tt0 -47.72 -36.95 12.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 100.0 m -66.8 -25.36 66.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.717 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.6 mt -74.75 -52.24 12.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.632 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.3 pp -66.79 -29.3 69.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.942 . . . . 0.0 109.657 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.429 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 11.0 tpt180 -78.0 -28.88 49.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -0.877 . . . . 0.0 109.511 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.754 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -68.83 -36.7 78.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.823 . . . . 0.0 109.732 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.444 HG21 ' CD1' ' A' ' 22' ' ' PHE . 40.2 t -73.09 -48.51 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.389 -0.82 . . . . 0.0 109.715 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 13' ' ' ILE . 5.6 tt0 -53.4 -49.67 66.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 152' ' ' LEU . 0.9 OUTLIER -60.45 -45.39 93.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.684 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.534 ' CE2' ' CE1' ' A' ' 154' ' ' HIS . 1.3 t80 -48.31 -72.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 110.035 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.19 -36.12 5.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 149' ' ' SER . 16.1 tp -62.74 -55.71 24.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -81.44 1.72 31.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.534 ' CE1' ' CE2' ' A' ' 150' ' ' TYR . 3.8 m-70 -104.45 98.62 8.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.47 80.57 1.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 110.062 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -72.23 -22.79 61.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 110.166 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.97 -173.58 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 110.305 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.542 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 75.9 t80 -99.4 5.67 46.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.375 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.291 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.562 HG22 ' HA ' ' A' ' 121' ' ' HIS . 2.7 t -79.59 152.96 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -1.125 . . . . 0.0 110.329 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -97.0 163.8 12.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.724 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -133.78 144.95 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 110.678 -179.662 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CG ' HG11 ' A' ' 133' ' ' VAL . 48.4 m-85 -154.85 56.44 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -0.771 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 2.2 pp20? -86.91 137.09 32.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 110.837 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -140.11 -175.66 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.674 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.28 152.16 25.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.056 -1.027 . . . . 0.0 110.589 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 10' ' ' THR . 1.5 m -135.35 -179.17 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 0.0 109.81 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 9' ' ' THR . 1.5 p -127.3 161.25 29.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.66 141.89 17.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.518 -0.739 . . . . 0.0 109.636 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.83 -12.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.32 -0.952 . . . . 0.0 108.559 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.811 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.3 mp -71.07 152.01 94.82 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.534 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.13 152.02 82.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.475 1.25 . . . . 0.0 110.886 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.798 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -76.86 -27.59 55.12 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.904 -178.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.22 -50.23 16.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.046 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -63.49 -43.15 98.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.785 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.73 -33.84 76.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.379 -0.825 . . . . 0.0 109.948 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.61 ' CD1' HD13 ' A' ' 23' ' ' ILE . 37.2 t80 -61.57 -64.89 0.8 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 12.0 mttt -48.13 -47.25 34.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.482 -0.761 . . . . 0.0 110.39 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.47 78.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.317 -0.864 . . . . 0.0 111.012 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -90.08 -10.1 45.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 110.65 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.61 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -115.02 -60.19 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 109.932 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 15.1 mt -68.29 -48.97 63.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.111 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.71 20.7 18.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.033 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.42 -60.9 5.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.01 -24.66 10.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 0.0 110.218 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -84.67 -46.57 11.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.522 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.807 HD23 HG11 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -73.88 -28.22 61.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.478 -179.739 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.526 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m-30 -49.38 -57.47 11.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.456 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 45.6 Cg_endo -72.02 -7.61 21.36 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.987 1.52 . . . . 0.0 110.728 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -101.58 -54.43 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.344 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.807 HG11 HD23 ' A' ' 29' ' ' LEU . 5.5 m -80.31 -13.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 110.528 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.69 71.84 12.64 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 0.0 110.08 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.51 0.37 9.19 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.047 1.551 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.94 -20.08 19.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -102.18 -38.9 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.82 136.8 53.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.65 -47.17 6.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.84 140.06 3.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.29 125.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 11.8 mt-10 -115.0 89.27 3.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 110.728 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 10.9 t-20 -54.17 116.76 2.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.449 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.3 mm -87.75 -38.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.271 1.034 . . . . 0.0 108.574 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 24.4 tt0 -151.66 174.05 13.95 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.449 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 63.79 159.92 0.3 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -106.19 29.62 6.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.399 -1.059 . . . . 0.0 110.192 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 96.16 -0.46 62.13 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.3 -161.96 22.78 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.0 Cg_endo -73.54 120.52 6.52 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.981 1.516 . . . . 0.0 110.551 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.02 1.3 61.41 Favored Glycine 0 N--CA 1.48 1.606 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.672 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.2 m -67.21 152.93 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -1.191 . . . . 0.0 109.435 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' ILE . 8.6 mt -124.56 131.38 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.48 -179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -143.89 134.76 25.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 179.471 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 2.2 ttpt -82.17 98.65 8.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.7 mt -85.95 132.55 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.696 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.5 OUTLIER -109.43 145.67 35.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 110.795 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 5.9 m-85 -109.46 140.72 22.37 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 109.987 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.28 133.31 19.14 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.542 . . . . 0.0 110.756 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.35 158.16 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 110.449 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 114.71 81.27 0.97 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.666 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 41.92 -166.04 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 121.385 -1.067 . . . . 0.0 109.885 179.436 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.666 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 46.9 Cg_endo -83.21 -44.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.393 1.207 . . . . 0.0 110.069 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -89.72 136.22 33.16 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.891 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.548 ' CG ' ' HB2' ' A' ' 58' ' ' PHE . 4.2 tptp -171.14 -40.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.182 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.741 ' O ' HG13 ' A' ' 67' ' ' VAL . 3.4 p90 -54.22 177.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 66' ' ' TYR . 4.3 m -160.54 164.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 110.503 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -109.63 40.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 109.848 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 7.7 t70 -38.76 130.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.486 -0.759 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ttp-105 -103.96 151.42 23.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.077 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.672 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.6 t -78.44 147.71 6.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 10.3 m-20 -97.4 -72.38 0.65 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.452 0.644 . . . . 0.0 110.431 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.9 tt0 -138.52 136.62 36.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.578 -0.701 . . . . 0.0 110.129 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.8 t -125.07 125.35 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.919 . . . . 0.0 109.995 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -123.85 127.89 48.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 109.885 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 5.4 t-80 -86.27 -20.02 29.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 0.0 111.075 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -106.19 -37.81 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.995 -1.066 . . . . 0.0 109.897 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -85.81 13.42 7.34 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.475 -0.766 . . . . 0.0 110.198 179.999 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 42.31 61.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.918 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -128.21 118.15 22.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 110.921 -179.329 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 52.7 t80 -133.83 98.03 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 32.3 m-20 -112.76 142.84 44.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 110.289 -179.468 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 10.9 p90 -142.2 138.43 31.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.342 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 35.6 m -104.45 165.12 11.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.082 -1.011 . . . . 0.0 111.062 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 69' ' ' ASP . 47.2 t -108.42 127.36 64.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.63 -74.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 111.388 -178.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 2.3 mt-10 -82.8 97.87 8.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.828 -1.17 . . . . 0.0 110.227 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.575 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . -128.48 155.5 20.5 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.538 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -45.38 -56.68 6.13 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -70.59 -41.44 3.22 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.866 1.456 . . . . 0.0 110.84 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 92' ' ' GLY . 77.4 mt -77.46 165.32 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.196 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -148.18 -52.56 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.31 -83.08 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.373 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.9 t -143.06 11.15 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.22 151.04 22.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.262 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.525 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 7.7 tt0 55.83 35.07 24.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.764 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 6.2 tttt -75.44 158.3 32.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.39 -0.819 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.2 mt -135.71 131.1 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -0.99 . . . . 0.0 110.662 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 m -116.18 109.95 18.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 0.0 109.527 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.601 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 3.0 m120 -99.56 138.41 36.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -128.94 131.62 47.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.822 179.593 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.657 ' CD1' HG23 ' A' ' 116' ' ' ILE . 40.3 mm -122.15 119.15 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 32.9 mttt -122.11 109.26 14.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.744 HG23 HD23 ' A' ' 114' ' ' LEU . 1.9 mp -94.92 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.2 132.31 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.309 -0.87 . . . . 0.0 110.248 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.06 145.39 25.99 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.418 0.627 . . . . 0.0 110.969 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.583 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 2.6 p -80.1 -163.5 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 45.9 Cg_endo -78.45 -23.53 8.51 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.106 1.056 . . . . 0.0 111.024 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 0.4 OUTLIER 174.42 33.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.016 -1.052 . . . . 0.0 110.156 179.98 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.62 35.41 2.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 107' ' ' THR . . . 94.97 -153.86 20.99 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.798 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -137.26 169.05 18.43 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.666 -0.902 . . . . 0.0 110.444 -179.414 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 10' ' ' THR . 23.0 mt -123.63 133.96 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 179.401 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.744 HD23 HG23 ' A' ' 104' ' ' ILE . 25.5 mt -97.9 142.37 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.81 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -127.86 97.16 4.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.316 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.657 HG23 ' CD1' ' A' ' 102' ' ' ILE . 3.0 mt -94.34 115.98 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.732 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.539 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 38.4 t -104.58 108.3 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -101.36 149.52 23.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.226 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 141.04 38.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.013 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.594 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -117.72 122.16 42.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.814 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.562 ' HA ' HG22 ' A' ' 2' ' ' VAL . 25.2 m-70 -105.23 110.14 22.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.99 167.95 14.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.523 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -102.31 152.75 20.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.115 179.842 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.04 -40.12 3.18 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.73 -66.98 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -1.16 . . . . 0.0 110.176 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.49 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 10.9 m170 -69.24 169.95 11.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.49 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 0.2 OUTLIER -159.98 137.9 9.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 109.581 179.857 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.5 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.3 p -108.27 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.396 -0.815 . . . . 0.0 111.062 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.1 142.1 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.953 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.472 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -52.59 -26.86 14.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.093 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.5 mm-40 -42.39 -58.33 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.716 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -59.85 -34.08 72.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 108.978 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.565 HG11 ' CG ' ' A' ' 5' ' ' TYR . 15.7 t -67.11 -49.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.447 -0.783 . . . . 0.0 109.259 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.5 ' HE2' ' NZ ' ' A' ' 137' ' ' LYS . 2.3 mmtt -50.74 -35.36 31.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -23.85 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.6 t -70.9 -37.47 72.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.117 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.5 ' NZ ' ' HE2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -75.77 -31.2 59.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 109.91 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.62 -47.25 80.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 37' ' ' ALA . 3.2 mm? -76.88 -45.06 29.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.855 . . . . 0.0 110.311 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.55 -47.24 52.22 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.607 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -56.67 -30.46 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -1.204 . . . . 0.0 110.425 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.4 m -70.73 -28.81 65.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.091 . . . . 0.0 109.653 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.4 mt -71.81 -48.69 44.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 109.867 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 144' ' ' LEU . 1.1 pp -63.55 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.421 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -75.05 -35.19 61.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.661 179.502 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -68.59 -29.22 67.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.56 -47.01 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.875 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -59.37 -46.8 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -62.26 -43.45 98.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 110.148 179.813 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -54.43 -71.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 110.389 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 13' ' ' ILE . 34.0 mt -39.65 -49.91 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.468 -0.77 . . . . 0.0 110.592 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.65 -61.63 2.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.274 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -55.51 -37.58 68.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.78 92.03 3.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.0 109.942 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -96.52 -21.64 17.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 110.645 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -106.1 20.16 19.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.99 . . . . 0.0 110.458 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.31 -170.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.168 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 0.1 OUTLIER -168.04 72.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 110.059 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 35.6 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t -109.22 154.87 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.355 -1.085 . . . . 0.0 110.091 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 0.7 OUTLIER -99.36 171.12 8.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 109.26 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.05 141.28 16.44 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.969 -1.082 . . . . 0.0 110.825 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.85 ' CD2' HG11 ' A' ' 133' ' ' VAL . 8.3 m-85 -159.38 59.17 0.4 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.538 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.483 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 11.2 pt-20 -81.85 152.67 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.428 -0.795 . . . . 0.0 110.662 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.71 -175.92 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 109.91 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.69 157.73 30.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.081 -1.012 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.497 HG21 HD22 ' A' ' 144' ' ' LEU . 1.1 t -146.51 -179.1 6.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.102 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -116.81 160.82 20.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.254 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.07 137.03 11.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.85 -12.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.673 HG23 ' HD2' ' A' ' 14' ' ' PRO . 35.3 mm -68.6 148.49 98.08 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.673 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.51 150.43 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.38 1.2 . . . . 0.0 110.752 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.746 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.95 -25.62 59.01 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.29 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.39 -52.3 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 110.356 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 8.4 ttt-85 -63.45 -38.38 90.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.868 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.899 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.0 tm? -68.89 -34.35 75.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.967 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 45.9 t80 -64.11 -68.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.485 ' HG2' ' CB ' ' A' ' 24' ' ' LEU . 8.7 tttt -45.84 -51.26 13.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.002 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.0 -38.77 79.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 110.054 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 15.1 t80 -84.72 -13.07 52.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.75 HD12 ' CD2' ' A' ' 81' ' ' TYR . 9.9 mm -118.9 -76.55 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.258 -0.901 . . . . 0.0 110.056 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' CB ' ' HG2' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -46.47 -56.3 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.033 179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.816 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -93.92 1.05 56.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 27' ' ' ASP . . . -46.91 -53.22 10.6 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 26' ' ' GLY . 3.3 p-10 -42.88 -29.94 0.36 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -1.134 . . . . 0.0 110.033 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 19.3 t30 -113.54 -11.36 13.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.003 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -83.63 -18.48 38.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.742 ' CD2' HD13 ' A' ' 38' ' ' ILE . 2.2 m-30 -75.43 -59.51 1.26 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.362 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.8 Cg_endo -71.19 -3.57 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.905 1.476 . . . . 0.0 110.492 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -91.97 -66.26 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.204 179.967 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 29' ' ' LEU . 6.2 m -85.93 -11.13 11.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.426 -0.797 . . . . 0.0 110.312 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -143.05 61.39 10.35 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.932 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.23 -5.93 18.02 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.091 1.574 . . . . 0.0 110.584 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.72 -25.58 38.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.42 -55.99 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 110.311 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -100.57 137.97 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.906 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.479 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -103.24 -33.33 9.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.1 OUTLIER -160.1 149.24 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.0 110.796 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.528 HG12 ' HE2' ' A' ' 54' ' ' LYS . 6.3 t -128.08 136.2 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 0.0 109.337 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 29.0 mt-10 -139.86 153.11 46.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.039 -1.038 . . . . 0.0 111.151 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.5 113.12 26.5 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.806 0.812 . . . . 0.0 109.636 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.2 mm -82.97 -39.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 122.185 0.993 . . . . 0.0 108.989 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' THR . 7.9 tp10 -153.58 173.04 16.28 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 110.464 -179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 71.81 171.0 14.14 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -109.74 35.71 3.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.377 -1.072 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.555 ' H ' HG21 ' A' ' 52' ' ' THR . . . 83.25 6.57 87.79 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.85 -159.44 35.03 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.0 Cg_endo -72.61 131.05 16.76 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.12 1.59 . . . . 0.0 110.476 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 -9.46 76.97 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 45' ' ' GLU . 22.2 m -60.85 153.62 24.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.068 -1.254 . . . . 0.0 109.496 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 45' ' ' GLU . 6.8 mt -116.25 125.62 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HE2' HG12 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -135.47 146.67 48.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 110.265 -179.955 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.735 ' HB2' HD11 ' A' ' 44' ' ' ILE . 30.5 ttpt -97.61 132.98 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.33 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.48 144.18 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' HB2' ' OG ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -114.56 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.124 -0.985 . . . . 0.0 110.221 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -121.18 133.4 24.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 48.7 Cg_endo -75.31 144.09 28.87 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.99 1.521 . . . . 0.0 110.487 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 50.01 -166.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.108 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 88.79 78.91 1.3 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 43.11 -167.94 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.375 -1.073 . . . . 0.0 109.873 179.368 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.64 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 45.6 Cg_endo -75.62 -41.13 0.61 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.264 1.139 . . . . 0.0 110.278 -179.346 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.1 m-85 -89.53 129.16 36.05 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 109.634 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' HE3' ' O ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -152.04 -46.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 110.13 -179.812 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -65.38 140.64 58.67 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 110.029 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.574 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.2 m -144.11 172.36 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.334 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.32 139.2 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.876 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 84' ' ' SER . 5.0 p-10 -133.2 133.47 42.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.0 ttm180 -96.26 146.42 24.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.701 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.4 t -73.94 145.12 11.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.836 -1.165 . . . . 0.0 110.404 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -94.07 -70.61 0.7 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.466 0.65 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.8 mt-10 -148.91 124.3 10.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 0.0 109.801 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 3.3 t -112.85 149.28 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.19 -0.944 . . . . 0.0 110.445 -179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 3.8 t0 -149.09 97.74 2.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -64.4 -7.92 11.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.895 -179.348 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -108.28 -46.22 3.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.016 -1.052 . . . . 0.0 109.765 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.36 13.54 4.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.735 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.7 m-30 47.42 50.87 14.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.059 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 6.3 tttt -123.77 117.28 24.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.993 -1.067 . . . . 0.0 110.779 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.75 ' CD2' HD12 ' A' ' 23' ' ' ILE . 17.3 t80 -134.44 103.75 5.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.344 -0.848 . . . . 0.0 109.779 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 31.2 m-20 -118.14 144.42 45.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.222 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 26.5 p90 -144.63 136.24 25.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' ARG . 74.5 m -96.77 171.09 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 111.209 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.515 HG11 HD13 ' A' ' 98' ' ' ILE . 41.6 t -108.95 125.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.75 -70.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.021 -1.049 . . . . 0.0 111.648 -178.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.16 98.82 11.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.543 -1.348 . . . . 0.0 110.375 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.574 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -116.55 151.71 18.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.519 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.98 -57.69 4.65 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.8 Cg_endo -74.0 -47.68 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.976 1.514 . . . . 0.0 110.953 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.28 157.75 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.004 . . . . 0.0 110.085 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.97 -71.54 0.19 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -111.38 -58.39 2.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -1.221 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.6 t -152.21 15.65 0.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.962 . . . . 0.0 110.538 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 123' ' ' LYS . 16.9 mt -91.28 147.86 22.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HG3' HG22 ' A' ' 122' ' ' THR . 4.9 mt-10 59.3 31.5 21.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 121' ' ' HIS . 4.6 mttt -70.55 151.36 45.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.5 mp -127.54 134.37 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.647 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.29 106.21 13.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.34 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -95.12 150.14 20.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.73 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 3.2 mp0 -143.18 142.06 31.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.772 . . . . 0.0 109.706 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 101' ' ' GLU . 61.6 mt -138.6 119.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 110.567 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 56.6 tttt -118.15 121.87 41.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.58 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 44.8 mt -108.84 118.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.368 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -122.9 152.6 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.402 -0.811 . . . . 0.0 109.774 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.98 166.35 14.55 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.633 -0.667 . . . . 0.0 111.121 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.765 HG23 ' HA ' ' A' ' 112' ' ' SER . 16.5 p -116.53 167.18 10.99 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.369 -0.832 . . . . 0.0 109.73 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 45.0 Cg_endo -71.59 -2.08 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.641 1.337 . . . . 0.0 110.612 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.37 -10.27 19.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.317 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.03 -35.64 3.85 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -77.22 -166.99 27.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.765 ' HA ' HG23 ' A' ' 107' ' ' THR . 0.2 OUTLIER -141.17 163.65 32.38 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -1.069 . . . . 0.0 110.596 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.502 HG13 HG22 ' A' ' 107' ' ' THR . 78.9 mt -112.31 124.41 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.782 . . . . 0.0 109.166 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 130.64 42.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.982 . . . . 0.0 110.827 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -121.23 114.87 22.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.544 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -105.62 128.33 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -111.55 110.36 20.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 110.03 179.761 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.74 135.89 45.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.171 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.37 137.35 45.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 110.212 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.613 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -112.33 144.73 41.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.872 . . . . 0.0 110.036 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 97' ' ' LYS . 31.8 m-70 -127.15 106.36 9.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 110.233 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -121.63 166.59 14.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -86.93 153.12 21.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.977 . . . . 0.0 110.61 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -47.75 -25.36 3.44 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.17 -50.83 6.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -1.196 . . . . 0.0 110.125 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -78.69 176.66 9.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.147 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -160.08 160.38 33.02 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.4 p -113.92 93.48 2.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.811 -0.555 . . . . 0.0 110.627 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.98 146.66 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.043 . . . . 0.0 109.799 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.467 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -62.48 -12.71 23.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -48.14 -69.94 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.973 -1.079 . . . . 0.0 109.861 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 136' ' ' SER . 0.8 OUTLIER -54.8 -27.49 42.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.516 179.598 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.85 HG11 ' CD2' ' A' ' 5' ' ' TYR . 16.1 t -71.07 -47.28 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 134' ' ' LYS . 22.8 ttpt -67.76 -31.8 71.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.089 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 139' ' ' LEU . . . -73.7 -39.04 64.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.786 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -67.23 -27.36 67.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -73.07 -42.15 63.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.91 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -63.8 -44.36 93.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -71.3 -33.16 69.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -55.36 -55.5 28.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.1 tm-20 -54.86 -44.96 74.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -1.154 . . . . 0.0 109.923 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 m -57.4 -32.77 67.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.831 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.678 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.9 mt -69.93 -53.4 18.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.022 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 144' ' ' LEU . 4.6 pp -72.03 -22.33 61.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.159 -0.963 . . . . 0.0 109.474 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.711 ' N ' HD12 ' A' ' 144' ' ' LEU . 30.8 ttt180 -83.14 -31.42 27.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 109.739 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.04 70.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 143' ' ' LEU . 25.2 t -69.81 -44.3 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.473 -0.767 . . . . 0.0 109.738 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.475 ' HA ' HG13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -62.51 -47.98 81.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.618 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.425 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -68.97 -16.48 63.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 110.074 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.07 -34.19 26.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 13' ' ' ILE . 10.8 mt -73.87 -56.19 5.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 110.171 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.47 -30.39 12.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.39 -8.72 55.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 0.0 110.437 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -105.22 92.07 4.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.124 -0.985 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.9 p -138.24 29.66 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.284 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -109.34 -31.33 7.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.9 . . . . 0.0 109.932 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 47.64 -163.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.376 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -78.43 -17.6 56.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.282 -0.886 . . . . 0.0 110.286 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.292 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.869 HG11 ' ND1' ' A' ' 121' ' ' HIS . 5.1 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.748 0.785 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -108.89 158.45 17.66 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.736 -0.602 . . . . 0.0 109.717 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.68 140.09 51.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.024 -1.048 . . . . 0.0 110.894 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 9.8 m-85 -146.52 61.99 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 7' ' ' THR . 12.9 pt-20 -87.59 157.48 19.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 111.129 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.4 p -156.64 174.93 14.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 0.0 109.944 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . 9.9 pt-20 -159.71 150.38 19.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 110.231 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 m -145.29 168.15 21.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.295 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.76 HG22 HG12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -106.91 164.29 12.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.218 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -157.68 144.46 18.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.426 -0.796 . . . . 0.0 109.855 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.491 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 15.1 t -79.8 -7.63 10.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.839 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.826 HG21 HD13 ' A' ' 151' ' ' LEU . 30.2 mm -78.85 146.87 69.44 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.656 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.93 145.94 81.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.659 1.347 . . . . 0.0 111.331 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.802 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -66.86 -28.41 68.32 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.54 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.95 2.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.943 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.478 ' NH1' ' HG3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -58.53 -37.04 74.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.728 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.6 tt -68.44 -39.44 81.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.007 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CE2' HG21 ' A' ' 23' ' ' ILE . 80.8 t80 -60.84 -65.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 109.983 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -43.04 -49.26 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.24 96.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.873 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -88.95 -9.17 52.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.232 -0.917 . . . . 0.0 110.811 -179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 24' ' ' LEU . 1.2 mp -118.16 -69.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.988 -1.07 . . . . 0.0 110.191 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.586 ' N ' HG22 ' A' ' 23' ' ' ILE . 6.0 mt -60.69 -43.42 97.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.57 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.596 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -115.36 13.42 16.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.349 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.88 -59.66 10.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.62 ' HB3' HG11 ' A' ' 41' ' ' VAL . 85.3 m-20 -52.21 -29.07 20.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -1.161 . . . . 0.0 110.304 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -86.29 -28.93 23.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.424 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.805 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -87.68 -21.73 25.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.312 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.764 ' HE1' HD13 ' A' ' 143' ' ' LEU . 0.5 OUTLIER -54.02 -57.55 17.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.533 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -73.34 -0.07 8.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.95 1.5 . . . . 0.0 110.832 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -103.44 -59.12 1.76 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.436 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 29' ' ' LEU . 33.6 m -90.7 12.91 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.356 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -159.77 75.87 3.0 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.297 -0.877 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.36 -7.97 21.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.008 1.53 . . . . 0.0 110.716 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -100.79 0.05 38.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 110.262 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.477 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -107.28 -69.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.167 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.406 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.1 mt -119.14 135.13 60.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.868 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 -49.94 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.316 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.467 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -157.09 171.33 20.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 110.304 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.792 HG13 ' CD1' ' A' ' 56' ' ' ILE . 40.6 t -129.81 140.52 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' CB ' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -133.28 84.27 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.406 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -50.4 117.74 2.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 0.0 110.283 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.615 HD12 HG22 ' A' ' 53' ' ' ILE . 12.5 mt -88.58 -37.83 10.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.271 1.034 . . . . 0.0 108.666 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.468 ' O ' HG23 ' A' ' 52' ' ' THR . 48.2 tt0 . . . . . 0 C--N 1.294 -1.813 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.335 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.591 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.9 Cg_endo -73.09 129.43 14.13 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.028 1.541 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.62 -3.92 81.79 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.74 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -63.68 154.66 32.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -1.215 . . . . 0.0 109.255 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 44' ' ' ILE . 8.7 mm -124.81 127.69 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -139.7 136.91 34.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.299 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HB3' ' CB ' ' A' ' 42' ' ' GLU . 22.1 tttt -80.5 98.41 7.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 110.297 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.792 ' CD1' HG13 ' A' ' 41' ' ' VAL . 43.6 mm -86.7 134.81 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -103.76 145.94 29.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.199 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -118.33 131.55 24.17 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.213 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 44.9 Cg_endo . . . . . 0 C--N 1.306 -1.668 0 O-C-N 123.953 1.501 . . . . 0.0 110.574 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' C ' HG12 ' A' ' 67' ' ' VAL . 20.3 p90 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.26 0.552 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -178.45 171.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.278 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -90.14 -61.76 1.61 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.513 -0.742 . . . . 0.0 109.598 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 68' ' ' LYS . 7.6 t70 59.2 124.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.481 ' NE ' HD11 ' A' ' 53' ' ' ILE . 1.8 ttt180 -110.78 147.85 33.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.5 t -67.02 152.03 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 7.7 t70 -99.95 -71.4 0.7 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.311 0.577 . . . . 0.0 110.459 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -145.85 104.19 3.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.439 -0.788 . . . . 0.0 109.985 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 81' ' ' TYR . 18.6 t -92.78 149.88 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.265 -0.897 . . . . 0.0 110.324 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -148.42 101.62 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 109.927 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 m-70 -76.23 1.18 16.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.584 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -116.5 -44.61 2.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.058 -1.026 . . . . 0.0 110.041 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.13 15.06 9.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.435 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.552 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 20.0 m-30 51.49 54.43 11.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.911 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -126.62 126.55 43.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.561 ' CG ' HG13 ' A' ' 23' ' ' ILE . 28.1 t80 -143.34 97.94 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.499 ' ND2' ' OE2' ' A' ' 101' ' ' GLU . 9.4 m-20 -114.37 146.48 40.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 23.6 p90 -142.22 139.96 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.864 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 50.5 m -106.04 164.91 11.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.095 -1.003 . . . . 0.0 110.928 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 91' ' ' ILE . 24.4 t -103.06 130.2 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.499 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -126.96 -68.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.287 -178.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 1.4 tt0 -91.93 78.83 5.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.621 -1.3 . . . . 0.0 110.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -94.8 153.03 20.75 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.529 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.46 -57.99 4.83 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -72.44 -41.56 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.545 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 86' ' ' ILE . 48.8 mt -61.62 134.3 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.23 -39.34 0.75 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -120.8 -84.14 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -1.091 . . . . 0.0 110.008 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 t -150.83 14.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.59 HD22 ' CB ' ' A' ' 123' ' ' LYS . 18.5 mt -88.81 156.92 18.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -0.969 . . . . 0.0 110.077 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-10 54.56 34.28 20.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.12 -0.987 . . . . 0.0 109.48 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -77.02 170.3 16.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 -179.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.64 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 4.6 mp -143.11 125.15 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.478 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 11.2 t -117.35 109.86 17.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.57 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 3.1 t-20 -98.92 169.94 9.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 117' ' ' SER . 18.6 mt-10 -152.38 130.11 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.777 -0.577 . . . . 0.0 109.565 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.452 HD12 ' HD2' ' A' ' 81' ' ' TYR . 27.5 mt -121.14 132.41 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 110.459 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HD2' ' HD2' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -139.61 122.54 16.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.802 HG22 ' HB1' ' A' ' 15' ' ' ALA . 3.3 mp -108.92 144.23 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.363 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -145.67 117.94 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.751 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -71.47 146.23 48.73 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.347 0.594 . . . . 0.0 110.554 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 112' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.024 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.675 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 7.6 t -141.78 -175.89 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.998 . . . . 0.0 110.525 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.76 HG12 HG22 ' A' ' 10' ' ' THR . 19.9 mt -134.99 128.19 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 109.599 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 114' ' ' LEU . 3.8 pp -108.81 139.39 43.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 8' ' ' GLU . 10.2 mttt -123.79 113.92 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.507 HG23 HD21 ' A' ' 100' ' ' ASN . 72.3 mt -107.77 115.13 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.797 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.53 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -103.4 135.92 44.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -126.71 144.25 50.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.144 -0.973 . . . . 0.0 110.815 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -126.55 150.9 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 109.884 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -131.57 105.65 7.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.869 ' ND1' HG11 ' A' ' 2' ' ' VAL . 24.1 m-70 -86.0 125.29 33.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 110.605 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.3 167.86 12.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.59 ' CB ' HD22 ' A' ' 95' ' ' LEU . 19.1 tptt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.33 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.364 0.602 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.1 t -121.8 99.5 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.434 -0.791 . . . . 0.0 109.89 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -64.46 125.81 25.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -42.57 -34.79 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.8 mp0 -39.83 -70.36 0.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.306 -0.871 . . . . 0.0 110.872 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -27.83 38.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.568 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.565 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 21.4 t -74.91 -49.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.2 -30.86 70.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.515 -0.741 . . . . 0.0 109.792 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.81 -30.42 61.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.623 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.0 t -73.39 -37.69 65.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.412 -0.805 . . . . 0.0 109.682 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -68.89 -38.31 79.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.6 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -68.0 -40.26 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 1.1 tp -72.83 -40.42 65.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.827 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.43 97.77 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.689 ' HA ' HD23 ' A' ' 144' ' ' LEU . 1.5 mm-40 -65.95 -34.72 78.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -1.133 . . . . 0.0 109.917 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 75.2 m -67.98 -29.96 69.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.927 . . . . 0.0 109.723 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.764 HD13 ' HE1' ' A' ' 30' ' ' PHE . 71.9 mt -70.25 -46.54 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -67.3 -30.84 70.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.745 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.5 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 4.5 ttt180 -79.5 -32.93 42.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 0.0 109.938 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 33' ' ' VAL . . . -63.41 -42.67 98.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.85 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.27 -47.49 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 110.007 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -56.98 -43.3 81.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.5 t -60.72 -49.82 75.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.647 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.3 t80 -52.35 -70.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.838 . . . . 0.0 110.473 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.826 HD13 HG21 ' A' ' 13' ' ' ILE . 1.2 mt -40.6 -35.43 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 110.684 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -25.09 50.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.007 . . . . 0.0 110.498 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 110.461 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.494 0.664 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.2 m-85 -100.91 137.5 39.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.384 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.24 146.8 44.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 110.91 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -152.29 56.63 0.82 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.472 0.654 . . . . 0.0 109.298 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 4.9 pt-20 -80.19 153.2 28.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 110.368 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -149.7 -175.6 5.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.882 . . . . 0.0 110.099 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -159.45 162.52 35.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.7 -176.24 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.07 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.469 HG22 HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -133.67 159.61 40.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.482 ' HB3' ' CG ' ' A' ' 148' ' ' GLU . 3.7 m -160.03 145.51 15.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 109.991 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.483 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 11.9 t -79.93 -7.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.41 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.661 HG23 ' HD2' ' A' ' 14' ' ' PRO . 41.7 mm -77.1 148.2 77.94 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.661 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.46 150.47 84.22 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 123.589 1.31 . . . . 0.0 111.063 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.804 ' HB3' ' HB2' ' A' ' 106' ' ' ALA . . . -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.438 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.15 -49.95 8.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.92 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 8.0 tpt180 -67.15 -34.33 77.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.712 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 5.8 tt -76.92 -35.41 57.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.655 ' CD1' HD13 ' A' ' 23' ' ' ILE . 75.2 t80 -61.12 -57.76 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.867 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 27.3 mttp -58.2 -41.21 83.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.828 . . . . 0.0 109.96 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.68 -32.91 70.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.67 ' CD1' HG21 ' A' ' 147' ' ' VAL . 7.9 t80 -87.98 -15.82 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.883 . . . . 0.0 110.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.655 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -120.15 -58.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.092 -1.005 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.529 HD11 ' CE1' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -63.05 -37.25 86.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.344 -0.848 . . . . 0.0 110.687 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -110.11 -0.81 17.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -46.0 -48.51 14.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -56.46 -17.21 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.307 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -113.1 -19.77 11.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.297 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.8 tp -93.99 -33.76 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.736 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.567 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -63.25 -58.21 17.0 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.701 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -76.7 46.11 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.825 1.434 . . . . 0.0 111.347 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.32 -54.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.921 -1.112 . . . . 0.0 110.397 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.565 ' CG2' ' HB1' ' A' ' 146' ' ' ALA . 9.9 p -84.85 -26.0 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.48 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.62 75.61 79.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.385 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.59 -3.98 14.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.389 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -91.21 -12.72 34.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.24 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.51 -72.65 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.908 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.444 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.3 mp -105.78 154.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.439 -0.788 . . . . 0.0 109.5 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 8.1 t -100.85 -56.44 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 110.415 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 36.5 m -153.55 175.34 13.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 110.489 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 56' ' ' ILE . 25.8 t -138.53 143.5 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.889 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.82 99.82 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.152 -0.967 . . . . 0.0 110.658 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.484 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 90.5 m-20 -58.36 117.33 4.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 54' ' ' LYS . 22.8 mm -85.87 -38.07 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.366 1.079 . . . . 0.0 108.301 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 53' ' ' ILE . 61.5 tt0 . . . . . 0 C--N 1.295 -1.772 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.084 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.68 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.31 124.05 7.55 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.018 1.536 . . . . 0.0 110.437 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.74 -3.0 70.57 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.68 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.2 m -61.43 152.13 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -1.164 . . . . 0.0 109.787 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 10.4 mt -112.75 136.48 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 110.327 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 54' ' ' LYS . 2.7 ptmt -153.13 139.18 18.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.229 -0.92 . . . . 0.0 110.305 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HG3' ' CD1' ' A' ' 66' ' ' TYR . 15.6 ttpp -91.67 109.28 20.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.499 HD12 ' OD1' ' A' ' 69' ' ' ASP . 96.7 mt -98.6 120.89 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.928 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 39' ' ' SER . 54.3 m -77.3 133.78 38.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.857 . . . . 0.0 110.46 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.29 140.05 22.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.025 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.72 -179.841 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' HG3' ' A' ' 55' ' ' LYS . 5.0 p90 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.869 0.843 . . . . 0.0 112.065 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.568 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -148.54 175.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -123.48 50.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.795 -1.191 . . . . 0.0 111.124 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' A' ' 56' ' ' ILE . 11.8 p-10 -61.78 131.03 48.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.943 . . . . 0.0 109.99 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -96.61 -179.22 4.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.625 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.0 t -90.27 151.39 3.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 120.916 -1.115 . . . . 0.0 109.891 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -100.44 -73.23 0.65 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.524 0.678 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -137.44 132.59 33.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.126 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.6 t -119.14 146.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 0.0 110.117 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.553 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -150.09 110.9 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.907 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -76.64 -12.84 60.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -109.94 -39.78 4.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.028 -1.045 . . . . 0.0 109.836 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -88.2 15.93 6.89 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.302 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 19.6 m-85 42.23 57.21 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.2 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.553 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.73 115.68 21.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.982 . . . . 0.0 110.679 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' A' ' 23' ' ' ILE . 13.1 t80 -135.82 102.17 4.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 32.7 m-20 -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.099 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.631 ' CE2' ' CB ' ' A' ' 100' ' ' ASN . 2.8 p90 -137.93 145.16 41.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.6 m -105.38 155.43 19.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.277 -0.889 . . . . 0.0 111.451 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 38.2 t -100.07 122.13 51.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -120.98 -66.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 111.531 -178.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -80.5 52.66 1.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.674 -1.266 . . . . 0.0 109.917 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.665 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -63.65 125.64 33.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.501 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -38.58 -58.46 1.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -72.88 -26.6 15.39 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.866 1.456 . . . . 0.0 110.555 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.665 HD12 ' HA3' ' A' ' 88' ' ' GLY . 17.9 mt -69.75 161.69 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.75 -51.95 0.08 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.456 ' C ' ' HG ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -87.6 50.66 2.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.091 -1.241 . . . . 0.0 110.593 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 49.23 24.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.528 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.576 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -118.56 175.43 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.948 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.615 ' O ' HD11 ' A' ' 91' ' ' ILE . 4.0 mt-10 54.89 32.6 18.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -80.02 159.39 26.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.409 -0.807 . . . . 0.0 110.069 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 120' ' ' TYR . 17.1 mt -143.03 137.09 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.687 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.48 94.45 4.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.76 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.631 ' CB ' ' CE2' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -84.31 141.31 31.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 2.5 mt-10 -128.28 146.37 50.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 110.168 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.4 mt -137.15 125.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 0.0 110.236 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.533 ' HE3' ' CG2' ' A' ' 105' ' ' VAL . 11.9 tttt -124.89 157.43 35.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 10.5 mt -148.09 119.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 110.495 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.533 ' CG2' ' HE3' ' A' ' 103' ' ' LYS . 83.6 t -118.52 129.63 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.414 -0.804 . . . . 0.0 109.987 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -80.59 154.18 27.59 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.414 0.626 . . . . 0.0 110.767 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.505 HG23 ' HA ' ' A' ' 112' ' ' SER . 6.8 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.868 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.632 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 3.8 t -147.45 -174.86 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -1.031 . . . . 0.0 110.593 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 68.4 mt -138.63 136.58 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.8 . . . . 0.0 109.383 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 114' ' ' LEU . 6.5 mp -105.19 136.29 44.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.08 104.23 8.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.438 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 116' ' ' ILE . 5.4 mp -99.56 139.55 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.83 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -126.54 105.82 9.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.42 -0.8 . . . . 0.0 110.081 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -98.43 142.49 29.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.219 -0.925 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.0 OUTLIER -135.97 127.57 28.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -111.8 123.41 50.18 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.151 -0.968 . . . . 0.0 110.014 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -104.51 116.39 32.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.853 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.14 169.36 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 109.777 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 110.243 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.115 0.483 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 128' ' ' VAL . 4.6 t -113.93 96.3 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.649 ' O ' HG23 ' A' ' 133' ' ' VAL . 14.4 mttm -64.3 127.24 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.966 . . . . 0.0 109.385 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.73 -46.3 63.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.983 . . . . 0.0 110.458 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' ALA . 6.9 tp10 -41.27 -47.68 3.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.012 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -70.3 -31.55 68.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 108.818 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 129' ' ' LYS . 14.5 t -74.05 -47.97 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 109.31 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 7.0 tmtt? -66.48 -30.78 71.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.197 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.14 -27.92 62.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -72.78 -40.6 65.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 110.365 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 134' ' ' LYS . 13.6 ptmt -77.24 -22.07 52.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 0.0 110.254 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.64 -57.46 11.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.335 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 142' ' ' THR . 38.6 mt -70.88 -42.05 70.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.219 -0.926 . . . . 0.0 110.429 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 139' ' ' LEU . . . -41.53 -44.63 4.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.3 tt0 -57.75 -36.28 71.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -1.2 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 139' ' ' LEU . 92.8 m -67.97 -22.0 65.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.477 HD13 ' CZ ' ' A' ' 30' ' ' PHE . 64.4 mt -76.39 -49.99 15.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.921 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.38 -23.81 65.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -83.25 -38.17 22.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.964 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.565 ' HB1' ' CG2' ' A' ' 33' ' ' VAL . . . -60.77 -39.97 90.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -0.915 . . . . 0.0 109.514 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 22' ' ' PHE . 40.2 t -71.36 -52.77 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.482 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.412 -0.805 . . . . 0.0 109.571 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -50.95 69.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.54 -70.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.295 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.661 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.066 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -61.83 -43.81 98.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.447 0.642 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.9 m-85 -97.13 154.29 17.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.673 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -127.26 149.34 50.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.911 -1.118 . . . . 0.0 111.038 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 40.9 m-85 -158.29 61.31 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.668 -0.645 . . . . 0.0 109.438 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 19.5 pt-20 -85.62 148.63 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 110.948 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.48 173.87 13.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 0.0 109.63 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.2 pm0 -147.61 169.98 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 0.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 152.12 29.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.746 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.53 161.57 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 110.552 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.465 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 9.4 t -159.85 138.16 10.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.639 -0.663 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 t -80.04 -14.25 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.866 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 44.3 mm -72.01 148.02 91.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.4 Cg_endo -66.85 150.07 83.22 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.432 1.228 . . . . 0.0 111.112 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.916 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -76.05 -29.42 58.02 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.405 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.81 -54.55 13.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.898 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 5.5 ttm180 -66.7 -35.69 80.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.437 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 114' ' ' LEU . 11.3 tp -75.25 -32.9 61.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 0.0 109.984 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.664 ' CD1' HD13 ' A' ' 23' ' ' ILE . 55.3 t80 -64.2 -68.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -52.75 -38.62 61.18 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.514 -0.741 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 -37.37 69.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 47.7 t80 -82.64 -20.79 35.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.664 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -110.84 -69.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.834 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.511 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -49.24 -41.42 37.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 110.1 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.565 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -108.6 0.65 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.187 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.93 -52.69 29.61 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -47.86 -29.36 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 20.8 t-20 -101.42 -29.64 11.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 0.0 110.269 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.035 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -80.56 -21.09 42.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.7 m-85 -66.1 -60.77 6.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.388 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -72.4 -0.11 8.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.989 1.521 . . . . 0.0 110.784 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 13.7 ttpt -101.78 -48.74 4.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.035 -1.04 . . . . 0.0 110.562 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.035 HG22 ' O ' ' A' ' 29' ' ' LEU . 17.0 m -91.44 7.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 110.6 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 75.39 3.34 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.143 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.33 -9.65 24.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.082 1.569 . . . . 0.0 110.69 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -92.81 -8.08 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 110.232 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -102.5 -72.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.016 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.48 131.33 57.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.443 -0.786 . . . . 0.0 109.758 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.5 OUTLIER -80.07 -34.9 37.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 110.208 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 39' ' ' SER . 2.0 p -178.09 157.77 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.44 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 60.5 t -117.49 152.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 109.982 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.9 tm-20 -139.05 89.68 2.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 15.9 t-20 -56.52 115.84 2.76 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.914 0.864 . . . . 0.0 110.532 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.726 HD12 HG22 ' A' ' 53' ' ' ILE . 6.0 mt -87.55 -39.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.902 0.858 . . . . 0.0 109.081 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 52' ' ' THR . 14.1 mt-10 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.833 0.825 . . . . 0.0 111.689 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.3 Cg_endo -72.65 128.7 13.7 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.009 1.531 . . . . 0.0 110.529 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.21 -7.17 62.04 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.663 ' HB ' HG21 ' A' ' 71' ' ' VAL . 2.3 m -69.76 144.42 52.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -1.164 . . . . 0.0 109.886 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.726 HG22 HD12 ' A' ' 44' ' ' ILE . 7.5 mt -114.55 141.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.936 -1.103 . . . . 0.0 109.264 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -153.38 134.43 14.01 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 110.069 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -86.49 116.78 24.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 111.041 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.467 HD11 ' HE2' ' A' ' 54' ' ' LYS . 56.0 mt -104.69 123.73 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.402 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 35.2 m -93.07 141.4 28.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 110.594 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -110.16 154.41 42.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.922 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.512 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 44.5 Cg_endo . . . . . 0 C--N 1.304 -1.813 0 O-C-N 124.0 1.526 . . . . 0.0 110.381 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.843 ' O ' HG13 ' A' ' 67' ' ' VAL . 6.4 p90 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.972 0.892 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 66' ' ' TYR . 1.9 m -166.84 167.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.553 ' HD2' ' CB ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -99.3 -64.75 1.01 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.613 -1.304 . . . . 0.0 110.017 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.528 ' OD1' HG13 ' A' ' 85' ' ' VAL . 9.2 m-20 59.08 129.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.888 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -112.56 149.56 32.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 108.908 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG21 ' HB ' ' A' ' 52' ' ' THR . 11.6 t -65.12 153.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.864 -1.147 . . . . 0.0 110.268 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.5 t70 -104.69 -75.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.407 0.622 . . . . 0.0 110.038 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -137.13 128.45 28.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.838 HG22 ' CD2' ' A' ' 81' ' ' TYR . 4.1 t -119.19 142.89 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -144.37 114.8 7.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.507 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -81.08 -10.58 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -108.93 -39.11 5.41 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.071 -1.018 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.64 9.27 27.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.518 -0.739 . . . . 0.0 109.997 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 48.32 51.41 15.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.185 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.92 117.54 24.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.269 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.838 ' CD2' HG22 ' A' ' 74' ' ' VAL . 45.9 t80 -137.83 106.16 5.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.773 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 35.2 m-20 -119.61 152.35 37.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.229 -0.919 . . . . 0.0 110.331 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 11.5 p90 -142.79 136.46 28.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' ARG . 50.4 m -95.6 168.13 10.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.117 -0.989 . . . . 0.0 111.132 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.528 HG13 ' OD1' ' A' ' 69' ' ' ASP . 53.8 t -107.98 123.94 63.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -74.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.815 -1.178 . . . . 0.0 111.451 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 2.8 mm-40 -91.87 71.65 5.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.195 . . . . 0.0 110.131 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.8 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . -151.24 161.54 29.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 52.55 -157.95 3.76 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.85 -0.86 10.96 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.032 1.543 . . . . 0.0 111.197 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CD1' HG12 ' A' ' 85' ' ' VAL . 50.0 mt -51.13 156.35 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.48 -58.0 0.2 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.2 p-10 -146.23 -49.09 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -1.162 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 t -145.08 12.45 1.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.81 144.94 28.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.492 ' HA ' HG23 ' A' ' 122' ' ' THR . 2.7 tt0 55.99 33.4 21.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 109.859 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -70.48 150.43 46.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.639 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mt -132.62 134.43 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.364 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -118.78 107.64 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.043 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.496 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 18.4 m-80 -92.73 127.93 38.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.305 -0.872 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 82' ' ' ASN . 4.1 mt-10 -121.22 143.9 48.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 116' ' ' ILE . 58.0 mt -137.63 129.59 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.469 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 ttpt -124.82 142.46 51.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.653 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.916 HG22 ' HB1' ' A' ' 15' ' ' ALA . 84.1 mt -130.65 103.98 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.471 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 113' ' ' ILE . 73.4 t -108.7 146.2 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.06 159.69 18.14 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.728 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 112' ' ' SER . 22.0 p . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 110.274 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -135.75 -176.52 4.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -1.089 . . . . 0.0 110.513 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 105' ' ' VAL . 33.6 mt -136.5 117.55 18.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.552 HD11 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -88.63 124.31 33.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 110.626 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 7.0 ttmt -116.14 100.02 7.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.78 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 102' ' ' ILE . 28.7 mt -96.48 139.57 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.395 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -122.16 109.3 14.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.2 t-20 -98.17 131.34 44.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.993 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 138.09 49.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.639 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.51 141.41 43.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 49.2 m-70 -123.37 95.99 4.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.492 HG23 ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -118.06 172.15 7.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 tttp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 110.14 -179.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.109 0.48 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.581 HG21 ' CG ' ' A' ' 120' ' ' TYR . 4.4 t -116.68 99.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.165 -0.959 . . . . 0.0 110.449 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.741 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -68.06 146.74 53.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.993 . . . . 0.0 109.498 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . . . -66.59 -9.66 37.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.971 -1.081 . . . . 0.0 110.808 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.505 ' HB2' ' CD ' ' A' ' 129' ' ' LYS . 12.9 mt-10 -68.0 -54.58 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.994 -1.066 . . . . 0.0 109.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.14 -23.7 63.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.89 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 129' ' ' LYS . 17.5 t -80.85 -46.59 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 130' ' ' ALA . 27.8 tttt -64.27 -26.02 68.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.955 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.41 74.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.885 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -75.91 -40.41 54.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -47.5 -69.43 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.7 -22.74 63.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.169 -0.957 . . . . 0.0 109.902 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.17 -32.86 51.11 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.503 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 34.8 mt-10 -72.46 -61.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -1.095 . . . . 0.0 110.082 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 146' ' ' ALA . 3.0 m -45.62 -33.37 2.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.904 -1.123 . . . . 0.0 109.708 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.54 -59.38 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.856 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.8 pp -65.9 -24.64 66.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -81.96 -29.23 32.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.47 -38.44 77.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.675 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.47 -44.91 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -56.29 -46.08 79.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.573 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.4 OUTLIER -64.24 -49.76 70.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.733 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -47.71 -71.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 110.038 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -46.22 -37.21 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.379 -0.825 . . . . 0.0 110.298 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 149' ' ' SER . 5.3 mt -59.33 -23.66 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 110.507 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.403 0.62 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.439 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 23.1 m-85 -95.28 155.01 16.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.626 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.64 140.97 51.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.718 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.403 ' CE2' HG11 ' A' ' 133' ' ' VAL . 20.2 m-85 -149.32 61.53 1.03 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.398 -0.813 . . . . 0.0 109.723 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 4.2 pt-20 -84.0 148.44 26.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.862 . . . . 0.0 110.915 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLU . 3.1 p -151.8 175.24 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.793 . . . . 0.0 109.565 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 11.8 pt-20 -155.26 146.42 22.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.93 -1.106 . . . . 0.0 110.621 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 m -129.26 143.18 50.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 110.019 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -82.06 159.69 23.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.416 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 m -156.77 136.91 12.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 12.1 m -79.98 -16.37 12.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.09 -1.006 . . . . 0.0 108.66 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.865 HG21 HD13 ' A' ' 151' ' ' LEU . 26.0 mm -67.03 149.44 98.51 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.74 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.69 150.55 83.59 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.509 1.268 . . . . 0.0 110.875 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -76.81 -27.02 55.05 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.57 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.07 -52.57 9.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 0.0 109.396 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.588 HD22 HG21 ' A' ' 104' ' ' ILE . 9.8 tt -75.5 -42.45 52.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.523 -0.735 . . . . 0.0 109.829 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.752 ' CD1' HD13 ' A' ' 23' ' ' ILE . 51.0 t80 -56.65 -62.23 1.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 0.0 110.17 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.477 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -53.41 -45.61 69.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.81 . . . . 0.0 110.277 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.49 65.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.459 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.718 ' HD2' HG11 ' A' ' 147' ' ' VAL . 5.8 t80 -88.13 -22.98 23.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.435 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.752 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -112.18 -58.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' CG ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -60.23 -30.35 69.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.876 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -122.24 11.65 10.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.935 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.23 -54.52 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 36.2 p-10 -55.44 -25.55 36.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -1.179 . . . . 0.0 110.393 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 37.2 m-20 -92.99 -41.21 10.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.676 HD21 ' CE2' ' A' ' 150' ' ' TYR . 0.6 OUTLIER -72.99 -31.31 64.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 110.524 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.762 ' CD2' HD13 ' A' ' 38' ' ' ILE . 2.0 m-85 -50.17 -61.96 3.14 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -72.4 -7.46 20.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.84 1.442 . . . . 0.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -93.42 -67.2 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.397 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 29' ' ' LEU . 24.3 m -88.98 -0.29 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.339 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -146.8 56.33 2.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 110.344 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 34' ' ' ALA . 45.4 Cg_endo -71.88 -23.19 22.48 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.335 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.84 -16.92 61.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.584 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -96.66 -58.74 1.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.195 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.762 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -110.47 137.78 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.969 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.15 -52.59 6.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 110.353 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.71 -179.23 7.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.192 -0.942 . . . . 0.0 110.453 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 41' ' ' VAL . 2.4 p -159.94 112.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.3 145.68 44.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.896 . . . . 0.0 110.044 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 1.4 m120 -93.88 121.95 35.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.684 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 54' ' ' LYS . 25.4 mm -83.8 -37.59 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.345 1.069 . . . . 0.0 108.363 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--N 1.295 -1.792 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.289 -179.866 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.75 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.8 Cg_endo -71.25 114.96 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.971 1.511 . . . . 0.0 110.315 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.14 -2.89 51.2 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.75 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.4 m -62.91 154.45 30.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.111 . . . . 0.0 109.815 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 44' ' ' ILE . 6.0 mt -125.35 136.1 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -154.48 139.32 17.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.915 . . . . 0.0 110.35 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -84.07 119.88 25.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.3 mt -103.24 118.04 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -85.75 140.49 30.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.49 158.53 37.06 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 42.7 Cg_endo . . . . . 0 C--N 1.304 -1.788 0 O-C-N 124.007 1.53 . . . . 0.0 110.908 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 9.0 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -157.52 172.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.098 -1.001 . . . . 0.0 110.662 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.565 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 2.5 mtpp -93.46 -65.02 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.662 -0.649 . . . . 0.0 109.811 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER 60.6 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ptm180 -106.37 167.22 9.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.672 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.6 t -82.18 152.32 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.88 -1.137 . . . . 0.0 110.348 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 48.5 t0 -101.2 -72.34 0.68 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.235 0.541 . . . . 0.0 109.878 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -146.82 124.58 11.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.361 -0.837 . . . . 0.0 110.124 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.61 149.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 5.3 t0 -151.94 115.06 4.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 109.908 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -85.86 3.14 43.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.647 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -110.34 -48.38 3.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.305 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -91.77 17.84 8.47 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.701 -0.624 . . . . 0.0 110.03 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 20.2 m-85 43.74 58.97 3.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.93 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 28.1 tttt -122.18 119.44 31.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -135.51 109.16 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 51.4 m-20 -125.86 150.29 47.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 110.427 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 51.3 p90 -142.64 139.64 31.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.447 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' ARG . 3.1 m -96.16 155.87 16.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.973 -1.079 . . . . 0.0 110.808 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' OD2' ' A' ' 69' ' ' ASP . 54.7 t -99.91 124.43 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.61 -76.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 110.956 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.525 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.68 78.88 9.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.649 -1.282 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.441 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -100.63 145.97 17.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.57 -50.01 8.44 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.5 Cg_endo -73.62 -48.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.636 1.335 . . . . 0.0 111.02 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 85' ' ' VAL . 33.7 mt -54.52 141.7 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.078 -1.014 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -108.73 -65.06 0.57 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 4.7 m-20 -114.3 -82.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -1.113 . . . . 0.0 110.0 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.9 p -134.27 12.2 3.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.975 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.752 HD22 ' HB2' ' A' ' 123' ' ' LYS . 37.2 mt -90.87 156.38 18.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.016 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.515 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 12.1 tt0 61.96 31.76 17.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.7 mtpt -65.25 161.56 19.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.552 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.588 HD11 ' HE1' ' A' ' 120' ' ' TYR . 87.6 mt -143.9 132.52 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 110.614 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 1.2 m -116.24 111.34 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 109.547 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 2.0 m-80 -103.06 142.17 34.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.548 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 4.2 mp0 -136.19 150.23 48.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.973 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.446 HG12 HD12 ' A' ' 116' ' ' ILE . 45.6 mt -140.63 125.55 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.509 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 2.4 ttpt -125.15 111.91 15.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 109.65 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.588 HG21 HD22 ' A' ' 18' ' ' LEU . 12.1 mt -102.96 112.59 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.43 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.78 142.32 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.827 . . . . 0.0 110.188 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.94 159.96 18.12 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.595 -0.691 . . . . 0.0 110.665 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.581 HG23 ' HA ' ' A' ' 112' ' ' SER . 14.9 p . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.823 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -135.98 -174.17 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.407 -1.055 . . . . 0.0 110.511 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' CG2' ' A' ' 107' ' ' THR . 23.5 mt -137.59 109.39 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.0 108.982 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -84.42 129.19 34.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG2' ' CB ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -122.44 98.47 5.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 109.692 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 116' ' ' ILE . 2.6 tt -94.82 120.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.509 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.472 ' HB3' ' OE1' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -102.04 116.26 32.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.051 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.454 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -103.08 158.62 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 1.8 ttmt -148.51 142.0 25.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.447 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.61 ' CD2' HG21 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -123.52 133.48 54.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -0.931 . . . . 0.0 110.106 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.619 ' N ' ' CD2' ' A' ' 121' ' ' HIS . 4.4 m-70 -119.37 97.67 5.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.52 163.21 14.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.951 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.752 ' HB2' HD22 ' A' ' 95' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.397 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.476 0.655 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.61 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.6 p -98.46 89.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.514 -0.742 . . . . 0.0 110.223 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.16 155.31 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.118 -0.989 . . . . 0.0 110.145 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -64.76 -33.15 75.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.278 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -41.03 -59.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -27.31 65.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 109.274 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 130' ' ' ALA . 18.8 t -77.2 -49.47 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.425 -0.797 . . . . 0.0 109.372 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.43 65.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.857 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.02 -21.44 59.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t -76.44 -43.72 38.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.467 -0.77 . . . . 0.0 110.056 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.75 -30.29 68.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.942 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.97 -40.45 46.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.882 . . . . 0.0 110.125 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.669 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -50.03 -40.99 36.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.871 ' HA ' HD23 ' A' ' 144' ' ' LEU . 23.2 tt0 -60.88 -43.98 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -1.122 . . . . 0.0 109.699 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 38.7 m -62.43 -30.36 71.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.533 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.669 HD12 ' HA2' ' A' ' 140' ' ' GLY . 74.1 mt -64.85 -45.55 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -66.64 -26.2 66.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.524 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -78.79 -39.66 35.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.82 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.59 88.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.579 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.718 HG11 ' HD2' ' A' ' 22' ' ' PHE . 60.0 t -69.92 -39.66 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.01 -50.86 69.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -17.25 63.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.448 -0.782 . . . . 0.0 110.749 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.676 ' CE2' HD21 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -79.81 -42.24 24.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.966 -1.084 . . . . 0.0 109.503 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.865 HD13 HG21 ' A' ' 13' ' ' ILE . 5.7 mt -67.48 -48.16 67.95 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.821 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -53.34 56.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.912 179.809 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.446 HG21 ' CE1' ' A' ' 121' ' ' HIS . 5.1 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.431 0.634 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -104.35 128.66 52.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 109.883 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.17 142.07 32.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.846 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.767 ' CE2' HG11 ' A' ' 133' ' ' VAL . 27.8 m-85 -149.93 54.96 0.94 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.46 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.496 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 0.1 OUTLIER -83.16 158.0 22.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.529 -0.732 . . . . 0.0 110.878 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -154.44 153.84 32.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.677 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -138.5 146.71 42.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.539 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.54 -178.97 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.43 HG22 HG12 ' A' ' 113' ' ' ILE . 1.6 p -121.64 163.29 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.949 . . . . 0.0 110.664 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 2.7 t -159.29 136.86 10.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.78 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.514 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 16.6 t -80.03 -13.87 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.125 -0.984 . . . . 0.0 109.008 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.863 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.1 mp -71.89 153.97 92.83 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.863 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.4 Cg_endo -67.93 149.15 77.49 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.619 1.326 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -75.08 -29.06 60.55 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.513 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -68.16 -55.07 13.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 16.3 mtt-85 -63.93 -36.63 84.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.568 HD23 HD13 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -71.79 -35.81 70.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.09 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.615 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 36.4 t80 -60.54 -58.73 7.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.921 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.484 ' HD3' ' O ' ' A' ' 16' ' ' ALA . 13.7 mtpt -50.69 -52.62 38.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.67 67.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.293 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -89.13 -12.06 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -124.45 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.742 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.616 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -50.34 -56.2 12.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.43 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 2.5 m-20 -111.95 35.43 3.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 109.829 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.13 -58.91 2.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.59 ' HB2' HG11 ' A' ' 41' ' ' VAL . 7.0 p-10 -53.03 -26.72 16.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 110.052 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -87.56 -34.8 18.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.568 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 13.9 mt -80.44 -38.75 29.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.316 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.635 ' HD2' HD13 ' A' ' 38' ' ' ILE . 2.0 m-30 -43.79 -57.72 5.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.619 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.8 Cg_endo -70.71 -18.89 32.21 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.884 1.465 . . . . 0.0 110.629 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.1 mtpp -86.15 -54.46 4.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.93 HG22 ' HB1' ' A' ' 146' ' ' ALA . 5.5 p -83.76 -25.33 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.48 77.29 15.5 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.01 -4.73 15.89 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.082 1.569 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.93 -26.5 60.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.124 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -95.6 -70.34 0.72 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.861 . . . . 0.0 109.967 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.635 HD13 ' HD2' ' A' ' 30' ' ' PHE . 1.7 mp -99.02 128.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.819 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -88.49 -44.69 10.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.29 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -159.5 139.96 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.974 HG13 HG12 ' A' ' 56' ' ' ILE . 3.8 t -119.04 130.87 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -135.61 101.82 4.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.686 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.5 m120 -50.64 118.86 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.22 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.526 ' CD1' ' HG2' ' A' ' 68' ' ' LYS . 12.8 mt -86.42 -37.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.336 1.065 . . . . 0.0 108.403 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 53' ' ' ILE . 24.6 tt0 . . . . . 0 C--N 1.296 -1.734 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.072 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.661 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.6 122.28 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.005 1.529 . . . . 0.0 110.293 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.73 59.9 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.661 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.4 m -54.85 158.72 2.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -1.167 . . . . 0.0 109.305 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 45.8 mt -125.79 142.57 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.048 -1.033 . . . . 0.0 110.559 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -145.32 150.39 36.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 14.7 ttpp -102.2 93.47 5.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.638 -0.664 . . . . 0.0 110.079 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.974 HG12 HG13 ' A' ' 41' ' ' VAL . 66.1 mt -87.92 122.47 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 110.055 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.513 ' CB ' ' OG ' ' A' ' 39' ' ' SER . 17.6 m -86.7 138.14 31.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.14 135.31 19.47 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 45.3 Cg_endo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.936 1.493 . . . . 0.0 110.416 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 10.8 p90 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.26 0.552 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -144.33 167.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.403 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.526 ' HG2' ' CD1' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -123.05 41.8 3.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.945 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 18.6 p-10 -41.84 136.21 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.9 ttm180 -97.46 151.84 19.58 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.659 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.1 t -75.75 149.06 6.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.67 -1.269 . . . . 0.0 110.459 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 46.2 t0 -101.87 -72.14 0.69 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.416 0.627 . . . . 0.0 110.306 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 122.47 11.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -0.855 . . . . 0.0 109.96 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.793 HG22 ' CD2' ' A' ' 81' ' ' TYR . 5.1 t -108.7 154.22 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 110.265 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.488 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 2.1 t0 -156.48 121.85 4.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.887 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.505 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -87.54 -15.29 37.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.788 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -102.37 -45.13 5.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.126 -0.984 . . . . 0.0 109.356 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.13 7.48 15.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.546 -0.722 . . . . 0.0 110.091 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.615 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.4 m-30 46.25 58.46 4.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.493 ' HG3' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.61 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.793 ' CD2' HG22 ' A' ' 74' ' ' VAL . 38.9 t80 -127.95 100.08 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 109.804 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.514 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 6.7 m120 -109.58 139.77 44.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.466 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.598 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 39.7 p90 -136.14 136.29 39.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 70' ' ' ARG . 10.6 m -100.13 162.51 12.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 111.223 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.735 HG11 HD13 ' A' ' 98' ' ' ILE . 24.3 t -104.54 123.66 58.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -123.4 -72.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.303 -179.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.75 88.27 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.268 . . . . 0.0 110.211 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -107.1 148.2 16.37 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.53 -51.91 5.44 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.9 Cg_endo -76.3 -46.96 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.934 1.492 . . . . 0.0 110.732 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 92' ' ' GLY . 52.8 mt -56.51 164.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.107 -0.995 . . . . 0.0 110.459 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -150.91 -69.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -86.4 -87.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -148.62 15.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.467 ' HB3' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -89.66 160.62 16.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 110.38 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 58.16 35.63 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.28 147.73 39.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.735 HD13 HG11 ' A' ' 85' ' ' VAL . 4.9 mp -127.77 137.01 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.763 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.7 114.69 19.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.87 . . . . 0.0 109.661 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.598 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 1.1 m120 -110.04 141.14 43.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -130.26 135.68 48.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.44 101.67 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.056 -1.027 . . . . 0.0 110.344 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HE3' ' HG3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -107.63 121.46 44.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.926 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.735 HG22 ' HB1' ' A' ' 15' ' ' ALA . 54.9 mt -110.48 139.35 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.6 t -138.77 135.78 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.372 -0.83 . . . . 0.0 109.816 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.16 145.92 25.66 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.486 0.66 . . . . 0.0 111.096 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.4 p . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.271 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.854 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -140.4 163.46 32.74 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.549 -0.971 . . . . 0.0 110.676 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 10' ' ' THR . 71.4 mt -119.85 127.33 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.53 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 114' ' ' LEU . 2.1 pp -105.79 112.87 26.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.001 -1.062 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -99.31 104.58 16.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.322 -0.861 . . . . 0.0 109.951 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.489 HG13 HD12 ' A' ' 114' ' ' LEU . 9.7 mt -89.56 125.38 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.496 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -112.63 112.51 24.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.126 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -106.39 155.63 19.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.8 mptt -147.21 131.02 17.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.511 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.646 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.21 128.28 55.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.742 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.446 ' CE1' HG21 ' A' ' 2' ' ' VAL . 23.0 m-70 -113.75 130.01 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -110.63 175.65 5.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 110.086 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 110.183 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.609 ' HA ' HG21 ' A' ' 122' ' ' THR . 5.7 mt-10 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.603 HG21 ' CE2' ' A' ' 120' ' ' TYR . 2.4 p -106.52 86.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 O-C-N 121.658 -0.651 . . . . 0.0 109.839 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 128' ' ' VAL . 1.3 mttp -39.56 144.66 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.508 -0.745 . . . . 0.0 110.603 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.504 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -57.31 -27.34 62.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 110.059 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ALA . 60.8 tt0 -41.57 -64.16 0.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -24.36 38.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.767 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.3 t -78.88 -50.95 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.365 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -24.55 67.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.465 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.58 -38.26 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.649 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 t -66.9 -31.94 72.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.316 -0.865 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -36.73 73.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.804 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.49 -48.08 79.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.844 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.88 -36.55 56.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.59 -50.25 61.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.1 tt0 -56.08 -33.21 64.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -1.194 . . . . 0.0 110.289 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.3 m -70.88 -24.76 62.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.565 ' O ' HG23 ' A' ' 147' ' ' VAL . 21.3 mt -75.7 -47.31 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.993 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.5 pp -70.66 -24.06 62.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.767 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.474 ' N ' HD12 ' A' ' 144' ' ' LEU . 15.0 tpt180 -81.05 -32.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.93 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -70.37 -35.42 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 143' ' ' LEU . 47.0 t -73.5 -46.03 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.465 -0.772 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 49.6 tt0 -54.79 -50.87 67.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.33 -47.35 84.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -48.73 -70.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.621 HD13 HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -49.31 -23.64 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.452 -0.78 . . . . 0.0 110.242 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -81.11 -20.47 41.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.528 HG22 ' ND1' ' A' ' 121' ' ' HIS . 4.8 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.382 0.61 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.5 m-85 -112.0 163.82 13.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.679 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.09 137.52 32.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.106 . . . . 0.0 110.714 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.479 ' O ' ' HB2' ' A' ' 118' ' ' ASN . 46.6 m-85 -144.89 57.89 1.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.777 . . . . 0.0 109.556 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 7' ' ' THR . 1.2 tm-20 -80.03 154.52 28.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 110.783 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -155.68 -179.06 7.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.494 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -158.04 151.74 23.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.0 110.47 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 t -140.4 169.57 17.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.928 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.4 162.99 13.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 110.256 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.403 ' OG ' ' HG3' ' A' ' 148' ' ' GLU . 3.6 t -158.86 137.88 11.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.444 -0.785 . . . . 0.0 109.916 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.98 -3.02 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.594 HG21 HD13 ' A' ' 151' ' ' LEU . 36.1 mm -81.58 147.47 59.51 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.049 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.88 150.56 83.11 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.473 1.249 . . . . 0.0 111.091 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -75.18 -33.15 61.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.935 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.03 -47.81 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.49 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 5.1 ttt180 -68.64 -38.92 80.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 109.764 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.74 ' CD2' HD21 ' A' ' 114' ' ' LEU . 2.4 tp -72.69 -30.45 64.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 76' ' ' HIS . 67.6 t80 -68.13 -63.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.368 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HG3' HD13 ' A' ' 24' ' ' LEU . 1.4 mptp? -53.24 -40.98 64.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -0.777 . . . . 0.0 110.512 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.76 -32.15 63.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.541 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.7 t80 -90.61 -8.72 49.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 1.2 mp -118.83 -65.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.891 HD11 ' CE1' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -61.33 -46.73 89.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 29' ' ' LEU . 1.1 t0 -97.05 -15.35 21.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -45.94 -42.51 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 4.6 m-20 -52.77 -27.98 20.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -113.31 -20.29 11.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.6 tp -86.66 -27.79 23.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 110.106 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.542 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.0 m-85 -54.84 -53.76 57.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.406 -0.809 . . . . 0.0 110.657 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -74.31 -4.59 15.66 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.833 1.438 . . . . 0.0 111.101 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.5 -40.71 8.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.59 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 29' ' ' LEU . 13.5 m -86.03 -26.66 6.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 110.8 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.24 88.44 5.81 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.092 -1.005 . . . . 0.0 110.594 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 59' ' ' PRO . 49.3 Cg_endo -76.34 0.68 9.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.006 1.53 . . . . 0.0 110.489 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -29.75 23.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.282 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -92.4 -66.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.445 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.2 mp -107.82 126.86 64.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.444 -0.785 . . . . 0.0 109.936 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 31' ' ' PRO . 2.9 t -83.35 -53.35 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.285 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -149.6 146.99 27.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.018 HG13 HD12 ' A' ' 56' ' ' ILE . 5.8 t -121.45 127.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.63 108.95 8.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.093 -1.005 . . . . 0.0 110.838 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 2.7 m120 -62.4 118.39 7.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 44' ' ' ILE . 12.1 mt -87.36 -37.71 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.236 1.017 . . . . 0.0 108.585 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HB3' HD12 ' A' ' 53' ' ' ILE . 23.8 tt0 . . . . . 0 C--N 1.296 -1.755 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.405 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.918 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.7 Cg_endo -72.47 110.22 2.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.112 1.585 . . . . 0.0 110.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.82 47.41 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.918 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 2.4 m -60.72 152.65 26.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.181 -1.188 . . . . 0.0 109.728 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.42 HG21 ' HE2' ' A' ' 68' ' ' LYS . 7.3 mt -119.43 133.95 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.455 ' HD3' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -141.08 150.84 43.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.533 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.48 ' C ' HD13 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -96.41 101.44 13.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 109.751 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 HG13 ' A' ' 41' ' ' VAL . 4.4 mm -94.48 134.01 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.963 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -102.97 131.81 49.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.92 . . . . 0.0 110.337 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.14 117.73 62.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.911 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.484 ' HG3' ' O ' ' A' ' 35' ' ' PRO . 48.7 Cg_endo . . . . . 0 C--N 1.307 -1.654 0 O-C-N 123.912 1.48 . . . . 0.0 110.638 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 33.6 p90 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.218 0.532 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 68' ' ' LYS . 1.4 p -167.16 171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 110.657 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' N ' HG22 ' A' ' 67' ' ' VAL . 8.7 tttt -106.89 46.42 0.93 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.715 -0.615 . . . . 0.0 109.912 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' CG2' ' A' ' 67' ' ' VAL . 48.5 m-20 -45.62 130.98 9.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.693 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttp180 -102.56 162.92 12.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.603 HG21 ' HB ' ' A' ' 52' ' ' THR . 12.3 t -86.56 151.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.596 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 32.1 t70 -100.33 -68.01 0.83 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.194 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.3 mt-10 -143.77 137.86 28.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.414 -0.804 . . . . 0.0 110.205 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 4.5 t -123.97 144.22 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.158 -0.964 . . . . 0.0 110.101 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -147.43 114.06 6.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.891 ' CE1' HD11 ' A' ' 24' ' ' LEU . 12.3 m170 -82.56 -2.07 52.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.338 -0.851 . . . . 0.0 110.708 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -118.08 -42.45 2.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.037 -1.039 . . . . 0.0 109.891 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.477 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -90.26 18.85 5.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.516 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.2 m-85 42.17 64.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.111 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.503 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -131.11 117.14 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.442 ' OH ' ' NZ ' ' A' ' 54' ' ' LYS . 9.5 t80 -137.34 99.63 4.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.536 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 56.8 m-20 -113.81 147.01 39.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 36.2 p90 -140.99 142.48 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 70' ' ' ARG . 26.3 m -107.07 165.14 11.58 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.176 -0.953 . . . . 0.0 110.974 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.696 HG12 HD13 ' A' ' 91' ' ' ILE . 71.4 t -108.06 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.499 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -123.06 -77.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.898 -1.126 . . . . 0.0 110.834 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -85.61 77.28 9.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.835 -1.166 . . . . 0.0 109.891 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.494 ' HA2' ' CB ' ' A' ' 67' ' ' VAL . . . -104.23 159.74 16.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.546 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.75 -54.84 5.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -71.06 -48.76 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.768 1.404 . . . . 0.0 111.013 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.696 HD13 HG12 ' A' ' 85' ' ' VAL . 4.8 mt -64.89 164.59 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.479 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -153.15 -40.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.3 -85.97 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -1.152 . . . . 0.0 110.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -139.26 6.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -92.91 158.44 15.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 58.39 31.3 20.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 110.162 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -75.31 146.35 41.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.787 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.599 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.1 mp -132.29 127.82 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -0.951 . . . . 0.0 110.685 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.49 116.24 30.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 109.679 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.52 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 12.6 m-80 -104.35 156.34 18.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.937 . . . . 0.0 110.749 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 94.2 mt-10 -144.91 138.38 26.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.792 . . . . 0.0 109.815 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -128.76 128.67 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.521 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -129.17 132.29 47.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.937 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.516 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 1.3 mp -121.66 129.17 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.85 123.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 111.195 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -58.12 162.9 3.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.864 -0.523 . . . . 0.0 110.503 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.521 HG22 ' C ' ' A' ' 106' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 111.371 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 11.3 t -157.19 -179.98 8.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.255 . . . . 0.0 111.218 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.468 HG13 HG21 ' A' ' 107' ' ' THR . 4.9 mt -125.21 124.79 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.74 HD21 ' CD2' ' A' ' 18' ' ' LEU . 2.1 mp -99.09 114.67 27.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 110.952 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -103.83 106.48 17.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.334 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 26.3 mt -101.99 127.27 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.679 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -105.43 143.44 33.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.801 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.52 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 2.0 m120 -131.07 153.15 49.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.413 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -146.26 132.65 19.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 110.375 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.671 ' CG ' HG21 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -110.07 131.5 55.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.81 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.528 ' ND1' HG22 ' A' ' 2' ' ' VAL . 66.5 m-70 -118.28 109.15 15.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 110.371 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.555 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -107.48 173.07 6.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 110.361 -179.859 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.555 ' HA ' HG21 ' A' ' 122' ' ' THR . 1.3 mm-40 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.466 0.65 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.671 HG21 ' CG ' ' A' ' 120' ' ' TYR . 1.8 t -122.82 105.38 15.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.499 -0.751 . . . . 0.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -78.22 126.76 31.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.371 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.57 -37.28 26.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.405 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -42.49 -48.85 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.024 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -70.51 -27.73 64.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 108.934 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 130' ' ' ALA . 16.9 t -76.5 -47.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.569 -0.707 . . . . 0.0 109.12 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -59.51 -27.94 66.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.658 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.92 66.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.1 t -66.87 -31.32 71.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -45.34 54.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 110.046 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.84 -57.36 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.884 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' ' HB ' ' A' ' 142' ' ' THR . 4.0 mm? -75.37 -35.08 61.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.034 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.86 -49.5 22.69 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.495 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 40.7 tt0 -55.88 -44.51 78.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -1.14 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 139' ' ' LEU . 17.1 m -55.57 -34.15 64.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.0 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 143' ' ' LEU . 17.4 mt -67.86 -49.36 62.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 144' ' ' LEU . 0.9 OUTLIER -69.87 -27.11 64.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.086 -1.009 . . . . 0.0 109.83 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.405 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 3.4 ttm180 -81.47 -28.81 33.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.92 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.11 -43.53 64.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 109.918 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 22' ' ' PHE . 77.8 t -72.22 -38.26 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.794 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.5 tt0 -65.06 -46.09 82.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -63.5 -40.73 97.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.586 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -73.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.977 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 13' ' ' ILE . 1.6 mt -50.11 -38.98 41.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.412 -0.805 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 3.9 mt -50.98 -26.77 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.808 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.938 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.764 HG11 ' ND1' ' A' ' 121' ' ' HIS . 8.6 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.687 0.755 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.562 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 3.4 m-85 -107.81 164.33 12.34 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.628 -0.67 . . . . 0.0 109.714 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.99 138.49 42.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.053 -1.029 . . . . 0.0 110.848 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.42 ' CE1' HG11 ' A' ' 133' ' ' VAL . 50.0 m-85 -146.57 53.89 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.3 pt-20 -81.66 144.43 31.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.766 . . . . 0.0 111.149 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -171.03 3.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.443 -0.786 . . . . 0.0 109.674 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -159.9 164.46 33.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 110.711 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -144.83 -169.92 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 110.048 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.592 ' H ' HG22 ' A' ' 9' ' ' THR . 3.1 p -129.52 160.94 31.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 110.35 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.98 135.3 8.14 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.622 -0.674 . . . . 0.0 109.834 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.96 -17.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 108.642 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.007 HG21 HD13 ' A' ' 151' ' ' LEU . 21.9 mm -68.24 150.35 97.76 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -65.92 151.71 83.37 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.508 1.267 . . . . 0.0 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.61 -25.06 59.0 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -78.13 -47.6 17.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.473 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -69.61 -34.12 73.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.707 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 104' ' ' ILE . 10.6 tp -74.38 -28.7 61.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 110.007 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' ILE . 50.6 t80 -70.44 -60.18 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -54.72 -45.79 74.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.43 70.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.63 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.459 ' HB3' HD12 ' A' ' 23' ' ' ILE . 8.2 t80 -91.54 -20.76 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.97 . . . . 0.0 110.461 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.499 HG13 ' CD2' ' A' ' 81' ' ' TYR . 1.3 mp -114.08 -62.8 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.67 -35.19 20.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.871 . . . . 0.0 110.209 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.58 26.45 4.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -61.0 -44.97 97.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' OD1' HG21 ' A' ' 41' ' ' VAL . 26.9 m-20 -64.88 -8.13 14.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -1.203 . . . . 0.0 110.412 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 4.6 t30 -107.68 -38.79 5.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.469 HD21 ' CZ ' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -80.64 -38.74 28.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -42.12 -59.27 2.77 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.449 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.2 Cg_endo -72.73 -10.65 25.27 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.637 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 6.6 tttm -90.78 -63.74 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 29' ' ' LEU . 11.1 m -81.51 -17.4 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 110.741 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.85 64.37 62.24 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 110.383 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.7 -13.26 20.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.001 1.527 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -79.05 -23.61 44.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -89.07 -61.01 1.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.428 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -106.42 155.45 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 109.841 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.49 -61.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 110.177 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.65 135.17 16.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 56' ' ' ILE . 1.7 p -124.04 128.77 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.125 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 2.9 mt-10 -130.77 159.61 36.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 110.344 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 54' ' ' LYS . 25.8 m120 -95.06 119.27 33.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.156 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.2 mm -87.14 -36.84 10.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.315 1.055 . . . . 0.0 108.479 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 53' ' ' ILE . 45.0 tt0 . . . . . 0 C--N 1.295 -1.8 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.444 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.822 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.7 Cg_endo -74.02 106.8 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.959 1.505 . . . . 0.0 110.27 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.98 5.48 33.08 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.822 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.1 m -69.74 157.16 37.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 109.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.483 HD11 HH21 ' A' ' 70' ' ' ARG . 6.3 mt -124.48 131.18 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -137.95 149.83 46.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.196 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HB2' HD11 ' A' ' 44' ' ' ILE . 1.6 tttp -98.34 109.62 22.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.565 -0.709 . . . . 0.0 110.758 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.725 HD12 ' OD2' ' A' ' 69' ' ' ASP . 72.9 mt -104.1 141.98 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.214 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -121.08 154.1 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 111.155 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.46 135.44 21.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 46.8 Cg_endo . . . . . 0 C--N 1.304 -1.787 0 O-C-N 123.847 1.446 . . . . 0.0 111.033 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 2.2 p90 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.597 HG12 ' HA2' ' A' ' 88' ' ' GLY . 18.3 m -151.51 156.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.566 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.6 mttt -111.43 46.67 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 109.724 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.725 ' OD2' HD12 ' A' ' 56' ' ' ILE . 4.2 p30 -39.35 140.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.947 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.483 HH21 HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -99.44 154.1 18.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.652 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.4 t -76.81 147.43 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.678 -1.264 . . . . 0.0 109.72 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 64.6 t0 -97.28 -69.45 0.76 Allowed 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.719 -0.613 . . . . 0.0 110.461 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 mm-40 -154.8 106.69 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 110.463 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 74' ' ' VAL . 4.3 p -83.26 149.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.129 -0.982 . . . . 0.0 109.706 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -139.2 112.54 8.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 110.48 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -87.75 1.52 53.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.584 -0.697 . . . . 0.0 110.123 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -113.14 -57.63 2.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.09 13.76 5.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.524 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 14.3 m-85 48.59 61.72 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -130.12 110.33 11.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.977 . . . . 0.0 110.699 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.499 ' CD2' HG13 ' A' ' 23' ' ' ILE . 4.0 t80 -120.13 96.98 5.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.496 -0.753 . . . . 0.0 109.602 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.527 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 7.1 m120 -102.75 138.89 39.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.6 p90 -136.63 137.92 40.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 70' ' ' ARG . 1.2 m -104.02 152.81 21.59 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.106 -0.996 . . . . 0.0 111.365 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 19.4 t -100.71 124.2 54.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.8 OUTLIER -124.92 -75.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.74 -178.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -65.1 70.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.758 -1.214 . . . . 0.0 109.793 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -96.6 131.86 10.8 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.92 -56.87 3.05 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.0 Cg_endo -71.52 -27.74 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.782 1.412 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.468 ' CD1' HG12 ' A' ' 85' ' ' VAL . 59.1 mt -72.81 158.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.56 -58.04 0.37 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -56.63 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 0.0 109.838 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 t -146.34 18.28 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.939 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 123' ' ' LYS . 1.2 mt -98.3 149.78 22.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.791 ' HA ' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER 52.42 33.98 14.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.373 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 9.9 tttt -67.38 164.68 18.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.451 -0.78 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.65 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -136.27 125.54 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.258 -0.901 . . . . 0.0 110.157 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.02 115.55 27.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.868 . . . . 0.0 109.488 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 1.6 m-80 -112.31 140.5 46.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.973 . . . . 0.0 110.709 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -127.35 132.3 50.24 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.444 -0.785 . . . . 0.0 109.59 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mt -120.45 105.39 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 110.625 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 32.6 tttm -104.44 117.41 34.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.582 HG21 HD23 ' A' ' 18' ' ' LEU . 3.8 mt -105.58 111.18 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.296 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.47 146.0 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.662 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.21 142.32 27.85 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.434 0.635 . . . . 0.0 111.066 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.563 HG23 ' HA ' ' A' ' 112' ' ' SER . 8.2 p . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.436 -0.79 . . . . 0.0 109.496 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.652 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -143.53 157.86 44.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.303 -1.116 . . . . 0.0 111.418 -179.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 113' ' ' ILE . 1.1 tt -107.2 129.61 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.498 HD11 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -93.03 136.61 33.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 110.588 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -125.35 105.71 9.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 109.654 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 116' ' ' ILE . 4.4 mp -105.62 105.74 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -90.42 133.21 35.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.551 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.446 ' ND2' ' ND2' ' A' ' 100' ' ' ASN . 2.5 t-20 -127.45 140.66 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.758 -1.214 . . . . 0.0 110.59 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -132.87 149.6 52.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 109.872 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.65 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -126.46 107.25 10.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.101 -1.0 . . . . 0.0 109.439 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.764 ' ND1' HG11 ' A' ' 2' ' ' VAL . 17.5 m-70 -88.52 93.02 9.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.986 . . . . 0.0 110.531 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -117.33 167.58 11.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.994 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HB2' HD23 ' A' ' 95' ' ' LEU . 10.1 tptt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.905 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.379 0.609 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.0 t -129.86 96.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.401 -0.812 . . . . 0.0 109.678 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -62.79 126.02 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.027 . . . . 0.0 109.612 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.22 -41.36 18.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 110.55 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.8 mt-10 -40.25 -58.62 1.46 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 110.244 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.97 -30.67 69.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.179 -0.95 . . . . 0.0 108.954 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 130' ' ' ALA . 22.7 t -72.7 -53.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 109.035 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -55.49 -28.62 55.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.191 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.14 -25.85 62.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 133' ' ' VAL . 26.9 t -68.6 -30.92 69.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -79.09 -49.56 12.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.92 -48.71 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.928 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.29 -39.75 53.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -54.07 -50.67 54.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.529 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 2.8 tt0 -57.78 -48.46 79.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -1.174 . . . . 0.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.6 -29.53 59.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.536 HD12 ' HA2' ' A' ' 140' ' ' GLY . 78.0 mt -72.78 -53.38 11.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -68.42 -22.17 64.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -81.88 -35.11 29.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.752 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.13 -40.96 91.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.12 -46.44 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.682 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -45.8 80.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -25.3 64.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.843 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.561 ' CD1' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.53 -41.07 63.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.007 HD13 HG21 ' A' ' 13' ' ' ILE . 4.5 mt -66.86 -34.64 78.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.86 -34.12 77.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.865 . . . . 0.0 110.197 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.72 HG11 ' ND1' ' A' ' 121' ' ' HIS . 4.7 m . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.754 0.787 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 7.4 m-85 -121.96 145.15 48.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 109.911 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.456 ' OD1' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -124.27 133.47 53.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 110.713 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.439 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 62.2 m-85 -139.42 57.13 1.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.526 -0.734 . . . . 0.0 109.447 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 7' ' ' THR . 3.1 tm-20 -80.2 153.81 28.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.585 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -156.04 176.1 13.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 109.719 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.474 ' HB3' ' HG3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -158.54 152.18 23.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.002 -1.061 . . . . 0.0 110.572 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.465 HG21 HD22 ' A' ' 144' ' ' LEU . 1.8 t -134.72 -170.77 2.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -122.36 165.57 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 138.24 10.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.423 -0.798 . . . . 0.0 109.754 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.425 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 61.7 t -80.11 -14.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.685 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.801 HG21 HD13 ' A' ' 151' ' ' LEU . 31.0 mm -70.24 149.42 95.97 Favored Pre-proline 0 N--CA 1.487 1.421 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -68.2 148.25 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.317 1.167 . . . . 0.0 110.82 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.37 -33.82 65.25 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.977 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.15 35.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.487 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -66.74 -37.28 84.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.962 . . . . 0.0 109.847 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.623 ' O ' HD23 ' A' ' 18' ' ' LEU . 7.8 tt -73.94 -32.16 63.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 76' ' ' HIS . 30.7 t80 -63.21 -55.93 20.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.727 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -58.05 -45.03 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.45 -31.08 71.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 20.3 t80 -89.72 -23.96 21.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.705 HD12 ' CD2' ' A' ' 81' ' ' TYR . 7.3 mm -106.18 -65.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.727 HD13 ' CG ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -51.92 -42.77 63.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.985 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 18.9 m-20 -115.39 23.54 12.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 110.193 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -62.83 -54.18 35.43 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.883 ' O ' HG21 ' A' ' 41' ' ' VAL . 21.5 m-20 -59.72 -13.15 8.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -1.141 . . . . 0.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -104.15 -36.26 7.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -83.44 -23.48 32.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.597 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -56.43 -60.25 9.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.6 Cg_endo -73.91 -3.56 13.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.944 1.497 . . . . 0.0 110.286 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 20.7 tttm -103.29 -32.93 9.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 110.433 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.053 HG22 ' HB1' ' A' ' 146' ' ' ALA . 1.6 p -101.68 -33.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.116 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB3' HD23 ' A' ' 143' ' ' LEU . . . -121.4 78.76 36.34 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.41 -0.806 . . . . 0.0 110.1 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 -18.98 31.17 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.99 1.521 . . . . 0.0 110.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.55 -4.29 57.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 110.276 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -107.5 -67.82 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.597 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.2 mp -112.15 152.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.544 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -113.84 -27.88 7.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.021 -1.05 . . . . 0.0 110.83 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.82 162.14 34.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.076 -1.015 . . . . 0.0 110.832 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.883 HG21 ' O ' ' A' ' 27' ' ' ASP . 3.7 m -142.62 133.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.45 -0.781 . . . . 0.0 109.719 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 55' ' ' LYS . 1.7 tt0 -135.7 110.45 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.524 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -69.2 118.31 11.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 110.257 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.676 HD12 HG22 ' A' ' 53' ' ' ILE . 11.6 mt -80.0 -39.98 20.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' OE1' HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.4 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.662 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.2 Cg_endo -71.64 96.18 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.913 1.481 . . . . 0.0 110.271 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.22 -0.74 6.08 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.704 ' HB ' HG21 ' A' ' 71' ' ' VAL . 88.4 m -67.69 160.58 27.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -1.159 . . . . 0.0 109.186 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.676 HG22 HD12 ' A' ' 44' ' ' ILE . 11.5 mt -130.38 142.55 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.833 -1.167 . . . . 0.0 111.017 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 19.1 pttt -159.87 136.88 9.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.569 -0.707 . . . . 0.0 110.196 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' GLU . 14.8 ttpt -87.91 113.54 23.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.9 mt -92.16 153.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.645 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -118.0 148.53 42.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 110.784 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -126.76 118.51 22.57 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 109.625 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 39' ' ' SER . 48.6 Cg_endo . . . . . 0 C--N 1.306 -1.669 0 O-C-N 123.89 1.468 . . . . 0.0 111.034 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 20.4 p90 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -173.0 172.93 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.496 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.0 ttmt -112.41 122.65 48.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 110.069 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -118.93 129.39 55.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.789 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -100.28 145.41 28.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.227 -0.921 . . . . 0.0 108.86 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.704 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.0 t -76.5 147.22 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.881 -1.137 . . . . 0.0 110.668 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 6.8 t70 -99.1 -71.71 0.68 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.448 0.642 . . . . 0.0 109.966 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 3.1 tp10 -141.64 133.1 26.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.45 -0.782 . . . . 0.0 110.168 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.798 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.6 t -118.37 157.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.531 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -159.77 124.26 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 110.064 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 18.7 m170 -98.63 1.17 46.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -112.82 -46.81 3.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.34 10.91 27.82 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 109.966 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-85 51.09 64.0 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 110.445 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -129.7 123.16 30.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.798 ' CD2' HG22 ' A' ' 74' ' ' VAL . 28.0 t80 -144.11 103.77 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 77.5 m-20 -113.97 140.58 48.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.216 -0.927 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 22.9 p90 -137.25 137.22 38.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.488 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 53.8 m -103.76 166.54 10.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.022 -1.049 . . . . 0.0 110.915 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 53.0 t -108.19 124.62 64.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -115.79 -67.89 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.899 -1.126 . . . . 0.0 112.0 -178.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.5 OUTLIER -88.24 82.1 7.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 67' ' ' VAL . . . -100.54 141.13 15.25 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.521 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.71 -58.59 2.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.6 Cg_endo -71.78 -45.18 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.933 1.491 . . . . 0.0 110.393 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.787 HD11 ' CD1' ' A' ' 98' ' ' ILE . 50.4 mt -58.07 149.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.7 -114.73 2.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -70.03 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -1.166 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.486 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 3.2 t -143.93 15.06 1.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.069 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.05 152.55 22.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 109.99 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.535 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 56.33 34.82 24.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.58 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -68.36 157.36 35.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.386 -0.821 . . . . 0.0 110.112 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.787 ' CD1' HD11 ' A' ' 91' ' ' ILE . 2.7 mp -137.12 131.16 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.94 . . . . 0.0 110.402 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.84 114.8 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.785 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.599 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 5.7 m120 -106.62 138.02 43.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.152 -0.968 . . . . 0.0 110.411 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.517 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 26.2 mt-10 -127.53 132.27 49.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 110.191 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.32 121.82 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.33 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 3.9 mttt -128.36 126.39 40.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 109.91 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 12.5 mt -115.36 130.25 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.165 -0.96 . . . . 0.0 110.655 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.12 143.94 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 109.603 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.11 138.77 31.15 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 110.8 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 112' ' ' SER . 1.7 t . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.96 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.802 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -136.72 164.02 29.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.092 . . . . 0.0 110.702 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.48 127.55 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 109.353 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.52 143.45 29.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 0.0 110.955 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 1.8 ttmt -135.13 105.01 6.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.465 -0.772 . . . . 0.0 109.795 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.8 mt -106.4 112.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.336 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -90.39 154.42 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -143.86 135.56 26.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -125.56 153.48 43.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.605 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -135.04 101.88 5.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.079 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.72 ' ND1' HG11 ' A' ' 2' ' ' VAL . 21.3 m-70 -85.98 120.54 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.047 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.09 173.58 6.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 0.0 110.012 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.396 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.33 0.586 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -121.5 93.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -58.69 129.57 42.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 109.562 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.43 -46.45 26.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.942 . . . . 0.0 110.541 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 130' ' ' ALA . 26.7 tt0 -40.18 -50.72 2.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.198 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -35.3 80.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.016 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 130' ' ' ALA . 15.9 t -72.55 -50.87 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.414 -0.804 . . . . 0.0 108.982 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 130' ' ' ALA . 3.2 ttpt -63.0 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.746 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.3 -44.23 72.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.628 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t -57.78 -33.01 68.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.19 12.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.888 . . . . 0.0 110.106 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -48.38 -52.9 19.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 110.285 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.9 mt -69.62 -44.52 70.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.845 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -49.33 -46.52 35.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.552 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 30.8 tt0 -61.29 -30.23 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -30.75 68.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.845 HD12 ' HA2' ' A' ' 140' ' ' GLY . 3.0 mt -73.03 -47.46 44.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.738 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.1 pp -69.44 -22.51 63.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 109.904 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' SER . 2.9 ttp180 -83.78 -34.54 24.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.053 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -63.35 -44.43 94.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.379 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.91 -49.66 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.557 -0.714 . . . . 0.0 109.94 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 8.9 tt0 -56.53 -46.43 80.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.641 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 1.1 t -64.93 -43.92 91.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.456 -0.777 . . . . 0.0 109.872 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -50.99 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.099 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 13' ' ' ILE . 3.8 mt -44.97 -34.39 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -34.2 62.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.829 . . . . 0.0 110.131 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.206 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.535 HG21 ' CE1' ' A' ' 121' ' ' HIS . 2.6 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.412 0.625 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -94.31 149.63 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -0.759 . . . . 0.0 109.427 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -121.54 144.49 48.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.125 -0.984 . . . . 0.0 110.634 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HG11 ' A' ' 133' ' ' VAL . 34.1 m-85 -153.77 69.92 0.81 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.436 -0.79 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 10.7 pt-20 -100.59 135.81 41.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.758 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.427 HG21 ' HD2' ' A' ' 137' ' ' LYS . 0.2 OUTLIER -134.92 177.93 7.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.017 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -158.12 161.12 37.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 110.356 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 10' ' ' THR . 3.1 m -147.6 -175.88 5.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 110.097 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.648 ' H ' HG22 ' A' ' 9' ' ' THR . 1.8 p -122.19 160.98 24.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 110.308 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -157.93 136.84 11.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.768 . . . . 0.0 109.803 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 34.6 m -80.02 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.103 -0.998 . . . . 0.0 109.154 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 151' ' ' LEU . 45.3 mm -77.75 149.22 77.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.5 Cg_endo -64.02 148.48 91.52 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.264 1.139 . . . . 0.0 111.187 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.46 -24.36 60.21 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.114 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.03 -50.96 11.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.277 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 3.0 tpm_? -64.57 -40.3 95.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.098 -1.001 . . . . 0.0 109.603 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.572 ' C ' HD23 ' A' ' 18' ' ' LEU . 8.5 tt -71.23 -37.47 72.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.598 -0.689 . . . . 0.0 110.187 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.715 ' CD1' HD13 ' A' ' 23' ' ' ILE . 76.4 t80 -61.59 -69.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.314 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.15 -51.77 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.878 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.1 74.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.0 t80 -84.86 -10.08 57.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.715 HD13 ' CD1' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -124.78 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.902 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.693 HD23 ' NE2' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -51.96 -42.25 62.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.264 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -104.3 -1.51 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -47.95 -52.69 16.07 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.475 ' OD2' ' HB ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -48.05 -23.15 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -1.21 . . . . 0.0 110.06 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -112.55 -23.84 10.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -84.81 -27.94 26.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.141 -0.974 . . . . 0.0 110.045 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.894 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -64.51 -60.08 9.25 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -74.01 53.14 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.823 1.433 . . . . 0.0 110.254 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.84 -58.1 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 29' ' ' LEU . 27.0 m -85.92 -16.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.373 -0.829 . . . . 0.0 110.45 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.56 71.18 5.46 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.48 -12.5 27.18 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.993 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.44 ' C ' ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -64.55 -21.15 66.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.467 -0.771 . . . . 0.0 110.115 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.9 -60.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.868 . . . . 0.0 110.02 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.894 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -113.56 145.01 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.747 . . . . 0.0 109.745 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.55 -57.69 2.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.7 t -155.3 157.51 37.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.554 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' A' ' 56' ' ' ILE . 59.0 t -114.4 138.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -129.35 87.24 2.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.895 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 6.2 m-20 -54.73 114.34 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.717 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 54' ' ' LYS . 4.9 mt -82.54 -38.51 15.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.197 0.999 . . . . 0.0 108.676 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.442 ' HB3' HD12 ' A' ' 53' ' ' ILE . 23.1 tt0 . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 121.655 0.741 . . . . 0.0 110.176 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.76 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.4 Cg_endo -72.95 101.54 1.33 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.048 1.552 . . . . 0.0 110.909 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 111.32 -1.25 28.08 Favored Glycine 0 N--CA 1.48 1.579 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.76 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.0 OUTLIER -58.4 154.14 14.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -1.201 . . . . 0.0 109.585 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 45' ' ' GLU . 18.2 mt -116.64 143.38 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -157.49 144.43 18.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 110.539 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -92.34 102.22 14.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' A' ' 41' ' ' VAL . 5.5 mm -82.76 130.09 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.86 . . . . 0.0 109.48 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.87 153.73 22.6 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.288 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 32.8 p90 -110.92 155.64 42.09 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 110.12 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.457 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 45.6 Cg_endo . . . . . 0 C--N 1.304 -1.782 0 O-C-N 124.032 1.543 . . . . 0.0 110.626 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 29.6 p90 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.066 0.46 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG13 ' C ' ' A' ' 66' ' ' TYR . 10.4 m -152.23 179.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 0.0 110.413 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.532 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 12.5 mttt -128.83 41.84 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.689 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' SER . 45.2 p-10 -39.17 138.94 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 110.816 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 84' ' ' SER . 8.8 ttm180 -100.08 155.24 17.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.401 -0.812 . . . . 0.0 108.887 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.654 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.2 t -79.94 144.04 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.8 -1.188 . . . . 0.0 110.195 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 46.8 m-20 -96.32 -69.2 0.76 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.292 0.568 . . . . 0.0 110.159 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -146.76 132.29 18.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 81' ' ' TYR . 2.0 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 1.1 m-20 -151.61 107.01 3.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.693 ' NE2' HD23 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -81.81 -10.38 59.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 110.398 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -108.82 -45.83 3.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.15 6.39 25.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.562 -0.711 . . . . 0.0 109.987 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-30 48.56 58.75 4.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.255 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.6 ttmt -134.09 110.38 9.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.469 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.559 ' HD2' HG22 ' A' ' 74' ' ' VAL . 13.2 t80 -126.82 122.1 33.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.881 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 73.1 m-20 -128.3 141.36 51.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 46.9 p90 -138.44 133.14 32.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.316 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 64.7 m -100.95 168.27 9.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.003 -1.061 . . . . 0.0 111.156 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -104.48 127.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -126.83 -75.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.97 -1.081 . . . . 0.0 111.196 -178.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -79.06 83.36 5.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.892 -1.13 . . . . 0.0 110.109 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -109.09 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.45 -54.0 3.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -73.33 -49.58 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.871 1.458 . . . . 0.0 110.826 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 86' ' ' ILE . 42.3 mt -58.8 138.0 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.024 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.27 -60.98 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -97.6 -90.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.194 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 t -139.92 9.11 2.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -86.77 162.14 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.239 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.655 ' HG3' HD12 ' A' ' 95' ' ' LEU . 6.5 mm-40 57.67 36.33 26.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.939 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -81.33 155.6 25.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.582 HG12 ' CD2' ' A' ' 120' ' ' TYR . 2.7 mp -138.64 129.05 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 110.516 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.07 120.47 41.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 1.9 m-20 -110.02 149.36 30.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.515 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 34.5 mt-10 -141.63 163.92 31.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.371 -0.831 . . . . 0.0 110.048 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.564 HG22 HD11 ' A' ' 104' ' ' ILE . 19.4 mt -153.57 106.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.806 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -108.11 118.41 36.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.415 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 104' ' ' ILE . 3.9 mp -110.35 133.52 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.055 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 113' ' ' ILE . 25.0 t -137.43 134.06 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 0.0 110.487 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -82.15 148.31 28.57 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.703 -0.623 . . . . 0.0 110.718 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.3 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.415 -0.803 . . . . 0.0 109.437 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.816 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -135.17 -178.74 5.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.477 -1.014 . . . . 0.0 110.557 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.446 HG13 ' C ' ' A' ' 112' ' ' SER . 25.1 mt -134.41 124.6 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.67 135.83 39.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.008 . . . . 0.0 110.65 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -128.64 98.99 5.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.778 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.1 mt -87.57 145.67 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.497 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -129.65 108.38 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -0.874 . . . . 0.0 110.005 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -109.81 128.4 55.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.415 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -128.64 137.11 51.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.053 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.595 ' CD2' HG21 ' A' ' 128' ' ' VAL . 5.9 t80 -109.67 143.01 40.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.535 ' CE1' HG21 ' A' ' 2' ' ' VAL . 13.5 m-70 -120.81 131.54 54.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.877 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -114.11 174.75 5.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.235 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.877 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 121.651 0.739 . . . . 0.0 109.784 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.4 p -112.98 108.55 25.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.369 0.604 . . . . 0.0 110.759 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 133.25 55.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.463 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -63.17 -9.44 11.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.734 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -55.21 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.171 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -54.84 -36.04 64.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.358 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG11 ' CD2' ' A' ' 5' ' ' TYR . 12.1 t -67.45 -47.79 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.541 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 1.4 mmtt -59.4 -34.48 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.428 -0.795 . . . . 0.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.89 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -74.74 -35.69 62.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.466 -0.771 . . . . 0.0 109.874 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.427 ' HD2' HG21 ' A' ' 7' ' ' THR . 26.1 ttpp -72.46 -37.11 68.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.837 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -58.5 -42.68 88.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 140' ' ' GLY . 2.0 tp -75.17 -43.85 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.631 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -45.27 -50.19 9.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.4 mt-10 -59.87 -31.35 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -1.159 . . . . 0.0 110.215 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.6 m -70.69 -27.48 64.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.012 -1.055 . . . . 0.0 109.649 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.631 HD12 ' HA2' ' A' ' 140' ' ' GLY . 50.8 mt -72.53 -49.38 33.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 110.061 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.679 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -65.6 -25.4 67.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.015 . . . . 0.0 109.472 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.2 OUTLIER -78.92 -33.8 45.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.427 -0.796 . . . . 0.0 109.676 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.97 84.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.381 -0.825 . . . . 0.0 109.638 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.6 t -71.19 -46.97 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -54.18 -46.5 72.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.63 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 t -61.01 -50.35 73.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.656 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.429 ' CE1' HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -48.07 -72.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 109.936 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.636 HD13 HG21 ' A' ' 13' ' ' ILE . 5.4 mt -43.09 -43.72 4.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.002 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -61.38 -43.31 99.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.202 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 110.381 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.391 0.615 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.8 m-85 -94.36 138.59 32.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.51 -0.744 . . . . 0.0 109.916 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.07 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.054 . . . . 0.0 110.42 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.513 ' CE2' HG11 ' A' ' 133' ' ' VAL . 17.6 m-85 -141.16 59.26 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.542 -0.723 . . . . 0.0 109.218 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.0 pt-20 -88.47 142.89 27.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.484 -0.76 . . . . 0.0 110.797 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.39 178.55 8.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.527 -0.733 . . . . 0.0 109.818 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HB2' ' HG3' ' A' ' 115' ' ' LYS . 2.3 pp20? -150.61 143.15 24.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 10' ' ' THR . 1.6 m -130.2 -174.76 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.599 ' H ' HG22 ' A' ' 9' ' ' THR . 1.2 p -119.95 159.43 24.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 110.614 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.495 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -154.26 135.58 14.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' OE2' ' A' ' 148' ' ' GLU . 17.7 m -79.91 -12.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.914 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.788 HG23 ' HD2' ' A' ' 14' ' ' PRO . 5.1 mm -71.31 150.44 94.24 Favored Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.788 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.31 150.77 86.89 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 123.293 1.154 . . . . 0.0 111.08 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.94 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.16 -29.85 63.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.88 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.26 -54.23 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 110.076 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -67.42 -30.97 70.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 109.771 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.574 ' HB2' HG22 ' A' ' 13' ' ' ILE . 29.1 tp -73.8 -29.19 62.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.959 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.746 ' CD1' HD13 ' A' ' 23' ' ' ILE . 71.8 t80 -71.71 -57.17 4.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 110.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 31.9 mtpt -54.34 -41.24 68.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.78 . . . . 0.0 110.298 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.58 -33.79 74.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -91.6 -7.34 50.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.719 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.746 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -121.16 -56.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 24' ' ' LEU . 8.4 mt -72.99 -25.25 60.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -130.03 14.53 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -58.69 -42.47 96.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' O ' HG21 ' A' ' 41' ' ' VAL . 55.6 m-20 -65.05 -27.19 68.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -1.14 . . . . 0.0 110.317 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.3 m-20 -92.14 -38.95 11.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.491 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.004 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.8 mp -76.13 -25.97 55.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -55.64 -59.69 10.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.914 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.5 Cg_endo -71.37 0.43 6.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.994 1.523 . . . . 0.0 111.256 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -105.58 -50.94 3.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.988 -1.07 . . . . 0.0 110.577 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.004 HG22 ' O ' ' A' ' 29' ' ' LEU . 35.9 m -87.33 -11.15 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -160.04 71.24 3.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.013 . . . . 0.0 110.396 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.73 -6.73 19.75 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.033 1.544 . . . . 0.0 110.504 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.503 ' O ' ' CG ' ' A' ' 59' ' ' PRO . 16.1 mt-30 -73.33 -30.01 63.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.558 ' CB ' HD23 ' A' ' 139' ' ' LEU . . . -89.52 -51.28 5.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.617 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.5 mp -112.32 141.39 28.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 110.031 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.444 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -109.74 -19.19 13.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.19 165.07 11.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.143 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.481 HG12 HG23 ' A' ' 56' ' ' ILE . 20.0 m -147.15 154.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.217 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 1.6 mt-10 -153.2 152.98 31.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.532 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.7 112.5 25.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.0 110.055 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.67 HD12 HG22 ' A' ' 53' ' ' ILE . 6.3 mt -80.2 -39.9 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.233 1.016 . . . . 0.0 108.346 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.827 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.908 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.81 87.54 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.071 1.564 . . . . 0.0 110.602 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.89 -6.63 3.78 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.908 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 95.5 m -67.91 164.07 20.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -1.211 . . . . 0.0 109.32 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.67 HG22 HD12 ' A' ' 44' ' ' ILE . 8.3 mt -137.13 149.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.729 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.515 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -155.21 141.6 18.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.393 -0.817 . . . . 0.0 110.561 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.5 tptm -90.39 113.03 24.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.663 -0.648 . . . . 0.0 110.508 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.481 HG23 HG12 ' A' ' 41' ' ' VAL . 28.4 mt -101.49 139.88 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.475 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -102.53 159.93 15.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.64 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -136.82 136.99 22.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 0.0 109.857 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 36' ' ' GLN . 46.5 Cg_endo . . . . . 0 C--N 1.304 -1.807 0 O-C-N 123.888 1.467 . . . . 0.0 110.466 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.524 ' C ' HG12 ' A' ' 67' ' ' VAL . 55.7 p90 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.609 0.719 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -179.68 172.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.858 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -115.64 132.33 56.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.902 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 8.9 p-10 -133.29 131.04 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' CG ' ' HB2' ' A' ' 84' ' ' SER . 8.2 ptt180 -98.23 151.24 20.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.071 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.741 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.6 t -80.02 147.05 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.782 -1.199 . . . . 0.0 110.251 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 11.3 t0 -97.56 -62.35 1.26 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.099 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.3 tt0 -155.22 120.91 5.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.236 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 81' ' ' TYR . 2.9 t -116.02 142.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.321 -0.862 . . . . 0.0 110.085 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -139.98 118.24 12.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.91 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -82.6 1.45 38.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.831 . . . . 0.0 110.796 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -119.86 -38.31 2.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.05 20.36 10.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.501 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 22.9 m-30 44.66 58.56 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.555 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -127.01 129.6 48.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.052 -1.03 . . . . 0.0 110.16 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.722 ' CD1' HG22 ' A' ' 74' ' ' VAL . 77.5 t80 -148.51 94.37 2.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.947 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 71.6 m-20 -109.98 137.78 47.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.195 -0.94 . . . . 0.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.7 p90 -137.89 143.48 40.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.9 . . . . 0.0 110.004 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 70' ' ' ARG . 74.2 m -106.17 170.61 7.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.075 -1.015 . . . . 0.0 111.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.428 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 53.9 t -112.16 125.38 69.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -116.61 -72.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.856 -1.152 . . . . 0.0 111.735 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -87.78 85.64 7.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.269 . . . . 0.0 110.436 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.478 ' HA2' HG23 ' A' ' 67' ' ' VAL . . . -106.42 141.31 15.46 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.558 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.02 -53.39 2.57 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.7 Cg_endo -71.66 -40.34 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.744 1.391 . . . . 0.0 110.512 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.57 140.19 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 0.0 110.025 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.59 -85.06 1.13 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -83.42 -80.04 0.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -1.172 . . . . 0.0 110.434 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -145.34 13.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.464 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.647 HD23 ' HB2' ' A' ' 123' ' ' LYS . 4.1 mp -87.7 153.73 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.051 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.4 tt0 61.34 36.05 17.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 0.4 OUTLIER -69.67 162.54 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.482 HG12 ' CD1' ' A' ' 120' ' ' TYR . 8.3 mt -145.89 136.02 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 110.565 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -120.97 117.27 26.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.656 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 7.0 m120 -101.37 141.27 34.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.76 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.521 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 0.9 OUTLIER -131.19 132.36 44.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.713 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.657 HD12 ' HD2' ' A' ' 81' ' ' TYR . 43.0 mt -126.5 124.34 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.002 -1.061 . . . . 0.0 110.704 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -129.12 127.23 41.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.672 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.559 HG22 ' HB1' ' A' ' 15' ' ' ALA . 93.3 mt -116.72 125.46 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.718 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.5 t -127.3 136.47 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.425 -0.797 . . . . 0.0 109.716 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.1 143.55 27.01 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.552 0.691 . . . . 0.0 111.035 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.3 p . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.647 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.94 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -133.27 155.99 48.39 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.724 -0.868 . . . . 0.0 110.774 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 113' ' ' ILE . 6.0 tt -109.66 120.12 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.05 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -101.45 122.49 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.931 -1.105 . . . . 0.0 111.18 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 8' ' ' GLU . 4.8 mttt -102.23 111.09 23.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 7' ' ' THR . 55.4 mt -97.19 140.29 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.638 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -125.87 118.04 24.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.074 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.85 125.41 48.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.173 -0.954 . . . . 0.0 110.23 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 3.6 mtpp -116.35 138.2 51.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 110.466 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.482 ' CD1' HG12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -112.83 124.72 53.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.262 -0.899 . . . . 0.0 109.707 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 36.0 m-70 -106.22 113.12 26.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.985 . . . . 0.0 110.355 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.559 HG21 HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -122.59 167.05 13.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.1 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.647 ' HB2' HD23 ' A' ' 95' ' ' LEU . 5.0 mmtp . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.6 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 128' ' ' VAL . 3.8 t -118.92 88.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 110.117 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -59.73 127.81 33.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -44.82 -45.46 10.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.113 -0.992 . . . . 0.0 110.204 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.0 mm-40 -38.64 -59.1 0.97 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -29.1 69.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 130' ' ' ALA . 8.9 t -78.6 -49.64 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 130' ' ' ALA . 12.6 mttt -63.21 -25.71 68.46 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.419 -0.801 . . . . 0.0 109.531 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.99 -39.56 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.542 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 t -65.46 -33.79 76.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 109.688 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -79.15 -46.09 18.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.769 . . . . 0.0 109.818 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' OG1' ' A' ' 142' ' ' THR . 1.7 mt-10 -43.25 -67.47 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.558 HD23 ' CB ' ' A' ' 37' ' ' ALA . 2.5 mp -67.04 -30.2 70.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.91 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.82 -63.81 4.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.534 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -52.23 -32.13 35.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -69.78 -27.24 64.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.675 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 69.3 mt -72.15 -50.31 28.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.749 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.601 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -68.14 -28.52 67.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.406 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.13 -34.53 43.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.794 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.22 77.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.882 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.65 -48.07 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.931 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -50.59 -41.05 54.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.432 179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -66.34 -47.55 73.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.593 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.895 ' CD1' HG12 ' A' ' 33' ' ' VAL . 1.8 t80 -45.69 -67.6 0.27 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.469 -0.77 . . . . 0.0 110.563 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 13' ' ' ILE . 10.3 mt -57.49 -39.03 75.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.362 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -49.2 -40.38 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.49 HG22 ' ND1' ' A' ' 121' ' ' HIS . 2.7 t . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.482 0.658 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 4.0 m-85 -93.33 167.63 11.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -138.25 144.23 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.994 . . . . 0.0 110.811 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 64.6 m-85 -156.12 57.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.74 . . . . 0.0 109.604 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 14.9 mt-10 -88.94 145.88 25.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.372 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -150.65 173.06 14.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 4.6 pt-20 -151.15 155.79 39.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 110.551 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.509 HG22 ' H ' ' A' ' 10' ' ' THR . 3.1 m -139.36 176.84 8.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -112.75 163.65 14.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 110.581 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -159.93 136.46 9.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.648 -0.657 . . . . 0.0 109.454 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 9.9 p -80.19 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.806 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.842 HG21 HD13 ' A' ' 151' ' ' LEU . 42.0 mm -71.81 149.15 92.71 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.662 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -64.9 148.66 89.97 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.463 1.244 . . . . 0.0 111.282 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -66.48 -47.11 74.08 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.82 74.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.499 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -63.38 -37.97 89.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -72.25 -35.84 68.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.432 -0.792 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' ILE . 40.1 t80 -64.55 -63.84 1.03 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -48.57 -48.46 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.102 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -38.6 91.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 4.1 t80 -86.3 -11.11 53.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.215 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.812 HD12 ' CG ' ' A' ' 81' ' ' TYR . 12.0 mm -114.72 -74.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.178 -0.951 . . . . 0.0 110.491 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 24' ' ' LEU . 20.3 mt -54.87 -51.76 64.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 110.471 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.99 8.73 36.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.17 -47.92 88.69 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 79.5 m-20 -58.51 -28.42 65.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -1.14 . . . . 0.0 110.252 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.411 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 m-20 -86.56 -46.79 9.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -35.79 80.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.222 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.707 ' CD2' HD13 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -48.97 -60.07 5.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.953 . . . . 0.0 110.046 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -73.5 53.77 2.74 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.048 1.552 . . . . 0.0 110.274 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -63.91 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 110.392 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 33' ' ' VAL . 33.2 m -82.96 -24.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 110.435 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -134.66 70.0 71.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.6 -14.58 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.995 1.524 . . . . 0.0 110.512 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -71.67 -24.19 61.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.37 -60.02 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.274 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.707 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -113.13 143.92 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -0.815 . . . . 0.0 109.888 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -47.56 8.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.266 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.4 133.89 2.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.273 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG1' ' HD3' ' A' ' 54' ' ' LYS . 94.6 t -100.46 142.01 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 53.9 mt-10 -140.88 99.28 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -61.52 117.78 6.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.517 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.4 mm -85.99 -37.59 11.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 108.425 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 1.4 tm-20 . . . . . 0 C--N 1.294 -1.806 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.437 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.816 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.97 99.19 0.65 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.807 1.425 . . . . 0.0 110.094 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 71' ' ' VAL . . . 109.48 9.39 25.34 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.816 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.1 m -65.39 166.75 9.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.407 -1.055 . . . . 0.0 109.364 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 14.6 mt -129.55 138.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 110.392 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HD3' ' CG1' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.743 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HB2' HD11 ' A' ' 44' ' ' ILE . 20.9 tttt -92.14 98.36 11.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.313 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.744 HD12 ' OD1' ' A' ' 69' ' ' ASP . 52.0 mt -87.88 120.55 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.633 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.93 143.3 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -0.963 . . . . 0.0 110.291 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.04 136.2 20.46 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.208 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--N 1.304 -1.763 0 O-C-N 123.997 1.525 . . . . 0.0 110.463 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.491 ' C ' HG12 ' A' ' 67' ' ' VAL . 27.9 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.268 0.556 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER 178.98 172.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.3 ttmt -119.18 52.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.523 -0.736 . . . . 0.0 110.47 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.744 ' OD1' HD12 ' A' ' 56' ' ' ILE . 10.2 p-10 -46.09 137.81 5.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.106 -0.996 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttm180 -100.75 157.85 16.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.228 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.582 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.6 t -84.7 146.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.877 -1.14 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.3 t70 -94.51 -68.91 0.78 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.275 0.56 . . . . 0.0 110.491 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -144.61 143.72 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 0.0 110.377 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 4.3 t -123.66 155.64 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.239 -0.913 . . . . 0.0 109.947 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.516 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -154.75 130.13 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 110.085 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -5.54 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 0.0 110.894 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -112.55 -40.6 4.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 109.884 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.88 16.21 16.6 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.337 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.7 m-85 46.74 69.01 0.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.78 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.516 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 6.2 tttt -131.19 127.14 37.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.812 ' CG ' HD12 ' A' ' 23' ' ' ILE . 34.1 t80 -150.67 88.66 1.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.459 -0.775 . . . . 0.0 109.39 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 86.3 m-20 -100.95 145.66 28.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.129 -0.982 . . . . 0.0 110.617 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 7.7 p90 -141.81 137.97 31.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.499 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ARG . 58.8 m -108.32 168.24 9.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.048 -1.032 . . . . 0.0 111.232 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.484 HG12 ' CD1' ' A' ' 91' ' ' ILE . 45.1 t -105.86 131.18 56.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER -129.5 -77.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.942 -1.099 . . . . 0.0 110.583 -179.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -69.58 65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.838 -1.164 . . . . 0.0 109.997 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.733 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -87.86 136.68 13.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.545 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -41.66 -54.87 4.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.0 Cg_endo -72.01 -42.1 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.823 1.433 . . . . 0.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.733 HD12 ' HA3' ' A' ' 88' ' ' GLY . 69.8 mt -56.31 145.82 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.23 -76.0 0.26 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.33 -75.94 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -1.136 . . . . 0.0 110.083 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.1 p -144.61 9.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.434 ' HB3' ' HE3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -93.06 161.91 14.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.13 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' OE1' HG13 ' A' ' 91' ' ' ILE . 0.9 OUTLIER 61.59 28.42 17.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.147 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 98' ' ' ILE . 10.5 ttmt -80.94 159.64 24.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.105 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.6 mp -141.13 133.0 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 110.641 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 m -114.79 115.64 27.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.604 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 19.3 m120 -104.77 142.76 34.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.631 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.533 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -130.6 128.63 41.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.807 . . . . 0.0 109.634 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 116' ' ' ILE . 17.5 mm -120.34 113.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.659 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 9.8 mtmm -125.37 139.79 53.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 109.648 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.431 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 7.2 mt -127.53 142.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.027 -1.046 . . . . 0.0 110.823 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.7 t -137.52 130.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 109.548 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.04 155.98 19.53 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.635 -0.665 . . . . 0.0 111.307 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 109.868 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -141.25 162.97 34.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -1.087 . . . . 0.0 110.639 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 10' ' ' THR . 49.0 mt -120.08 120.92 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 109.377 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.5 pp -98.28 131.99 44.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 8' ' ' GLU . 19.8 mttt -112.4 110.97 21.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 7' ' ' THR . 29.0 mm -94.95 119.92 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -106.81 120.65 42.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.131 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -115.0 147.13 40.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -137.35 133.26 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.073 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.592 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -109.93 138.35 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.444 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.49 ' ND1' HG22 ' A' ' 2' ' ' VAL . 75.1 m-70 -123.69 102.37 7.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.477 HG21 HG23 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -114.92 165.35 12.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.943 . . . . 0.0 110.099 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 95' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.417 ' C ' HG21 ' A' ' 122' ' ' THR . 11.2 mt-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.123 0.487 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -128.94 92.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.921 . . . . 0.0 110.023 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HG3' ' HB3' ' A' ' 131' ' ' GLU . 20.1 ptmt -69.4 131.19 44.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.312 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 134' ' ' LYS . . . -40.47 -38.59 0.86 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 110.826 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.478 ' HB3' ' HG3' ' A' ' 129' ' ' LYS . 9.8 tp10 -39.16 -65.96 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.07 -29.93 61.26 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.556 HG11 ' CE1' ' A' ' 5' ' ' TYR . 12.9 t -74.01 -49.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 0.0 109.423 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -62.37 -32.72 73.57 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.23 -17.79 64.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.651 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -81.27 -33.38 32.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 109.845 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -28.51 60.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.893 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -60.61 -62.14 2.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.033 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.52 -30.68 66.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.705 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -59.25 -38.8 93.76 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.571 ' HA ' HD23 ' A' ' 144' ' ' LEU . 2.7 mt-10 -61.59 -38.5 87.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.151 -1.205 . . . . 0.0 110.254 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.5 m -66.83 -27.75 67.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.109 -0.994 . . . . 0.0 109.875 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.705 HD12 ' HA2' ' A' ' 140' ' ' GLY . 66.1 mt -73.33 -46.41 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.315 -0.866 . . . . 0.0 110.005 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -68.27 -30.01 68.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.005 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.431 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.65 -33.87 40.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.28 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -64.3 -46.97 81.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.29 -41.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.975 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.4 tm-20 -60.3 -48.37 82.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.64 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -44.19 93.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.462 -0.774 . . . . 0.0 110.002 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 1.2 t80 -50.55 -71.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 110.368 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.842 HD13 HG21 ' A' ' 13' ' ' ILE . 13.0 mt -49.4 -32.77 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 110.668 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -64.82 -34.49 78.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.084 -1.01 . . . . 0.0 110.404 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.704 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.47 HG22 ' ND1' ' A' ' 121' ' ' HIS . 2.6 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.374 0.607 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -118.68 127.4 53.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 4' ' ' ASN . 10.1 p-10 -131.93 124.97 30.52 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.857 -1.152 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.616 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 93.9 m-85 -103.38 74.29 1.26 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -80.06 149.12 30.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.863 . . . . 0.0 110.528 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -160.07 -173.55 4.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.588 -0.695 . . . . 0.0 109.818 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -159.36 153.33 23.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 0.0 110.478 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 170.07 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.909 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.478 HG22 HG12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -116.63 159.84 21.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.265 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.6 m -158.86 141.66 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.645 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.494 HG23 HD12 ' A' ' 13' ' ' ILE . 12.5 m -79.85 -10.97 12.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.607 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.71 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.2 mp -67.92 149.91 98.0 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.71 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.81 151.71 83.55 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.397 1.209 . . . . 0.0 110.796 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.846 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.42 -23.09 58.89 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.698 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.42 -56.57 3.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.941 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -59.84 -32.69 70.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.945 . . . . 0.0 109.798 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -71.47 -41.73 69.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.252 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 41.4 t80 -60.89 -66.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 37.8 mttt -47.2 -42.85 20.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 110.29 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.59 69.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.449 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' HB3' HD12 ' A' ' 23' ' ' ILE . 7.9 t80 -89.88 -12.17 39.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.607 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.1 mp -124.11 -62.27 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -52.76 -34.78 54.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.878 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' GLY . 1.1 m-20 -125.0 -6.29 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.019 -1.05 . . . . 0.0 110.793 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -44.89 -45.67 9.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 15.3 p-10 -51.56 -33.41 32.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.309 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 28' ' ' ASN . 21.8 t-20 -100.41 -33.35 10.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.759 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -69.01 -41.89 77.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.728 ' CD1' HD13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -45.04 -58.93 4.83 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.301 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.6 Cg_endo -72.04 -2.73 12.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.998 1.525 . . . . 0.0 110.621 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 4.8 mmtp -104.51 -60.61 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.7 m -84.69 -18.15 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.454 -0.779 . . . . 0.0 110.528 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HB1' ' CD2' ' A' ' 143' ' ' LEU . . . -135.01 68.52 70.58 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.591 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.47 -1.4 11.28 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.036 1.545 . . . . 0.0 110.119 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.62 -20.94 25.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 110.333 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -104.67 -58.21 1.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.459 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.728 HD13 ' CD1' ' A' ' 30' ' ' PHE . 1.2 mp -104.1 129.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 110.093 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -83.85 -48.38 10.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.357 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -163.72 155.95 17.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 56' ' ' ILE . 61.5 t -118.69 146.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.87 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -144.15 90.38 2.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.347 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 74.4 m-20 -56.38 119.35 5.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.454 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.532 ' CD1' ' HD3' ' A' ' 68' ' ' LYS . 15.2 mt -87.83 -37.81 11.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.232 1.015 . . . . 0.0 108.525 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 52' ' ' THR . 32.1 tt0 . . . . . 0 C--N 1.294 -1.821 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.379 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.564 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -74.0 122.44 7.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.079 1.568 . . . . 0.0 110.376 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.6 0.66 62.5 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.674 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -71.01 156.54 39.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.464 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 44' ' ' ILE . 5.3 mt -119.83 135.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.934 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HA ' HG13 ' A' ' 44' ' ' ILE . 6.7 ptmt -149.33 143.44 25.8 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 110.278 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -89.22 106.48 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' CD1' HG13 ' A' ' 41' ' ' VAL . 41.9 mm -89.55 122.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.882 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.461 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 52.1 m -84.15 142.0 30.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 110.38 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.19 146.05 33.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 124.077 1.567 . . . . 0.0 110.563 -179.737 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' VAL . 4.3 p90 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.386 0.612 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 66' ' ' TYR . 19.6 m -156.79 140.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.473 -0.767 . . . . 0.0 109.768 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -83.83 127.48 33.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.023 . . . . 0.0 110.401 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 83' ' ' TYR . 12.1 t70 -126.24 124.44 40.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.824 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.9 ttp85 -98.73 144.08 28.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.0 109.031 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -75.26 146.3 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.819 -1.175 . . . . 0.0 110.126 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 22.6 t70 -98.68 -72.43 0.65 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.43 0.634 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -135.94 144.06 45.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.718 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.5 t -130.65 128.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 13.4 m-20 -135.97 104.03 5.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.458 ' CD2' ' N ' ' A' ' 76' ' ' HIS . 13.6 m-70 -79.37 -9.92 59.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.273 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -111.27 -37.81 5.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -89.66 3.22 53.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 110.045 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.609 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.6 m-30 55.7 59.67 3.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 75' ' ' ASP . 12.1 tttp -139.36 114.87 9.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 110.074 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.718 ' CD2' HG22 ' A' ' 74' ' ' VAL . 59.8 t80 -136.26 116.47 13.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.1 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.448 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 53.5 m-20 -127.47 151.08 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 27.2 p90 -145.28 136.63 25.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.877 . . . . 0.0 109.506 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.2 m -100.51 164.5 11.88 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.121 -0.987 . . . . 0.0 111.14 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG22 ' OD2' ' A' ' 69' ' ' ASP . 55.4 t -108.82 126.15 65.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -115.52 -74.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.767 -1.208 . . . . 0.0 111.869 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.89 59.34 3.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.655 -1.278 . . . . 0.0 110.274 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 148.95 16.95 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 52.5 -157.18 4.05 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.35 6.71 4.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.067 1.561 . . . . 0.0 111.021 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.0 mt -51.47 148.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.63 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' THR . . . -152.88 141.96 8.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.87 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -1.173 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 16.7 p -147.61 14.72 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.408 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 96' ' ' GLU . 1.6 pp -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.793 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.787 ' HB2' HD12 ' A' ' 95' ' ' LEU . 1.6 mt-10 53.31 34.84 18.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.115 -0.991 . . . . 0.0 109.247 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -71.68 157.72 37.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.543 -0.723 . . . . 0.0 110.262 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 120' ' ' TYR . 61.9 mt -142.18 125.35 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 110.628 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.63 108.55 13.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.539 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -97.03 142.96 28.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.707 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 102' ' ' ILE . 25.5 mt-10 -130.23 164.18 25.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -0.796 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 101' ' ' GLU . 23.1 mm -151.63 110.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -113.59 134.17 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.151 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.556 ' C ' HG23 ' A' ' 105' ' ' VAL . 52.9 mt -117.86 152.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.399 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.556 HG23 ' C ' ' A' ' 104' ' ' ILE . 27.0 t -153.22 119.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 109.856 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -75.86 151.06 37.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.477 0.656 . . . . 0.0 111.037 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 111' ' ' GLY . 3.1 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.654 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.846 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -135.57 168.71 18.74 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.705 -0.879 . . . . 0.0 110.505 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.478 HG12 HG22 ' A' ' 10' ' ' THR . 50.0 mt -127.92 124.36 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.194 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 1.6 pp -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 111.024 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -110.31 114.8 28.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.6 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.473 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 35.5 mt -90.89 131.95 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.366 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -118.31 105.58 11.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 110.258 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 4.6 t-20 -92.94 155.38 17.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.022 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -152.76 132.99 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -132.75 103.18 5.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 89.2 m-70 -82.2 142.38 32.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.984 -1.072 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 p -106.28 -170.29 1.7 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 0.0 109.887 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 1.2 ttmt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 110.273 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.39 0.614 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.604 HG21 ' HB3' ' A' ' 120' ' ' TYR . 2.6 t -112.67 101.51 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 110.076 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 133' ' ' VAL . 1.6 mmtp -68.57 129.08 38.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.24 -49.12 61.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 111.071 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -38.4 -48.36 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -68.73 -34.09 75.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.079 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.616 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 6.0 t -75.15 -47.46 35.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 130' ' ' ALA . 9.5 tttp -61.1 -31.16 70.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.424 -0.797 . . . . 0.0 109.561 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.88 -49.48 51.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 t -65.83 -33.01 74.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 0.0 109.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -71.7 -34.86 69.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.052 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -49.95 -55.61 13.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 37' ' ' ALA . 4.3 mm? -67.05 -36.0 81.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.015 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.1 -40.13 13.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.64 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.4 OUTLIER -70.29 -63.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -1.072 . . . . 0.0 109.878 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.2 m -51.32 -22.33 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 13.2 mt -69.94 -54.25 14.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.985 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -57.63 -25.43 60.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.085 -1.01 . . . . 0.0 109.257 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -82.3 -33.58 28.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.98 85.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.449 -0.782 . . . . 0.0 109.743 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.21 -52.52 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.428 -0.795 . . . . 0.0 109.869 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 26.7 tt0 -51.73 -36.6 47.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.879 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 2.4 t -67.36 -54.45 20.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 110.026 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 151' ' ' LEU . 1.3 t80 -48.74 -69.95 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 0.0 110.433 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 13' ' ' ILE . 10.9 mt -41.56 -46.35 3.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.524 -0.735 . . . . 0.0 110.75 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.9 mt -70.34 -27.6 64.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.915 . . . . 0.0 110.549 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 110.198 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.402 0.62 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.531 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 18.1 m-85 -100.7 161.79 13.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.421 -0.799 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -138.19 140.98 40.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 110.369 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.748 ' CE2' HG11 ' A' ' 133' ' ' VAL . 23.4 m-85 -152.18 59.18 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.855 . . . . 0.0 109.775 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 4.5 tm-20 -80.98 153.22 27.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.525 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -149.93 163.27 38.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.684 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.38 164.45 34.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.669 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.14 -179.9 7.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -112.75 160.52 17.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 110.407 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.72 136.71 10.52 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.528 -0.732 . . . . 0.0 109.812 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.473 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 19.6 m -79.91 -16.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.139 -0.975 . . . . 0.0 108.57 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.758 HG21 HD13 ' A' ' 151' ' ' LEU . 24.9 mm -65.79 148.59 98.15 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.1 150.06 85.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.613 1.323 . . . . 0.0 110.917 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.717 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.27 -30.64 62.21 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.903 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.32 -49.32 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.083 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.553 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 1.2 tpt180 -66.57 -32.02 73.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.952 . . . . 0.0 109.709 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 114' ' ' LEU . 1.5 tt -74.81 -37.63 62.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CE1' HG13 ' A' ' 23' ' ' ILE . 6.1 t80 -64.05 -57.06 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.04 -52.85 59.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 110.292 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.84 69.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.698 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 36.2 t80 -91.96 -16.14 27.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.203 -0.936 . . . . 0.0 110.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.573 HG13 ' CE1' ' A' ' 19' ' ' PHE . 12.5 mm -109.21 -69.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.104 -0.997 . . . . 0.0 110.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HA ' HD23 ' A' ' 24' ' ' LEU . 9.2 mt -59.03 -34.48 71.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.455 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.5 -14.17 16.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.88 -30.55 9.29 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.91 -36.83 77.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -1.131 . . . . 0.0 110.396 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 8.0 p-10 -109.13 -22.89 11.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -72.5 -42.54 64.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -47.44 -59.91 4.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.353 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -72.46 -1.26 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.04 1.548 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.3 mttt -99.41 -65.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 29' ' ' LEU . 35.6 m -82.91 5.31 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 110.516 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -157.04 64.33 3.3 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.293 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.16 1.82 6.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.075 1.566 . . . . 0.0 110.738 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -89.44 -19.31 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.56 -69.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.0 mp -94.42 149.55 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.326 -0.858 . . . . 0.0 109.504 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.437 ' HB3' ' CA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.93 -33.47 9.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 110.75 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.76 171.16 11.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.958 -1.088 . . . . 0.0 110.822 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.3 t -138.9 139.0 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.933 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -145.08 112.25 6.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 110.64 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -69.7 114.9 8.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 110.113 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 55' ' ' LYS . 16.6 mm -80.63 -38.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.275 1.036 . . . . 0.0 108.484 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 6.4 tp10 . . . . . 0 C--N 1.294 -1.815 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.043 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG11 ' A' ' 71' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 49.8 Cg_endo -75.88 131.73 13.59 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.056 1.556 . . . . 0.0 110.354 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' A' ' 70' ' ' ARG . . . 90.74 -1.26 78.17 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.649 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.6 m -72.69 167.6 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.545 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 10.0 mt -127.04 131.17 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.804 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.945 ' CE ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -144.0 141.46 30.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 110.561 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HB2' HD11 ' A' ' 44' ' ' ILE . 13.9 tptt -99.38 107.63 19.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 110.459 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.945 HD11 ' CE ' ' A' ' 54' ' ' LYS . 28.4 mm -88.22 128.04 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -92.59 156.04 17.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 67' ' ' VAL . 30.0 m-85 -132.93 141.46 41.1 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.119 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 124.037 1.546 . . . . 0.0 110.431 -179.839 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.781 ' O ' HG13 ' A' ' 67' ' ' VAL . 5.0 p90 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 66' ' ' TYR . 2.5 m -162.95 133.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 110.048 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 16.5 ttpt -91.67 141.25 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -0.957 . . . . 0.0 110.046 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.82 134.04 36.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 109.839 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.496 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 3.8 ttm180 -95.4 134.3 38.38 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.649 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.7 t -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.014 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 12.6 t0 -99.41 -72.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.445 0.64 . . . . 0.0 110.407 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 tt0 -137.39 138.25 39.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.526 -0.734 . . . . 0.0 110.175 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.024 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.1 t -124.69 143.34 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.725 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 m-20 -150.91 93.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -72.85 -1.66 17.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -110.34 -33.23 6.69 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.331 -0.856 . . . . 0.0 108.821 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.48 16.22 27.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.676 -0.64 . . . . 0.0 109.997 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.564 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.2 m-30 44.91 48.71 9.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 5.8 ttpt -126.42 113.6 17.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.109 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 1.024 ' CD2' HG22 ' A' ' 74' ' ' VAL . 42.1 t80 -138.31 117.62 12.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 110.191 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 29.2 t-20 -124.7 165.45 17.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.171 -0.956 . . . . 0.0 109.889 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 7.7 p90 -159.37 134.55 8.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 14.4 m -93.29 161.98 14.18 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.173 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.9 t -103.51 123.71 57.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG22 ' HZ1' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -117.07 -72.92 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 111.61 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -82.91 89.63 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.596 -1.315 . . . . 0.0 110.49 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.489 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -109.08 152.04 17.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.14 -61.37 2.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.5 Cg_endo -71.69 -47.33 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.964 1.507 . . . . 0.0 110.64 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.0 mt -53.98 150.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.089 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.83 -72.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.71 -75.88 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.168 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.55 21.36 0.92 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.141 -0.975 . . . . 0.0 110.495 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.587 HD23 ' CB ' ' A' ' 123' ' ' LYS . 2.5 mp -96.69 158.94 15.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.947 . . . . 0.0 110.337 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 57.09 35.39 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.996 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -67.72 151.69 46.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.817 HD11 ' CE1' ' A' ' 120' ' ' TYR . 19.7 mt -139.54 129.26 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 t -119.29 111.55 18.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.397 -0.814 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.575 ' OD1' HG22 ' A' ' 98' ' ' ILE . 1.8 m-20 -103.52 144.4 31.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.69 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 117' ' ' SER . 13.2 tm-20 -122.84 163.28 20.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.403 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.447 HG13 ' C ' ' A' ' 101' ' ' GLU . 92.5 mt -145.52 102.42 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.898 . . . . 0.0 110.043 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -111.41 128.31 55.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.652 HG22 ' HB1' ' A' ' 15' ' ' ALA . 15.8 mt -118.96 124.68 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 110.379 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.8 t -129.12 133.24 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.293 -0.88 . . . . 0.0 110.109 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.94 147.78 24.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.665 -0.647 . . . . 0.0 111.288 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.7 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 0.0 109.022 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.717 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -140.79 167.49 22.05 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.577 -0.955 . . . . 0.0 110.552 -179.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 107' ' ' THR . 3.5 mt -117.4 120.71 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.204 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -91.75 142.02 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.992 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -130.8 96.49 4.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.605 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.9 115.51 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.567 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.545 ' CB ' ' HB3' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -91.36 152.13 20.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.67 124.86 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.097 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.88 144.5 49.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.11 -0.994 . . . . 0.0 110.471 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.817 ' CE1' HD11 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -122.02 135.35 54.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.989 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.54 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 22.5 m-70 -117.42 120.05 36.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 110.467 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.711 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.45 167.3 10.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.587 ' CB ' HD23 ' A' ' 95' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.492 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.711 ' HA ' HG21 ' A' ' 122' ' ' THR . 10.0 pt-20 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.719 0.771 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 128' ' ' VAL . 2.3 p -113.35 95.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.675 -0.641 . . . . 0.0 110.631 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 128' ' ' VAL . 15.4 mttt -42.87 139.04 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.8 -9.66 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 110.062 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -67.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.954 . . . . 0.0 109.887 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -53.7 -30.65 44.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.217 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.748 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.8 t -71.62 -52.07 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.496 -0.753 . . . . 0.0 109.486 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -61.84 -29.21 70.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.85 . . . . 0.0 109.792 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.88 60.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.788 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.3 t -71.66 -31.21 66.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.835 . . . . 0.0 110.097 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -74.89 -36.91 62.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -62.77 -46.62 87.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 110.072 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -38.85 58.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.2 -34.91 89.86 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.673 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.92 -50.68 65.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -1.142 . . . . 0.0 110.211 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -58.78 -24.57 61.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.424 HD23 ' CB ' ' A' ' 34' ' ' ALA . 36.0 mt -74.65 -42.79 57.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -67.58 -27.82 67.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 149' ' ' SER . 0.0 OUTLIER -81.76 -32.03 31.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 109.831 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.66 93.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.783 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' A' ' 22' ' ' PHE . 60.9 t -73.2 -43.68 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.815 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 27.2 tt0 -59.43 -43.98 92.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.834 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -62.01 -42.41 99.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 109.57 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -57.14 -73.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 110.098 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.758 HD13 HG21 ' A' ' 13' ' ' ILE . 1.4 mt -42.5 -33.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.142 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -58.98 -32.08 69.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.336 -0.853 . . . . 0.0 110.172 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.354 0.597 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.518 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 20.8 m-85 -107.47 169.09 8.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 109.865 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -149.21 143.18 25.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.798 ' CE2' HG11 ' A' ' 133' ' ' VAL . 55.5 m-85 -154.86 60.57 0.66 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 109.581 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -80.16 150.93 30.0 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.587 0.708 . . . . 0.0 110.501 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.428 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -147.75 174.5 11.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.486 -0.759 . . . . 0.0 109.712 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -158.7 163.54 36.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.724 ' HB ' HD21 ' A' ' 114' ' ' LEU . 12.0 m -159.91 154.99 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 110.213 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.49 163.37 13.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.478 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -158.47 138.92 12.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 76.2 t -80.0 -14.01 13.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.136 -0.978 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.918 HG21 HD12 ' A' ' 151' ' ' LEU . 22.0 mm -67.52 150.3 97.92 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.766 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.3 Cg_endo -67.09 149.95 82.33 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.503 1.265 . . . . 0.0 110.701 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.92 -25.2 58.74 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.892 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 -54.79 6.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.476 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 14.5 mtp180 -65.8 -31.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.722 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.526 HD23 HG21 ' A' ' 104' ' ' ILE . 30.0 tp -71.29 -32.39 68.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.811 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.848 ' CD2' HD13 ' A' ' 23' ' ' ILE . 6.3 t80 -70.45 -64.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -46.67 -42.55 16.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 110.481 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . . . -70.68 -36.04 73.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.517 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 17.4 t80 -91.96 -11.3 36.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.816 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.848 HD13 ' CD2' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -118.75 -62.19 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 109.982 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -72.87 -23.43 60.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.833 . . . . 0.0 110.109 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.526 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . 1.7 t70 -128.85 3.13 5.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -59.85 -37.81 93.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.697 ' O ' HG21 ' A' ' 41' ' ' VAL . 76.4 m-20 -59.61 -25.45 64.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -1.101 . . . . 0.0 110.262 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -98.67 -22.62 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.45 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.888 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -93.04 -22.89 18.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -58.13 -58.08 21.36 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 109.932 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 49.4 Cg_endo -75.36 2.9 6.29 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.065 1.56 . . . . 0.0 110.679 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 1.2 mtpt -105.27 -60.09 1.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.016 -1.052 . . . . 0.0 110.76 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 29' ' ' LEU . 23.4 m -82.73 -18.88 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 143' ' ' LEU . . . -138.41 72.08 44.78 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.79 -16.8 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.03 1.542 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -74.78 -16.22 60.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.665 ' HB2' HD23 ' A' ' 139' ' ' LEU . . . -103.85 -63.74 1.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 110.053 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.8 mp -93.62 144.14 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.486 -0.758 . . . . 0.0 110.305 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 0.1 OUTLIER -103.03 -40.26 6.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.02 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.499 ' HB2' ' CB ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -166.93 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 27' ' ' ASP . 3.7 m -134.55 153.48 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -157.91 104.37 1.92 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 111.297 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.66 117.74 7.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.645 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 55' ' ' LYS . 14.2 mm -84.26 -38.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.231 1.015 . . . . 0.0 108.779 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 52' ' ' THR . 47.1 tt0 . . . . . 0 C--N 1.295 -1.764 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.245 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.687 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -76.08 119.23 5.26 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.054 1.555 . . . . 0.0 110.438 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.99 2.26 59.45 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.693 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -67.87 156.78 36.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.171 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 44' ' ' ILE . 10.9 mt -121.86 131.15 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.222 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.45 140.63 30.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' C ' HD13 ' A' ' 56' ' ' ILE . 11.7 ttmt -93.78 119.01 32.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.569 HD12 HG12 ' A' ' 41' ' ' VAL . 7.9 mm -102.34 128.03 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.089 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 40' ' ' SER . 0.7 OUTLIER -90.01 153.75 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.333 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -119.56 134.95 23.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.153 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.304 -1.782 0 O-C-N 123.991 1.521 . . . . 0.0 110.146 179.662 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.612 ' C ' HG12 ' A' ' 67' ' ' VAL . 12.8 p90 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.296 0.57 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER 173.16 171.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 110.377 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.47 137.83 52.26 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.594 -0.691 . . . . 0.0 109.746 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 85' ' ' VAL . 94.1 m-20 -125.22 125.78 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 110.656 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 52' ' ' THR . 1.4 ttt180 -94.07 133.59 37.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.693 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.4 t -72.58 144.38 13.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.825 -1.172 . . . . 0.0 110.743 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 86.4 m-20 -92.87 -68.92 0.77 Allowed 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.339 0.59 . . . . 0.0 110.193 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.8 tp10 -143.35 134.67 26.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.177 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 81' ' ' TYR . 3.8 t -117.29 147.79 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.897 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.35 105.0 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -80.47 -4.42 53.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -108.12 -33.2 7.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.182 -0.949 . . . . 0.0 109.305 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.66 4.52 43.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.665 -0.647 . . . . 0.0 110.109 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.55 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 22.9 m-85 53.56 46.71 25.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.07 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.39 109.97 15.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.149 -0.97 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.501 ' CD2' HG22 ' A' ' 74' ' ' VAL . 44.5 t80 -127.62 107.47 9.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.897 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 7.8 m120 -114.23 140.57 48.47 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.091 -1.005 . . . . 0.0 109.999 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 100' ' ' ASN . 48.8 p90 -143.16 138.62 29.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.7 m -103.97 172.17 6.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 111.376 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.817 HG11 HD13 ' A' ' 98' ' ' ILE . 42.4 t -111.21 126.57 68.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.574 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -120.94 -76.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.818 -1.176 . . . . 0.0 111.518 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.6 102.42 7.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.818 -1.176 . . . . 0.0 110.652 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -129.42 145.43 16.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.54 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.59 -57.28 3.93 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.6 Cg_endo -71.21 -30.58 15.72 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.394 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.574 HG21 ' O ' ' A' ' 86' ' ' ILE . 73.9 mt -78.64 147.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.81 -36.32 0.73 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.07 -74.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.493 ' H ' HD12 ' A' ' 95' ' ' LEU . 14.1 t -137.3 4.52 2.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.928 . . . . 0.0 110.416 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 95' ' ' LEU . 5.6 mp -84.37 150.88 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.935 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.9 34.25 21.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.59 162.53 29.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 110.253 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.817 HD13 HG11 ' A' ' 85' ' ' VAL . 4.0 mp -136.5 131.42 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 119' ' ' LYS . 1.8 m -118.75 119.73 35.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.364 -0.835 . . . . 0.0 109.603 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 13.9 m-80 -112.17 160.6 17.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 110.721 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.474 ' CG ' ' CG ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -150.84 132.1 14.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.11 125.67 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.027 -1.046 . . . . 0.0 110.564 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 69.5 tttt -129.7 119.22 23.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.858 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.526 HG21 HD23 ' A' ' 18' ' ' LEU . 70.5 mt -118.42 112.49 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.763 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.0 t -112.01 141.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.414 -0.804 . . . . 0.0 109.879 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.0 147.08 25.18 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.499 -0.75 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.7 p . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 0.0 109.089 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.861 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -136.87 163.04 31.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.755 -0.85 . . . . 0.0 110.644 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 113' ' ' ILE . 1.7 tt -112.16 126.81 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.166 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 9' ' ' THR . 2.0 pp -106.14 135.72 47.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.869 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -124.52 106.55 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 0.0 109.712 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 67.5 mt -97.22 112.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.47 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -97.8 114.02 25.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.27 135.37 48.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 99' ' ' SER . 4.7 mttt -126.22 155.74 41.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.371 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.612 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -132.04 130.21 41.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 71.8 m-70 -113.11 140.2 48.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.159 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.96 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.3 OUTLIER -129.78 170.71 13.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.974 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.96 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 120' ' ' TYR . 2.1 p -87.12 108.78 18.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 121.475 -0.765 . . . . 0.0 110.291 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -50.61 156.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -79.57 -7.46 58.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -50.4 -73.27 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -22.92 6.12 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 5' ' ' TYR . 11.5 t -76.09 -48.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.845 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -26.76 65.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.392 -0.817 . . . . 0.0 109.58 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -38.74 63.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.859 . . . . 0.0 109.366 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -60.52 -35.97 77.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.688 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -68.49 -48.14 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.869 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -52.43 -58.72 5.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.925 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -72.37 -33.06 66.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.08 -42.52 31.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.662 ' HA ' HD23 ' A' ' 144' ' ' LEU . 2.6 tp10 -63.11 -47.69 81.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -1.187 . . . . 0.0 109.975 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.1 m -59.89 -26.86 66.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.085 -1.009 . . . . 0.0 109.747 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.533 HD13 ' HE1' ' A' ' 30' ' ' PHE . 17.3 mt -67.68 -49.98 59.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.981 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.3 pp -66.97 -23.21 65.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.01 -1.056 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.446 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 2.0 tmm_? -80.9 -35.85 31.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.067 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 150' ' ' TYR . . . -65.32 -44.23 88.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.733 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.83 -45.26 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.514 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' A' ' 13' ' ' ILE . 1.1 tt0 -60.35 -56.24 23.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.51 47.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.585 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.24 -25.52 31.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.918 HD12 HG21 ' A' ' 13' ' ' ILE . 43.1 mt -88.8 -25.12 22.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -22.64 33.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.423 -179.824 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 120' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.368 0.604 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.506 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.2 m-85 -101.4 152.89 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.753 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.76 142.65 51.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.042 -1.036 . . . . 0.0 110.843 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.76 ' CD2' HG11 ' A' ' 133' ' ' VAL . 1.1 m-85 -154.12 53.7 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.645 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 7' ' ' THR . 1.9 pt-20 -81.61 160.0 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 110.557 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 6' ' ' GLU . 3.5 p -159.8 172.26 17.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.857 . . . . 0.0 109.874 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 12.7 pt-20 -146.34 141.88 27.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.017 . . . . 0.0 110.381 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 10' ' ' THR . 78.7 m -131.69 166.95 20.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 9' ' ' THR . 1.5 p -102.23 164.01 11.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.336 -0.853 . . . . 0.0 110.425 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 10' ' ' THR . 3.6 m -159.84 134.8 7.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.514 HG21 HD11 ' A' ' 152' ' ' LEU . 21.3 m -80.03 -14.06 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.61 HG23 ' HD2' ' A' ' 14' ' ' PRO . 36.2 mm -73.56 148.7 88.07 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.551 -0.718 . . . . 0.0 109.146 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.91 150.59 85.56 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.55 1.29 . . . . 0.0 110.965 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -70.09 -35.09 73.93 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.942 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.55 -56.44 6.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER -62.31 -36.29 81.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.909 HD22 HG21 ' A' ' 104' ' ' ILE . 4.4 tt -74.13 -33.94 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.407 -0.808 . . . . 0.0 110.241 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 32.5 t80 -60.81 -61.06 2.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.957 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttt -57.08 -36.87 71.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 110.058 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.51 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.403 ' CD1' HG21 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -91.91 -11.29 36.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.483 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.0 OUTLIER -121.69 -64.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -58.13 -48.38 80.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -105.01 7.55 34.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.155 -0.966 . . . . 0.0 110.463 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.85 -48.65 65.53 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB2' HG21 ' A' ' 41' ' ' VAL . 5.3 p-10 -57.67 -26.54 61.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.236 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -99.34 -30.93 11.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.649 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.673 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -81.54 -35.62 30.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.301 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.553 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 2.4 m-30 -44.8 -59.15 4.41 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 110.348 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -71.79 -10.45 26.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.877 1.462 . . . . 0.0 110.774 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -92.64 -57.26 2.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.984 . . . . 0.0 110.739 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 29' ' ' LEU . 27.1 m -94.18 -2.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 110.988 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -149.42 71.27 9.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.92 -1.112 . . . . 0.0 110.76 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.26 -20.11 16.67 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.005 1.529 . . . . 0.0 110.026 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -80.55 -29.06 37.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 110.092 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.02 -55.92 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 110.133 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.2 151.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.453 -0.78 . . . . 0.0 110.318 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 1.3 t -98.7 -46.49 5.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.865 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.426 ' C ' HG13 ' A' ' 41' ' ' VAL . 22.1 t -162.37 174.07 13.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 110.099 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 27' ' ' ASP . 24.7 m -147.71 146.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -144.26 151.06 38.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.447 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -100.09 116.73 32.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.868 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.6 mm -86.12 -37.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.19 0.995 . . . . 0.0 108.679 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 52' ' ' THR . 27.5 tt0 . . . . . 0 C--N 1.295 -1.798 0 CA-C-O 121.701 0.763 . . . . 0.0 110.734 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.66 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.8 Cg_endo -75.03 117.8 5.03 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.019 1.536 . . . . 0.0 110.744 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.14 2.02 56.95 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.66 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.3 m -69.79 149.42 47.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.039 -1.271 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.462 HG12 ' HG3' ' A' ' 70' ' ' ARG . 4.7 mt -115.31 128.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.548 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -137.03 148.87 47.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.92 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.868 ' HB2' HD11 ' A' ' 44' ' ' ILE . 8.6 tttt -94.13 95.07 8.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.822 -0.549 . . . . 0.0 109.988 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 66' ' ' TYR . 13.7 mt -84.04 137.0 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -109.03 133.3 53.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.622 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.97 144.35 29.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 109.842 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--N 1.306 -1.676 0 O-C-N 123.972 1.511 . . . . 0.0 110.475 -179.717 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' C ' HG13 ' A' ' 67' ' ' VAL . 18.3 p90 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.274 0.559 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.505 HG13 ' C ' ' A' ' 66' ' ' TYR . 18.2 m -154.47 154.38 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 25.8 ttmt -105.39 48.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -48.19 132.07 16.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 84' ' ' SER . 38.0 ttt180 -96.43 151.09 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 108.637 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.64 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.5 t -76.55 147.81 7.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.619 -1.301 . . . . 0.0 110.375 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 29.5 t0 -101.55 -74.07 0.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.373 0.606 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 mm-40 -141.32 146.6 36.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.209 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.763 HG22 ' HD1' ' A' ' 81' ' ' TYR . 2.9 t -137.37 127.95 38.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -124.64 113.65 18.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 109.747 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -13.45 60.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 111.105 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -106.68 -35.49 6.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.017 -1.052 . . . . 0.0 109.672 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.486 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.31 14.88 19.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.597 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 41.68 48.26 3.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.382 -0.824 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -116.65 113.7 23.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.217 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.763 ' HD1' HG22 ' A' ' 74' ' ' VAL . 41.1 t80 -133.04 120.29 21.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.383 -0.823 . . . . 0.0 110.071 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 42.6 t-20 -130.69 162.42 29.49 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 110.194 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 100' ' ' ASN . 23.7 p90 -153.94 140.86 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.2 m -98.08 154.01 18.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 98' ' ' ILE . 39.1 t -99.39 123.05 51.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.492 HD11 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -125.09 -77.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 111.041 -178.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.556 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 3.9 tm-20 -71.97 65.62 0.55 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -86.36 140.72 17.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.18 -53.83 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.9 Cg_endo -74.59 -45.26 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.784 1.412 . . . . 0.0 110.704 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 92' ' ' GLY . 49.2 mt -59.51 172.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.012 . . . . 0.0 110.189 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -152.42 -65.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.56 -85.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 110.107 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.6 p -140.12 19.2 2.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 110.35 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -94.28 153.83 17.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.557 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 36.2 mt-10 57.14 36.02 27.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.396 -0.815 . . . . 0.0 109.932 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.469 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.6 mttt -69.2 153.26 43.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.915 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.56 HG12 ' CE1' ' A' ' 120' ' ' TYR . 12.6 mt -138.93 132.0 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.722 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.6 m -121.91 110.36 15.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.623 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 5.0 m120 -104.03 125.89 50.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -110.18 167.13 10.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.457 ' CG1' ' O ' ' A' ' 101' ' ' GLU . 12.2 mt -155.39 118.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.479 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 5.9 tttt -119.46 114.19 21.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.909 HG21 HD22 ' A' ' 18' ' ' LEU . 2.7 mp -103.28 125.43 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 112' ' ' SER . 42.6 t -131.21 145.71 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.246 -0.909 . . . . 0.0 110.542 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.96 153.43 21.3 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.777 -0.577 . . . . 0.0 110.218 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.501 HG21 HG13 ' A' ' 113' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.064 -1.022 . . . . 0.0 111.331 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -157.14 170.63 22.07 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.501 HG13 HG21 ' A' ' 107' ' ' THR . 48.4 mt -122.76 120.58 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.517 ' HG ' ' CG1' ' A' ' 104' ' ' ILE . 1.4 mp -86.95 122.05 30.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.667 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -104.27 97.48 7.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.8 mt -85.67 144.59 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.861 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.512 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -128.05 120.58 27.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.55 123.93 51.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.015 -1.053 . . . . 0.0 110.612 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -120.76 128.43 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.746 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 1.031 ' CE2' HG22 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -109.31 143.5 38.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -0.985 . . . . 0.0 110.243 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 66.9 m-70 -128.11 129.64 46.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.058 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -113.85 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.384 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.748 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 128' ' ' VAL . 2.7 p -100.05 98.15 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.372 -0.83 . . . . 0.0 110.527 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 128' ' ' VAL . 3.8 mttm -54.94 -172.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.49 16.73 16.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.85 -72.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.875 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -30.49 38.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 109.201 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.031 HG22 ' CE2' ' A' ' 120' ' ' TYR . 11.3 t -70.88 -48.83 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.463 -0.773 . . . . 0.0 109.531 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -65.46 -36.31 83.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 0.0 110.173 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.52 72.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.661 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 t -66.4 -38.36 87.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.752 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -64.22 -43.8 93.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.993 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -51.18 -53.79 31.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.32 -24.35 62.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -57.63 -44.03 94.1 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 15.8 mt-10 -64.43 -57.51 9.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -1.161 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.8 m -46.27 -29.94 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 143' ' ' LEU . 20.2 mt -70.61 -59.33 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.847 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -66.72 -17.89 65.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.172 -0.955 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' SER . 0.0 OUTLIER -84.12 -33.64 24.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.798 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 33' ' ' VAL . . . -69.11 -44.05 73.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.907 . . . . 0.0 109.438 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 22' ' ' PHE . 41.7 t -67.95 -43.97 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.679 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -61.2 -36.74 80.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.249 -0.907 . . . . 0.0 109.374 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.9 OUTLIER -68.08 -52.87 30.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 0.0 109.755 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -47.46 -69.92 0.11 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 110.312 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 13' ' ' ILE . 2.3 mt -46.21 -36.53 6.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.394 -0.817 . . . . 0.0 110.403 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.514 HD11 HG21 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -71.3 -56.41 6.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.084 -1.01 . . . . 0.0 110.297 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.933 . . . . 0.0 110.241 -179.876 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.754 HG11 ' ND1' ' A' ' 121' ' ' HIS . 4.2 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.729 0.776 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -107.31 153.04 23.32 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.261 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 143.8 48.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.971 -1.08 . . . . 0.0 111.183 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.854 ' CE2' HG11 ' A' ' 133' ' ' VAL . 10.8 m-85 -153.59 58.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 0.0 109.151 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 9.9 pt-20 -84.94 145.07 27.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 110.807 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -146.78 167.53 23.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 3.5 pm0 -147.42 166.87 25.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.99 . . . . 0.0 110.369 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.12 -168.4 2.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 p -130.35 160.81 32.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.461 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.449 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . 41.5 m -159.95 139.26 11.03 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 14.8 p -79.83 -6.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.203 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.731 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.9 mm -74.27 148.96 86.64 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.731 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.0 150.25 88.33 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.561 1.296 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -67.04 -36.99 83.29 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.457 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.66 -54.16 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.565 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.542 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 12.0 ttt180 -57.83 -39.5 77.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 1.4 tt -67.32 -39.1 85.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.705 ' CD1' HD13 ' A' ' 23' ' ' ILE . 61.9 t80 -61.23 -71.0 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 0.0 110.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -47.4 -45.67 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.144 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 0.0 110.496 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 16.2 t80 -90.86 -7.09 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.705 HD13 ' CD1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -121.42 -64.9 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.978 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.483 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -61.82 -48.27 81.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 110.299 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 28' ' ' ASN . 29.9 t0 -110.82 16.7 21.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 110.313 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.72 -61.18 6.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -45.89 -23.88 0.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -1.125 . . . . 0.0 110.711 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.412 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 29.3 t-20 -89.74 -32.51 16.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 0.0 110.518 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mp -84.4 -18.08 37.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -62.49 -61.81 6.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.675 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -72.72 53.76 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.841 1.443 . . . . 0.0 110.981 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -151.64 -63.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.119 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.519 HG11 ' CE1' ' A' ' 150' ' ' TYR . 17.0 m -86.18 -19.93 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.44 66.12 35.52 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 110.264 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.66 -10.77 21.97 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.003 1.528 . . . . 0.0 110.397 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -22.91 64.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.285 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.459 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -95.19 -55.91 2.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.536 HG12 HG21 ' A' ' 56' ' ' ILE . 1.4 mp -107.72 137.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 110.112 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.19 -29.33 14.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.987 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.5 m -178.61 145.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.012 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 2.3 p -126.99 119.21 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.167 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -115.01 119.68 37.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.3 m-20 -65.54 117.59 8.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.493 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.733 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.8 mm -79.91 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.36 1.076 . . . . 0.0 108.422 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.2 mm-40 . . . . . 0 C--N 1.295 -1.761 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.064 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.884 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 43.8 Cg_endo -70.72 83.68 0.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.05 1.553 . . . . 0.0 110.286 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.86 -8.69 2.25 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.884 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 32.7 m -67.69 165.54 17.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.965 -1.315 . . . . 0.0 109.257 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 19.5 mt -138.03 143.37 33.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.961 -1.087 . . . . 0.0 111.056 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -154.9 136.9 14.63 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.733 ' HB2' HD11 ' A' ' 44' ' ' ILE . 1.1 ttpm? -95.56 112.48 24.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 111.404 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.536 HG21 HG12 ' A' ' 38' ' ' ILE . 15.1 mt -98.17 122.33 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 109.266 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.488 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -84.08 150.89 25.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.691 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -111.19 137.06 20.87 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.198 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.459 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 48.6 Cg_endo . . . . . 0 C--N 1.304 -1.765 0 O-C-N 123.994 1.523 . . . . 0.0 110.529 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.595 ' CD1' ' HE2' ' A' ' 55' ' ' LYS . 21.5 p90 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.227 0.537 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 ' OD1' ' A' ' 69' ' ' ASP . 4.2 m -143.09 175.74 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.177 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.9 ttpt -122.46 37.93 4.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 84' ' ' SER . 4.6 p-10 -42.24 138.57 1.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.618 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.0 ptt180 -102.81 167.26 9.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 108.947 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.696 HG21 ' HB ' ' A' ' 52' ' ' THR . 16.3 t -77.85 152.34 5.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.94 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 34.2 t70 -104.71 -66.34 0.97 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -144.7 130.09 18.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.251 -0.906 . . . . 0.0 110.742 -179.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 5.4 t -116.12 150.83 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.578 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -158.33 111.23 2.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.221 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -21.25 51.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -104.77 -40.32 6.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.19 -0.944 . . . . 0.0 109.756 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -84.48 7.22 20.56 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.762 . . . . 0.0 110.274 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.526 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 8.0 m-85 46.25 59.26 3.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.29 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -131.27 107.94 9.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.965 -1.084 . . . . 0.0 110.741 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.672 ' O ' HD12 ' A' ' 102' ' ' ILE . 13.9 t80 -125.99 104.1 8.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.54 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 37.3 m-20 -121.02 149.1 43.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.2 p90 -139.04 138.38 37.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' ARG . 5.7 m -101.89 159.94 14.92 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.906 -1.121 . . . . 0.0 111.008 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 55.5 t -106.98 121.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.16 -75.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.067 -1.021 . . . . 0.0 110.873 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' OE1' ' CA ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -74.04 95.24 2.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.72 -1.238 . . . . 0.0 110.101 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -122.79 138.31 11.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.551 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.4 -54.36 3.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.4 Cg_endo -72.47 -48.43 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.831 1.437 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.415 ' CD1' HG12 ' A' ' 85' ' ' VAL . 64.4 mt -54.5 160.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.178 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.59 -70.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.592 ' H ' HD23 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -103.31 74.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 110.198 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 46.6 p 43.7 24.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.592 HD23 ' H ' ' A' ' 93' ' ' ASP . 3.6 pp -96.96 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 0.0 110.126 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.585 ' CB ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER 56.45 34.66 24.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -67.95 151.48 47.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.301 -0.874 . . . . 0.0 110.018 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.654 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -126.79 120.67 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.612 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -108.83 104.23 13.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.56 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -96.25 145.43 25.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.782 -179.249 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.54 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 1.2 mp0 -136.11 139.73 43.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.437 -0.79 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 81' ' ' TYR . 3.0 mp -130.21 100.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 110.476 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 59.3 tttt -104.76 124.47 49.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.01 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 50.0 mt -110.45 138.63 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.895 . . . . 0.0 110.377 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 t -139.2 138.87 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.05 -1.031 . . . . 0.0 109.912 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.08 144.08 26.7 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.497 0.665 . . . . 0.0 110.479 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.9 p . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.81 . . . . 0.0 108.924 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -134.51 163.56 29.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.785 -0.832 . . . . 0.0 110.538 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.46 HG13 HG22 ' A' ' 107' ' ' THR . 9.1 mt -109.49 133.25 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 109.349 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.471 HD23 HD11 ' A' ' 116' ' ' ILE . 0.0 OUTLIER -97.88 133.93 41.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.976 -1.078 . . . . 0.0 110.803 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -129.55 98.66 4.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.413 -0.804 . . . . 0.0 109.642 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 1.5 mp -101.02 136.86 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.933 . . . . 0.0 110.421 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -113.33 125.44 54.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.374 -0.829 . . . . 0.0 110.232 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.78 134.0 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.633 ' HG2' HG21 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -125.82 143.59 51.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.956 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.654 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -125.56 104.02 8.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.97 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.754 ' ND1' HG11 ' A' ' 2' ' ' VAL . 33.2 m-70 -83.42 101.44 11.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.88 . . . . 0.0 110.409 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.5 166.98 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.804 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.325 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.551 0.691 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.638 HG21 ' CD2' ' A' ' 120' ' ' TYR . 3.0 p -104.79 86.62 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -48.48 150.29 1.39 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -60.46 -27.34 67.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.959 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 130' ' ' ALA . 28.5 mt-10 -41.71 -64.59 0.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 110.046 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -55.12 -29.7 58.23 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.854 HG11 ' CE2' ' A' ' 5' ' ' TYR . 9.3 t -72.88 -50.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.415 -0.803 . . . . 0.0 109.442 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.2 -21.4 60.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.198 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 -32.29 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.122 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -35.58 37.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -49.36 -60.57 2.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 110.004 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -76.94 -31.7 56.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 110.116 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.52 -55.03 14.38 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.586 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -50.06 -40.3 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.154 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.06 -24.91 67.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.987 . . . . 0.0 109.695 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 54.7 mt -73.81 -51.49 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.94 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.4 pp -64.54 -22.01 66.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 149' ' ' SER . 17.4 tpt85 -81.66 -43.08 19.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.444 -0.785 . . . . 0.0 109.682 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -57.75 -36.72 72.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.3 t -73.22 -53.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 109.603 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.449 ' OE2' ' HA ' ' A' ' 11' ' ' SER . 50.7 tt0 -53.48 -53.15 55.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -58.6 -36.3 73.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.128 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.519 ' CE1' HG11 ' A' ' 33' ' ' VAL . 1.2 t80 -48.93 -71.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.573 -0.704 . . . . 0.0 109.823 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.634 HD22 HG23 ' A' ' 13' ' ' ILE . 1.9 mp -56.45 -26.53 54.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.725 . . . . 0.0 110.071 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -77.74 -14.38 59.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.32 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -179.875 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 120' ' ' TYR . 4.5 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.427 0.632 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.6 m-85 -111.24 151.31 28.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.33 135.61 49.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 110.363 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.683 ' CE2' HG11 ' A' ' 133' ' ' VAL . 28.2 m-85 -148.39 70.68 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.445 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -95.19 154.21 17.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 6' ' ' GLU . 2.1 p -158.15 -169.77 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.507 -0.746 . . . . 0.0 109.844 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.9 pt-20 -159.96 150.93 19.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.748 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.706 HG21 HD21 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -132.17 153.39 50.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.402 -0.811 . . . . 0.0 109.77 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.892 HG22 ' CD1' ' A' ' 113' ' ' ILE . 1.8 p -92.93 160.2 15.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.741 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.48 ' OG ' ' CD1' ' A' ' 114' ' ' LEU . 17.3 m -158.07 137.78 12.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 109.673 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.425 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 56.7 t -80.05 -11.0 12.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.795 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.0 OUTLIER -75.85 150.73 84.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.795 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.3 Cg_endo -66.71 150.74 83.52 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.716 1.377 . . . . 0.0 111.145 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 104' ' ' ILE . . . -73.73 -19.57 60.76 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.497 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.8 -54.87 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 14.4 ttp180 -64.15 -38.35 90.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.759 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.622 ' HB2' HG22 ' A' ' 13' ' ' ILE . 6.4 tt -71.29 -33.48 69.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.703 ' CD2' HD13 ' A' ' 23' ' ' ILE . 33.8 t80 -62.26 -65.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.115 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -51.64 -47.82 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 110.266 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.29 73.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 25.9 t80 -91.73 -13.01 32.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.703 HD13 ' CD2' ' A' ' 19' ' ' PHE . 1.1 mp -114.98 -71.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.192 -0.942 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.576 ' N ' HG22 ' A' ' 23' ' ' ILE . 8.1 mt -62.22 -34.2 76.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.845 . . . . 0.0 110.766 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.4 m-20 -118.0 23.8 11.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.156 -0.965 . . . . 0.0 110.444 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.56 -38.22 33.19 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.506 ' O ' HG11 ' A' ' 41' ' ' VAL . 1.9 p30 -56.49 -30.57 63.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -1.152 . . . . 0.0 110.408 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 25' ' ' ASP . 4.9 p-10 -96.02 -18.81 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 tp -82.21 -39.75 22.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 110.341 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.588 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -53.05 -62.04 3.99 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.224 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.8 Cg_endo -73.27 54.89 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.813 1.428 . . . . 0.0 110.476 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.7 -67.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 110.564 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.14 -15.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.512 -0.742 . . . . 0.0 110.449 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.25 76.87 4.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.346 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.0 -2.19 11.64 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.044 1.549 . . . . 0.0 110.214 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -72.72 -28.31 62.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.624 ' CB ' HD11 ' A' ' 143' ' ' LEU . . . -86.42 -61.66 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.961 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.586 HD13 ' CG ' ' A' ' 30' ' ' PHE . 1.2 mp -105.8 128.91 59.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.402 -0.811 . . . . 0.0 109.699 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -91.33 -25.3 19.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.18 -0.95 . . . . 0.0 110.485 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.39 141.02 0.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.693 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.641 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.1 p -127.47 139.88 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mm-40 -142.23 158.74 43.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.973 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -103.87 115.73 31.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.465 -0.772 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.436 HD11 ' HG3' ' A' ' 68' ' ' LYS . 10.0 mt -81.23 -39.01 17.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.811 ' OE1' HD12 ' A' ' 53' ' ' ILE . 2.8 tp10 . . . . . 0 C--N 1.296 -1.739 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.708 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.735 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.32 89.34 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.6 -3.03 3.17 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.189 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.735 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 33.5 m -78.48 161.34 27.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.319 . . . . 0.0 109.697 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.811 HD12 ' OE1' ' A' ' 45' ' ' GLU . 14.0 mt -130.9 144.91 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.911 -1.118 . . . . 0.0 110.619 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -152.47 144.45 23.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.778 . . . . 0.0 109.784 179.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -93.52 117.45 30.1 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.434 -0.791 . . . . 0.0 110.757 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.641 ' CD1' HG23 ' A' ' 41' ' ' VAL . 16.5 mm -102.73 141.76 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -112.19 142.72 44.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.048 -1.032 . . . . 0.0 110.437 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -118.2 123.2 29.61 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 O-C-N 123.855 1.45 . . . . 0.0 110.383 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.456 ' C ' HG12 ' A' ' 67' ' ' VAL . 40.6 p90 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.855 0.836 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.556 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -173.91 172.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.569 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -107.95 128.68 54.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.161 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' A' ' 85' ' ' VAL . 17.0 m-20 -127.19 130.67 50.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 2.4 ttp180 -101.15 145.26 29.02 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 0.0 108.935 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.735 HG21 ' HB ' ' A' ' 52' ' ' THR . 9.7 t -67.9 149.79 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.965 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t70 -101.33 -68.95 0.79 Allowed 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.403 0.621 . . . . 0.0 110.386 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.1 tt0 -145.8 121.94 10.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 110.339 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.683 HG22 ' HD1' ' A' ' 81' ' ' TYR . 3.7 t -108.91 151.6 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 1.2 m-20 -152.08 113.77 4.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -88.89 2.13 54.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 110.144 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -117.43 -40.84 3.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.692 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.1 11.77 28.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.219 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.547 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 50.35 57.79 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.547 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 3.8 mtpt -129.61 126.27 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.683 ' HD1' HG22 ' A' ' 74' ' ' VAL . 16.4 t80 -143.63 106.62 4.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 62.7 t-20 -117.0 165.99 12.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.631 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.3 p90 -161.17 137.76 8.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.818 . . . . 0.0 109.467 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 69.8 m -106.85 168.53 9.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.581 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' A' ' 69' ' ' ASP . 39.8 t -106.58 127.87 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -114.8 -70.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 111.879 -178.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.569 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -90.48 98.09 11.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.492 -1.38 . . . . 0.0 110.147 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -111.33 141.53 16.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.03 -58.7 3.63 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.0 Cg_endo -74.06 -31.46 7.88 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.986 1.519 . . . . 0.0 110.461 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 91' ' ' ILE . 54.0 mt -67.66 145.61 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.306 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.11 -92.21 2.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.58 -72.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.9 p -132.06 15.11 4.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.47 146.67 23.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 110.315 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 62.33 33.05 16.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.972 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -79.08 149.66 32.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.519 HG12 ' CE1' ' A' ' 120' ' ' TYR . 11.0 mt -127.69 153.93 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.816 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.3 m -145.64 105.39 3.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.489 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 7.7 m120 -101.19 124.4 46.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.147 -0.971 . . . . 0.0 110.889 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.531 ' HG3' ' ND2' ' A' ' 82' ' ' ASN . 1.9 tt0 -106.71 152.41 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.545 -0.722 . . . . 0.0 109.776 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.442 HG13 ' C ' ' A' ' 101' ' ' GLU . 13.5 mt -137.6 144.44 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.206 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.711 ' O ' HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -143.98 132.42 22.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 103' ' ' LYS . 7.3 mm -119.94 119.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 109.908 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 112' ' ' SER . 14.4 t -133.49 126.15 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 110.918 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -72.96 158.17 35.99 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.149 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.534 HG21 HG12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.026 -1.046 . . . . 0.0 111.22 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 13.7 t -159.99 -178.86 7.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 111.274 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.892 ' CD1' HG22 ' A' ' 10' ' ' THR . 39.1 mm -130.0 117.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.48 ' CD1' ' OG ' ' A' ' 11' ' ' SER . 3.4 mp -87.2 121.12 29.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.966 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -104.34 106.83 17.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.662 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 116' ' ' ILE . 1.2 tt -105.63 132.17 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 40.7 t -121.1 115.18 22.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 5' ' ' TYR . 2.1 t-20 -99.25 134.71 41.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 134.3 50.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.519 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -116.75 131.93 56.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.87 . . . . 0.0 109.998 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 86.9 m-70 -116.25 101.51 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.038 . . . . 0.0 110.29 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.28 167.15 11.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.201 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 110.367 -179.875 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.262 0.553 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.1 t -132.09 103.43 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 110.092 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -75.95 139.91 41.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.496 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -61.76 -10.17 8.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.989 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.42 -52.88 41.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.875 -1.141 . . . . 0.0 109.878 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -28.91 68.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 108.881 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.683 HG11 ' CE2' ' A' ' 5' ' ' TYR . 22.1 t -76.98 -49.97 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.5 -0.75 . . . . 0.0 109.12 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 15.6 tptt -66.58 -27.33 67.64 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.722 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.96 -33.47 63.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.762 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.6 t -67.07 -34.69 78.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.106 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -29.57 66.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.24 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.23 -66.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -17.91 62.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.43 -41.12 86.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.621 ' HA ' HD23 ' A' ' 144' ' ' LEU . 1.8 tt0 -67.62 -42.2 82.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 110.109 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -61.47 -29.01 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.495 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.624 HD11 ' CB ' ' A' ' 37' ' ' ALA . 18.1 mt -68.85 -54.5 15.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.409 -0.807 . . . . 0.0 109.908 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 9' ' ' THR . 1.1 pp -61.48 -29.43 69.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.499 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -72.86 -34.05 66.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.429 -0.794 . . . . 0.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.56 -43.21 90.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.98 -40.86 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.609 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 2.8 tt0 -54.66 -48.9 71.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.842 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t -59.53 -50.36 74.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -47.18 -70.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.66 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.7 HD13 HG21 ' A' ' 13' ' ' ILE . 8.5 mt -47.59 -45.17 27.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -50.92 -46.25 60.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 110.277 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.786 HG11 ' ND1' ' A' ' 121' ' ' HIS . 13.1 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.618 0.723 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 31.9 m-85 -117.62 141.58 48.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.996 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.6 141.14 46.72 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.022 . . . . 0.0 110.258 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CE1' HG11 ' A' ' 133' ' ' VAL . 42.8 m-85 -147.16 55.63 1.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.725 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.67 148.85 30.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.787 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.61 -0.681 . . . . 0.0 109.78 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.81 158.03 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 -171.4 3.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.586 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.81 162.16 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.407 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 20.1 m -159.2 143.36 15.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 0.0 109.936 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.607 HG13 HD12 ' A' ' 13' ' ' ILE . 7.2 p -79.94 -12.85 13.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.618 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.69 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.2 mp -69.95 149.28 96.42 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.28 149.59 85.09 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.437 1.23 . . . . 0.0 111.157 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.821 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.63 -25.91 59.54 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.53 -53.53 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.918 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.523 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -66.1 -34.2 77.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.8 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.605 ' HB2' HG22 ' A' ' 13' ' ' ILE . 7.0 tt -74.95 -30.99 61.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.615 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.599 ' CE1' HG13 ' A' ' 23' ' ' ILE . 59.3 t80 -67.92 -71.82 0.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.995 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -50.45 -42.68 54.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.853 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -66.21 -36.16 82.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.493 -0.754 . . . . 0.0 110.294 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 25.8 t80 -91.98 -10.93 37.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.599 HG13 ' CE1' ' A' ' 19' ' ' PHE . 7.7 mm -100.35 -74.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.211 -0.931 . . . . 0.0 110.157 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.995 HD12 ' HG2' ' A' ' 20' ' ' LYS . 19.8 mt -68.0 -40.99 82.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.44 -0.788 . . . . 0.0 109.796 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -85.39 -18.79 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 110.026 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.52 -40.43 62.19 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.79 ' O ' HG21 ' A' ' 41' ' ' VAL . 9.5 m-20 -55.74 -26.04 43.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -1.157 . . . . 0.0 110.11 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 67.6 m-20 -109.19 -23.32 11.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.591 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.6 mp -85.33 -28.48 25.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.219 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.564 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.6 m-30 -54.2 -59.79 9.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.6 Cg_endo -73.41 0.19 8.38 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.99 1.521 . . . . 0.0 110.556 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -96.25 -69.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.685 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 29' ' ' LEU . 25.2 m -81.81 7.27 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.396 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.16 2.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.325 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.33 -2.03 11.49 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.979 1.515 . . . . 0.0 110.653 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -90.62 -3.49 57.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.274 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' HD3' ' A' ' 59' ' ' PRO . . . -110.88 -71.56 0.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp -99.13 138.59 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.453 -0.78 . . . . 0.0 110.162 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 1.2 t -81.57 -48.82 11.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -163.65 176.75 9.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.296 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.79 HG21 ' O ' ' A' ' 27' ' ' ASP . 2.6 m -135.45 147.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 1.1 tt0 -136.44 161.29 36.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.84 110.16 20.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.937 HD11 ' HB2' ' A' ' 55' ' ' LYS . 15.5 mm -82.04 -39.45 16.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 122.231 1.015 . . . . 0.0 108.414 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.0 tm-20 . . . . . 0 C--N 1.296 -1.752 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.166 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.701 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.28 94.84 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.876 1.461 . . . . 0.0 110.221 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.38 -6.92 4.64 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.758 ' HB ' HG21 ' A' ' 71' ' ' VAL . 38.1 m -80.25 162.74 24.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -1.112 . . . . 0.0 109.53 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 31.5 mt -137.41 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.099 -1.001 . . . . 0.0 110.37 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.632 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -148.79 142.7 25.76 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.267 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 44' ' ' ILE . 25.0 tttp -91.77 117.24 29.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.532 -0.73 . . . . 0.0 110.197 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.687 ' CD1' HG12 ' A' ' 41' ' ' VAL . 39.7 mm -97.15 119.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.244 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 39' ' ' SER . 3.7 m -82.54 130.68 35.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.869 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.455 ' CD2' ' HD2' ' A' ' 59' ' ' PRO . 2.3 m-85 -108.24 163.63 16.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 110.617 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 45.2 Cg_endo . . . . . 0 C--N 1.304 -1.769 0 O-C-N 124.238 1.652 . . . . 0.0 110.726 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.466 ' C ' HG13 ' A' ' 67' ' ' VAL . 8.3 p90 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.765 0.793 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.466 HG13 ' C ' ' A' ' 66' ' ' TYR . 29.2 m -152.21 150.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 11.6 mtmt -110.48 139.91 45.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.95 -1.094 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 20.2 p-10 -134.73 133.58 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 110.276 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 84' ' ' SER . 7.4 ttt180 -100.07 139.65 35.43 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.758 HG21 ' HB ' ' A' ' 52' ' ' THR . 14.1 t -61.31 153.92 5.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.541 -1.349 . . . . 0.0 111.039 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 18.4 t0 -106.32 -73.6 0.68 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.874 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.31 112.63 7.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.385 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.552 HG22 ' CE2' ' A' ' 81' ' ' TYR . 2.6 t -102.89 141.5 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' LYS . 16.8 t0 -142.63 120.55 12.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.64 1.33 57.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 110.383 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -115.39 -35.63 4.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.089 -1.007 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -102.14 20.81 15.97 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.488 -0.758 . . . . 0.0 110.503 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.8 m-30 43.21 56.72 4.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 75' ' ' ASP . 25.7 tttt -125.99 123.16 37.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -142.48 105.09 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.087 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 47.3 m-20 -121.0 144.01 48.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 110.185 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 31.1 p90 -135.49 137.37 42.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.848 . . . . 0.0 109.379 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.5 m -94.66 161.66 14.1 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 110.977 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.515 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 25.2 t -102.69 128.22 55.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -119.33 -74.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.06 -1.025 . . . . 0.0 111.349 -178.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.546 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -92.11 64.84 4.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.638 -1.289 . . . . 0.0 109.881 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . -131.77 159.67 23.3 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 44.98 -157.08 0.24 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.83 1.57 6.9 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.024 1.539 . . . . 0.0 110.782 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.542 HD11 HD13 ' A' ' 98' ' ' ILE . 75.9 mt -51.63 155.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.052 . . . . 0.0 110.321 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.1 -107.08 0.24 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.45 ' C ' HG23 ' A' ' 94' ' ' THR . 18.4 m-20 -47.7 -86.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.933 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.45 HG23 ' C ' ' A' ' 93' ' ' ASP . 30.6 p -148.23 12.34 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -92.82 157.85 16.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 110.239 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.4 mm-40 59.51 33.04 22.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.902 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.522 ' C ' HD12 ' A' ' 98' ' ' ILE . 1.2 ttpm? -76.55 159.36 30.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.622 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mp -142.02 127.59 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.875 . . . . 0.0 110.228 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t -116.42 112.9 22.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.603 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -99.24 136.62 38.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 110.495 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 90.2 mt-10 -125.97 144.28 50.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.794 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.4 mt -136.08 113.6 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.352 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.45 124.66 48.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.692 HG22 ' HB1' ' A' ' 15' ' ' ALA . 3.2 mt -118.2 127.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.0 t -132.56 141.59 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.93 144.45 26.55 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.393 0.616 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 111' ' ' GLY . 4.4 p . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.493 2.496 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -133.6 163.59 29.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.813 -0.816 . . . . 0.0 110.671 -179.3 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 113' ' ' ILE . 29.3 mt -108.32 131.6 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.42 -0.8 . . . . 0.0 109.022 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -106.01 135.29 47.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.937 -1.102 . . . . 0.0 110.504 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.45 111.12 11.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' THR . 3.2 mt -102.84 125.61 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 110.587 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.535 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -109.55 119.39 39.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.807 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.426 HD21 HG23 ' A' ' 98' ' ' ILE . 2.3 t-20 -118.26 141.66 48.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.319 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.3 mtpp -124.9 151.73 44.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 109.993 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.622 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -130.26 99.8 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 109.759 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.786 ' ND1' HG11 ' A' ' 2' ' ' VAL . 14.7 m-70 -86.01 105.83 16.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.804 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.642 HG21 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -113.02 172.94 6.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.1 tttt . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.866 . . . . 0.0 110.386 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -122.36 89.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.442 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -60.18 132.03 52.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.615 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . . . -54.9 -16.84 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.018 . . . . 0.0 110.632 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.22 -59.01 5.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.898 -1.126 . . . . 0.0 109.495 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -63.59 -30.2 71.34 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 109.061 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG11 ' CE1' ' A' ' 5' ' ' TYR . 16.1 t -71.74 -47.25 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 8.3 ttpp -65.07 -30.67 71.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.773 . . . . 0.0 110.048 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.44 -19.94 61.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.0 t -72.43 -43.47 63.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 110.092 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 138' ' ' GLU . 21.9 ptmt -79.91 -37.71 34.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 137' ' ' LYS . 6.5 tt0 -51.8 -57.58 8.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 -25.94 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -60.44 -46.49 94.25 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -62.26 -44.11 97.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.26 -1.141 . . . . 0.0 110.453 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.6 m -62.67 -22.82 66.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.003 -1.06 . . . . 0.0 109.775 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 143' ' ' LEU . 19.6 mt -74.32 -52.66 11.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 110.041 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.64 -27.32 66.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.602 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 27.0 mmt180 -77.17 -29.26 54.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.878 . . . . 0.0 109.492 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 150' ' ' TYR . . . -67.41 -49.64 62.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 22' ' ' PHE . 92.9 t -62.3 -41.55 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.694 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -63.38 -50.67 69.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.678 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -67.33 -16.78 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.676 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.46 ' CD2' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -83.53 -38.45 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.6 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 13' ' ' ILE . 8.7 mt -68.72 -55.29 11.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 110.285 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.63 -27.31 1.83 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.936 . . . . 0.0 109.994 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 110.018 179.797 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.523 0.677 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.488 ' CD2' ' HB ' ' A' ' 128' ' ' VAL . 1.2 m-85 -91.4 164.27 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -143.95 143.56 31.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CD2' HG11 ' A' ' 133' ' ' VAL . 68.2 m-85 -155.49 65.83 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.587 -0.695 . . . . 0.0 109.291 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 1.8 pp20? -85.15 153.1 22.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 110.888 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.43 176.45 9.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.972 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 2.0 pt-20 -158.44 149.38 20.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.127 -0.983 . . . . 0.0 110.483 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 -170.04 2.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -125.95 168.37 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.442 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -158.81 138.26 11.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.553 -0.717 . . . . 0.0 109.595 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 13' ' ' ILE . 4.0 p -79.89 -14.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.559 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.836 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.0 OUTLIER -72.39 152.16 92.03 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.73 150.3 86.27 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 123.505 1.266 . . . . 0.0 111.132 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.25 -22.07 59.49 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.642 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.24 -57.31 3.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt-85 -60.38 -29.49 68.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.571 ' CD2' HD11 ' A' ' 114' ' ' LEU . 4.3 tp -74.28 -42.19 59.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 23' ' ' ILE . 42.4 t80 -59.52 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 110.166 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.0 ttpt -53.49 -45.29 69.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.556 ' O ' HD22 ' A' ' 29' ' ' LEU . . . -70.83 -28.6 64.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.868 . . . . 0.0 110.588 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 42.1 t80 -92.03 -17.55 24.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.915 . . . . 0.0 110.486 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.62 HD13 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -117.64 -63.55 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.497 ' HA ' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -48.14 -47.89 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 110.265 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.1 m-20 -107.15 -12.03 15.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 30' ' ' PHE . . . -41.8 -30.49 0.64 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.63 -59.49 4.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -1.179 . . . . 0.0 110.048 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -87.89 -17.26 31.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.689 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.1 tp -75.72 -45.39 36.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 110.131 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.528 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.6 m-85 -43.46 -57.72 5.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 110.457 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.2 Cg_endo -70.05 -8.91 24.77 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.914 1.481 . . . . 0.0 110.608 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 6.0 ttmm -95.57 -46.2 6.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 29' ' ' LEU . 28.0 m -91.91 -8.11 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.381 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.09 81.05 3.35 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.82 -6.32 18.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.975 1.513 . . . . 0.0 110.298 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.18 -18.43 27.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.269 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.813 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -97.39 -71.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 30' ' ' PHE . 1.1 mp -99.69 152.58 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.546 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.39 -33.15 5.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.537 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.07 146.79 6.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.089 -1.007 . . . . 0.0 110.596 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.995 HG13 ' CD1' ' A' ' 56' ' ' ILE . 47.5 t -133.5 139.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 84.6 tt0 -152.48 158.74 43.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.441 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -104.49 117.88 35.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 110.377 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.74 HD11 ' HB2' ' A' ' 55' ' ' LYS . 21.6 mm -83.16 -38.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.301 1.048 . . . . 0.0 108.335 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.541 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 25.3 tp10 . . . . . 0 C--N 1.296 -1.741 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.099 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.956 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.48 100.86 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.858 1.452 . . . . 0.0 110.243 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 111.39 1.32 27.91 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.956 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.1 m -61.12 155.81 19.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -1.117 . . . . 0.0 109.5 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 11.7 mm -112.94 133.14 59.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.943 . . . . 0.0 109.775 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.837 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -145.34 144.5 30.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.102 -0.999 . . . . 0.0 110.285 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.74 ' HB2' HD11 ' A' ' 44' ' ' ILE . 5.6 tttm -92.83 112.67 24.7 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.619 -0.676 . . . . 0.0 110.608 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.995 ' CD1' HG13 ' A' ' 41' ' ' VAL . 38.8 mm -103.85 138.77 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 109.347 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.45 141.67 47.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 110.757 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -116.67 135.03 22.85 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.94 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo . . . . . 0 C--N 1.304 -1.787 0 O-C-N 123.93 1.49 . . . . 0.0 110.784 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.674 ' C ' HG12 ' A' ' 67' ' ' VAL . 6.7 p90 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.195 0.521 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.747 HG21 HG13 ' A' ' 85' ' ' VAL . 0.8 OUTLIER 168.81 171.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.367 -0.833 . . . . 0.0 110.586 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.572 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -106.03 54.36 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.642 -0.662 . . . . 0.0 109.938 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD1' HG13 ' A' ' 67' ' ' VAL . 5.2 m-20 -41.83 129.41 3.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.338 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -98.14 150.65 21.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 108.896 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.643 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -81.03 144.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.71 -1.243 . . . . 0.0 110.219 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 36.3 t0 -98.42 -71.0 0.7 Allowed 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.367 0.603 . . . . 0.0 110.004 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -143.84 113.01 6.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 0.0 110.047 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 4.9 t -104.17 136.21 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.267 -0.896 . . . . 0.0 109.932 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 74' ' ' VAL . 83.4 m-20 -141.07 113.03 7.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -82.51 -3.02 55.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -110.42 -36.68 5.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.201 -0.937 . . . . 0.0 109.653 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.39 15.24 20.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.598 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 m-30 45.86 51.97 10.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 110.34 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -129.21 124.54 34.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.973 -1.079 . . . . 0.0 110.751 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' CD2' HG12 ' A' ' 23' ' ' ILE . 2.2 t80 -139.44 101.6 4.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.421 -0.799 . . . . 0.0 109.861 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.516 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 74.0 m-20 -113.87 136.04 53.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.0 p90 -134.71 133.04 39.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.582 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' ARG . 68.3 m -99.41 170.58 8.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 111.433 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.747 HG13 HG21 ' A' ' 67' ' ' VAL . 48.9 t -106.71 131.27 56.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.39 -79.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.899 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 68' ' ' LYS . 1.1 tt0 -91.87 106.52 18.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.941 -1.099 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 67' ' ' VAL . . . 164.13 175.74 35.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 47.27 -159.81 0.41 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.92 -7.76 21.7 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.135 1.597 . . . . 0.0 110.691 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.537 ' CD1' HG12 ' A' ' 85' ' ' VAL . 47.7 mt -51.55 154.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.35 -58.1 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -121.33 -69.2 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.252 . . . . 0.0 110.645 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 t -147.31 9.14 0.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 0.0 110.748 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -92.7 155.74 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 0.0 110.091 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' HB2' HD12 ' A' ' 95' ' ' LEU . 1.9 mt-10 57.84 36.33 26.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -78.82 159.35 27.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 110.408 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.498 HG13 ' CD1' ' A' ' 120' ' ' TYR . 2.3 mt -139.82 137.69 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.528 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 m -123.46 112.72 17.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.33 -0.856 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 13.7 m120 -99.39 130.03 45.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.516 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 2.6 mt-10 -123.76 139.74 53.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.852 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.604 HG23 HG12 ' A' ' 116' ' ' ILE . 16.9 mt -135.59 114.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.369 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -114.53 124.22 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.862 . . . . 0.0 109.878 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.3 mp -111.92 134.79 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.416 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -140.58 137.94 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 0.0 110.417 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.67 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.0 146.62 25.41 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.78 -0.575 . . . . 0.0 110.968 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.5 p . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.352 -0.843 . . . . 0.0 108.957 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.817 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -137.34 166.38 23.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.477 -1.013 . . . . 0.0 111.13 -179.087 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.5 mt -118.86 126.0 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 109.103 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -97.12 146.08 25.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 0.0 110.863 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 13.4 mttt -141.58 109.97 5.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.525 -0.734 . . . . 0.0 109.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.604 HG12 HG23 ' A' ' 102' ' ' ILE . 19.0 mt -105.92 135.45 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.6 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.509 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -116.7 115.78 26.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.129 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -103.88 126.1 50.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.392 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -115.5 130.14 56.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.316 -0.865 . . . . 0.0 109.959 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.498 ' CD1' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -116.72 117.21 29.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.453 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.424 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 25.3 m-70 -94.26 130.64 40.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.629 HG23 HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -114.96 169.24 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 110.088 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.514 ' HA ' HG21 ' A' ' 122' ' ' THR . 72.1 mt-10 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.19 0.519 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.629 HG23 HG23 ' A' ' 122' ' ' THR . 2.3 t -121.14 116.11 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 133' ' ' VAL . 11.0 mttt -80.16 132.4 35.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.731 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.96 -48.41 52.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 110.913 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.9 mt-10 -36.98 -55.97 0.9 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 110.907 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.48 77.05 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.618 HG11 ' CD2' ' A' ' 5' ' ' TYR . 7.2 t -74.68 -48.3 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 109.315 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 130' ' ' ALA . 14.2 tptt -67.42 -30.22 69.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.531 -0.73 . . . . 0.0 109.824 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.54 60.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -35.1 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -79.74 -23.93 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.23 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -53.86 -52.81 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 4.6 mt -75.15 -28.75 60.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.468 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.666 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -55.49 -46.57 80.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.639 ' HA ' HD23 ' A' ' 144' ' ' LEU . 33.5 tt0 -56.34 -52.53 64.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -1.205 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.3 m -57.61 -28.86 64.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.201 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 37' ' ' ALA . 84.7 mt -69.48 -46.08 67.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 110.358 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.1 pp -68.77 -26.13 65.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.779 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -81.93 -41.0 21.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -56.1 -50.37 71.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.37 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.4 -48.84 86.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.475 -0.765 . . . . 0.0 108.954 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 36.5 tt0 -53.03 -46.83 68.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.8 t -67.43 -51.27 53.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.423 ' CE1' HG12 ' A' ' 33' ' ' VAL . 1.8 t80 -44.9 -69.38 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.809 . . . . 0.0 110.392 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 151' ' ' LEU . 29.9 mt -49.17 -37.1 21.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.503 -0.748 . . . . 0.0 110.629 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.2 mt -77.1 -18.84 57.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.048 -1.033 . . . . 0.0 110.373 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.935 . . . . 0.0 110.071 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.998 HG23 ' C ' ' A' ' 120' ' ' TYR . 9.3 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.586 0.708 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.89 -178.93 3.86 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.67 138.39 34.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.861 -1.149 . . . . 0.0 111.018 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.526 ' CD1' HG11 ' A' ' 133' ' ' VAL . 65.0 m-85 -144.44 54.83 1.27 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 9.0 pt-20 -80.1 152.55 29.24 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.543 0.687 . . . . 0.0 110.962 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.74 172.72 13.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -157.84 153.54 26.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.03 -169.14 3.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 110.12 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -132.14 167.64 19.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.349 -0.845 . . . . 0.0 110.391 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.899 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 17.3 t -79.92 -17.25 12.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.712 HG21 HD13 ' A' ' 151' ' ' LEU . 17.8 mm -70.42 149.31 95.71 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.6 Cg_endo -65.72 146.75 84.68 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.143 1.075 . . . . 0.0 111.053 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.836 ' HB2' ' CB ' ' A' ' 112' ' ' SER . . . -71.86 -30.13 65.11 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.45 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.54 -56.85 10.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.937 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -35.15 79.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -69.78 -38.31 76.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.485 -0.76 . . . . 0.0 109.418 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 41.9 t80 -62.2 -59.1 5.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.895 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -49.76 -48.42 50.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 110.314 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.84 76.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.6 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.2 t80 -88.43 -14.01 39.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.614 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' PHE . 1.3 mp -114.62 -48.9 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.95 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -72.12 -48.56 42.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 110.036 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.973 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -115.99 20.81 14.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.993 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.02 -58.18 14.97 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.663 ' OD1' HG11 ' A' ' 41' ' ' VAL . 21.8 m-20 -56.71 -19.08 14.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -1.174 . . . . 0.0 110.213 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.82 -37.03 10.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.9 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.034 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.9 mp -79.97 -20.84 44.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 0.0 110.163 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.52 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 1.1 m-85 -58.37 -57.03 29.33 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.552 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 48.7 Cg_endo -73.0 -13.62 26.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.054 1.555 . . . . 0.0 110.945 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.17 -43.38 11.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.989 . . . . 0.0 110.58 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.034 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.8 m -89.68 -24.76 5.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 110.315 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.36 78.84 7.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.48 -31.31 7.26 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.093 1.575 . . . . 0.0 110.63 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.37 -18.65 11.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.062 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.779 ' HA ' HD23 ' A' ' 139' ' ' LEU . . . -96.83 -48.0 5.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.221 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -123.29 146.49 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 109.923 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.423 ' C ' ' OG ' ' A' ' 40' ' ' SER . 1.6 t -92.56 -53.05 4.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -162.32 172.51 15.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 0.0 110.634 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.964 HG13 HG12 ' A' ' 56' ' ' ILE . 12.6 t -145.83 138.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.311 -0.868 . . . . 0.0 109.886 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mt-10 -137.62 163.89 30.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.723 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.7 116.56 32.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.724 HD11 ' HB2' ' A' ' 55' ' ' LYS . 23.9 mm -83.63 -37.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.345 1.069 . . . . 0.0 108.372 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 6.1 tp10 . . . . . 0 C--N 1.293 -1.857 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.679 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 45.4 Cg_endo -71.72 118.35 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.939 1.494 . . . . 0.0 110.249 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.75 54.68 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.703 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.4 m -68.41 154.46 41.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -1.183 . . . . 0.0 109.348 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 9.3 mt -116.96 133.39 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.011 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 1.4 ptpt -143.28 147.54 34.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.661 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.724 ' HB2' HD11 ' A' ' 44' ' ' ILE . 12.7 tttp -105.35 118.27 36.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.688 -0.633 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.964 HG12 HG13 ' A' ' 41' ' ' VAL . 23.0 mt -107.26 147.83 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.082 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -107.25 139.49 41.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.127 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -112.58 125.63 29.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.307 -1.63 0 O-C-N 123.852 1.448 . . . . 0.0 110.557 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.5 p90 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.551 0.691 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -170.57 172.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 0.0 109.801 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.571 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.25 151.51 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.161 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 84' ' ' SER . 6.8 p-10 -148.41 135.39 20.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 110.357 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 84' ' ' SER . 14.6 ttp-105 -99.02 141.22 32.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.394 -0.816 . . . . 0.0 108.849 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.703 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.4 t -72.56 147.14 10.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.847 -1.158 . . . . 0.0 110.199 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 82' ' ' ASN . 4.7 m-20 -93.04 -70.09 0.72 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.404 0.621 . . . . 0.0 109.98 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.5 tt0 -149.91 131.28 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.74 146.68 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 35.2 m-20 -145.63 119.98 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -88.9 0.19 56.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -116.67 -35.96 4.05 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.75 8.74 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.46 -0.775 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.56 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.5 m-30 53.62 69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 5.4 tttt -136.79 133.1 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.377 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.437 ' HB2' HG12 ' A' ' 23' ' ' ILE . 9.7 t80 -149.86 94.58 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.883 . . . . 0.0 110.071 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.51 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 33.2 m-20 -116.78 145.2 43.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.568 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 36.3 p90 -146.76 137.38 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.494 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 62.2 m -98.78 170.83 8.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 111.232 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 41.5 t -108.35 127.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.96 -70.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 111.272 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -85.05 95.6 9.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.594 -1.316 . . . . 0.0 110.052 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -116.93 139.82 15.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.53 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.11 -57.12 2.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.2 Cg_endo -71.91 -38.34 4.17 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.922 1.485 . . . . 0.0 110.308 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' N ' ' A' ' 92' ' ' GLY . 46.5 mt -68.16 170.53 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.573 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -162.66 -77.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.92 -90.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -1.196 . . . . 0.0 110.297 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.1 t -146.94 18.39 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.2 164.76 12.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 110.105 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.92 34.43 22.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 121' ' ' HIS . 1.1 ttmt -76.42 150.95 36.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.233 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.651 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 56.2 mt -128.39 132.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 t -119.17 102.41 8.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.579 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.568 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 3.4 m120 -87.08 135.51 33.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 52.1 mt-10 -131.45 134.6 46.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 110.095 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.542 HG22 HD11 ' A' ' 104' ' ' ILE . 12.7 mt -128.33 126.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.031 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.684 HG22 ' HB1' ' A' ' 15' ' ' ALA . 4.5 mp -134.45 141.09 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.752 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.5 t -141.9 144.16 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 109.546 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.06 162.7 16.64 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.395 -0.815 . . . . 0.0 111.09 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.5 p . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.501 -0.749 . . . . 0.0 109.245 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.836 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -142.44 159.98 41.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.708 -0.878 . . . . 0.0 110.627 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.7 tt -109.19 142.0 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.945 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.72 150.49 41.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 110.181 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.15 124.29 18.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 2.4 mt -111.19 117.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -102.05 111.8 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.33 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.05 123.49 47.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.121 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -116.56 151.54 35.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.354 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.998 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -131.6 99.72 4.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.834 . . . . 0.0 110.193 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.781 ' N ' HG23 ' A' ' 2' ' ' VAL . 85.5 m-70 -79.8 113.69 18.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.37 172.47 6.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.979 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.604 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.461 ' HA ' HG21 ' A' ' 122' ' ' THR . 4.1 mt-10 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.355 0.598 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.762 HG21 ' CG ' ' A' ' 120' ' ' TYR . 2.8 t -116.08 101.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -54.75 125.19 19.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.027 -1.045 . . . . 0.0 109.501 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -53.16 -48.06 68.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 110.396 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.1 mt-10 -35.63 -55.22 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.58 -0.7 . . . . 0.0 110.661 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -42.35 92.85 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 108.998 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 5' ' ' TYR . 14.1 t -68.03 -48.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.248 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -59.86 -31.46 69.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.529 -0.732 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.89 -47.72 61.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -24.08 67.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.173 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.44 -36.09 45.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.88 . . . . 0.0 110.184 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -44.67 83.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.12 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.779 HD23 ' HA ' ' A' ' 37' ' ' ALA . 3.1 mp -73.47 -31.54 63.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 110.019 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.822 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -65.72 -41.1 96.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.601 ' HA ' HD23 ' A' ' 144' ' ' LEU . 5.4 mm-40 -56.67 -37.05 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -1.203 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.8 m -70.15 -18.86 63.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.822 HD12 ' HA2' ' A' ' 140' ' ' GLY . 98.0 mt -77.13 -44.82 28.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 0.0 109.896 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.601 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -66.93 -29.94 69.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 17.2 ttp180 -77.64 -36.4 51.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.765 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.12 67.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.785 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.0 t -60.23 -47.26 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.444 -0.785 . . . . 0.0 109.781 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 35.8 tt0 -51.64 -48.91 63.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 -43.67 85.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.948 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -52.03 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.159 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.712 HD13 HG21 ' A' ' 13' ' ' ILE . 35.5 mt -42.62 -51.82 5.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -48.72 -25.21 1.69 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.074 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.418 0.628 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.413 ' CD1' ' CG1' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -106.54 161.93 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.949 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.79 139.21 50.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.942 . . . . 0.0 110.156 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.84 56.21 1.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.025 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -82.83 153.7 25.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.38 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.4 p -156.14 169.06 25.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.814 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 15.2 pt-20 -158.8 138.37 11.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 110.619 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 t -133.15 -172.6 2.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.316 -0.865 . . . . 0.0 109.928 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -117.97 159.52 23.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.7 t -152.67 136.75 16.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.689 -0.632 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 27.2 m -79.96 -12.17 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.017 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.668 HG23 ' HD2' ' A' ' 14' ' ' PRO . 41.2 mm -69.86 148.4 96.39 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.668 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.0 Cg_endo -65.58 151.23 85.37 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.503 1.265 . . . . 0.0 111.007 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.68 -29.16 61.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.035 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.6 -48.46 16.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.287 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.526 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -68.14 -37.54 81.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.994 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' HB2' HG22 ' A' ' 13' ' ' ILE . 25.7 tp -74.79 -26.24 59.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.185 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' CE1' HG13 ' A' ' 23' ' ' ILE . 75.2 t80 -69.69 -59.69 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 110.046 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -57.18 -39.95 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.387 -0.821 . . . . 0.0 110.128 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -72.54 -31.99 65.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.846 . . . . 0.0 110.546 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.444 ' CD1' HG21 ' A' ' 147' ' ' VAL . 33.8 t80 -91.9 -18.25 24.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.558 HG13 ' CE1' ' A' ' 19' ' ' PHE . 9.3 mm -104.06 -67.33 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.454 HD11 ' HE1' ' A' ' 76' ' ' HIS . 0.3 OUTLIER -72.49 -27.54 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' OD1' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -109.38 -5.06 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.356 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.42 -56.54 24.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.98 -23.84 1.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 110.556 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -100.37 -39.79 7.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 110.305 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 1.9 tp -71.18 -38.01 72.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.0 m-30 -48.21 -61.02 3.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 110.55 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.0 Cg_endo -71.65 -2.09 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.972 1.512 . . . . 0.0 110.715 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -104.28 -36.11 7.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 110.469 -179.756 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.754 HG22 ' HB1' ' A' ' 146' ' ' ALA . 7.2 p -96.67 -26.08 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.959 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.24 78.61 8.58 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.78 2.75 6.16 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.117 1.588 . . . . 0.0 110.964 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.05 -38.36 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 110.481 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.55 -49.4 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.229 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.43 146.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.987 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.519 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -100.95 -32.3 10.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.212 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.5 168.11 2.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.601 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 56' ' ' ILE . 4.7 t -138.51 141.27 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.598 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -144.62 110.94 5.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.067 -1.021 . . . . 0.0 110.757 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.6 116.89 5.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.214 -0.929 . . . . 0.0 110.419 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.722 HD12 HG22 ' A' ' 53' ' ' ILE . 12.3 mt -84.97 -39.64 14.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 122.172 0.987 . . . . 0.0 108.556 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 52' ' ' THR . 22.3 tt0 . . . . . 0 C--N 1.296 -1.731 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.537 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.3 Cg_endo -72.83 118.04 5.39 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.026 1.54 . . . . 0.0 110.381 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 -1.65 40.88 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.694 ' HB ' HG21 ' A' ' 71' ' ' VAL . 7.0 m -67.35 154.64 40.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.252 . . . . 0.0 109.226 179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.722 HG22 HD12 ' A' ' 44' ' ' ILE . 9.9 mt -121.97 135.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 110.512 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.559 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -142.38 138.71 31.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.99 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -92.43 101.08 13.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.574 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.507 HG12 HG13 ' A' ' 41' ' ' VAL . 22.3 mt -88.97 129.09 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.542 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.1 m -93.24 141.22 28.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.473 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.18 131.27 22.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.863 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 39' ' ' SER . 47.3 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 O-C-N 123.874 1.46 . . . . 0.0 110.663 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 32.8 p90 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.269 0.557 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.574 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -170.35 172.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.191 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.587 ' O ' HD11 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -121.25 62.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.477 -0.765 . . . . 0.0 110.468 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -52.97 133.08 38.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.906 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -97.81 142.86 29.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.937 . . . . 0.0 108.716 179.491 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.694 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.5 t -69.73 149.56 10.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.645 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.3 t70 -101.29 -74.42 0.62 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.434 0.635 . . . . 0.0 110.044 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.2 tt0 -135.39 136.13 41.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.109 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.443 HG22 ' HD2' ' A' ' 81' ' ' TYR . 2.8 t -120.78 147.32 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -152.57 101.32 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.454 ' HE1' HD11 ' A' ' 24' ' ' LEU . 13.0 m-70 -75.14 -9.42 58.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.736 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -102.78 -34.09 9.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 108.638 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.75 11.26 39.15 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.342 0.591 . . . . 0.0 109.752 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 23.4 m-30 44.36 43.85 6.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 110.191 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 5.7 tttm -118.09 114.21 22.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.267 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 8.3 t80 -131.48 109.36 10.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 6.9 m120 -112.4 145.97 39.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 110.031 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 3.6 p90 -137.74 138.26 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.811 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' ARG . 7.0 m -98.82 159.58 14.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.177 -0.952 . . . . 0.0 110.858 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 98' ' ' ILE . 24.7 t -104.19 122.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.587 HD11 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -121.92 -76.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.085 -1.009 . . . . 0.0 110.953 -178.561 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 16.0 mm-40 -70.49 57.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.753 -1.217 . . . . 0.0 109.996 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -69.54 126.8 19.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.51 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.83 -54.1 3.62 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.2 Cg_endo -75.99 -40.99 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.875 1.46 . . . . 0.0 110.594 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.567 HD12 ' HA3' ' A' ' 88' ' ' GLY . 36.0 mt -50.98 138.37 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.076 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.55 -94.55 1.83 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.82 -80.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 110.171 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.03 19.79 2.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 110.065 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.411 ' CB ' ' HB2' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -94.67 165.51 12.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.227 -0.92 . . . . 0.0 110.245 -179.888 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 3.2 tp10 56.35 33.17 21.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 8.8 tttm -67.84 167.34 13.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.564 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.1 mt -143.93 127.86 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.42 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.48 ' HB3' ' CB ' ' A' ' 119' ' ' LYS . 12.9 t -115.1 112.31 22.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.599 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -105.85 152.39 23.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.873 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.513 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 30.9 mt-10 -145.24 129.27 17.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.785 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.823 ' CD1' HG23 ' A' ' 116' ' ' ILE . 19.5 mm -122.26 128.95 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.03 -1.044 . . . . 0.0 110.384 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 4.9 tttt -129.63 117.24 20.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 110.038 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.701 HG23 ' CD2' ' A' ' 114' ' ' LEU . 64.4 mt -110.66 109.2 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 110.72 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 112' ' ' SER . 42.1 t -115.47 151.03 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.748 0.785 . . . . 0.0 109.595 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.05 168.38 12.87 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.642 -0.662 . . . . 0.0 110.867 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.703 HG22 ' CD1' ' A' ' 113' ' ' ILE . 7.7 p . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -134.49 162.85 31.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 110.743 -179.496 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.703 ' CD1' HG22 ' A' ' 107' ' ' THR . 5.2 mt -110.37 117.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.396 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.701 ' CD2' HG23 ' A' ' 104' ' ' ILE . 21.6 mt -87.76 129.18 35.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.913 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 104.76 9.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.823 HG23 ' CD1' ' A' ' 102' ' ' ILE . 4.1 mp -105.04 122.27 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.094 -1.004 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -105.95 120.95 43.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.473 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.423 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -114.93 139.02 50.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.236 -179.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER -132.55 142.2 49.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.564 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -121.21 133.07 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.044 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.55 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 59.9 m-70 -111.57 129.41 56.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.23 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.978 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.95 173.47 6.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.425 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HB2' ' CB ' ' A' ' 95' ' ' LEU . 3.4 tttt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.331 -0.856 . . . . 0.0 110.203 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.978 ' HA ' HG21 ' A' ' 122' ' ' THR . 38.6 mt-10 . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.666 0.746 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.554 HG21 ' CD2' ' A' ' 120' ' ' TYR . 1.8 p -79.97 137.38 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.572 -0.705 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 126.71 31.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.973 ' HA ' HG12 ' A' ' 133' ' ' VAL . . . -65.92 -57.24 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.931 -1.106 . . . . 0.0 111.249 -178.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -40.95 -26.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.889 -1.132 . . . . 0.0 110.143 -179.273 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -84.68 -42.88 14.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.175 -0.953 . . . . 0.0 109.164 178.509 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.973 HG12 ' HA ' ' A' ' 130' ' ' ALA . 8.0 p -78.98 -33.77 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.339 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -70.56 -23.6 62.63 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.242 -0.911 . . . . 0.0 109.277 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -73.29 -20.9 60.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.829 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.7 t -71.94 -29.87 64.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 110.19 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -78.04 -47.15 19.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -45.95 -61.17 1.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -14.49 61.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -64.18 -54.41 30.25 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.562 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.4 tt0 -47.72 -36.95 12.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 100.0 m -66.8 -25.36 66.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.717 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.6 mt -74.75 -52.24 12.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.632 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.3 pp -66.79 -29.3 69.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.942 . . . . 0.0 109.657 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.429 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 11.0 tpt180 -78.0 -28.88 49.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -0.877 . . . . 0.0 109.511 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.754 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -68.83 -36.7 78.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.823 . . . . 0.0 109.732 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.444 HG21 ' CD1' ' A' ' 22' ' ' PHE . 40.2 t -73.09 -48.51 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.389 -0.82 . . . . 0.0 109.715 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 13' ' ' ILE . 5.6 tt0 -53.4 -49.67 66.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 152' ' ' LEU . 0.9 OUTLIER -60.45 -45.39 93.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.684 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -48.31 -72.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 110.035 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.19 -36.12 5.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 149' ' ' SER . 16.1 tp -62.74 -55.71 24.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 -179.946 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.562 HG22 ' HA ' ' A' ' 121' ' ' HIS . 2.7 t . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.427 0.632 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -97.0 163.8 12.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.724 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -133.78 144.95 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 110.678 -179.662 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CG ' HG11 ' A' ' 133' ' ' VAL . 48.4 m-85 -154.85 56.44 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -0.771 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 2.2 pp20? -86.91 137.09 32.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 110.837 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -140.11 -175.66 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.674 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.28 152.16 25.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.056 -1.027 . . . . 0.0 110.589 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 10' ' ' THR . 1.5 m -135.35 -179.17 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 0.0 109.81 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 9' ' ' THR . 1.5 p -127.3 161.25 29.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.66 141.89 17.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.518 -0.739 . . . . 0.0 109.636 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.83 -12.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.32 -0.952 . . . . 0.0 108.559 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.811 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.3 mp -71.07 152.01 94.82 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.13 152.02 82.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.475 1.25 . . . . 0.0 110.886 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.798 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -76.86 -27.59 55.12 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.904 -178.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.22 -50.23 16.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.046 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -63.49 -43.15 98.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.785 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.73 -33.84 76.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.379 -0.825 . . . . 0.0 109.948 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.61 ' CD1' HD13 ' A' ' 23' ' ' ILE . 37.2 t80 -61.57 -64.89 0.8 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 12.0 mttt -48.13 -47.25 34.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.482 -0.761 . . . . 0.0 110.39 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.47 78.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.317 -0.864 . . . . 0.0 111.012 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -90.08 -10.1 45.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 110.65 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.61 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -115.02 -60.19 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 109.932 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.692 HD11 ' HE1' ' A' ' 76' ' ' HIS . 15.1 mt -68.29 -48.97 63.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.111 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.71 20.7 18.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.033 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.42 -60.9 5.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.01 -24.66 10.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 0.0 110.218 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -84.67 -46.57 11.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.522 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.807 HD23 HG11 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -73.88 -28.22 61.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.478 -179.739 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.526 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m-30 -49.38 -57.47 11.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.456 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 45.6 Cg_endo -72.02 -7.61 21.36 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.987 1.52 . . . . 0.0 110.728 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -101.58 -54.43 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.344 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.807 HG11 HD23 ' A' ' 29' ' ' LEU . 5.5 m -80.31 -13.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 110.528 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.69 71.84 12.64 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 0.0 110.08 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.51 0.37 9.19 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.047 1.551 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.94 -20.08 19.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -102.18 -38.9 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.82 136.8 53.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.65 -47.17 6.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.84 140.06 3.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.29 125.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 11.8 mt-10 -115.0 89.27 3.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 110.728 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 10.9 t-20 -54.17 116.76 2.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.449 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.3 mm -87.75 -38.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.271 1.034 . . . . 0.0 108.574 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 52' ' ' THR . 24.4 tt0 . . . . . 0 C--N 1.295 -1.776 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.449 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.679 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.0 Cg_endo -73.54 120.52 6.52 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.981 1.516 . . . . 0.0 110.551 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.02 1.3 61.41 Favored Glycine 0 N--CA 1.48 1.606 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.679 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 1.2 m -67.21 152.93 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -1.191 . . . . 0.0 109.435 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' ILE . 8.6 mt -124.56 131.38 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.48 -179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -143.89 134.76 25.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 179.471 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 2.2 ttpt -82.17 98.65 8.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.7 mt -85.95 132.55 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.696 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.5 OUTLIER -109.43 145.67 35.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 110.795 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 37' ' ' ALA . 5.9 m-85 -109.46 140.72 22.37 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 109.987 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.542 . . . . 0.0 110.756 -179.738 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.741 ' O ' HG13 ' A' ' 67' ' ' VAL . 3.4 p90 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 66' ' ' TYR . 4.3 m -160.54 164.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 110.503 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -109.63 40.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 109.848 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 7.7 t70 -38.76 130.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.486 -0.759 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ttp-105 -103.96 151.42 23.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.077 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.672 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.6 t -78.44 147.71 6.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 10.3 m-20 -97.4 -72.38 0.65 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.452 0.644 . . . . 0.0 110.431 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.9 tt0 -138.52 136.62 36.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.578 -0.701 . . . . 0.0 110.129 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.8 t -125.07 125.35 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.919 . . . . 0.0 109.995 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -123.85 127.89 48.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 109.885 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.692 ' HE1' HD11 ' A' ' 24' ' ' LEU . 1.2 t60 -86.27 -20.02 29.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 0.0 111.075 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -106.19 -37.81 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.995 -1.066 . . . . 0.0 109.897 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -85.81 13.42 7.34 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.475 -0.766 . . . . 0.0 110.198 179.999 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 42.31 61.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.918 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -128.21 118.15 22.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 110.921 -179.329 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 52.7 t80 -133.83 98.03 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 32.3 m-20 -112.76 142.84 44.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 110.289 -179.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 10.9 p90 -142.2 138.43 31.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.342 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 35.6 m -104.45 165.12 11.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.082 -1.011 . . . . 0.0 111.062 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 69' ' ' ASP . 47.2 t -108.42 127.36 64.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.63 -74.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 111.388 -178.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 2.3 mt-10 -82.8 97.87 8.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.828 -1.17 . . . . 0.0 110.227 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.575 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . -128.48 155.5 20.5 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.538 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -45.38 -56.68 6.13 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -70.59 -41.44 3.22 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.866 1.456 . . . . 0.0 110.84 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 92' ' ' GLY . 77.4 mt -77.46 165.32 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.196 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -148.18 -52.56 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.31 -83.08 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.373 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.9 t -143.06 11.15 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.22 151.04 22.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.262 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.525 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 7.7 tt0 55.83 35.07 24.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.764 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 6.2 tttt -75.44 158.3 32.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.39 -0.819 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.2 mt -135.71 131.1 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -0.99 . . . . 0.0 110.662 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 m -116.18 109.95 18.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 0.0 109.527 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.601 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 3.0 m120 -99.56 138.41 36.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -128.94 131.62 47.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.822 179.593 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.657 ' CD1' HG23 ' A' ' 116' ' ' ILE . 40.3 mm -122.15 119.15 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 32.9 mttt -122.11 109.26 14.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.744 HG23 HD23 ' A' ' 114' ' ' LEU . 1.9 mp -94.92 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.2 132.31 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.309 -0.87 . . . . 0.0 110.248 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.06 145.39 25.99 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.418 0.627 . . . . 0.0 110.969 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.6 p . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.798 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -137.26 169.05 18.43 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.666 -0.902 . . . . 0.0 110.444 -179.414 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 10' ' ' THR . 23.0 mt -123.63 133.96 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 179.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.744 HD23 HG23 ' A' ' 104' ' ' ILE . 25.5 mt -97.9 142.37 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.81 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -127.86 97.16 4.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.316 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.657 HG23 ' CD1' ' A' ' 102' ' ' ILE . 3.0 mt -94.34 115.98 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.732 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.539 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 38.4 t -104.58 108.3 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.464 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 4.3 t-20 -101.36 149.52 23.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.226 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 141.04 38.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.013 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.594 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -117.72 122.16 42.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.814 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.562 ' HA ' HG22 ' A' ' 2' ' ' VAL . 25.2 m-70 -105.23 110.14 22.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.99 167.95 14.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.523 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.115 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.342 0.591 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.5 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.3 p -108.27 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.396 -0.815 . . . . 0.0 111.062 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.1 142.1 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.953 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.472 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -52.59 -26.86 14.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.093 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.5 mm-40 -42.39 -58.33 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.716 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -59.85 -34.08 72.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 108.978 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.565 HG11 ' CG ' ' A' ' 5' ' ' TYR . 15.7 t -67.11 -49.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.447 -0.783 . . . . 0.0 109.259 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.5 ' HE2' ' NZ ' ' A' ' 137' ' ' LYS . 2.3 mmtt -50.74 -35.36 31.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -23.85 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.6 t -70.9 -37.47 72.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.117 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.5 ' NZ ' ' HE2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -75.77 -31.2 59.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 109.91 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.62 -47.25 80.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 37' ' ' ALA . 3.2 mm? -76.88 -45.06 29.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.855 . . . . 0.0 110.311 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.55 -47.24 52.22 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.607 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -56.67 -30.46 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -1.204 . . . . 0.0 110.425 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.4 m -70.73 -28.81 65.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.091 . . . . 0.0 109.653 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.4 mt -71.81 -48.69 44.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 109.867 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 144' ' ' LEU . 1.1 pp -63.55 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.421 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -75.05 -35.19 61.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.661 179.502 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -68.59 -29.22 67.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.56 -47.01 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.875 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -59.37 -46.8 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -62.26 -43.45 98.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 110.148 179.813 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -54.43 -71.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 110.389 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 13' ' ' ILE . 34.0 mt -39.65 -49.91 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.468 -0.77 . . . . 0.0 110.592 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.65 -61.63 2.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.274 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.109 179.97 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.455 0.645 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 0.7 OUTLIER -99.36 171.12 8.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 109.26 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.05 141.28 16.44 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.969 -1.082 . . . . 0.0 110.825 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.85 ' CD2' HG11 ' A' ' 133' ' ' VAL . 8.3 m-85 -159.38 59.17 0.4 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.538 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.483 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 11.2 pt-20 -81.85 152.67 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.428 -0.795 . . . . 0.0 110.662 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.71 -175.92 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 109.91 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.69 157.73 30.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.081 -1.012 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.497 HG21 HD22 ' A' ' 144' ' ' LEU . 1.1 t -146.51 -179.1 6.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.102 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -116.81 160.82 20.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.254 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.07 137.03 11.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.85 -12.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.673 HG23 ' HD2' ' A' ' 14' ' ' PRO . 35.3 mm -68.6 148.49 98.08 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.673 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.51 150.43 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.38 1.2 . . . . 0.0 110.752 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.746 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.95 -25.62 59.01 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.29 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.39 -52.3 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 110.356 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 8.4 ttt-85 -63.45 -38.38 90.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.868 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.899 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.0 tm? -68.89 -34.35 75.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.967 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 45.9 t80 -64.11 -68.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.485 ' HG2' ' CB ' ' A' ' 24' ' ' LEU . 8.7 tttt -45.84 -51.26 13.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.002 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.0 -38.77 79.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 110.054 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 15.1 t80 -84.72 -13.07 52.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.75 HD12 ' CD2' ' A' ' 81' ' ' TYR . 9.9 mm -118.9 -76.55 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.258 -0.901 . . . . 0.0 110.056 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' CB ' ' HG2' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -46.47 -56.3 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.033 179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.816 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -93.92 1.05 56.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 27' ' ' ASP . . . -46.91 -53.22 10.6 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 26' ' ' GLY . 3.3 p-10 -42.88 -29.94 0.36 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -1.134 . . . . 0.0 110.033 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 19.3 t30 -113.54 -11.36 13.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.003 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -83.63 -18.48 38.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.742 ' CD2' HD13 ' A' ' 38' ' ' ILE . 2.2 m-30 -75.43 -59.51 1.26 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.362 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.8 Cg_endo -71.19 -3.57 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.905 1.476 . . . . 0.0 110.492 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -91.97 -66.26 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.204 179.967 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 29' ' ' LEU . 6.2 m -85.93 -11.13 11.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.426 -0.797 . . . . 0.0 110.312 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -143.05 61.39 10.35 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.932 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.23 -5.93 18.02 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.091 1.574 . . . . 0.0 110.584 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.72 -25.58 38.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.42 -55.99 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 110.311 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -100.57 137.97 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.906 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.479 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -103.24 -33.33 9.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.1 OUTLIER -160.1 149.24 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.0 110.796 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.528 HG12 ' HE2' ' A' ' 54' ' ' LYS . 6.3 t -128.08 136.2 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 0.0 109.337 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 29.0 mt-10 -139.86 153.11 46.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.039 -1.038 . . . . 0.0 111.151 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.5 113.12 26.5 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.806 0.812 . . . . 0.0 109.636 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.2 mm -82.97 -39.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 122.185 0.993 . . . . 0.0 108.989 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' THR . 7.9 tp10 . . . . . 0 C--N 1.295 -1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 110.464 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.792 ' N ' ' HG1' ' A' ' 52' ' ' THR . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.0 Cg_endo -72.61 131.05 16.76 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.12 1.59 . . . . 0.0 110.476 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 -9.46 76.97 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 45' ' ' GLU . 22.2 m -60.85 153.62 24.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.068 -1.254 . . . . 0.0 109.496 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 45' ' ' GLU . 6.8 mt -116.25 125.62 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HE2' HG12 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -135.47 146.67 48.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 110.265 -179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.735 ' HB2' HD11 ' A' ' 44' ' ' ILE . 30.5 ttpt -97.61 132.98 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.33 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.48 144.18 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.478 ' HB2' ' OG ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -114.56 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.124 -0.985 . . . . 0.0 110.221 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -121.18 133.4 24.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 48.7 Cg_endo . . . . . 0 C--N 1.307 -1.621 0 O-C-N 123.99 1.521 . . . . 0.0 110.487 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.186 0.517 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.574 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.2 m -144.11 172.36 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.334 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.32 139.2 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.876 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 84' ' ' SER . 5.0 p-10 -133.2 133.47 42.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.0 ttm180 -96.26 146.42 24.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.701 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.4 t -73.94 145.12 11.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.836 -1.165 . . . . 0.0 110.404 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -94.07 -70.61 0.7 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.466 0.65 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.8 mt-10 -148.91 124.3 10.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 0.0 109.801 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 3.3 t -112.85 149.28 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.19 -0.944 . . . . 0.0 110.445 -179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 3.8 t0 -149.09 97.74 2.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -64.4 -7.92 11.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.895 -179.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -108.28 -46.22 3.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.016 -1.052 . . . . 0.0 109.765 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.36 13.54 4.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.735 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.7 m-30 47.42 50.87 14.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.059 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 6.3 tttt -123.77 117.28 24.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.993 -1.067 . . . . 0.0 110.779 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.75 ' CD2' HD12 ' A' ' 23' ' ' ILE . 17.3 t80 -134.44 103.75 5.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.344 -0.848 . . . . 0.0 109.779 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 31.2 m-20 -118.14 144.42 45.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.222 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 26.5 p90 -144.63 136.24 25.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' ARG . 74.5 m -96.77 171.09 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 111.209 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.515 HG11 HD13 ' A' ' 98' ' ' ILE . 41.6 t -108.95 125.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.75 -70.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.021 -1.049 . . . . 0.0 111.648 -178.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.16 98.82 11.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.543 -1.348 . . . . 0.0 110.375 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.574 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -116.55 151.71 18.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.519 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.98 -57.69 4.65 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.8 Cg_endo -74.0 -47.68 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.976 1.514 . . . . 0.0 110.953 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.28 157.75 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.004 . . . . 0.0 110.085 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.97 -71.54 0.19 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -111.38 -58.39 2.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -1.221 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.6 t -152.21 15.65 0.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.962 . . . . 0.0 110.538 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 123' ' ' LYS . 16.9 mt -91.28 147.86 22.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HG3' HG22 ' A' ' 122' ' ' THR . 4.9 mt-10 59.3 31.5 21.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 121' ' ' HIS . 4.6 mttt -70.55 151.36 45.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.5 mp -127.54 134.37 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.647 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.29 106.21 13.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.34 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -95.12 150.14 20.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.73 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 3.2 mp0 -143.18 142.06 31.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.772 . . . . 0.0 109.706 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 101' ' ' GLU . 61.6 mt -138.6 119.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 110.567 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 56.6 tttt -118.15 121.87 41.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.58 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 44.8 mt -108.84 118.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.368 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -122.9 152.6 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.402 -0.811 . . . . 0.0 109.774 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.98 166.35 14.55 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.633 -0.667 . . . . 0.0 111.121 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.765 HG23 ' HA ' ' A' ' 112' ' ' SER . 16.5 p . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.369 -0.832 . . . . 0.0 109.73 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 107' ' ' THR . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.765 ' HA ' HG23 ' A' ' 107' ' ' THR . 0.2 OUTLIER -141.17 163.65 32.38 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -1.069 . . . . 0.0 110.596 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.502 HG13 HG22 ' A' ' 107' ' ' THR . 78.9 mt -112.31 124.41 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.782 . . . . 0.0 109.166 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 130.64 42.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.982 . . . . 0.0 110.827 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -121.23 114.87 22.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.544 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -105.62 128.33 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -111.55 110.36 20.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 110.03 179.761 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.74 135.89 45.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.171 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.37 137.35 45.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 110.212 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.613 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -112.33 144.73 41.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.872 . . . . 0.0 110.036 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 97' ' ' LYS . 31.8 m-70 -127.15 106.36 9.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 110.233 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -121.63 166.59 14.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.977 . . . . 0.0 110.61 -179.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 121.784 0.802 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.4 p -113.92 93.48 2.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.811 -0.555 . . . . 0.0 110.627 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.98 146.66 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.043 . . . . 0.0 109.799 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.467 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -62.48 -12.71 23.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -48.14 -69.94 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.973 -1.079 . . . . 0.0 109.861 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 136' ' ' SER . 0.8 OUTLIER -54.8 -27.49 42.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.516 179.598 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.85 HG11 ' CD2' ' A' ' 5' ' ' TYR . 16.1 t -71.07 -47.28 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 134' ' ' LYS . 22.8 ttpt -67.76 -31.8 71.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.089 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 139' ' ' LEU . . . -73.7 -39.04 64.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.786 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -67.23 -27.36 67.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -73.07 -42.15 63.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.91 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -63.8 -44.36 93.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -71.3 -33.16 69.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -55.36 -55.5 28.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.1 tm-20 -54.86 -44.96 74.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -1.154 . . . . 0.0 109.923 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 m -57.4 -32.77 67.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.831 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.678 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.9 mt -69.93 -53.4 18.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.022 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 144' ' ' LEU . 4.6 pp -72.03 -22.33 61.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.159 -0.963 . . . . 0.0 109.474 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.711 ' N ' HD12 ' A' ' 144' ' ' LEU . 30.8 ttt180 -83.14 -31.42 27.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 109.739 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.04 70.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 143' ' ' LEU . 25.2 t -69.81 -44.3 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.473 -0.767 . . . . 0.0 109.738 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.475 ' HA ' HG13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -62.51 -47.98 81.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.618 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.425 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -68.97 -16.48 63.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 110.074 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.07 -34.19 26.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 13' ' ' ILE . 10.8 mt -73.87 -56.19 5.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 110.171 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.47 -30.39 12.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 0.0 110.437 -179.781 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.869 HG11 ' ND1' ' A' ' 121' ' ' HIS . 5.1 m -94.05 -162.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -1.147 . . . . 0.0 110.292 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -108.89 158.45 17.66 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.736 -0.602 . . . . 0.0 109.717 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.68 140.09 51.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.024 -1.048 . . . . 0.0 110.894 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 9.8 m-85 -146.52 61.99 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 7' ' ' THR . 12.9 pt-20 -87.59 157.48 19.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 111.129 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.4 p -156.64 174.93 14.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.5 -0.75 . . . . 0.0 109.944 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 115' ' ' LYS . 9.9 pt-20 -159.71 150.38 19.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.13 -0.981 . . . . 0.0 110.231 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 m -145.29 168.15 21.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.295 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.76 HG22 HG12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -106.91 164.29 12.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.218 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -157.68 144.46 18.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.426 -0.796 . . . . 0.0 109.855 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.491 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 15.1 t -79.8 -7.63 10.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.839 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.826 HG21 HD13 ' A' ' 151' ' ' LEU . 30.2 mm -78.85 146.87 69.44 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.656 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.93 145.94 81.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.659 1.347 . . . . 0.0 111.331 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.802 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -66.86 -28.41 68.32 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.54 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.95 2.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.943 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.478 ' NH1' ' HG3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -58.53 -37.04 74.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.728 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.6 tt -68.44 -39.44 81.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.007 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.579 ' CE2' HG21 ' A' ' 23' ' ' ILE . 80.8 t80 -60.84 -65.36 0.7 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 109.983 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -43.04 -49.26 6.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.427 -0.795 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.24 96.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.872 . . . . 0.0 110.873 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -88.95 -9.17 52.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.232 -0.917 . . . . 0.0 110.811 -179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 24' ' ' LEU . 1.2 mp -118.16 -69.65 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.988 -1.07 . . . . 0.0 110.191 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.586 ' N ' HG22 ' A' ' 23' ' ' ILE . 6.0 mt -60.69 -43.42 97.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.57 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.596 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -115.36 13.42 16.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.349 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.88 -59.66 10.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.62 ' HB3' HG11 ' A' ' 41' ' ' VAL . 85.3 m-20 -52.21 -29.07 20.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -1.161 . . . . 0.0 110.304 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -86.29 -28.93 23.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.424 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.805 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -87.68 -21.73 25.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.312 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.764 ' HE1' HD13 ' A' ' 143' ' ' LEU . 0.5 OUTLIER -54.02 -57.55 17.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.533 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -73.34 -0.07 8.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.95 1.5 . . . . 0.0 110.832 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -103.44 -59.12 1.76 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.436 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 29' ' ' LEU . 33.6 m -90.7 12.91 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.356 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -159.77 75.87 3.0 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.297 -0.877 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.36 -7.97 21.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.008 1.53 . . . . 0.0 110.716 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -100.79 0.05 38.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 110.262 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.477 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -107.28 -69.16 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 110.167 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.406 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.1 mt -119.14 135.13 60.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.404 -0.81 . . . . 0.0 109.868 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.63 -49.94 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.316 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.467 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -157.09 171.33 20.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 110.304 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.792 HG13 ' CD1' ' A' ' 56' ' ' ILE . 40.6 t -129.81 140.52 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.28 -0.888 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' CB ' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -133.28 84.27 2.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.406 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -50.4 117.74 2.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 0.0 110.283 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.615 HD12 HG22 ' A' ' 53' ' ' ILE . 12.5 mt -88.58 -37.83 10.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.271 1.034 . . . . 0.0 108.666 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 48.2 tt0 -153.78 174.41 14.58 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.335 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.554 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 66.79 159.96 0.92 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -104.8 32.17 4.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -1.104 . . . . 0.0 109.765 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' HG21 ' A' ' 74' ' ' VAL . . . 93.14 0.67 67.77 Favored Glycine 0 N--CA 1.48 1.574 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.37 -163.85 29.43 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.9 Cg_endo -73.09 129.43 14.13 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.028 1.541 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.62 -3.92 81.79 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.74 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -63.68 154.66 32.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -1.215 . . . . 0.0 109.255 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 44' ' ' ILE . 8.7 mm -124.81 127.69 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -139.7 136.91 34.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.108 -0.995 . . . . 0.0 110.299 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HB3' ' CB ' ' A' ' 42' ' ' GLU . 22.1 tttt -80.5 98.41 7.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 110.297 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.792 ' CD1' HG13 ' A' ' 41' ' ' VAL . 43.6 mm -86.7 134.81 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -103.76 145.94 29.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 110.199 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -118.33 131.55 24.17 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.213 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 44.9 Cg_endo -71.77 89.53 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.953 1.501 . . . . 0.0 110.574 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -138.51 -169.69 2.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.046 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.22 -15.88 4.08 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.445 ' CB ' ' HD2' ' A' ' 63' ' ' PRO . 0.9 OUTLIER -59.06 175.33 0.34 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.259 -1.142 . . . . 0.0 110.257 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 62' ' ' PHE . 44.5 Cg_endo -71.61 -45.47 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.971 1.511 . . . . 0.0 109.957 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.484 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 23.4 m-85 -116.43 127.76 54.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.425 -0.797 . . . . 0.0 109.852 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 66' ' ' TYR . 9.3 ptpt -142.09 -44.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -0.981 . . . . 0.0 110.42 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' C ' HG12 ' A' ' 67' ' ' VAL . 20.3 p90 -65.42 -170.05 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.975 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -178.45 171.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.278 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.561 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -90.14 -61.76 1.61 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.513 -0.742 . . . . 0.0 109.598 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 68' ' ' LYS . 7.6 t70 59.2 124.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.481 ' NE ' HD11 ' A' ' 53' ' ' ILE . 1.8 ttt180 -110.78 147.85 33.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.5 t -67.02 152.03 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.882 -1.136 . . . . 0.0 110.283 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 7.7 t70 -99.95 -71.4 0.7 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.311 0.577 . . . . 0.0 110.459 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -145.85 104.19 3.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.439 -0.788 . . . . 0.0 109.985 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 81' ' ' TYR . 18.6 t -92.78 149.88 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.265 -0.897 . . . . 0.0 110.324 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -148.42 101.62 3.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 109.927 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 m-70 -76.23 1.18 16.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.584 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -116.5 -44.61 2.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.058 -1.026 . . . . 0.0 110.041 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.13 15.06 9.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 110.435 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.552 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 20.0 m-30 51.49 54.43 11.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 109.911 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -126.62 126.55 43.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.561 ' CG ' HG13 ' A' ' 23' ' ' ILE . 28.1 t80 -143.34 97.94 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.499 ' ND2' ' OE2' ' A' ' 101' ' ' GLU . 9.4 m-20 -114.37 146.48 40.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.224 -0.923 . . . . 0.0 110.233 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 23.6 p90 -142.22 139.96 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.864 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 50.5 m -106.04 164.91 11.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.095 -1.003 . . . . 0.0 110.928 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 91' ' ' ILE . 24.4 t -103.06 130.2 53.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.499 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -126.96 -68.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.287 -178.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 1.4 tt0 -91.93 78.83 5.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.621 -1.3 . . . . 0.0 110.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -94.8 153.03 20.75 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.529 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.46 -57.99 4.83 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -72.44 -41.56 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.965 1.508 . . . . 0.0 110.545 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 86' ' ' ILE . 48.8 mt -61.62 134.3 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -118.23 -39.34 0.75 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -120.8 -84.14 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -1.091 . . . . 0.0 110.008 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 t -150.83 14.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.59 HD22 ' CB ' ' A' ' 123' ' ' LYS . 18.5 mt -88.81 156.92 18.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -0.969 . . . . 0.0 110.077 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.6 mt-10 54.56 34.28 20.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.12 -0.987 . . . . 0.0 109.48 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -77.02 170.3 16.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 -179.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.64 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 4.6 mp -143.11 125.15 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 110.478 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 11.2 t -117.35 109.86 17.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.57 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 3.1 t-20 -98.92 169.94 9.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.981 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 117' ' ' SER . 18.6 mt-10 -152.38 130.11 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.777 -0.577 . . . . 0.0 109.565 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.452 HD12 ' HD2' ' A' ' 81' ' ' TYR . 27.5 mt -121.14 132.41 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 110.459 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HD2' ' HD2' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -139.61 122.54 16.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.068 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.802 HG22 ' HB1' ' A' ' 15' ' ' ALA . 3.3 mp -108.92 144.23 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.363 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -145.67 117.94 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.751 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -71.47 146.23 48.73 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.347 0.594 . . . . 0.0 110.554 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 112' ' ' SER . 0.6 OUTLIER -125.46 153.87 72.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.024 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.5 55.59 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.962 1.507 . . . . 0.0 110.411 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -139.59 10.08 2.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 110.059 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.77 24.16 36.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -167.89 -162.76 20.51 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.675 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 7.6 t -141.78 -175.89 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.998 . . . . 0.0 110.525 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.76 HG12 HG22 ' A' ' 10' ' ' THR . 19.9 mt -134.99 128.19 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 109.599 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 114' ' ' LEU . 3.8 pp -108.81 139.39 43.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 8' ' ' GLU . 10.2 mttt -123.79 113.92 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.507 HG23 HD21 ' A' ' 100' ' ' ASN . 72.3 mt -107.77 115.13 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.797 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.53 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -103.4 135.92 44.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -126.71 144.25 50.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.144 -0.973 . . . . 0.0 110.815 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -126.55 150.9 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.337 -0.852 . . . . 0.0 109.884 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -131.57 105.65 7.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.145 -0.972 . . . . 0.0 109.763 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.869 ' ND1' HG11 ' A' ' 2' ' ' VAL . 24.1 m-70 -86.0 125.29 33.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -0.917 . . . . 0.0 110.605 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.3 167.86 12.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.59 ' CB ' HD22 ' A' ' 95' ' ' LEU . 19.1 tptt -159.92 -170.09 2.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.33 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 42.55 -151.57 0.29 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.29 12.05 23.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -1.126 . . . . 0.0 110.154 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -82.92 172.5 12.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 110.13 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -153.53 -166.66 2.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 110.246 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.1 t -121.8 99.5 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.434 -0.791 . . . . 0.0 109.89 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -64.46 125.81 25.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -42.57 -34.79 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 110.533 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.8 mp0 -39.83 -70.36 0.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.306 -0.871 . . . . 0.0 110.872 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -27.83 38.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 109.568 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.565 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 21.4 t -74.91 -49.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.2 -30.86 70.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.515 -0.741 . . . . 0.0 109.792 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.81 -30.42 61.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.623 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.0 t -73.39 -37.69 65.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.412 -0.805 . . . . 0.0 109.682 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -68.89 -38.31 79.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.6 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -68.0 -40.26 83.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 1.1 tp -72.83 -40.42 65.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.827 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.43 97.77 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.689 ' HA ' HD23 ' A' ' 144' ' ' LEU . 1.5 mm-40 -65.95 -34.72 78.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -1.133 . . . . 0.0 109.917 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 75.2 m -67.98 -29.96 69.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.927 . . . . 0.0 109.723 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.764 HD13 ' HE1' ' A' ' 30' ' ' PHE . 71.9 mt -70.25 -46.54 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -67.3 -30.84 70.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.745 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.5 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 4.5 ttt180 -79.5 -32.93 42.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 0.0 109.938 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 33' ' ' VAL . . . -63.41 -42.67 98.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.85 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.2 t -71.27 -47.49 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 110.007 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -56.98 -43.3 81.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.5 t -60.72 -49.82 75.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.647 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.3 t80 -52.35 -70.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.838 . . . . 0.0 110.473 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.826 HD13 HG21 ' A' ' 13' ' ' ILE . 1.2 mt -40.6 -35.43 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 110.684 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -25.09 50.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.007 . . . . 0.0 110.498 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . -89.71 26.15 1.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.973 . . . . 0.0 110.461 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.527 ' C ' ' CD2' ' A' ' 154' ' ' HIS . 3.9 p-80 -81.07 175.76 10.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 110.481 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 t -150.17 83.58 1.38 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 109.995 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.14 -15.35 14.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.46 163.04 33.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.162 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -108.12 -51.2 2.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.918 . . . . 0.0 110.297 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.257 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t -59.09 142.6 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 110.289 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.2 m-85 -100.91 137.5 39.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.384 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.24 146.8 44.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 110.91 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -152.29 56.63 0.82 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.472 0.654 . . . . 0.0 109.298 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 4.9 pt-20 -80.19 153.2 28.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 110.368 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -149.7 -175.6 5.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.882 . . . . 0.0 110.099 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -159.45 162.52 35.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.7 -176.24 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.07 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.469 HG22 HG12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -133.67 159.61 40.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.482 ' HB3' ' CG ' ' A' ' 148' ' ' GLU . 3.7 m -160.03 145.51 15.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.636 -0.665 . . . . 0.0 109.991 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.483 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 11.9 t -79.93 -7.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.41 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.661 HG23 ' HD2' ' A' ' 14' ' ' PRO . 41.7 mm -77.1 148.2 77.94 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.661 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.46 150.47 84.22 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 O-C-N 123.589 1.31 . . . . 0.0 111.063 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.804 ' HB3' ' HB2' ' A' ' 106' ' ' ALA . . . -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.438 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.15 -49.95 8.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.92 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 8.0 tpt180 -67.15 -34.33 77.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.712 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 5.8 tt -76.92 -35.41 57.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.655 ' CD1' HD13 ' A' ' 23' ' ' ILE . 75.2 t80 -61.12 -57.76 11.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.867 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 27.3 mttp -58.2 -41.21 83.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.828 . . . . 0.0 109.96 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.68 -32.91 70.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.67 ' CD1' HG21 ' A' ' 147' ' ' VAL . 7.9 t80 -87.98 -15.82 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.883 . . . . 0.0 110.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.655 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -120.15 -58.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.092 -1.005 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.529 HD11 ' CE1' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -63.05 -37.25 86.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.344 -0.848 . . . . 0.0 110.687 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -110.11 -0.81 17.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -46.0 -48.51 14.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -56.46 -17.21 7.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.307 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -113.1 -19.77 11.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.297 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.8 tp -93.99 -33.76 13.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.736 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.567 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -63.25 -58.21 17.0 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.701 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -76.7 46.11 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.825 1.434 . . . . 0.0 111.347 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.32 -54.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.921 -1.112 . . . . 0.0 110.397 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.565 ' CG2' ' HB1' ' A' ' 146' ' ' ALA . 9.9 p -84.85 -26.0 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 110.48 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.62 75.61 79.59 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.196 -0.94 . . . . 0.0 110.385 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.59 -3.98 14.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.389 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -91.21 -12.72 34.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 110.24 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.51 -72.65 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.908 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.444 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.3 mp -105.78 154.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.439 -0.788 . . . . 0.0 109.5 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 8.1 t -100.85 -56.44 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 110.415 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 36.5 m -153.55 175.34 13.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 110.489 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 56' ' ' ILE . 25.8 t -138.53 143.5 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.889 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.82 99.82 3.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.152 -0.967 . . . . 0.0 110.658 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.484 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 90.5 m-20 -58.36 117.33 4.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.112 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 54' ' ' LYS . 22.8 mm -85.87 -38.07 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 122.366 1.079 . . . . 0.0 108.301 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 61.5 tt0 -152.45 174.1 14.29 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.084 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 72.64 166.43 9.46 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -110.85 37.77 2.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -1.119 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 82.14 2.07 90.49 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.55 -160.79 23.72 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.31 124.05 7.55 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.018 1.536 . . . . 0.0 110.437 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.74 -3.0 70.57 Favored Glycine 0 N--CA 1.481 1.66 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.625 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.2 m -61.43 152.13 30.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -1.164 . . . . 0.0 109.787 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 10.4 mt -112.75 136.48 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 110.327 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 54' ' ' LYS . 2.7 ptmt -153.13 139.18 18.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.229 -0.92 . . . . 0.0 110.305 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HG3' ' CD1' ' A' ' 66' ' ' TYR . 15.6 ttpp -91.67 109.28 20.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.499 HD12 ' OD1' ' A' ' 69' ' ' ASP . 96.7 mt -98.6 120.89 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.928 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 39' ' ' SER . 54.3 m -77.3 133.78 38.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.857 . . . . 0.0 110.46 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.29 140.05 22.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.025 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 60' ' ' GLU . 45.0 Cg_endo -72.25 77.47 2.04 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER 50.09 -178.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 110.462 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.63 -50.27 0.82 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.61 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -100.68 -179.22 0.78 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.288 -1.125 . . . . 0.0 109.682 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.61 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 42.9 Cg_endo -69.84 -27.71 25.78 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.718 1.378 . . . . 0.0 109.873 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CB ' ' HA3' ' A' ' 89' ' ' GLY . 0.2 OUTLIER -115.41 137.27 52.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.394 -0.816 . . . . 0.0 109.635 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -55.18 -79.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.348 -0.845 . . . . 0.0 111.152 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' HG3' ' A' ' 55' ' ' LYS . 5.0 p90 -92.09 179.58 5.54 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.869 0.843 . . . . 0.0 112.065 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.568 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -148.54 175.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.568 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -123.48 50.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.795 -1.191 . . . . 0.0 111.124 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' A' ' 56' ' ' ILE . 11.8 p-10 -61.78 131.03 48.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.19 -0.943 . . . . 0.0 109.99 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -96.61 -179.22 4.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.625 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.0 t -90.27 151.39 3.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 120.916 -1.115 . . . . 0.0 109.891 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -100.44 -73.23 0.65 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.524 0.678 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -137.44 132.59 33.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.417 -0.802 . . . . 0.0 110.126 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.6 t -119.14 146.35 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 0.0 110.117 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.553 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -150.09 110.9 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.907 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.529 ' CE1' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -76.64 -12.84 60.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -109.94 -39.78 4.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.028 -1.045 . . . . 0.0 109.836 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -88.2 15.93 6.89 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.302 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 19.6 m-85 42.23 57.21 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.2 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.553 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.73 115.68 21.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.128 -0.982 . . . . 0.0 110.679 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' A' ' 23' ' ' ILE . 13.1 t80 -135.82 102.17 4.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.415 -0.803 . . . . 0.0 109.603 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 32.7 m-20 -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.099 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.631 ' CE2' ' CB ' ' A' ' 100' ' ' ASN . 2.8 p90 -137.93 145.16 41.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.26 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.6 m -105.38 155.43 19.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.277 -0.889 . . . . 0.0 111.451 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 38.2 t -100.07 122.13 51.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -120.98 -66.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 111.531 -178.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -80.5 52.66 1.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.674 -1.266 . . . . 0.0 109.917 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.665 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -63.65 125.64 33.53 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.501 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -38.58 -58.46 1.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -72.88 -26.6 15.39 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.866 1.456 . . . . 0.0 110.555 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.665 HD12 ' HA3' ' A' ' 88' ' ' GLY . 17.9 mt -69.75 161.69 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.75 -51.95 0.08 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' C ' ' HG ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -87.6 50.66 2.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.091 -1.241 . . . . 0.0 110.593 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 49.23 24.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.528 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.576 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -118.56 175.43 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.948 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.615 ' O ' HD11 ' A' ' 91' ' ' ILE . 4.0 mt-10 54.89 32.6 18.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -80.02 159.39 26.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.409 -0.807 . . . . 0.0 110.069 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 120' ' ' TYR . 17.1 mt -143.03 137.09 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.687 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.48 94.45 4.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.76 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.631 ' CB ' ' CE2' ' A' ' 83' ' ' TYR . 0.4 OUTLIER -84.31 141.31 31.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 2.5 mt-10 -128.28 146.37 50.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 110.168 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.4 mt -137.15 125.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 0.0 110.236 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.533 ' HE3' ' CG2' ' A' ' 105' ' ' VAL . 11.9 tttt -124.89 157.43 35.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 10.5 mt -148.09 119.35 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 110.495 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.533 ' CG2' ' HE3' ' A' ' 103' ' ' LYS . 83.6 t -118.52 129.63 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.414 -0.804 . . . . 0.0 109.987 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -80.59 154.18 27.59 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.414 0.626 . . . . 0.0 110.767 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.505 HG23 ' HA ' ' A' ' 112' ' ' SER . 6.8 p -114.51 167.14 10.14 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 0.0 109.868 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 48.0 Cg_endo -73.92 -2.48 12.31 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.882 1.464 . . . . 0.0 110.423 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -88.28 -12.43 43.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.3 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.94 -12.8 26.94 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . -105.74 -164.7 23.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.632 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 3.8 t -147.45 -174.86 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.447 -1.031 . . . . 0.0 110.593 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 68.4 mt -138.63 136.58 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.8 . . . . 0.0 109.383 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 114' ' ' LEU . 6.5 mp -105.19 136.29 44.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.08 104.23 8.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.438 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 116' ' ' ILE . 5.4 mp -99.56 139.55 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 110.83 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -126.54 105.82 9.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.42 -0.8 . . . . 0.0 110.081 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -98.43 142.49 29.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.219 -0.925 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.0 OUTLIER -135.97 127.57 28.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -111.8 123.41 50.18 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.151 -0.968 . . . . 0.0 110.014 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -104.51 116.39 32.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.853 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.14 169.36 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 109.777 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -156.91 -169.11 2.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 110.243 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 44.16 -138.73 4.44 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.12 1.84 45.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -1.157 . . . . 0.0 110.484 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -73.92 167.78 20.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.209 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -150.72 -171.44 3.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 0.0 109.882 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 128' ' ' VAL . 4.6 t -113.93 96.3 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.186 -0.946 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.649 ' O ' HG23 ' A' ' 133' ' ' VAL . 14.4 mttm -64.3 127.24 30.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.966 . . . . 0.0 109.385 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.73 -46.3 63.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.983 . . . . 0.0 110.458 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' ALA . 6.9 tp10 -41.27 -47.68 3.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.012 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -70.3 -31.55 68.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 108.818 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 129' ' ' LYS . 14.5 t -74.05 -47.97 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 109.31 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 7.0 tmtt? -66.48 -30.78 71.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.197 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.14 -27.92 62.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -72.78 -40.6 65.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 110.365 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 134' ' ' LYS . 13.6 ptmt -77.24 -22.07 52.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.963 . . . . 0.0 110.254 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.64 -57.46 11.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.335 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 142' ' ' THR . 38.6 mt -70.88 -42.05 70.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.219 -0.926 . . . . 0.0 110.429 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 139' ' ' LEU . . . -41.53 -44.63 4.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.3 tt0 -57.75 -36.28 71.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -1.2 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 139' ' ' LEU . 92.8 m -67.97 -22.0 65.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 109.871 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.477 HD13 ' CZ ' ' A' ' 30' ' ' PHE . 64.4 mt -76.39 -49.99 15.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.921 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.38 -23.81 65.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -83.25 -38.17 22.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.964 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.565 ' HB1' ' CG2' ' A' ' 33' ' ' VAL . . . -60.77 -39.97 90.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -0.915 . . . . 0.0 109.514 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 22' ' ' PHE . 40.2 t -71.36 -52.77 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.482 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.0 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.412 -0.805 . . . . 0.0 109.571 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -50.95 69.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -45.54 -70.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.295 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.661 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.0 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.066 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -61.83 -43.81 98.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.86 -1.14 30.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -120.99 17.58 11.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.101 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.57 10.96 18.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.223 -0.923 . . . . 0.0 110.267 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.39 11.76 33.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 110.179 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.63 -172.89 2.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.135 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 158' ' ' TYR . 59.8 t80 -138.82 55.46 1.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.118 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 27.0 p30 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.208 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.99 143.14 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -1.149 . . . . 0.0 110.194 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.9 m-85 -97.13 154.29 17.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.673 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -127.26 149.34 50.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.911 -1.118 . . . . 0.0 111.038 -179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 40.9 m-85 -158.29 61.31 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.668 -0.645 . . . . 0.0 109.438 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 19.5 pt-20 -85.62 148.63 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 110.948 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.48 173.87 13.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 0.0 109.63 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.2 pm0 -147.61 169.98 18.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 0.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.57 152.12 29.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.746 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.53 161.57 13.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 110.552 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.465 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 9.4 t -159.85 138.16 10.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.639 -0.663 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 t -80.04 -14.25 13.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.866 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 44.3 mm -72.01 148.02 91.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.4 Cg_endo -66.85 150.07 83.22 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.432 1.228 . . . . 0.0 111.112 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.916 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -76.05 -29.42 58.02 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.405 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.81 -54.55 13.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.898 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 5.5 ttm180 -66.7 -35.69 80.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.938 . . . . 0.0 109.437 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 114' ' ' LEU . 11.3 tp -75.25 -32.9 61.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 0.0 109.984 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.664 ' CD1' HD13 ' A' ' 23' ' ' ILE . 55.3 t80 -64.2 -68.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.972 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -52.75 -38.62 61.18 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.514 -0.741 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.0 -37.37 69.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 47.7 t80 -82.64 -20.79 35.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.664 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -110.84 -69.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.834 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -49.24 -41.42 37.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 110.1 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.565 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -108.6 0.65 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.187 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.93 -52.69 29.61 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -47.86 -29.36 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 20.8 t-20 -101.42 -29.64 11.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 0.0 110.269 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.035 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -80.56 -21.09 42.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.7 m-85 -66.1 -60.77 6.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.388 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.1 Cg_endo -72.4 -0.11 8.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.989 1.521 . . . . 0.0 110.784 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 13.7 ttpt -101.78 -48.74 4.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.035 -1.04 . . . . 0.0 110.562 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.035 HG22 ' O ' ' A' ' 29' ' ' LEU . 17.0 m -91.44 7.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 110.6 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 75.39 3.34 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.143 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.33 -9.65 24.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.082 1.569 . . . . 0.0 110.69 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -92.81 -8.08 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 110.232 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -102.5 -72.26 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.016 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.48 131.33 57.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.443 -0.786 . . . . 0.0 109.758 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' SER . 0.5 OUTLIER -80.07 -34.9 37.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 110.208 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 39' ' ' SER . 2.0 p -178.09 157.77 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.44 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 60.5 t -117.49 152.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 109.982 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.9 tm-20 -139.05 89.68 2.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 15.9 t-20 -56.52 115.84 2.76 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.914 0.864 . . . . 0.0 110.532 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.726 HD12 HG22 ' A' ' 53' ' ' ILE . 6.0 mt -87.55 -39.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.902 0.858 . . . . 0.0 109.081 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 52' ' ' THR . 14.1 mt-10 -130.32 176.48 8.09 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.833 0.825 . . . . 0.0 111.689 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 45' ' ' GLU . . . 33.83 -156.57 0.01 OUTLIER Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -123.46 -19.15 5.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.39 -1.065 . . . . 0.0 109.869 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 49' ' ' GLY . . . 161.88 -21.67 0.2 Allowed Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 48' ' ' GLY . . . -53.16 -171.55 0.04 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.3 Cg_endo -72.65 128.7 13.7 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.009 1.531 . . . . 0.0 110.529 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.21 -7.17 62.04 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.663 ' HB ' HG21 ' A' ' 71' ' ' VAL . 2.3 m -69.76 144.42 52.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -1.164 . . . . 0.0 109.886 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.726 HG22 HD12 ' A' ' 44' ' ' ILE . 7.5 mt -114.55 141.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.936 -1.103 . . . . 0.0 109.264 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -153.38 134.43 14.01 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 110.069 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -86.49 116.78 24.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 111.041 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.467 HD11 ' HE2' ' A' ' 54' ' ' LYS . 56.0 mt -104.69 123.73 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.402 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 35.2 m -93.07 141.4 28.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 110.594 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.437 ' HB2' ' C ' ' A' ' 65' ' ' LYS . 2.5 m-85 -110.16 154.41 42.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.922 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.512 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 44.5 Cg_endo -71.83 168.04 24.93 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.0 1.526 . . . . 0.0 110.381 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 61' ' ' GLY . 63.9 tt0 -60.8 163.82 5.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.334 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' N ' ' HG2' ' A' ' 60' ' ' GLU . . . 148.05 -44.64 0.77 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.495 ' CB ' ' HD2' ' A' ' 63' ' ' PRO . 1.3 m-85 -130.5 177.75 2.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.286 -1.126 . . . . 0.0 109.918 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 62' ' ' PHE . 42.1 Cg_endo -67.76 -43.15 5.66 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.713 1.375 . . . . 0.0 110.562 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -98.93 130.77 45.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.839 . . . . 0.0 110.028 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' C ' ' HB2' ' A' ' 58' ' ' PHE . 8.6 mtmm -122.34 -81.8 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 110.528 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.843 ' O ' HG13 ' A' ' 67' ' ' VAL . 6.4 p90 -58.01 167.99 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.972 0.892 . . . . 0.0 111.291 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 66' ' ' TYR . 1.9 m -166.84 167.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.553 ' HD2' ' CB ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -99.3 -64.75 1.01 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.613 -1.304 . . . . 0.0 110.017 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.528 ' OD1' HG13 ' A' ' 85' ' ' VAL . 9.2 m-20 59.08 129.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.895 . . . . 0.0 110.888 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -112.56 149.56 32.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 108.908 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG21 ' HB ' ' A' ' 52' ' ' THR . 11.6 t -65.12 153.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.864 -1.147 . . . . 0.0 110.268 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.5 t70 -104.69 -75.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.407 0.622 . . . . 0.0 110.038 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -137.13 128.45 28.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.838 HG22 ' CD2' ' A' ' 81' ' ' TYR . 4.1 t -119.19 142.89 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -144.37 114.8 7.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.507 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -81.08 -10.58 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.399 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -108.93 -39.11 5.41 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.071 -1.018 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.64 9.27 27.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.518 -0.739 . . . . 0.0 109.997 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 48.32 51.41 15.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.185 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.92 117.54 24.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.269 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.838 ' CD2' HG22 ' A' ' 74' ' ' VAL . 45.9 t80 -137.83 106.16 5.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.773 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 35.2 m-20 -119.61 152.35 37.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.229 -0.919 . . . . 0.0 110.331 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 11.5 p90 -142.79 136.46 28.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' ARG . 50.4 m -95.6 168.13 10.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.117 -0.989 . . . . 0.0 111.132 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.528 HG13 ' OD1' ' A' ' 69' ' ' ASP . 53.8 t -107.98 123.94 63.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -74.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.815 -1.178 . . . . 0.0 111.451 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 2.8 mm-40 -91.87 71.65 5.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.195 . . . . 0.0 110.131 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.8 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . -151.24 161.54 29.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 52.55 -157.95 3.76 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.85 -0.86 10.96 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.032 1.543 . . . . 0.0 111.197 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CD1' HG12 ' A' ' 85' ' ' VAL . 50.0 mt -51.13 156.35 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 0.0 110.047 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.48 -58.0 0.2 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.2 p-10 -146.23 -49.09 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -1.162 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 t -145.08 12.45 1.4 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.81 144.94 28.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.121 -0.987 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.492 ' HA ' HG23 ' A' ' 122' ' ' THR . 2.7 tt0 55.99 33.4 21.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 109.859 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -70.48 150.43 46.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.639 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mt -132.62 134.43 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.364 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -118.78 107.64 13.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.043 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.496 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 18.4 m-80 -92.73 127.93 38.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.305 -0.872 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' HA ' ' OD1' ' A' ' 82' ' ' ASN . 4.1 mt-10 -121.22 143.9 48.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 116' ' ' ILE . 58.0 mt -137.63 129.59 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.469 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 ttpt -124.82 142.46 51.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.653 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.916 HG22 ' HB1' ' A' ' 15' ' ' ALA . 84.1 mt -130.65 103.98 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.471 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 113' ' ' ILE . 73.4 t -108.7 146.2 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.06 159.69 18.14 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.612 -0.68 . . . . 0.0 110.728 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 112' ' ' SER . 22.0 p -118.81 165.86 15.67 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 110.274 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 46.3 Cg_endo -73.29 -1.88 11.27 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.901 1.474 . . . . 0.0 110.401 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -92.96 -9.53 39.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.11 -8.43 35.91 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.49 -167.12 21.06 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -135.75 -176.52 4.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -1.089 . . . . 0.0 110.513 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 105' ' ' VAL . 33.6 mt -136.5 117.55 18.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.552 HD11 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -88.63 124.31 33.94 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 110.626 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 7.0 ttmt -116.14 100.02 7.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.78 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 102' ' ' ILE . 28.7 mt -96.48 139.57 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.395 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -122.16 109.3 14.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.142 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.2 t-20 -98.17 131.34 44.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.993 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 138.09 49.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.639 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.51 141.41 43.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 49.2 m-70 -123.37 95.99 4.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.492 HG23 ' HA ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -118.06 172.15 7.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 124' ' ' GLY . 18.6 tttp -100.23 154.89 18.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 110.14 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.62 -29.6 0.78 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.5 -81.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -1.123 . . . . 0.0 110.136 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 126' ' ' HIS . 39.1 m170 -64.33 -178.08 0.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 110.06 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.413 ' CG ' ' O ' ' A' ' 126' ' ' HIS . 24.5 mt-10 -155.43 -173.49 4.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.889 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.581 HG21 ' CG ' ' A' ' 120' ' ' TYR . 4.4 t -116.68 99.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.165 -0.959 . . . . 0.0 110.449 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.741 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -68.06 146.74 53.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.993 . . . . 0.0 109.498 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . . . -66.59 -9.66 37.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.971 -1.081 . . . . 0.0 110.808 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.505 ' HB2' ' CD ' ' A' ' 129' ' ' LYS . 12.9 mt-10 -68.0 -54.58 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.994 -1.066 . . . . 0.0 109.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.14 -23.7 63.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.89 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 129' ' ' LYS . 17.5 t -80.85 -46.59 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 130' ' ' ALA . 27.8 tttt -64.27 -26.02 68.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.955 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.23 -37.41 74.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.885 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -75.91 -40.41 54.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -47.5 -69.43 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.7 -22.74 63.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.169 -0.957 . . . . 0.0 109.902 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.17 -32.86 51.11 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.503 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 34.8 mt-10 -72.46 -61.31 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -1.095 . . . . 0.0 110.082 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 146' ' ' ALA . 3.0 m -45.62 -33.37 2.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.904 -1.123 . . . . 0.0 109.708 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.54 -59.38 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.856 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 141' ' ' GLU . 1.8 pp -65.9 -24.64 66.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -81.96 -29.23 32.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 142' ' ' THR . . . -69.47 -38.44 77.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.797 . . . . 0.0 109.675 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.47 -44.91 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -56.29 -46.08 79.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.573 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.4 OUTLIER -64.24 -49.76 70.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 109.733 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -47.71 -71.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 110.038 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -46.22 -37.21 6.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.379 -0.825 . . . . 0.0 110.298 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 149' ' ' SER . 5.3 mt -59.33 -23.66 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 110.507 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.81 -5.38 51.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -100.36 37.38 1.69 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.183 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.3 m -97.61 23.35 7.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.395 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -94.0 -27.4 16.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.025 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.75 178.62 4.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 110.034 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -96.9 -63.28 1.15 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.187 -0.946 . . . . 0.0 110.382 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.257 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.96 148.26 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -1.185 . . . . 0.0 110.371 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.439 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 23.1 m-85 -95.28 155.01 16.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.626 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.64 140.97 51.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.718 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.403 ' CE2' HG11 ' A' ' 133' ' ' VAL . 20.2 m-85 -149.32 61.53 1.03 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.398 -0.813 . . . . 0.0 109.723 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 4.2 pt-20 -84.0 148.44 26.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.862 . . . . 0.0 110.915 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLU . 3.1 p -151.8 175.24 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.432 -0.793 . . . . 0.0 109.565 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 11.8 pt-20 -155.26 146.42 22.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.93 -1.106 . . . . 0.0 110.621 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 m -129.26 143.18 50.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 110.019 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 p -82.06 159.69 23.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.416 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 m -156.77 136.91 12.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 12.1 m -79.98 -16.37 12.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.09 -1.006 . . . . 0.0 108.66 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.865 HG21 HD13 ' A' ' 151' ' ' LEU . 26.0 mm -67.03 149.44 98.51 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.74 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.69 150.55 83.59 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.509 1.268 . . . . 0.0 110.875 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -76.81 -27.02 55.05 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.57 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.07 -52.57 9.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 0.0 109.396 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.588 HD22 HG21 ' A' ' 104' ' ' ILE . 9.8 tt -75.5 -42.45 52.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.523 -0.735 . . . . 0.0 109.829 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.752 ' CD1' HD13 ' A' ' 23' ' ' ILE . 51.0 t80 -56.65 -62.23 1.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 0.0 110.17 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.477 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -53.41 -45.61 69.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.81 . . . . 0.0 110.277 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.49 65.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.459 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.718 ' HD2' HG11 ' A' ' 147' ' ' VAL . 5.8 t80 -88.13 -22.98 23.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.435 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.752 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -112.18 -58.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' CG ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -60.23 -30.35 69.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.876 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -122.24 11.65 10.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.935 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.23 -54.52 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 36.2 p-10 -55.44 -25.55 36.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.196 -1.179 . . . . 0.0 110.393 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 37.2 m-20 -92.99 -41.21 10.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.676 HD21 ' CE2' ' A' ' 150' ' ' TYR . 0.6 OUTLIER -72.99 -31.31 64.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.882 . . . . 0.0 110.524 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.762 ' CD2' HD13 ' A' ' 38' ' ' ILE . 2.0 m-85 -50.17 -61.96 3.14 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -72.4 -7.46 20.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.84 1.442 . . . . 0.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -93.42 -67.2 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.397 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 29' ' ' LEU . 24.3 m -88.98 -0.29 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.339 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -146.8 56.33 2.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 110.344 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 34' ' ' ALA . 45.4 Cg_endo -71.88 -23.19 22.48 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.335 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.84 -16.92 61.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.584 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -96.66 -58.74 1.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.195 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.762 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -110.47 137.78 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.969 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.15 -52.59 6.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 110.353 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.71 -179.23 7.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.192 -0.942 . . . . 0.0 110.453 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 41' ' ' VAL . 2.4 p -159.94 112.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.3 145.68 44.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.896 . . . . 0.0 110.044 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 1.4 m120 -93.88 121.95 35.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.199 -0.938 . . . . 0.0 110.684 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 54' ' ' LYS . 25.4 mm -83.8 -37.59 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.345 1.069 . . . . 0.0 108.363 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 31.8 tt0 -153.57 174.3 14.62 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.289 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 66.4 173.31 5.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 47' ' ' ASN . 10.8 t-20 -124.92 45.12 2.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -1.049 . . . . 0.0 109.795 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.539 ' H ' HG21 ' A' ' 52' ' ' THR . . . 79.81 14.55 80.79 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -96.32 -168.4 34.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.8 Cg_endo -71.25 114.96 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.971 1.511 . . . . 0.0 110.315 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.14 -2.89 51.2 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.672 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.4 m -62.91 154.45 30.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -1.111 . . . . 0.0 109.815 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 44' ' ' ILE . 6.0 mt -125.35 136.1 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 110.095 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -154.48 139.32 17.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.915 . . . . 0.0 110.35 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -84.07 119.88 25.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 110.768 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.3 mt -103.24 118.04 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 109.631 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.8 m -85.75 140.49 30.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CB ' ' HB3' ' A' ' 65' ' ' LYS . 19.4 m-85 -112.49 158.53 37.06 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 42.7 Cg_endo -70.55 -169.9 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.007 1.53 . . . . 0.0 110.908 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.8 -170.36 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.852 . . . . 0.0 110.645 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.89 -38.31 2.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.9 OUTLIER -135.24 177.09 2.4 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.335 -1.097 . . . . 0.0 110.007 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.571 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 44.6 Cg_endo -71.59 -54.87 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.958 1.504 . . . . 0.0 110.093 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 36.6 m-85 -111.64 129.58 56.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.851 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.553 ' HB3' ' CB ' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -144.07 -38.71 0.3 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.324 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 9.0 p90 -62.25 148.5 44.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.963 . . . . 0.0 109.632 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -157.52 172.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.098 -1.001 . . . . 0.0 110.662 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.565 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 2.5 mtpp -93.46 -65.02 1.02 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.662 -0.649 . . . . 0.0 109.811 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER 60.6 120.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ptm180 -106.37 167.22 9.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.307 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.672 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.6 t -82.18 152.32 4.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.88 -1.137 . . . . 0.0 110.348 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 48.5 t0 -101.2 -72.34 0.68 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.235 0.541 . . . . 0.0 109.878 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -146.82 124.58 11.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.361 -0.837 . . . . 0.0 110.124 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.61 149.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 5.3 t0 -151.94 115.06 4.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 0.0 109.908 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -85.86 3.14 43.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.647 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 m -110.34 -48.38 3.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -0.956 . . . . 0.0 109.305 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -91.77 17.84 8.47 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.701 -0.624 . . . . 0.0 110.03 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 20.2 m-85 43.74 58.97 3.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 109.93 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 28.1 tttt -122.18 119.44 31.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -135.51 109.16 7.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 51.4 m-20 -125.86 150.29 47.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 110.427 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 51.3 p90 -142.64 139.64 31.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 0.0 109.447 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' ARG . 3.1 m -96.16 155.87 16.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.973 -1.079 . . . . 0.0 110.808 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' OD2' ' A' ' 69' ' ' ASP . 54.7 t -99.91 124.43 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.61 -76.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.948 -1.095 . . . . 0.0 110.956 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.68 78.88 9.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.649 -1.282 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.441 ' HA2' ' HB ' ' A' ' 67' ' ' VAL . . . -100.63 145.97 17.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -44.57 -50.01 8.44 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.5 Cg_endo -73.62 -48.44 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.636 1.335 . . . . 0.0 111.02 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 85' ' ' VAL . 33.7 mt -54.52 141.7 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.078 -1.014 . . . . 0.0 110.42 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -108.73 -65.06 0.57 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 4.7 m-20 -114.3 -82.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -1.113 . . . . 0.0 110.0 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.9 p -134.27 12.2 3.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.975 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.752 HD22 ' HB2' ' A' ' 123' ' ' LYS . 37.2 mt -90.87 156.38 18.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.016 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 12.1 tt0 61.96 31.76 17.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.7 mtpt -65.25 161.56 19.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.552 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.588 HD11 ' HE1' ' A' ' 120' ' ' TYR . 87.6 mt -143.9 132.52 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 110.614 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 1.2 m -116.24 111.34 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 109.547 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 2.0 m-80 -103.06 142.17 34.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 110.722 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.548 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 4.2 mp0 -136.19 150.23 48.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.973 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.446 HG12 HD12 ' A' ' 116' ' ' ILE . 45.6 mt -140.63 125.55 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.509 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 2.4 ttpt -125.15 111.91 15.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 109.65 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.588 HG21 HD22 ' A' ' 18' ' ' LEU . 12.1 mt -102.96 112.59 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.43 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.78 142.32 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.827 . . . . 0.0 110.188 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.94 159.96 18.12 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.595 -0.691 . . . . 0.0 110.665 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.581 HG23 ' HA ' ' A' ' 112' ' ' SER . 14.9 p -119.75 166.25 15.38 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 44.0 Cg_endo -71.18 -10.84 28.04 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.875 1.46 . . . . 0.0 110.409 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -79.0 -17.07 56.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 110.315 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.16 -17.23 12.76 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -105.71 -164.63 23.37 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.823 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -135.98 -174.17 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.407 -1.055 . . . . 0.0 110.511 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.412 HG13 ' CG2' ' A' ' 107' ' ' THR . 23.5 mt -137.59 109.39 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.0 108.982 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -84.42 129.19 34.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG2' ' CB ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -122.44 98.47 5.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.806 . . . . 0.0 109.692 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 116' ' ' ILE . 2.6 tt -94.82 120.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.509 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.472 ' HB3' ' OE1' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -102.04 116.26 32.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.051 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.454 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -103.08 158.62 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 1.8 ttmt -148.51 142.0 25.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.447 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.61 ' CD2' HG21 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -123.52 133.48 54.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -0.931 . . . . 0.0 110.106 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.619 ' N ' ' CD2' ' A' ' 121' ' ' HIS . 4.4 m-70 -119.37 97.67 5.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.52 163.21 14.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.951 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.752 ' HB2' HD22 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -101.46 160.61 14.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.397 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -49.75 -24.96 6.45 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.48 -54.72 4.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.122 -1.222 . . . . 0.0 110.57 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.491 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 51.7 m170 -79.64 175.92 10.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 110.269 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.491 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -160.11 137.34 9.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.701 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.61 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.6 p -98.46 89.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.514 -0.742 . . . . 0.0 110.223 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.16 155.31 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.118 -0.989 . . . . 0.0 110.145 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -64.76 -33.15 75.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.278 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -41.03 -59.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -27.31 65.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 109.274 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 130' ' ' ALA . 18.8 t -77.2 -49.47 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.425 -0.797 . . . . 0.0 109.372 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.43 65.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.857 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.02 -21.44 59.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.511 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t -76.44 -43.72 38.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.467 -0.77 . . . . 0.0 110.056 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.75 -30.29 68.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.877 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.942 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.97 -40.45 46.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.882 . . . . 0.0 110.125 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.669 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -50.03 -40.99 36.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.871 ' HA ' HD23 ' A' ' 144' ' ' LEU . 23.2 tt0 -60.88 -43.98 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -1.122 . . . . 0.0 109.699 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 38.7 m -62.43 -30.36 71.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.533 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.669 HD12 ' HA2' ' A' ' 140' ' ' GLY . 74.1 mt -64.85 -45.55 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.156 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -66.64 -26.2 66.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.844 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.524 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -78.79 -39.66 35.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.82 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.59 88.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 109.579 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.718 HG11 ' HD2' ' A' ' 22' ' ' PHE . 60.0 t -69.92 -39.66 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.411 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.01 -50.86 69.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -17.25 63.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.448 -0.782 . . . . 0.0 110.749 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.676 ' CE2' HD21 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -79.81 -42.24 24.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.966 -1.084 . . . . 0.0 109.503 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.865 HD13 HG21 ' A' ' 13' ' ' ILE . 5.7 mt -67.48 -48.16 67.95 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.821 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -53.34 56.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.83 62.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.912 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.67 97.07 6.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 110.063 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 57.6 m -146.8 75.43 1.39 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.292 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 34.2 m-20 -85.12 -35.18 21.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.038 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 156' ' ' ASP . . . 68.38 178.18 0.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.211 -0.931 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -173.73 -49.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.069 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.147 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.446 HG21 ' CE1' ' A' ' 121' ' ' HIS . 5.1 t -54.78 151.21 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -1.168 . . . . 0.0 110.074 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -104.35 128.66 52.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 109.883 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.17 142.07 32.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.846 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.767 ' CE2' HG11 ' A' ' 133' ' ' VAL . 27.8 m-85 -149.93 54.96 0.94 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.46 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.496 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 0.1 OUTLIER -83.16 158.0 22.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.529 -0.732 . . . . 0.0 110.878 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -154.44 153.84 32.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.677 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -138.5 146.71 42.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.084 -1.01 . . . . 0.0 110.539 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.54 -178.97 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 110.09 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.43 HG22 HG12 ' A' ' 113' ' ' ILE . 1.6 p -121.64 163.29 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.949 . . . . 0.0 110.664 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 2.7 t -159.29 136.86 10.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.78 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.514 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 16.6 t -80.03 -13.87 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.125 -0.984 . . . . 0.0 109.008 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.863 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.1 mp -71.89 153.97 92.83 Favored Pre-proline 0 N--CA 1.488 1.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.863 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.4 Cg_endo -67.93 149.15 77.49 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.619 1.326 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -75.08 -29.06 60.55 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.513 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -68.16 -55.07 13.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 16.3 mtt-85 -63.93 -36.63 84.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.652 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.568 HD23 HD13 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -71.79 -35.81 70.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.428 -0.795 . . . . 0.0 110.09 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.615 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 36.4 t80 -60.54 -58.73 7.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.921 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' HD3' ' O ' ' A' ' 16' ' ' ALA . 13.7 mtpt -50.69 -52.62 38.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.67 67.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.293 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -89.13 -12.06 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -124.45 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.742 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.616 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -50.34 -56.2 12.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.338 -0.851 . . . . 0.0 109.825 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.43 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 2.5 m-20 -111.95 35.43 3.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 109.829 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.13 -58.91 2.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.59 ' HB2' HG11 ' A' ' 41' ' ' VAL . 7.0 p-10 -53.03 -26.72 16.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 110.052 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -87.56 -34.8 18.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.568 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 13.9 mt -80.44 -38.75 29.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.316 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.635 ' HD2' HD13 ' A' ' 38' ' ' ILE . 2.0 m-30 -43.79 -57.72 5.52 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.619 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.8 Cg_endo -70.71 -18.89 32.21 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.884 1.465 . . . . 0.0 110.629 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.1 mtpp -86.15 -54.46 4.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.281 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.93 HG22 ' HB1' ' A' ' 146' ' ' ALA . 5.5 p -83.76 -25.33 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.48 77.29 15.5 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.01 -4.73 15.89 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.082 1.569 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.93 -26.5 60.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.124 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -95.6 -70.34 0.72 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.861 . . . . 0.0 109.967 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.635 HD13 ' HD2' ' A' ' 30' ' ' PHE . 1.7 mp -99.02 128.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.819 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -88.49 -44.69 10.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.29 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -159.5 139.96 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.974 HG13 HG12 ' A' ' 56' ' ' ILE . 3.8 t -119.04 130.87 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -135.61 101.82 4.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.686 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.5 m120 -50.64 118.86 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 110.22 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.526 ' CD1' ' HG2' ' A' ' 68' ' ' LYS . 12.8 mt -86.42 -37.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.336 1.065 . . . . 0.0 108.403 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 24.6 tt0 -143.61 174.43 10.79 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.072 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 57.4 160.49 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -103.88 1.73 31.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -1.203 . . . . 0.0 110.115 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.21 -1.4 4.52 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.86 -167.64 19.98 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.6 122.28 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.005 1.529 . . . . 0.0 110.293 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.73 59.9 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.659 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.4 m -54.85 158.72 2.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -1.167 . . . . 0.0 109.305 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 45.8 mt -125.79 142.57 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.048 -1.033 . . . . 0.0 110.559 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -145.32 150.39 36.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 110.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 14.7 ttpp -102.2 93.47 5.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.638 -0.664 . . . . 0.0 110.079 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.974 HG12 HG13 ' A' ' 41' ' ' VAL . 66.1 mt -87.92 122.47 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 110.055 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.513 ' CB ' ' OG ' ' A' ' 39' ' ' SER . 17.6 m -86.7 138.14 31.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -106.14 135.31 19.47 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 45.3 Cg_endo -72.8 121.11 7.08 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.936 1.493 . . . . 0.0 110.416 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -172.44 -171.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 62' ' ' PHE . . . -106.04 -52.89 0.77 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 15.2 m-85 -44.51 163.85 0.18 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.278 -1.131 . . . . 0.0 110.05 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 43.9 Cg_endo -71.36 -50.62 0.3 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.038 1.546 . . . . 0.0 110.846 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.427 ' CD2' ' HG2' ' A' ' 63' ' ' PRO . 26.2 m-85 -82.87 128.51 34.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.388 -0.82 . . . . 0.0 110.325 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 58' ' ' PHE . 9.8 pttp -164.63 -43.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 109.883 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 10.8 p90 -63.09 165.72 6.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.788 . . . . 0.0 109.951 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -144.33 167.79 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.403 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.526 ' HG2' ' CD1' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -123.05 41.8 3.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.945 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 18.6 p-10 -41.84 136.21 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.9 ttm180 -97.46 151.84 19.58 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.659 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.1 t -75.75 149.06 6.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.67 -1.269 . . . . 0.0 110.459 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 46.2 t0 -101.87 -72.14 0.69 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.416 0.627 . . . . 0.0 110.306 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 122.47 11.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -0.855 . . . . 0.0 109.96 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.793 HG22 ' CD2' ' A' ' 81' ' ' TYR . 5.1 t -108.7 154.22 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 110.265 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.488 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 2.1 t0 -156.48 121.85 4.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.887 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.505 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -87.54 -15.29 37.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 110.788 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -102.37 -45.13 5.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.126 -0.984 . . . . 0.0 109.356 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.13 7.48 15.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.546 -0.722 . . . . 0.0 110.091 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.615 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.4 m-30 46.25 58.46 4.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.493 ' HG3' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 110.61 -179.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.793 ' CD2' HG22 ' A' ' 74' ' ' VAL . 38.9 t80 -127.95 100.08 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 109.804 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.514 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 6.7 m120 -109.58 139.77 44.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.466 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.598 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 39.7 p90 -136.14 136.29 39.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 70' ' ' ARG . 10.6 m -100.13 162.51 12.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 111.223 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.735 HG11 HD13 ' A' ' 98' ' ' ILE . 24.3 t -104.54 123.66 58.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -123.4 -72.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.303 -179.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -83.75 88.27 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.268 . . . . 0.0 110.211 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -107.1 148.2 16.37 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.53 -51.91 5.44 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.9 Cg_endo -76.3 -46.96 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.934 1.492 . . . . 0.0 110.732 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 92' ' ' GLY . 52.8 mt -56.51 164.15 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.107 -0.995 . . . . 0.0 110.459 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -150.91 -69.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -86.4 -87.94 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.881 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.7 t -148.62 15.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.467 ' HB3' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -89.66 160.62 16.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 110.38 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 58.16 35.63 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.28 147.73 39.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.735 HD13 HG11 ' A' ' 85' ' ' VAL . 4.9 mp -127.77 137.01 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.763 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.7 114.69 19.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.87 . . . . 0.0 109.661 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.598 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 1.1 m120 -110.04 141.14 43.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -130.26 135.68 48.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.44 101.67 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.056 -1.027 . . . . 0.0 110.344 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HE3' ' HG3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -107.63 121.46 44.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.926 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.735 HG22 ' HB1' ' A' ' 15' ' ' ALA . 54.9 mt -110.48 139.35 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.6 t -138.77 135.78 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.372 -0.83 . . . . 0.0 109.816 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.16 145.92 25.66 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.486 0.66 . . . . 0.0 111.096 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.4 p -89.24 -167.04 0.12 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.271 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 46.0 Cg_endo -79.77 70.86 7.33 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.399 1.21 . . . . 0.0 110.281 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER 68.48 35.62 3.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.394 -0.816 . . . . 0.0 110.144 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.52 16.37 4.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 107' ' ' THR . . . 106.23 -159.76 14.92 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.854 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -140.4 163.46 32.74 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.549 -0.971 . . . . 0.0 110.676 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 10' ' ' THR . 71.4 mt -119.85 127.33 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.53 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 114' ' ' LEU . 2.1 pp -105.79 112.87 26.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.001 -1.062 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -99.31 104.58 16.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.322 -0.861 . . . . 0.0 109.951 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.489 HG13 HD12 ' A' ' 114' ' ' LEU . 9.7 mt -89.56 125.38 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.496 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -112.63 112.51 24.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.126 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -106.39 155.63 19.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.8 mptt -147.21 131.02 17.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.511 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.646 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -110.21 128.28 55.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.742 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.446 ' CE1' HG21 ' A' ' 2' ' ' VAL . 23.0 m-70 -113.75 130.01 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.056 -1.028 . . . . 0.0 110.249 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -110.63 175.65 5.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 110.086 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -147.2 165.6 29.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 110.183 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 43.04 -124.55 4.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -111.8 10.76 20.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -1.121 . . . . 0.0 110.071 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 13.9 m-70 -69.02 168.05 14.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.293 -0.88 . . . . 0.0 109.878 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.609 ' HA ' HG21 ' A' ' 122' ' ' THR . 5.7 mt-10 -155.75 150.96 26.72 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.179 -0.951 . . . . 0.0 109.442 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.603 HG21 ' CE2' ' A' ' 120' ' ' TYR . 2.4 p -106.52 86.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 O-C-N 121.658 -0.651 . . . . 0.0 109.839 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 128' ' ' VAL . 1.3 mttp -39.56 144.66 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.508 -0.745 . . . . 0.0 110.603 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.504 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -57.31 -27.34 62.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 110.059 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ALA . 60.8 tt0 -41.57 -64.16 0.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -24.36 38.83 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.767 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.3 t -78.88 -50.95 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.365 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -24.55 67.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.465 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.58 -38.26 70.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.649 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 t -66.9 -31.94 72.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.316 -0.865 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -36.73 73.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.804 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.49 -48.08 79.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.844 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.88 -36.55 56.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.231 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.59 -50.25 61.36 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.1 tt0 -56.08 -33.21 64.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -1.194 . . . . 0.0 110.289 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.3 m -70.88 -24.76 62.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.565 ' O ' HG23 ' A' ' 147' ' ' VAL . 21.3 mt -75.7 -47.31 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.993 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.5 pp -70.66 -24.06 62.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.767 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.474 ' N ' HD12 ' A' ' 144' ' ' LEU . 15.0 tpt180 -81.05 -32.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.93 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -70.37 -35.42 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.407 -0.808 . . . . 0.0 109.685 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 143' ' ' LEU . 47.0 t -73.5 -46.03 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.465 -0.772 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 49.6 tt0 -54.79 -50.87 67.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.33 -47.35 84.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -48.73 -70.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.894 . . . . 0.0 110.068 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.621 HD13 HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -49.31 -23.64 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.452 -0.78 . . . . 0.0 110.242 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -81.11 -20.47 41.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.4 3.56 37.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.91 8.1 44.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.221 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 36.9 m -95.14 52.14 1.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 0.0 110.221 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.44 18.97 6.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.029 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.01 -37.21 75.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.353 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.34 70.31 0.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.184 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.25 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.528 HG22 ' ND1' ' A' ' 121' ' ' HIS . 4.8 t 57.72 153.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -1.108 . . . . 0.0 110.412 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.5 m-85 -112.0 163.82 13.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.679 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.09 137.52 32.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.106 . . . . 0.0 110.714 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.479 ' O ' ' HB2' ' A' ' 118' ' ' ASN . 46.6 m-85 -144.89 57.89 1.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.777 . . . . 0.0 109.556 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 7' ' ' THR . 1.2 tm-20 -80.03 154.52 28.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 110.783 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -155.68 -179.06 7.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.518 -0.739 . . . . 0.0 109.494 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -158.04 151.74 23.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.0 110.47 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 t -140.4 169.57 17.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.928 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.4 162.99 13.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 110.256 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.403 ' OG ' ' HG3' ' A' ' 148' ' ' GLU . 3.6 t -158.86 137.88 11.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.444 -0.785 . . . . 0.0 109.916 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.98 -3.02 5.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.594 HG21 HD13 ' A' ' 151' ' ' LEU . 36.1 mm -81.58 147.47 59.51 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.049 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.88 150.56 83.11 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.473 1.249 . . . . 0.0 111.091 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -75.18 -33.15 61.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.935 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.03 -47.81 49.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.49 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 5.1 ttt180 -68.64 -38.92 80.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.97 . . . . 0.0 109.764 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.74 ' CD2' HD21 ' A' ' 114' ' ' LEU . 2.4 tp -72.69 -30.45 64.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 76' ' ' HIS . 67.6 t80 -68.13 -63.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.368 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HG3' HD13 ' A' ' 24' ' ' LEU . 1.4 mptp? -53.24 -40.98 64.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -0.777 . . . . 0.0 110.512 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.76 -32.15 63.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 110.541 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.7 t80 -90.61 -8.72 49.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 19' ' ' PHE . 1.2 mp -118.83 -65.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.094 -1.004 . . . . 0.0 110.048 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.891 HD11 ' CE1' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -61.33 -46.73 89.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 29' ' ' LEU . 1.1 t0 -97.05 -15.35 21.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -45.94 -42.51 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 4.6 m-20 -52.77 -27.98 20.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -1.151 . . . . 0.0 110.014 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -113.31 -20.29 11.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.6 tp -86.66 -27.79 23.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 110.106 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.542 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 2.0 m-85 -54.84 -53.76 57.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.406 -0.809 . . . . 0.0 110.657 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -74.31 -4.59 15.66 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.833 1.438 . . . . 0.0 111.101 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.5 -40.71 8.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 110.59 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 29' ' ' LEU . 13.5 m -86.03 -26.66 6.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 110.8 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.24 88.44 5.81 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.092 -1.005 . . . . 0.0 110.594 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 59' ' ' PRO . 49.3 Cg_endo -76.34 0.68 9.17 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.006 1.53 . . . . 0.0 110.489 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -29.75 23.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.282 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -92.4 -66.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.159 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.445 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.2 mp -107.82 126.86 64.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.444 -0.785 . . . . 0.0 109.936 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 31' ' ' PRO . 2.9 t -83.35 -53.35 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.285 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 t -149.6 146.99 27.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.018 HG13 HD12 ' A' ' 56' ' ' ILE . 5.8 t -121.45 127.59 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.63 108.95 8.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.093 -1.005 . . . . 0.0 110.838 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 2.7 m120 -62.4 118.39 7.43 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 44' ' ' ILE . 12.1 mt -87.36 -37.71 11.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.236 1.017 . . . . 0.0 108.585 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 23.8 tt0 -148.64 174.7 11.87 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.405 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 71.18 -174.92 40.15 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.77 43.21 3.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -1.197 . . . . 0.0 110.295 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' H ' HG21 ' A' ' 52' ' ' THR . . . 72.3 27.95 68.93 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.11 -158.97 12.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.7 Cg_endo -72.47 110.22 2.93 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.112 1.585 . . . . 0.0 110.619 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.82 47.41 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.603 ' HB ' HG21 ' A' ' 71' ' ' VAL . 2.4 m -60.72 152.65 26.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.181 -1.188 . . . . 0.0 109.728 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.42 HG21 ' HE2' ' A' ' 68' ' ' LYS . 7.3 mt -119.43 133.95 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' HD3' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -141.08 150.84 43.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.533 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.48 ' C ' HD13 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -96.41 101.44 13.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.639 -0.663 . . . . 0.0 109.751 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 HG13 ' A' ' 41' ' ' VAL . 4.4 mm -94.48 134.01 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.963 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -102.97 131.81 49.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.92 . . . . 0.0 110.337 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.418 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 1.0 OUTLIER -100.14 117.73 62.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.911 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.484 ' HG3' ' O ' ' A' ' 35' ' ' PRO . 48.7 Cg_endo -75.54 137.62 20.77 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.912 1.48 . . . . 0.0 110.638 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 10.2 tt0 -177.98 -72.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.215 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.02 -34.24 0.86 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.401 ' CB ' ' HD2' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -54.29 173.5 0.21 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.289 -1.124 . . . . 0.0 110.059 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 62' ' ' PHE . 43.8 Cg_endo -71.02 -55.26 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.997 1.525 . . . . 0.0 109.898 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 22.0 m-85 -96.51 167.52 11.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.952 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 165.81 -55.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 33.6 p90 -58.22 177.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.485 -0.759 . . . . 0.0 110.281 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 68' ' ' LYS . 1.4 p -167.16 171.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.0 110.657 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' N ' HG22 ' A' ' 67' ' ' VAL . 8.7 tttt -106.89 46.42 0.93 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.715 -0.615 . . . . 0.0 109.912 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' CG2' ' A' ' 67' ' ' VAL . 48.5 m-20 -45.62 130.98 9.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.693 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttp180 -102.56 162.92 12.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.603 HG21 ' HB ' ' A' ' 52' ' ' THR . 12.3 t -86.56 151.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.596 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 32.1 t70 -100.33 -68.01 0.83 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.194 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.3 mt-10 -143.77 137.86 28.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.414 -0.804 . . . . 0.0 110.205 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 4.5 t -123.97 144.22 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.158 -0.964 . . . . 0.0 110.101 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -147.43 114.06 6.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.891 ' CE1' HD11 ' A' ' 24' ' ' LEU . 12.3 m170 -82.56 -2.07 52.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.338 -0.851 . . . . 0.0 110.708 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -118.08 -42.45 2.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.037 -1.039 . . . . 0.0 109.891 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.477 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -90.26 18.85 5.57 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.516 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.2 m-85 42.17 64.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.111 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.503 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -131.11 117.14 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.442 ' OH ' ' NZ ' ' A' ' 54' ' ' LYS . 9.5 t80 -137.34 99.63 4.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.835 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.536 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 56.8 m-20 -113.81 147.01 39.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 36.2 p90 -140.99 142.48 34.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 70' ' ' ARG . 26.3 m -107.07 165.14 11.58 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.176 -0.953 . . . . 0.0 110.974 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.696 HG12 HD13 ' A' ' 91' ' ' ILE . 71.4 t -108.06 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.499 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -123.06 -77.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.898 -1.126 . . . . 0.0 110.834 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -85.61 77.28 9.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.835 -1.166 . . . . 0.0 109.891 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.494 ' HA2' ' CB ' ' A' ' 67' ' ' VAL . . . -104.23 159.74 16.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.546 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.75 -54.84 5.69 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -71.06 -48.76 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.768 1.404 . . . . 0.0 111.013 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.696 HD13 HG12 ' A' ' 85' ' ' VAL . 4.8 mt -64.89 164.59 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.024 -1.048 . . . . 0.0 110.418 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.479 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -153.15 -40.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.3 -85.97 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -1.152 . . . . 0.0 110.146 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -139.26 6.8 2.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -92.91 158.44 15.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 58.39 31.3 20.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 110.162 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -75.31 146.35 41.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.787 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.599 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.1 mp -132.29 127.82 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.178 -0.951 . . . . 0.0 110.685 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.49 116.24 30.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 109.679 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.52 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 12.6 m-80 -104.35 156.34 18.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.937 . . . . 0.0 110.749 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 94.2 mt-10 -144.91 138.38 26.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.792 . . . . 0.0 109.815 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -128.76 128.67 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.521 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -129.17 132.29 47.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.33 -0.856 . . . . 0.0 109.937 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.516 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 1.3 mp -121.66 129.17 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.85 123.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 111.195 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -58.12 162.9 3.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.864 -0.523 . . . . 0.0 110.503 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.73 HG23 ' CD ' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -160.0 -61.05 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 111.371 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.73 ' CD ' HG23 ' A' ' 107' ' ' THR . 49.4 Cg_endo -74.27 53.1 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.082 1.043 . . . . 0.0 111.099 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 108' ' ' PRO . 1.2 m-20 40.6 55.13 2.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.905 . . . . 0.0 110.549 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 146.63 -56.14 0.52 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -75.78 -169.05 26.39 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 11.3 t -157.19 -179.98 8.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.255 . . . . 0.0 111.218 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.468 HG13 HG21 ' A' ' 107' ' ' THR . 4.9 mt -125.21 124.79 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.74 HD21 ' CD2' ' A' ' 18' ' ' LEU . 2.1 mp -99.09 114.67 27.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 110.952 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -103.83 106.48 17.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.334 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 26.3 mt -101.99 127.27 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.679 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -105.43 143.44 33.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.801 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.52 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 2.0 m120 -131.07 153.15 49.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.413 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -146.26 132.65 19.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.925 . . . . 0.0 110.375 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.671 ' CG ' HG21 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -110.07 131.5 55.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.81 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.528 ' ND1' HG22 ' A' ' 2' ' ' VAL . 66.5 m-70 -118.28 109.15 15.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 0.0 110.371 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.555 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -107.48 173.07 6.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' ASP . 1.6 ttpm? -110.32 176.06 5.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 110.361 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.09 60.58 0.22 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' LYS . 42.8 t0 -175.29 -67.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.37 -1.076 . . . . 0.0 109.831 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -81.91 172.15 13.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.937 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.555 ' HA ' HG21 ' A' ' 122' ' ' THR . 1.3 mm-40 -145.17 -164.14 1.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 110.266 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.671 HG21 ' CG ' ' A' ' 120' ' ' TYR . 1.8 t -122.82 105.38 15.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.499 -0.751 . . . . 0.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -78.22 126.76 31.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.371 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.57 -37.28 26.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.063 -1.023 . . . . 0.0 110.405 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -42.49 -48.85 5.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.024 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -70.51 -27.73 64.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 108.934 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 130' ' ' ALA . 16.9 t -76.5 -47.59 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.569 -0.707 . . . . 0.0 109.12 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -59.51 -27.94 66.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.658 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.92 66.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.1 t -66.87 -31.32 71.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.948 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -45.34 54.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 110.046 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.84 -57.36 4.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.884 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' ' HB ' ' A' ' 142' ' ' THR . 4.0 mm? -75.37 -35.08 61.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.034 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.86 -49.5 22.69 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.495 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 40.7 tt0 -55.88 -44.51 78.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -1.14 . . . . 0.0 110.017 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 139' ' ' LEU . 17.1 m -55.57 -34.15 64.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.0 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 143' ' ' LEU . 17.4 mt -67.86 -49.36 62.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 144' ' ' LEU . 0.9 OUTLIER -69.87 -27.11 64.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.086 -1.009 . . . . 0.0 109.83 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.405 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 3.4 ttm180 -81.47 -28.81 33.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.92 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.11 -43.53 64.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 109.918 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 22' ' ' PHE . 77.8 t -72.22 -38.26 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.794 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.5 tt0 -65.06 -46.09 82.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -63.5 -40.73 97.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.586 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -73.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 109.977 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 13' ' ' ILE . 1.6 mt -50.11 -38.98 41.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.412 -0.805 . . . . 0.0 110.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 3.9 mt -50.98 -26.77 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.808 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.56 -20.4 13.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.938 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 151' ' ' LEU . 22.4 t-160 -93.27 -40.09 10.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 110.064 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.2 m -92.67 17.3 10.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 0.0 110.243 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -66.69 -36.09 81.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.931 . . . . 0.0 110.082 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.83 -145.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.055 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -92.09 -28.07 17.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 0.0 110.142 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 29.5 p-10 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.29 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.764 HG11 ' ND1' ' A' ' 121' ' ' HIS . 8.6 m -109.94 -164.55 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.147 -1.207 . . . . 0.0 110.118 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.562 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 3.4 m-85 -107.81 164.33 12.34 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.628 -0.67 . . . . 0.0 109.714 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.99 138.49 42.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.053 -1.029 . . . . 0.0 110.848 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.42 ' CE1' HG11 ' A' ' 133' ' ' VAL . 50.0 m-85 -146.57 53.89 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.3 pt-20 -81.66 144.43 31.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.475 -0.766 . . . . 0.0 111.149 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -171.03 3.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.443 -0.786 . . . . 0.0 109.674 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -159.9 164.46 33.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 110.711 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 10' ' ' THR . 1.0 OUTLIER -144.83 -169.92 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 110.048 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.592 ' H ' HG22 ' A' ' 9' ' ' THR . 3.1 p -129.52 160.94 31.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 110.35 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.98 135.3 8.14 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.622 -0.674 . . . . 0.0 109.834 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.96 -17.06 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 108.642 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.007 HG21 HD13 ' A' ' 151' ' ' LEU . 21.9 mm -68.24 150.35 97.76 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -65.92 151.71 83.37 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.508 1.267 . . . . 0.0 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.61 -25.06 59.0 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -78.13 -47.6 17.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.473 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -69.61 -34.12 73.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.707 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 104' ' ' ILE . 10.6 tp -74.38 -28.7 61.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 110.007 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 23' ' ' ILE . 50.6 t80 -70.44 -60.18 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -54.72 -45.79 74.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.43 70.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.63 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.459 ' HB3' HD12 ' A' ' 23' ' ' ILE . 8.2 t80 -91.54 -20.76 21.35 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.97 . . . . 0.0 110.461 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.499 HG13 ' CD2' ' A' ' 81' ' ' TYR . 1.3 mp -114.08 -62.8 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 110.036 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.67 -35.19 20.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.871 . . . . 0.0 110.209 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.58 26.45 4.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -61.0 -44.97 97.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' OD1' HG21 ' A' ' 41' ' ' VAL . 26.9 m-20 -64.88 -8.13 14.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -1.203 . . . . 0.0 110.412 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 4.6 t30 -107.68 -38.79 5.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.671 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.469 HD21 ' CZ ' ' A' ' 150' ' ' TYR . 0.1 OUTLIER -80.64 -38.74 28.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.555 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -42.12 -59.27 2.77 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.449 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.2 Cg_endo -72.73 -10.65 25.27 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.637 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 6.6 tttm -90.78 -63.74 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 29' ' ' LEU . 11.1 m -81.51 -17.4 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 110.741 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.85 64.37 62.24 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 110.383 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.7 -13.26 20.04 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.001 1.527 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -79.05 -23.61 44.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -89.07 -61.01 1.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.428 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -106.42 155.45 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 109.841 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.49 -61.04 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 110.177 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.65 135.17 16.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG2' HG12 ' A' ' 56' ' ' ILE . 1.7 p -124.04 128.77 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.125 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 2.9 mt-10 -130.77 159.61 36.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 110.344 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 54' ' ' LYS . 25.8 m120 -95.06 119.27 33.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.156 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.2 mm -87.14 -36.84 10.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.315 1.055 . . . . 0.0 108.479 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.535 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 45.0 tt0 -145.51 174.0 11.54 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.444 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 62.73 166.01 0.58 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -114.39 41.62 2.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -1.14 . . . . 0.0 110.207 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.31 29.07 51.32 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.97 -162.8 18.07 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.7 Cg_endo -74.02 106.8 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.959 1.505 . . . . 0.0 110.27 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.98 5.48 33.08 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.652 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -69.74 157.16 37.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 109.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.483 HD11 HH21 ' A' ' 70' ' ' ARG . 6.3 mt -124.48 131.18 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -137.95 149.83 46.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.196 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HB2' HD11 ' A' ' 44' ' ' ILE . 1.6 tttp -98.34 109.62 22.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.565 -0.709 . . . . 0.0 110.758 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.725 HD12 ' OD2' ' A' ' 69' ' ' ASP . 72.9 mt -104.1 141.98 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.214 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -121.08 154.1 36.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 111.155 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.46 135.44 21.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 46.8 Cg_endo -73.67 97.58 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.847 1.446 . . . . 0.0 111.033 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.573 ' HG2' ' CE2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -165.13 -150.69 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 110.482 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.96 -42.99 1.46 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.573 ' CE2' ' HG2' ' A' ' 60' ' ' GLU . 8.8 p90 -60.12 138.26 91.29 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.114 -1.227 . . . . 0.0 110.401 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.34 -24.54 10.68 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.053 1.554 . . . . 0.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.566 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 4.9 m-85 -80.18 -162.44 0.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 110.432 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 80.37 -39.89 0.18 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.921 -0.487 . . . . 0.0 110.925 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 2.2 p90 -55.37 159.43 2.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.865 -1.147 . . . . 0.0 109.652 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.597 HG12 ' HA2' ' A' ' 88' ' ' GLY . 18.3 m -151.51 156.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 110.566 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.6 mttt -111.43 46.67 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 109.724 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.725 ' OD2' HD12 ' A' ' 56' ' ' ILE . 4.2 p30 -39.35 140.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.0 110.947 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.483 HH21 HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -99.44 154.1 18.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.652 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.4 t -76.81 147.43 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.678 -1.264 . . . . 0.0 109.72 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 64.6 t0 -97.28 -69.45 0.76 Allowed 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.719 -0.613 . . . . 0.0 110.461 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 mm-40 -154.8 106.69 2.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 110.463 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 74' ' ' VAL . 4.3 p -83.26 149.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.129 -0.982 . . . . 0.0 109.706 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -139.2 112.54 8.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 110.48 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -87.75 1.52 53.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.584 -0.697 . . . . 0.0 110.123 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -113.14 -57.63 2.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.254 -0.904 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.09 13.76 5.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.613 -0.68 . . . . 0.0 110.133 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.524 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 14.3 m-85 48.59 61.72 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.861 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -130.12 110.33 11.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.977 . . . . 0.0 110.699 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.499 ' CD2' HG13 ' A' ' 23' ' ' ILE . 4.0 t80 -120.13 96.98 5.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.496 -0.753 . . . . 0.0 109.602 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.527 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 7.1 m120 -102.75 138.89 39.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.6 p90 -136.63 137.92 40.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 70' ' ' ARG . 1.2 m -104.02 152.81 21.59 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.106 -0.996 . . . . 0.0 111.365 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 19.4 t -100.71 124.2 54.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.8 OUTLIER -124.92 -75.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.74 -178.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -65.1 70.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.758 -1.214 . . . . 0.0 109.793 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.597 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -96.6 131.86 10.8 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.92 -56.87 3.05 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.0 Cg_endo -71.52 -27.74 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.782 1.412 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.468 ' CD1' HG12 ' A' ' 85' ' ' VAL . 59.1 mt -72.81 158.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.56 -58.04 0.37 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.74 -56.63 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -1.06 . . . . 0.0 109.838 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 t -146.34 18.28 1.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.939 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 123' ' ' LYS . 1.2 mt -98.3 149.78 22.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.791 ' HA ' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER 52.42 33.98 14.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.373 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 9.9 tttt -67.38 164.68 18.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.451 -0.78 . . . . 0.0 110.21 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.65 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -136.27 125.54 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.258 -0.901 . . . . 0.0 110.157 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.02 115.55 27.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.868 . . . . 0.0 109.488 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 1.6 m-80 -112.31 140.5 46.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.973 . . . . 0.0 110.709 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -127.35 132.3 50.24 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.444 -0.785 . . . . 0.0 109.59 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mt -120.45 105.39 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 110.625 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 32.6 tttm -104.44 117.41 34.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.582 HG21 HD23 ' A' ' 18' ' ' LEU . 3.8 mt -105.58 111.18 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.296 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.47 146.0 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.662 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.21 142.32 27.85 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.434 0.635 . . . . 0.0 111.066 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.563 HG23 ' HA ' ' A' ' 112' ' ' SER . 8.2 p -96.32 169.48 8.89 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.436 -0.79 . . . . 0.0 109.496 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 45.6 Cg_endo -71.53 -0.35 8.1 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.674 1.355 . . . . 0.0 111.024 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -94.69 -2.49 51.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.028 -1.045 . . . . 0.0 110.238 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.8 -19.81 43.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.05 -164.12 33.7 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.652 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -143.53 157.86 44.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.303 -1.116 . . . . 0.0 111.418 -179.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 113' ' ' ILE . 1.1 tt -107.2 129.61 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.498 HD11 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -93.03 136.61 33.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.081 -1.012 . . . . 0.0 110.588 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -125.35 105.71 9.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 109.654 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 116' ' ' ILE . 4.4 mp -105.62 105.74 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -90.42 133.21 35.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.551 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.446 ' ND2' ' ND2' ' A' ' 100' ' ' ASN . 2.5 t-20 -127.45 140.66 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.758 -1.214 . . . . 0.0 110.59 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -132.87 149.6 52.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 109.872 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.65 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -126.46 107.25 10.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.101 -1.0 . . . . 0.0 109.439 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.764 ' ND1' HG11 ' A' ' 2' ' ' VAL . 17.5 m-70 -88.52 93.02 9.41 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.123 -0.986 . . . . 0.0 110.531 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -117.33 167.58 11.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.994 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.503 ' HB2' HD23 ' A' ' 95' ' ' LEU . 10.1 tptt -115.69 162.64 16.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.905 . . . . 0.0 110.193 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.57 -39.87 3.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.41 -85.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -1.188 . . . . 0.0 110.293 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.516 ' CD2' ' N ' ' A' ' 126' ' ' HIS . 14.6 m170 -67.66 -179.75 1.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -153.56 -172.13 4.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 110.435 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.0 t -129.86 96.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.401 -0.812 . . . . 0.0 109.678 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -62.79 126.02 25.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.027 . . . . 0.0 109.612 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.22 -41.36 18.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.0 . . . . 0.0 110.55 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.8 mt-10 -40.25 -58.62 1.46 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 110.244 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.97 -30.67 69.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.179 -0.95 . . . . 0.0 108.954 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 130' ' ' ALA . 22.7 t -72.7 -53.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.446 -0.784 . . . . 0.0 109.035 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -55.49 -28.62 55.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.191 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.14 -25.85 62.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 133' ' ' VAL . 26.9 t -68.6 -30.92 69.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.375 -0.828 . . . . 0.0 109.781 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -79.09 -49.56 12.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.92 -48.71 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.928 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.29 -39.75 53.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -54.07 -50.67 54.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.529 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 2.8 tt0 -57.78 -48.46 79.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -1.174 . . . . 0.0 110.17 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.6 -29.53 59.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.135 -0.978 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.536 HD12 ' HA2' ' A' ' 140' ' ' GLY . 78.0 mt -72.78 -53.38 11.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -68.42 -22.17 64.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -81.88 -35.11 29.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.752 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.13 -40.96 91.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.12 -46.44 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 109.682 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -45.8 80.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -25.3 64.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.415 -0.803 . . . . 0.0 109.843 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.561 ' CD1' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.53 -41.07 63.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.007 HD13 HG21 ' A' ' 13' ' ' ILE . 4.5 mt -66.86 -34.64 78.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.426 -0.796 . . . . 0.0 109.899 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.86 -34.12 77.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.865 . . . . 0.0 110.197 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.22 -13.32 60.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.65 84.7 1.74 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 110.418 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 38.7 t -144.57 38.35 1.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.917 . . . . 0.0 110.241 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.67 -39.07 0.19 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.055 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.26 159.91 41.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.74 53.4 0.68 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 110.183 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.0 t30 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.669 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.72 HG11 ' ND1' ' A' ' 121' ' ' HIS . 4.7 m 38.46 -160.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.598 -0.943 . . . . 0.0 110.756 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 7.4 m-85 -121.96 145.15 48.4 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.716 -0.615 . . . . 0.0 109.911 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.456 ' OD1' ' HG3' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -124.27 133.47 53.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.086 -1.009 . . . . 0.0 110.713 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.439 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 62.2 m-85 -139.42 57.13 1.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.526 -0.734 . . . . 0.0 109.447 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 7' ' ' THR . 3.1 tm-20 -80.2 153.81 28.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.585 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -156.04 176.1 13.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 109.719 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.474 ' HB3' ' HG3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -158.54 152.18 23.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.002 -1.061 . . . . 0.0 110.572 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.465 HG21 HD22 ' A' ' 144' ' ' LEU . 1.8 t -134.72 -170.77 2.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -122.36 165.57 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.91 138.24 10.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.423 -0.798 . . . . 0.0 109.754 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.425 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 61.7 t -80.11 -14.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.685 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.801 HG21 HD13 ' A' ' 151' ' ' LEU . 31.0 mm -70.24 149.42 95.97 Favored Pre-proline 0 N--CA 1.487 1.421 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.8 Cg_endo -68.2 148.25 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.317 1.167 . . . . 0.0 110.82 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.37 -33.82 65.25 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.977 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.93 -51.15 35.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.487 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -66.74 -37.28 84.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.962 . . . . 0.0 109.847 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.623 ' O ' HD23 ' A' ' 18' ' ' LEU . 7.8 tt -73.94 -32.16 63.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 76' ' ' HIS . 30.7 t80 -63.21 -55.93 20.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.727 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -58.05 -45.03 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.45 -31.08 71.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 20.3 t80 -89.72 -23.96 21.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.705 HD12 ' CD2' ' A' ' 81' ' ' TYR . 7.3 mm -106.18 -65.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.167 -0.958 . . . . 0.0 110.152 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.727 HD13 ' CG ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -51.92 -42.77 63.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.985 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 18.9 m-20 -115.39 23.54 12.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 110.193 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -62.83 -54.18 35.43 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.883 ' O ' HG21 ' A' ' 41' ' ' VAL . 21.5 m-20 -59.72 -13.15 8.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.26 -1.141 . . . . 0.0 110.492 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -104.15 -36.26 7.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.28 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -83.44 -23.48 32.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.597 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -56.43 -60.25 9.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.202 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.6 Cg_endo -73.91 -3.56 13.96 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.944 1.497 . . . . 0.0 110.286 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 20.7 tttm -103.29 -32.93 9.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.932 . . . . 0.0 110.433 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.053 HG22 ' HB1' ' A' ' 146' ' ' ALA . 1.6 p -101.68 -33.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.116 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB3' HD23 ' A' ' 143' ' ' LEU . . . -121.4 78.76 36.34 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.41 -0.806 . . . . 0.0 110.1 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 -18.98 31.17 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.99 1.521 . . . . 0.0 110.542 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.55 -4.29 57.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 110.276 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' O ' ' HD2' ' A' ' 59' ' ' PRO . . . -107.5 -67.82 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.597 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.2 mp -112.15 152.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.544 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -113.84 -27.88 7.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.021 -1.05 . . . . 0.0 110.83 -179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.82 162.14 34.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.076 -1.015 . . . . 0.0 110.832 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.883 HG21 ' O ' ' A' ' 27' ' ' ASP . 3.7 m -142.62 133.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.45 -0.781 . . . . 0.0 109.719 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 55' ' ' LYS . 1.7 tt0 -135.7 110.45 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.524 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -69.2 118.31 11.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 110.257 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.676 HD12 HG22 ' A' ' 53' ' ' ILE . 11.6 mt -80.0 -39.98 20.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' OE1' HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -97.13 -159.39 0.73 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.4 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.49 57.11 0.32 Allowed Glycine 0 C--N 1.296 -1.683 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.429 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 49.3 t30 -116.31 -26.88 7.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.361 -1.082 . . . . 0.0 109.808 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 54.46 20.04 15.27 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' H ' ' HG1' ' A' ' 52' ' ' THR . . . -126.65 -158.62 9.93 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 44.2 Cg_endo -71.64 96.18 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.913 1.481 . . . . 0.0 110.271 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.22 -0.74 6.08 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.704 ' HB ' HG21 ' A' ' 71' ' ' VAL . 88.4 m -67.69 160.58 27.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -1.159 . . . . 0.0 109.186 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.676 HG22 HD12 ' A' ' 44' ' ' ILE . 11.5 mt -130.38 142.55 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.833 -1.167 . . . . 0.0 111.017 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 43' ' ' ASN . 19.1 pttt -159.87 136.88 9.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.569 -0.707 . . . . 0.0 110.196 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' GLU . 14.8 ttpt -87.91 113.54 23.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.9 mt -92.16 153.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.645 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -118.0 148.53 42.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 110.784 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 47.4 m-85 -126.76 118.51 22.57 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 109.625 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 39' ' ' SER . 48.6 Cg_endo -74.2 132.21 16.27 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.89 1.468 . . . . 0.0 111.034 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.629 ' CB ' ' CZ ' ' A' ' 62' ' ' PHE . 4.0 tt0 176.11 -151.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 0.0 110.072 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -129.45 -13.07 2.38 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.493 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CZ ' ' CB ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -45.02 170.87 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.879 -1.365 . . . . 0.0 110.46 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 41.8 Cg_endo -68.06 -35.91 18.71 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.486 1.256 . . . . 0.0 109.504 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 8.8 m-85 -87.56 -167.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.5 -0.75 . . . . 0.0 109.176 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 3.8 tttp -164.99 -76.69 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.093 -1.004 . . . . 0.0 110.7 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 20.4 p90 -92.05 -168.0 1.9 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 110.863 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -173.0 172.93 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.496 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.0 ttmt -112.41 122.65 48.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 110.069 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.8 OUTLIER -118.93 129.39 55.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.789 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -100.28 145.41 28.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.227 -0.921 . . . . 0.0 108.86 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.704 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.0 t -76.5 147.22 7.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.881 -1.137 . . . . 0.0 110.668 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 6.8 t70 -99.1 -71.71 0.68 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.448 0.642 . . . . 0.0 109.966 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 3.1 tp10 -141.64 133.1 26.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.45 -0.782 . . . . 0.0 110.168 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.798 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.6 t -118.37 157.83 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.531 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -159.77 124.26 3.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 110.064 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 18.7 m170 -98.63 1.17 46.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -112.82 -46.81 3.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.34 10.91 27.82 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.62 -0.675 . . . . 0.0 109.966 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-85 51.09 64.0 2.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 110.445 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.1 OUTLIER -129.7 123.16 30.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.798 ' CD2' HG22 ' A' ' 74' ' ' VAL . 28.0 t80 -144.11 103.77 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.198 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 77.5 m-20 -113.97 140.58 48.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.216 -0.927 . . . . 0.0 109.997 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 22.9 p90 -137.25 137.22 38.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.488 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 53.8 m -103.76 166.54 10.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.022 -1.049 . . . . 0.0 110.915 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 53.0 t -108.19 124.62 64.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -115.79 -67.89 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.899 -1.126 . . . . 0.0 112.0 -178.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.5 OUTLIER -88.24 82.1 7.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 67' ' ' VAL . . . -100.54 141.13 15.25 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.521 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.71 -58.59 2.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.6 Cg_endo -71.78 -45.18 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.933 1.491 . . . . 0.0 110.393 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.787 HD11 ' CD1' ' A' ' 98' ' ' ILE . 50.4 mt -58.07 149.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.7 -114.73 2.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -70.03 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -1.166 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.486 ' HA ' ' HD2' ' A' ' 97' ' ' LYS . 3.2 t -143.93 15.06 1.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.868 . . . . 0.0 110.069 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.05 152.55 22.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 109.99 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.535 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 56.33 34.82 24.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.58 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -68.36 157.36 35.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.386 -0.821 . . . . 0.0 110.112 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.787 ' CD1' HD11 ' A' ' 91' ' ' ILE . 2.7 mp -137.12 131.16 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.94 . . . . 0.0 110.402 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.84 114.8 23.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.785 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.599 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 5.7 m120 -106.62 138.02 43.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.152 -0.968 . . . . 0.0 110.411 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.517 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 26.2 mt-10 -127.53 132.27 49.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 110.191 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.32 121.82 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 110.33 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 3.9 mttt -128.36 126.39 40.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 109.91 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 12.5 mt -115.36 130.25 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.165 -0.96 . . . . 0.0 110.655 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.12 143.94 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 109.603 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.11 138.77 31.15 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 110.8 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 112' ' ' SER . 1.7 t -108.75 151.96 42.02 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.96 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.28 54.96 2.39 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.924 1.486 . . . . 0.0 110.452 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.32 11.25 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.025 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.7 19.82 50.12 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 107' ' ' THR . . . -159.5 -165.8 17.18 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.802 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -136.72 164.02 29.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.092 . . . . 0.0 110.702 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.48 127.55 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 109.353 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.52 143.45 29.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 0.0 110.955 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 1.8 ttmt -135.13 105.01 6.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.465 -0.772 . . . . 0.0 109.795 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.8 mt -106.4 112.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 110.336 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -90.39 154.42 19.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.229 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -143.86 135.56 26.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -125.56 153.48 43.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.605 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -135.04 101.88 5.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.079 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.72 ' ND1' HG11 ' A' ' 2' ' ' VAL . 21.3 m-70 -85.98 120.54 27.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 110.047 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.09 173.58 6.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 0.0 110.012 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.51 177.16 11.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 0.0 110.396 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.78 -138.92 7.96 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.19 -9.23 37.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -1.118 . . . . 0.0 110.356 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -53.61 174.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.397 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -158.62 -167.28 2.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -121.5 93.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.811 . . . . 0.0 110.265 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -58.69 129.57 42.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 109.562 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -47.43 -46.45 26.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.942 . . . . 0.0 110.541 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 130' ' ' ALA . 26.7 tt0 -40.18 -50.72 2.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.374 -0.829 . . . . 0.0 110.198 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -35.3 80.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.016 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 130' ' ' ALA . 15.9 t -72.55 -50.87 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.414 -0.804 . . . . 0.0 108.982 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 130' ' ' ALA . 3.2 ttpt -63.0 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.746 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.3 -44.23 72.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.628 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t -57.78 -33.01 68.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.356 -0.84 . . . . 0.0 109.823 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.19 12.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.888 . . . . 0.0 110.106 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -48.38 -52.9 19.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 110.285 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.9 mt -69.62 -44.52 70.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.845 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -49.33 -46.52 35.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.552 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 30.8 tt0 -61.29 -30.23 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -30.75 68.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.845 HD12 ' HA2' ' A' ' 140' ' ' GLY . 3.0 mt -73.03 -47.46 44.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.738 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.1 pp -69.44 -22.51 63.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 109.904 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' SER . 2.9 ttp180 -83.78 -34.54 24.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.053 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -63.35 -44.43 94.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.379 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.91 -49.66 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.557 -0.714 . . . . 0.0 109.94 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 8.9 tt0 -56.53 -46.43 80.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 109.641 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 1.1 t -64.93 -43.92 91.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.456 -0.777 . . . . 0.0 109.872 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -50.99 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.099 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 13' ' ' ILE . 3.8 mt -44.97 -34.39 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -34.2 62.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.829 . . . . 0.0 110.131 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -56.96 -23.26 44.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.206 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -137.17 154.18 50.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 110.282 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.3 m -109.75 115.47 29.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 109.834 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -75.79 -54.56 6.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.55 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.445 ' HB1' ' OD1' ' A' ' 159' ' ' ASN . . . -145.5 169.97 17.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.958 . . . . 0.0 110.58 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.89 -2.68 34.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.439 -0.788 . . . . 0.0 110.238 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.445 ' OD1' ' HB1' ' A' ' 157' ' ' ALA . 6.5 m120 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.182 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.535 HG21 ' CE1' ' A' ' 121' ' ' HIS . 2.6 t -126.02 144.52 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -1.144 . . . . 0.0 110.228 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -94.31 149.63 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -0.759 . . . . 0.0 109.427 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.51 ' ND2' ' HG3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -121.54 144.49 48.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.125 -0.984 . . . . 0.0 110.634 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CD2' HG11 ' A' ' 133' ' ' VAL . 34.1 m-85 -153.77 69.92 0.81 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.436 -0.79 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 10.7 pt-20 -100.59 135.81 41.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.758 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.427 HG21 ' HD2' ' A' ' 137' ' ' LYS . 0.2 OUTLIER -134.92 177.93 7.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.017 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -158.12 161.12 37.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 110.356 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.648 HG22 ' H ' ' A' ' 10' ' ' THR . 3.1 m -147.6 -175.88 5.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 110.097 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.648 ' H ' HG22 ' A' ' 9' ' ' THR . 1.8 p -122.19 160.98 24.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 110.308 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -157.93 136.84 11.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.472 -0.768 . . . . 0.0 109.803 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 34.6 m -80.02 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.103 -0.998 . . . . 0.0 109.154 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 151' ' ' LEU . 45.3 mm -77.75 149.22 77.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 37.5 Cg_endo -64.02 148.48 91.52 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.264 1.139 . . . . 0.0 111.187 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.46 -24.36 60.21 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.114 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.03 -50.96 11.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.277 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 3.0 tpm_? -64.57 -40.3 95.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.098 -1.001 . . . . 0.0 109.603 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.572 ' C ' HD23 ' A' ' 18' ' ' LEU . 8.5 tt -71.23 -37.47 72.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.598 -0.689 . . . . 0.0 110.187 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.715 ' CD1' HD13 ' A' ' 23' ' ' ILE . 76.4 t80 -61.59 -69.77 0.23 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.314 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.15 -51.77 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.294 -0.878 . . . . 0.0 110.184 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.1 74.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 30.0 t80 -84.86 -10.08 57.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.715 HD13 ' CD1' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -124.78 -71.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.902 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.693 HD23 ' NE2' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -51.96 -42.25 62.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 110.264 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -104.3 -1.51 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -47.95 -52.69 16.07 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' OD2' ' HB ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -48.05 -23.15 0.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -1.21 . . . . 0.0 110.06 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -112.55 -23.84 10.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 110.442 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -84.81 -27.94 26.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.141 -0.974 . . . . 0.0 110.045 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.894 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -64.51 -60.08 9.25 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.4 Cg_endo -74.01 53.14 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.823 1.433 . . . . 0.0 110.254 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.84 -58.1 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 29' ' ' LEU . 27.0 m -85.92 -16.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.373 -0.829 . . . . 0.0 110.45 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.56 71.18 5.46 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.48 -12.5 27.18 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.993 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.44 ' C ' ' HG3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -64.55 -21.15 66.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.467 -0.771 . . . . 0.0 110.115 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.9 -60.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.868 . . . . 0.0 110.02 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.894 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -113.56 145.01 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.747 . . . . 0.0 109.745 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.55 -57.69 2.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.7 t -155.3 157.51 37.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.554 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' A' ' 56' ' ' ILE . 59.0 t -114.4 138.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -129.35 87.24 2.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.088 -1.007 . . . . 0.0 110.895 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 6.2 m-20 -54.73 114.34 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.717 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 54' ' ' LYS . 4.9 mt -82.54 -38.51 15.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.197 0.999 . . . . 0.0 108.676 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.541 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 23.1 tt0 -157.43 174.44 15.4 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.655 0.741 . . . . 0.0 110.176 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.541 ' N ' ' HG2' ' A' ' 45' ' ' GLU . . . 75.77 155.97 5.81 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -103.33 43.22 1.1 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -1.101 . . . . 0.0 109.425 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.43 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 70.06 23.95 76.81 Favored Glycine 0 N--CA 1.48 1.572 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -96.72 -162.47 32.45 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.4 Cg_endo -72.95 101.54 1.33 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.048 1.552 . . . . 0.0 110.909 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 111.32 -1.25 28.08 Favored Glycine 0 N--CA 1.48 1.579 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.654 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -58.4 154.14 14.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -1.201 . . . . 0.0 109.585 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 45' ' ' GLU . 18.2 mt -116.64 143.38 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -157.49 144.43 18.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 110.539 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -92.34 102.22 14.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' A' ' 41' ' ' VAL . 5.5 mm -82.76 130.09 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.86 . . . . 0.0 109.48 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.87 153.73 22.6 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.288 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 32.8 p90 -110.92 155.64 42.09 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 110.12 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.457 ' O ' ' CD2' ' A' ' 58' ' ' PHE . 45.6 Cg_endo -72.72 175.46 10.23 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.032 1.543 . . . . 0.0 110.626 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.37 161.01 0.72 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.316 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.14 -85.33 0.15 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.249 -1.541 . . . . 0.0 109.249 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.593 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -101.47 -179.25 0.77 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.246 -1.149 . . . . 0.0 109.776 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.593 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 43.0 Cg_endo -70.26 -53.9 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.731 1.385 . . . . 0.0 109.753 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.575 ' CE2' ' HG2' ' A' ' 63' ' ' PRO . 1.5 p90 -123.27 165.98 16.03 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.472 -0.768 . . . . 0.0 110.025 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.547 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER 169.65 -28.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 109.861 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 29.6 p90 -52.56 158.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.427 -0.796 . . . . 0.0 109.815 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 65' ' ' LYS . 10.4 m -152.23 179.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 0.0 110.413 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.532 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 12.5 mttt -128.83 41.84 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.689 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' SER . 45.2 p-10 -39.17 138.94 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.554 -0.716 . . . . 0.0 110.816 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 84' ' ' SER . 8.8 ttm180 -100.08 155.24 17.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.401 -0.812 . . . . 0.0 108.887 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.654 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.2 t -79.94 144.04 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.8 -1.188 . . . . 0.0 110.195 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 46.8 m-20 -96.32 -69.2 0.76 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.292 0.568 . . . . 0.0 110.159 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -146.76 132.29 18.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 81' ' ' TYR . 2.0 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 1.1 m-20 -151.61 107.01 3.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -0.915 . . . . 0.0 110.179 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.693 ' NE2' HD23 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -81.81 -10.38 59.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 0.0 110.398 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -108.82 -45.83 3.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.15 6.39 25.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.562 -0.711 . . . . 0.0 109.987 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 18.4 m-30 48.56 58.75 4.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 110.255 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.6 ttmt -134.09 110.38 9.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.469 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.559 ' HD2' HG22 ' A' ' 74' ' ' VAL . 13.2 t80 -126.82 122.1 33.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.881 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 73.1 m-20 -128.3 141.36 51.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 46.9 p90 -138.44 133.14 32.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.316 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 64.7 m -100.95 168.27 9.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.003 -1.061 . . . . 0.0 111.156 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -104.48 127.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -126.83 -75.15 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.97 -1.081 . . . . 0.0 111.196 -178.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -79.06 83.36 5.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.892 -1.13 . . . . 0.0 110.109 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -109.09 145.63 16.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.45 -54.0 3.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.1 Cg_endo -73.33 -49.58 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.871 1.458 . . . . 0.0 110.826 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 86' ' ' ILE . 42.3 mt -58.8 138.0 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.024 . . . . 0.0 110.223 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.27 -60.98 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -97.6 -90.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.194 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 t -139.92 9.11 2.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.369 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -86.77 162.14 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.239 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.655 ' HG3' HD12 ' A' ' 95' ' ' LEU . 6.5 mm-40 57.67 36.33 26.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.939 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -81.33 155.6 25.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.851 . . . . 0.0 109.882 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.582 HG12 ' CD2' ' A' ' 120' ' ' TYR . 2.7 mp -138.64 129.05 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 110.516 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.07 120.47 41.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 1.9 m-20 -110.02 149.36 30.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.515 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 34.5 mt-10 -141.63 163.92 31.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.371 -0.831 . . . . 0.0 110.048 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.564 HG22 HD11 ' A' ' 104' ' ' ILE . 19.4 mt -153.57 106.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.806 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -108.11 118.41 36.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.415 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 104' ' ' ILE . 3.9 mp -110.35 133.52 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.055 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 113' ' ' ILE . 25.0 t -137.43 134.06 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 0.0 110.487 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -82.15 148.31 28.57 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.703 -0.623 . . . . 0.0 110.718 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 111' ' ' GLY . 1.3 p -92.02 -167.03 0.12 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.415 -0.803 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 47.4 Cg_endo -80.05 69.29 8.0 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.403 1.212 . . . . 0.0 110.699 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 9.8 t70 68.08 39.59 2.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 110.575 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.48 26.86 1.97 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 107' ' ' THR . . . 103.02 -161.03 16.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.816 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -135.17 -178.74 5.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.477 -1.014 . . . . 0.0 110.557 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.446 HG13 ' C ' ' A' ' 112' ' ' SER . 25.1 mt -134.41 124.6 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.248 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.67 135.83 39.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.008 . . . . 0.0 110.65 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -128.64 98.99 5.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.778 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.1 mt -87.57 145.67 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.497 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -129.65 108.38 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -0.874 . . . . 0.0 110.005 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -109.81 128.4 55.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.415 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -128.64 137.11 51.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.053 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.595 ' CD2' HG21 ' A' ' 128' ' ' VAL . 5.9 t80 -109.67 143.01 40.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.535 ' CE1' HG21 ' A' ' 2' ' ' VAL . 13.5 m-70 -120.81 131.54 54.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.877 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -114.11 174.75 5.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -140.98 177.26 8.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 110.235 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 42.86 -126.26 4.74 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -119.49 15.24 12.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -1.16 . . . . 0.0 110.363 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -80.46 -178.71 6.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 110.059 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.877 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -159.98 168.14 26.35 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.19 -0.943 . . . . 0.0 109.784 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.4 p -112.98 108.55 25.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.369 0.604 . . . . 0.0 110.759 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 133.25 55.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.463 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -63.17 -9.44 11.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.734 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -55.21 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.171 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -54.84 -36.04 64.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.358 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG11 ' CD2' ' A' ' 5' ' ' TYR . 12.1 t -67.45 -47.79 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.541 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 1.4 mmtt -59.4 -34.48 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.428 -0.795 . . . . 0.0 110.062 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.89 60.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -74.74 -35.69 62.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.466 -0.771 . . . . 0.0 109.874 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.427 ' HD2' HG21 ' A' ' 7' ' ' THR . 26.1 ttpp -72.46 -37.11 68.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.837 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -58.5 -42.68 88.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 140' ' ' GLY . 2.0 tp -75.17 -43.85 49.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.631 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -45.27 -50.19 9.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.4 mt-10 -59.87 -31.35 69.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -1.159 . . . . 0.0 110.215 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.6 m -70.69 -27.48 64.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.012 -1.055 . . . . 0.0 109.649 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.631 HD12 ' HA2' ' A' ' 140' ' ' GLY . 50.8 mt -72.53 -49.38 33.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 110.061 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.679 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -65.6 -25.4 67.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.015 . . . . 0.0 109.472 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.2 OUTLIER -78.92 -33.8 45.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.427 -0.796 . . . . 0.0 109.676 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.33 -36.97 84.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.381 -0.825 . . . . 0.0 109.638 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.6 t -71.19 -46.97 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -54.18 -46.5 72.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.63 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.2 t -61.01 -50.35 73.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.656 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.429 ' CE1' HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -48.07 -72.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 109.936 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.636 HD13 HG21 ' A' ' 13' ' ' ILE . 5.4 mt -43.09 -43.72 4.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.002 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -61.38 -43.31 99.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.202 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.04 -12.96 21.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 110.381 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.56 -161.4 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.947 . . . . 0.0 110.181 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 60.7 m -138.7 89.88 2.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 110.041 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -93.21 -65.12 1.02 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.883 . . . . 0.0 110.242 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 156' ' ' ASP . . . -56.01 -163.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.292 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -72.18 -15.76 61.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 110.281 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.355 -179.872 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.87 139.85 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -1.149 . . . . 0.0 110.128 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.8 m-85 -94.36 138.59 32.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.51 -0.744 . . . . 0.0 109.916 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.09 137.07 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.054 . . . . 0.0 110.42 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.513 ' CE2' HG11 ' A' ' 133' ' ' VAL . 17.6 m-85 -141.16 59.26 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.542 -0.723 . . . . 0.0 109.218 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.0 pt-20 -88.47 142.89 27.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.484 -0.76 . . . . 0.0 110.797 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.39 178.55 8.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.527 -0.733 . . . . 0.0 109.818 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HB2' ' HG3' ' A' ' 115' ' ' LYS . 2.3 pp20? -150.61 143.15 24.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 110.245 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 10' ' ' THR . 1.6 m -130.2 -174.76 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.599 ' H ' HG22 ' A' ' 9' ' ' THR . 1.2 p -119.95 159.43 24.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 110.614 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.495 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -154.26 135.58 14.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' OE2' ' A' ' 148' ' ' GLU . 17.7 m -79.91 -12.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.914 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.788 HG23 ' HD2' ' A' ' 14' ' ' PRO . 5.1 mm -71.31 150.44 94.24 Favored Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.788 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.31 150.77 86.89 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 123.293 1.154 . . . . 0.0 111.08 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.94 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -73.16 -29.85 63.15 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.88 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.26 -54.23 8.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 110.076 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -67.42 -30.97 70.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.935 . . . . 0.0 109.771 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.574 ' HB2' HG22 ' A' ' 13' ' ' ILE . 29.1 tp -73.8 -29.19 62.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.369 -0.832 . . . . 0.0 109.959 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.746 ' CD1' HD13 ' A' ' 23' ' ' ILE . 71.8 t80 -71.71 -57.17 4.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 110.005 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 31.9 mtpt -54.34 -41.24 68.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.453 -0.78 . . . . 0.0 110.298 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.58 -33.79 74.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.209 -0.932 . . . . 0.0 110.612 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -91.6 -7.34 50.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.719 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.746 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -121.16 -56.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 24' ' ' LEU . 8.4 mt -72.99 -25.25 60.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -130.03 14.53 5.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -58.69 -42.47 96.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' O ' HG21 ' A' ' 41' ' ' VAL . 55.6 m-20 -65.05 -27.19 68.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -1.14 . . . . 0.0 110.317 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.3 m-20 -92.14 -38.95 11.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.491 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.004 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.8 mp -76.13 -25.97 55.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.924 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -55.64 -59.69 10.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.914 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.5 Cg_endo -71.37 0.43 6.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.994 1.523 . . . . 0.0 111.256 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -105.58 -50.94 3.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.988 -1.07 . . . . 0.0 110.577 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.004 HG22 ' O ' ' A' ' 29' ' ' LEU . 35.9 m -87.33 -11.15 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 0.0 110.555 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -160.04 71.24 3.11 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.079 -1.013 . . . . 0.0 110.396 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.73 -6.73 19.75 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.033 1.544 . . . . 0.0 110.504 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.503 ' O ' ' CG ' ' A' ' 59' ' ' PRO . 16.1 mt-30 -73.33 -30.01 63.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.174 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.558 ' CB ' HD23 ' A' ' 139' ' ' LEU . . . -89.52 -51.28 5.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.617 HD13 ' CD2' ' A' ' 30' ' ' PHE . 1.5 mp -112.32 141.39 28.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 110.031 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.444 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -109.74 -19.19 13.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.19 165.07 11.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.856 . . . . 0.0 110.143 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.481 HG12 HG23 ' A' ' 56' ' ' ILE . 20.0 m -147.15 154.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 110.217 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.515 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 1.6 mt-10 -153.2 152.98 31.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 110.532 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.7 112.5 25.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.0 110.055 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.67 HD12 HG22 ' A' ' 53' ' ' ILE . 6.3 mt -80.2 -39.9 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.233 1.016 . . . . 0.0 108.346 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.43 -160.17 0.78 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.827 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.35 59.66 0.32 Allowed Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 48' ' ' GLY . 1.6 m-80 -125.29 -19.22 5.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -1.08 . . . . 0.0 110.268 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.542 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 44.21 42.78 7.02 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.514 ' H ' ' HG1' ' A' ' 52' ' ' THR . . . -153.24 -154.67 6.83 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.81 87.54 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.071 1.564 . . . . 0.0 110.602 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.89 -6.63 3.78 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.741 ' HB ' HG21 ' A' ' 71' ' ' VAL . 95.5 m -67.91 164.07 20.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.141 -1.211 . . . . 0.0 109.32 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.67 HG22 HD12 ' A' ' 44' ' ' ILE . 8.3 mt -137.13 149.14 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.729 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.515 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -155.21 141.6 18.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.393 -0.817 . . . . 0.0 110.561 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' GLU . 4.5 tptm -90.39 113.03 24.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.663 -0.648 . . . . 0.0 110.508 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.481 HG23 HG12 ' A' ' 41' ' ' VAL . 28.4 mt -101.49 139.88 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.475 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -102.53 159.93 15.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.64 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -136.82 136.99 22.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.407 -0.808 . . . . 0.0 109.857 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 36' ' ' GLN . 46.5 Cg_endo -73.06 129.57 14.34 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.888 1.467 . . . . 0.0 110.466 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 179.62 172.42 0.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.192 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.81 19.44 9.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.593 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.8 OUTLIER -92.7 178.32 1.7 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.045 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.593 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 42.8 Cg_endo -68.35 -31.76 27.52 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.869 1.457 . . . . 0.0 110.376 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.515 ' CE1' ' HA2' ' A' ' 89' ' ' GLY . 0.2 OUTLIER -114.41 137.28 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.0 109.965 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' TYR . 6.4 mtpm? -138.16 -79.32 0.36 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.373 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.524 ' C ' HG12 ' A' ' 67' ' ' VAL . 55.7 p90 -55.22 -165.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.802 . . . . 0.0 110.491 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -179.68 172.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.628 -0.67 . . . . 0.0 109.858 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.558 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -115.64 132.33 56.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.394 -0.816 . . . . 0.0 109.902 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 8.9 p-10 -133.29 131.04 39.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' CG ' ' HB2' ' A' ' 84' ' ' SER . 8.2 ptt180 -98.23 151.24 20.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.071 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.741 HG21 ' HB ' ' A' ' 52' ' ' THR . 4.6 t -80.02 147.05 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.782 -1.199 . . . . 0.0 110.251 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 11.3 t0 -97.56 -62.35 1.26 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.099 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.3 tt0 -155.22 120.91 5.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.236 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.722 HG22 ' CD1' ' A' ' 81' ' ' TYR . 2.9 t -116.02 142.4 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.321 -0.862 . . . . 0.0 110.085 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -139.98 118.24 12.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.91 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -82.6 1.45 38.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.831 . . . . 0.0 110.796 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -119.86 -38.31 2.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.05 20.36 10.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.501 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 22.9 m-30 44.66 58.56 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -0.978 . . . . 0.0 110.141 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.555 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -127.01 129.6 48.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.052 -1.03 . . . . 0.0 110.16 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.722 ' CD1' HG22 ' A' ' 74' ' ' VAL . 77.5 t80 -148.51 94.37 2.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.947 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 71.6 m-20 -109.98 137.78 47.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.195 -0.94 . . . . 0.0 109.943 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.7 p90 -137.89 143.48 40.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.9 . . . . 0.0 110.004 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 70' ' ' ARG . 74.2 m -106.17 170.61 7.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.075 -1.015 . . . . 0.0 111.178 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.428 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 53.9 t -112.16 125.38 69.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -116.61 -72.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.856 -1.152 . . . . 0.0 111.735 -178.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -87.78 85.64 7.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.269 . . . . 0.0 110.436 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.478 ' HA2' HG23 ' A' ' 67' ' ' VAL . . . -106.42 141.31 15.46 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.558 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.02 -53.39 2.57 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 44.7 Cg_endo -71.66 -40.34 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.744 1.391 . . . . 0.0 110.512 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.57 140.19 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 0.0 110.025 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -116.59 -85.06 1.13 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -83.42 -80.04 0.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -1.172 . . . . 0.0 110.434 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -145.34 13.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.464 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.647 HD23 ' HB2' ' A' ' 123' ' ' LYS . 4.1 mp -87.7 153.73 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.051 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 1.4 tt0 61.34 36.05 17.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 0.4 OUTLIER -69.67 162.54 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.482 HG12 ' CD1' ' A' ' 120' ' ' TYR . 8.3 mt -145.89 136.02 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 110.565 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -120.97 117.27 26.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.656 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 7.0 m120 -101.37 141.27 34.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.76 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.521 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 0.9 OUTLIER -131.19 132.36 44.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.713 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.657 HD12 ' HD2' ' A' ' 81' ' ' TYR . 43.0 mt -126.5 124.34 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.002 -1.061 . . . . 0.0 110.704 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -129.12 127.23 41.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.672 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.559 HG22 ' HB1' ' A' ' 15' ' ' ALA . 93.3 mt -116.72 125.46 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 110.718 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.5 t -127.3 136.47 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.425 -0.797 . . . . 0.0 109.716 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.1 143.55 27.01 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.552 0.691 . . . . 0.0 111.035 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.3 p -82.84 -163.08 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 45.4 Cg_endo -78.53 -28.64 4.24 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.094 1.05 . . . . 0.0 110.999 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.67 35.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.122 -0.986 . . . . 0.0 110.385 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.99 27.89 2.87 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.647 ' O ' HG23 ' A' ' 107' ' ' THR . . . 100.32 -154.79 19.46 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.94 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -133.27 155.99 48.39 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.724 -0.868 . . . . 0.0 110.774 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 113' ' ' ILE . 6.0 tt -109.66 120.12 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.05 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -101.45 122.49 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.931 -1.105 . . . . 0.0 111.18 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 8' ' ' GLU . 4.8 mttt -102.23 111.09 23.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 7' ' ' THR . 55.4 mt -97.19 140.29 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.638 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -125.87 118.04 24.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.348 -0.845 . . . . 0.0 110.074 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.85 125.41 48.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.173 -0.954 . . . . 0.0 110.23 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 3.6 mtpp -116.35 138.2 51.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 110.466 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.482 ' CD1' HG12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -112.83 124.72 53.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.262 -0.899 . . . . 0.0 109.707 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 36.0 m-70 -106.22 113.12 26.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.985 . . . . 0.0 110.355 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.559 HG21 HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -122.59 167.05 13.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.1 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.647 ' HB2' HD23 ' A' ' 95' ' ' LEU . 5.0 mmtp -104.51 155.09 19.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -43.79 -27.03 0.87 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.67 -65.42 0.9 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -1.218 . . . . 0.0 110.313 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -83.08 170.14 15.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 110.096 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -139.51 -167.15 2.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.16 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 128' ' ' VAL . 3.8 t -118.92 88.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 110.117 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -59.73 127.81 33.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -44.82 -45.46 10.15 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.113 -0.992 . . . . 0.0 110.204 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.0 mm-40 -38.64 -59.1 0.97 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 110.618 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -29.1 69.08 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 130' ' ' ALA . 8.9 t -78.6 -49.64 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 130' ' ' ALA . 12.6 mttt -63.21 -25.71 68.46 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.419 -0.801 . . . . 0.0 109.531 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.99 -39.56 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.542 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 t -65.46 -33.79 76.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 109.688 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -79.15 -46.09 18.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.769 . . . . 0.0 109.818 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' OG1' ' A' ' 142' ' ' THR . 1.7 mt-10 -43.25 -67.47 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.558 HD23 ' CB ' ' A' ' 37' ' ' ALA . 2.5 mp -67.04 -30.2 70.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.91 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.82 -63.81 4.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.534 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -52.23 -32.13 35.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -69.78 -27.24 64.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.675 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 69.3 mt -72.15 -50.31 28.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.749 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.601 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -68.14 -28.52 67.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.406 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.13 -34.53 43.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.794 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.18 -34.22 77.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.882 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.65 -48.07 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.931 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -50.59 -41.05 54.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.432 179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -66.34 -47.55 73.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.593 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.895 ' CD1' HG12 ' A' ' 33' ' ' VAL . 1.8 t80 -45.69 -67.6 0.27 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.469 -0.77 . . . . 0.0 110.563 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 13' ' ' ILE . 10.3 mt -57.49 -39.03 75.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.362 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -49.2 -40.38 33.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.48 11.92 7.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -104.54 -6.67 20.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 110.113 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.94 39.0 0.94 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.895 . . . . 0.0 110.138 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -126.57 -36.5 2.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.203 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.01 175.5 9.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 110.084 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.46 43.64 2.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.322 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.1 t30 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.183 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 2.7 t 58.8 146.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.381 -1.07 . . . . 0.0 110.237 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 4.0 m-85 -93.33 167.63 11.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -138.25 144.23 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.994 . . . . 0.0 110.811 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 64.6 m-85 -156.12 57.93 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.74 . . . . 0.0 109.604 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 14.9 mt-10 -88.94 145.88 25.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.372 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -150.65 173.06 14.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 4.6 pt-20 -151.15 155.79 39.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 110.551 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.509 HG22 ' H ' ' A' ' 10' ' ' THR . 3.1 m -139.36 176.84 8.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.513 HG22 HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -112.75 163.65 14.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 110.581 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -159.93 136.46 9.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.648 -0.657 . . . . 0.0 109.454 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 9.9 p -80.19 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.806 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.842 HG21 HD13 ' A' ' 151' ' ' LEU . 42.0 mm -71.81 149.15 92.71 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.662 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -64.9 148.66 89.97 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.463 1.244 . . . . 0.0 111.282 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -66.48 -47.11 74.08 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.82 74.6 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.499 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -63.38 -37.97 89.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -72.25 -35.84 68.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.432 -0.792 . . . . 0.0 110.399 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' ILE . 40.1 t80 -64.55 -63.84 1.03 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -48.57 -48.46 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 110.102 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -38.6 91.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 4.1 t80 -86.3 -11.11 53.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.215 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.812 HD12 ' CG ' ' A' ' 81' ' ' TYR . 12.0 mm -114.72 -74.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.178 -0.951 . . . . 0.0 110.491 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 24' ' ' LEU . 20.3 mt -54.87 -51.76 64.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 110.471 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.99 8.73 36.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.17 -47.92 88.69 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' O ' ' CD ' ' A' ' 31' ' ' PRO . 79.5 m-20 -58.51 -28.42 65.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -1.14 . . . . 0.0 110.252 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.411 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 81.4 m-20 -86.56 -46.79 9.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -35.79 80.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.222 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.707 ' CD2' HD13 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -48.97 -60.07 5.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.953 . . . . 0.0 110.046 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -73.5 53.77 2.74 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.048 1.552 . . . . 0.0 110.274 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.05 -63.91 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 110.392 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 33' ' ' VAL . 33.2 m -82.96 -24.2 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 110.435 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -134.66 70.0 71.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.172 -0.955 . . . . 0.0 110.41 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.6 -14.58 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.995 1.524 . . . . 0.0 110.512 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -71.67 -24.19 61.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.37 -60.02 2.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.274 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.707 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -113.13 143.92 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -0.815 . . . . 0.0 109.888 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -47.56 8.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.266 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.4 133.89 2.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.273 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG1' ' HD3' ' A' ' 54' ' ' LYS . 94.6 t -100.46 142.01 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 53.9 mt-10 -140.88 99.28 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -61.52 117.78 6.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.517 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.4 mm -85.99 -37.59 11.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.335 1.064 . . . . 0.0 108.425 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 46' ' ' GLY . 1.4 tm-20 -111.23 -151.11 0.47 Allowed 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.437 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 45' ' ' GLU . . . -40.78 168.07 0.01 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.7 16.97 1.97 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -1.188 . . . . 0.0 110.832 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.52 ' O ' HG21 ' A' ' 74' ' ' VAL . . . 142.07 -3.93 2.03 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.742 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 48' ' ' GLY . . . -45.74 171.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.97 99.19 0.65 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.807 1.425 . . . . 0.0 110.094 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 71' ' ' VAL . . . 109.48 9.39 25.34 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.582 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -65.39 166.75 9.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.407 -1.055 . . . . 0.0 109.364 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 14.6 mt -129.55 138.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 110.392 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HD3' ' CG1' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.743 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HB2' HD11 ' A' ' 44' ' ' ILE . 20.9 tttt -92.14 98.36 11.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 110.313 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.744 HD12 ' OD1' ' A' ' 69' ' ' ASP . 52.0 mt -87.88 120.55 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.633 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.93 143.3 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -0.963 . . . . 0.0 110.291 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.04 136.2 20.46 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 110.208 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.22 137.98 29.63 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.997 1.525 . . . . 0.0 110.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 48.98 -169.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -0.904 . . . . 0.0 110.248 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 92.87 77.67 1.38 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.663 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 41.47 -165.56 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.38 -1.071 . . . . 0.0 110.061 179.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.663 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 45.4 Cg_endo -77.29 -51.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.373 1.196 . . . . 0.0 110.625 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 3.4 m-85 -83.31 153.38 24.66 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.411 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 34.4 pttt 173.67 -41.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.221 -0.924 . . . . 0.0 110.389 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.491 ' C ' HG12 ' A' ' 67' ' ' VAL . 27.9 p90 -63.83 -173.18 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 110.11 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER 178.98 172.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.567 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 8.3 ttmt -119.18 52.64 1.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.523 -0.736 . . . . 0.0 110.47 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.744 ' OD1' HD12 ' A' ' 56' ' ' ILE . 10.2 p-10 -46.09 137.81 5.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.106 -0.996 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 84' ' ' SER . 18.2 ttm180 -100.75 157.85 16.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.228 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.6 t -84.7 146.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.877 -1.14 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 14.3 t70 -94.51 -68.91 0.78 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.275 0.56 . . . . 0.0 110.491 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -144.61 143.72 30.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 0.0 110.377 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 48' ' ' GLY . 4.3 t -123.66 155.64 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.239 -0.913 . . . . 0.0 109.947 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.516 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -154.75 130.13 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 0.0 110.085 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -5.54 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 0.0 110.894 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -112.55 -40.6 4.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.019 -1.05 . . . . 0.0 109.884 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.88 16.21 16.6 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.337 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.7 m-85 46.74 69.01 0.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.78 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.516 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 6.2 tttt -131.19 127.14 37.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.812 ' CG ' HD12 ' A' ' 23' ' ' ILE . 34.1 t80 -150.67 88.66 1.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.459 -0.775 . . . . 0.0 109.39 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 86.3 m-20 -100.95 145.66 28.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.129 -0.982 . . . . 0.0 110.617 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 7.7 p90 -141.81 137.97 31.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.499 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ARG . 58.8 m -108.32 168.24 9.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.048 -1.032 . . . . 0.0 111.232 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.484 HG12 ' CD1' ' A' ' 91' ' ' ILE . 45.1 t -105.86 131.18 56.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.7 OUTLIER -129.5 -77.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.942 -1.099 . . . . 0.0 110.583 -179.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -69.58 65.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.838 -1.164 . . . . 0.0 109.997 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.733 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -87.86 136.68 13.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.545 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -41.66 -54.87 4.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.0 Cg_endo -72.01 -42.1 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.823 1.433 . . . . 0.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.733 HD12 ' HA3' ' A' ' 88' ' ' GLY . 69.8 mt -56.31 145.82 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.23 -76.0 0.26 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.33 -75.94 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -1.136 . . . . 0.0 110.083 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.1 p -144.61 9.98 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.569 HD13 ' CD2' ' A' ' 126' ' ' HIS . 0.6 OUTLIER -93.06 161.91 14.25 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.13 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' OE1' HG13 ' A' ' 91' ' ' ILE . 0.9 OUTLIER 61.59 28.42 17.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.147 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 98' ' ' ILE . 10.5 ttmt -80.94 159.64 24.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.105 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.6 mp -141.13 133.0 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 110.641 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 m -114.79 115.64 27.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.32 -0.863 . . . . 0.0 109.571 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.604 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 19.3 m120 -104.77 142.76 34.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.0 110.631 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.533 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -130.6 128.63 41.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.807 . . . . 0.0 109.634 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 116' ' ' ILE . 17.5 mm -120.34 113.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.659 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 9.8 mtmm -125.37 139.79 53.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 109.648 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.431 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 7.2 mt -127.53 142.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.027 -1.046 . . . . 0.0 110.823 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.7 t -137.52 130.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 109.548 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.04 155.98 19.53 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.635 -0.665 . . . . 0.0 111.307 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.46 ' OG1' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -128.49 157.8 73.71 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 109.868 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HD2' ' OG1' ' A' ' 107' ' ' THR . 43.8 Cg_endo -70.51 -3.53 12.69 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.967 1.509 . . . . 0.0 110.487 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.43 -10.04 59.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 110.018 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.22 28.06 6.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 107' ' ' THR . . . -164.89 -168.08 26.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -141.25 162.97 34.2 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -1.087 . . . . 0.0 110.639 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 10' ' ' THR . 49.0 mt -120.08 120.92 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 109.377 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.5 pp -98.28 131.99 44.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.524 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 8' ' ' GLU . 19.8 mttt -112.4 110.97 21.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 7' ' ' THR . 29.0 mm -94.95 119.92 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -106.81 120.65 42.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.131 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -115.0 147.13 40.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -137.35 133.26 34.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.073 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.592 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -109.93 138.35 46.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.444 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.49 ' ND1' HG22 ' A' ' 2' ' ' VAL . 75.1 m-70 -123.69 102.37 7.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.477 HG21 HG23 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -114.92 165.35 12.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.943 . . . . 0.0 110.099 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -100.69 158.59 15.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -43.2 -29.69 1.04 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.76 -61.59 1.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -1.104 . . . . 0.0 110.23 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.569 ' CD2' HD13 ' A' ' 95' ' ' LEU . 21.9 m-70 -84.94 164.63 18.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.955 . . . . 0.0 110.261 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.417 ' C ' HG21 ' A' ' 122' ' ' THR . 11.2 mt-10 -144.34 -170.29 3.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.232 -0.918 . . . . 0.0 109.951 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -128.94 92.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.921 . . . . 0.0 110.023 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HG3' ' HB3' ' A' ' 131' ' ' GLU . 20.1 ptmt -69.4 131.19 44.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.312 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 134' ' ' LYS . . . -40.47 -38.59 0.86 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 110.826 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.478 ' HB3' ' HG3' ' A' ' 129' ' ' LYS . 9.8 tp10 -39.16 -65.96 0.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.07 -29.93 61.26 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.556 HG11 ' CE1' ' A' ' 5' ' ' TYR . 12.9 t -74.01 -49.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 0.0 109.423 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -62.37 -32.72 73.57 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.23 -17.79 64.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.651 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.2 t -81.27 -33.38 32.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 109.845 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -28.51 60.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.893 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -60.61 -62.14 2.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.033 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.52 -30.68 66.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.705 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -59.25 -38.8 93.76 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.571 ' HA ' HD23 ' A' ' 144' ' ' LEU . 2.7 mt-10 -61.59 -38.5 87.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.151 -1.205 . . . . 0.0 110.254 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.5 m -66.83 -27.75 67.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.109 -0.994 . . . . 0.0 109.875 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.705 HD12 ' HA2' ' A' ' 140' ' ' GLY . 66.1 mt -73.33 -46.41 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.315 -0.866 . . . . 0.0 110.005 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -68.27 -30.01 68.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 110.005 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.431 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -79.65 -33.87 40.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 110.28 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -64.3 -46.97 81.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.29 -41.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.975 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 1.4 tm-20 -60.3 -48.37 82.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.64 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -44.19 93.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.462 -0.774 . . . . 0.0 110.002 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 1.2 t80 -50.55 -71.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 110.368 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.842 HD13 HG21 ' A' ' 13' ' ' ILE . 13.0 mt -49.4 -32.77 12.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 110.668 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -64.82 -34.49 78.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.084 -1.01 . . . . 0.0 110.404 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -58.85 -33.97 71.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -99.03 -174.65 2.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.432 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 155' ' ' SER . 3.0 t -141.08 51.57 1.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.567 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 10.4 t0 50.0 25.91 1.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.945 . . . . 0.0 109.679 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 156' ' ' ASP . . . 61.94 -170.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.449 -0.782 . . . . 0.0 109.996 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.64 38.18 1.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.123 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.24 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.47 HG22 ' ND1' ' A' ' 121' ' ' HIS . 2.6 t -146.81 143.96 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -1.207 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -118.68 127.4 53.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 4' ' ' ASN . 10.1 p-10 -131.93 124.97 30.52 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.857 -1.152 . . . . 0.0 110.432 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.616 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 93.9 m-85 -103.38 74.29 1.26 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -80.06 149.12 30.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.863 . . . . 0.0 110.528 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -160.07 -173.55 4.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.588 -0.695 . . . . 0.0 109.818 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -159.36 153.33 23.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 0.0 110.478 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 170.07 16.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.909 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.478 HG22 HG12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -116.63 159.84 21.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.265 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.6 m -158.86 141.66 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.645 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.494 HG23 HD12 ' A' ' 13' ' ' ILE . 12.5 m -79.85 -10.97 12.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.607 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.71 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.2 mp -67.92 149.91 98.0 Favored Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.71 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.81 151.71 83.55 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 O-C-N 123.397 1.209 . . . . 0.0 110.796 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.846 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.42 -23.09 58.89 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.698 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.42 -56.57 3.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.941 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -59.84 -32.69 70.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.945 . . . . 0.0 109.798 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -71.47 -41.73 69.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.252 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 41.4 t80 -60.89 -66.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 37.8 mttt -47.2 -42.85 20.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 110.29 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.59 69.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.449 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' HB3' HD12 ' A' ' 23' ' ' ILE . 7.9 t80 -89.88 -12.17 39.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.293 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.607 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.1 mp -124.11 -62.27 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -52.76 -34.78 54.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.878 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' GLY . 1.1 m-20 -125.0 -6.29 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.019 -1.05 . . . . 0.0 110.793 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -44.89 -45.67 9.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 15.3 p-10 -51.56 -33.41 32.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -1.172 . . . . 0.0 110.309 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 28' ' ' ASN . 21.8 t-20 -100.41 -33.35 10.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.759 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -69.01 -41.89 77.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.149 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.728 ' CD1' HD13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -45.04 -58.93 4.83 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.301 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.6 Cg_endo -72.04 -2.73 12.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.998 1.525 . . . . 0.0 110.621 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 4.8 mmtp -104.51 -60.61 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.7 m -84.69 -18.15 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.454 -0.779 . . . . 0.0 110.528 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HB1' ' CD2' ' A' ' 143' ' ' LEU . . . -135.01 68.52 70.58 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.591 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.47 -1.4 11.28 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.036 1.545 . . . . 0.0 110.119 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.62 -20.94 25.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.285 -0.884 . . . . 0.0 110.333 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -104.67 -58.21 1.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.459 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.728 HD13 ' CD1' ' A' ' 30' ' ' PHE . 1.2 mp -104.1 129.6 56.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 110.093 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -83.85 -48.38 10.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.357 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -163.72 155.95 17.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 0.0 110.556 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 56' ' ' ILE . 61.5 t -118.69 146.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.87 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -144.15 90.38 2.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.347 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 74.4 m-20 -56.38 119.35 5.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.454 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.532 ' CD1' ' HD3' ' A' ' 68' ' ' LYS . 15.2 mt -87.83 -37.81 11.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.232 1.015 . . . . 0.0 108.525 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.548 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 32.1 tt0 -145.45 174.65 10.96 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.379 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.548 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 61.71 167.6 0.54 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.04 21.09 17.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -1.041 . . . . 0.0 110.036 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.518 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 99.85 12.83 39.09 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -89.63 -162.8 38.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -74.0 122.44 7.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.079 1.568 . . . . 0.0 110.376 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.6 0.66 62.5 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.674 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -71.01 156.54 39.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -1.172 . . . . 0.0 109.464 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 44' ' ' ILE . 5.3 mt -119.83 135.24 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.934 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HA ' HG13 ' A' ' 44' ' ' ILE . 6.7 ptmt -149.33 143.44 25.8 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 110.278 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -89.22 106.48 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 110.48 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' CD1' HG13 ' A' ' 41' ' ' VAL . 41.9 mm -89.55 122.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.882 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.461 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 52.1 m -84.15 142.0 30.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 110.38 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 0.5 OUTLIER -110.19 146.05 33.42 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 110.168 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.6 63.8 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.077 1.567 . . . . 0.0 110.563 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 47.05 -168.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.382 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.65 -40.92 2.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.538 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 1.1 m-85 -96.57 175.97 2.38 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 47.4 Cg_endo -73.95 -25.17 14.45 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.877 1.462 . . . . 0.0 110.207 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' HB2' ' HA2' ' A' ' 89' ' ' GLY . 2.1 m-85 -111.96 131.01 55.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.249 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -52.6 -82.58 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.288 -0.882 . . . . 0.0 109.831 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' VAL . 4.3 p90 -92.02 -170.54 2.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.804 . . . . 0.0 110.471 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 66' ' ' TYR . 19.6 m -156.79 140.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.473 -0.767 . . . . 0.0 109.768 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -83.83 127.48 33.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.023 . . . . 0.0 110.401 -179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 83' ' ' TYR . 12.1 t70 -126.24 124.44 40.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.824 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.9 ttp85 -98.73 144.08 28.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.0 109.031 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -75.26 146.3 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.819 -1.175 . . . . 0.0 110.126 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 22.6 t70 -98.68 -72.43 0.65 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.43 0.634 . . . . 0.0 110.071 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -135.94 144.06 45.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.718 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.5 t -130.65 128.95 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 13.4 m-20 -135.97 104.03 5.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.458 ' CD2' ' N ' ' A' ' 76' ' ' HIS . 13.6 m-70 -79.37 -9.92 59.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.273 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -111.27 -37.81 5.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -89.66 3.22 53.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.443 -0.786 . . . . 0.0 110.045 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.609 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.6 m-30 55.7 59.67 3.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 75' ' ' ASP . 12.1 tttp -139.36 114.87 9.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 110.074 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.718 ' CD2' HG22 ' A' ' 74' ' ' VAL . 59.8 t80 -136.26 116.47 13.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.1 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.448 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 53.5 m-20 -127.47 151.08 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 27.2 p90 -145.28 136.63 25.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.877 . . . . 0.0 109.506 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.2 m -100.51 164.5 11.88 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.121 -0.987 . . . . 0.0 111.14 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG22 ' OD2' ' A' ' 69' ' ' ASP . 55.4 t -108.82 126.15 65.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -115.52 -74.7 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.767 -1.208 . . . . 0.0 111.869 -177.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.89 59.34 3.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.655 -1.278 . . . . 0.0 110.274 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 148.95 16.95 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . 52.5 -157.18 4.05 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.35 6.71 4.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.067 1.561 . . . . 0.0 111.021 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.0 mt -51.47 148.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.63 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' THR . . . -152.88 141.96 8.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 50.87 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -1.173 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 16.7 p -147.61 14.72 1.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.408 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 96' ' ' GLU . 1.6 pp -83.37 147.78 27.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.793 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.787 ' HB2' HD12 ' A' ' 95' ' ' LEU . 1.6 mt-10 53.31 34.84 18.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.115 -0.991 . . . . 0.0 109.247 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -71.68 157.72 37.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.543 -0.723 . . . . 0.0 110.262 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.725 HD11 ' CZ ' ' A' ' 120' ' ' TYR . 61.9 mt -142.18 125.35 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 110.628 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.63 108.55 13.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.539 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -97.03 142.96 28.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.707 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 102' ' ' ILE . 25.5 mt-10 -130.23 164.18 25.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -0.796 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 101' ' ' GLU . 23.1 mm -151.63 110.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -113.59 134.17 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.151 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.556 ' C ' HG23 ' A' ' 105' ' ' VAL . 52.9 mt -117.86 152.3 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 110.399 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.556 HG23 ' C ' ' A' ' 104' ' ' ILE . 27.0 t -153.22 119.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 109.856 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -75.86 151.06 37.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.477 0.656 . . . . 0.0 111.037 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 111' ' ' GLY . 3.1 p -90.43 -161.73 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 48.1 Cg_endo -79.01 -28.18 4.07 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 122.917 0.956 . . . . 0.0 110.692 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 3.8 t0 177.1 34.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -136.12 29.98 2.77 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.654 ' O ' HG23 ' A' ' 107' ' ' THR . . . 100.4 -156.0 19.46 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 120.995 -1.297 . . . . 0.0 110.04 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.846 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -135.57 168.71 18.74 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.705 -0.879 . . . . 0.0 110.505 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.478 HG12 HG22 ' A' ' 10' ' ' THR . 50.0 mt -127.92 124.36 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.194 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 1.6 pp -108.34 137.4 46.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 111.024 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -110.31 114.8 28.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.6 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.473 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 35.5 mt -90.89 131.95 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.366 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -118.31 105.58 11.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 110.258 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 4.6 t-20 -92.94 155.38 17.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.022 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -152.76 132.99 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.141 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.725 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -132.75 103.18 5.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 89.2 m-70 -82.2 142.38 32.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.984 -1.072 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 p -106.28 -170.29 1.7 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.36 -0.837 . . . . 0.0 109.887 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 1.2 ttmt -110.34 55.42 0.65 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 110.273 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 42.88 26.5 0.46 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -164.57 -63.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -1.086 . . . . 0.0 109.835 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 59.7 m-70 -57.5 -170.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.597 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 126' ' ' HIS . 27.0 mt-10 -154.23 -177.47 6.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.09 -1.006 . . . . 0.0 110.608 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.604 HG21 ' HB3' ' A' ' 120' ' ' TYR . 2.6 t -112.67 101.51 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 110.076 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 133' ' ' VAL . 1.6 mmtp -68.57 129.08 38.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -51.24 -49.12 61.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 111.071 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -38.4 -48.36 1.34 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -68.73 -34.09 75.03 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.079 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.616 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 6.0 t -75.15 -47.46 35.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 130' ' ' ALA . 9.5 tttp -61.1 -31.16 70.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.424 -0.797 . . . . 0.0 109.561 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.88 -49.48 51.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 t -65.83 -33.01 74.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 0.0 109.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -71.7 -34.86 69.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.052 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -49.95 -55.61 13.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 37' ' ' ALA . 4.3 mm? -67.05 -36.0 81.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.015 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -47.1 -40.13 13.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.64 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.4 OUTLIER -70.29 -63.43 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -1.072 . . . . 0.0 109.878 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.2 m -51.32 -22.33 2.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 13.2 mt -69.94 -54.25 14.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.985 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -57.63 -25.43 60.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.085 -1.01 . . . . 0.0 109.257 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -82.3 -33.58 28.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.98 85.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.449 -0.782 . . . . 0.0 109.743 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.21 -52.52 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.428 -0.795 . . . . 0.0 109.869 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 26.7 tt0 -51.73 -36.6 47.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.879 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 2.4 t -67.36 -54.45 20.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 110.026 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 151' ' ' LEU . 1.3 t80 -48.74 -69.95 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 0.0 110.433 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 13' ' ' ILE . 10.9 mt -41.56 -46.35 3.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.524 -0.735 . . . . 0.0 110.75 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.9 mt -70.34 -27.6 64.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.915 . . . . 0.0 110.549 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.88 -30.29 70.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 110.198 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.6 150.25 21.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.869 . . . . 0.0 110.094 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.1 t -101.61 97.48 7.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.53 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.582 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 11.4 t0 -129.75 31.91 4.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 156' ' ' ASP . . . 62.18 164.11 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.323 -0.861 . . . . 0.0 110.272 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' A' ' 159' ' ' ASN . 9.5 m-85 -79.93 -15.09 58.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 110.233 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.272 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -72.49 146.92 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -1.177 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.531 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 18.1 m-85 -100.7 161.79 13.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.421 -0.799 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.497 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -138.19 140.98 40.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 110.369 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.748 ' CE2' HG11 ' A' ' 133' ' ' VAL . 23.4 m-85 -152.18 59.18 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.855 . . . . 0.0 109.775 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 4.5 tm-20 -80.98 153.22 27.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.525 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -149.93 163.27 38.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.684 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.38 164.45 34.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.669 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.14 -179.9 7.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -112.75 160.52 17.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 110.407 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.72 136.71 10.52 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.528 -0.732 . . . . 0.0 109.812 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.473 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 19.6 m -79.91 -16.58 12.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.139 -0.975 . . . . 0.0 108.57 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.758 HG21 HD13 ' A' ' 151' ' ' LEU . 24.9 mm -65.79 148.59 98.15 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.1 150.06 85.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.613 1.323 . . . . 0.0 110.917 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.717 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.27 -30.64 62.21 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.903 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.32 -49.32 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.083 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.553 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 1.2 tpt180 -66.57 -32.02 73.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.952 . . . . 0.0 109.709 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 114' ' ' LEU . 1.5 tt -74.81 -37.63 62.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CE1' HG13 ' A' ' 23' ' ' ILE . 6.1 t80 -64.05 -57.06 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.04 -52.85 59.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 110.292 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.82 -28.84 69.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.698 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 36.2 t80 -91.96 -16.14 27.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.203 -0.936 . . . . 0.0 110.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.573 HG13 ' CE1' ' A' ' 19' ' ' PHE . 12.5 mm -109.21 -69.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.104 -0.997 . . . . 0.0 110.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HA ' HD23 ' A' ' 24' ' ' LEU . 9.2 mt -59.03 -34.48 71.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.455 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.5 -14.17 16.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.347 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.88 -30.55 9.29 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.91 -36.83 77.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -1.131 . . . . 0.0 110.396 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 8.0 p-10 -109.13 -22.89 11.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -72.5 -42.54 64.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.8 OUTLIER -47.44 -59.91 4.85 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.353 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -72.46 -1.26 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.04 1.548 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 5.3 mttt -99.41 -65.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 29' ' ' LEU . 35.6 m -82.91 5.31 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 110.516 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -157.04 64.33 3.3 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.293 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.16 1.82 6.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.075 1.566 . . . . 0.0 110.738 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -89.44 -19.31 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.56 -69.16 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 38' ' ' ILE . 2.0 mp -94.42 149.55 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.326 -0.858 . . . . 0.0 109.504 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.437 ' HB3' ' CA ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -102.93 -33.47 9.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.055 -1.028 . . . . 0.0 110.75 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.76 171.16 11.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.958 -1.088 . . . . 0.0 110.822 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.3 t -138.9 139.0 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.398 -0.814 . . . . 0.0 109.933 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -145.08 112.25 6.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -0.997 . . . . 0.0 110.64 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -69.7 114.9 8.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 110.113 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 55' ' ' LYS . 16.6 mm -80.63 -38.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 122.275 1.036 . . . . 0.0 108.484 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 6.4 tp10 -139.58 174.16 10.79 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.043 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.533 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 43.87 -158.98 0.12 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -128.63 -18.04 3.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 0.0 110.68 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.408 ' N ' HG21 ' A' ' 52' ' ' THR . . . 155.49 -18.35 0.51 Allowed Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG11 ' A' ' 71' ' ' VAL . . . -56.38 -169.39 0.09 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 49.8 Cg_endo -75.88 131.73 13.59 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.056 1.556 . . . . 0.0 110.354 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' A' ' 70' ' ' ARG . . . 90.74 -1.26 78.17 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.649 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.6 m -72.69 167.6 20.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.545 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 10.0 mt -127.04 131.17 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.804 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.945 ' CE ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -144.0 141.46 30.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 110.561 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HB2' HD11 ' A' ' 44' ' ' ILE . 13.9 tptt -99.38 107.63 19.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 110.459 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.945 HD11 ' CE ' ' A' ' 54' ' ' LYS . 28.4 mm -88.22 128.04 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -92.59 156.04 17.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 67' ' ' VAL . 30.0 m-85 -132.93 141.46 41.1 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.119 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 112.6 3.51 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.037 1.546 . . . . 0.0 110.431 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -155.82 159.87 39.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.329 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.18 -27.56 15.56 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 1.4 m-85 -61.79 175.8 0.5 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.35 -1.088 . . . . 0.0 110.094 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 43.7 Cg_endo -71.12 -53.56 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.777 1.409 . . . . 0.0 110.177 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.457 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 19.5 m-85 -86.41 164.65 16.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.33 -0.856 . . . . 0.0 109.909 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 4.6 pttt 174.75 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 110.335 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.781 ' O ' HG13 ' A' ' 67' ' ' VAL . 5.0 p90 -67.03 177.6 1.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 110.293 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 66' ' ' TYR . 2.5 m -162.95 133.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 110.048 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 16.5 ttpt -91.67 141.25 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -0.957 . . . . 0.0 110.046 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.82 134.04 36.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 109.839 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.496 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 3.8 ttm180 -95.4 134.3 38.38 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.649 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.7 t -65.53 146.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 118.683 -1.207 . . . . 0.0 110.014 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 12.6 t0 -99.41 -72.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.445 0.64 . . . . 0.0 110.407 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 tt0 -137.39 138.25 39.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.526 -0.734 . . . . 0.0 110.175 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.024 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.1 t -124.69 143.34 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.725 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 m-20 -150.91 93.31 1.92 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -72.85 -1.66 17.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -110.34 -33.23 6.69 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.331 -0.856 . . . . 0.0 108.821 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.48 16.22 27.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.676 -0.64 . . . . 0.0 109.997 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.564 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.2 m-30 44.91 48.71 9.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 5.8 ttpt -126.42 113.6 17.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.109 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 1.024 ' CD2' HG22 ' A' ' 74' ' ' VAL . 42.1 t80 -138.31 117.62 12.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 110.191 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 29.2 t-20 -124.7 165.45 17.91 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.171 -0.956 . . . . 0.0 109.889 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 7.7 p90 -159.37 134.55 8.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.478 -0.764 . . . . 0.0 109.393 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 70' ' ' ARG . 14.4 m -93.29 161.98 14.18 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.173 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.9 t -103.51 123.71 57.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG22 ' HZ1' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -117.07 -72.92 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 111.61 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -82.91 89.63 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.596 -1.315 . . . . 0.0 110.49 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.489 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -109.08 152.04 17.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.14 -61.37 2.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.5 Cg_endo -71.69 -47.33 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.964 1.507 . . . . 0.0 110.64 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.0 mt -53.98 150.96 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.089 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.83 -72.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.71 -75.88 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.168 . . . . 0.0 110.575 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.55 21.36 0.92 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.141 -0.975 . . . . 0.0 110.495 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.587 HD23 ' CB ' ' A' ' 123' ' ' LYS . 2.5 mp -96.69 158.94 15.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.947 . . . . 0.0 110.337 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 57.09 35.39 26.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.996 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -67.72 151.69 46.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.817 HD11 ' CE1' ' A' ' 120' ' ' TYR . 19.7 mt -139.54 129.26 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.977 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 t -119.29 111.55 18.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.397 -0.814 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.575 ' OD1' HG22 ' A' ' 98' ' ' ILE . 1.8 m-20 -103.52 144.4 31.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.69 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 117' ' ' SER . 13.2 tm-20 -122.84 163.28 20.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.344 -0.847 . . . . 0.0 110.403 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.447 HG13 ' C ' ' A' ' 101' ' ' GLU . 92.5 mt -145.52 102.42 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.898 . . . . 0.0 110.043 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -111.41 128.31 55.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 110.188 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.652 HG22 ' HB1' ' A' ' 15' ' ' ALA . 15.8 mt -118.96 124.68 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.126 -0.984 . . . . 0.0 110.379 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.8 t -129.12 133.24 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.293 -0.88 . . . . 0.0 110.109 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.94 147.78 24.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.665 -0.647 . . . . 0.0 111.288 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.593 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.7 p -86.19 -165.38 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 0.0 109.022 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 48.0 Cg_endo -80.51 69.51 7.92 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.26 1.137 . . . . 0.0 110.625 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 15.8 t0 69.02 39.35 1.79 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.266 -0.896 . . . . 0.0 110.331 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.2 38.36 1.25 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . 93.07 -161.97 25.84 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.717 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -140.79 167.49 22.05 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.577 -0.955 . . . . 0.0 110.552 -179.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 107' ' ' THR . 3.5 mt -117.4 120.71 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.204 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -91.75 142.02 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.992 -179.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -130.8 96.49 4.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.605 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.9 115.51 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.567 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.545 ' CB ' ' HB3' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -91.36 152.13 20.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.67 124.86 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.097 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.88 144.5 49.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.11 -0.994 . . . . 0.0 110.471 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.817 ' CE1' HD11 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -122.02 135.35 54.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.989 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.54 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 22.5 m-70 -117.42 120.05 36.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 110.467 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.711 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.45 167.3 10.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 109.954 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.587 ' CB ' HD23 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -141.82 170.81 15.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.169 -0.957 . . . . 0.0 110.492 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.37 -156.24 0.83 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -85.14 17.16 3.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -1.139 . . . . 0.0 110.225 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -81.58 175.68 10.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.207 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.711 ' HA ' HG21 ' A' ' 122' ' ' THR . 10.0 pt-20 -159.97 170.43 21.36 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.235 -0.915 . . . . 0.0 109.765 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 128' ' ' VAL . 2.3 p -113.35 95.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.675 -0.641 . . . . 0.0 110.631 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 128' ' ' VAL . 15.4 mttt -42.87 139.04 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.8 -9.66 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 110.062 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -67.69 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.173 -0.954 . . . . 0.0 109.887 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -53.7 -30.65 44.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.217 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.748 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.8 t -71.62 -52.07 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.496 -0.753 . . . . 0.0 109.486 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -61.84 -29.21 70.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.85 . . . . 0.0 109.792 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.88 60.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.788 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.3 t -71.66 -31.21 66.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.835 . . . . 0.0 110.097 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -74.89 -36.91 62.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -62.77 -46.62 87.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 110.072 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.61 -38.85 58.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 110.193 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.2 -34.91 89.86 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.673 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.92 -50.68 65.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -1.142 . . . . 0.0 110.211 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -58.78 -24.57 61.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.325 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.424 HD23 ' CB ' ' A' ' 34' ' ' ALA . 36.0 mt -74.65 -42.79 57.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -67.58 -27.82 67.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 149' ' ' SER . 0.0 OUTLIER -81.76 -32.03 31.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 109.831 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.66 93.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.783 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' A' ' 22' ' ' PHE . 60.9 t -73.2 -43.68 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.815 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 27.2 tt0 -59.43 -43.98 92.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.834 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -62.01 -42.41 99.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 109.57 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -57.14 -73.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 110.098 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.758 HD13 HG21 ' A' ' 13' ' ' ILE . 1.4 mt -42.5 -33.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.142 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -58.98 -32.08 69.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.87 -13.83 55.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.336 -0.853 . . . . 0.0 110.172 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -85.98 -45.52 11.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 110.381 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.77 47.4 1.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.945 . . . . 0.0 110.479 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -89.98 -28.05 19.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.957 . . . . 0.0 110.032 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -164.07 -68.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.863 . . . . 0.0 110.269 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -165.67 -41.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 110.247 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.235 179.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.24 148.0 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.145 . . . . 0.0 110.084 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.518 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 20.8 m-85 -107.47 169.09 8.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 109.865 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -149.21 143.18 25.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.798 ' CE2' HG11 ' A' ' 133' ' ' VAL . 55.5 m-85 -154.86 60.57 0.66 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.451 -0.781 . . . . 0.0 109.581 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -80.16 150.93 30.0 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.587 0.708 . . . . 0.0 110.501 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.428 ' N ' ' HG2' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -147.75 174.5 11.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.486 -0.759 . . . . 0.0 109.712 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -158.7 163.54 36.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.724 ' HB ' HD21 ' A' ' 114' ' ' LEU . 12.0 m -159.91 154.99 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 110.213 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.49 163.37 13.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.478 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -158.47 138.92 12.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 76.2 t -80.0 -14.01 13.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.136 -0.978 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.918 HG21 HD12 ' A' ' 151' ' ' LEU . 22.0 mm -67.52 150.3 97.92 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.766 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.3 Cg_endo -67.09 149.95 82.33 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.503 1.265 . . . . 0.0 110.701 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.92 -25.2 58.74 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.892 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.56 -54.79 6.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 14.5 mtp180 -65.8 -31.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.722 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.526 HD23 HG21 ' A' ' 104' ' ' ILE . 30.0 tp -71.29 -32.39 68.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.811 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.848 ' CD2' HD13 ' A' ' 23' ' ' ILE . 6.3 t80 -70.45 -64.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -46.67 -42.55 16.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 110.481 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . . . -70.68 -36.04 73.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.517 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 17.4 t80 -91.96 -11.3 36.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.816 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.848 HD13 ' CD2' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -118.75 -62.19 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 109.982 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -72.87 -23.43 60.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.833 . . . . 0.0 110.109 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.526 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . 1.7 t70 -128.85 3.13 5.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -59.85 -37.81 93.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.697 ' O ' HG21 ' A' ' 41' ' ' VAL . 76.4 m-20 -59.61 -25.45 64.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -1.101 . . . . 0.0 110.262 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -98.67 -22.62 15.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.45 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.888 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -93.04 -22.89 18.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.275 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -58.13 -58.08 21.36 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 109.932 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 30' ' ' PHE . 49.4 Cg_endo -75.36 2.9 6.29 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.065 1.56 . . . . 0.0 110.679 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 1.2 mtpt -105.27 -60.09 1.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.016 -1.052 . . . . 0.0 110.76 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 29' ' ' LEU . 23.4 m -82.73 -18.88 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.834 . . . . 0.0 110.613 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 143' ' ' LEU . . . -138.41 72.08 44.78 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.79 -16.8 23.32 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.03 1.542 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -74.78 -16.22 60.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.665 ' HB2' HD23 ' A' ' 139' ' ' LEU . . . -103.85 -63.74 1.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 110.053 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.8 mp -93.62 144.14 10.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.486 -0.758 . . . . 0.0 110.305 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 0.1 OUTLIER -103.03 -40.26 6.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 110.02 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.499 ' HB2' ' CB ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -166.93 161.33 15.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 27' ' ' ASP . 3.7 m -134.55 153.48 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -157.91 104.37 1.92 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 111.297 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.66 117.74 7.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.645 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 55' ' ' LYS . 14.2 mm -84.26 -38.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.231 1.015 . . . . 0.0 108.779 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 47.1 tt0 -153.55 175.04 13.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.245 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 67.9 163.93 2.54 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -107.47 35.49 3.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -1.107 . . . . 0.0 110.099 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.447 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 84.1 8.92 83.18 Favored Glycine 0 N--CA 1.48 1.613 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.28 -159.68 34.27 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.6 Cg_endo -76.08 119.23 5.26 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.054 1.555 . . . . 0.0 110.438 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.99 2.26 59.45 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.693 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -67.87 156.78 36.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -1.17 . . . . 0.0 109.171 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 44' ' ' ILE . 10.9 mt -121.86 131.15 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 110.222 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.45 140.63 30.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.192 -0.942 . . . . 0.0 110.221 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' C ' HD13 ' A' ' 56' ' ' ILE . 11.7 ttmt -93.78 119.01 32.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.569 HD12 HG12 ' A' ' 41' ' ' VAL . 7.9 mm -102.34 128.03 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.089 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 40' ' ' SER . 0.7 OUTLIER -90.01 153.75 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.333 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.403 ' HB2' ' C ' ' A' ' 65' ' ' LYS . 4.1 m-85 -119.56 134.95 23.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.153 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.31 113.26 3.55 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.991 1.521 . . . . 0.0 110.146 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.97 173.8 8.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 110.28 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.51 8.45 28.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.513 ' CG ' ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -89.96 178.13 2.08 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.202 -1.175 . . . . 0.0 110.197 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.513 ' HD2' ' CG ' ' A' ' 62' ' ' PHE . 46.7 Cg_endo -72.72 -55.71 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.102 1.58 . . . . 0.0 110.719 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 9.8 p90 -98.32 148.01 24.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 0.0 110.527 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' C ' ' HB2' ' A' ' 58' ' ' PHE . 6.2 pttt -174.94 -41.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.716 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.612 ' C ' HG12 ' A' ' 67' ' ' VAL . 12.8 p90 -63.46 -168.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.47 -0.769 . . . . 0.0 110.014 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.612 HG12 ' C ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER 173.16 171.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 110.377 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.47 137.83 52.26 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.594 -0.691 . . . . 0.0 109.746 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 85' ' ' VAL . 94.1 m-20 -125.22 125.78 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 110.656 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 52' ' ' THR . 1.4 ttt180 -94.07 133.59 37.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.693 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.4 t -72.58 144.38 13.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.825 -1.172 . . . . 0.0 110.743 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 86.4 m-20 -92.87 -68.92 0.77 Allowed 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.339 0.59 . . . . 0.0 110.193 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.8 tp10 -143.35 134.67 26.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.393 -0.817 . . . . 0.0 110.177 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 81' ' ' TYR . 3.8 t -117.29 147.79 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.897 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.35 105.0 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.299 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -80.47 -4.42 53.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -108.12 -33.2 7.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.182 -0.949 . . . . 0.0 109.305 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.66 4.52 43.32 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.665 -0.647 . . . . 0.0 110.109 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.55 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 22.9 m-85 53.56 46.71 25.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.07 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.39 109.97 15.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.149 -0.97 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.501 ' CD2' HG22 ' A' ' 74' ' ' VAL . 44.5 t80 -127.62 107.47 9.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.897 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 7.8 m120 -114.23 140.57 48.47 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.091 -1.005 . . . . 0.0 109.999 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 100' ' ' ASN . 48.8 p90 -143.16 138.62 29.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.7 m -103.97 172.17 6.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 111.376 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.817 HG11 HD13 ' A' ' 98' ' ' ILE . 42.4 t -111.21 126.57 68.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.574 ' O ' HG21 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -120.94 -76.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.818 -1.176 . . . . 0.0 111.518 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -78.6 102.42 7.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.818 -1.176 . . . . 0.0 110.652 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -129.42 145.43 16.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.54 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -42.59 -57.28 3.93 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.6 Cg_endo -71.21 -30.58 15.72 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.394 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.574 HG21 ' O ' ' A' ' 86' ' ' ILE . 73.9 mt -78.64 147.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.81 -36.32 0.73 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.07 -74.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 110.212 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.493 ' H ' HD12 ' A' ' 95' ' ' LEU . 14.1 t -137.3 4.52 2.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.928 . . . . 0.0 110.416 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 95' ' ' LEU . 5.6 mp -84.37 150.88 25.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.935 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.9 34.25 21.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.58 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.59 162.53 29.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 110.253 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.817 HD13 HG11 ' A' ' 85' ' ' VAL . 4.0 mp -136.5 131.42 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 119' ' ' LYS . 1.8 m -118.75 119.73 35.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.364 -0.835 . . . . 0.0 109.603 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 13.9 m-80 -112.17 160.6 17.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 110.721 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.474 ' CG ' ' CG ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -150.84 132.1 14.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.11 125.67 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.027 -1.046 . . . . 0.0 110.564 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 69.5 tttt -129.7 119.22 23.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 109.858 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.526 HG21 HD23 ' A' ' 18' ' ' LEU . 70.5 mt -118.42 112.49 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.763 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.0 t -112.01 141.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.414 -0.804 . . . . 0.0 109.879 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.0 147.08 25.18 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.499 -0.75 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.7 p -86.38 -162.86 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 0.0 109.089 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 45.1 Cg_endo -79.59 -27.72 3.93 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.011 1.006 . . . . 0.0 110.952 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 6.9 p-10 178.36 33.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 110.362 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.79 21.59 3.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 107' ' ' THR . . . 106.21 -151.69 17.01 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.161 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.861 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -136.87 163.04 31.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.755 -0.85 . . . . 0.0 110.644 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 113' ' ' ILE . 1.7 tt -112.16 126.81 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.166 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.724 HD21 ' HB ' ' A' ' 9' ' ' THR . 2.0 pp -106.14 135.72 47.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.869 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -124.52 106.55 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.834 . . . . 0.0 109.712 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 67.5 mt -97.22 112.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.47 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -97.8 114.02 25.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.27 135.37 48.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 99' ' ' SER . 4.7 mttt -126.22 155.74 41.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.371 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.612 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -132.04 130.21 41.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 71.8 m-70 -113.11 140.2 48.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.159 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.96 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.3 OUTLIER -129.78 170.71 13.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.974 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 126' ' ' HIS . 0.7 OUTLIER -159.68 -177.95 6.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 110.421 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 125' ' ' ASP . . . 45.95 40.9 10.08 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 124' ' ' GLY . 9.2 m-20 61.79 15.69 7.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -1.139 . . . . 0.0 110.333 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.471 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 63.7 m170 -82.34 175.28 10.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.394 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.96 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER -159.99 136.66 9.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.487 -0.758 . . . . 0.0 109.146 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 120' ' ' TYR . 2.1 p -87.12 108.78 18.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 121.475 -0.765 . . . . 0.0 110.291 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -50.61 156.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -79.57 -7.46 58.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -50.4 -73.27 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -22.92 6.12 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.476 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 5' ' ' TYR . 11.5 t -76.09 -48.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.845 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -26.76 65.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.392 -0.817 . . . . 0.0 109.58 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -38.74 63.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.325 -0.859 . . . . 0.0 109.366 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -60.52 -35.97 77.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.688 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -68.49 -48.14 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.869 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -52.43 -58.72 5.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.925 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -72.37 -33.06 66.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.08 -42.52 31.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.662 ' HA ' HD23 ' A' ' 144' ' ' LEU . 2.6 tp10 -63.11 -47.69 81.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -1.187 . . . . 0.0 109.975 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.1 m -59.89 -26.86 66.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.085 -1.009 . . . . 0.0 109.747 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.533 HD13 ' HE1' ' A' ' 30' ' ' PHE . 17.3 mt -67.68 -49.98 59.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.981 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.3 pp -66.97 -23.21 65.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.01 -1.056 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.446 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 2.0 tmm_? -80.9 -35.85 31.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.067 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 150' ' ' TYR . . . -65.32 -44.23 88.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.733 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.83 -45.26 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.514 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' A' ' 13' ' ' ILE . 1.1 tt0 -60.35 -56.24 23.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -14.51 47.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.585 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.24 -25.52 31.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.918 HD12 HG21 ' A' ' 13' ' ' ILE . 43.1 mt -88.8 -25.12 22.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.12 -22.64 33.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 0.0 110.44 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -61.08 -26.01 67.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.423 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.22 22.03 16.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 110.416 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.43 -0.82 56.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.0 110.1 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -92.44 2.74 56.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.27 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.09 167.44 14.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.933 . . . . 0.0 110.193 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.42 -49.07 13.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.917 . . . . 0.0 110.262 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.124 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 120' ' ' TYR . 2.9 t -125.17 150.91 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -1.1 . . . . 0.0 109.999 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.506 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 3.2 m-85 -101.4 152.89 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.753 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.76 142.65 51.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.042 -1.036 . . . . 0.0 110.843 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.76 ' CD2' HG11 ' A' ' 133' ' ' VAL . 1.1 m-85 -154.12 53.7 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.645 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 7' ' ' THR . 1.9 pt-20 -81.61 160.0 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 110.557 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 6' ' ' GLU . 3.5 p -159.8 172.26 17.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.857 . . . . 0.0 109.874 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 12.7 pt-20 -146.34 141.88 27.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.073 -1.017 . . . . 0.0 110.381 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 10' ' ' THR . 78.7 m -131.69 166.95 20.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 9' ' ' THR . 1.5 p -102.23 164.01 11.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.336 -0.853 . . . . 0.0 110.425 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 10' ' ' THR . 3.6 m -159.84 134.8 7.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.514 HG21 HD11 ' A' ' 152' ' ' LEU . 21.3 m -80.03 -14.06 13.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.61 HG23 ' HD2' ' A' ' 14' ' ' PRO . 36.2 mm -73.56 148.7 88.07 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.551 -0.718 . . . . 0.0 109.146 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.91 150.59 85.56 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.55 1.29 . . . . 0.0 110.965 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -70.09 -35.09 73.93 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.942 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.55 -56.44 6.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.9 . . . . 0.0 110.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER -62.31 -36.29 81.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.909 HD22 HG21 ' A' ' 104' ' ' ILE . 4.4 tt -74.13 -33.94 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.407 -0.808 . . . . 0.0 110.241 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 32.5 t80 -60.81 -61.06 2.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.957 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttt -57.08 -36.87 71.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.371 -0.831 . . . . 0.0 110.058 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.51 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.403 ' CD1' HG21 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -91.91 -11.29 36.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.951 . . . . 0.0 110.316 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.483 HG12 ' CG ' ' A' ' 81' ' ' TYR . 1.0 OUTLIER -121.69 -64.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -58.13 -48.38 80.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.422 -0.799 . . . . 0.0 110.556 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -105.01 7.55 34.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.155 -0.966 . . . . 0.0 110.463 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.85 -48.65 65.53 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB2' HG21 ' A' ' 41' ' ' VAL . 5.3 p-10 -57.67 -26.54 61.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.236 . . . . 0.0 110.58 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -99.34 -30.93 11.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.649 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.673 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -81.54 -35.62 30.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.301 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.553 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 2.4 m-30 -44.8 -59.15 4.41 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 110.348 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -71.79 -10.45 26.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.877 1.462 . . . . 0.0 110.774 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -92.64 -57.26 2.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.984 . . . . 0.0 110.739 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 29' ' ' LEU . 27.1 m -94.18 -2.02 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 110.988 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -149.42 71.27 9.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.92 -1.112 . . . . 0.0 110.76 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.26 -20.11 16.67 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.005 1.529 . . . . 0.0 110.026 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -80.55 -29.06 37.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 110.092 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.02 -55.92 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 110.133 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.2 151.25 20.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.453 -0.78 . . . . 0.0 110.318 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 1.3 t -98.7 -46.49 5.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.865 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.426 ' C ' HG13 ' A' ' 41' ' ' VAL . 22.1 t -162.37 174.07 13.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 110.099 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 27' ' ' ASP . 24.7 m -147.71 146.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -144.26 151.06 38.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.447 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -100.09 116.73 32.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.868 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.6 mm -86.12 -37.32 11.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.19 0.995 . . . . 0.0 108.679 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.532 ' HG2' ' N ' ' A' ' 46' ' ' GLY . 27.5 tt0 -157.08 173.64 16.7 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.701 0.763 . . . . 0.0 110.734 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' N ' ' HG2' ' A' ' 45' ' ' GLU . . . 75.97 -173.35 53.76 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -128.65 43.94 3.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -1.073 . . . . 0.0 110.1 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 69.02 7.52 56.67 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.96 -156.26 32.31 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.8 Cg_endo -75.03 117.8 5.03 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.019 1.536 . . . . 0.0 110.744 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.14 2.02 56.95 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.64 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.3 m -69.79 149.42 47.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.039 -1.271 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.462 HG12 ' HG3' ' A' ' 70' ' ' ARG . 4.7 mt -115.31 128.12 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.548 ' CA ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -137.03 148.87 47.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.92 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.868 ' HB2' HD11 ' A' ' 44' ' ' ILE . 8.6 tttt -94.13 95.07 8.75 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.822 -0.549 . . . . 0.0 109.988 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 66' ' ' TYR . 13.7 mt -84.04 137.0 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -109.03 133.3 53.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.622 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -107.97 144.35 29.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 109.842 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.26 95.17 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.972 1.511 . . . . 0.0 110.475 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.47 163.34 32.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.396 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -90.17 -37.29 6.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.456 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 2.5 m-30 -46.9 172.75 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.313 -1.11 . . . . 0.0 110.325 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 43.0 Cg_endo -69.72 -48.76 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.911 1.48 . . . . 0.0 109.798 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 11.9 m-85 -99.49 166.72 11.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.453 -0.78 . . . . 0.0 109.785 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER 173.71 -36.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 110.148 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' C ' HG13 ' A' ' 67' ' ' VAL . 18.3 p90 -71.17 172.02 9.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.378 -0.826 . . . . 0.0 110.261 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.505 HG13 ' C ' ' A' ' 66' ' ' TYR . 18.2 m -154.47 154.38 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 25.8 ttmt -105.39 48.51 0.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -48.19 132.07 16.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 84' ' ' SER . 38.0 ttt180 -96.43 151.09 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 108.637 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.64 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.5 t -76.55 147.81 7.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.619 -1.301 . . . . 0.0 110.375 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 29.5 t0 -101.55 -74.07 0.63 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.373 0.606 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 mm-40 -141.32 146.6 36.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.209 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.763 HG22 ' HD1' ' A' ' 81' ' ' TYR . 2.9 t -137.37 127.95 38.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -124.64 113.65 18.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 109.747 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.68 -13.45 60.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.396 -0.815 . . . . 0.0 111.105 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 m -106.68 -35.49 6.99 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.017 -1.052 . . . . 0.0 109.672 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.486 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -94.31 14.88 19.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.597 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 41.68 48.26 3.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.382 -0.824 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -116.65 113.7 23.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.217 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.763 ' HD1' HG22 ' A' ' 74' ' ' VAL . 41.1 t80 -133.04 120.29 21.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.383 -0.823 . . . . 0.0 110.071 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 42.6 t-20 -130.69 162.42 29.49 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 110.194 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 100' ' ' ASN . 23.7 p90 -153.94 140.86 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 70' ' ' ARG . 1.2 m -98.08 154.01 18.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 98' ' ' ILE . 39.1 t -99.39 123.05 51.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.492 HD11 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -125.09 -77.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 111.041 -178.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.556 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 3.9 tm-20 -71.97 65.62 0.55 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -86.36 140.72 17.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.18 -53.83 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 46.9 Cg_endo -74.59 -45.26 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.784 1.412 . . . . 0.0 110.704 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 92' ' ' GLY . 49.2 mt -59.51 172.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.012 . . . . 0.0 110.189 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -152.42 -65.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.56 -85.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 110.107 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.6 p -140.12 19.2 2.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 110.35 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -94.28 153.83 17.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.557 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 36.2 mt-10 57.14 36.02 27.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.396 -0.815 . . . . 0.0 109.932 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.469 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 1.6 mttt -69.2 153.26 43.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.915 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.56 HG12 ' CE1' ' A' ' 120' ' ' TYR . 12.6 mt -138.93 132.0 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.722 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.6 m -121.91 110.36 15.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.623 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 5.0 m120 -104.03 125.89 50.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 110.721 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB2' ' ND2' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -110.18 167.13 10.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.457 ' CG1' ' O ' ' A' ' 101' ' ' GLU . 12.2 mt -155.39 118.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.479 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 5.9 tttt -119.46 114.19 21.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.909 HG21 HD22 ' A' ' 18' ' ' LEU . 2.7 mp -103.28 125.43 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.575 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 112' ' ' SER . 42.6 t -131.21 145.71 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.246 -0.909 . . . . 0.0 110.542 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.96 153.43 21.3 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.777 -0.577 . . . . 0.0 110.218 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.705 HG23 ' HD3' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -130.08 -56.49 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.064 -1.022 . . . . 0.0 111.331 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.705 ' HD3' HG23 ' A' ' 107' ' ' THR . 45.5 Cg_endo -88.35 43.11 0.75 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.076 1.04 . . . . 0.0 110.793 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 108' ' ' PRO . 0.6 OUTLIER 42.7 28.18 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.91 . . . . 0.0 110.244 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 108' ' ' PRO . . . -163.75 -36.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -111.89 -174.65 19.73 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -157.14 170.63 22.07 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.501 HG13 HG21 ' A' ' 107' ' ' THR . 48.4 mt -122.76 120.58 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.517 ' HG ' ' CG1' ' A' ' 104' ' ' ILE . 1.4 mp -86.95 122.05 30.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.667 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -104.27 97.48 7.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.8 mt -85.67 144.59 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.861 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.512 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -128.05 120.58 27.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.486 -0.759 . . . . 0.0 109.522 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.55 123.93 51.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.015 -1.053 . . . . 0.0 110.612 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -120.76 128.43 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.746 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 1.031 ' CE2' HG22 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -109.31 143.5 38.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -0.985 . . . . 0.0 110.243 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 96' ' ' GLU . 66.9 m-70 -128.11 129.64 46.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.058 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -113.85 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.3 OUTLIER -145.33 164.37 31.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.384 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 41.59 -126.12 3.61 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -103.39 14.74 30.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -1.107 . . . . 0.0 109.975 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.488 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 9.4 m170 -70.39 165.81 21.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.321 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.748 ' HA ' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER -160.16 137.7 9.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.307 -0.871 . . . . 0.0 109.28 179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 128' ' ' VAL . 2.7 p -100.05 98.15 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.372 -0.83 . . . . 0.0 110.527 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 128' ' ' VAL . 3.8 mttm -54.94 -172.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.49 16.73 16.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.85 -72.54 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.875 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -30.49 38.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 109.201 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.031 HG22 ' CE2' ' A' ' 120' ' ' TYR . 11.3 t -70.88 -48.83 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.463 -0.773 . . . . 0.0 109.531 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -65.46 -36.31 83.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 0.0 110.173 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.02 -35.52 72.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.661 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.6 t -66.4 -38.36 87.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.752 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -64.22 -43.8 93.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.993 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -51.18 -53.79 31.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.32 -24.35 62.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -57.63 -44.03 94.1 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 15.8 mt-10 -64.43 -57.51 9.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -1.161 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.8 m -46.27 -29.94 1.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.095 -1.003 . . . . 0.0 110.121 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 143' ' ' LEU . 20.2 mt -70.61 -59.33 2.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.847 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 144' ' ' LEU . 2.3 pp -66.72 -17.89 65.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.172 -0.955 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' SER . 0.0 OUTLIER -84.12 -33.64 24.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.798 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 33' ' ' VAL . . . -69.11 -44.05 73.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.907 . . . . 0.0 109.438 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 22' ' ' PHE . 41.7 t -67.95 -43.97 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.679 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -61.2 -36.74 80.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.249 -0.907 . . . . 0.0 109.374 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.9 OUTLIER -68.08 -52.87 30.22 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 0.0 109.755 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -47.46 -69.92 0.11 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 110.312 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 13' ' ' ILE . 2.3 mt -46.21 -36.53 6.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.394 -0.817 . . . . 0.0 110.403 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.514 HD11 HG21 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -71.3 -56.41 6.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.084 -1.01 . . . . 0.0 110.297 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -56.6 -27.56 58.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.933 . . . . 0.0 110.241 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -118.56 117.8 29.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.9 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.7 t -101.12 -26.72 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 110.521 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 157' ' ' ALA . 46.1 m-20 -129.16 1.47 5.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.101 -1.0 . . . . 0.0 110.323 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 156' ' ' ASP . . . 50.31 -177.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -0.932 . . . . 0.0 110.087 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -151.49 50.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 110.392 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.215 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.754 HG11 ' ND1' ' A' ' 121' ' ' HIS . 4.2 m -74.37 -165.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.429 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 2.7 m-85 -107.31 153.04 23.32 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.261 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 143.8 48.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.971 -1.08 . . . . 0.0 111.183 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.854 ' CE2' HG11 ' A' ' 133' ' ' VAL . 10.8 m-85 -153.59 58.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 0.0 109.151 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 9.9 pt-20 -84.94 145.07 27.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 110.807 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -146.78 167.53 23.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 3.5 pm0 -147.42 166.87 25.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.99 . . . . 0.0 110.369 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.12 -168.4 2.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 p -130.35 160.81 32.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.461 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.449 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . 41.5 m -159.95 139.26 11.03 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 14.8 p -79.83 -6.39 9.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.203 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.731 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.9 mm -74.27 148.96 86.64 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.731 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.8 Cg_endo -65.0 150.25 88.33 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.561 1.296 . . . . 0.0 111.166 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -67.04 -36.99 83.29 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.457 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.66 -54.16 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.565 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.542 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 12.0 ttt180 -57.83 -39.5 77.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 1.4 tt -67.32 -39.1 85.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.705 ' CD1' HD13 ' A' ' 23' ' ' ILE . 61.9 t80 -61.23 -71.0 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 0.0 110.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -47.4 -45.67 25.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 110.144 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.62 84.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.367 -0.833 . . . . 0.0 110.496 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 16.2 t80 -90.86 -7.09 53.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.705 HD13 ' CD1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -121.42 -64.9 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.978 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.483 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -61.82 -48.27 81.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 110.299 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 28' ' ' ASN . 29.9 t0 -110.82 16.7 21.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 110.313 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.72 -61.18 6.43 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -45.89 -23.88 0.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -1.125 . . . . 0.0 110.711 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.412 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 29.3 t-20 -89.74 -32.51 16.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 0.0 110.518 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mp -84.4 -18.08 37.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -62.49 -61.81 6.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.675 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -72.72 53.76 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.841 1.443 . . . . 0.0 110.981 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -151.64 -63.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.119 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.519 HG11 ' CE1' ' A' ' 150' ' ' TYR . 17.0 m -86.18 -19.93 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.44 66.12 35.52 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.204 -0.935 . . . . 0.0 110.264 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.66 -10.77 21.97 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.003 1.528 . . . . 0.0 110.397 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -22.91 64.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.285 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.459 ' O ' ' CD ' ' A' ' 59' ' ' PRO . . . -95.19 -55.91 2.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.536 HG12 HG21 ' A' ' 56' ' ' ILE . 1.4 mp -107.72 137.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 110.112 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.19 -29.33 14.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.987 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.5 m -178.61 145.19 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.012 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 2.3 p -126.99 119.21 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 110.167 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -115.01 119.68 37.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.3 m-20 -65.54 117.59 8.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.493 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.733 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.8 mm -79.91 -38.71 19.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 122.36 1.076 . . . . 0.0 108.422 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.2 mm-40 -100.15 -161.38 0.86 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.064 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.31 53.83 0.34 Allowed Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -116.3 -24.83 7.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -1.053 . . . . 0.0 110.003 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.529 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 50.77 78.16 0.11 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . 166.66 -160.19 33.74 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 43.8 Cg_endo -70.72 83.68 0.85 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.05 1.553 . . . . 0.0 110.286 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.86 -8.69 2.25 Favored Glycine 0 N--CA 1.478 1.477 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.696 ' HB ' HG21 ' A' ' 71' ' ' VAL . 32.7 m -67.69 165.54 17.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.965 -1.315 . . . . 0.0 109.257 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 45' ' ' GLU . 19.5 mt -138.03 143.37 33.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.961 -1.087 . . . . 0.0 111.056 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -154.9 136.9 14.63 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.733 ' HB2' HD11 ' A' ' 44' ' ' ILE . 1.1 ttpm? -95.56 112.48 24.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 111.404 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.536 HG21 HG12 ' A' ' 38' ' ' ILE . 15.1 mt -98.17 122.33 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 109.266 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.488 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -84.08 150.89 25.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.691 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -111.19 137.06 20.87 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.198 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.459 ' CD ' ' O ' ' A' ' 37' ' ' ALA . 48.6 Cg_endo -75.23 76.27 3.54 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.994 1.523 . . . . 0.0 110.529 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -125.67 179.57 5.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.149 -0.969 . . . . 0.0 110.346 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -99.56 -45.33 2.15 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.463 ' O ' ' O ' ' A' ' 61' ' ' GLY . 1.9 m-85 -42.92 166.01 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.272 -1.134 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.09 -59.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.933 1.491 . . . . 0.0 110.434 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -84.07 144.3 29.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.859 . . . . 0.0 109.834 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -174.07 -49.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.986 . . . . 0.0 110.554 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.595 ' CD1' ' HE2' ' A' ' 55' ' ' LYS . 21.5 p90 -64.06 162.79 13.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.258 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 ' OD1' ' A' ' 69' ' ' ASP . 4.2 m -143.09 175.74 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.177 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 69' ' ' ASP . 1.9 ttpt -122.46 37.93 4.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 110.108 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 84' ' ' SER . 4.6 p-10 -42.24 138.57 1.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.618 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 84' ' ' SER . 11.0 ptt180 -102.81 167.26 9.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 108.947 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.696 HG21 ' HB ' ' A' ' 52' ' ' THR . 16.3 t -77.85 152.34 5.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.79 -1.194 . . . . 0.0 109.94 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 82' ' ' ASN . 34.2 t70 -104.71 -66.34 0.97 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -144.7 130.09 18.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.251 -0.906 . . . . 0.0 110.742 -179.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 5.4 t -116.12 150.83 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.811 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.578 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -158.33 111.23 2.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.221 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -21.25 51.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -104.77 -40.32 6.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.19 -0.944 . . . . 0.0 109.756 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -84.48 7.22 20.56 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.48 -0.762 . . . . 0.0 110.274 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.526 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 8.0 m-85 46.25 59.26 3.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.29 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -131.27 107.94 9.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.965 -1.084 . . . . 0.0 110.741 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.672 ' O ' HD12 ' A' ' 102' ' ' ILE . 13.9 t80 -125.99 104.1 8.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.54 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 37.3 m-20 -121.02 149.1 43.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 9.2 p90 -139.04 138.38 37.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.218 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' ARG . 5.7 m -101.89 159.94 14.92 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.906 -1.121 . . . . 0.0 111.008 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 55.5 t -106.98 121.98 60.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.16 -75.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.067 -1.021 . . . . 0.0 110.873 -179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' OE1' ' CA ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -74.04 95.24 2.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.72 -1.238 . . . . 0.0 110.101 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -122.79 138.31 11.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.551 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.4 -54.36 3.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.4 Cg_endo -72.47 -48.43 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.831 1.437 . . . . 0.0 110.809 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.415 ' CD1' HG12 ' A' ' 85' ' ' VAL . 64.4 mt -54.5 160.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.178 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.59 -70.4 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.592 ' H ' HD23 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -103.31 74.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -1.108 . . . . 0.0 110.198 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 46.6 p 43.7 24.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.592 HD23 ' H ' ' A' ' 93' ' ' ASP . 3.6 pp -96.96 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.162 -0.961 . . . . 0.0 110.126 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.585 ' CB ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER 56.45 34.66 24.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.668 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -67.95 151.48 47.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.301 -0.874 . . . . 0.0 110.018 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.654 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 2.9 mp -126.79 120.67 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.612 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -108.83 104.23 13.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.56 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -96.25 145.43 25.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.782 -179.249 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.54 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 1.2 mp0 -136.11 139.73 43.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.437 -0.79 . . . . 0.0 109.596 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.672 HD12 ' O ' ' A' ' 81' ' ' TYR . 3.0 mp -130.21 100.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 110.476 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 59.3 tttt -104.76 124.47 49.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.01 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 79' ' ' PHE . 50.0 mt -110.45 138.63 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.895 . . . . 0.0 110.377 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 t -139.2 138.87 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.05 -1.031 . . . . 0.0 109.912 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.08 144.08 26.7 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.497 0.665 . . . . 0.0 110.479 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.598 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.9 p -79.86 -163.71 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.81 . . . . 0.0 108.924 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 44.3 Cg_endo -78.06 -32.19 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.008 1.004 . . . . 0.0 110.543 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 108' ' ' PRO . 1.7 m-20 -173.68 35.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 110.3 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.77 61.75 0.46 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.638 -1.267 . . . . 0.0 110.301 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 107' ' ' THR . . . 73.09 -154.53 49.68 Favored Glycine 0 N--CA 1.491 2.358 0 O-C-N 121.223 -1.163 . . . . 0.0 110.332 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -134.51 163.56 29.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.785 -0.832 . . . . 0.0 110.538 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.46 HG13 HG22 ' A' ' 107' ' ' THR . 9.1 mt -109.49 133.25 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 109.349 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.471 HD23 HD11 ' A' ' 116' ' ' ILE . 0.0 OUTLIER -97.88 133.93 41.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.976 -1.078 . . . . 0.0 110.803 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -129.55 98.66 4.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.413 -0.804 . . . . 0.0 109.642 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 1.5 mp -101.02 136.86 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.933 . . . . 0.0 110.421 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 0.9 OUTLIER -113.33 125.44 54.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.374 -0.829 . . . . 0.0 110.232 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.78 134.0 53.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.229 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.633 ' HG2' HG21 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -125.82 143.59 51.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.956 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.654 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -125.56 104.02 8.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.97 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.754 ' ND1' HG11 ' A' ' 2' ' ' VAL . 33.2 m-70 -83.42 101.44 11.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.88 . . . . 0.0 110.409 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.5 166.98 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.804 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 124' ' ' GLY . 5.6 ttpt -107.44 145.75 32.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.325 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.87 -30.11 0.93 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.0 -55.77 5.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -1.222 . . . . 0.0 110.403 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.445 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 96.6 m-70 -78.83 179.15 7.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -159.99 136.52 9.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 109.897 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.638 HG21 ' CD2' ' A' ' 120' ' ' TYR . 3.0 p -104.79 86.62 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -48.48 150.29 1.39 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -60.46 -27.34 67.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.933 . . . . 0.0 109.959 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 130' ' ' ALA . 28.5 mt-10 -41.71 -64.59 0.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 110.046 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -55.12 -29.7 58.23 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.245 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.854 HG11 ' CE2' ' A' ' 5' ' ' TYR . 9.3 t -72.88 -50.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.415 -0.803 . . . . 0.0 109.442 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.2 -21.4 60.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.198 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t -79.41 -32.29 42.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.122 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -35.58 37.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -49.36 -60.57 2.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 110.004 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -76.94 -31.7 56.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 110.116 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -49.52 -55.03 14.38 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.586 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -50.06 -40.3 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -1.154 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.06 -24.91 67.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.987 . . . . 0.0 109.695 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 139' ' ' LEU . 54.7 mt -73.81 -51.49 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.94 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.4 pp -64.54 -22.01 66.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 149' ' ' SER . 17.4 tpt85 -81.66 -43.08 19.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.444 -0.785 . . . . 0.0 109.682 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -57.75 -36.72 72.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.3 t -73.22 -53.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 0.0 109.603 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.449 ' OE2' ' HA ' ' A' ' 11' ' ' SER . 50.7 tt0 -53.48 -53.15 55.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -58.6 -36.3 73.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.128 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.519 ' CE1' HG11 ' A' ' 33' ' ' VAL . 1.2 t80 -48.93 -71.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.573 -0.704 . . . . 0.0 109.823 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.634 HD22 HG23 ' A' ' 13' ' ' ILE . 1.9 mp -56.45 -26.53 54.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.725 . . . . 0.0 110.071 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -77.74 -14.38 59.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 110.32 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -119.32 18.05 12.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.186 -0.946 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -99.74 119.51 38.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.065 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.52 112.68 25.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.267 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -70.0 -20.35 63.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.17 -152.14 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 110.088 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.08 -60.62 1.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.296 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 4.5 t 57.3 155.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -1.111 . . . . 0.0 110.11 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 1.6 m-85 -111.24 151.31 28.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.98 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.33 135.61 49.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 110.363 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.683 ' CE2' HG11 ' A' ' 133' ' ' VAL . 28.2 m-85 -148.39 70.68 1.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.445 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -95.19 154.21 17.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 6' ' ' GLU . 2.1 p -158.15 -169.77 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.507 -0.746 . . . . 0.0 109.844 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.9 pt-20 -159.96 150.93 19.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.748 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.706 HG21 HD21 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -132.17 153.39 50.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.402 -0.811 . . . . 0.0 109.77 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.892 HG22 ' CD1' ' A' ' 113' ' ' ILE . 1.8 p -92.93 160.2 15.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.741 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.48 ' OG ' ' CD1' ' A' ' 114' ' ' LEU . 17.3 m -158.07 137.78 12.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 109.673 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.425 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 56.7 t -80.05 -11.0 12.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.795 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.0 OUTLIER -75.85 150.73 84.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.795 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.3 Cg_endo -66.71 150.74 83.52 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.716 1.377 . . . . 0.0 111.145 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 104' ' ' ILE . . . -73.73 -19.57 60.76 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.497 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.8 -54.87 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 14.4 ttp180 -64.15 -38.35 90.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.759 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.622 ' HB2' HG22 ' A' ' 13' ' ' ILE . 6.4 tt -71.29 -33.48 69.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.703 ' CD2' HD13 ' A' ' 23' ' ' ILE . 33.8 t80 -62.26 -65.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.115 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -51.64 -47.82 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 110.266 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 -32.29 73.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 25.9 t80 -91.73 -13.01 32.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.703 HD13 ' CD2' ' A' ' 19' ' ' PHE . 1.1 mp -114.98 -71.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.192 -0.942 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.576 ' N ' HG22 ' A' ' 23' ' ' ILE . 8.1 mt -62.22 -34.2 76.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.845 . . . . 0.0 110.766 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.4 m-20 -118.0 23.8 11.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.156 -0.965 . . . . 0.0 110.444 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.56 -38.22 33.19 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.506 ' O ' HG11 ' A' ' 41' ' ' VAL . 1.9 p30 -56.49 -30.57 63.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -1.152 . . . . 0.0 110.408 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 25' ' ' ASP . 4.9 p-10 -96.02 -18.81 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 tp -82.21 -39.75 22.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 110.341 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.588 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -53.05 -62.04 3.99 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.224 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.8 Cg_endo -73.27 54.89 2.88 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.813 1.428 . . . . 0.0 110.476 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.7 -67.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 110.564 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.14 -15.88 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.512 -0.742 . . . . 0.0 110.449 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.25 76.87 4.5 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.346 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.0 -2.19 11.64 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.044 1.549 . . . . 0.0 110.214 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -72.72 -28.31 62.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.117 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.624 ' CB ' HD11 ' A' ' 143' ' ' LEU . . . -86.42 -61.66 1.69 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.961 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.586 HD13 ' CG ' ' A' ' 30' ' ' PHE . 1.2 mp -105.8 128.91 59.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.402 -0.811 . . . . 0.0 109.699 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -91.33 -25.3 19.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.18 -0.95 . . . . 0.0 110.485 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.39 141.02 0.68 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.693 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.641 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.1 p -127.47 139.88 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mm-40 -142.23 158.74 43.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.973 . . . . 0.0 110.824 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -103.87 115.73 31.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.465 -0.772 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.436 HD11 ' HG3' ' A' ' 68' ' ' LYS . 10.0 mt -81.23 -39.01 17.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.811 ' OE1' HD12 ' A' ' 53' ' ' ILE . 2.8 tp10 -99.13 -157.77 0.63 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.708 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.25 61.51 0.26 Allowed Glycine 0 N--CA 1.482 1.715 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.475 ' H ' HG23 ' A' ' 52' ' ' THR . 0.6 OUTLIER -120.82 -23.33 5.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -1.12 . . . . 0.0 109.845 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 48.13 89.26 0.01 OUTLIER Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . 151.48 -158.87 27.96 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.7 Cg_endo -72.32 89.34 0.81 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.6 -3.03 3.17 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.189 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.735 ' HB ' HG21 ' A' ' 71' ' ' VAL . 33.5 m -78.48 161.34 27.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.957 -1.319 . . . . 0.0 109.697 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.811 HD12 ' OE1' ' A' ' 45' ' ' GLU . 14.0 mt -130.9 144.91 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.911 -1.118 . . . . 0.0 110.619 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -152.47 144.45 23.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.778 . . . . 0.0 109.784 179.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -93.52 117.45 30.1 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.434 -0.791 . . . . 0.0 110.757 -179.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.641 ' CD1' HG23 ' A' ' 41' ' ' VAL . 16.5 mm -102.73 141.76 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -112.19 142.72 44.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.048 -1.032 . . . . 0.0 110.437 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 14.2 m-85 -118.2 123.2 29.61 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 49.3 Cg_endo -76.6 126.67 9.1 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.855 1.45 . . . . 0.0 110.383 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.655 ' CB ' ' CZ ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -172.99 -145.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.052 -1.03 . . . . 0.0 110.396 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -130.28 -19.58 1.36 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.496 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.655 ' CZ ' ' CB ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -45.25 170.89 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.812 -1.405 . . . . 0.0 110.544 -179.557 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 43.8 Cg_endo -71.79 -33.63 9.92 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.59 1.31 . . . . 0.0 109.133 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 32.6 m-85 -84.21 -163.99 0.87 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.596 -0.69 . . . . 0.0 109.209 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.561 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 3.5 ttmt -168.39 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.712 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.456 ' C ' HG12 ' A' ' 67' ' ' VAL . 40.6 p90 -92.04 -165.74 1.41 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.855 0.836 . . . . 0.0 111.172 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.556 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -173.91 172.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.569 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -107.95 128.68 54.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 110.161 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' A' ' 85' ' ' VAL . 17.0 m-20 -127.19 130.67 50.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' SER . 2.4 ttp180 -101.15 145.26 29.02 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.351 -0.843 . . . . 0.0 108.935 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.735 HG21 ' HB ' ' A' ' 52' ' ' THR . 9.7 t -67.9 149.79 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.965 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t70 -101.33 -68.95 0.79 Allowed 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 121.403 0.621 . . . . 0.0 110.386 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.1 tt0 -145.8 121.94 10.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 110.339 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.683 HG22 ' HD1' ' A' ' 81' ' ' TYR . 3.7 t -108.91 151.6 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.191 -0.943 . . . . 0.0 109.723 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 1.2 m-20 -152.08 113.77 4.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -88.89 2.13 54.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.387 -0.821 . . . . 0.0 110.144 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -117.43 -40.84 3.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.692 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.1 11.77 28.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.219 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.547 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 23.2 m-30 50.35 57.79 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.547 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 3.8 mtpt -129.61 126.27 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.683 ' HD1' HG22 ' A' ' 74' ' ' VAL . 16.4 t80 -143.63 106.62 4.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 83' ' ' TYR . 62.7 t-20 -117.0 165.99 12.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.631 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.3 p90 -161.17 137.76 8.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.818 . . . . 0.0 109.467 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' ARG . 69.8 m -106.85 168.53 9.13 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.581 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' A' ' 69' ' ' ASP . 39.8 t -106.58 127.87 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -114.8 -70.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 111.879 -178.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.569 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -90.48 98.09 11.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.492 -1.38 . . . . 0.0 110.147 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -111.33 141.53 16.58 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.03 -58.7 3.63 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.0 Cg_endo -74.06 -31.46 7.88 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.986 1.519 . . . . 0.0 110.461 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 91' ' ' ILE . 54.0 mt -67.66 145.61 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.306 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.11 -92.21 2.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.58 -72.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 81.9 p -132.06 15.11 4.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.875 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.47 146.67 23.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 110.315 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 62.33 33.05 16.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.972 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -79.08 149.66 32.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.519 HG12 ' CE1' ' A' ' 120' ' ' TYR . 11.0 mt -127.69 153.93 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.816 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.3 m -145.64 105.39 3.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.489 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 7.7 m120 -101.19 124.4 46.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.147 -0.971 . . . . 0.0 110.889 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.531 ' HG3' ' ND2' ' A' ' 82' ' ' ASN . 1.9 tt0 -106.71 152.41 23.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.545 -0.722 . . . . 0.0 109.776 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.442 HG13 ' C ' ' A' ' 101' ' ' GLU . 13.5 mt -137.6 144.44 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.206 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.711 ' O ' HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -143.98 132.42 22.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 103' ' ' LYS . 7.3 mm -119.94 119.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.913 . . . . 0.0 109.908 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' A' ' 112' ' ' SER . 14.4 t -133.49 126.15 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 110.918 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -72.96 158.17 35.99 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.149 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.771 HG23 ' HD3' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -137.37 -61.15 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.026 -1.046 . . . . 0.0 111.22 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.771 ' HD3' HG23 ' A' ' 107' ' ' THR . 51.1 Cg_endo -82.88 41.09 1.04 Allowed 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 122.775 0.882 . . . . 0.0 110.781 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 108' ' ' PRO . 5.1 t70 42.19 31.48 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.033 -1.042 . . . . 0.0 110.396 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.15 -37.54 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 12' ' ' VAL . . . -115.64 -166.91 14.97 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 13.7 t -159.99 -178.86 7.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 111.274 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.892 ' CD1' HG22 ' A' ' 10' ' ' THR . 39.1 mm -130.0 117.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.48 ' CD1' ' OG ' ' A' ' 11' ' ' SER . 3.4 mp -87.2 121.12 29.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.966 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -104.34 106.83 17.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.662 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 116' ' ' ILE . 1.2 tt -105.63 132.17 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.931 . . . . 0.0 110.565 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 40.7 t -121.1 115.18 22.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 5' ' ' TYR . 2.1 t-20 -99.25 134.71 41.71 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 134.3 50.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.519 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -116.75 131.93 56.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.307 -0.87 . . . . 0.0 109.998 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 86.9 m-70 -116.25 101.51 8.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.038 . . . . 0.0 110.29 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.28 167.15 11.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.201 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 124' ' ' GLY . 4.1 ttmt -104.64 164.54 11.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 110.367 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -44.71 -40.1 6.42 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.5 -74.42 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -1.164 . . . . 0.0 110.157 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 30.2 m170 -67.67 178.92 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.257 -0.902 . . . . 0.0 110.298 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 126' ' ' HIS . 55.0 mt-10 -156.61 -170.07 3.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.205 -0.934 . . . . 0.0 110.438 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.1 t -132.09 103.43 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 110.092 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -75.95 139.91 41.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -0.996 . . . . 0.0 109.496 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 134' ' ' LYS . . . -61.76 -10.17 8.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.989 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.42 -52.88 41.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.875 -1.141 . . . . 0.0 109.878 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -28.91 68.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 108.881 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.683 HG11 ' CE2' ' A' ' 5' ' ' TYR . 22.1 t -76.98 -49.97 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.5 -0.75 . . . . 0.0 109.12 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 130' ' ' ALA . 15.6 tptt -66.58 -27.33 67.64 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.846 -0.741 . . . . 0.0 109.722 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.96 -33.47 63.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.762 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.6 t -67.07 -34.69 78.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.106 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -29.57 66.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.24 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.23 -66.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -17.91 62.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.43 -41.12 86.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.621 ' HA ' HD23 ' A' ' 144' ' ' LEU . 1.8 tt0 -67.62 -42.2 82.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -1.165 . . . . 0.0 110.109 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -61.47 -29.01 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.052 -1.03 . . . . 0.0 109.495 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.624 HD11 ' CB ' ' A' ' 37' ' ' ALA . 18.1 mt -68.85 -54.5 15.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.409 -0.807 . . . . 0.0 109.908 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 9' ' ' THR . 1.1 pp -61.48 -29.43 69.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.495 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.499 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -72.86 -34.05 66.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.429 -0.794 . . . . 0.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.56 -43.21 90.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.386 -0.821 . . . . 0.0 109.989 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.98 -40.86 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.609 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 2.8 tt0 -54.66 -48.9 71.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.842 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t -59.53 -50.36 74.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 154' ' ' HIS . 1.6 t80 -47.18 -70.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.66 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.7 HD13 HG21 ' A' ' 13' ' ' ILE . 8.5 mt -47.59 -45.17 27.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -0.852 . . . . 0.0 110.388 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -50.92 -46.25 60.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 110.277 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -89.58 -15.75 32.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 0.0 110.241 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -89.58 -1.95 58.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.952 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.76 55.37 1.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.315 -0.866 . . . . 0.0 110.406 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -93.2 -32.98 14.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.301 -0.874 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.99 -30.79 70.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -65.03 -9.6 23.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.0 110.181 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.215 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.786 HG11 ' ND1' ' A' ' 121' ' ' HIS . 13.1 m -126.41 -165.84 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -1.099 . . . . 0.0 110.531 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . 31.9 m-85 -117.62 141.58 48.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.996 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.6 141.14 46.72 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.022 . . . . 0.0 110.258 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' CE1' HG11 ' A' ' 133' ' ' VAL . 42.8 m-85 -147.16 55.63 1.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.725 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -80.67 148.85 30.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.787 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.61 -0.681 . . . . 0.0 109.78 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.81 158.03 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 110.736 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 -171.4 3.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.586 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.81 162.16 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.407 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 20.1 m -159.2 143.36 15.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 0.0 109.936 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.607 HG13 HD12 ' A' ' 13' ' ' ILE . 7.2 p -79.94 -12.85 13.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.618 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.69 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.2 mp -69.95 149.28 96.42 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.2 Cg_endo -66.28 149.59 85.09 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.437 1.23 . . . . 0.0 111.157 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.821 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.63 -25.91 59.54 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.53 -53.53 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.918 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -66.1 -34.2 77.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.8 179.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.605 ' HB2' HG22 ' A' ' 13' ' ' ILE . 7.0 tt -74.95 -30.99 61.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.615 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.599 ' CE1' HG13 ' A' ' 23' ' ' ILE . 59.3 t80 -67.92 -71.82 0.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.995 ' HG2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -50.45 -42.68 54.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.853 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . . . -66.21 -36.16 82.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.493 -0.754 . . . . 0.0 110.294 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 25.8 t80 -91.98 -10.93 37.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.599 HG13 ' CE1' ' A' ' 19' ' ' PHE . 7.7 mm -100.35 -74.51 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.211 -0.931 . . . . 0.0 110.157 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.995 HD12 ' HG2' ' A' ' 20' ' ' LYS . 19.8 mt -68.0 -40.99 82.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.44 -0.788 . . . . 0.0 109.796 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -85.39 -18.79 32.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.439 -0.788 . . . . 0.0 110.026 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.52 -40.43 62.19 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.79 ' O ' HG21 ' A' ' 41' ' ' VAL . 9.5 m-20 -55.74 -26.04 43.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -1.157 . . . . 0.0 110.11 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 67.6 m-20 -109.19 -23.32 11.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.591 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.6 mp -85.33 -28.48 25.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.219 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.564 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.6 m-30 -54.2 -59.79 9.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.6 Cg_endo -73.41 0.19 8.38 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.99 1.521 . . . . 0.0 110.556 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -96.25 -69.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.685 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 29' ' ' LEU . 25.2 m -81.81 7.27 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 110.396 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.16 2.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 110.325 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.33 -2.03 11.49 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.979 1.515 . . . . 0.0 110.653 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -90.62 -3.49 57.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.274 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' HD3' ' A' ' 59' ' ' PRO . . . -110.88 -71.56 0.76 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 110.118 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp -99.13 138.59 23.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.453 -0.78 . . . . 0.0 110.162 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 1.2 t -81.57 -48.82 11.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -163.65 176.75 9.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.09 -1.006 . . . . 0.0 110.296 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.79 HG21 ' O ' ' A' ' 27' ' ' ASP . 2.6 m -135.45 147.15 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 1.1 tt0 -136.44 161.29 36.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.84 110.16 20.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.937 HD11 ' HB2' ' A' ' 55' ' ' LYS . 15.5 mm -82.04 -39.45 16.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-O 122.231 1.015 . . . . 0.0 108.414 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . 2.0 tm-20 -105.77 -159.71 0.72 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.166 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.73 59.77 0.33 Allowed Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.467 ' H ' HG23 ' A' ' 52' ' ' THR . 0.7 OUTLIER -123.53 -19.26 5.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -1.182 . . . . 0.0 110.272 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.529 ' N ' ' OG1' ' A' ' 52' ' ' THR . . . 45.12 70.98 0.54 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . 164.11 -159.12 31.9 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.28 94.84 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.876 1.461 . . . . 0.0 110.221 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.38 -6.92 4.64 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.758 ' HB ' HG21 ' A' ' 71' ' ' VAL . 38.1 m -80.25 162.74 24.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -1.112 . . . . 0.0 109.53 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 31.5 mt -137.41 143.43 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.099 -1.001 . . . . 0.0 110.37 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.632 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -148.79 142.7 25.76 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.267 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 44' ' ' ILE . 25.0 tttp -91.77 117.24 29.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.532 -0.73 . . . . 0.0 110.197 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.687 ' CD1' HG12 ' A' ' 41' ' ' VAL . 39.7 mm -97.15 119.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.244 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 39' ' ' SER . 3.7 m -82.54 130.68 35.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.869 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 2.3 m-85 -108.24 163.63 16.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 110.617 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 45.2 Cg_endo -74.18 -165.87 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.238 1.652 . . . . 0.0 110.726 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.52 155.8 21.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.892 . . . . 0.0 110.828 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.74 -93.3 0.13 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.541 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 6.5 p90 -64.51 168.99 5.6 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.363 -1.081 . . . . 0.0 109.85 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 38.8 Cg_endo -64.13 -26.52 65.2 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.54 1.284 . . . . 0.0 110.305 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -81.82 179.37 7.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.185 178.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 22.6 mttt -129.32 -73.32 0.57 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.108 -0.995 . . . . 0.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.466 ' C ' HG13 ' A' ' 67' ' ' VAL . 8.3 p90 -92.06 177.77 6.07 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.765 0.793 . . . . 0.0 111.057 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.466 HG13 ' C ' ' A' ' 66' ' ' TYR . 29.2 m -152.21 150.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HB2' ' CB ' ' A' ' 87' ' ' GLU . 11.6 mtmt -110.48 139.91 45.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.95 -1.094 . . . . 0.0 110.305 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 54' ' ' LYS . 20.2 p-10 -134.73 133.58 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 110.276 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 84' ' ' SER . 7.4 ttt180 -100.07 139.65 35.43 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.758 HG21 ' HB ' ' A' ' 52' ' ' THR . 14.1 t -61.31 153.92 5.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.541 -1.349 . . . . 0.0 111.039 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 18.4 t0 -106.32 -73.6 0.68 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.874 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -141.31 112.63 7.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.385 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.552 HG22 ' CE2' ' A' ' 81' ' ' TYR . 2.6 t -102.89 141.5 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' LYS . 16.8 t0 -142.63 120.55 12.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.64 1.33 57.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 110.383 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.6 m -115.39 -35.63 4.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.089 -1.007 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -102.14 20.81 15.97 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.488 -0.758 . . . . 0.0 110.503 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.8 m-30 43.21 56.72 4.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 75' ' ' ASP . 25.7 tttt -125.99 123.16 37.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -142.48 105.09 4.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.087 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 101' ' ' GLU . 47.3 m-20 -121.0 144.01 48.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 110.185 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 31.1 p90 -135.49 137.37 42.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.848 . . . . 0.0 109.379 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 70' ' ' ARG . 19.5 m -94.66 161.66 14.1 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 110.977 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.515 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 25.2 t -102.69 128.22 55.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -119.33 -74.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.06 -1.025 . . . . 0.0 111.349 -178.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.546 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -92.11 64.84 4.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.638 -1.289 . . . . 0.0 109.881 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . -131.77 159.67 23.3 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 44.98 -157.08 0.24 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.83 1.57 6.9 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.024 1.539 . . . . 0.0 110.782 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.542 HD11 HD13 ' A' ' 98' ' ' ILE . 75.9 mt -51.63 155.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.016 -1.052 . . . . 0.0 110.321 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.1 -107.08 0.24 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.45 ' C ' HG23 ' A' ' 94' ' ' THR . 18.4 m-20 -47.7 -86.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -1.132 . . . . 0.0 109.933 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.45 HG23 ' C ' ' A' ' 93' ' ' ASP . 30.6 p -148.23 12.34 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 110.308 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -92.82 157.85 16.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 110.239 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 121' ' ' HIS . 1.4 mm-40 59.51 33.04 22.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.902 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.522 ' C ' HD12 ' A' ' 98' ' ' ILE . 1.2 ttpm? -76.55 159.36 30.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.622 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 3.8 mp -142.02 127.59 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.875 . . . . 0.0 110.228 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t -116.42 112.9 22.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.603 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -99.24 136.62 38.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 110.495 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 90.2 mt-10 -125.97 144.28 50.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.794 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.4 mt -136.08 113.6 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.352 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.45 124.66 48.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -0.847 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.692 HG22 ' HB1' ' A' ' 15' ' ' ALA . 3.2 mt -118.2 127.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.0 t -132.56 141.59 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -87.93 144.45 26.55 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.393 0.616 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 111' ' ' GLY . 4.4 p -79.91 -165.01 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.588 ' CD ' ' HB ' ' A' ' 107' ' ' THR . 46.3 Cg_endo -80.94 -23.67 5.32 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.187 1.098 . . . . 0.0 110.956 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.33 31.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.105 -0.997 . . . . 0.0 110.242 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -141.78 42.72 1.13 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.314 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 107' ' ' THR . . . 88.69 -153.46 23.98 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.52 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -133.6 163.59 29.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.813 -0.816 . . . . 0.0 110.671 -179.3 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 113' ' ' ILE . 29.3 mt -108.32 131.6 58.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.42 -0.8 . . . . 0.0 109.022 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -106.01 135.29 47.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.937 -1.102 . . . . 0.0 110.504 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.45 111.12 11.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' THR . 3.2 mt -102.84 125.61 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 110.587 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.535 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -109.55 119.39 39.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.807 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.426 HD21 HG23 ' A' ' 98' ' ' ILE . 2.3 t-20 -118.26 141.66 48.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.319 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 1.3 mtpp -124.9 151.73 44.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 109.993 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.622 ' CE1' ' CG1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -130.26 99.8 5.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.925 . . . . 0.0 109.759 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.786 ' ND1' HG11 ' A' ' 2' ' ' VAL . 14.7 m-70 -86.01 105.83 16.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.804 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.642 HG21 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -113.02 172.94 6.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 8.1 tttt -108.42 154.03 22.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.866 . . . . 0.0 110.386 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -43.95 -47.59 7.87 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -54.07 -61.87 2.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -1.177 . . . . 0.0 110.466 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.465 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 68.4 m-70 -83.06 176.75 8.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.909 . . . . 0.0 110.631 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 126' ' ' HIS . 3.4 mt-10 -146.36 -171.18 3.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.793 . . . . 0.0 109.682 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -122.36 89.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.442 ' O ' HG23 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -60.18 132.03 52.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.615 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . . . -54.9 -16.84 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.018 . . . . 0.0 110.632 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.22 -59.01 5.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.898 -1.126 . . . . 0.0 109.495 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -63.59 -30.2 71.34 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 109.061 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG11 ' CE1' ' A' ' 5' ' ' TYR . 16.1 t -71.74 -47.25 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 8.3 ttpp -65.07 -30.67 71.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.773 . . . . 0.0 110.048 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.44 -19.94 61.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.0 t -72.43 -43.47 63.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 110.092 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 138' ' ' GLU . 21.9 ptmt -79.91 -37.71 34.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 137' ' ' LYS . 6.5 tt0 -51.8 -57.58 8.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.136 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.09 -25.94 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -60.44 -46.49 94.25 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -62.26 -44.11 97.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.26 -1.141 . . . . 0.0 110.453 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.6 m -62.67 -22.82 66.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.003 -1.06 . . . . 0.0 109.775 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 143' ' ' LEU . 19.6 mt -74.32 -52.66 11.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 110.041 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.2 pp -67.64 -27.32 66.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.602 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 27.0 mmt180 -77.17 -29.26 54.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.878 . . . . 0.0 109.492 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 150' ' ' TYR . . . -67.41 -49.64 62.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 22' ' ' PHE . 92.9 t -62.3 -41.55 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.694 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -63.38 -50.67 69.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.678 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -67.33 -16.78 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.676 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.46 ' CD2' ' HG ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -83.53 -38.45 21.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.6 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 13' ' ' ILE . 8.7 mt -68.72 -55.29 11.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 110.285 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.63 -27.31 1.83 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.936 . . . . 0.0 109.994 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.25 22.28 8.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 110.018 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 151' ' ' LEU . 40.8 t-80 -94.01 -59.0 2.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.0 110.362 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.5 m -145.64 40.94 1.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.957 . . . . 0.0 110.266 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -138.68 -48.06 0.51 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.939 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.68 -63.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 110.124 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 60.72 35.93 19.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 110.105 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.284 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.33 138.81 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -1.125 . . . . 0.0 110.127 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.488 ' CD2' ' HB ' ' A' ' 128' ' ' VAL . 1.2 m-85 -91.4 164.27 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.451 -0.781 . . . . 0.0 109.601 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -143.95 143.56 31.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CD2' HG11 ' A' ' 133' ' ' VAL . 68.2 m-85 -155.49 65.83 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.587 -0.695 . . . . 0.0 109.291 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 1.8 pp20? -85.15 153.1 22.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 110.888 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -146.43 176.45 9.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.972 179.649 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 2.0 pt-20 -158.44 149.38 20.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.127 -0.983 . . . . 0.0 110.483 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.4 -170.04 2.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -125.95 168.37 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.442 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -158.81 138.26 11.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.553 -0.717 . . . . 0.0 109.595 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 HD12 ' A' ' 13' ' ' ILE . 4.0 p -79.89 -14.15 13.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.559 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.836 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.0 OUTLIER -72.39 152.16 92.03 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -65.73 150.3 86.27 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 123.505 1.266 . . . . 0.0 111.132 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.25 -22.07 59.49 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.642 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.24 -57.31 3.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.03 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt-85 -60.38 -29.49 68.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.571 ' CD2' HD11 ' A' ' 114' ' ' LEU . 4.3 tp -74.28 -42.19 59.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE2' HD13 ' A' ' 23' ' ' ILE . 42.4 t80 -59.52 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.875 . . . . 0.0 110.166 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.0 ttpt -53.49 -45.29 69.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.248 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.556 ' O ' HD22 ' A' ' 29' ' ' LEU . . . -70.83 -28.6 64.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.868 . . . . 0.0 110.588 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 42.1 t80 -92.03 -17.55 24.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.915 . . . . 0.0 110.486 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.62 HD13 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -117.64 -63.55 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.497 ' HA ' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -48.14 -47.89 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 110.265 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.1 m-20 -107.15 -12.03 15.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 30' ' ' PHE . . . -41.8 -30.49 0.64 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.63 -59.49 4.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.196 -1.179 . . . . 0.0 110.048 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -87.89 -17.26 31.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.689 ' O ' HG22 ' A' ' 33' ' ' VAL . 2.1 tp -75.72 -45.39 36.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 110.131 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.528 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.6 m-85 -43.46 -57.72 5.21 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 110.457 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.2 Cg_endo -70.05 -8.91 24.77 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.914 1.481 . . . . 0.0 110.608 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 6.0 ttmm -95.57 -46.2 6.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 29' ' ' LEU . 28.0 m -91.91 -8.11 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.381 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.09 81.05 3.35 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.217 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.82 -6.32 18.43 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 123.975 1.513 . . . . 0.0 110.298 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -89.18 -18.43 27.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.269 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.813 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -97.39 -71.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 30' ' ' PHE . 1.1 mp -99.69 152.58 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.368 -0.833 . . . . 0.0 109.546 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.39 -33.15 5.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.537 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.07 146.79 6.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.089 -1.007 . . . . 0.0 110.596 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.995 HG13 ' CD1' ' A' ' 56' ' ' ILE . 47.5 t -133.5 139.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 110.059 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 84.6 tt0 -152.48 158.74 43.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.441 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -104.49 117.88 35.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 110.377 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.74 HD11 ' HB2' ' A' ' 55' ' ' LYS . 21.6 mm -83.16 -38.23 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 122.301 1.048 . . . . 0.0 108.335 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.563 ' HG3' ' N ' ' A' ' 46' ' ' GLY . 25.3 tp10 -148.25 173.55 12.9 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.099 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.563 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 63.41 169.62 1.35 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -116.25 37.34 3.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -1.149 . . . . 0.0 110.09 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.06 37.52 9.95 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -111.42 -168.62 18.64 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.48 100.86 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.858 1.452 . . . . 0.0 110.243 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 111.39 1.32 27.91 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.643 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.1 m -61.12 155.81 19.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -1.117 . . . . 0.0 109.5 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 11.7 mm -112.94 133.14 59.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.943 . . . . 0.0 109.775 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.837 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -145.34 144.5 30.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.102 -0.999 . . . . 0.0 110.285 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.74 ' HB2' HD11 ' A' ' 44' ' ' ILE . 5.6 tttm -92.83 112.67 24.7 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.619 -0.676 . . . . 0.0 110.608 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.995 ' CD1' HG13 ' A' ' 41' ' ' VAL . 38.8 mm -103.85 138.77 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 109.347 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.45 141.67 47.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 110.757 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.459 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 1.9 m-85 -116.67 135.03 22.85 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.94 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo -75.4 135.4 18.32 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.93 1.49 . . . . 0.0 110.784 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 51.53 178.06 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 0.0 110.682 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 104.09 79.67 1.35 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.676 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 42.27 -164.43 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.367 -1.078 . . . . 0.0 109.686 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.676 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 45.4 Cg_endo -80.37 -32.38 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.228 1.12 . . . . 0.0 110.285 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 21.8 p90 -90.56 128.51 36.59 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.228 -0.92 . . . . 0.0 109.956 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 58' ' ' PHE . 1.5 pttp -161.6 -41.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 110.392 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.674 ' C ' HG12 ' A' ' 67' ' ' VAL . 6.7 p90 -80.73 -175.33 5.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 110.085 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.747 HG21 HG13 ' A' ' 85' ' ' VAL . 0.8 OUTLIER 168.81 171.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.367 -0.833 . . . . 0.0 110.586 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.572 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -106.03 54.36 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.642 -0.662 . . . . 0.0 109.938 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD1' HG13 ' A' ' 67' ' ' VAL . 5.2 m-20 -41.83 129.41 3.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.338 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -98.14 150.65 21.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 108.896 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.643 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -81.03 144.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.71 -1.243 . . . . 0.0 110.219 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 36.3 t0 -98.42 -71.0 0.7 Allowed 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.367 0.603 . . . . 0.0 110.004 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -143.84 113.01 6.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 0.0 110.047 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 4.9 t -104.17 136.21 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.267 -0.896 . . . . 0.0 109.932 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 74' ' ' VAL . 83.4 m-20 -141.07 113.03 7.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -82.51 -3.02 55.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.246 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -110.42 -36.68 5.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.201 -0.937 . . . . 0.0 109.653 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.39 15.24 20.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 110.365 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.598 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 m-30 45.86 51.97 10.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 110.34 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -129.21 124.54 34.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.973 -1.079 . . . . 0.0 110.751 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' CD2' HG12 ' A' ' 23' ' ' ILE . 2.2 t80 -139.44 101.6 4.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.421 -0.799 . . . . 0.0 109.861 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.516 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 74.0 m-20 -113.87 136.04 53.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 44.0 p90 -134.71 133.04 39.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.582 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' ARG . 68.3 m -99.41 170.58 8.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 111.433 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.747 HG13 HG21 ' A' ' 67' ' ' VAL . 48.9 t -106.71 131.27 56.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.39 -79.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.936 -1.103 . . . . 0.0 110.899 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 68' ' ' LYS . 1.1 tt0 -91.87 106.52 18.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.941 -1.099 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 67' ' ' VAL . . . 164.13 175.74 35.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 64' ' ' PHE . . . 47.27 -159.81 0.41 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.92 -7.76 21.7 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.135 1.597 . . . . 0.0 110.691 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' CD1' HG12 ' A' ' 85' ' ' VAL . 47.7 mt -51.55 154.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.022 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.35 -58.1 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -121.33 -69.2 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.252 . . . . 0.0 110.645 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 t -147.31 9.14 0.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 0.0 110.748 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -92.7 155.74 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 0.0 110.091 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.431 ' HB2' HD12 ' A' ' 95' ' ' LEU . 1.9 mt-10 57.84 36.33 26.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -78.82 159.35 27.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -0.75 . . . . 0.0 110.408 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.498 HG13 ' CD1' ' A' ' 120' ' ' TYR . 2.3 mt -139.82 137.69 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 0.0 110.528 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 m -123.46 112.72 17.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.33 -0.856 . . . . 0.0 109.661 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.56 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 13.7 m120 -99.39 130.03 45.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.516 ' HG2' ' ND2' ' A' ' 82' ' ' ASN . 2.6 mt-10 -123.76 139.74 53.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.852 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.604 HG23 HG12 ' A' ' 116' ' ' ILE . 16.9 mt -135.59 114.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.369 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -114.53 124.22 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.862 . . . . 0.0 109.878 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.3 mp -111.92 134.79 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.416 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.9 t -140.58 137.94 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 0.0 110.417 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.67 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.0 146.62 25.41 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.78 -0.575 . . . . 0.0 110.968 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.593 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.5 p -84.92 -164.9 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.352 -0.843 . . . . 0.0 108.957 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 46.1 Cg_endo -80.05 70.12 7.65 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.267 1.14 . . . . 0.0 110.247 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 0.7 OUTLIER 67.66 33.85 4.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.19 38.64 1.68 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 107' ' ' THR . . . 91.67 -161.91 27.49 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.817 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -137.34 166.38 23.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.477 -1.013 . . . . 0.0 111.13 -179.087 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.5 mt -118.86 126.0 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 109.103 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -97.12 146.08 25.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 0.0 110.863 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 13.4 mttt -141.58 109.97 5.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.525 -0.734 . . . . 0.0 109.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.604 HG12 HG23 ' A' ' 102' ' ' ILE . 19.0 mt -105.92 135.45 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.134 -0.979 . . . . 0.0 110.6 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.509 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -116.7 115.78 26.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 110.129 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -103.88 126.1 50.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.392 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -115.5 130.14 56.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.316 -0.865 . . . . 0.0 109.959 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.498 ' CD1' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -116.72 117.21 29.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.02 -1.05 . . . . 0.0 110.453 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.424 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 25.3 m-70 -94.26 130.64 40.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.246 -0.909 . . . . 0.0 110.265 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.629 HG23 HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -114.96 169.24 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 110.088 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' ASP . 0.7 OUTLIER -101.39 63.99 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 48.45 -91.32 0.01 OUTLIER Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -40.34 -55.55 2.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -1.104 . . . . 0.0 110.576 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.471 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 77.2 m-70 -66.29 176.8 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 0.0 110.435 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.514 ' HA ' HG21 ' A' ' 122' ' ' THR . 72.1 mt-10 -154.44 -171.93 4.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 110.17 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.629 HG23 HG23 ' A' ' 122' ' ' THR . 2.3 t -121.14 116.11 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 133' ' ' VAL . 11.0 mttt -80.16 132.4 35.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.731 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -49.96 -48.41 52.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 110.913 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.9 mt-10 -36.98 -55.97 0.9 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 110.907 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.48 77.05 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.618 HG11 ' CD2' ' A' ' 5' ' ' TYR . 7.2 t -74.68 -48.3 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 109.315 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 130' ' ' ALA . 14.2 tptt -67.42 -30.22 69.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.531 -0.73 . . . . 0.0 109.824 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.54 60.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -35.1 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.449 -0.782 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -79.74 -23.93 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.85 . . . . 0.0 110.23 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -53.86 -52.81 59.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 4.6 mt -75.15 -28.75 60.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.468 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.666 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -55.49 -46.57 80.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.639 ' HA ' HD23 ' A' ' 144' ' ' LEU . 33.5 tt0 -56.34 -52.53 64.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.152 -1.205 . . . . 0.0 110.283 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 22.3 m -57.61 -28.86 64.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.201 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 37' ' ' ALA . 84.7 mt -69.48 -46.08 67.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 110.358 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.1 pp -68.77 -26.13 65.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.022 -1.049 . . . . 0.0 109.779 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.463 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -81.93 -41.0 21.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -56.1 -50.37 71.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.37 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 t -62.4 -48.84 86.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.475 -0.765 . . . . 0.0 108.954 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 36.5 tt0 -53.03 -46.83 68.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.8 t -67.43 -51.27 53.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.423 ' CE1' HG12 ' A' ' 33' ' ' VAL . 1.8 t80 -44.9 -69.38 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.809 . . . . 0.0 110.392 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 151' ' ' LEU . 29.9 mt -49.17 -37.1 21.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.503 -0.748 . . . . 0.0 110.629 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 1.2 mt -77.1 -18.84 57.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.048 -1.033 . . . . 0.0 110.373 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.56 -12.35 17.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.935 . . . . 0.0 110.071 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.432 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 17.8 t60 -119.69 102.54 8.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 110.205 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 40.8 t -115.07 3.54 14.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.246 -0.909 . . . . 0.0 110.563 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.06 -70.42 0.15 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.487 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.39 -162.33 1.31 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.602 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -85.04 8.42 17.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -0.842 . . . . 0.0 110.312 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.998 HG23 ' C ' ' A' ' 120' ' ' TYR . 9.3 p -176.44 154.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -1.16 . . . . 0.0 110.466 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.89 -178.93 3.86 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.67 138.39 34.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.861 -1.149 . . . . 0.0 111.018 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.526 ' CD1' HG11 ' A' ' 133' ' ' VAL . 65.0 m-85 -144.44 54.83 1.27 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 9.0 pt-20 -80.1 152.55 29.24 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.543 0.687 . . . . 0.0 110.962 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.74 172.72 13.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -157.84 153.54 26.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.03 -169.14 3.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 110.12 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -132.14 167.64 19.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.349 -0.845 . . . . 0.0 110.391 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.899 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 17.3 t -79.92 -17.25 12.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.712 HG21 HD13 ' A' ' 151' ' ' LEU . 17.8 mm -70.42 149.31 95.71 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' A' ' 13' ' ' ILE . 37.6 Cg_endo -65.72 146.75 84.68 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.143 1.075 . . . . 0.0 111.053 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.836 ' HB2' ' CB ' ' A' ' 112' ' ' SER . . . -71.86 -30.13 65.11 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.45 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.54 -56.85 10.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.937 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -35.15 79.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 tt -69.78 -38.31 76.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.485 -0.76 . . . . 0.0 109.418 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 41.9 t80 -62.2 -59.1 5.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.895 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -49.76 -48.42 50.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 110.314 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.84 76.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 110.6 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.2 t80 -88.43 -14.01 39.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 110.614 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' PHE . 1.3 mp -114.62 -48.9 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.95 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -72.12 -48.56 42.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.349 -0.845 . . . . 0.0 110.036 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.973 ' HB3' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -115.99 20.81 14.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.993 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.02 -58.18 14.97 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.663 ' OD1' HG11 ' A' ' 41' ' ' VAL . 21.8 m-20 -56.71 -19.08 14.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -1.174 . . . . 0.0 110.213 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.82 -37.03 10.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.9 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.034 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.9 mp -79.97 -20.84 44.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 0.0 110.163 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.52 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 1.1 m-85 -58.37 -57.03 29.33 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.552 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 48.7 Cg_endo -73.0 -13.62 26.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.054 1.555 . . . . 0.0 110.945 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.17 -43.38 11.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.989 . . . . 0.0 110.58 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.034 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.8 m -89.68 -24.76 5.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 110.315 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.36 78.84 7.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.48 -31.31 7.26 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.093 1.575 . . . . 0.0 110.63 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.37 -18.65 11.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.062 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.779 ' HA ' HD23 ' A' ' 139' ' ' LEU . . . -96.83 -48.0 5.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.221 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -123.29 146.49 28.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 109.923 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.423 ' C ' ' OG ' ' A' ' 40' ' ' SER . 1.6 t -92.56 -53.05 4.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 110.421 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.423 ' OG ' ' C ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -162.32 172.51 15.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 0.0 110.634 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.964 HG13 HG12 ' A' ' 56' ' ' ILE . 12.6 t -145.83 138.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.311 -0.868 . . . . 0.0 109.886 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.1 mt-10 -137.62 163.89 30.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.723 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.7 116.56 32.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.724 HD11 ' HB2' ' A' ' 55' ' ' LYS . 23.9 mm -83.63 -37.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.345 1.069 . . . . 0.0 108.372 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HB3' ' CG1' ' A' ' 53' ' ' ILE . 6.1 tp10 -149.61 173.24 13.86 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.059 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 61.86 173.55 1.54 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -123.37 33.71 5.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 110.257 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' H ' HG21 ' A' ' 52' ' ' THR . . . 99.0 -7.01 60.33 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.94 -172.5 26.34 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 45.4 Cg_endo -71.72 118.35 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.939 1.494 . . . . 0.0 110.249 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.75 54.68 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.703 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.4 m -68.41 154.46 41.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -1.183 . . . . 0.0 109.348 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 45' ' ' GLU . 9.3 mt -116.96 133.39 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.011 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 1.4 ptpt -143.28 147.54 34.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.661 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.724 ' HB2' HD11 ' A' ' 44' ' ' ILE . 12.7 tttp -105.35 118.27 36.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.688 -0.633 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.964 HG12 HG13 ' A' ' 41' ' ' VAL . 23.0 mt -107.26 147.83 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.082 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 m -107.25 139.49 41.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.127 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 14.7 m-85 -112.58 125.63 29.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 60' ' ' GLU . 50.1 Cg_endo -77.87 125.32 7.3 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.852 1.448 . . . . 0.0 110.557 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 1.7 tt0 171.25 -157.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.135 -0.978 . . . . 0.0 110.292 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -129.9 -8.09 3.52 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.773 -1.204 . . . . 0.0 110.351 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -44.94 171.79 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.033 -1.275 . . . . 0.0 110.551 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 62' ' ' PHE . 39.5 Cg_endo -65.11 -48.12 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.386 1.203 . . . . 0.0 110.016 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.583 ' O ' ' CD1' ' A' ' 64' ' ' PHE . 19.6 p90 -86.84 140.33 29.79 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.333 -0.855 . . . . 0.0 109.258 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -106.75 -75.67 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.996 -1.065 . . . . 0.0 110.993 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -91.7 -171.45 2.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.147 -0.971 . . . . 0.0 110.956 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.571 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -170.57 172.98 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 0.0 109.801 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.571 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -117.25 151.51 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 110.161 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 84' ' ' SER . 6.8 p-10 -148.41 135.39 20.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 110.357 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 84' ' ' SER . 14.6 ttp-105 -99.02 141.22 32.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.394 -0.816 . . . . 0.0 108.849 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.703 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.4 t -72.56 147.14 10.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.847 -1.158 . . . . 0.0 110.199 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 82' ' ' ASN . 4.7 m-20 -93.04 -70.09 0.72 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.404 0.621 . . . . 0.0 109.98 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.5 tt0 -149.91 131.28 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.388 -0.82 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.74 146.68 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 80' ' ' LYS . 35.2 m-20 -145.63 119.98 9.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -88.9 0.19 56.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -116.67 -35.96 4.05 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.75 8.74 44.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.46 -0.775 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.56 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.5 m-30 53.62 69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 5.4 tttt -136.79 133.1 35.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.377 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.437 ' HB2' HG12 ' A' ' 23' ' ' ILE . 9.7 t80 -149.86 94.58 2.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.883 . . . . 0.0 110.071 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.51 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 33.2 m-20 -116.78 145.2 43.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.568 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 36.3 p90 -146.76 137.38 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.494 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 62.2 m -98.78 170.83 8.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 111.232 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 41.5 t -108.35 127.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.96 -70.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 111.272 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -85.05 95.6 9.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.594 -1.316 . . . . 0.0 110.052 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -116.93 139.82 15.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.53 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -39.11 -57.12 2.13 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 45.2 Cg_endo -71.91 -38.34 4.17 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.922 1.485 . . . . 0.0 110.308 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' N ' ' A' ' 92' ' ' GLY . 46.5 mt -68.16 170.53 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.573 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -162.66 -77.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.92 -90.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -1.196 . . . . 0.0 110.297 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.1 t -146.94 18.39 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.2 164.76 12.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 110.105 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER 54.92 34.43 22.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.565 -179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 121' ' ' HIS . 1.1 ttmt -76.42 150.95 36.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.415 -0.803 . . . . 0.0 110.233 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.651 ' CG1' ' CE1' ' A' ' 120' ' ' TYR . 56.2 mt -128.39 132.94 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 2.1 t -119.17 102.41 8.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.579 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.568 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 3.4 m120 -87.08 135.51 33.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 52.1 mt-10 -131.45 134.6 46.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 110.095 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.542 HG22 HD11 ' A' ' 104' ' ' ILE . 12.7 mt -128.33 126.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.031 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.439 -0.788 . . . . 0.0 109.945 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.684 HG22 ' HB1' ' A' ' 15' ' ' ALA . 4.5 mp -134.45 141.09 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 110.752 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.5 t -141.9 144.16 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 109.546 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 112' ' ' SER . . . -88.06 162.7 16.64 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.395 -0.815 . . . . 0.0 111.09 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 1.5 p -108.86 -166.91 0.1 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.501 -0.749 . . . . 0.0 109.245 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 47.1 Cg_endo -80.45 70.02 7.7 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.413 1.217 . . . . 0.0 110.311 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 23.0 t0 67.32 40.87 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.39 -0.819 . . . . 0.0 110.186 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.92 40.77 1.11 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 107' ' ' THR . . . 86.54 -159.11 31.7 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.836 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -142.44 159.98 41.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.708 -0.878 . . . . 0.0 110.627 -179.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.7 tt -109.19 142.0 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.945 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.72 150.49 41.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 110.181 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.15 124.29 18.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.315 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 2.4 mt -111.19 117.67 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -102.05 111.8 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.33 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.05 123.49 47.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.121 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -116.56 151.54 35.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 110.354 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.998 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -131.6 99.72 4.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.834 . . . . 0.0 110.193 -179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.781 ' N ' HG23 ' A' ' 2' ' ' VAL . 85.5 m-70 -79.8 113.69 18.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.37 172.47 6.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.979 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -145.5 -177.03 5.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.604 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 43.25 -153.14 0.27 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.22 9.12 21.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -1.116 . . . . 0.0 110.245 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -76.68 167.74 21.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 110.131 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.461 ' HA ' HG21 ' A' ' 122' ' ' THR . 4.1 mt-10 -152.95 -168.97 3.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -0.96 . . . . 0.0 110.429 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.762 HG21 ' CG ' ' A' ' 120' ' ' TYR . 2.8 t -116.08 101.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -54.75 125.19 19.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.027 -1.045 . . . . 0.0 109.501 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' VAL . . . -53.16 -48.06 68.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 110.396 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 130' ' ' ALA . 4.1 mt-10 -35.63 -55.22 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.58 -0.7 . . . . 0.0 110.661 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -42.35 92.85 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 108.998 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 5' ' ' TYR . 14.1 t -68.03 -48.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.248 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -59.86 -31.46 69.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.529 -0.732 . . . . 0.0 109.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.89 -47.72 61.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -24.08 67.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.173 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.44 -36.09 45.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.88 . . . . 0.0 110.184 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -44.67 83.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.12 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.779 HD23 ' HA ' ' A' ' 37' ' ' ALA . 3.1 mp -73.47 -31.54 63.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 110.019 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.822 ' HA2' HD12 ' A' ' 143' ' ' LEU . . . -65.72 -41.1 96.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.601 ' HA ' HD23 ' A' ' 144' ' ' LEU . 5.4 mm-40 -56.67 -37.05 70.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -1.203 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.8 m -70.15 -18.86 63.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.666 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.822 HD12 ' HA2' ' A' ' 140' ' ' GLY . 98.0 mt -77.13 -44.82 28.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 0.0 109.896 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.601 HD23 ' HA ' ' A' ' 141' ' ' GLU . 1.6 pp -66.93 -29.94 69.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.465 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 17.2 ttp180 -77.64 -36.4 51.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.765 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.12 67.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.785 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.0 t -60.23 -47.26 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.444 -0.785 . . . . 0.0 109.781 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 35.8 tt0 -51.64 -48.91 63.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 -43.67 85.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.948 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -52.03 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.159 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.712 HD13 HG21 ' A' ' 13' ' ' ILE . 35.5 mt -42.62 -51.82 5.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -48.72 -25.21 1.69 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.074 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 150' ' ' TYR . . . -105.87 1.74 27.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.33 -55.36 3.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.153 -0.967 . . . . 0.0 110.132 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.4 m -130.28 11.72 5.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 110.061 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.64 26.69 9.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -172.4 -83.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.908 . . . . 0.0 110.177 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.4 t80 52.28 84.98 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.169 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.23 -179.933 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 3.3 t 58.11 151.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -1.08 . . . . 0.0 110.333 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.413 ' CD1' ' CG1' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -106.54 161.93 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.949 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.79 139.21 50.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.942 . . . . 0.0 110.156 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.84 56.21 1.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.025 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -82.83 153.7 25.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.38 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.4 p -156.14 169.06 25.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.857 . . . . 0.0 109.814 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 15.2 pt-20 -158.8 138.37 11.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 110.619 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 t -133.15 -172.6 2.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.316 -0.865 . . . . 0.0 109.928 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -117.97 159.52 23.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 110.525 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.7 t -152.67 136.75 16.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.689 -0.632 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 27.2 m -79.96 -12.17 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.017 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.668 HG23 ' HD2' ' A' ' 14' ' ' PRO . 41.2 mm -69.86 148.4 96.39 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.668 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.0 Cg_endo -65.58 151.23 85.37 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.503 1.265 . . . . 0.0 111.007 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.68 -29.16 61.13 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.035 -178.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.6 -48.46 16.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.287 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.526 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -68.14 -37.54 81.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.994 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' HB2' HG22 ' A' ' 13' ' ' ILE . 25.7 tp -74.79 -26.24 59.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.185 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' CE1' HG13 ' A' ' 23' ' ' ILE . 75.2 t80 -69.69 -59.69 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 110.046 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -57.18 -39.95 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.387 -0.821 . . . . 0.0 110.128 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . . . -72.54 -31.99 65.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.347 -0.846 . . . . 0.0 110.546 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.444 ' CD1' HG21 ' A' ' 147' ' ' VAL . 33.8 t80 -91.9 -18.25 24.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.558 HG13 ' CE1' ' A' ' 19' ' ' PHE . 9.3 mm -104.06 -67.33 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.454 HD11 ' HE1' ' A' ' 76' ' ' HIS . 0.3 OUTLIER -72.49 -27.54 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 110.332 -179.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' OD1' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -109.38 -5.06 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.356 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.42 -56.54 24.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.98 -23.84 1.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -1.144 . . . . 0.0 110.556 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -100.37 -39.79 7.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 110.305 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 1.9 tp -71.18 -38.01 72.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.0 m-30 -48.21 -61.02 3.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 110.55 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.0 Cg_endo -71.65 -2.09 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.972 1.512 . . . . 0.0 110.715 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -104.28 -36.11 7.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 110.469 -179.756 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.754 HG22 ' HB1' ' A' ' 146' ' ' ALA . 7.2 p -96.67 -26.08 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.959 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.24 78.61 8.58 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.78 2.75 6.16 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.117 1.588 . . . . 0.0 110.964 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.05 -38.36 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 110.481 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.55 -49.4 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.229 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 mp -111.43 146.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.421 -0.799 . . . . 0.0 109.987 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.519 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -100.95 -32.3 10.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.212 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.5 168.11 2.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.601 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG13 HG12 ' A' ' 56' ' ' ILE . 4.7 t -138.51 141.27 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.598 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -144.62 110.94 5.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.067 -1.021 . . . . 0.0 110.757 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.6 116.89 5.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.214 -0.929 . . . . 0.0 110.419 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.722 HD12 HG22 ' A' ' 53' ' ' ILE . 12.3 mt -84.97 -39.64 14.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 122.172 0.987 . . . . 0.0 108.556 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 52' ' ' THR . 22.3 tt0 -145.43 174.3 11.26 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 48.16 -172.32 0.05 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -124.64 -13.57 6.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -1.144 . . . . 0.0 110.22 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 74' ' ' VAL . . . 156.86 -23.02 0.47 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' GLY . . . -52.06 -174.77 0.03 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 46.3 Cg_endo -72.83 118.04 5.39 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.026 1.54 . . . . 0.0 110.381 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 -1.65 40.88 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.694 ' HB ' HG21 ' A' ' 71' ' ' VAL . 7.0 m -67.35 154.64 40.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.071 -1.252 . . . . 0.0 109.226 179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.722 HG22 HD12 ' A' ' 44' ' ' ILE . 9.9 mt -121.97 135.87 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 110.512 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -142.38 138.71 31.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.99 179.619 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -92.43 101.08 13.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 110.574 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.507 HG12 HG13 ' A' ' 41' ' ' VAL . 22.3 mt -88.97 129.09 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.542 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.1 m -93.24 141.22 28.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.473 -179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 1.2 m-85 -112.18 131.27 22.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.863 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 39' ' ' SER . 47.3 Cg_endo -73.01 127.41 12.11 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.874 1.46 . . . . 0.0 110.663 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER 177.28 -160.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.198 179.832 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . -125.46 -30.92 0.87 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.519 ' O ' ' CD ' ' A' ' 65' ' ' LYS . 3.7 m-85 -47.16 170.98 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.203 -1.174 . . . . 0.0 110.002 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 62' ' ' PHE . 44.1 Cg_endo -72.34 -59.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.948 1.499 . . . . 0.0 110.494 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -90.37 130.53 36.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.342 -0.849 . . . . 0.0 110.157 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' CD ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -149.07 -48.93 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.148 -0.97 . . . . 0.0 110.51 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 32.8 p90 -70.71 -178.65 1.91 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 0.0 110.207 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.574 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -170.35 172.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.191 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.587 ' O ' HD11 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -121.25 62.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.477 -0.765 . . . . 0.0 110.468 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -52.97 133.08 38.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.906 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -97.81 142.86 29.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.937 . . . . 0.0 108.716 179.491 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.694 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.5 t -69.73 149.56 10.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.645 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.3 t70 -101.29 -74.42 0.62 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.434 0.635 . . . . 0.0 110.044 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 4.2 tt0 -135.39 136.13 41.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.109 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 48' ' ' GLY . 2.8 t -120.78 147.32 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -152.57 101.32 2.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.454 ' HE1' HD11 ' A' ' 24' ' ' LEU . 13.0 m-70 -75.14 -9.42 58.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 110.736 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -102.78 -34.09 9.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 108.638 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.75 11.26 39.15 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.342 0.591 . . . . 0.0 109.752 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 104' ' ' ILE . 23.4 m-30 44.36 43.85 6.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.366 -0.834 . . . . 0.0 110.191 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 5.7 tttm -118.09 114.21 22.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.267 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 8.3 t80 -131.48 109.36 10.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 6.9 m120 -112.4 145.97 39.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 110.031 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 100' ' ' ASN . 3.6 p90 -137.74 138.26 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.811 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' ARG . 7.0 m -98.82 159.58 14.86 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.177 -0.952 . . . . 0.0 110.858 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 98' ' ' ILE . 24.7 t -104.19 122.97 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.587 HD11 ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -121.92 -76.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.085 -1.009 . . . . 0.0 110.953 -178.561 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 68' ' ' LYS . 16.0 mm-40 -70.49 57.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.753 -1.217 . . . . 0.0 109.996 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 91' ' ' ILE . . . -69.54 126.8 19.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.51 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -40.83 -54.1 3.62 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.2 Cg_endo -75.99 -40.99 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.875 1.46 . . . . 0.0 110.594 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.567 HD12 ' HA3' ' A' ' 88' ' ' GLY . 36.0 mt -50.98 138.37 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.076 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.55 -94.55 1.83 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.82 -80.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 110.171 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.03 19.79 2.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 110.065 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.411 ' CB ' ' HB2' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -94.67 165.51 12.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.227 -0.92 . . . . 0.0 110.245 -179.888 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 121' ' ' HIS . 3.2 tp10 56.35 33.17 21.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 8.8 tttm -67.84 167.34 13.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.564 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.1 mt -143.93 127.86 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.42 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.48 ' HB3' ' CB ' ' A' ' 119' ' ' LYS . 12.9 t -115.1 112.31 22.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.599 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -105.85 152.39 23.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.873 -179.373 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.513 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 30.9 mt-10 -145.24 129.27 17.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.785 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.823 ' CD1' HG23 ' A' ' 116' ' ' ILE . 19.5 mm -122.26 128.95 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.03 -1.044 . . . . 0.0 110.384 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 4.9 tttt -129.63 117.24 20.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 110.038 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.701 HG23 ' CD2' ' A' ' 114' ' ' LEU . 64.4 mt -110.66 109.2 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 110.72 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 112' ' ' SER . 42.1 t -115.47 151.03 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.748 0.785 . . . . 0.0 109.595 179.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -88.05 168.38 12.87 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.642 -0.662 . . . . 0.0 110.867 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.703 HG22 ' CD1' ' A' ' 113' ' ' ILE . 7.7 p -124.21 167.81 14.56 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.507 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 45.5 Cg_endo -71.11 -6.0 18.25 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.784 1.412 . . . . 0.0 110.258 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.48 -17.84 25.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.381 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 121.25 -27.93 6.21 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -90.63 -169.73 43.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -134.49 162.85 31.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 110.743 -179.496 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.703 ' CD1' HG22 ' A' ' 107' ' ' THR . 5.2 mt -110.37 117.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.396 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.701 ' CD2' HG23 ' A' ' 104' ' ' ILE . 21.6 mt -87.76 129.18 35.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.913 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 104.76 9.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.823 HG23 ' CD1' ' A' ' 102' ' ' ILE . 4.1 mp -105.04 122.27 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.094 -1.004 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -105.95 120.95 43.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.473 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.423 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -114.93 139.02 50.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.236 -179.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER -132.55 142.2 49.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.242 179.788 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.564 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -121.21 133.07 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.044 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.55 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 59.9 m-70 -111.57 129.41 56.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.23 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.978 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -112.95 173.47 6.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.425 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HB2' ' CB ' ' A' ' 95' ' ' LEU . 3.4 tttt -136.47 -172.29 3.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.331 -0.856 . . . . 0.0 110.203 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . 43.9 -134.95 5.78 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.92 -0.82 12.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -1.126 . . . . 0.0 110.303 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 0.4 OUTLIER -78.6 -166.8 0.93 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.99 179.885 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.978 ' HA ' HG21 ' A' ' 122' ' ' THR . 38.6 mt-10 -153.43 179.47 8.76 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 109.299 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.554 HG21 ' CD2' ' A' ' 120' ' ' TYR . 1.8 p -79.97 137.38 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.572 -0.705 . . . . 0.0 110.542 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 126.71 31.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.973 ' HA ' HG12 ' A' ' 133' ' ' VAL . . . -65.92 -57.24 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.931 -1.106 . . . . 0.0 111.249 -178.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -40.95 -26.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.889 -1.132 . . . . 0.0 110.143 -179.273 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -84.68 -42.88 14.88 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.175 -0.953 . . . . 0.0 109.164 178.509 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.973 HG12 ' HA ' ' A' ' 130' ' ' ALA . 8.0 p -78.98 -33.77 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.339 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -70.56 -23.6 62.63 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.242 -0.911 . . . . 0.0 109.277 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -73.29 -20.9 60.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.829 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.7 t -71.94 -29.87 64.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 110.19 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -78.04 -47.15 19.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -45.95 -61.17 1.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -14.49 61.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -64.18 -54.41 30.25 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.562 ' HA ' ' CD2' ' A' ' 144' ' ' LEU . 1.4 tt0 -47.72 -36.95 12.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 100.0 m -66.8 -25.36 66.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.717 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 147' ' ' VAL . 36.6 mt -74.75 -52.24 12.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.632 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 141' ' ' GLU . 2.3 pp -66.79 -29.3 69.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.942 . . . . 0.0 109.657 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.429 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 11.0 tpt180 -78.0 -28.88 49.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -0.877 . . . . 0.0 109.511 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.754 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -68.83 -36.7 78.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.823 . . . . 0.0 109.732 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.444 HG21 ' CD1' ' A' ' 22' ' ' PHE . 40.2 t -73.09 -48.51 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.389 -0.82 . . . . 0.0 109.715 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 13' ' ' ILE . 5.6 tt0 -53.4 -49.67 66.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 152' ' ' LEU . 0.9 OUTLIER -60.45 -45.39 93.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.684 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.534 ' CE2' ' CE1' ' A' ' 154' ' ' HIS . 1.3 t80 -48.31 -72.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 110.035 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.19 -36.12 5.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 149' ' ' SER . 16.1 tp -62.74 -55.71 24.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.158 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -81.44 1.72 31.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.534 ' CE1' ' CE2' ' A' ' 150' ' ' TYR . 3.8 m-70 -104.45 98.62 8.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.282 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.47 80.57 1.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 110.062 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -72.23 -22.79 61.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 110.166 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.97 -173.58 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 110.305 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.542 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 75.9 t80 -99.4 5.67 46.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.375 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.291 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.562 HG22 ' HA ' ' A' ' 121' ' ' HIS . 2.7 t -79.59 152.96 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -1.125 . . . . 0.0 110.329 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -97.0 163.8 12.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.724 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -133.78 144.95 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 110.678 -179.662 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CG ' HG11 ' A' ' 133' ' ' VAL . 48.4 m-85 -154.85 56.44 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -0.771 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 2.2 pp20? -86.91 137.09 32.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 110.837 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 p -140.11 -175.66 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.674 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.28 152.16 25.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.056 -1.027 . . . . 0.0 110.589 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 10' ' ' THR . 1.5 m -135.35 -179.17 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 0.0 109.81 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 9' ' ' THR . 1.5 p -127.3 161.25 29.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.66 141.89 17.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.518 -0.739 . . . . 0.0 109.636 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.83 -12.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.32 -0.952 . . . . 0.0 108.559 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.811 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.3 mp -71.07 152.01 94.82 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.13 152.02 82.26 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.475 1.25 . . . . 0.0 110.886 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.798 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -76.86 -27.59 55.12 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.904 -178.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.22 -50.23 16.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 110.046 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -63.49 -43.15 98.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.785 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.73 -33.84 76.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.379 -0.825 . . . . 0.0 109.948 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.61 ' CD1' HD13 ' A' ' 23' ' ' ILE . 37.2 t80 -61.57 -64.89 0.8 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 12.0 mttt -48.13 -47.25 34.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.482 -0.761 . . . . 0.0 110.39 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.47 78.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.317 -0.864 . . . . 0.0 111.012 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -90.08 -10.1 45.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.105 -0.997 . . . . 0.0 110.65 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.61 HD13 ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -115.02 -60.19 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 109.932 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.692 HD11 ' HE1' ' A' ' 76' ' ' HIS . 15.1 mt -68.29 -48.97 63.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.111 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.71 20.7 18.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.033 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.42 -60.9 5.83 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.01 -24.66 10.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 0.0 110.218 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -84.67 -46.57 11.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.522 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.807 HD23 HG11 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -73.88 -28.22 61.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.478 -179.739 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.526 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m-30 -49.38 -57.47 11.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.456 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 45.6 Cg_endo -72.02 -7.61 21.36 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.987 1.52 . . . . 0.0 110.728 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -101.58 -54.43 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.344 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.807 HG11 HD23 ' A' ' 29' ' ' LEU . 5.5 m -80.31 -13.17 13.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 110.528 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.69 71.84 12.64 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.173 -0.954 . . . . 0.0 110.08 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.51 0.37 9.19 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.047 1.551 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.94 -20.08 19.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -102.18 -38.9 7.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.82 136.8 53.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.65 -47.17 6.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.248 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.84 140.06 3.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.29 125.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.88 . . . . 0.0 109.835 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 11.8 mt-10 -115.0 89.27 3.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 110.728 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 10.9 t-20 -54.17 116.76 2.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.449 HD11 ' HB2' ' A' ' 55' ' ' LYS . 20.3 mm -87.75 -38.2 11.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.271 1.034 . . . . 0.0 108.574 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 46' ' ' GLY . 24.4 tt0 -151.66 174.05 13.95 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.449 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . 63.79 159.92 0.3 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -106.19 29.62 6.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.399 -1.059 . . . . 0.0 110.192 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' A' ' 52' ' ' THR . . . 96.16 -0.46 62.13 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.3 -161.96 22.78 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 48.0 Cg_endo -73.54 120.52 6.52 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.981 1.516 . . . . 0.0 110.551 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.02 1.3 61.41 Favored Glycine 0 N--CA 1.48 1.606 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.672 ' HB ' HG21 ' A' ' 71' ' ' VAL . 1.2 m -67.21 152.93 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -1.191 . . . . 0.0 109.435 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' ILE . 8.6 mt -124.56 131.38 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.48 -179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CD ' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -143.89 134.76 25.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 179.471 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 2.2 ttpt -82.17 98.65 8.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.895 . . . . 0.0 110.429 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.7 mt -85.95 132.55 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.696 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 66' ' ' TYR . 0.5 OUTLIER -109.43 145.67 35.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 110.795 -179.423 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 5.9 m-85 -109.46 140.72 22.37 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 109.987 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.28 133.31 19.14 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.029 1.542 . . . . 0.0 110.756 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.35 158.16 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 110.449 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 114.71 81.27 0.97 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.666 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 41.92 -166.04 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 121.385 -1.067 . . . . 0.0 109.885 179.436 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.666 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 46.9 Cg_endo -83.21 -44.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.393 1.207 . . . . 0.0 110.069 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -89.72 136.22 33.16 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.891 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.548 ' CG ' ' HB2' ' A' ' 58' ' ' PHE . 4.2 tptp -171.14 -40.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.182 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.741 ' O ' HG13 ' A' ' 67' ' ' VAL . 3.4 p90 -54.22 177.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 66' ' ' TYR . 4.3 m -160.54 164.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 110.503 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -109.63 40.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 109.848 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 7.7 t70 -38.76 130.73 1.4 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.486 -0.759 . . . . 0.0 110.889 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.8 ttp-105 -103.96 151.42 23.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.077 179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.672 HG21 ' HB ' ' A' ' 52' ' ' THR . 2.6 t -78.44 147.71 6.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 10.3 m-20 -97.4 -72.38 0.65 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.452 0.644 . . . . 0.0 110.431 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.9 tt0 -138.52 136.62 36.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.578 -0.701 . . . . 0.0 110.129 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.8 t -125.07 125.35 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.919 . . . . 0.0 109.995 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -123.85 127.89 48.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 109.885 179.647 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.692 ' HE1' HD11 ' A' ' 24' ' ' LEU . 1.2 t60 -86.27 -20.02 29.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.353 -0.842 . . . . 0.0 111.075 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -106.19 -37.81 6.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.995 -1.066 . . . . 0.0 109.897 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -85.81 13.42 7.34 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.475 -0.766 . . . . 0.0 110.198 179.999 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 21.5 m-85 42.31 61.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 109.918 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -128.21 118.15 22.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 110.921 -179.329 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 52.7 t80 -133.83 98.03 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 72' ' ' ASP . 32.3 m-20 -112.76 142.84 44.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 110.289 -179.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 10.9 p90 -142.2 138.43 31.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.342 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 35.6 m -104.45 165.12 11.27 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.082 -1.011 . . . . 0.0 111.062 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 69' ' ' ASP . 47.2 t -108.42 127.36 64.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.63 -74.32 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 111.388 -178.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 2.3 mt-10 -82.8 97.87 8.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.828 -1.17 . . . . 0.0 110.227 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.575 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . -128.48 155.5 20.5 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.538 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -45.38 -56.68 6.13 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 43.8 Cg_endo -70.59 -41.44 3.22 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.866 1.456 . . . . 0.0 110.84 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 92' ' ' GLY . 77.4 mt -77.46 165.32 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.976 . . . . 0.0 110.196 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' N ' HG22 ' A' ' 91' ' ' ILE . . . -148.18 -52.56 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.31 -83.08 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -1.173 . . . . 0.0 110.373 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.9 t -143.06 11.15 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.466 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.22 151.04 22.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.262 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.525 ' CA ' ' O ' ' A' ' 121' ' ' HIS . 7.7 tt0 55.83 35.07 24.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.764 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 6.2 tttt -75.44 158.3 32.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.39 -0.819 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.2 mt -135.71 131.1 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -0.99 . . . . 0.0 110.662 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 m -116.18 109.95 18.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.376 -0.827 . . . . 0.0 109.527 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.601 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 3.0 m120 -99.56 138.41 36.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -128.94 131.62 47.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.822 179.593 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.657 ' CD1' HG23 ' A' ' 116' ' ' ILE . 40.3 mm -122.15 119.15 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 110.269 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 32.9 mttt -122.11 109.26 14.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.744 HG23 HD23 ' A' ' 114' ' ' LEU . 1.9 mp -94.92 137.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.2 132.31 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.309 -0.87 . . . . 0.0 110.248 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -88.06 145.39 25.99 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.418 0.627 . . . . 0.0 110.969 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.583 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 2.6 p -80.1 -163.5 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 107' ' ' THR . 45.9 Cg_endo -78.45 -23.53 8.51 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.106 1.056 . . . . 0.0 111.024 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 0.4 OUTLIER 174.42 33.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.016 -1.052 . . . . 0.0 110.156 179.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.62 35.41 2.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 107' ' ' THR . . . 94.97 -153.86 20.99 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.798 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -137.26 169.05 18.43 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.666 -0.902 . . . . 0.0 110.444 -179.414 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 10' ' ' THR . 23.0 mt -123.63 133.96 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 0.0 109.423 179.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.744 HD23 HG23 ' A' ' 104' ' ' ILE . 25.5 mt -97.9 142.37 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.145 -0.972 . . . . 0.0 110.81 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -127.86 97.16 4.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.316 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.657 HG23 ' CD1' ' A' ' 102' ' ' ILE . 3.0 mt -94.34 115.98 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.732 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.539 ' HA ' ' CB ' ' A' ' 6' ' ' GLU . 38.4 t -104.58 108.3 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.464 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 4.3 t-20 -101.36 149.52 23.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.226 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 141.04 38.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.013 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.594 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -117.72 122.16 42.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.814 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.562 ' HA ' HG22 ' A' ' 2' ' ' VAL . 25.2 m-70 -105.23 110.14 22.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.99 167.95 14.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.523 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -102.31 152.75 20.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.115 179.842 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 123' ' ' LYS . . . -42.04 -40.12 3.18 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.73 -66.98 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -1.16 . . . . 0.0 110.176 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.49 ' C ' ' CG ' ' A' ' 127' ' ' GLU . 10.9 m170 -69.24 169.95 11.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.49 ' CG ' ' C ' ' A' ' 126' ' ' HIS . 0.2 OUTLIER -159.98 137.9 9.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 109.581 179.857 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.5 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.3 p -108.27 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.396 -0.815 . . . . 0.0 111.062 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.1 142.1 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.953 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.472 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -52.59 -26.86 14.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.093 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 130' ' ' ALA . 2.5 mm-40 -42.39 -58.33 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.716 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -59.85 -34.08 72.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 108.978 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.565 HG11 ' CG ' ' A' ' 5' ' ' TYR . 15.7 t -67.11 -49.7 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.447 -0.783 . . . . 0.0 109.259 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.5 ' HE2' ' NZ ' ' A' ' 137' ' ' LYS . 2.3 mmtt -50.74 -35.36 31.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.712 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -23.85 60.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.6 t -70.9 -37.47 72.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.117 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.5 ' NZ ' ' HE2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -75.77 -31.2 59.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 109.91 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -56.62 -47.25 80.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.322 -0.861 . . . . 0.0 110.061 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 37' ' ' ALA . 3.2 mm? -76.88 -45.06 29.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.855 . . . . 0.0 110.311 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.55 -47.24 52.22 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.607 ' HA ' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -56.67 -30.46 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.153 -1.204 . . . . 0.0 110.425 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.4 m -70.73 -28.81 65.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.091 . . . . 0.0 109.653 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.4 mt -71.81 -48.69 44.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 109.867 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 144' ' ' LEU . 1.1 pp -63.55 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.421 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -75.05 -35.19 61.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 109.661 179.502 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 150' ' ' TYR . . . -68.59 -29.22 67.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.56 -47.01 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.875 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -59.37 -46.8 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -62.26 -43.45 98.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 110.148 179.813 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -54.43 -71.82 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 110.389 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 13' ' ' ILE . 34.0 mt -39.65 -49.91 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.468 -0.77 . . . . 0.0 110.592 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.65 -61.63 2.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.274 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -55.51 -37.58 68.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.78 92.03 3.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.396 -0.815 . . . . 0.0 109.942 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.7 t -96.52 -21.64 17.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 110.645 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -106.1 20.16 19.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.99 . . . . 0.0 110.458 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.31 -170.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.168 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 0.1 OUTLIER -168.04 72.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 110.059 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 158' ' ' TYR . 35.6 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t -109.22 154.87 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.355 -1.085 . . . . 0.0 110.091 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 0.7 OUTLIER -99.36 171.12 8.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 109.26 179.271 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.05 141.28 16.44 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.969 -1.082 . . . . 0.0 110.825 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.85 ' CD2' HG11 ' A' ' 133' ' ' VAL . 8.3 m-85 -159.38 59.17 0.4 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.538 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.483 ' CB ' ' HA ' ' A' ' 117' ' ' SER . 11.2 pt-20 -81.85 152.67 26.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.428 -0.795 . . . . 0.0 110.662 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.71 -175.92 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 109.91 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.69 157.73 30.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.081 -1.012 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.497 HG21 HD22 ' A' ' 144' ' ' LEU . 1.1 t -146.51 -179.1 6.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.102 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -116.81 160.82 20.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.254 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.07 137.03 11.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.397 -0.814 . . . . 0.0 109.821 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.85 -12.97 13.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.673 HG23 ' HD2' ' A' ' 14' ' ' PRO . 35.3 mm -68.6 148.49 98.08 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.673 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.1 Cg_endo -66.51 150.43 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.38 1.2 . . . . 0.0 110.752 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.746 ' HB2' ' HB3' ' A' ' 112' ' ' SER . . . -74.95 -25.62 59.01 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.29 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.39 -52.3 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 110.356 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . 8.4 ttt-85 -63.45 -38.38 90.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.868 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.899 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.0 tm? -68.89 -34.35 75.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.967 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 79' ' ' PHE . 45.9 t80 -64.11 -68.46 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.303 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.485 ' HG2' ' CB ' ' A' ' 24' ' ' LEU . 8.7 tttt -45.84 -51.26 13.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.844 . . . . 0.0 110.002 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 29' ' ' LEU . . . -59.0 -38.77 79.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 110.054 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 15.1 t80 -84.72 -13.07 52.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.416 -0.803 . . . . 0.0 110.018 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.75 HD12 ' CD2' ' A' ' 81' ' ' TYR . 9.9 mm -118.9 -76.55 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.258 -0.901 . . . . 0.0 110.056 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' CB ' ' HG2' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -46.47 -56.3 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.033 179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.816 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -93.92 1.05 56.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 27' ' ' ASP . . . -46.91 -53.22 10.6 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 26' ' ' GLY . 3.3 p-10 -42.88 -29.94 0.36 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.271 -1.134 . . . . 0.0 110.033 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 19.3 t30 -113.54 -11.36 13.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 110.003 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -83.63 -18.48 38.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.742 ' CD2' HD13 ' A' ' 38' ' ' ILE . 2.2 m-30 -75.43 -59.51 1.26 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.362 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.8 Cg_endo -71.19 -3.57 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.905 1.476 . . . . 0.0 110.492 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -91.97 -66.26 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.204 179.967 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 29' ' ' LEU . 6.2 m -85.93 -11.13 11.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.426 -0.797 . . . . 0.0 110.312 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -143.05 61.39 10.35 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.932 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.23 -5.93 18.02 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.091 1.574 . . . . 0.0 110.584 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.72 -25.58 38.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.42 -55.99 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 110.311 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 30' ' ' PHE . 0.8 OUTLIER -100.57 137.97 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.906 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.479 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -103.24 -33.33 9.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 57' ' ' SER . 0.1 OUTLIER -160.1 149.24 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.0 110.796 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.528 HG12 ' HE2' ' A' ' 54' ' ' LYS . 6.3 t -128.08 136.2 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 0.0 109.337 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' ' CA ' ' A' ' 54' ' ' LYS . 29.0 mt-10 -139.86 153.11 46.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.039 -1.038 . . . . 0.0 111.151 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.5 113.12 26.5 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.806 0.812 . . . . 0.0 109.636 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' HB2' ' A' ' 55' ' ' LYS . 19.2 mm -82.97 -39.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 122.185 0.993 . . . . 0.0 108.989 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 52' ' ' THR . 7.9 tp10 -153.58 173.04 16.28 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.691 0.758 . . . . 0.0 110.464 -179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . 71.81 171.0 14.14 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -109.74 35.71 3.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.377 -1.072 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.555 ' H ' HG21 ' A' ' 52' ' ' THR . . . 83.25 6.57 87.79 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.85 -159.44 35.03 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' A' ' 73' ' ' GLU . 47.0 Cg_endo -72.61 131.05 16.76 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.12 1.59 . . . . 0.0 110.476 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.49 -9.46 76.97 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 45' ' ' GLU . 22.2 m -60.85 153.62 24.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.068 -1.254 . . . . 0.0 109.496 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 45' ' ' GLU . 6.8 mt -116.25 125.62 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HE2' HG12 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -135.47 146.67 48.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 110.265 -179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.735 ' HB2' HD11 ' A' ' 44' ' ' ILE . 30.5 ttpt -97.61 132.98 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.33 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -111.48 144.18 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' HB2' ' OG ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -114.56 141.24 48.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.124 -0.985 . . . . 0.0 110.221 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -121.18 133.4 24.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 48.7 Cg_endo -75.31 144.09 28.87 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.99 1.521 . . . . 0.0 110.487 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 50.01 -166.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.108 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' PHE . . . 88.79 78.91 1.3 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 43.11 -167.94 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.375 -1.073 . . . . 0.0 109.873 179.368 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.64 ' HD2' ' CD2' ' A' ' 62' ' ' PHE . 45.6 Cg_endo -75.62 -41.13 0.61 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.264 1.139 . . . . 0.0 110.278 -179.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.1 m-85 -89.53 129.16 36.05 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 109.634 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' HE3' ' O ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -152.04 -46.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 110.13 -179.812 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -65.38 140.64 58.67 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 110.029 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.574 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.2 m -144.11 172.36 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.334 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.32 139.2 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.876 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 84' ' ' SER . 5.0 p-10 -133.2 133.47 42.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 110.235 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.0 ttm180 -96.26 146.42 24.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.701 HG21 ' HB ' ' A' ' 52' ' ' THR . 3.4 t -73.94 145.12 11.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.836 -1.165 . . . . 0.0 110.404 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 6.9 t70 -94.07 -70.61 0.7 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.466 0.65 . . . . 0.0 109.915 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 2.8 mt-10 -148.91 124.3 10.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.363 -0.836 . . . . 0.0 109.801 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 3.3 t -112.85 149.28 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.19 -0.944 . . . . 0.0 110.445 -179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 3.8 t0 -149.09 97.74 2.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -64.4 -7.92 11.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.201 -0.937 . . . . 0.0 110.895 -179.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -108.28 -46.22 3.76 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.016 -1.052 . . . . 0.0 109.765 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.36 13.54 4.29 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.735 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 21.7 m-30 47.42 50.87 14.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.059 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 6.3 tttt -123.77 117.28 24.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.993 -1.067 . . . . 0.0 110.779 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.75 ' CD2' HD12 ' A' ' 23' ' ' ILE . 17.3 t80 -134.44 103.75 5.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.344 -0.848 . . . . 0.0 109.779 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 72' ' ' ASP . 31.2 m-20 -118.14 144.42 45.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 110.222 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 83' ' ' TYR . 26.5 p90 -144.63 136.24 25.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' ARG . 74.5 m -96.77 171.09 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 111.209 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.515 HG11 HD13 ' A' ' 98' ' ' ILE . 41.6 t -108.95 125.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.75 -70.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.021 -1.049 . . . . 0.0 111.648 -178.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.16 98.82 11.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.543 -1.348 . . . . 0.0 110.375 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.574 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -116.55 151.71 18.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.519 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -43.98 -57.69 4.65 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 89' ' ' GLY . 47.8 Cg_endo -74.0 -47.68 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.976 1.514 . . . . 0.0 110.953 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.28 157.75 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.004 . . . . 0.0 110.085 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.97 -71.54 0.19 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -111.38 -58.39 2.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.125 -1.221 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.6 t -152.21 15.65 0.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.962 . . . . 0.0 110.538 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 123' ' ' LYS . 16.9 mt -91.28 147.86 22.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HG3' HG22 ' A' ' 122' ' ' THR . 4.9 mt-10 59.3 31.5 21.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 121' ' ' HIS . 4.6 mttt -70.55 151.36 45.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' A' ' 120' ' ' TYR . 4.5 mp -127.54 134.37 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.647 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.29 106.21 13.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.34 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -95.12 150.14 20.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.73 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 117' ' ' SER . 3.2 mp0 -143.18 142.06 31.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.772 . . . . 0.0 109.706 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 101' ' ' GLU . 61.6 mt -138.6 119.03 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 110.567 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 56.6 tttt -118.15 121.87 41.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.58 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 44.8 mt -108.84 118.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.368 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.3 t -122.9 152.6 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.402 -0.811 . . . . 0.0 109.774 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -87.98 166.35 14.55 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.633 -0.667 . . . . 0.0 111.121 -179.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.765 HG23 ' HA ' ' A' ' 112' ' ' SER . 16.5 p -116.53 167.18 10.99 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.369 -0.832 . . . . 0.0 109.73 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 45.0 Cg_endo -71.59 -2.08 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.641 1.337 . . . . 0.0 110.612 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.37 -10.27 19.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 110.317 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.03 -35.64 3.85 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -77.22 -166.99 27.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.765 ' HA ' HG23 ' A' ' 107' ' ' THR . 0.2 OUTLIER -141.17 163.65 32.38 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -1.069 . . . . 0.0 110.596 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.502 HG13 HG22 ' A' ' 107' ' ' THR . 78.9 mt -112.31 124.41 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.782 . . . . 0.0 109.166 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 130.64 42.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.982 . . . . 0.0 110.827 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -121.23 114.87 22.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.363 -0.836 . . . . 0.0 109.544 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -105.62 128.33 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -111.55 110.36 20.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 110.03 179.761 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.74 135.89 45.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.171 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.37 137.35 45.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 110.212 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.613 ' CE1' HG12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -112.33 144.73 41.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.872 . . . . 0.0 110.036 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 97' ' ' LYS . 31.8 m-70 -127.15 106.36 9.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 110.233 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -121.63 166.59 14.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -86.93 153.12 21.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.977 . . . . 0.0 110.61 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -47.75 -25.36 3.44 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.17 -50.83 6.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -1.196 . . . . 0.0 110.125 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -78.69 176.66 9.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.147 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -160.08 160.38 33.02 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 120' ' ' TYR . 2.4 p -113.92 93.48 2.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.811 -0.555 . . . . 0.0 110.627 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.98 146.66 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.043 . . . . 0.0 109.799 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.467 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . . . -62.48 -12.71 23.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -48.14 -69.94 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.973 -1.079 . . . . 0.0 109.861 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 136' ' ' SER . 0.8 OUTLIER -54.8 -27.49 42.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.516 179.598 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.85 HG11 ' CD2' ' A' ' 5' ' ' TYR . 16.1 t -71.07 -47.28 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 134' ' ' LYS . 22.8 ttpt -67.76 -31.8 71.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.089 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 139' ' ' LEU . . . -73.7 -39.04 64.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.786 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -67.23 -27.36 67.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -73.07 -42.15 63.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.91 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -63.8 -44.36 93.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.84 . . . . 0.0 109.889 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -71.3 -33.16 69.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.754 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 143' ' ' LEU . . . -55.36 -55.5 28.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.1 tm-20 -54.86 -44.96 74.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -1.154 . . . . 0.0 109.923 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 m -57.4 -32.77 67.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.831 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.678 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.9 mt -69.93 -53.4 18.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.022 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 144' ' ' LEU . 4.6 pp -72.03 -22.33 61.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.159 -0.963 . . . . 0.0 109.474 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.711 ' N ' HD12 ' A' ' 144' ' ' LEU . 30.8 ttt180 -83.14 -31.42 27.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 109.739 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.04 70.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.385 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 143' ' ' LEU . 25.2 t -69.81 -44.3 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.473 -0.767 . . . . 0.0 109.738 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.475 ' HA ' HG13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -62.51 -47.98 81.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.618 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.425 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -68.97 -16.48 63.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 110.074 179.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.07 -34.19 26.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 13' ' ' ILE . 10.8 mt -73.87 -56.19 5.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 110.171 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.47 -30.39 12.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.39 -8.72 55.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 0.0 110.437 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -105.22 92.07 4.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.124 -0.985 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.9 p -138.24 29.66 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.284 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -109.34 -31.33 7.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.9 . . . . 0.0 109.932 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 47.64 -163.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.376 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -78.43 -17.6 56.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.282 -0.886 . . . . 0.0 110.286 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.292 -179.975 . . . . . . . . 0 0 . 1 stop_ save_